data_2ase_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ase _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 3' ' ' THR . 90.5 mt-30 . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.894 0.378 . . . . 99.989999999999995 110.819 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 52' ' ' THR . 1.8 t -39.93 142.19 0.37 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.021 -0.536 . . . . 99.989999999999995 109.876 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.3 tp -128.57 149.68 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.623 -0.431 . . . . 99.989999999999995 110.953 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -95.93 141.09 29.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 99.989999999999995 111.019 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.524 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -134.76 147.49 50.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.75 -0.659 . . . . 99.989999999999995 109.825 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.421 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 28.4 m -131.9 147.28 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.304 -0.558 . . . . 99.989999999999995 111.14 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -109.0 124.45 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.158 0.504 . . . . 99.989999999999995 110.942 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -127.25 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.417 -0.81 . . . . 99.989999999999995 109.849 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.71 -164.36 11.44 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.576 -0.821 . . . . 99.989999999999995 111.611 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.7 t0 -78.62 126.53 30.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.802 0.334 . . . . 99.989999999999995 110.833 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.14 -88.62 0.01 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.423 -0.671 . . . . 99.989999999999995 111.423 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -136.6 127.7 27.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.78 0.324 . . . . 99.989999999999995 110.167 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.464 ' O ' ' C ' ' A' ' 15' ' ' GLY . 8.6 m -140.64 150.8 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 99.989999999999995 111.305 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.782 ' H ' ' HG1' ' A' ' 115' ' ' THR . . . 23.76 54.24 0.04 OUTLIER Glycine 0 N--CA 1.471 1.015 0 CA-C-N 115.708 -0.678 . . . . 99.989999999999995 112.888 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.5 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 85.1 mttt -35.12 -58.85 0.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.825 0.305 . . . . 99.989999999999995 111.825 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 20' ' ' LEU . 4.0 m -130.37 -55.94 1.09 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.4 0.518 . . . . 99.989999999999995 112.4 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 17' ' ' THR . 87.7 m -34.84 -28.58 0.01 OUTLIER 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.045 0.45 . . . . 99.989999999999995 111.049 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 17' ' ' THR . 4.2 tt -76.3 -43.39 41.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.057 -0.52 . . . . 99.989999999999995 111.432 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 17' ' ' THR . 96.0 mt -59.33 -35.96 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 99.989999999999995 111.089 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.638 ' C ' ' HG1' ' A' ' 24' ' ' THR . 12.8 pt -90.14 8.19 3.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.021 -0.536 . . . . 99.989999999999995 111.766 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.464 ' OG ' ' SG ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -39.85 -77.83 0.02 OUTLIER 'General case' 0 C--O 1.241 0.611 0 C-N-CA 119.885 -0.726 . . . . 99.989999999999995 110.504 -179.177 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.603 ' C ' ' H ' ' A' ' 25' ' ' THR . 14.9 p90 -39.93 -34.72 0.3 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 118.226 0.466 . . . . 99.989999999999995 111.499 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.638 ' HG1' ' C ' ' A' ' 21' ' ' ILE . 1.1 m -45.95 -14.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.936 -0.764 . . . . 99.989999999999995 108.936 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.603 ' H ' ' C ' ' A' ' 23' ' ' TYR . 55.7 m 50.53 37.31 15.68 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.546 -0.752 . . . . 99.989999999999995 109.705 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.498 ' O ' ' O ' ' A' ' 27' ' ' LYS . 91.7 m-20 -63.12 -40.37 97.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 99.989999999999995 111.168 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' ' O ' ' A' ' 26' ' ' ASN . 36.8 mttt 57.84 131.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.886 0.374 . . . . 99.989999999999995 110.457 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.606 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.8 mt -39.6 -55.84 3.24 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.156 -0.475 . . . . 99.989999999999995 111.984 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 28' ' ' LEU . 85.0 Cg_exo -38.64 -15.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.65 2.233 . . . . 99.989999999999995 113.048 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 28' ' ' LEU . 23.0 t -104.32 131.29 51.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.663 -0.415 . . . . 99.989999999999995 110.573 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.54 -29.36 68.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 99.989999999999995 111.104 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -53.91 122.04 9.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.75 0.31 . . . . 99.989999999999995 110.806 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.484 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 14.8 p -178.18 50.73 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.925 -0.579 . . . . 99.989999999999995 110.543 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 14.7 Cg_endo -59.68 131.42 40.0 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.626 2.217 . . . . 99.989999999999995 112.002 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 p -119.55 5.39 11.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 99.989999999999995 110.672 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.1 t -62.11 -40.59 88.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 99.989999999999995 110.808 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -109.79 132.94 53.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 111.204 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -84.67 124.02 31.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 99.989999999999995 109.796 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -99.37 144.99 27.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.046 0.45 . . . . 99.989999999999995 111.205 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.524 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 20.4 p90 -167.13 19.6 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.713 -0.676 . . . . 99.989999999999995 109.45 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.62 100.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.259 -0.882 . . . . 99.989999999999995 109.58 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 t -137.38 134.03 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 99.989999999999995 110.977 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 43' ' ' THR . 8.9 t -103.62 108.21 19.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 99.989999999999995 110.603 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -135.17 144.2 34.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 99.989999999999995 110.219 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.5 ptp -111.46 146.03 37.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 99.989999999999995 110.545 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 47' ' ' GLY . 39.1 mm -118.73 125.7 74.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 99.989999999999995 110.127 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 32.12 45.51 0.19 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.527 -0.629 . . . . 99.989999999999995 111.527 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.51 47.76 5.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.093 -0.575 . . . . 99.989999999999995 111.742 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 2.8 mt-10 -133.46 77.48 65.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.359 . . . . 99.989999999999995 110.108 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.29 106.85 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.965 2.443 . . . . 99.989999999999995 112.959 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.552 ' CE1' ' O ' ' A' ' 169' ' ' PHE . 30.7 p90 -155.84 166.27 34.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.564 -0.532 . . . . 99.989999999999995 109.564 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.486 ' O ' ' OG1' ' A' ' 3' ' ' THR . 1.0 OUTLIER -131.3 127.18 37.19 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.599 -0.44 . . . . 99.989999999999995 110.955 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.5 tp -119.35 127.79 53.49 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.491 -0.322 . . . . 99.989999999999995 111.019 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -93.1 144.17 16.9 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 109.733 -1.347 . . . . 99.989999999999995 109.733 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.524 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 64.9 mt -137.29 129.74 29.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.471 -0.491 . . . . 99.989999999999995 112.201 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -97.3 -164.27 1.13 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.736 -0.468 . . . . 99.989999999999995 109.736 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 58' ' ' THR . 49.1 p30 -162.33 -162.38 0.82 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.948 -0.301 . . . . 99.989999999999995 111.401 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.667 ' CG2' ' H ' ' A' ' 59' ' ' ALA . 4.4 t -8.25 -112.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.039 0.837 . . . . 99.989999999999995 112.803 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.667 ' H ' ' CG2' ' A' ' 58' ' ' THR . . . 39.81 83.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 99.989999999999995 110.42 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 N-CA-C 111.195 -0.762 . . . . 99.989999999999995 111.195 -179.77 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 121.017 0.437 . . . . 99.989999999999995 110.124 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -136.65 151.15 48.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 99.989999999999995 110.538 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -112.1 -19.61 12.23 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.671 -0.412 . . . . 99.989999999999995 110.924 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.7 t -122.24 120.43 61.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.486 -0.325 . . . . 99.989999999999995 110.144 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -87.53 122.18 30.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.128 0.489 . . . . 99.989999999999995 111.548 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.505 ' CD2' ' SG ' ' A' ' 6' ' ' CYS . 10.6 mp -111.73 114.2 27.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.512 -0.767 . . . . 99.989999999999995 110.002 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.4 m -98.59 129.23 49.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.224 -0.658 . . . . 99.989999999999995 109.224 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.451 ' HG ' ' CD1' ' A' ' 19' ' ' LEU . 6.8 t -129.86 135.86 48.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.499 0.666 . . . . 99.989999999999995 112.042 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -142.24 144.92 33.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.143 -0.935 . . . . 99.989999999999995 109.372 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.6 t -66.55 130.69 44.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.896 -0.779 . . . . 99.989999999999995 108.896 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.515 ' CG1' ' OG1' ' A' ' 138' ' ' THR . 10.7 t -63.64 4.24 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 113.368 0.877 . . . . 99.989999999999995 113.368 -177.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' SER . 14.7 p -129.99 144.1 39.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 118.557 0.617 . . . . 99.989999999999995 109.556 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.599 ' C ' ' H ' ' A' ' 88' ' ' SER . 0.7 OUTLIER 83.65 92.16 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.79 -0.448 . . . . 99.989999999999995 109.79 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -48.11 -0.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.648 2.232 . . . . 99.989999999999995 113.113 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.599 ' H ' ' C ' ' A' ' 86' ' ' SER . 19.9 m -66.19 -61.52 1.98 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.54 -0.464 . . . . 99.989999999999995 110.888 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.8 p -64.94 -35.02 79.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.191 -0.458 . . . . 99.989999999999995 111.525 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.01 -50.52 48.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.056 0.391 . . . . 99.989999999999995 112.056 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -64.12 -24.16 67.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.28 -0.418 . . . . 99.989999999999995 111.851 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 96' ' ' LYS . 14.0 m120 -86.99 -64.09 1.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.766 -0.374 . . . . 99.989999999999995 111.858 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.416 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 30.1 t -41.07 -61.92 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.611 0.597 . . . . 99.989999999999995 112.611 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 142' ' ' ALA . 43.5 mtpt -67.96 -21.26 65.1 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.913 0.708 . . . . 99.989999999999995 112.913 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 68.3 tt0 -106.11 -63.24 1.28 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.166 0.802 . . . . 99.989999999999995 113.166 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 92' ' ' ASN . 17.4 mttp -67.19 -35.95 80.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.298 1.221 . . . . 99.989999999999995 114.298 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 97' ' ' TRP . 29.7 m95 -84.82 -33.93 22.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.982 -0.687 . . . . 99.989999999999995 111.899 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.471 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -44.69 -54.34 13.01 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.704 -0.398 . . . . 99.989999999999995 111.267 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 16.6 Cg_endo -60.46 -36.49 86.28 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.568 1.512 . . . . 99.989999999999995 111.61 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.84 -40.51 97.66 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.357 -0.537 . . . . 99.989999999999995 110.096 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 83.7 mt -73.8 -38.52 50.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 99.989999999999995 110.869 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.8 p -61.42 -37.42 83.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 99.989999999999995 111.562 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -56.69 -36.99 70.25 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.911 -0.316 . . . . 99.989999999999995 111.22 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -55.19 -44.74 75.57 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.899 -0.32 . . . . 99.989999999999995 111.268 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.5 153.8 29.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.689 -0.404 . . . . 99.989999999999995 110.735 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -43.34 -76.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.293 1.995 . . . . 99.989999999999995 112.141 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -140.47 142.85 35.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 99.989999999999995 110.844 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.587 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -152.79 156.57 33.09 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 99.989999999999995 110.09 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.29 128.73 31.23 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.209 1.94 . . . . 99.989999999999995 110.91 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.727 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -124.0 123.5 40.51 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.46 -0.496 . . . . 99.989999999999995 111.72 -178.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 8.8 mp -97.68 129.86 44.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 110.44 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -96.76 129.32 44.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.333 -0.394 . . . . 99.989999999999995 110.561 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.489 ' CG1' ' N ' ' A' ' 114' ' ' GLY . 51.5 t -147.38 168.12 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 99.989999999999995 111.347 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.489 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -135.51 166.63 24.46 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.538 -1.025 . . . . 99.989999999999995 110.538 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.782 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 11.2 t -123.56 174.58 7.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.109 0.48 . . . . 99.989999999999995 112.017 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.56 ' O ' ' C ' ' A' ' 117' ' ' ILE . 33.1 mt-30 34.16 31.04 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.361 -0.836 . . . . 99.989999999999995 110.232 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.605 ' CG2' ' N ' ' A' ' 118' ' ' ASP . 7.7 tt 24.84 -138.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 O-C-N 123.944 0.777 . . . . 99.989999999999995 109.452 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.605 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 61.8 m-20 -84.87 71.93 10.83 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.348 -0.541 . . . . 99.989999999999995 109.573 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 120' ' ' ARG . 5.9 tt 66.1 91.42 0.08 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.596 -0.729 . . . . 99.989999999999995 110.631 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 119' ' ' LEU . 56.9 ttp180 . . . . . 0 N--CA 1.469 0.479 0 O-C-N 124.259 0.974 . . . . 99.989999999999995 111.181 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.149 0 N-CA-C 111.814 0.301 . . . . 99.989999999999995 111.814 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.515 ' OG1' ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -133.23 -65.29 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 112.241 0.46 . . . . 99.989999999999995 112.241 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.491 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.6 Cg_exo -20.54 -73.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 124.001 3.134 . . . . 99.989999999999995 113.983 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -114.82 -31.05 6.25 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.573 -0.451 . . . . 99.989999999999995 111.496 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 m -55.78 -42.61 75.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.451 -0.341 . . . . 99.989999999999995 111.305 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.513 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -69.55 -38.22 77.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.8 -0.36 . . . . 99.989999999999995 111.526 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.59 -35.27 79.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.561 -0.29 . . . . 99.989999999999995 111.316 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.97 -50.41 72.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.51 -0.314 . . . . 99.989999999999995 111.319 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.05 -33.04 74.85 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.849 -0.34 . . . . 99.989999999999995 111.684 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.502 ' N ' ' HZ1' ' A' ' 94' ' ' LYS . . . -69.78 -41.4 75.18 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.96 -0.756 . . . . 99.989999999999995 108.96 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 -62.43 -35.11 78.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.747 -1.115 . . . . 99.989999999999995 109.468 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -47.39 -30.83 3.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.739 -1.208 . . . . 99.989999999999995 107.739 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.1 mt -123.48 -117.67 0.29 Allowed 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.625 -1.25 . . . . 99.989999999999995 107.625 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 151' ' ' ALA . 76.9 tttt -177.46 69.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.905 -0.589 . . . . 99.989999999999995 111.219 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -53.13 -121.94 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.666 0.746 . . . . 99.989999999999995 111.093 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' A' ' 110' ' ' PHE . 71.6 t -155.02 -61.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.051 -0.977 . . . . 99.989999999999995 109.213 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.527 ' C ' ' CG ' ' A' ' 154' ' ' TYR . 18.5 mttp -101.76 -173.65 2.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.204 -0.453 . . . . 99.989999999999995 109.815 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -170.03 95.5 0.26 Allowed 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.386 -1.339 . . . . 99.989999999999995 107.386 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.609 ' CG2' ' H ' ' A' ' 156' ' ' GLU . 3.6 p -171.92 -167.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 114.799 -1.091 . . . . 99.989999999999995 109.399 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.609 ' H ' ' CG2' ' A' ' 155' ' ' VAL . 27.9 mp0 -130.66 -170.62 2.38 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.032 -0.986 . . . . 99.989999999999995 109.313 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.477 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -171.76 121.13 0.48 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.878 0.847 . . . . 99.989999999999995 109.508 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.64 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -173.88 92.74 0.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.237 -0.892 . . . . 99.989999999999995 109.097 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 31.34 31.25 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.774 -1.557 . . . . 99.989999999999995 109.578 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.64 ' N ' ' O ' ' A' ' 158' ' ' SER . 21.7 tp -164.76 -77.45 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.767 -1.106 . . . . 99.989999999999995 109.805 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.82 ' C ' ' H ' ' A' ' 163' ' ' LYS . 2.8 m -58.98 3.45 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.295 -0.562 . . . . 99.989999999999995 110.132 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.623 ' H ' ' C ' ' A' ' 160' ' ' LEU . 13.9 pt20 -64.8 30.38 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 107.954 -1.128 . . . . 99.989999999999995 107.954 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.82 ' H ' ' C ' ' A' ' 161' ' ' THR . 94.2 mttt -90.89 3.95 53.17 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.563 -1.643 . . . . 99.989999999999995 106.563 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -118.2 -70.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 107.685 -2.166 . . . . 99.989999999999995 107.685 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.435 ' CD1' ' SG ' ' A' ' 157' ' ' CYS . 7.3 mt -41.03 -14.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 120.667 -0.413 . . . . 99.989999999999995 110.899 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 164' ' ' GLY . 60.0 tttp -82.93 -50.58 8.43 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.928 -1.138 . . . . 99.989999999999995 107.928 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 164' ' ' GLY . 29.9 m120 -77.61 3.73 13.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.499 -1.228 . . . . 99.989999999999995 109.487 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 171' ' ' GLU . 33.2 t -84.04 -51.76 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 116.098 -0.501 . . . . 99.989999999999995 109.759 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.552 ' O ' ' CE1' ' A' ' 51' ' ' TYR . 6.7 m-85 -37.69 -42.36 0.56 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.288 -0.565 . . . . 99.989999999999995 109.808 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -67.52 -40.64 85.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.386 -0.37 . . . . 99.989999999999995 110.35 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 168' ' ' VAL . 76.7 mm-40 -67.03 -23.31 65.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.05 0.453 . . . . 99.989999999999995 109.951 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.5 85.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.623 . . . . 99.989999999999995 110.903 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 14.0 tt -60.58 -31.69 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.407 -0.517 . . . . 99.989999999999995 109.625 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.1 tp -65.7 -38.56 89.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 99.989999999999995 110.139 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.47 -33.8 76.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.868 -0.606 . . . . 99.989999999999995 110.833 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.14 -32.5 69.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.391 -0.368 . . . . 99.989999999999995 110.501 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.64 -36.01 69.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 99.989999999999995 110.386 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 99.989999999999995 110.641 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 3' ' ' THR . 91.6 mt-30 . . . . . 0 C--O 1.231 0.09 0 N-CA-C 110.135 -0.32 . . . . 99.989999999999995 110.135 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.715 ' CB ' ' HG1' ' A' ' 52' ' ' THR . 2.0 t -36.83 135.07 0.46 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.241 0.543 . . . . 99.989999999999995 110.737 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 tp -127.27 150.76 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.26 -0.882 . . . . 99.989999999999995 110.282 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -114.05 157.91 21.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.214 0.53 . . . . 99.989999999999995 111.623 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.23 153.35 47.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.424 -0.807 . . . . 99.989999999999995 109.388 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.48 133.09 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.539 -0.465 . . . . 99.989999999999995 112.027 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 10.5 p -50.02 120.86 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 115.789 -0.641 . . . . 99.989999999999995 111.166 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 81' ' ' CYS . 47.9 t -127.63 131.49 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.339 -0.615 . . . . 99.989999999999995 109.339 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.19 -169.91 37.56 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.591 -0.814 . . . . 99.989999999999995 111.314 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 92' ' ' ASN . 58.5 t0 -123.29 139.63 53.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.923 0.392 . . . . 99.989999999999995 110.677 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 63.42 -117.19 10.5 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.847 -0.901 . . . . 99.989999999999995 110.847 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.95 128.83 10.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.822 0.344 . . . . 99.989999999999995 110.421 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.524 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 24.2 m -136.53 164.33 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 99.989999999999995 110.552 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.483 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -74.65 80.76 0.89 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 120.945 -0.645 . . . . 99.989999999999995 112.118 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.564 ' H ' ' CD ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -81.46 -1.16 44.83 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.469 -0.43 . . . . 99.989999999999995 110.914 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.3 p -68.42 -53.32 24.47 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.562 -0.455 . . . . 99.989999999999995 111.107 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.586 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 93.2 m -69.25 -22.42 63.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.69 0.757 . . . . 99.989999999999995 109.811 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.47 -56.06 16.67 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.103 -0.953 . . . . 99.989999999999995 110.626 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 22' ' ' SER . 14.3 tp -69.11 -34.09 74.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.596 -0.729 . . . . 99.989999999999995 111.027 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 tp -55.17 -10.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 110.818 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 97.3 p -42.21 -80.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.491 -0.484 . . . . 99.989999999999995 111.076 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.539 ' N ' ' OG ' ' A' ' 22' ' ' SER . 79.7 t80 -62.08 -33.37 74.3 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.352 -0.539 . . . . 99.989999999999995 111.482 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.7 m -47.86 -45.14 29.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.22 -0.445 . . . . 99.989999999999995 111.819 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -151.9 -12.53 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.322 -0.551 . . . . 99.989999999999995 111.804 -179.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 25' ' ' THR . 47.9 t30 53.98 119.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.73 0.3 . . . . 99.989999999999995 111.18 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 mttm 61.08 62.87 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.272 -0.422 . . . . 99.989999999999995 110.567 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -116.19 89.66 26.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 99.989999999999995 111.074 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.05 158.91 1.15 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.375 2.05 . . . . 99.989999999999995 111.691 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.2 m -55.13 141.89 33.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.99 0.424 . . . . 99.989999999999995 110.931 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.637 ' C ' ' H ' ' A' ' 33' ' ' VAL . 84.0 tt0 -178.56 88.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.624 -0.716 . . . . 99.989999999999995 109.633 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' O ' ' C ' ' A' ' 33' ' ' VAL . 56.6 t80 64.77 -13.2 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 99.989999999999995 110.17 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.637 ' H ' ' C ' ' A' ' 31' ' ' GLU . 39.0 t 36.17 61.83 2.94 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 99.989999999999995 111.426 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.58 133.52 32.36 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.362 2.041 . . . . 99.989999999999995 111.562 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 p -128.63 163.11 25.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 99.989999999999995 111.029 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -118.98 132.36 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.539 . . . . 99.989999999999995 109.953 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.97 -3.3 24.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.847 -0.341 . . . . 99.989999999999995 111.124 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -60.82 -48.5 81.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.582 -0.447 . . . . 99.989999999999995 110.575 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -176.8 172.87 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 99.989999999999995 110.417 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 55' ' ' LEU . 82.8 m-85 -125.66 15.94 8.13 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.284 -0.636 . . . . 99.989999999999995 109.284 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.86 98.02 5.46 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.633 -0.712 . . . . 99.989999999999995 110.602 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.22 135.8 52.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.022 -0.99 . . . . 99.989999999999995 109.628 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 51' ' ' TYR . 2.1 t -107.83 138.87 43.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.173 0.511 . . . . 99.989999999999995 111.71 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.2 144.62 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.439 -0.801 . . . . 99.989999999999995 109.861 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.1 mtm -112.11 136.46 51.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.883 -0.327 . . . . 99.989999999999995 110.713 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.88 99.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.31 -0.405 . . . . 99.989999999999995 110.553 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.02 56.76 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.583 -0.607 . . . . 99.989999999999995 111.583 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.47 41.69 24.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.919 -0.872 . . . . 99.989999999999995 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.02 76.87 75.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 99.989999999999995 110.68 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.433 ' C ' ' CD2' ' A' ' 51' ' ' TYR . 82.1 Cg_endo -86.0 117.68 1.65 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.113 2.542 . . . . 99.989999999999995 112.563 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.492 ' O ' ' OG1' ' A' ' 43' ' ' THR . 97.8 m-85 -154.49 174.04 15.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 99.989999999999995 109.777 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.715 ' HG1' ' CB ' ' A' ' 3' ' ' THR . 0.7 OUTLIER -121.75 126.97 50.11 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.668 -0.413 . . . . 99.989999999999995 110.499 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.646 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -109.9 123.41 49.55 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.676 -0.409 . . . . 99.989999999999995 110.264 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.76 135.51 12.6 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.894 -1.282 . . . . 99.989999999999995 109.894 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.538 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 5.8 mp -142.58 108.89 5.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.013 -0.675 . . . . 99.989999999999995 112.091 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.416 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 75.3 m-85 -80.26 168.99 18.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.798 -0.816 . . . . 99.989999999999995 108.798 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 58' ' ' THR . 51.9 p30 -138.11 -179.4 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.256 -0.276 . . . . 99.989999999999995 110.256 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.551 ' O ' ' CB ' ' A' ' 59' ' ' ALA . 13.4 m 48.62 174.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 99.989999999999995 110.857 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . 87.06 124.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.616 . . . . 99.989999999999995 110.704 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 C-N-CA 120.958 -0.639 . . . . 99.989999999999995 111.578 -179.98 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.553 0.216 . . . . 99.989999999999995 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 t -133.99 157.36 46.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.693 0.282 . . . . 99.989999999999995 110.348 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.487 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 59.9 t0 -150.17 -10.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.615 -0.434 . . . . 99.989999999999995 111.396 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 t -119.03 106.22 19.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 120.509 -0.476 . . . . 99.989999999999995 111.285 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -81.16 129.96 34.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 99.989999999999995 111.013 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.4 tp -114.21 113.09 24.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.852 -0.613 . . . . 99.989999999999995 110.6 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.73 132.56 33.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.05 -0.352 . . . . 99.989999999999995 110.05 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' VAL . 49.4 t -132.81 116.71 16.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.094 0.473 . . . . 99.989999999999995 111.287 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.432 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 39.6 p90 -153.53 155.72 36.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 99.989999999999995 109.792 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 86' ' ' SER . 30.1 t -71.85 128.85 37.07 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.18 -0.608 . . . . 99.989999999999995 109.479 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.77 -2.17 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.503 0.557 . . . . 99.989999999999995 112.503 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 85' ' ' VAL . 7.2 p -127.75 30.98 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.554 -0.458 . . . . 99.989999999999995 110.461 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.493 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 5.2 p -122.51 82.94 47.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 99.989999999999995 110.472 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -51.44 -30.29 34.29 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.667 2.245 . . . . 99.989999999999995 112.286 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.477 ' O ' ' OD1' ' A' ' 92' ' ' ASN . 22.5 m -67.72 -47.65 68.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 99.989999999999995 110.444 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.493 ' OG ' ' OG ' ' A' ' 86' ' ' SER . 97.0 p -67.87 -35.22 78.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 110.151 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.46 -47.51 85.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.529 -0.759 . . . . 99.989999999999995 110.802 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -71.49 -18.52 62.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.776 -0.647 . . . . 99.989999999999995 111.609 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 88' ' ' SER . 11.3 m120 -93.17 -67.08 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.164 0.431 . . . . 99.989999999999995 112.164 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 89' ' ' SER . 31.0 m -45.23 -50.1 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.454 0.539 . . . . 99.989999999999995 112.454 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 59.5 mttm -70.71 -32.27 69.42 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.796 0.665 . . . . 99.989999999999995 112.796 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 83.5 tt0 -107.6 -60.92 1.64 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.28 0.844 . . . . 99.989999999999995 113.28 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 92' ' ' ASN . 75.4 mttt -63.44 -34.92 78.81 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.278 1.214 . . . . 99.989999999999995 114.278 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.419 ' CE3' ' OE1' ' A' ' 100' ' ' GLU . 49.8 m95 -86.26 -29.4 23.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.847 -0.741 . . . . 99.989999999999995 111.523 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.496 ' O ' ' OG1' ' A' ' 102' ' ' THR . 2.1 t -44.77 -53.98 14.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.332 -0.547 . . . . 99.989999999999995 110.853 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 29.1 Cg_endo -65.14 -33.13 51.04 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.615 1.543 . . . . 99.989999999999995 111.474 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.419 ' OE1' ' CE3' ' A' ' 97' ' ' TRP . 84.6 tt0 -59.76 -37.73 79.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.972 -0.558 . . . . 99.989999999999995 110.8 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.1 pt -94.91 -29.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.881 -0.328 . . . . 99.989999999999995 111.329 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 55.1 m -52.33 -40.72 62.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.853 -0.339 . . . . 99.989999999999995 110.62 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -53.78 -33.33 55.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 99.989999999999995 110.871 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -54.55 -43.56 72.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 99.989999999999995 111.119 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -152.3 152.88 30.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.848 -0.341 . . . . 99.989999999999995 110.769 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.69 -42.87 2.17 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.664 2.243 . . . . 99.989999999999995 112.651 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 13.3 tttm -138.34 130.19 28.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 99.989999999999995 111.084 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 t -165.66 147.45 6.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.053 -0.521 . . . . 99.989999999999995 110.262 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.39 135.57 58.43 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.187 1.925 . . . . 99.989999999999995 111.427 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.695 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -116.52 119.28 35.1 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.473 -0.491 . . . . 99.989999999999995 111.005 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -94.64 119.37 33.18 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.496 -0.482 . . . . 99.989999999999995 110.445 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.0 mt -90.94 130.19 36.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 99.989999999999995 109.592 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 114' ' ' GLY . 52.0 t -153.22 162.49 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.368 0.604 . . . . 99.989999999999995 112.122 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.555 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -137.08 170.37 23.55 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.612 -1.395 . . . . 99.989999999999995 109.612 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 9.8 t -136.06 167.03 22.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.343 0.572 . . . . 99.989999999999995 111.776 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.534 ' O ' ' O ' ' A' ' 117' ' ' ILE . 40.7 mt-30 55.6 25.76 8.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.995 -0.548 . . . . 99.989999999999995 109.881 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.692 ' N ' ' OG ' ' A' ' 158' ' ' SER . 6.3 tt 30.28 -151.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.867 -0.606 . . . . 99.989999999999995 110.304 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.569 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 52.9 p30 -122.86 29.76 6.69 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.649 -0.871 . . . . 99.989999999999995 108.649 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.619 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 7.7 tt -139.78 -43.02 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.736 -1.12 . . . . 99.989999999999995 110.242 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 25.7 mmt180 . . . . . 0 CA--C 1.516 -0.348 0 N-CA-C 108.355 -0.98 . . . . 99.989999999999995 108.355 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.447 ' C ' ' OG1' ' A' ' 141' ' ' THR . 7.7 tt . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.696 0.284 . . . . 99.989999999999995 111.019 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.503 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.99 -65.77 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.21 0.448 . . . . 99.989999999999995 112.21 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.503 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.2 Cg_exo -24.27 -68.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 123.7 2.933 . . . . 99.989999999999995 114.38 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -109.12 -35.13 6.39 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.653 -0.419 . . . . 99.989999999999995 112.102 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.447 ' OG1' ' C ' ' A' ' 137' ' ' ILE . 61.0 p -56.42 -38.2 71.24 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.966 -0.294 . . . . 99.989999999999995 111.344 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.3 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.745 0.307 . . . . 99.989999999999995 111.18 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.48 -37.52 81.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 99.989999999999995 112.007 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -59.88 -50.4 73.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 99.989999999999995 110.879 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 80.4 mt -58.87 -28.91 66.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.871 -0.604 . . . . 99.989999999999995 111.795 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.48 -38.74 87.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.533 -0.467 . . . . 99.989999999999995 110.058 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -58.47 -40.39 82.59 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.64 -0.709 . . . . 99.989999999999995 110.296 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -53.88 -29.59 42.3 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.532 -0.914 . . . . 99.989999999999995 108.532 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 146' ' ' ALA . 81.8 mt -137.76 -112.02 0.17 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.92 -1.036 . . . . 99.989999999999995 109.045 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.568 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 59.9 mttm -143.78 -136.87 0.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.816 -0.629 . . . . 99.989999999999995 111.094 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 153.89 -160.85 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 O-C-N 123.319 0.387 . . . . 99.989999999999995 110.229 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 88.2 t -155.88 -68.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.454 -0.573 . . . . 99.989999999999995 109.454 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -101.94 177.97 4.75 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.618 -0.512 . . . . 99.989999999999995 109.618 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.603 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 27.3 p90 -169.11 94.11 0.3 Allowed 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.435 -1.321 . . . . 99.989999999999995 107.435 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.468 ' CG2' ' C ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -170.72 -167.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.673 -1.149 . . . . 99.989999999999995 109.409 -177.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -126.37 -172.3 2.59 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.594 -1.185 . . . . 99.989999999999995 109.33 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.538 ' SG ' ' O ' ' A' ' 114' ' ' GLY . 1.2 p -171.71 117.2 0.4 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.547 -0.909 . . . . 99.989999999999995 108.547 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.692 ' OG ' ' N ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -173.14 93.75 0.11 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.216 -0.902 . . . . 99.989999999999995 108.974 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.626 ' H ' ' NE2' ' A' ' 162' ' ' GLN . . . 31.51 32.69 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.34 -1.755 . . . . 99.989999999999995 109.722 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.64 ' C ' ' H ' ' A' ' 162' ' ' GLN . 5.6 tt -165.98 -77.5 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 114.748 -1.115 . . . . 99.989999999999995 109.995 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.827 ' C ' ' H ' ' A' ' 163' ' ' LYS . 2.4 m -59.3 5.6 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.643 -0.423 . . . . 99.989999999999995 110.18 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.64 ' H ' ' C ' ' A' ' 160' ' ' LEU . 87.4 mt-30 -65.77 30.96 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.883 -1.154 . . . . 99.989999999999995 107.883 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.827 ' H ' ' C ' ' A' ' 161' ' ' THR . 99.5 mttt -90.57 5.43 47.89 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 106.921 -1.511 . . . . 99.989999999999995 106.921 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -128.41 -71.4 0.15 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 108.184 -1.966 . . . . 99.989999999999995 108.184 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 164' ' ' GLY . 3.9 mm? -37.45 -21.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.052 0.453 . . . . 99.989999999999995 110.341 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.634 ' N ' ' O ' ' A' ' 164' ' ' GLY . 16.7 tttm -78.98 -52.56 8.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.613 -0.884 . . . . 99.989999999999995 108.613 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 164' ' ' GLY . 14.7 t-20 -78.98 4.06 15.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.431 -1.259 . . . . 99.989999999999995 109.907 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 171' ' ' GLU . 2.9 t -76.57 -58.2 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 116.141 -0.482 . . . . 99.989999999999995 110.9 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.468 ' C ' ' O ' ' A' ' 168' ' ' VAL . 71.6 m-85 -35.48 -37.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.482 -0.487 . . . . 99.989999999999995 109.73 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 168' ' ' VAL . 76.4 m-20 -71.28 -45.16 63.79 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.996 -0.547 . . . . 99.989999999999995 110.622 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 168' ' ' VAL . 97.1 mt-10 -69.37 -27.47 65.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.206 -0.452 . . . . 99.989999999999995 110.988 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.3 -30.79 71.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.114 -0.494 . . . . 99.989999999999995 110.56 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.2 pp -66.08 -27.1 39.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.486 -0.561 . . . . 99.989999999999995 109.486 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.73 -37.38 78.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 99.989999999999995 109.526 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.01 -19.54 64.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.67 -0.696 . . . . 99.989999999999995 110.462 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.85 -35.76 75.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 99.989999999999995 110.27 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 62.0 mt -59.44 -33.47 71.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 99.989999999999995 110.19 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 99.989999999999995 110.426 -179.845 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 3' ' ' THR . 91.0 mt-30 . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.827 0.346 . . . . 99.989999999999995 110.574 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -40.5 114.93 0.5 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.446 -0.343 . . . . 99.989999999999995 110.388 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.7 tp -117.59 144.38 25.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.191 -0.458 . . . . 99.989999999999995 110.207 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -91.99 140.1 29.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 99.989999999999995 110.612 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -141.01 151.26 43.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.992 -0.549 . . . . 99.989999999999995 110.711 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.431 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 29.3 m -127.2 142.86 42.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.089 -0.505 . . . . 99.989999999999995 110.585 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.613 ' CG1' ' HG ' ' A' ' 81' ' ' CYS . 43.3 t -111.19 124.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.199 0.523 . . . . 99.989999999999995 110.895 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.6 m -133.42 161.51 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.39 -0.823 . . . . 99.989999999999995 109.938 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.684 ' N ' ' NZ ' ' A' ' 16' ' ' LYS . . . -172.75 -168.76 34.5 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.603 -0.808 . . . . 99.989999999999995 111.584 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.596 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 42.9 t0 -80.35 121.86 26.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 99.989999999999995 110.817 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.567 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . -45.72 98.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.038 -0.825 . . . . 99.989999999999995 111.038 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 151.34 20.58 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.663 0.273 . . . . 99.989999999999995 111.522 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.63 135.97 58.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.514 -0.474 . . . . 99.989999999999995 111.037 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.71 88.76 0.74 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.62 -0.592 . . . . 99.989999999999995 111.62 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.684 ' NZ ' ' N ' ' A' ' 10' ' ' GLY . 84.7 mttt -81.65 -0.21 41.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.664 0.269 . . . . 99.989999999999995 110.79 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.4 m -80.49 -70.29 0.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.463 -0.335 . . . . 99.989999999999995 111.163 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.0 m -50.91 -25.25 4.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.62 0.724 . . . . 99.989999999999995 109.345 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.61 ' CD2' ' SG ' ' A' ' 81' ' ' CYS . 62.4 tp -55.05 -55.0 35.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.595 -1.184 . . . . 99.989999999999995 111.375 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 22' ' ' SER . 82.1 mt -69.96 -32.66 71.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 99.989999999999995 110.813 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 93.2 mt -62.06 -1.8 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.825 -0.625 . . . . 99.989999999999995 110.966 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.699 ' HG ' ' N ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -56.35 -75.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.395 -0.522 . . . . 99.989999999999995 111.059 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.699 ' N ' ' HG ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -62.5 -28.64 69.98 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 119.921 -0.712 . . . . 99.989999999999995 111.165 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.651 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 2.6 m -54.46 -48.5 71.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.258 0.466 . . . . 99.989999999999995 112.258 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.8 p -131.52 -21.84 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.543 -0.463 . . . . 99.989999999999995 111.474 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 22' ' ' SER . 83.0 m-20 61.43 114.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 99.989999999999995 111.131 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' N ' ' NE2' ' A' ' 162' ' ' GLN . 75.0 mttt 61.92 59.21 1.76 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.037 -0.529 . . . . 99.989999999999995 111.093 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 tp -125.34 66.85 54.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.742 -0.383 . . . . 99.989999999999995 111.026 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.51 145.06 37.08 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.595 2.197 . . . . 99.989999999999995 111.877 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 32' ' ' TYR . 89.1 p -138.2 153.34 49.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.868 0.366 . . . . 99.989999999999995 110.759 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.48 -32.62 74.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 99.989999999999995 110.474 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.488 ' O ' ' OG ' ' A' ' 30' ' ' SER . 63.5 t80 -115.37 156.44 25.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 99.989999999999995 109.927 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 t -118.56 83.83 22.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.833 -0.347 . . . . 99.989999999999995 111.825 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -63.89 144.41 88.18 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.666 2.244 . . . . 99.989999999999995 111.508 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.0 p -123.97 156.9 35.57 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.771 -0.372 . . . . 99.989999999999995 110.946 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.16 131.34 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 99.989999999999995 110.461 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 78.1 t80 -97.42 -9.28 27.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 99.989999999999995 110.886 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.41 -70.96 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.889 -0.325 . . . . 99.989999999999995 111.111 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -173.8 174.06 3.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 99.989999999999995 110.669 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.0 23.83 2.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.506 -0.553 . . . . 99.989999999999995 109.506 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.51 98.62 10.22 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.637 -0.71 . . . . 99.989999999999995 110.446 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.486 ' O ' ' OG1' ' A' ' 52' ' ' THR . 15.6 m -115.55 158.16 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.063 -0.971 . . . . 99.989999999999995 110.219 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.6 t -123.22 140.92 52.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.015 0.436 . . . . 99.989999999999995 111.225 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 p -149.04 152.49 12.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.7 . . . . 99.989999999999995 110.968 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.7 mtm -101.3 123.35 45.26 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.128 -0.693 . . . . 99.989999999999995 109.128 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.1 tt -134.17 136.79 52.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.204 -0.599 . . . . 99.989999999999995 111.217 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.19 28.06 4.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.374 -0.69 . . . . 99.989999999999995 111.374 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.5 49.04 16.05 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.681 -0.968 . . . . 99.989999999999995 110.681 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -131.45 78.13 72.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.753 0.311 . . . . 99.989999999999995 110.329 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.598 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 20.6 Cg_exo -61.62 99.37 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.736 2.291 . . . . 99.989999999999995 112.143 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 83.5 m-85 -161.12 -179.38 7.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.015 -0.538 . . . . 99.989999999999995 110.508 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 4.8 t -144.43 144.15 31.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.648 -0.421 . . . . 99.989999999999995 110.37 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.1 mm? -111.64 127.32 55.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.618 -0.433 . . . . 99.989999999999995 110.526 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -83.1 122.67 5.83 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 109.241 -1.544 . . . . 99.989999999999995 109.241 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.419 ' CD2' ' SG ' ' A' ' 6' ' ' CYS . 86.5 mt -127.55 145.6 50.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.297 0.57 . . . . 99.989999999999995 112.254 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.488 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 39.7 t80 -119.55 -168.39 1.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.568 -1.271 . . . . 99.989999999999995 107.568 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 59' ' ' ALA . 52.0 p30 -174.11 -162.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.574 0.624 . . . . 99.989999999999995 110.327 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 60' ' ' GLY . 81.7 p 43.23 -93.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 99.989999999999995 110.7 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 43.6 17.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 99.989999999999995 110.717 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 58' ' ' THR . . . . . . . . 0 CA--C 1.528 0.87 0 N-CA-C 111.533 -0.627 . . . . 99.989999999999995 111.533 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.506 ' O ' ' C ' ' A' ' 75' ' ' THR . 95.7 mt-30 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.349 0.118 . . . . 99.989999999999995 110.924 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.506 ' C ' ' O ' ' A' ' 74' ' ' GLN . 2.1 t 23.19 61.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.603 0.564 . . . . 99.989999999999995 111.439 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.01 -39.22 93.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 99.989999999999995 110.957 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.88 104.11 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.404 -0.362 . . . . 99.989999999999995 110.54 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -78.92 125.15 28.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.162 0.506 . . . . 99.989999999999995 111.87 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.46 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 10.5 mp -112.59 128.43 56.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.53 -0.759 . . . . 99.989999999999995 109.974 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.0 m -109.88 136.84 44.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.541 -0.54 . . . . 99.989999999999995 109.541 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.613 ' HG ' ' CG1' ' A' ' 8' ' ' VAL . 1.3 m -112.36 127.23 55.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.075 0.464 . . . . 99.989999999999995 111.43 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 113' ' ' VAL . 48.7 p90 -149.73 115.75 5.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.66 -0.7 . . . . 99.989999999999995 110.419 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.483 ' O ' ' OG ' ' A' ' 89' ' ' SER . 35.5 t -58.59 139.78 55.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.089 -0.708 . . . . 99.989999999999995 109.089 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 84' ' ' VAL . 11.1 p -101.01 38.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 119.81 -0.756 . . . . 99.989999999999995 111.544 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 85' ' ' VAL . 1.9 p -129.3 -7.38 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.836 -0.346 . . . . 99.989999999999995 110.832 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.1 154.71 55.92 Favored Pre-proline 0 C--N 1.331 -0.218 0 C-N-CA 120.878 -0.329 . . . . 99.989999999999995 110.733 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.594 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 57.8 Cg_endo -73.04 -40.79 1.58 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.667 2.245 . . . . 99.989999999999995 112.758 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.4 p -82.86 -7.94 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.379 -0.373 . . . . 99.989999999999995 111.31 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 83' ' ' SER . 84.2 p -60.63 -41.1 94.2 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.772 -0.371 . . . . 99.989999999999995 111.177 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.594 ' CE1' ' O ' ' A' ' 87' ' ' PRO . 22.6 p90 -89.35 -41.25 12.24 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.89 -0.324 . . . . 99.989999999999995 111.181 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.2 tt0 -57.7 -32.81 67.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.365 -0.379 . . . . 99.989999999999995 111.116 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 90.5 m-20 -77.34 -39.38 47.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.724 -0.39 . . . . 99.989999999999995 111.326 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 t -84.8 -66.87 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 113.299 0.851 . . . . 99.989999999999995 113.299 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.43 -17.67 55.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.441 0.904 . . . . 99.989999999999995 113.441 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.528 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 95.3 mt-10 -125.72 -48.44 1.65 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.185 1.18 . . . . 99.989999999999995 114.185 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -78.53 -41.01 33.39 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.247 0.832 . . . . 99.989999999999995 113.247 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.606 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 57.6 m95 -92.61 -25.53 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.381 -0.928 . . . . 99.989999999999995 112.29 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.539 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -56.34 -45.37 99.93 Favored Pre-proline 0 CA--C 1.527 0.092 0 C-N-CA 119.951 -0.699 . . . . 99.989999999999995 110.118 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 25.7 Cg_exo -57.46 -43.92 47.03 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.119 1.88 . . . . 99.989999999999995 110.76 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -57.4 -42.52 82.4 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 119.714 -0.794 . . . . 99.989999999999995 109.555 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.7 mt -69.79 -36.34 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.986 -0.552 . . . . 99.989999999999995 109.908 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 105' ' ' CYS . 49.8 m -57.11 -31.68 65.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.486 -0.779 . . . . 99.989999999999995 111.178 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -46.85 -45.54 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.717 -0.393 . . . . 99.989999999999995 110.063 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -59.9 -33.47 71.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 99.989999999999995 109.953 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' THR . 5.1 t 70.79 58.9 0.46 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.773 -0.649 . . . . 99.989999999999995 110.847 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.49 120.44 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.731 2.287 . . . . 99.989999999999995 112.057 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.7 0.29 57.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.391 . . . . 99.989999999999995 110.437 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.436 ' H ' ' HG1' ' A' ' 108' ' ' THR . 0.6 OUTLIER -77.3 157.4 80.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.963 -0.562 . . . . 99.989999999999995 110.419 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -50.08 144.61 21.79 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.606 2.204 . . . . 99.989999999999995 111.662 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.734 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -118.8 119.18 33.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.193 0.521 . . . . 99.989999999999995 110.577 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 8.5 mp -97.63 130.89 44.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.992 -0.549 . . . . 99.989999999999995 111.38 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.3 mt -94.58 129.04 41.56 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.172 -0.677 . . . . 99.989999999999995 109.172 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.603 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 30.5 t -136.33 153.64 31.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.205 -0.452 . . . . 99.989999999999995 111.146 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.455 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -134.96 168.28 23.73 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.377 -0.689 . . . . 99.989999999999995 111.377 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 117' ' ' ILE . 3.4 p -124.81 177.44 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.167 0.508 . . . . 99.989999999999995 110.794 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.55 ' O ' ' C ' ' A' ' 117' ' ' ILE . 16.4 tt0 36.55 30.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.5 -0.773 . . . . 99.989999999999995 111.158 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 118' ' ' ASP . 6.0 tt 19.94 -138.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 O-C-N 123.602 0.564 . . . . 99.989999999999995 110.012 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.596 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 1.0 OUTLIER -93.27 55.5 2.3 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.626 -0.829 . . . . 99.989999999999995 109.846 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 120' ' ' ARG . 2.3 tt 85.93 77.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.479 -0.328 . . . . 99.989999999999995 110.824 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.54 ' C ' ' O ' ' A' ' 119' ' ' LEU . 45.2 mtm180 . . . . . 0 N--CA 1.47 0.551 0 O-C-N 123.944 0.778 . . . . 99.989999999999995 110.817 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.442 ' CG2' ' OG1' ' A' ' 141' ' ' THR . 73.3 mt . . . . . 0 C--O 1.231 0.107 0 N-CA-C 110.037 -0.357 . . . . 99.989999999999995 110.037 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.643 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -131.38 -39.66 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.08 0.77 . . . . 99.989999999999995 113.08 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.643 ' CD ' ' H ' ' A' ' 138' ' ' THR . 69.4 Cg_endo -88.93 -48.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.126 1.884 . . . . 99.989999999999995 114.591 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.412 ' CB ' ' HZ2' ' A' ' 144' ' ' LYS . 97.3 mt-10 -66.67 -52.74 41.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.355 0.872 . . . . 99.989999999999995 113.355 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.442 ' OG1' ' CG2' ' A' ' 137' ' ' ILE . 30.9 p -83.32 -10.74 58.31 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.821 1.045 . . . . 99.989999999999995 113.821 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -83.93 -63.07 1.41 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.339 -0.944 . . . . 99.989999999999995 111.365 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.15 -39.1 93.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.408 -0.36 . . . . 99.989999999999995 111.97 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.412 ' HZ2' ' CB ' ' A' ' 140' ' ' GLU . 26.6 mttt -66.34 -57.07 8.26 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.694 -0.402 . . . . 99.989999999999995 111.361 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.38 -33.8 71.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.502 -0.317 . . . . 99.989999999999995 111.322 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.53 -38.67 87.66 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.127 -0.694 . . . . 99.989999999999995 109.127 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -61.4 -40.58 94.89 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.235 -0.893 . . . . 99.989999999999995 110.065 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -51.95 -32.42 33.2 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.988 -1.115 . . . . 99.989999999999995 107.988 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 146' ' ' ALA . 75.6 mt -130.59 -116.61 0.23 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.602 -1.181 . . . . 99.989999999999995 108.178 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 53.2 mmtt -133.32 -145.32 0.24 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.622 -0.717 . . . . 99.989999999999995 111.041 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 151.41 -166.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.816 -0.629 . . . . 99.989999999999995 110.894 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 41.2 t -159.16 -66.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.843 -0.617 . . . . 99.989999999999995 110.68 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 2.5 tttm -105.58 -176.83 3.19 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.241 -0.436 . . . . 99.989999999999995 110.079 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 153' ' ' LYS . 13.8 m-85 -161.13 95.95 1.07 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.643 -1.614 . . . . 99.989999999999995 106.643 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.82 144.46 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-O 121.925 0.869 . . . . 99.989999999999995 111.956 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.658 ' O ' ' OG1' ' A' ' 161' ' ' THR . 8.3 mm-40 -126.75 98.57 5.42 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 105.907 -1.886 . . . . 99.989999999999995 105.907 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.425 ' SG ' ' N ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -113.95 144.21 43.45 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 123.127 1.441 . . . . 99.989999999999995 113.609 -175.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 160' ' ' LEU . 38.2 t -158.38 93.6 1.22 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 111.793 -2.458 . . . . 99.989999999999995 106.621 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 37.23 29.71 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.257 -1.338 . . . . 99.989999999999995 109.587 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.773 ' O ' ' N ' ' A' ' 162' ' ' GLN . 77.2 mt -145.32 -82.05 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.013 -0.994 . . . . 99.989999999999995 110.425 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.724 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -53.6 44.25 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.504 0.502 . . . . 99.989999999999995 112.341 -177.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.773 ' N ' ' O ' ' A' ' 160' ' ' LEU . 2.2 pt20 -75.72 14.72 0.6 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.86 -1.904 . . . . 99.989999999999995 105.86 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.724 ' H ' ' C ' ' A' ' 161' ' ' THR . 89.8 mttt -78.33 -4.91 50.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.822 -1.536 . . . . 99.989999999999995 107.434 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.7 -70.99 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 107.754 -2.139 . . . . 99.989999999999995 107.754 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -38.25 -19.1 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.733 -0.387 . . . . 99.989999999999995 111.447 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 164' ' ' GLY . 60.2 tttm -84.12 -48.33 9.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.342 -0.984 . . . . 99.989999999999995 108.342 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 164' ' ' GLY . 77.8 m-20 -78.53 6.53 8.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.685 -1.143 . . . . 99.989999999999995 109.029 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 169' ' ' PHE . 5.7 t -83.26 -60.09 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 115.652 -0.704 . . . . 99.989999999999995 110.196 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.689 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 57.8 m-85 -40.34 -47.8 2.58 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.033 -0.667 . . . . 99.989999999999995 110.355 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -67.13 -43.17 83.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 99.989999999999995 110.845 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.56 -27.04 66.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.033 -0.531 . . . . 99.989999999999995 111.325 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.68 -33.25 75.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.333 -0.394 . . . . 99.989999999999995 110.096 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.76 -37.81 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.954 -0.566 . . . . 99.989999999999995 109.578 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 174' ' ' LEU . 3.5 mm? -64.27 -31.92 73.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.743 -0.662 . . . . 99.989999999999995 110.049 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.2 -27.4 68.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.84 -0.618 . . . . 99.989999999999995 110.807 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.79 -32.6 74.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 99.989999999999995 110.206 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.81 -35.76 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.856 -0.611 . . . . 99.989999999999995 110.618 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.369 -0.378 . . . . 99.989999999999995 110.683 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 3' ' ' THR . 25.3 mt-30 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.861 0.363 . . . . 99.989999999999995 110.543 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -37.76 128.34 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 99.989999999999995 110.055 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.7 tt -122.2 135.73 61.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.664 . . . . 99.989999999999995 110.425 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -77.15 145.93 37.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.049 0.452 . . . . 99.989999999999995 111.517 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -139.65 136.73 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.674 -0.694 . . . . 99.989999999999995 110.033 179.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m -130.48 148.15 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.364 . . . . 99.989999999999995 111.485 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.554 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 47.1 t -115.95 120.78 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.263 0.554 . . . . 99.989999999999995 111.078 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.95 158.27 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.275 -0.875 . . . . 99.989999999999995 110.095 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.596 ' N ' ' HZ3' ' A' ' 16' ' ' LYS . . . -164.49 -174.65 34.49 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.974 -0.851 . . . . 99.989999999999995 110.974 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.609 ' H ' ' CG2' ' A' ' 93' ' ' VAL . 23.5 t70 -81.2 121.94 26.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.019 0.438 . . . . 99.989999999999995 110.588 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . 43.75 64.6 1.83 Allowed Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.248 -0.741 . . . . 99.989999999999995 111.248 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.524 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . -16.98 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.854 0.359 . . . . 99.989999999999995 111.948 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.422 ' CG1' ' OE1' ' A' ' 116' ' ' GLN . 99.5 t -66.32 -55.78 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.045 -0.525 . . . . 99.989999999999995 110.94 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.76 59.63 0.31 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.716 -0.755 . . . . 99.989999999999995 111.902 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HZ3' ' N ' ' A' ' 10' ' ' GLY . 17.8 mttt -77.25 -7.2 55.54 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.659 -0.318 . . . . 99.989999999999995 110.838 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.673 ' HG1' ' CG1' ' A' ' 33' ' ' VAL . 70.7 p -63.17 -44.69 94.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.595 -0.275 . . . . 99.989999999999995 111.582 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.5 m -84.64 -14.04 49.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.59 0.71 . . . . 99.989999999999995 110.167 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.498 ' CD2' ' SG ' ' A' ' 81' ' ' CYS . 14.0 tp -73.58 -42.99 60.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.031 -0.986 . . . . 99.989999999999995 110.847 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 tp -65.45 -39.14 91.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.409 -0.814 . . . . 99.989999999999995 112.429 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.622 ' C ' ' HG1' ' A' ' 24' ' ' THR . 10.5 pt -76.38 -3.51 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.633 0.605 . . . . 99.989999999999995 112.633 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 21' ' ' ILE . 2.0 m -42.14 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.394 -0.923 . . . . 99.989999999999995 110.768 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.607 ' C ' ' H ' ' A' ' 25' ' ' THR . 40.0 t80 -54.31 -39.94 67.46 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.029 0.377 . . . . 99.989999999999995 111.96 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.622 ' HG1' ' C ' ' A' ' 21' ' ' ILE . 23.0 p -49.57 -9.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.492 -0.483 . . . . 99.989999999999995 110.013 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.607 ' H ' ' C ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER 76.5 95.52 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.781 -0.645 . . . . 99.989999999999995 110.749 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -141.11 -69.56 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.912 -0.585 . . . . 99.989999999999995 110.4 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.705 ' H ' ' NE2' ' A' ' 162' ' ' GLN . 30.9 tttt 48.22 53.09 12.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.929 -0.397 . . . . 99.989999999999995 109.929 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mt -147.0 87.24 6.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 99.989999999999995 111.036 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.42 134.08 55.89 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.056 1.838 . . . . 99.989999999999995 111.378 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -125.02 145.08 50.07 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.762 -0.375 . . . . 99.989999999999995 110.872 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.37 -31.65 72.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 99.989999999999995 110.519 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -123.03 146.25 47.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.084 -0.507 . . . . 99.989999999999995 110.037 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.673 ' CG1' ' HG1' ' A' ' 17' ' ' THR . 15.9 m -119.79 88.13 39.2 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.975 -0.29 . . . . 99.989999999999995 111.31 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -53.77 148.06 38.38 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.639 2.226 . . . . 99.989999999999995 112.316 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.6 m -76.68 142.92 40.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 99.989999999999995 110.762 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.45 163.29 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 99.989999999999995 110.68 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -115.97 156.96 25.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 99.989999999999995 110.522 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 0.8 OUTLIER 51.73 -146.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 99.989999999999995 109.993 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 15.6 t-20 81.66 64.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 99.989999999999995 110.56 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.608 ' CD2' ' O ' ' A' ' 40' ' ' TYR . 26.6 p90 -157.0 38.53 0.31 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.064 -0.717 . . . . 99.989999999999995 109.064 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.14 98.35 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.008 -0.996 . . . . 99.989999999999995 109.612 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.507 ' O ' ' OG1' ' A' ' 52' ' ' THR . 18.5 t -135.66 130.45 49.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.736 -0.665 . . . . 99.989999999999995 110.318 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 t -94.54 133.94 37.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.26 -0.427 . . . . 99.989999999999995 110.685 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -135.25 142.86 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 99.989999999999995 110.608 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.3 mtm -113.15 130.27 56.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 99.989999999999995 110.298 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 48' ' ' GLY . 7.7 tp -131.96 136.2 57.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.507 -0.315 . . . . 99.989999999999995 110.636 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 31.14 35.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-N 116.129 -0.487 . . . . 99.989999999999995 111.889 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 79.63 65.37 1.78 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.902 -0.666 . . . . 99.989999999999995 111.572 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -151.26 88.09 4.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.154 -0.313 . . . . 99.989999999999995 110.154 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.59 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 42.7 Cg_endo -76.04 112.55 3.52 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.09 1.86 . . . . 99.989999999999995 112.575 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 95.9 m-85 -162.59 166.95 24.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.072 -0.714 . . . . 99.989999999999995 109.072 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 6.8 t -138.04 148.4 45.05 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.125 -0.63 . . . . 99.989999999999995 111.217 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.74 133.3 54.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.345 -0.389 . . . . 99.989999999999995 110.748 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -73.0 148.15 40.8 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.262 -1.135 . . . . 99.989999999999995 110.262 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.463 ' H ' ' CA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -132.52 119.11 20.11 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 120.09 -0.644 . . . . 99.989999999999995 112.33 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.554 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 17.2 t80 -107.9 -176.34 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.759 -0.83 . . . . 99.989999999999995 108.759 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 52.7 p30 -176.86 -165.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.371 . . . . 99.989999999999995 111.065 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 57' ' ' ASP . 31.5 p 36.59 -148.86 0.01 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.011 -0.54 . . . . 99.989999999999995 111.073 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 54.75 172.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 99.989999999999995 110.322 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.724 0 N-CA-C 111.196 -0.762 . . . . 99.989999999999995 111.196 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.466 0.174 . . . . 99.989999999999995 111.219 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.448 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 10.3 t -41.18 135.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.831 0.348 . . . . 99.989999999999995 110.685 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -91.95 -24.37 19.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 99.989999999999995 110.725 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 t -119.14 110.02 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 99.989999999999995 110.216 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.448 ' CE1' ' CG2' ' A' ' 75' ' ' THR . 96.8 m-85 -86.33 126.65 34.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.165 0.507 . . . . 99.989999999999995 112.006 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 7.3 mp -106.38 110.01 22.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.528 -0.76 . . . . 99.989999999999995 109.367 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 113' ' ' VAL . 39.0 t -74.53 129.0 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.944 -0.391 . . . . 99.989999999999995 109.944 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.498 ' SG ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -122.27 129.89 52.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.113 0.482 . . . . 99.989999999999995 112.003 -179.03 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 82' ' ' PHE . 4.0 p90 -166.42 125.75 1.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.294 -0.866 . . . . 99.989999999999995 109.36 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.502 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 84.2 p -52.89 146.36 10.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.81 -0.756 . . . . 99.989999999999995 109.319 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.58 4.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.194 -0.602 . . . . 99.989999999999995 112.493 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.576 ' O ' ' CB ' ' A' ' 86' ' ' SER . 80.3 t -127.79 148.86 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.73 -0.388 . . . . 99.989999999999995 110.25 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 88' ' ' SER . 1.9 t 93.24 96.24 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.244 0 O-C-N 123.643 0.589 . . . . 99.989999999999995 110.328 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.446 ' O ' ' CE2' ' A' ' 90' ' ' PHE . 61.9 Cg_exo -48.97 -2.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.67 2.247 . . . . 99.989999999999995 112.72 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.586 ' H ' ' C ' ' A' ' 86' ' ' SER . 2.2 t -97.48 -34.73 10.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.886 -0.326 . . . . 99.989999999999995 110.998 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -57.01 -40.74 77.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.37 -0.377 . . . . 99.989999999999995 111.702 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.461 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 2.4 p90 -82.29 -32.8 29.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 99.989999999999995 110.319 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.1 tt0 -54.3 -28.67 43.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.646 -0.707 . . . . 99.989999999999995 110.925 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' LYS . 72.1 m-20 -90.51 -64.79 1.08 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.299 -0.56 . . . . 99.989999999999995 110.578 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.609 ' CG2' ' H ' ' A' ' 11' ' ' ASP . 54.7 t -50.12 -60.59 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.012 -0.54 . . . . 99.989999999999995 112.35 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.479 ' CE ' ' CE1' ' A' ' 82' ' ' PHE . 26.6 mttt -71.57 -9.83 58.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.524 0.565 . . . . 99.989999999999995 112.524 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -126.32 -62.02 1.18 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.962 0.727 . . . . 99.989999999999995 112.962 -178.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 92' ' ' ASN . 20.0 tptm -64.77 -34.6 78.73 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.251 0.834 . . . . 99.989999999999995 113.251 -178.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.4 ' O ' ' C ' ' A' ' 98' ' ' VAL . 51.1 m95 -81.94 -34.95 29.57 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.917 -0.713 . . . . 99.989999999999995 110.681 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.452 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -39.21 -55.21 3.16 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.44 -0.346 . . . . 99.989999999999995 111.184 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 17.2 Cg_endo -60.0 -37.19 86.58 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 121.553 1.502 . . . . 99.989999999999995 111.175 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -61.75 -42.68 99.28 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.406 -0.518 . . . . 99.989999999999995 110.162 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.92 -39.68 67.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.122 -0.49 . . . . 99.989999999999995 110.793 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.418 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 44.1 p -62.71 -12.71 25.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.915 -0.584 . . . . 99.989999999999995 111.05 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -54.18 -41.59 68.73 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.871 -0.332 . . . . 99.989999999999995 110.173 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -87.85 -15.41 36.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 99.989999999999995 110.482 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 102' ' ' THR . 22.2 m 55.35 58.59 10.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 99.989999999999995 110.916 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -78.17 124.09 6.45 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.644 2.229 . . . . 99.989999999999995 112.01 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -92.27 2.97 56.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.406 . . . . 99.989999999999995 110.729 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.483 ' H ' ' HG1' ' A' ' 108' ' ' THR . 0.6 OUTLIER -72.35 155.18 91.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 99.989999999999995 110.88 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.33 149.11 57.58 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.96 2.44 . . . . 99.989999999999995 112.115 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.737 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -130.72 139.14 50.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.272 0.558 . . . . 99.989999999999995 110.521 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.43 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 7.0 mp -104.76 136.16 44.78 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.366 -0.533 . . . . 99.989999999999995 110.558 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 18.3 tp -88.11 128.43 35.43 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.15 -0.685 . . . . 99.989999999999995 109.15 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' VAL . 1.9 t -142.29 151.89 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 119.85 -0.74 . . . . 99.989999999999995 111.682 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.433 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -134.46 171.54 22.22 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.645 -0.982 . . . . 99.989999999999995 110.645 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.4 ' H ' ' HA ' ' A' ' 83' ' ' SER . 1.5 p -119.82 173.73 6.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.97 0.414 . . . . 99.989999999999995 110.461 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.604 ' O ' ' O ' ' A' ' 117' ' ' ILE . 33.8 mt-30 37.8 34.0 0.05 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 118.826 -0.607 . . . . 99.989999999999995 111.24 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.623 ' CG2' ' N ' ' A' ' 118' ' ' ASP . 2.5 tt 19.96 -143.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 123.595 0.559 . . . . 99.989999999999995 110.485 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.623 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 59.5 t0 -59.98 -2.92 0.47 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.723 -0.791 . . . . 99.989999999999995 110.726 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.596 ' N ' ' O ' ' A' ' 116' ' ' GLN . 59.2 tp 132.52 92.01 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.182 0.926 . . . . 99.989999999999995 110.105 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.522 ' C ' ' O ' ' A' ' 119' ' ' LEU . 41.7 ptt85 . . . . . 0 N--CA 1.471 0.604 0 O-C-N 124.201 0.938 . . . . 99.989999999999995 111.625 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.1 mm . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.913 0.387 . . . . 99.989999999999995 110.84 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.408 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.91 -53.89 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 99.989999999999995 111.57 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.408 ' CD ' ' H ' ' A' ' 138' ' ' THR . 66.1 Cg_endo -92.87 -36.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.559 2.173 . . . . 99.989999999999995 113.294 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.53 -70.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.637 0.606 . . . . 99.989999999999995 112.637 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.3 p -123.11 4.42 9.27 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.043 0.757 . . . . 99.989999999999995 113.043 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.45 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -79.84 -71.08 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.72 -0.792 . . . . 99.989999999999995 110.829 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.41 ' OE1' ' CD1' ' A' ' 154' ' ' TYR . 77.7 mm-40 -73.24 -31.46 64.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 99.989999999999995 111.191 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -56.97 -38.26 72.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 99.989999999999995 111.69 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.46 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 9.9 mp -86.06 -6.91 58.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.852 0.358 . . . . 99.989999999999995 110.99 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -91.17 -61.56 1.63 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.672 -0.411 . . . . 99.989999999999995 111.129 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -61.07 -37.8 83.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.971 -0.558 . . . . 99.989999999999995 112.192 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.67 -12.61 23.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.849 0.685 . . . . 99.989999999999995 112.849 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 0.6 OUTLIER -124.71 29.4 6.24 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.102 -0.639 . . . . 99.989999999999995 112.485 -178.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 49.0 mttp 95.01 143.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.375 0.67 . . . . 99.989999999999995 111.454 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 152.88 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.25 -0.886 . . . . 99.989999999999995 110.104 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' A' ' 110' ' ' PHE . 89.1 t -159.32 -59.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.912 -0.585 . . . . 99.989999999999995 110.232 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 12.3 mmtm -104.69 -170.94 1.83 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.495 -0.32 . . . . 99.989999999999995 110.605 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 153' ' ' LYS . 18.5 m-85 -153.67 96.4 2.0 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.75 -1.204 . . . . 99.989999999999995 107.75 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.2 m -134.79 98.49 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-O 121.36 0.6 . . . . 99.989999999999995 110.559 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.583 ' O ' ' OG1' ' A' ' 161' ' ' THR . 91.1 mt-10 -103.16 99.06 8.9 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 106.517 -1.66 . . . . 99.989999999999995 106.517 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.569 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -119.0 155.68 30.96 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 123.306 1.527 . . . . 99.989999999999995 114.362 -175.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' LEU . 47.0 t -164.07 94.73 0.75 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 111.341 -2.663 . . . . 99.989999999999995 106.858 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 39.54 26.58 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.303 -1.317 . . . . 99.989999999999995 109.647 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.737 ' O ' ' N ' ' A' ' 162' ' ' GLN . 76.0 mt -142.05 -81.17 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.284 -0.871 . . . . 99.989999999999995 110.169 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -57.19 45.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 O-C-N 123.36 0.412 . . . . 99.989999999999995 110.778 -178.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.737 ' N ' ' O ' ' A' ' 160' ' ' LEU . 77.2 mt-30 -85.73 14.67 5.53 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 105.268 -2.123 . . . . 99.989999999999995 105.268 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.626 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.8 mttt -88.95 1.75 54.96 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 112.613 -2.085 . . . . 99.989999999999995 107.115 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.61 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -129.74 -73.6 0.14 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 108.739 -1.744 . . . . 99.989999999999995 108.739 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 164' ' ' GLY . 12.4 mt -41.72 -17.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.48 -0.888 . . . . 99.989999999999995 111.017 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.61 ' N ' ' O ' ' A' ' 164' ' ' GLY . 22.3 tttp -83.06 -48.47 10.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.055 -1.091 . . . . 99.989999999999995 108.055 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' GLY . 21.2 m120 -75.1 2.38 10.85 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.541 -1.209 . . . . 99.989999999999995 109.225 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 169' ' ' PHE . 24.7 t -84.1 -53.72 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 115.826 -0.624 . . . . 99.989999999999995 110.628 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 168' ' ' VAL . 6.0 m-85 -37.31 -52.78 1.1 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.804 -0.635 . . . . 99.989999999999995 111.207 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 53.1 p-10 -65.8 -39.23 90.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.545 -0.462 . . . . 99.989999999999995 111.199 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.615 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 99.2 mt-10 -70.67 -22.05 62.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.767 0.318 . . . . 99.989999999999995 110.7 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.21 77.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.628 -0.508 . . . . 99.989999999999995 109.628 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.49 -37.45 70.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.835 -0.621 . . . . 99.989999999999995 109.333 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.6 tp -57.25 -34.51 68.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.579 -0.737 . . . . 99.989999999999995 109.541 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.51 -23.69 67.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.632 -0.713 . . . . 99.989999999999995 111.152 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.95 -30.96 72.0 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.722 -0.391 . . . . 99.989999999999995 110.328 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.39 -35.54 70.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 99.989999999999995 110.607 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 99.989999999999995 110.679 -179.816 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 3' ' ' THR . 89.7 mt-30 . . . . . 0 C--O 1.227 -0.107 0 CA-C-O 120.684 0.278 . . . . 99.989999999999995 110.264 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -39.39 140.77 0.42 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.939 -0.393 . . . . 99.989999999999995 109.939 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp -130.35 152.43 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.938 -0.574 . . . . 99.989999999999995 110.955 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -102.5 162.79 12.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.293 0.568 . . . . 99.989999999999995 111.567 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.53 157.2 46.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.146 -0.933 . . . . 99.989999999999995 109.329 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.5 t -122.16 134.81 64.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.711 -0.396 . . . . 99.989999999999995 111.54 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 9.3 p -50.05 125.73 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.963 -0.562 . . . . 99.989999999999995 110.223 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.04 133.44 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.681 -0.408 . . . . 99.989999999999995 110.424 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.544 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . 106.06 -67.99 0.24 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.178 -0.769 . . . . 99.989999999999995 111.178 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 60' ' ' GLY . 81.7 m-20 58.53 -82.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.581 0.229 . . . . 99.989999999999995 111.377 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 40.57 33.75 0.62 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.737 -0.945 . . . . 99.989999999999995 110.737 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 47.88 101.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.789 0.328 . . . . 99.989999999999995 110.564 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.678 ' CG2' ' H ' ' A' ' 15' ' ' GLY . 26.4 m -135.5 -111.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 99.989999999999995 111.057 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.678 ' H ' ' CG2' ' A' ' 14' ' ' VAL . . . -169.12 63.64 0.18 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.883 -0.887 . . . . 99.989999999999995 110.883 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -73.11 -2.9 23.28 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.088 -0.245 . . . . 99.989999999999995 111.215 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.8 p -61.43 -41.33 97.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.539 -0.3 . . . . 99.989999999999995 111.295 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.2 m -95.81 -7.57 36.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.054 0.454 . . . . 99.989999999999995 111.013 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.561 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 24.9 tp -66.7 -68.25 0.39 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.036 -0.529 . . . . 99.989999999999995 111.109 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.461 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 67.4 mt -65.66 -26.48 67.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.768 -0.651 . . . . 99.989999999999995 111.615 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 tt -58.86 -18.93 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.453 -0.499 . . . . 99.989999999999995 110.697 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.586 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -66.53 -75.95 0.09 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.384 -0.927 . . . . 99.989999999999995 111.397 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.688 ' CZ ' ' CZ ' ' A' ' 169' ' ' PHE . 1.9 p90 -41.24 -31.8 0.24 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 119.541 -0.864 . . . . 99.989999999999995 109.659 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.466 ' N ' ' CG ' ' A' ' 23' ' ' TYR . 2.5 m -57.12 -46.68 82.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.719 -0.673 . . . . 99.989999999999995 111.272 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.445 ' OG1' ' C ' ' A' ' 24' ' ' THR . 0.0 OUTLIER 175.99 -6.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.819 -0.352 . . . . 99.989999999999995 111.524 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 59.1 t-20 57.3 87.13 0.07 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.644 -0.422 . . . . 99.989999999999995 110.756 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -89.93 8.18 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 99.989999999999995 111.103 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 62.79 148.93 0.1 OUTLIER Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.535 -0.302 . . . . 99.989999999999995 110.288 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -42.04 143.18 1.32 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.247 1.965 . . . . 99.989999999999995 112.413 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.1 p -130.9 154.89 47.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 99.989999999999995 110.305 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' OE2' ' CE2' ' A' ' 32' ' ' TYR . 22.1 pt-20 -71.28 -15.65 62.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 99.989999999999995 110.854 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.422 ' CE2' ' OE2' ' A' ' 31' ' ' GLU . 69.3 m-85 -112.51 138.35 49.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 99.989999999999995 110.647 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.7 77.67 69.58 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 99.989999999999995 110.063 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.22 140.01 34.41 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.715 2.277 . . . . 99.989999999999995 112.334 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.7 p -116.6 25.68 10.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 99.989999999999995 110.271 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 m -124.05 160.49 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 99.989999999999995 110.628 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.449 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 80.9 t80 59.78 72.04 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 99.989999999999995 110.522 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -65.01 147.71 52.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 99.989999999999995 110.348 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.509 ' O ' ' O ' ' A' ' 55' ' ' LEU . 10.3 m120 -89.49 144.96 25.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 99.989999999999995 110.383 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.1 p90 -175.57 -4.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.376 . . . . 99.989999999999995 110.556 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.98 99.8 3.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.406 -0.361 . . . . 99.989999999999995 110.889 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.5 ' O ' ' OG1' ' A' ' 52' ' ' THR . 21.8 t -140.78 133.45 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 99.989999999999995 110.17 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.9 111.92 24.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.419 . . . . 99.989999999999995 110.825 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.7 t -137.43 145.83 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.919 -0.582 . . . . 99.989999999999995 111.154 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.657 ' N ' ' SD ' ' A' ' 45' ' ' MET . 2.3 mmt -97.08 132.93 42.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.668 -0.493 . . . . 99.989999999999995 109.668 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mt -120.66 127.0 75.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.74 -0.384 . . . . 99.989999999999995 111.141 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.73 31.12 5.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.218 -0.753 . . . . 99.989999999999995 111.218 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.05 52.13 6.48 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.898 -0.881 . . . . 99.989999999999995 110.898 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -138.75 79.07 29.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.047 -0.353 . . . . 99.989999999999995 110.047 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 36.1 Cg_exo -52.82 103.96 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.941 2.427 . . . . 99.989999999999995 112.965 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 76.6 m-85 -159.99 169.66 22.97 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.394 -0.595 . . . . 99.989999999999995 109.394 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 10.1 t -140.32 135.91 32.68 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.851 -0.74 . . . . 99.989999999999995 111.61 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -115.39 132.86 56.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.937 -0.574 . . . . 99.989999999999995 110.122 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 40' ' ' TYR . . . -107.77 126.41 8.31 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.431 -1.467 . . . . 99.989999999999995 109.431 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 39' ' ' ASN . 4.0 mp -136.3 125.97 25.46 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.953 -0.699 . . . . 99.989999999999995 111.845 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.431 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 69.7 m-85 -77.39 160.69 28.57 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.19 -0.67 . . . . 99.989999999999995 109.19 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 58' ' ' THR . 55.9 p30 -166.26 174.73 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.35 -0.241 . . . . 99.989999999999995 110.35 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.604 ' OG1' ' N ' ' A' ' 59' ' ' ALA . 1.7 t 147.63 -140.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.826 0.704 . . . . 99.989999999999995 109.568 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.604 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -140.37 135.55 32.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.49 -0.323 . . . . 99.989999999999995 110.132 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' ' OD2' ' A' ' 11' ' ' ASP . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.672 -0.971 . . . . 99.989999999999995 110.672 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.518 0.199 . . . . 99.989999999999995 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.491 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 5.5 p -85.05 159.9 20.11 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.94 -0.304 . . . . 99.989999999999995 110.469 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 75' ' ' THR . 97.0 m-20 -139.96 3.2 2.0 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.82 -0.352 . . . . 99.989999999999995 111.83 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.26 109.71 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.428 -0.509 . . . . 99.989999999999995 110.615 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -78.44 122.5 25.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 111.399 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.408 ' C ' ' CD2' ' A' ' 79' ' ' LEU . 7.4 tt -121.52 116.73 25.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.712 -0.677 . . . . 99.989999999999995 110.379 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.472 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 41.4 t -90.37 130.19 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.161 -0.472 . . . . 99.989999999999995 110.268 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 118.84 26.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 99.989999999999995 110.901 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -144.69 163.91 32.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.729 -0.669 . . . . 99.989999999999995 109.74 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 85' ' ' VAL . 35.6 t -85.83 134.22 33.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.32 -0.622 . . . . 99.989999999999995 109.32 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.0 t -41.81 -17.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 120.229 -0.588 . . . . 99.989999999999995 112.103 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.556 ' O ' ' CB ' ' A' ' 86' ' ' SER . 38.9 t -135.22 131.81 52.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.167 -0.613 . . . . 99.989999999999995 110.731 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 2.9 m 151.94 81.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 99.989999999999995 110.19 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -52.75 -29.61 42.97 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.385 2.056 . . . . 99.989999999999995 111.855 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.0 m -71.08 -49.98 38.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 99.989999999999995 109.796 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.6 p -62.02 -30.91 71.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 99.989999999999995 110.318 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -57.8 -50.71 72.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 99.989999999999995 111.498 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -79.09 -18.79 52.72 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.708 -0.397 . . . . 99.989999999999995 111.164 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 25.4 m120 -93.78 -10.42 34.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.242 -0.583 . . . . 99.989999999999995 110.344 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.472 ' CG1' ' CG1' ' A' ' 80' ' ' VAL . 52.3 t -104.4 -71.25 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.392 0.615 . . . . 99.989999999999995 112.241 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.533 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 78.8 mttt -69.67 -21.3 63.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.498 -0.774 . . . . 99.989999999999995 112.272 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.544 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 97.4 mt-10 -106.07 -38.4 6.31 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.434 0.901 . . . . 99.989999999999995 113.434 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -76.21 -30.66 58.06 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 119.351 -0.94 . . . . 99.989999999999995 111.881 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 23.3 m95 -89.57 -42.61 11.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.458 . . . . 99.989999999999995 111.299 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 2.2 t -40.22 -54.38 4.67 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 120.639 -0.424 . . . . 99.989999999999995 111.249 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.544 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 27.9 Cg_endo -64.2 -37.84 39.07 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.649 1.566 . . . . 99.989999999999995 112.162 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.57 -37.94 89.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.384 -0.371 . . . . 99.989999999999995 111.257 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.8 pt -86.29 -28.22 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.687 -0.405 . . . . 99.989999999999995 111.127 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 105' ' ' CYS . 86.3 m -59.99 -36.47 77.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.488 -0.324 . . . . 99.989999999999995 110.922 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -56.18 -37.69 69.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.41 -0.359 . . . . 99.989999999999995 110.88 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -55.99 -46.32 78.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.397 -0.365 . . . . 99.989999999999995 110.935 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 102' ' ' THR . 1.3 m -146.83 155.39 48.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.478 -0.328 . . . . 99.989999999999995 110.693 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.76 -60.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.482 2.122 . . . . 99.989999999999995 111.872 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -125.31 128.47 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 99.989999999999995 110.529 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.596 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -157.42 152.39 21.31 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.11 -0.495 . . . . 99.989999999999995 110.079 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -56.73 126.01 20.89 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.028 1.819 . . . . 99.989999999999995 111.39 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.691 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -116.58 111.29 19.68 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.356 -0.538 . . . . 99.989999999999995 110.453 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 7.7 mp -86.54 123.14 31.42 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.217 -0.593 . . . . 99.989999999999995 111.053 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.7 tp -100.94 123.58 45.34 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.904 -0.776 . . . . 99.989999999999995 108.904 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.7 t -136.18 147.47 28.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.455 -0.498 . . . . 99.989999999999995 111.47 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.478 ' O ' ' CD1' ' A' ' 19' ' ' LEU . . . -121.14 153.01 16.69 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.416 -1.074 . . . . 99.989999999999995 110.416 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 p -114.3 172.49 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.168 0.509 . . . . 99.989999999999995 110.804 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.578 ' O ' ' O ' ' A' ' 117' ' ' ILE . 31.5 mt-30 48.73 21.29 0.41 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.43 -0.805 . . . . 99.989999999999995 111.164 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.578 ' O ' ' O ' ' A' ' 116' ' ' GLN . 0.3 OUTLIER 36.32 -160.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.401 0 N-CA-C 108.284 -1.006 . . . . 99.989999999999995 108.284 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.563 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 19.1 m-20 -69.07 75.42 0.33 Allowed 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 118.788 -1.165 . . . . 99.989999999999995 109.463 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.559 ' O ' ' C ' ' A' ' 120' ' ' ARG . 98.0 mt 64.86 85.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.111 -0.949 . . . . 99.989999999999995 110.832 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 119' ' ' LEU . 57.1 ttm-85 . . . . . 0 N--CA 1.472 0.646 0 O-C-N 124.108 0.88 . . . . 99.989999999999995 111.132 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.548 0.213 . . . . 99.989999999999995 111.153 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.43 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -118.69 -50.28 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 113.638 0.977 . . . . 99.989999999999995 113.638 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.43 ' HD2' ' H ' ' A' ' 138' ' ' THR . 72.9 Cg_endo -81.87 -83.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.127 1.885 . . . . 99.989999999999995 114.464 -176.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.51 -43.8 98.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 99.989999999999995 111.701 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' A' ' 142' ' ' ALA . 81.9 p -60.56 -40.96 93.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.125 0.417 . . . . 99.989999999999995 112.125 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.451 ' N ' ' HG1' ' A' ' 141' ' ' THR . . . -77.31 -36.46 54.02 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.839 -0.344 . . . . 99.989999999999995 111.601 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.66 -42.33 96.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 99.989999999999995 111.755 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -66.4 -46.57 76.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.804 0.335 . . . . 99.989999999999995 110.986 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.4 tt -53.72 -35.16 60.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.133 -0.485 . . . . 99.989999999999995 111.06 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.03 -38.38 88.27 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 120.699 -0.4 . . . . 99.989999999999995 110.39 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -62.91 -39.78 95.6 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.749 -0.66 . . . . 99.989999999999995 110.789 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -52.31 -32.56 38.34 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.08 -1.081 . . . . 99.989999999999995 108.08 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 146' ' ' ALA . 62.6 mt -133.29 -113.41 0.22 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.577 -1.192 . . . . 99.989999999999995 108.479 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.563 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 51.3 mttp -143.83 -132.94 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 99.989999999999995 110.464 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 156.09 -165.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.866 0.365 . . . . 99.989999999999995 110.448 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.8 t -143.83 -51.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.39 -0.596 . . . . 99.989999999999995 109.39 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 3.5 tttm -143.62 -169.92 3.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.176 -0.465 . . . . 99.989999999999995 109.847 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -166.18 96.02 0.59 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.569 -0.9 . . . . 99.989999999999995 108.569 179.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 114' ' ' GLY . 16.5 m -136.14 153.61 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 115.621 -0.718 . . . . 99.989999999999995 110.474 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.594 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -133.11 94.0 3.27 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.542 -1.281 . . . . 99.989999999999995 107.542 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.618 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.5 OUTLIER -110.87 148.1 33.14 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 123.155 1.455 . . . . 99.989999999999995 113.504 -176.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.47 ' C ' ' N ' ' A' ' 160' ' ' LEU . 8.8 t -155.3 91.29 1.32 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 111.576 -2.556 . . . . 99.989999999999995 105.224 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.484 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . 42.03 28.16 0.09 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.984 -1.462 . . . . 99.989999999999995 108.739 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.623 ' O ' ' N ' ' A' ' 162' ' ' GLN . 47.0 mt -139.52 -74.02 0.37 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.619 -0.719 . . . . 99.989999999999995 111.841 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.747 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.1 m -57.82 44.12 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 120.918 0.39 . . . . 99.989999999999995 112.05 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.623 ' N ' ' O ' ' A' ' 160' ' ' LEU . 38.4 tt0 -74.83 19.32 0.14 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.122 -1.807 . . . . 99.989999999999995 106.122 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.747 ' H ' ' C ' ' A' ' 161' ' ' THR . 56.8 mttp -108.14 -1.49 20.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.583 -1.644 . . . . 99.989999999999995 107.779 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.17 -38.07 0.23 Allowed Glycine 0 C--O 1.225 -0.46 0 N-CA-C 109.599 -1.4 . . . . 99.989999999999995 109.599 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.9 tp -73.62 -22.99 59.84 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.034 0.445 . . . . 99.989999999999995 110.53 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -61.86 -34.15 75.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 99.989999999999995 109.231 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.597 ' O ' ' N ' ' A' ' 170' ' ' ASP . 7.9 m120 -72.29 -59.07 2.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.096 -1.446 . . . . 99.989999999999995 107.096 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.501 ' C ' ' O ' ' A' ' 167' ' ' ASN . 59.0 t -29.25 -55.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.693 -1.14 . . . . 99.989999999999995 110.446 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.688 ' CZ ' ' CZ ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -56.9 -48.76 77.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.254 -0.978 . . . . 99.989999999999995 110.316 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 167' ' ' ASN . 56.0 t0 -67.63 -47.44 69.6 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.783 0.325 . . . . 99.989999999999995 111.477 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.51 -29.05 70.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.444 . . . . 99.989999999999995 111.324 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.49 66.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.096 -0.705 . . . . 99.989999999999995 109.096 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.32 -37.09 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.482 -0.781 . . . . 99.989999999999995 109.741 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.8 -37.73 77.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.621 -0.718 . . . . 99.989999999999995 110.426 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.54 -28.05 69.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.972 -0.558 . . . . 99.989999999999995 110.589 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -57.26 -37.1 71.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 99.989999999999995 110.979 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 177' ' ' LEU . 8.0 mp -60.04 -32.18 70.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.422 -0.354 . . . . 99.989999999999995 110.669 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.381 -0.372 . . . . 99.989999999999995 110.504 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 121.029 0.442 . . . . 99.989999999999995 110.305 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.5 t -40.37 125.59 2.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.87 -0.605 . . . . 99.989999999999995 110.392 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.49 149.93 22.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.03 -0.532 . . . . 99.989999999999995 109.894 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -105.08 147.3 28.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.223 0.535 . . . . 99.989999999999995 112.002 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -132.61 145.23 50.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.351 -0.84 . . . . 99.989999999999995 109.393 179.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 t -127.4 135.9 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.507 -0.477 . . . . 99.989999999999995 111.548 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 56' ' ' PHE . 5.2 t -74.81 120.81 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 120.257 -0.577 . . . . 99.989999999999995 110.443 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.5 130.66 74.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.104 -0.498 . . . . 99.989999999999995 109.875 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' HA3' ' HZ2' ' A' ' 16' ' ' LYS . . . 177.51 -162.01 29.67 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.595 -1.002 . . . . 99.989999999999995 110.595 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' ALA . 44.7 t0 -148.85 -117.09 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.992 0.425 . . . . 99.989999999999995 111.084 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . -29.83 -29.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.436 -0.802 . . . . 99.989999999999995 112.657 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -38.18 136.65 0.61 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.421 0.611 . . . . 99.989999999999995 110.046 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.88 27.48 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 99.989999999999995 111.77 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' CA ' ' NE2' ' A' ' 116' ' ' GLN . . . -143.22 36.87 1.54 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.512 -0.852 . . . . 99.989999999999995 112.053 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.566 ' CB ' ' H ' ' A' ' 58' ' ' THR . 26.8 mttt -74.59 -7.58 53.61 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.8 -0.36 . . . . 99.989999999999995 111.043 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.598 ' C ' ' H ' ' A' ' 19' ' ' LEU . 85.7 m -78.38 -69.63 0.54 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.821 -0.352 . . . . 99.989999999999995 110.897 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.4 m -61.75 0.16 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.357 0.598 . . . . 99.989999999999995 109.913 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.598 ' H ' ' C ' ' A' ' 17' ' ' THR . 7.8 tt -69.72 -52.29 26.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.091 -0.959 . . . . 99.989999999999995 110.989 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.63 -32.45 64.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.647 -0.706 . . . . 99.989999999999995 111.144 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.4 mt -55.03 -20.26 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.501 . . . . 99.989999999999995 110.929 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.489 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 5.2 m -50.62 -74.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.602 -0.439 . . . . 99.989999999999995 111.457 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.707 ' CZ ' ' CZ ' ' A' ' 169' ' ' PHE . 23.9 p90 -63.03 -28.08 69.85 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 120.566 -0.454 . . . . 99.989999999999995 111.141 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.4 m -51.17 -46.03 61.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 99.989999999999995 111.562 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.9 m -157.44 -19.46 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 99.989999999999995 110.41 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 22' ' ' SER . 1.4 m-80 64.16 133.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.934 -0.575 . . . . 99.989999999999995 110.904 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' NZ ' ' NE2' ' A' ' 162' ' ' GLN . 40.6 mttp 66.71 59.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.876 -0.602 . . . . 99.989999999999995 111.734 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 tp -128.87 67.28 77.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.4 0.619 . . . . 99.989999999999995 110.295 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -79.55 6.52 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.147 2.564 . . . . 99.989999999999995 112.533 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.6 m -49.18 137.21 14.03 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.666 -0.414 . . . . 99.989999999999995 110.384 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.26 -34.81 78.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 99.989999999999995 110.799 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -59.03 -40.85 86.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.356 -0.384 . . . . 99.989999999999995 110.527 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.8 t 52.39 77.84 0.43 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 99.989999999999995 110.573 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.07 141.73 36.88 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.603 2.202 . . . . 99.989999999999995 112.038 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.5 m -126.26 149.61 48.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 99.989999999999995 110.674 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.15 157.63 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 99.989999999999995 110.396 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -57.25 -41.03 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 99.989999999999995 111.52 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.35 130.15 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.978 0.418 . . . . 99.989999999999995 111.042 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LEU . 87.4 m-20 -123.9 14.95 9.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 99.989999999999995 110.516 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.547 ' CB ' ' CE1' ' A' ' 56' ' ' PHE . 22.3 p90 -175.73 12.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 99.989999999999995 109.9 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.22 99.9 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.638 -0.71 . . . . 99.989999999999995 109.844 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.6 t -144.68 140.57 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 99.989999999999995 110.889 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.6 t -124.51 132.01 53.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 110.343 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.8 t -133.69 138.9 49.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 99.989999999999995 110.762 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.9 mtm -113.49 120.92 42.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.154 -0.476 . . . . 99.989999999999995 110.153 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.8 pp -128.15 154.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.825 -0.35 . . . . 99.989999999999995 110.936 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.491 ' O ' ' OE1' ' A' ' 49' ' ' GLU . . . 32.81 27.95 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.597 -0.601 . . . . 99.989999999999995 111.597 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 74.19 50.22 10.83 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.956 -0.858 . . . . 99.989999999999995 110.956 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.491 ' OE1' ' O ' ' A' ' 47' ' ' GLY . 4.1 mp0 -130.4 96.53 24.16 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 110.026 -0.361 . . . . 99.989999999999995 110.026 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' C ' ' CD1' ' A' ' 51' ' ' TYR . 57.7 Cg_endo -76.8 108.65 2.69 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.05 1.833 . . . . 99.989999999999995 113.033 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' A' ' 50' ' ' PRO . 93.7 m-85 -150.55 165.44 33.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.799 -0.637 . . . . 99.989999999999995 109.957 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.21 125.78 30.14 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.427 -0.509 . . . . 99.989999999999995 111.709 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.8 tp -113.1 125.4 54.33 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.243 -0.435 . . . . 99.989999999999995 110.813 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -89.43 136.42 13.54 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.572 -1.411 . . . . 99.989999999999995 109.572 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' ASN . 29.2 tp -137.11 125.69 23.7 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.744 -0.783 . . . . 99.989999999999995 112.85 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CE1' ' CB ' ' A' ' 40' ' ' TYR . 26.3 m-85 -97.93 -177.93 3.92 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.471 -0.936 . . . . 99.989999999999995 108.471 177.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' O ' ' OG1' ' A' ' 58' ' ' THR . 50.8 p30 -171.49 -174.89 1.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.379 -0.23 . . . . 99.989999999999995 110.379 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.566 ' H ' ' CB ' ' A' ' 16' ' ' LYS . 29.3 p 56.89 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.087 0.47 . . . . 99.989999999999995 111.664 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.566 ' CB ' ' HZ1' ' A' ' 16' ' ' LYS . . . -177.77 149.35 0.59 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.636 -0.711 . . . . 99.989999999999995 110.075 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.662 0 N-CA-C 110.34 -1.104 . . . . 99.989999999999995 110.34 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.56 0.219 . . . . 99.989999999999995 110.714 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.4 p 48.66 46.48 21.3 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.939 -0.304 . . . . 99.989999999999995 110.96 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -62.03 -37.81 86.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 99.989999999999995 110.381 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.532 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -119.34 99.79 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 99.989999999999995 110.345 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -71.14 127.76 33.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.978 -0.556 . . . . 99.989999999999995 111.958 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 9.1 mp -114.69 137.13 52.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.474 -0.785 . . . . 99.989999999999995 109.766 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 113' ' ' VAL . 62.3 t -104.75 132.4 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.986 -0.376 . . . . 99.989999999999995 109.986 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.452 ' SG ' ' CD1' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -114.38 123.81 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 99.989999999999995 111.54 -179.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.464 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 44.1 p90 -150.78 128.53 11.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.648 -0.705 . . . . 99.989999999999995 110.047 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -62.64 126.32 26.92 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.874 -0.787 . . . . 99.989999999999995 108.874 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.69 -20.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.564 -0.454 . . . . 99.989999999999995 111.675 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 85' ' ' VAL . 7.7 p -105.79 11.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.442 -0.503 . . . . 99.989999999999995 111.183 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.14 84.42 45.79 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 99.989999999999995 110.416 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -52.84 -27.38 34.48 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.457 2.104 . . . . 99.989999999999995 112.491 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.8 m -64.91 -44.84 88.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.806 -0.358 . . . . 99.989999999999995 111.199 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.561 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 83.8 p -70.71 -24.91 62.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 99.989999999999995 110.995 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.452 ' CD1' ' C ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -73.4 -40.45 64.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.007 -0.542 . . . . 99.989999999999995 111.44 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.09 -37.33 84.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.196 -0.456 . . . . 99.989999999999995 112.148 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -93.01 -39.82 10.89 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.963 -0.695 . . . . 99.989999999999995 112.071 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 89' ' ' SER . 37.4 t -51.68 -64.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.41 . . . . 99.989999999999995 111.573 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -72.61 -8.58 55.98 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.651 -0.42 . . . . 99.989999999999995 112.031 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.545 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 81.0 tt0 -103.77 -71.99 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.194 1.183 . . . . 99.989999999999995 114.194 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -88.07 -9.13 54.29 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.493 1.294 . . . . 99.989999999999995 114.493 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -97.4 -41.24 8.32 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.558 -0.857 . . . . 99.989999999999995 110.135 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -53.1 -54.64 42.15 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.117 -0.492 . . . . 99.989999999999995 110.996 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.545 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 17.9 Cg_endo -60.47 -34.05 93.34 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.674 1.583 . . . . 99.989999999999995 112.283 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -57.96 -37.56 74.4 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.688 -0.405 . . . . 99.989999999999995 110.954 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.1 pt -95.37 -31.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.465 -0.334 . . . . 99.989999999999995 111.495 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 28.7 m -51.08 -37.86 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.316 . . . . 99.989999999999995 110.948 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -50.63 -31.84 17.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 99.989999999999995 110.994 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.662 ' ND1' ' SG ' ' A' ' 105' ' ' CYS . 50.4 t-80 -57.33 -45.58 84.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.487 -0.324 . . . . 99.989999999999995 111.346 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.662 ' SG ' ' ND1' ' A' ' 104' ' ' HIS . 0.8 OUTLIER -174.59 82.74 0.34 Allowed Pre-proline 0 C--O 1.233 0.188 0 C-N-CA 120.746 -0.381 . . . . 99.989999999999995 110.962 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -63.13 -16.78 56.64 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.921 2.414 . . . . 99.989999999999995 112.808 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -77.64 -3.19 39.67 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.02 -0.272 . . . . 99.989999999999995 111.633 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 105' ' ' CYS . 13.9 p -94.8 150.31 37.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.984 -0.286 . . . . 99.989999999999995 110.826 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.95 142.69 93.82 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.437 2.091 . . . . 99.989999999999995 111.274 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.705 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -119.98 125.83 49.34 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.548 0.69 . . . . 99.989999999999995 111.404 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -99.92 133.69 43.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.463 -0.789 . . . . 99.989999999999995 110.777 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.8 mt -99.99 124.86 45.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.654 -0.703 . . . . 99.989999999999995 109.444 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 80' ' ' VAL . 41.5 t -128.05 129.44 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.516 -0.474 . . . . 99.989999999999995 111.302 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -106.47 142.54 15.65 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.032 -1.227 . . . . 99.989999999999995 110.032 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.32 169.1 8.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.12 0.486 . . . . 99.989999999999995 110.339 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.915 ' O ' ' N ' ' A' ' 118' ' ' ASP . 56.8 mm-40 52.1 23.52 2.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.727 -0.67 . . . . 99.989999999999995 110.918 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.592 ' CG2' ' H ' ' A' ' 119' ' ' LEU . 15.8 tt 27.66 -46.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 115.773 1.768 . . . . 99.989999999999995 115.773 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.915 ' N ' ' O ' ' A' ' 116' ' ' GLN . 47.0 t0 120.69 6.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.401 1.081 . . . . 99.989999999999995 108.505 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.592 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 8.9 tp -133.13 -24.74 1.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.913 -1.039 . . . . 99.989999999999995 109.8 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.751 HH21 ' NE2' ' A' ' 116' ' ' GLN . 65.5 ttp85 . . . . . 0 CA--C 1.516 -0.345 0 N-CA-C 108.534 -0.913 . . . . 99.989999999999995 108.534 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--O 1.232 0.133 0 N-CA-C 109.438 -0.578 . . . . 99.989999999999995 109.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.435 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -132.31 -52.48 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.19 0 N-CA-C 114.412 1.264 . . . . 99.989999999999995 114.412 -178.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 143' ' ' GLU . 86.1 Cg_endo -83.87 -93.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.975 1.783 . . . . 99.989999999999995 114.585 -175.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.0 -38.83 76.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.358 -0.837 . . . . 99.989999999999995 111.554 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.435 ' HG1' ' N ' ' A' ' 142' ' ' ALA . 64.2 p -69.59 -34.55 74.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.362 -0.381 . . . . 99.989999999999995 111.602 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.435 ' N ' ' HG1' ' A' ' 141' ' ' THR . . . -91.96 -42.3 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.54 -0.464 . . . . 99.989999999999995 110.361 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 139' ' ' PRO . 84.2 tt0 -60.98 -39.67 90.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 99.989999999999995 111.001 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -63.53 -43.92 95.73 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.763 -0.375 . . . . 99.989999999999995 111.171 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 145' ' ' LEU . 3.1 mm? -79.23 -7.16 58.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.455 -0.339 . . . . 99.989999999999995 111.913 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.03 -66.43 0.9 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.232 -0.587 . . . . 99.989999999999995 111.581 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -59.77 -37.56 79.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.935 -0.575 . . . . 99.989999999999995 112.491 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -93.66 -13.82 27.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.909 0.707 . . . . 99.989999999999995 112.909 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.8 tp -134.75 51.09 2.13 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 119.582 -0.847 . . . . 99.989999999999995 112.249 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 67.7 mttm 65.11 158.7 0.1 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.205 0.526 . . . . 99.989999999999995 111.311 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 158.06 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.35 -0.841 . . . . 99.989999999999995 111.444 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.6 t -142.5 -66.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.695 -0.684 . . . . 99.989999999999995 109.379 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -136.42 -167.75 2.12 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.773 -0.649 . . . . 99.989999999999995 110.411 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -150.27 97.15 2.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.706 -0.85 . . . . 99.989999999999995 108.706 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 155' ' ' VAL . 21.1 m -116.2 97.96 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.669 -0.696 . . . . 99.989999999999995 110.147 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.661 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -95.33 98.75 10.81 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.512 -1.662 . . . . 99.989999999999995 106.512 178.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.535 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -125.61 149.31 48.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 123.007 1.384 . . . . 99.989999999999995 113.098 -176.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.731 ' HG ' ' HE ' ' A' ' 120' ' ' ARG . 22.3 t -157.03 92.76 1.29 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 111.906 -2.406 . . . . 99.989999999999995 106.289 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 42.27 27.42 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.095 -1.411 . . . . 99.989999999999995 109.242 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.676 ' O ' ' N ' ' A' ' 162' ' ' GLN . 19.8 mt -144.57 -73.37 0.26 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.809 -0.632 . . . . 99.989999999999995 112.125 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.661 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 2.2 m -57.06 65.31 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.315 0.578 . . . . 99.989999999999995 111.8 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.676 ' N ' ' O ' ' A' ' 160' ' ' LEU . 7.9 pt20 -82.68 15.07 2.77 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.066 -2.198 . . . . 99.989999999999995 105.066 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.66 ' H ' ' C ' ' A' ' 161' ' ' THR . 24.9 tttt -86.44 -6.53 58.89 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 113.421 -1.718 . . . . 99.989999999999995 108.486 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 167' ' ' ASN . . . -131.4 -74.73 0.12 Allowed Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 109.111 -1.596 . . . . 99.989999999999995 109.111 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 14.8 mt -41.49 -22.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.993 -0.683 . . . . 99.989999999999995 111.746 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.6 tttt -77.85 -46.59 21.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.823 -1.177 . . . . 99.989999999999995 107.823 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 164' ' ' GLY . 32.4 m120 -76.03 -0.45 21.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.856 -1.52 . . . . 99.989999999999995 109.784 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 171' ' ' GLU . 46.7 t -83.91 -60.14 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 116.489 -0.323 . . . . 99.989999999999995 110.762 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.707 ' CZ ' ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -43.05 -45.64 5.32 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.001 -0.68 . . . . 99.989999999999995 110.018 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.653 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 32.6 p30 -70.03 -30.56 67.88 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.291 -0.564 . . . . 99.989999999999995 109.779 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.653 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 85.5 tt0 -64.72 -31.38 72.58 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.486 -0.325 . . . . 99.989999999999995 110.133 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.12 -29.43 68.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.158 -0.682 . . . . 99.989999999999995 109.158 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 77.3 mt -52.41 -39.75 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.989 -1.115 . . . . 99.989999999999995 107.989 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.14 -37.79 88.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.988 -1.005 . . . . 99.989999999999995 109.589 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -76.78 -13.03 60.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.636 -0.711 . . . . 99.989999999999995 110.708 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.14 -29.21 69.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.916 0.388 . . . . 99.989999999999995 110.15 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.65 -35.27 70.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.033 -0.53 . . . . 99.989999999999995 110.431 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 99.989999999999995 110.575 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.94 0.4 . . . . 99.989999999999995 110.459 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.9 p -42.73 113.68 0.5 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 99.989999999999995 110.384 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.8 tt -117.28 138.97 46.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.145 -0.48 . . . . 99.989999999999995 110.133 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -96.47 150.85 20.15 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.136 0.493 . . . . 99.989999999999995 111.106 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.52 ' SG ' ' CD2' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -143.1 137.03 28.87 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.808 -0.633 . . . . 99.989999999999995 111.013 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 p -106.61 139.66 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.961 -0.563 . . . . 99.989999999999995 109.692 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.6 t -115.63 131.35 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 120.287 -0.565 . . . . 99.989999999999995 111.592 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 t -128.58 138.69 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.539 -0.755 . . . . 99.989999999999995 109.839 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 60' ' ' GLY . . . -135.4 -177.33 14.89 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.785 -0.721 . . . . 99.989999999999995 111.497 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 53.8 p30 -72.25 -123.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.345 . . . . 99.989999999999995 111.221 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.582 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . -151.21 72.51 0.28 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.929 -0.868 . . . . 99.989999999999995 110.929 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 152.23 27.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.58 0.224 . . . . 99.989999999999995 111.398 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.4 ' CG1' ' H ' ' A' ' 83' ' ' SER . 16.8 m -125.28 133.85 68.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.659 -0.416 . . . . 99.989999999999995 110.412 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.3 93.59 1.86 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.264 -0.493 . . . . 99.989999999999995 112.429 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -73.27 -8.53 56.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.013 0.435 . . . . 99.989999999999995 110.102 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -59.27 -55.12 38.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 99.989999999999995 111.029 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -58.91 -36.19 74.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.701 . . . . 99.989999999999995 109.317 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 4.0 tt -65.71 -54.09 32.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.002 -0.999 . . . . 99.989999999999995 110.699 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.529 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -59.78 -32.53 70.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.063 0.459 . . . . 99.989999999999995 110.207 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.488 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 33.7 mt -62.36 -9.6 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.694 . . . . 99.989999999999995 111.378 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -53.43 -82.16 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.182 -1.007 . . . . 99.989999999999995 110.936 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -52.62 -31.61 37.45 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 120.268 -0.573 . . . . 99.989999999999995 110.851 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.403 ' HG1' ' HA ' ' A' ' 21' ' ' ILE . 10.3 m -47.18 -39.63 14.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -140.98 -87.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.662 -0.699 . . . . 99.989999999999995 109.985 178.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.559 ' N ' ' OG1' ' A' ' 25' ' ' THR . 2.1 t-20 156.58 83.94 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.993 -0.743 . . . . 99.989999999999995 108.993 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' H ' ' NE2' ' A' ' 162' ' ' GLN . 24.7 tttt 65.53 91.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 99.989999999999995 110.646 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 tp -125.14 85.64 57.84 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.984 -0.553 . . . . 99.989999999999995 110.45 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.61 47.18 2.25 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.85 2.367 . . . . 99.989999999999995 112.692 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.9 m -64.13 152.67 39.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.329 -0.396 . . . . 99.989999999999995 110.349 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -59.41 -39.57 83.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.382 -0.372 . . . . 99.989999999999995 110.555 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.6 ' CE2' ' O ' ' A' ' 33' ' ' VAL . 81.7 t80 -137.38 136.27 37.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.273 -0.422 . . . . 99.989999999999995 110.416 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 17.1 m -78.03 148.78 75.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 99.989999999999995 110.387 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.97 -162.4 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.386 2.057 . . . . 99.989999999999995 112.059 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.3 p -76.11 164.88 25.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 99.989999999999995 110.166 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -126.56 158.0 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.407 . . . . 99.989999999999995 110.805 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -117.93 161.04 20.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.917 -0.583 . . . . 99.989999999999995 110.363 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 51.5 p30 -77.92 4.29 12.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.974 0.416 . . . . 99.989999999999995 110.454 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -127.28 132.17 50.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 99.989999999999995 110.14 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -125.7 15.71 8.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.453 -0.573 . . . . 99.989999999999995 109.453 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.0 97.69 10.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.696 -0.684 . . . . 99.989999999999995 110.225 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.7 t -111.91 143.36 21.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.903 -1.044 . . . . 99.989999999999995 110.084 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 43' ' ' THR . 14.2 t -118.84 121.49 40.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 99.989999999999995 110.756 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -136.11 166.41 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.62 . . . . 99.989999999999995 110.59 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.2 mtm -111.82 128.51 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 99.989999999999995 110.028 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 tt -130.63 123.57 55.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.709 -0.396 . . . . 99.989999999999995 110.442 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.26 28.55 54.89 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.008 -0.837 . . . . 99.989999999999995 111.008 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.87 51.34 7.91 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.499 -1.04 . . . . 99.989999999999995 110.499 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -130.52 89.54 43.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 110.378 -0.23 . . . . 99.989999999999995 110.378 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.597 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 41.9 Cg_endo -74.72 103.9 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.135 1.89 . . . . 99.989999999999995 112.707 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 53.2 m-85 -162.01 174.81 12.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.838 -0.619 . . . . 99.989999999999995 109.564 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 t -145.94 141.67 27.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.109 -0.636 . . . . 99.989999999999995 110.908 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.2 tp -107.84 129.24 55.09 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.264 -0.426 . . . . 99.989999999999995 110.607 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -96.48 119.58 6.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.845 -0.902 . . . . 99.989999999999995 110.845 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.411 ' CD2' ' SG ' ' A' ' 6' ' ' CYS . 71.7 mt -115.99 153.31 31.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 99.989999999999995 110.644 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 56' ' ' PHE . 46.2 t80 -135.52 32.66 3.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 99.989999999999995 111.446 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' O ' ' OG1' ' A' ' 58' ' ' THR . 49.5 p30 -80.44 -173.59 4.16 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.742 0.306 . . . . 99.989999999999995 111.247 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 57' ' ' ASP . 1.2 m 168.74 -58.06 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.201 -0.454 . . . . 99.989999999999995 110.371 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . 164.02 139.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.072 -0.513 . . . . 99.989999999999995 110.204 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 10' ' ' GLY . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 110.177 -1.169 . . . . 99.989999999999995 110.177 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 . . . . . 0 CA--C 1.523 -0.06 0 CA-C-O 120.783 0.325 . . . . 99.989999999999995 110.448 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.0 p -129.82 158.43 39.48 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.652 -0.499 . . . . 99.989999999999995 109.652 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.41 ' OD2' ' OE2' ' A' ' 178' ' ' GLU . 93.3 m-20 -121.84 -23.79 5.4 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.533 -0.467 . . . . 99.989999999999995 111.221 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.16 124.27 55.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.26 -0.576 . . . . 99.989999999999995 111.526 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -89.8 127.38 35.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 99.989999999999995 110.94 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.52 ' CD2' ' SG ' ' A' ' 6' ' ' CYS . 10.6 mp -104.64 135.58 45.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.703 -0.68 . . . . 99.989999999999995 110.814 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.83 131.94 69.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.951 -0.568 . . . . 99.989999999999995 109.794 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.64 135.82 53.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.306 0.574 . . . . 99.989999999999995 111.315 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.491 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 41.2 p90 -160.41 132.29 6.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.298 -0.865 . . . . 99.989999999999995 109.758 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.4 ' H ' ' CG1' ' A' ' 14' ' ' VAL . 75.7 p -59.0 135.98 57.8 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.817 -0.753 . . . . 99.989999999999995 109.447 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -114.76 23.64 5.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 119.874 -0.73 . . . . 99.989999999999995 110.197 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 p -63.6 -38.06 81.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.464 -0.789 . . . . 99.989999999999995 110.273 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.77 155.78 80.05 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 99.989999999999995 110.562 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -59.79 -13.59 23.02 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.897 2.398 . . . . 99.989999999999995 112.684 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 m -66.16 -67.06 0.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.926 -0.31 . . . . 99.989999999999995 111.004 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.3 m -60.61 -38.16 83.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.357 -0.383 . . . . 99.989999999999995 110.693 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.443 ' CZ ' ' OG1' ' A' ' 141' ' ' THR . 0.3 OUTLIER -60.03 -36.27 76.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.898 -0.592 . . . . 99.989999999999995 111.121 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.476 ' OE2' ' OE1' ' A' ' 95' ' ' GLU . 45.0 tp10 -81.91 -23.42 36.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.441 . . . . 99.989999999999995 111.848 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.62 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 80.3 m-20 -85.84 5.46 32.6 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 112.68 0.622 . . . . 99.989999999999995 112.68 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.461 ' CG1' ' CG ' ' A' ' 82' ' ' PHE . 1.5 p -119.07 -65.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.164 -0.614 . . . . 99.989999999999995 111.689 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.537 ' HZ1' ' CD2' ' A' ' 112' ' ' LEU . 74.0 mttt -54.8 -19.69 6.97 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.406 -0.518 . . . . 99.989999999999995 110.467 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.476 ' OE1' ' OE2' ' A' ' 91' ' ' GLU . 85.2 tt0 -113.89 -27.63 7.68 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.635 0.976 . . . . 99.989999999999995 113.635 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -113.01 -40.31 3.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.188 1.181 . . . . 99.989999999999995 114.188 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.62 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 47.4 m95 -90.63 -51.1 5.56 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.301 -0.96 . . . . 99.989999999999995 111.484 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.437 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 3.0 t -50.28 -58.9 8.27 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.479 -0.328 . . . . 99.989999999999995 111.414 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.4 Cg_endo -51.84 -39.13 68.61 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.652 1.568 . . . . 99.989999999999995 112.013 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.99 -43.79 98.32 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.368 -0.533 . . . . 99.989999999999995 110.015 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.2 mt -70.28 -36.56 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 99.989999999999995 110.494 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 105' ' ' CYS . 56.8 m -53.19 -43.33 67.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.838 -0.619 . . . . 99.989999999999995 110.852 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -63.39 -42.98 98.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 99.989999999999995 110.841 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.07 -42.39 98.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 99.989999999999995 111.63 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -103.97 161.57 22.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 99.989999999999995 111.204 -179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.469 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 41.5 Cg_endo -70.23 -157.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.856 2.371 . . . . 99.989999999999995 112.381 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -86.18 9.07 18.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 99.989999999999995 110.915 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.88 156.07 0.76 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.48 -0.327 . . . . 99.989999999999995 110.464 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.51 143.71 54.57 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.683 2.255 . . . . 99.989999999999995 111.821 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.752 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -129.72 114.84 16.48 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.558 -0.457 . . . . 99.989999999999995 110.852 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.95 122.72 27.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.604 . . . . 99.989999999999995 109.424 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.537 ' CD2' ' HZ1' ' A' ' 94' ' ' LYS . 27.5 tp -85.53 133.05 34.09 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.767 -0.373 . . . . 99.989999999999995 110.015 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.491 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -142.47 163.73 17.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.525 -0.47 . . . . 99.989999999999995 111.418 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.499 ' O ' ' CD1' ' A' ' 19' ' ' LEU . . . -146.4 176.59 25.24 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.486 -1.046 . . . . 99.989999999999995 110.486 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 116' ' ' GLN . 9.2 p -127.94 179.93 5.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 117.191 0.496 . . . . 99.989999999999995 109.87 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.538 ' O ' ' C ' ' A' ' 117' ' ' ILE . 9.5 mt-30 37.36 33.64 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.456 . . . . 99.989999999999995 110.487 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.538 ' C ' ' O ' ' A' ' 116' ' ' GLN . 1.0 OUTLIER 23.82 -141.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.236 0 O-C-N 123.506 0.503 . . . . 99.989999999999995 111.149 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.513 ' OD2' ' CG2' ' A' ' 138' ' ' THR . 86.7 m-20 -86.65 -2.48 58.55 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.203 -0.599 . . . . 99.989999999999995 112.568 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.465 ' O ' ' C ' ' A' ' 120' ' ' ARG . 6.0 tp 178.11 45.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.677 0.275 . . . . 99.989999999999995 111.18 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 119' ' ' LEU . 57.7 ttp180 . . . . . 0 C--N 1.326 -0.414 0 N-CA-C 112.816 0.673 . . . . 99.989999999999995 112.816 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.1 tt . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 110.161 -0.311 . . . . 99.989999999999995 110.161 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.591 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -131.12 -45.74 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.648 0.61 . . . . 99.989999999999995 112.648 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.591 ' CD ' ' H ' ' A' ' 138' ' ' THR . 56.9 Cg_endo -88.2 -62.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.585 2.19 . . . . 99.989999999999995 114.389 -177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 139' ' ' PRO . 95.9 mt-10 -29.76 -72.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.528 0.566 . . . . 99.989999999999995 112.528 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.443 ' OG1' ' CZ ' ' A' ' 90' ' ' PHE . 23.1 p -127.8 7.92 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.462 0.912 . . . . 99.989999999999995 113.462 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.499 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -83.5 -70.64 0.55 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.694 -0.803 . . . . 99.989999999999995 110.754 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -74.1 -40.58 62.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 99.989999999999995 111.632 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -62.13 -36.48 81.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.38 . . . . 99.989999999999995 111.445 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 35.6 tp -72.26 -22.47 61.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.185 -0.461 . . . . 99.989999999999995 111.232 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.65 -33.26 75.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.089 0.471 . . . . 99.989999999999995 110.81 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -59.89 -45.93 90.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 99.989999999999995 110.336 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -84.94 -29.53 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 99.989999999999995 110.736 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 55.5 tp -43.21 -28.46 0.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.002 -0.545 . . . . 99.989999999999995 112.268 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.527 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 63.0 mttm 88.17 -0.13 0.42 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.647 0.379 . . . . 99.989999999999995 110.009 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.46 -132.49 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.194 0.521 . . . . 99.989999999999995 111.518 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 110' ' ' PHE . 3.7 t -151.84 -54.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.499 -0.773 . . . . 99.989999999999995 110.336 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.416 ' HG3' ' H ' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -107.25 -167.76 1.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.458 -0.337 . . . . 99.989999999999995 110.348 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.616 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 34.2 p90 -161.95 97.13 1.03 Allowed 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.835 -0.802 . . . . 99.989999999999995 108.835 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.61 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.957 0.884 . . . . 99.989999999999995 111.613 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.645 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -153.39 96.93 2.09 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.305 -1.739 . . . . 99.989999999999995 106.305 178.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.419 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -112.83 145.49 40.56 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 123.274 1.511 . . . . 99.989999999999995 113.157 -176.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.437 ' HB2' ' N ' ' A' ' 116' ' ' GLN . 13.6 t -173.35 90.19 0.08 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 111.707 -2.497 . . . . 99.989999999999995 107.168 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 57.07 29.38 16.41 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.801 -1.545 . . . . 99.989999999999995 111.695 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.666 ' C ' ' H ' ' A' ' 162' ' ' GLN . 21.2 tp -156.18 -85.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.413 -0.588 . . . . 99.989999999999995 109.413 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.768 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.9 OUTLIER -46.41 -9.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.313 -0.625 . . . . 99.989999999999995 109.313 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.666 ' H ' ' C ' ' A' ' 160' ' ' LEU . 19.4 mt-30 -51.35 -1.58 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.094 -0.706 . . . . 99.989999999999995 109.094 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.768 ' H ' ' C ' ' A' ' 161' ' ' THR . 43.0 mttm -82.01 -2.69 52.47 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.721 -1.585 . . . . 99.989999999999995 106.721 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -116.45 -70.13 0.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 108.322 -1.911 . . . . 99.989999999999995 108.322 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 19' ' ' LEU . 43.1 tp -39.81 -16.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.478 -0.489 . . . . 99.989999999999995 110.826 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 164' ' ' GLY . 79.3 tttt -80.99 -53.51 6.37 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.964 -1.124 . . . . 99.989999999999995 107.964 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 164' ' ' GLY . 40.1 t-20 -71.15 -2.51 16.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.582 -1.19 . . . . 99.989999999999995 109.667 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 171' ' ' GLU . 29.6 t -78.3 -47.45 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.14 -0.482 . . . . 99.989999999999995 110.016 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 168' ' ' VAL . 63.0 t80 -39.12 -43.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.732 -0.667 . . . . 99.989999999999995 109.533 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.7 -37.82 88.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 99.989999999999995 110.36 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 168' ' ' VAL . 96.8 mt-10 -72.71 -20.82 61.15 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.049 0.452 . . . . 99.989999999999995 110.132 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.66 -36.73 85.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.614 -0.721 . . . . 99.989999999999995 110.742 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.425 ' CG1' ' N ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -62.04 -36.45 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.463 -0.569 . . . . 99.989999999999995 109.463 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.425 ' N ' ' CG1' ' A' ' 173' ' ' ILE . 45.3 tp -61.39 -35.01 76.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.712 -0.676 . . . . 99.989999999999995 110.016 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.55 -29.66 69.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.673 . . . . 99.989999999999995 110.852 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.62 72.63 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.943 0.401 . . . . 99.989999999999995 110.285 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 32.8 tp -57.17 -35.86 70.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 99.989999999999995 110.671 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.41 ' OE2' ' OD2' ' A' ' 76' ' ' ASP . 97.0 mt-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 99.989999999999995 110.44 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 176' ' ' ALA . 91.2 mt-30 . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 121.17 0.509 . . . . 99.989999999999995 110.667 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' A' ' 52' ' ' THR . 11.4 p -84.01 157.22 21.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.382 -0.826 . . . . 99.989999999999995 109.117 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.1 tt -134.12 152.9 34.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.454 -0.498 . . . . 99.989999999999995 110.821 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -103.04 146.79 27.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.036 0.445 . . . . 99.989999999999995 111.186 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -139.51 158.35 44.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.825 -0.625 . . . . 99.989999999999995 110.018 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.492 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 12.2 p -127.6 134.4 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.516 -0.311 . . . . 99.989999999999995 110.771 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 t -110.98 133.81 55.31 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 C-N-CA 120.367 -0.533 . . . . 99.989999999999995 110.812 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.3 t -114.62 132.47 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.003 -0.544 . . . . 99.989999999999995 110.225 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' A' ' 59' ' ' ALA . . . -103.37 123.34 7.76 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.086 -0.806 . . . . 99.989999999999995 111.086 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 13' ' ' ALA . 25.5 t70 -82.76 121.48 26.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.602 0.239 . . . . 99.989999999999995 110.397 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 56.75 -0.82 0.14 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.599 -0.6 . . . . 99.989999999999995 111.599 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 11' ' ' ASP . . . 82.12 125.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.661 -0.496 . . . . 99.989999999999995 109.661 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.743 ' H ' ' HZ1' ' A' ' 16' ' ' LYS . 1.8 m -142.27 -88.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.571 -0.452 . . . . 99.989999999999995 111.816 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.49 ' H ' ' CG2' ' A' ' 14' ' ' VAL . . . -159.59 55.51 0.34 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.718 -0.753 . . . . 99.989999999999995 111.997 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.743 ' HZ1' ' H ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -63.71 -34.64 78.31 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.673 -0.31 . . . . 99.989999999999995 111.339 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.1 m -52.18 -43.84 64.36 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.901 0.334 . . . . 99.989999999999995 111.901 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.429 ' SG ' ' CD2' ' A' ' 28' ' ' LEU . 74.2 m -61.14 -26.97 68.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.168 0.509 . . . . 99.989999999999995 110.667 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.53 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -78.96 -35.91 42.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.726 -0.67 . . . . 99.989999999999995 111.173 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.416 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 81.4 mt -63.82 -36.09 82.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.303 . . . . 99.989999999999995 111.487 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.409 ' HA ' ' HG1' ' A' ' 24' ' ' THR . 17.9 pt -98.78 12.85 5.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.86 -0.336 . . . . 99.989999999999995 111.616 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.587 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 13.1 p -48.36 -77.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.248 -0.581 . . . . 99.989999999999995 110.893 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -62.77 -38.06 89.11 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 119.021 -1.072 . . . . 99.989999999999995 110.582 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.409 ' HG1' ' HA ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -48.68 -44.69 38.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 99.989999999999995 110.265 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER 171.2 77.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.787 -0.642 . . . . 99.989999999999995 109.796 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.512 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -58.05 83.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 99.989999999999995 110.521 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 25' ' ' THR . 24.1 mttm -148.17 60.26 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 99.989999999999995 110.712 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.559 ' H ' ' CB ' ' A' ' 159' ' ' ALA . 11.0 tp -123.34 68.56 39.06 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.467 -0.493 . . . . 99.989999999999995 110.89 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.78 -14.0 26.89 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.561 2.174 . . . . 99.989999999999995 112.246 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.9 p -67.78 120.8 14.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.945 0.403 . . . . 99.989999999999995 110.628 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -67.8 -32.67 73.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 99.989999999999995 111.145 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -56.66 -41.47 77.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.368 -0.378 . . . . 99.989999999999995 111.03 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.1 t 54.06 70.38 1.75 Allowed Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.777 -0.369 . . . . 99.989999999999995 110.432 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -53.93 137.45 68.65 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.817 2.345 . . . . 99.989999999999995 112.61 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.0 m -128.45 140.36 51.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 99.989999999999995 110.6 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 37' ' ' PHE . 9.1 p -159.75 -52.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.45 -0.341 . . . . 99.989999999999995 110.789 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.501 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 66.9 t80 -100.07 130.79 46.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.374 -0.376 . . . . 99.989999999999995 110.845 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 89.9 m-20 -75.83 136.9 40.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 99.989999999999995 110.495 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -111.48 148.27 33.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 99.989999999999995 110.784 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -176.14 -7.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.947 -0.569 . . . . 99.989999999999995 109.98 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.79 103.25 4.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.899 -0.591 . . . . 99.989999999999995 110.393 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.6 131.82 62.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 99.989999999999995 110.641 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -105.64 123.03 47.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.47 . . . . 99.989999999999995 110.744 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.78 157.3 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.546 . . . . 99.989999999999995 110.473 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 66.1 mtm -129.97 132.0 46.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 99.989999999999995 110.338 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.6 tt -135.17 131.77 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.734 -0.386 . . . . 99.989999999999995 110.97 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.37 26.57 51.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.552 -0.619 . . . . 99.989999999999995 111.552 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.55 58.43 3.86 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.838 -0.905 . . . . 99.989999999999995 110.838 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -136.23 101.36 10.21 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.286 -0.264 . . . . 99.989999999999995 110.286 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.43 103.19 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 122.266 1.977 . . . . 99.989999999999995 113.004 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -154.12 169.7 22.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 99.989999999999995 109.832 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.4 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.0 OUTLIER -136.11 125.47 24.89 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 119.942 -0.703 . . . . 99.989999999999995 112.093 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.5 tp -107.86 121.16 44.18 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.215 -0.448 . . . . 99.989999999999995 110.221 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -94.42 134.41 12.01 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.294 -1.123 . . . . 99.989999999999995 110.294 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -140.95 117.96 11.18 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.275 -0.57 . . . . 99.989999999999995 111.493 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.422 ' H ' ' HA ' ' A' ' 7' ' ' VAL . 10.9 t80 -65.97 -158.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.7 -0.852 . . . . 99.989999999999995 108.7 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 58' ' ' THR . 50.2 p30 -166.88 172.76 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.652 0.263 . . . . 99.989999999999995 110.63 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER 35.31 -157.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 99.989999999999995 110.836 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . 158.23 -50.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.888 -0.597 . . . . 99.989999999999995 110.271 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.611 -0.996 . . . . 99.989999999999995 110.611 179.655 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.729 0.299 . . . . 99.989999999999995 110.797 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.1 m -126.65 127.51 45.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 99.989999999999995 110.529 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -83.63 -36.22 24.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 99.989999999999995 110.546 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.68 122.86 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.985 -0.552 . . . . 99.989999999999995 110.291 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -84.97 123.3 30.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.365 0.602 . . . . 99.989999999999995 111.377 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 tt -115.39 130.76 56.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.139 -0.937 . . . . 99.989999999999995 109.754 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -118.4 135.53 58.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.807 -0.357 . . . . 99.989999999999995 110.152 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.413 ' SG ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -130.79 132.07 45.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 99.989999999999995 110.893 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.444 ' H ' ' HA2' ' A' ' 114' ' ' GLY . 44.5 p90 -152.84 143.89 23.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.592 -0.731 . . . . 99.989999999999995 110.173 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.577 ' N ' ' HG1' ' A' ' 115' ' ' THR . 14.0 t -53.12 132.22 37.91 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.577 -0.527 . . . . 99.989999999999995 109.577 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.51 24.18 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.999 -0.546 . . . . 99.989999999999995 111.755 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.8 7.82 7.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.025 -0.534 . . . . 99.989999999999995 110.659 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.632 ' HG ' ' HG ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -124.29 150.01 62.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 99.989999999999995 110.124 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.93 -38.31 3.02 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.43 2.087 . . . . 99.989999999999995 113.345 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.1 p -85.67 -18.62 32.67 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.403 0.52 . . . . 99.989999999999995 112.403 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.632 ' HG ' ' HG ' ' A' ' 86' ' ' SER . 50.6 m -59.09 -35.2 72.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.88 -0.328 . . . . 99.989999999999995 111.746 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 90' ' ' PHE . 2.1 p90 -89.77 -29.25 18.81 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.795 -0.362 . . . . 99.989999999999995 111.381 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.73 -31.93 73.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.521 -0.308 . . . . 99.989999999999995 111.714 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -80.56 -38.09 30.21 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.443 -0.503 . . . . 99.989999999999995 111.939 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.39 -62.78 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.321 0.86 . . . . 99.989999999999995 113.321 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.493 ' NZ ' ' CB ' ' A' ' 142' ' ' ALA . 19.7 mttt -70.69 -7.12 42.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.01 0.744 . . . . 99.989999999999995 113.01 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 76.7 tt0 -131.37 -52.97 1.02 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.559 0.948 . . . . 99.989999999999995 113.559 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -74.34 -42.54 59.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.033 0.753 . . . . 99.989999999999995 113.033 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.538 ' NE1' ' OD1' ' A' ' 11' ' ' ASP . 96.5 m95 -88.58 -32.77 17.96 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.852 0.686 . . . . 99.989999999999995 112.852 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.518 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -53.22 -45.03 98.54 Favored Pre-proline 0 N--CA 1.466 0.364 0 C-N-CA 120.564 -0.454 . . . . 99.989999999999995 111.526 -178.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 12.8 Cg_exo -64.0 -45.12 10.97 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.259 1.973 . . . . 99.989999999999995 111.515 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.64 -40.78 80.05 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.106 -0.638 . . . . 99.989999999999995 109.793 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.22 -35.38 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 99.989999999999995 110.418 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.2 m -52.75 -39.46 62.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 99.989999999999995 111.162 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.22 -46.43 79.5 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.875 -0.33 . . . . 99.989999999999995 110.625 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -61.14 -44.95 96.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 99.989999999999995 110.908 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.9 87.57 48.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 99.989999999999995 110.531 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -51.59 -34.84 54.35 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.312 2.008 . . . . 99.989999999999995 112.212 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -143.55 112.31 6.54 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.738 -0.385 . . . . 99.989999999999995 110.602 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.606 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -171.08 151.81 3.3 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.329 -0.396 . . . . 99.989999999999995 110.292 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.62 142.49 98.01 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.308 2.005 . . . . 99.989999999999995 111.257 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.725 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -135.92 137.4 41.32 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.413 -0.515 . . . . 99.989999999999995 111.39 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.46 130.27 42.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.083 -0.508 . . . . 99.989999999999995 110.828 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -97.05 127.45 43.03 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.157 -0.683 . . . . 99.989999999999995 109.157 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.29 167.46 7.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.236 -0.586 . . . . 99.989999999999995 111.655 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.444 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -142.59 170.92 24.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.069 -1.212 . . . . 99.989999999999995 110.069 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.577 ' HG1' ' N ' ' A' ' 83' ' ' SER . 3.1 p -122.9 177.6 5.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.182 0.515 . . . . 99.989999999999995 110.115 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.701 ' O ' ' N ' ' A' ' 118' ' ' ASP . 83.2 mt-30 57.78 11.28 1.3 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.517 -0.765 . . . . 99.989999999999995 111.402 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.703 ' CG2' ' H ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 35.57 19.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.342 0 CA-C-O 120.979 0.419 . . . . 99.989999999999995 111.178 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 116' ' ' GLN . 2.4 p30 50.48 13.82 0.14 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.906 -0.588 . . . . 99.989999999999995 111.692 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.9 tp -144.12 -36.1 0.35 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 119.804 -0.758 . . . . 99.989999999999995 112.816 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.703 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 8.0 tpm_? . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 111.938 0.347 . . . . 99.989999999999995 111.938 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' A' ' 137' ' ' ILE . 15.5 tt . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.847 0.356 . . . . 99.989999999999995 111.072 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.714 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 6.8 m -128.56 -30.5 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.707 1.003 . . . . 99.989999999999995 113.707 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.714 ' CD ' ' H ' ' A' ' 138' ' ' THR . 79.7 Cg_exo -44.41 -59.7 1.03 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.691 1.594 . . . . 99.989999999999995 112.754 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -122.07 -35.14 3.21 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.721 -0.392 . . . . 99.989999999999995 111.73 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.7 m -53.98 -40.42 66.87 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.935 -0.306 . . . . 99.989999999999995 111.061 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.493 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . . . -80.18 -37.37 33.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.665 0.269 . . . . 99.989999999999995 111.265 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.2 -41.44 83.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.306 -0.406 . . . . 99.989999999999995 111.409 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.14 -42.42 99.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 99.989999999999995 110.513 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 89.3 mt -64.23 -34.12 77.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.796 -0.638 . . . . 99.989999999999995 111.326 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.73 -30.59 62.92 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.885 -0.326 . . . . 99.989999999999995 111.472 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -54.43 -38.26 66.07 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.487 0.551 . . . . 99.989999999999995 112.487 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 149' ' ' LEU . 55.0 p30 -123.27 -26.56 4.27 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.957 0.725 . . . . 99.989999999999995 112.957 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.59 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 5.9 tp -74.94 2.35 10.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.408 -0.517 . . . . 99.989999999999995 111.315 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 47.7 mttt 100.44 147.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.624 0.77 . . . . 99.989999999999995 110.384 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 155.25 -173.27 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.902 -0.59 . . . . 99.989999999999995 111.08 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 110' ' ' PHE . 46.3 t -150.35 -57.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.188 -0.914 . . . . 99.989999999999995 109.281 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -98.76 -176.36 3.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.763 -0.653 . . . . 99.989999999999995 109.656 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.619 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 31.6 p90 -170.62 97.13 0.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.823 -0.751 . . . . 99.989999999999995 109.958 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -161.3 -176.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.406 -0.815 . . . . 99.989999999999995 110.186 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.747 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.4 OUTLIER -148.18 96.08 2.57 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.086 -0.961 . . . . 99.989999999999995 108.838 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.487 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -108.64 147.26 32.13 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 123.129 1.443 . . . . 99.989999999999995 113.058 -178.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.514 ' HB2' ' N ' ' A' ' 116' ' ' GLN . 5.3 t -165.94 90.98 0.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 111.64 -2.527 . . . . 99.989999999999995 106.102 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.559 ' CB ' ' H ' ' A' ' 28' ' ' LEU . . . 48.5 31.6 2.94 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.261 -1.791 . . . . 99.989999999999995 109.962 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.816 ' O ' ' N ' ' A' ' 162' ' ' GLN . 1.9 mt -153.46 -76.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.517 -0.765 . . . . 99.989999999999995 111.886 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.75 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.1 m -51.78 44.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 112.838 0.681 . . . . 99.989999999999995 112.838 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.816 ' N ' ' O ' ' A' ' 160' ' ' LEU . 36.2 tt0 -72.7 8.47 1.46 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 104.839 -2.282 . . . . 99.989999999999995 104.839 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.75 ' H ' ' C ' ' A' ' 161' ' ' THR . 26.4 mttt -81.24 -6.31 58.73 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.196 -1.82 . . . . 99.989999999999995 108.16 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -126.89 -67.84 0.16 Allowed Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 106.648 -2.581 . . . . 99.989999999999995 106.648 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.457 ' CD1' ' SG ' ' A' ' 157' ' ' CYS . 4.7 mt -41.68 -7.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.025 -0.67 . . . . 99.989999999999995 112.652 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 164' ' ' GLY . 48.7 tttt -83.51 -45.49 13.53 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.455 -0.942 . . . . 99.989999999999995 108.455 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 164' ' ' GLY . 24.4 m120 -81.22 4.75 19.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.031 -0.986 . . . . 99.989999999999995 109.29 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.406 ' CG2' ' HA ' ' A' ' 165' ' ' LEU . 58.2 t -86.8 -62.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.514 -0.766 . . . . 99.989999999999995 110.765 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -45.19 -40.44 7.21 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 119.641 -0.824 . . . . 99.989999999999995 109.217 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -68.04 -42.96 79.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.075 -0.511 . . . . 99.989999999999995 110.203 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.99 -27.85 69.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 99.989999999999995 109.973 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.76 -32.29 73.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.636 -0.711 . . . . 99.989999999999995 110.92 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.1 pp -64.61 -27.21 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.658 -0.417 . . . . 99.989999999999995 110.338 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.84 -35.02 79.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 99.989999999999995 110.569 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.46 -28.93 62.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.119 -0.491 . . . . 99.989999999999995 111.839 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -59.46 -42.18 91.41 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.808 0.299 . . . . 99.989999999999995 111.808 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.85 -25.93 66.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.411 . . . . 99.989999999999995 110.483 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 99.989999999999995 110.52 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' THR . 90.4 mt-30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.871 0.367 . . . . 99.989999999999995 110.581 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -40.52 134.96 1.65 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.676 -0.49 . . . . 99.989999999999995 109.676 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.2 tp -123.79 144.6 32.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.091 -0.504 . . . . 99.989999999999995 110.727 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -100.88 153.83 19.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.272 0.558 . . . . 99.989999999999995 111.365 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -135.65 160.38 38.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.814 . . . . 99.989999999999995 109.892 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.537 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 33.1 m -125.4 157.47 34.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.786 -0.366 . . . . 99.989999999999995 110.458 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.47 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 21.6 t -108.76 126.65 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 120.377 -0.529 . . . . 99.989999999999995 111.294 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.9 t -133.66 129.26 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 99.989999999999995 109.651 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.602 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . -164.59 -143.09 3.6 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.226 -0.988 . . . . 99.989999999999995 111.444 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.5 t0 -83.42 111.63 19.2 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.652 -0.499 . . . . 99.989999999999995 109.652 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 28.2 -90.3 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.986 -0.846 . . . . 99.989999999999995 110.986 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -131.23 126.8 36.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.071 0.462 . . . . 99.989999999999995 111.56 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.55 ' C ' ' H ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -136.52 -174.4 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.7 -0.682 . . . . 99.989999999999995 109.303 178.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -65.08 42.24 0.11 Allowed Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.218 -0.753 . . . . 99.989999999999995 111.218 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 59' ' ' ALA . 37.1 mttt -62.05 -36.4 81.5 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.586 0.217 . . . . 99.989999999999995 111.586 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.7 m -66.04 -48.85 69.71 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.109 0.411 . . . . 99.989999999999995 112.109 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -62.37 -29.92 70.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.152 0.501 . . . . 99.989999999999995 110.727 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.7 tp -57.29 -41.36 79.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.416 -0.811 . . . . 99.989999999999995 110.858 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tt -66.99 -37.93 85.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 99.989999999999995 110.672 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.454 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 93.4 mt -70.31 3.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.613 -0.721 . . . . 99.989999999999995 111.195 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.483 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 10.5 t -62.38 -74.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.765 -0.374 . . . . 99.989999999999995 111.864 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.614 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 0.7 OUTLIER -59.93 -31.06 69.49 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 119.73 -0.788 . . . . 99.989999999999995 110.234 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 6.7 m -52.04 -43.36 63.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.666 -0.697 . . . . 99.989999999999995 111.489 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -163.14 -38.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.601 -0.439 . . . . 99.989999999999995 111.377 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 22' ' ' SER . 2.6 p-10 43.55 95.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.759 -0.46 . . . . 99.989999999999995 109.759 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -152.92 13.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 99.989999999999995 111.4 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 tp 61.24 60.64 3.07 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.213 0.53 . . . . 99.989999999999995 110.519 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.35 -168.43 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.862 2.375 . . . . 99.989999999999995 112.003 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 m -56.71 151.04 14.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 110.455 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.76 -34.74 74.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 99.989999999999995 111.069 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -115.54 132.21 56.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.426 -0.352 . . . . 99.989999999999995 110.737 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.05 70.64 82.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 110.394 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.07 9.53 3.02 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.994 2.463 . . . . 99.989999999999995 112.678 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.1 m -51.5 -38.92 56.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 99.989999999999995 110.65 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.7 p -130.09 141.8 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.398 . . . . 99.989999999999995 110.252 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -58.2 -49.5 76.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.368 -0.378 . . . . 99.989999999999995 110.279 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 51.3 p30 -176.14 157.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 99.989999999999995 110.544 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' LEU . 38.0 t-20 -124.45 169.27 12.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 99.989999999999995 110.55 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.456 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -178.36 11.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 99.989999999999995 110.172 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.24 100.31 3.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.857 -0.61 . . . . 99.989999999999995 109.857 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.411 ' CG1' ' OH ' ' A' ' 23' ' ' TYR . 42.2 t -134.87 134.17 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 99.989999999999995 111.217 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.8 t -119.44 126.64 51.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.941 -0.572 . . . . 99.989999999999995 110.422 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.76 144.88 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 99.989999999999995 110.676 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 73.8 mtm -105.76 123.53 48.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.527 . . . . 99.989999999999995 110.14 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.4 mt -132.72 117.11 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.867 -0.333 . . . . 99.989999999999995 110.804 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.35 70.96 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.116 -0.793 . . . . 99.989999999999995 111.116 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.07 43.9 15.46 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.78 -0.928 . . . . 99.989999999999995 110.78 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.494 ' OE1' ' OD1' ' A' ' 170' ' ' ASP . 64.8 mt-10 -123.2 86.01 51.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 110.509 -0.182 . . . . 99.989999999999995 110.509 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.467 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 50.2 Cg_endo -76.9 102.02 1.57 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.211 1.941 . . . . 99.989999999999995 112.423 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 88.9 m-85 -155.46 170.39 22.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.728 -0.669 . . . . 99.989999999999995 109.965 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.402 ' H ' ' HB ' ' A' ' 3' ' ' THR . 3.4 p -134.8 142.83 46.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.248 -0.581 . . . . 99.989999999999995 111.159 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.0 tp -122.36 126.85 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 99.989999999999995 109.954 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -98.07 130.72 10.33 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.557 -0.83 . . . . 99.989999999999995 111.695 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 39' ' ' ASN . 66.6 mt -116.76 123.41 47.09 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.079 -0.341 . . . . 99.989999999999995 110.079 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.532 ' O ' ' O ' ' A' ' 57' ' ' ASP . 34.9 t80 -91.15 32.13 1.05 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.5 -0.48 . . . . 99.989999999999995 111.961 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 56' ' ' PHE . 50.5 p30 -36.24 168.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.062 0.458 . . . . 99.989999999999995 112.059 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.515 ' H ' ' CB ' ' A' ' 16' ' ' LYS . 46.4 m 59.8 53.67 4.72 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.052 -0.522 . . . . 99.989999999999995 111.174 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.595 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . . . -141.36 157.34 45.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.391 . . . . 99.989999999999995 110.429 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.738 0 N-CA-C 111.44 -0.664 . . . . 99.989999999999995 111.44 179.898 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.537 0.208 . . . . 99.989999999999995 110.978 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.7 t -131.09 150.63 52.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.231 -0.285 . . . . 99.989999999999995 110.231 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD2' ' OE2' ' A' ' 178' ' ' GLU . 88.1 m-20 -127.37 -15.69 5.08 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.58 -0.448 . . . . 99.989999999999995 111.639 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.12 107.56 13.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.493 -0.483 . . . . 99.989999999999995 110.941 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -74.04 135.29 43.06 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.424 -0.511 . . . . 99.989999999999995 110.721 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tt -117.47 125.26 50.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.788 -0.642 . . . . 99.989999999999995 109.966 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.7 m -100.66 132.27 46.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.513 -0.475 . . . . 99.989999999999995 109.949 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.7 t -125.91 128.46 47.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.398 0.618 . . . . 99.989999999999995 111.675 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.486 ' CZ ' ' CE ' ' A' ' 94' ' ' LYS . 12.8 p90 -153.44 157.63 40.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.394 -0.821 . . . . 99.989999999999995 109.511 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.52 ' OG ' ' CB ' ' A' ' 89' ' ' SER . 16.3 p -66.42 132.33 48.06 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.151 -1.055 . . . . 99.989999999999995 108.151 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.71 32.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 119.795 -0.762 . . . . 99.989999999999995 112.934 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' A' ' 119' ' ' LEU . 32.6 m -121.62 160.78 22.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.075 0.464 . . . . 99.989999999999995 110.347 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -42.22 -58.61 3.34 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 113.143 0.794 . . . . 99.989999999999995 113.143 -179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 89' ' ' SER . 20.0 Cg_exo -22.69 65.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 124.634 3.556 . . . . 99.989999999999995 115.984 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 86' ' ' SER . 50.5 m 34.02 10.76 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.305 1.224 . . . . 99.989999999999995 114.305 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 87' ' ' PRO . 88.5 p -69.46 -33.67 73.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.388 0.54 . . . . 99.989999999999995 110.806 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.6 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 5.8 p90 -89.12 -41.38 12.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 99.989999999999995 111.202 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.6 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.7 tt0 -55.98 -34.17 65.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.94 -0.573 . . . . 99.989999999999995 112.267 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 96' ' ' LYS . 73.4 m-20 -85.75 -64.4 1.16 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.486 -0.485 . . . . 99.989999999999995 112.123 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 52.7 t -49.67 -52.97 11.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.714 0.635 . . . . 99.989999999999995 112.714 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.486 ' CE ' ' CZ ' ' A' ' 82' ' ' PHE . 23.3 mttm -67.37 -20.08 65.51 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.734 0.642 . . . . 99.989999999999995 112.734 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 84.4 tt0 -126.61 -58.54 1.32 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.228 0.825 . . . . 99.989999999999995 113.228 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 92' ' ' ASN . 14.7 tptp -60.49 -35.2 75.36 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.937 0.718 . . . . 99.989999999999995 112.937 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 10' ' ' GLY . 42.2 m95 -84.16 -35.0 23.9 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.032 -0.667 . . . . 99.989999999999995 111.006 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 97' ' ' TRP . 2.3 t -37.45 -54.53 2.1 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.779 -0.368 . . . . 99.989999999999995 111.162 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.431 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 20.0 Cg_endo -63.64 -36.5 52.4 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 121.271 1.314 . . . . 99.989999999999995 110.979 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 97' ' ' TRP . 48.2 tp10 -61.45 -43.91 98.04 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.384 -0.526 . . . . 99.989999999999995 110.042 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.9 mt -74.74 -35.3 36.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 99.989999999999995 110.812 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 42.7 m -50.49 -41.7 53.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 99.989999999999995 111.023 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -57.7 -39.9 78.24 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.81 -0.356 . . . . 99.989999999999995 110.363 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -58.37 -44.9 89.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 99.989999999999995 111.003 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.483 ' O ' ' OG1' ' A' ' 108' ' ' THR . 8.6 t -167.48 108.61 0.61 Allowed Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.917 -0.313 . . . . 99.989999999999995 110.925 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.49 150.56 22.09 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.199 1.933 . . . . 99.989999999999995 112.419 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 60.41 49.37 6.91 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.208 -0.451 . . . . 99.989999999999995 110.972 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -121.42 108.81 35.34 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.35 -0.387 . . . . 99.989999999999995 110.814 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -47.82 148.29 6.39 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.993 1.796 . . . . 99.989999999999995 111.441 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 152' ' ' VAL . 20.3 p90 -151.02 161.63 42.37 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.453 -0.899 . . . . 99.989999999999995 112.824 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 mp -96.6 127.51 42.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.013 -0.994 . . . . 99.989999999999995 110.347 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 tp -88.77 119.86 29.64 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.49 -0.93 . . . . 99.989999999999995 108.49 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 114' ' ' GLY . 40.0 t -136.3 165.3 29.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 99.989999999999995 111.815 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -142.15 174.36 23.29 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.817 -1.313 . . . . 99.989999999999995 109.817 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 12.5 t -137.79 161.14 37.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.949 0.404 . . . . 99.989999999999995 110.451 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.542 ' O ' ' C ' ' A' ' 117' ' ' ILE . 2.8 mm100 54.55 33.19 18.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.066 -0.516 . . . . 99.989999999999995 110.773 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.634 ' CG2' ' N ' ' A' ' 118' ' ' ASP . 7.2 tt 21.84 -138.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.424 0 O-C-N 123.544 0.527 . . . . 99.989999999999995 110.812 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.634 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 23.7 p30 -87.07 83.49 7.46 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.9 -0.72 . . . . 99.989999999999995 109.277 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.589 ' N ' ' CG1' ' A' ' 85' ' ' VAL . 16.6 tp 56.75 42.5 26.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.354 -0.839 . . . . 99.989999999999995 109.023 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 . . . . . 0 CA--C 1.519 -0.238 0 CA-C-N 115.586 -0.734 . . . . 99.989999999999995 109.152 -179.311 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.849 0.356 . . . . 99.989999999999995 110.226 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.519 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.49 -64.34 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.761 -0.376 . . . . 99.989999999999995 111.802 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.519 ' HD2' ' H ' ' A' ' 138' ' ' THR . 72.1 Cg_exo -22.52 -72.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 123.495 2.797 . . . . 99.989999999999995 113.485 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -102.45 -44.28 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.538 -0.465 . . . . 99.989999999999995 112.047 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 41.9 m -51.39 -46.26 62.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.428 0.529 . . . . 99.989999999999995 112.428 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.425 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . . . -76.73 -38.57 54.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.496 -0.482 . . . . 99.989999999999995 111.825 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.444 ' CD ' ' O ' ' A' ' 139' ' ' PRO . 97.7 mt-10 -60.21 -39.47 86.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.555 -0.458 . . . . 99.989999999999995 111.255 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.96 -49.62 75.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 99.989999999999995 109.96 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 91.1 mt -57.56 -31.93 66.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 99.989999999999995 111.475 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.69 75.73 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.503 -0.479 . . . . 99.989999999999995 109.942 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -59.75 -35.38 74.47 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.614 -0.721 . . . . 99.989999999999995 109.611 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -49.56 -31.17 9.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.94 -1.133 . . . . 99.989999999999995 107.94 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.6 mt -126.68 -114.64 0.28 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.816 -1.084 . . . . 99.989999999999995 108.633 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -175.9 71.85 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.132 -0.485 . . . . 99.989999999999995 111.87 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.415 ' CB ' ' CE1' ' A' ' 110' ' ' PHE . . . -61.01 -138.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.841 0.353 . . . . 99.989999999999995 110.628 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 110' ' ' PHE . 54.9 t -154.16 -50.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 110.829 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.56 ' NZ ' ' OE1' ' A' ' 171' ' ' GLU . 1.1 mmtm -114.41 -175.62 2.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 121.093 -0.243 . . . . 99.989999999999995 110.651 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.653 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -170.7 96.21 0.22 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.832 -1.173 . . . . 99.989999999999995 107.832 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.51 142.95 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.515 0.674 . . . . 99.989999999999995 111.245 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.736 ' O ' ' OG1' ' A' ' 161' ' ' THR . 3.6 pt-20 -119.92 96.19 5.07 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.487 -1.301 . . . . 99.989999999999995 107.487 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -120.25 131.11 54.8 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 114.403 1.26 . . . . 99.989999999999995 114.403 -176.165 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 160' ' ' LEU . 77.1 p -119.83 87.94 2.84 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 103.929 -2.619 . . . . 99.989999999999995 103.929 173.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 37.02 26.93 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.245 -1.02 . . . . 99.989999999999995 108.245 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.865 ' O ' ' N ' ' A' ' 162' ' ' GLN . 34.9 tp -133.64 -79.25 0.47 Allowed 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 114.811 -1.086 . . . . 99.989999999999995 111.467 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 4.6 m -45.59 49.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.323 0.86 . . . . 99.989999999999995 113.323 -176.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.865 ' N ' ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -71.49 0.81 7.52 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 104.623 -2.362 . . . . 99.989999999999995 104.623 175.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.659 ' H ' ' C ' ' A' ' 161' ' ' THR . 8.7 mtmp? -58.86 -23.54 60.99 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 113.546 -1.661 . . . . 99.989999999999995 106.849 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -119.28 -65.99 0.29 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 107.387 -2.285 . . . . 99.989999999999995 107.387 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.41 ' CB ' ' OG ' ' A' ' 22' ' ' SER . 0.5 OUTLIER -40.67 -10.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.689 0.626 . . . . 99.989999999999995 112.689 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.647 ' N ' ' O ' ' A' ' 164' ' ' GLY . 41.8 tttp -91.52 -42.05 10.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.706 -1.22 . . . . 99.989999999999995 107.706 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.584 ' N ' ' O ' ' A' ' 164' ' ' GLY . 78.3 m-20 -81.98 -0.03 42.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.651 -1.159 . . . . 99.989999999999995 109.135 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.7 t -77.98 -57.82 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 109.495 -0.557 . . . . 99.989999999999995 109.495 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.614 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 46.8 m-85 -48.79 -43.54 38.16 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 119.816 -0.754 . . . . 99.989999999999995 109.686 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.494 ' OD1' ' OE1' ' A' ' 49' ' ' GLU . 62.6 t0 -67.12 -49.48 64.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.205 0.526 . . . . 99.989999999999995 109.913 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.56 ' OE1' ' NZ ' ' A' ' 153' ' ' LYS . 87.5 tt0 -59.06 -25.54 63.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.403 -0.591 . . . . 99.989999999999995 109.403 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.02 -32.2 61.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.813 -0.631 . . . . 99.989999999999995 109.314 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.413 ' CG2' ' O ' ' A' ' 170' ' ' ASP . 3.6 tt -59.13 -30.08 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.28 -0.637 . . . . 99.989999999999995 109.28 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.7 tp -57.42 -38.54 74.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.602 -0.726 . . . . 99.989999999999995 110.1 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.79 62.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 99.989999999999995 111.131 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.59 -32.28 73.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.828 0.346 . . . . 99.989999999999995 110.562 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.02 -34.04 71.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 99.989999999999995 110.456 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.483 ' OE2' ' OD2' ' A' ' 76' ' ' ASP . 96.9 mt-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 99.989999999999995 110.561 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' THR . 92.6 mt-30 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.827 0.346 . . . . 99.989999999999995 110.53 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.6 OUTLIER -38.48 133.56 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 99.989999999999995 110.16 -179.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 tp -131.06 152.21 37.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.761 -0.654 . . . . 99.989999999999995 110.336 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 54' ' ' GLY . 25.2 mttm -109.26 161.26 15.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.198 0.523 . . . . 99.989999999999995 111.504 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -122.85 144.96 48.86 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.491 -0.777 . . . . 99.989999999999995 109.457 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.5 145.28 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.345 0.498 . . . . 99.989999999999995 112.345 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.0 128.12 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.495 -0.775 . . . . 99.989999999999995 112.05 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 81' ' ' CYS . 44.8 t -141.77 128.45 19.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.097 -0.956 . . . . 99.989999999999995 108.788 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.53 -174.96 38.13 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.884 -1.151 . . . . 99.989999999999995 112.106 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.404 ' H ' ' CG2' ' A' ' 93' ' ' VAL . 60.5 t0 -90.96 124.24 35.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.973 0.416 . . . . 99.989999999999995 110.755 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . -47.39 101.82 0.04 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.89 -0.884 . . . . 99.989999999999995 110.89 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 150.16 30.67 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.707 0.299 . . . . 99.989999999999995 110.871 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.2 m -127.47 132.84 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.685 -0.406 . . . . 99.989999999999995 111.024 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.53 97.75 2.27 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.169 -0.539 . . . . 99.989999999999995 112.555 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.428 ' HD2' ' H ' ' A' ' 58' ' ' THR . 23.4 mttm -83.0 -2.51 55.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.674 0.273 . . . . 99.989999999999995 110.964 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.2 m -65.93 -57.78 7.07 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.562 -0.29 . . . . 99.989999999999995 111.742 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.3 m -68.73 -25.95 65.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.489 0.661 . . . . 99.989999999999995 110.14 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 7.4 tp -50.94 -56.15 13.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.124 -0.944 . . . . 99.989999999999995 111.641 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 22' ' ' SER . 55.2 mt -71.19 -35.09 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.425 -0.352 . . . . 99.989999999999995 111.83 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 tt -47.7 -11.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.443 -0.503 . . . . 99.989999999999995 110.268 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.721 ' HG ' ' H ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -55.75 -76.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 119.686 -0.806 . . . . 99.989999999999995 110.318 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.721 ' H ' ' HG ' ' A' ' 22' ' ' SER . 49.7 t80 -56.59 -39.21 73.15 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 119.202 -0.999 . . . . 99.989999999999995 110.916 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -66.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.548 0.573 . . . . 99.989999999999995 112.548 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 73.6 p -111.72 -23.57 10.55 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.351 0.501 . . . . 99.989999999999995 112.351 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 25' ' ' THR . 31.6 t30 83.35 95.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.909 0.385 . . . . 99.989999999999995 110.658 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 26' ' ' ASN . 11.2 pttm 33.32 73.26 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.279 0.561 . . . . 99.989999999999995 111.574 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.26 79.45 70.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.906 -0.588 . . . . 99.989999999999995 110.414 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.89 146.69 77.82 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.912 2.408 . . . . 99.989999999999995 112.742 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -128.33 143.18 50.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 99.989999999999995 110.139 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.86 -36.61 72.58 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.828 -0.349 . . . . 99.989999999999995 110.734 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 33' ' ' VAL . 77.4 t80 -124.82 138.23 54.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.211 -0.45 . . . . 99.989999999999995 110.597 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.408 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 9.6 t -73.0 123.32 89.46 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.261 -0.427 . . . . 99.989999999999995 110.519 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.39 158.12 36.81 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.227 1.951 . . . . 99.989999999999995 112.057 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -76.97 157.03 31.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 99.989999999999995 110.437 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.38 156.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 99.989999999999995 110.835 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.83 156.83 29.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 99.989999999999995 110.186 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -73.94 88.57 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.947 0.403 . . . . 99.989999999999995 110.357 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -144.77 108.73 4.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 110.347 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.65 ' CB ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -101.2 -24.71 14.21 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.858 -0.423 . . . . 99.989999999999995 109.858 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.27 95.53 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 120.12 -0.632 . . . . 99.989999999999995 109.352 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.4 t -134.81 137.59 50.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.037 -0.983 . . . . 99.989999999999995 111.232 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 t -120.41 133.98 55.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 99.989999999999995 110.726 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.408 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 8.8 p -141.31 141.8 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 99.989999999999995 110.408 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.9 mtm -110.5 118.84 37.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.451 -0.34 . . . . 99.989999999999995 110.435 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.0 mt -129.14 119.57 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.334 -0.394 . . . . 99.989999999999995 110.554 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.94 25.85 73.22 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.046 -0.822 . . . . 99.989999999999995 111.046 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.22 48.54 14.6 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.742 -0.943 . . . . 99.989999999999995 110.742 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -131.87 105.27 14.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 110.38 -0.23 . . . . 99.989999999999995 110.38 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.59 100.09 1.2 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.132 1.888 . . . . 99.989999999999995 112.479 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.479 ' CD1' ' CD1' ' A' ' 173' ' ' ILE . 33.5 p90 -142.08 165.58 27.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.458 . . . . 99.989999999999995 110.317 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.29 127.49 35.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.067 0.461 . . . . 99.989999999999995 111.812 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.8 tp -107.36 138.08 44.22 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.833 -0.621 . . . . 99.989999999999995 109.842 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -81.6 147.6 26.9 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.365 -1.094 . . . . 99.989999999999995 110.365 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.65 ' H ' ' CB ' ' A' ' 40' ' ' TYR . 48.3 mt -99.51 98.52 9.41 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 119.623 -0.831 . . . . 99.989999999999995 111.243 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 57' ' ' ASP . 7.9 p90 -55.54 -27.36 48.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.747 -1.115 . . . . 99.989999999999995 111.51 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 58' ' ' THR . 63.6 t0 -17.09 139.88 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.947 0.779 . . . . 99.989999999999995 112.578 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.54 ' CB ' ' O ' ' A' ' 57' ' ' ASP . 1.1 m 155.33 149.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.832 -0.622 . . . . 99.989999999999995 110.304 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.12 151.96 20.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.309 -0.405 . . . . 99.989999999999995 110.543 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.654 0 N-CA-C 110.655 -0.978 . . . . 99.989999999999995 110.655 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.503 ' O ' ' O ' ' A' ' 75' ' ' THR . 97.4 mt-30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.866 0.365 . . . . 99.989999999999995 111.031 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 74' ' ' GLN . 59.8 p 44.43 -178.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.888 -0.596 . . . . 99.989999999999995 111.208 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -123.3 -26.96 4.19 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.345 -0.389 . . . . 99.989999999999995 111.636 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.34 110.67 31.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 120.473 -0.491 . . . . 99.989999999999995 110.941 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -76.13 132.19 39.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.088 0.471 . . . . 99.989999999999995 111.52 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.488 ' CD2' ' CE1' ' A' ' 56' ' ' PHE . 4.1 mp -109.1 99.64 8.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.611 -0.722 . . . . 99.989999999999995 110.699 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 17.4 t -65.38 134.74 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.008 -0.542 . . . . 99.989999999999995 109.734 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' VAL . 19.0 t -123.85 130.32 52.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.427 . . . . 99.989999999999995 111.093 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.46 ' CG ' ' O ' ' A' ' 82' ' ' PHE . 39.0 p90 -167.87 129.17 1.44 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.738 -0.665 . . . . 99.989999999999995 110.347 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.452 ' HA ' ' H ' ' A' ' 115' ' ' THR . 90.1 p -56.69 134.24 54.58 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.724 -1.213 . . . . 99.989999999999995 107.724 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.526 ' CG1' ' OG1' ' A' ' 138' ' ' THR . 6.3 t -90.38 8.2 3.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 120.011 -0.676 . . . . 99.989999999999995 112.446 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.26 20.39 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.943 0.402 . . . . 99.989999999999995 110.163 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 t -139.61 137.7 19.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.57 . . . . 99.989999999999995 110.196 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.494 ' O ' ' CD1' ' A' ' 90' ' ' PHE . 61.0 Cg_endo -73.76 -27.04 12.94 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.197 1.932 . . . . 99.989999999999995 113.224 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.2 p -81.6 -29.38 33.32 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.138 0.422 . . . . 99.989999999999995 112.138 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -62.25 -37.42 85.36 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.872 -0.331 . . . . 99.989999999999995 111.612 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.528 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 2.0 p90 -91.25 -36.95 13.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.884 0.373 . . . . 99.989999999999995 111.328 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 85.6 tt0 -56.56 -38.43 71.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.028 -0.533 . . . . 99.989999999999995 112.182 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 96' ' ' LYS . 9.6 m120 -90.0 -47.39 7.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.883 -0.727 . . . . 99.989999999999995 111.211 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.458 ' CG1' ' CG1' ' A' ' 80' ' ' VAL . 42.9 t -57.31 -56.09 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.84 0.681 . . . . 99.989999999999995 112.84 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -71.32 -11.44 60.91 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.083 0.401 . . . . 99.989999999999995 112.083 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -125.73 -65.78 0.98 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.852 0.686 . . . . 99.989999999999995 112.852 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 92' ' ' ASN . 81.1 mttt -61.17 -33.31 73.22 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.411 0.893 . . . . 99.989999999999995 113.411 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -83.2 -31.47 27.06 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.973 -0.691 . . . . 99.989999999999995 110.777 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.483 ' O ' ' OG1' ' A' ' 102' ' ' THR . 2.2 t -40.77 -54.28 5.36 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.608 -0.437 . . . . 99.989999999999995 110.977 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 33.1 Cg_endo -66.11 -32.03 44.24 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.667 1.578 . . . . 99.989999999999995 111.51 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -61.62 -38.52 87.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.014 -0.539 . . . . 99.989999999999995 110.984 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.0 pt -94.42 -30.7 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 120.872 -0.331 . . . . 99.989999999999995 111.515 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' CYS . 55.4 m -60.28 -41.08 92.57 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.869 -0.332 . . . . 99.989999999999995 110.928 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -60.62 -39.13 87.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.349 -0.387 . . . . 99.989999999999995 110.556 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -57.26 -44.03 83.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 99.989999999999995 111.014 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -150.53 159.93 33.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 99.989999999999995 110.876 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.48 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 9.6 Cg_endo -55.32 155.86 18.89 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.877 2.385 . . . . 99.989999999999995 111.851 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -62.93 130.05 43.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.407 -0.36 . . . . 99.989999999999995 110.317 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.99 158.83 54.95 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 99.989999999999995 110.502 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.47 143.91 10.92 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.166 1.911 . . . . 99.989999999999995 112.064 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 152' ' ' VAL . 21.2 p90 -147.62 156.83 43.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.691 -0.804 . . . . 99.989999999999995 112.103 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 129.61 48.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.018 -0.992 . . . . 99.989999999999995 110.421 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.8 mt -84.26 132.12 34.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.285 -0.566 . . . . 99.989999999999995 109.498 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.3 t -144.69 151.47 15.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.28 -0.418 . . . . 99.989999999999995 111.048 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.494 ' O ' ' CD1' ' A' ' 19' ' ' LEU . . . -145.36 176.21 24.5 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.628 -0.796 . . . . 99.989999999999995 111.625 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.452 ' H ' ' HA ' ' A' ' 83' ' ' SER . 9.2 p -121.66 179.13 4.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.852 -0.425 . . . . 99.989999999999995 109.852 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.572 ' N ' ' CB ' ' A' ' 158' ' ' SER . 98.7 mm-40 36.44 37.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.018 -0.537 . . . . 99.989999999999995 111.049 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.595 ' CG2' ' H ' ' A' ' 119' ' ' LEU . 5.8 tt 29.42 -150.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.435 0 O-C-N 123.071 0.232 . . . . 99.989999999999995 110.512 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -108.76 11.09 26.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.433 -0.507 . . . . 99.989999999999995 110.991 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.595 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 5.7 mp -139.22 12.19 2.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.893 -0.594 . . . . 99.989999999999995 110.981 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.523 ' C ' ' O ' ' A' ' 119' ' ' LEU . 25.4 ptt180 . . . . . 0 N--CA 1.467 0.392 0 O-C-N 123.204 0.315 . . . . 99.989999999999995 110.18 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.421 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 15.3 tt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.897 0.38 . . . . 99.989999999999995 110.596 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.612 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -119.6 -41.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 112.916 0.71 . . . . 99.989999999999995 112.916 -178.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.612 ' CD ' ' H ' ' A' ' 138' ' ' THR . 73.2 Cg_exo -47.97 -64.04 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.215 1.944 . . . . 99.989999999999995 113.262 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -105.9 -44.69 4.55 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.393 0.516 . . . . 99.989999999999995 112.393 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.5 m -51.85 -43.3 63.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.952 -0.299 . . . . 99.989999999999995 111.762 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.77 -28.01 33.48 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.584 -0.446 . . . . 99.989999999999995 110.912 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.25 -44.13 95.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 99.989999999999995 111.03 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -63.86 -41.61 97.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 99.989999999999995 110.37 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 87.2 mt -61.31 -31.44 71.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.863 -0.608 . . . . 99.989999999999995 111.268 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.31 -40.49 70.78 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.244 -0.582 . . . . 99.989999999999995 109.46 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -56.48 -37.06 69.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.375 -0.829 . . . . 99.989999999999995 109.405 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.74 -25.35 10.87 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.054 -1.091 . . . . 99.989999999999995 108.054 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.3 mt -134.73 -115.12 0.2 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.456 -1.247 . . . . 99.989999999999995 107.844 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 151' ' ' ALA . 37.9 pttt 178.42 75.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.076 -0.511 . . . . 99.989999999999995 111.46 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.498 ' CB ' ' CE1' ' A' ' 110' ' ' PHE . . . -56.04 -145.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.975 0.417 . . . . 99.989999999999995 111.843 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 110' ' ' PHE . 75.1 t -136.69 -56.03 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.558 -0.746 . . . . 99.989999999999995 110.978 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.455 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 24.6 tttt -125.46 -167.68 1.72 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.635 -0.257 . . . . 99.989999999999995 110.793 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 153' ' ' LYS . 51.0 m-85 -156.67 96.71 1.66 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.691 -1.225 . . . . 99.989999999999995 107.691 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.32 139.52 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 122.148 0.975 . . . . 99.989999999999995 111.515 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.742 ' O ' ' OG1' ' A' ' 161' ' ' THR . 10.4 pt-20 -122.36 98.0 5.72 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.539 -1.664 . . . . 99.989999999999995 106.613 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.469 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -123.94 145.75 48.94 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 123.18 1.467 . . . . 99.989999999999995 113.112 -175.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.572 ' CB ' ' N ' ' A' ' 116' ' ' GLN . 10.0 t -173.22 93.89 0.1 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 112.013 -2.358 . . . . 99.989999999999995 107.831 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 50.21 38.74 18.08 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.642 -1.163 . . . . 99.989999999999995 110.332 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.72 ' O ' ' N ' ' A' ' 162' ' ' GLN . 22.1 tp -165.09 -82.17 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.866 -0.606 . . . . 99.989999999999995 111.031 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.742 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.8 OUTLIER -52.37 55.54 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.418 0.525 . . . . 99.989999999999995 112.418 -177.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.72 ' N ' ' O ' ' A' ' 160' ' ' LEU . 2.3 pp0? -80.42 15.8 1.52 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 105.692 -1.966 . . . . 99.989999999999995 105.692 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.645 ' H ' ' C ' ' A' ' 161' ' ' THR . 99.5 mttt -84.65 -3.44 58.51 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 113.751 -1.568 . . . . 99.989999999999995 108.426 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.45 -72.62 0.1 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.276 -1.93 . . . . 99.989999999999995 108.276 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -40.61 -16.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.333 -0.547 . . . . 99.989999999999995 111.366 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' A' ' 164' ' ' GLY . 81.2 tttt -84.57 -49.53 8.5 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.415 -0.957 . . . . 99.989999999999995 108.415 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 164' ' ' GLY . 81.3 m-20 -78.16 4.5 12.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.806 -1.088 . . . . 99.989999999999995 109.371 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.29 -58.73 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.885 -0.598 . . . . 99.989999999999995 110.2 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.477 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 94.4 m-85 -44.41 -44.7 8.57 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.032 -0.667 . . . . 99.989999999999995 109.521 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.404 ' N ' ' HH ' ' A' ' 51' ' ' TYR . 60.0 t0 -69.38 -44.41 71.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.401 -0.363 . . . . 99.989999999999995 110.398 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.99 -25.17 68.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.22 -0.446 . . . . 99.989999999999995 110.15 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.46 -35.58 68.07 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.261 -0.644 . . . . 99.989999999999995 109.261 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 51' ' ' TYR . 91.6 mt -55.19 -43.09 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.616 -0.883 . . . . 99.989999999999995 108.616 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 8.0 mp -70.28 -36.18 74.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.296 -0.865 . . . . 99.989999999999995 110.002 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.63 -32.97 74.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.891 -0.595 . . . . 99.989999999999995 110.393 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.59 72.76 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.784 -0.45 . . . . 99.989999999999995 109.784 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.2 tp -59.32 -35.25 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.928 -0.578 . . . . 99.989999999999995 109.684 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 99.989999999999995 110.53 179.912 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 121.288 0.566 . . . . 99.989999999999995 110.062 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.402 ' HB ' ' HG1' ' A' ' 52' ' ' THR . 0.6 OUTLIER -107.83 150.27 27.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.551 -0.75 . . . . 99.989999999999995 110.6 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp -127.36 147.25 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 99.989999999999995 110.526 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -86.0 135.38 33.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.872 0.368 . . . . 99.989999999999995 110.539 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -135.94 130.9 34.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.0 -0.545 . . . . 99.989999999999995 110.283 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.9 134.75 44.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.221 -0.659 . . . . 99.989999999999995 109.221 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.545 ' CG1' ' OD1' ' A' ' 57' ' ' ASP . 75.1 t -114.09 125.83 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 120.194 -0.602 . . . . 99.989999999999995 111.302 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 p -136.94 146.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.339 -0.846 . . . . 99.989999999999995 109.486 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . -117.66 -157.44 10.68 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.663 -0.78 . . . . 99.989999999999995 111.558 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 11' ' ' ASP . 51.3 p30 -74.09 24.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.067 0.46 . . . . 99.989999999999995 110.029 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 125.34 -77.32 0.38 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.557 -1.017 . . . . 99.989999999999995 110.557 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.86 94.9 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 99.989999999999995 110.472 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.04 169.56 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 99.989999999999995 110.389 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.589 ' C ' ' HG1' ' A' ' 115' ' ' THR . . . -69.05 56.46 0.57 Allowed Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.958 -0.457 . . . . 99.989999999999995 111.958 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -81.03 0.81 34.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.883 0.373 . . . . 99.989999999999995 110.255 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.8 p -69.16 -38.83 78.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.038 -0.528 . . . . 99.989999999999995 111.469 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.85 -14.54 31.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.136 0.494 . . . . 99.989999999999995 110.603 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.419 ' CD2' ' SG ' ' A' ' 81' ' ' CYS . 22.1 tp -59.8 -45.36 92.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.593 -0.731 . . . . 99.989999999999995 111.375 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pp -74.07 -33.77 63.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 99.989999999999995 111.333 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.75 -5.72 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.194 -0.457 . . . . 99.989999999999995 110.346 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.492 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 43.7 t -44.82 -80.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.428 -0.509 . . . . 99.989999999999995 111.315 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -55.78 -38.33 69.77 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 120.361 -0.536 . . . . 99.989999999999995 110.535 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.592 ' O ' ' CB ' ' A' ' 25' ' ' THR . 3.7 m -44.54 -34.12 2.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.453 -0.794 . . . . 99.989999999999995 110.208 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' THR . 13.3 m 107.78 92.14 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.32 1.012 . . . . 99.989999999999995 109.839 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.513 ' ND2' ' CB ' ' A' ' 159' ' ' ALA . 27.8 t30 -110.22 -75.93 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 99.989999999999995 110.308 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt 57.95 43.42 21.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.999 -0.546 . . . . 99.989999999999995 111.246 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp 41.33 68.8 2.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.873 0.368 . . . . 99.989999999999995 110.248 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.48 157.15 22.11 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 123.014 2.476 . . . . 99.989999999999995 112.596 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.575 ' C ' ' H ' ' A' ' 32' ' ' TYR . 20.2 m -56.91 -27.95 61.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 99.989999999999995 110.315 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -57.82 -2.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 99.989999999999995 110.265 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.575 ' H ' ' C ' ' A' ' 30' ' ' SER . 41.4 m-85 70.43 -116.01 0.1 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.765 -0.652 . . . . 99.989999999999995 111.145 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.28 79.45 66.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.859 -0.336 . . . . 99.989999999999995 111.482 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.53 154.08 44.41 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.663 2.242 . . . . 99.989999999999995 111.323 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -130.01 147.35 51.75 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.525 -0.47 . . . . 99.989999999999995 110.967 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.6 t -131.01 140.18 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.668 -0.696 . . . . 99.989999999999995 109.948 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -95.62 134.87 38.02 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.745 -0.382 . . . . 99.989999999999995 110.798 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 59.32 45.21 14.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.922 -0.581 . . . . 99.989999999999995 111.213 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LEU . 51.6 t-20 -97.79 124.03 41.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.346 . . . . 99.989999999999995 110.532 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.631 ' CG ' ' N ' ' A' ' 41' ' ' ALA . 17.4 p90 -165.28 -48.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.96 -0.564 . . . . 99.989999999999995 109.488 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.631 ' N ' ' CG ' ' A' ' 40' ' ' TYR . . . -77.99 104.36 8.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.769 -0.65 . . . . 99.989999999999995 110.635 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.75 126.2 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.281 -0.872 . . . . 99.989999999999995 109.324 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.6 t -82.6 127.38 33.3 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.259 0.552 . . . . 99.989999999999995 111.583 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.05 142.42 35.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.31 -0.859 . . . . 99.989999999999995 110.553 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.5 ptp -143.71 140.59 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 99.989999999999995 110.049 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.611 ' O ' ' N ' ' A' ' 48' ' ' GLY . 42.7 mm -119.81 102.85 13.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.754 -0.378 . . . . 99.989999999999995 110.238 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 20.98 43.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.719 0 O-C-N 123.784 0.678 . . . . 99.989999999999995 111.844 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -151.12 -76.64 0.02 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.383 -0.687 . . . . 99.989999999999995 111.383 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' OE1' ' OH ' ' A' ' 51' ' ' TYR . 6.5 mt-10 -153.8 161.83 28.23 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 121.0 -0.28 . . . . 99.989999999999995 110.367 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -84.45 139.26 7.84 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 C-N-CA 122.806 2.337 . . . . 99.989999999999995 113.197 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' OH ' ' OE1' ' A' ' 49' ' ' GLU . 42.4 m-85 -152.36 159.85 43.38 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.034 -1.099 . . . . 99.989999999999995 108.034 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.402 ' HG1' ' HB ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -135.45 140.39 44.83 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 119.566 -0.854 . . . . 99.989999999999995 111.746 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -109.86 139.18 45.22 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.565 -0.532 . . . . 99.989999999999995 109.565 178.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.557 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -92.75 120.13 6.07 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.896 -0.669 . . . . 99.989999999999995 111.937 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.485 ' H ' ' CA ' ' A' ' 40' ' ' TYR . 57.9 mt -114.87 124.92 52.95 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.926 -0.398 . . . . 99.989999999999995 109.926 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 57' ' ' ASP . 25.3 t80 -115.48 34.44 4.91 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.744 0.646 . . . . 99.989999999999995 112.744 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.545 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 72.2 m-20 -45.75 -177.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.147 0.499 . . . . 99.989999999999995 111.496 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 57' ' ' ASP . 1.7 p 76.59 147.98 0.1 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.524 -0.762 . . . . 99.989999999999995 110.936 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.05 -173.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.9 -0.591 . . . . 99.989999999999995 111.118 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.739 0 N-CA-C 110.845 -0.902 . . . . 99.989999999999995 110.845 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.83 0.348 . . . . 99.989999999999995 110.747 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.2 t -135.98 153.42 51.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 99.989999999999995 110.977 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -117.72 -19.28 9.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 99.989999999999995 110.47 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.0 t -127.2 114.56 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.266 -0.425 . . . . 99.989999999999995 110.556 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.15 126.0 34.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.293 0.568 . . . . 99.989999999999995 112.182 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.41 ' CD2' ' C ' ' A' ' 79' ' ' LEU . 6.8 tt -124.59 126.41 45.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.156 -0.929 . . . . 99.989999999999995 109.799 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.67 136.45 54.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.564 -0.289 . . . . 99.989999999999995 110.234 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.496 ' SG ' ' C ' ' A' ' 114' ' ' GLY . 17.7 t -130.62 129.64 42.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.364 0.602 . . . . 99.989999999999995 111.906 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.527 ' H ' ' HA2' ' A' ' 114' ' ' GLY . 42.3 p90 -139.15 154.14 48.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.448 -0.796 . . . . 99.989999999999995 110.028 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.0 t -67.98 134.0 49.99 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.56 -0.456 . . . . 99.989999999999995 110.204 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 48.5 t -96.26 26.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.991 -0.683 . . . . 99.989999999999995 111.719 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.469 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 62.9 t -122.58 12.87 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 99.989999999999995 110.953 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.2 m -137.34 145.32 49.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.529 . . . . 99.989999999999995 110.009 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.436 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 60.4 Cg_endo -73.75 -20.79 19.64 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.26 1.973 . . . . 99.989999999999995 112.76 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.8 m -91.52 -25.22 19.36 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.916 -0.313 . . . . 99.989999999999995 111.771 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.3 m -64.03 -40.97 97.52 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.876 -0.329 . . . . 99.989999999999995 111.712 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 87' ' ' PRO . 2.7 p90 -85.13 -29.36 24.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.097 0.475 . . . . 99.989999999999995 110.808 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.94 -28.14 64.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.697 -0.683 . . . . 99.989999999999995 111.587 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 93' ' ' VAL . 11.0 m120 -87.53 -70.17 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.579 0.585 . . . . 99.989999999999995 112.579 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -31.95 -64.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.507 0.558 . . . . 99.989999999999995 112.507 -178.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HZ1' ' HA ' ' A' ' 142' ' ' ALA . 16.0 mttp -64.49 -33.27 75.5 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.543 0.942 . . . . 99.989999999999995 113.543 -177.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 88.7 mt-10 -107.73 -63.59 1.29 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.049 1.129 . . . . 99.989999999999995 114.049 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -62.02 -38.93 90.53 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.117 1.155 . . . . 99.989999999999995 114.117 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.573 ' CZ2' ' O ' ' A' ' 10' ' ' GLY . 74.1 m95 -77.0 -30.58 55.98 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.988 -0.685 . . . . 99.989999999999995 111.376 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.4 t -45.72 -55.33 12.82 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.874 0.324 . . . . 99.989999999999995 111.874 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 19.4 Cg_endo -60.03 -36.94 87.82 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.733 1.622 . . . . 99.989999999999995 111.717 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.486 ' OE1' ' CE3' ' A' ' 97' ' ' TRP . 85.2 tt0 -59.59 -44.29 93.41 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.217 -0.593 . . . . 99.989999999999995 109.724 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.4 mt -76.38 -31.37 20.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.981 -0.554 . . . . 99.989999999999995 110.204 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 105' ' ' CYS . 37.1 m -52.85 -37.63 60.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.717 -0.674 . . . . 99.989999999999995 110.999 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -49.58 -40.07 37.29 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.708 -0.397 . . . . 99.989999999999995 110.21 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.563 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 80.5 m80 -78.6 -20.54 50.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 99.989999999999995 110.052 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 6.8 p 39.13 58.6 6.01 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.929 -0.578 . . . . 99.989999999999995 110.791 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.79 133.36 12.6 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.794 2.329 . . . . 99.989999999999995 112.145 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -89.5 -1.13 57.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.957 0.408 . . . . 99.989999999999995 110.167 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.82 155.79 84.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.918 -0.583 . . . . 99.989999999999995 110.744 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.96 150.04 58.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.761 2.307 . . . . 99.989999999999995 111.98 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.729 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -129.65 131.15 46.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.894 -0.41 . . . . 99.989999999999995 109.894 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 7.3 mp -93.96 130.54 40.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.117 0.484 . . . . 99.989999999999995 111.877 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.4 tp -102.11 130.4 48.7 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.738 -0.838 . . . . 99.989999999999995 108.738 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.46 179.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.073 -0.651 . . . . 99.989999999999995 111.529 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.527 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -149.04 178.9 26.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.82 -0.912 . . . . 99.989999999999995 110.82 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.589 ' HG1' ' C ' ' A' ' 15' ' ' GLY . 13.0 t -128.27 163.74 24.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.811 0.339 . . . . 99.989999999999995 110.298 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.683 ' H ' ' HG ' ' A' ' 158' ' ' SER . 96.9 mt-30 56.49 18.19 3.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.016 -0.538 . . . . 99.989999999999995 110.272 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.674 ' CG1' ' H ' ' A' ' 120' ' ' ARG . 15.7 pt 33.94 -150.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.565 -0.289 . . . . 99.989999999999995 110.363 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 118' ' ' ASP . 50.9 p30 -118.32 17.28 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.718 -0.393 . . . . 99.989999999999995 110.403 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.72 -36.14 0.32 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.115 -0.493 . . . . 99.989999999999995 112.245 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.674 ' H ' ' CG1' ' A' ' 117' ' ' ILE . 65.3 ttp85 . . . . . 0 CA--C 1.515 -0.368 0 C-N-CA 119.53 -0.868 . . . . 99.989999999999995 109.812 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.461 0.084 0 N-CA-C 109.568 -0.53 . . . . 99.989999999999995 109.568 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.557 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -129.98 -48.19 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.29 0.478 . . . . 99.989999999999995 112.29 -178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.557 ' CD ' ' H ' ' A' ' 138' ' ' THR . 59.7 Cg_endo -87.66 -67.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.416 2.078 . . . . 99.989999999999995 114.598 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 139' ' ' PRO . 77.7 mm-40 -31.55 -72.88 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.993 0.738 . . . . 99.989999999999995 112.993 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.2 p -116.79 4.38 12.99 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.877 1.066 . . . . 99.989999999999995 113.877 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.402 ' HA ' ' HZ1' ' A' ' 94' ' ' LYS . . . -94.2 -65.2 1.0 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.486 -0.886 . . . . 99.989999999999995 110.512 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' THR . 84.2 tt0 -69.79 -41.49 75.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.442 -0.345 . . . . 99.989999999999995 111.219 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -66.68 -38.16 86.23 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.832 0.349 . . . . 99.989999999999995 111.462 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.3 tp -74.73 -19.97 60.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.241 -0.436 . . . . 99.989999999999995 111.582 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.14 -36.71 77.74 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.178 0.513 . . . . 99.989999999999995 110.833 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -58.83 -41.16 86.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.542 -0.754 . . . . 99.989999999999995 110.236 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -89.96 -27.06 20.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 99.989999999999995 110.663 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 54.3 tp -44.52 -25.98 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 119.143 -0.456 . . . . 99.989999999999995 112.113 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.604 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 55.5 mttp 91.54 -0.93 0.17 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.898 0.479 . . . . 99.989999999999995 110.407 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -59.04 -136.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.327 0.584 . . . . 99.989999999999995 111.789 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -159.92 -36.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.364 -0.835 . . . . 99.989999999999995 110.278 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -110.31 -179.07 3.67 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.292 -0.633 . . . . 99.989999999999995 109.292 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.623 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 34.7 p90 -169.82 97.43 0.3 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 119.798 -0.761 . . . . 99.989999999999995 109.798 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.467 ' O ' ' CD ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -161.15 171.94 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 115.243 -0.89 . . . . 99.989999999999995 109.98 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.734 ' O ' ' OG1' ' A' ' 161' ' ' THR . 20.1 mm-40 -138.81 96.51 3.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.404 -1.332 . . . . 99.989999999999995 107.404 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.466 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -107.02 147.75 29.55 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 123.17 1.462 . . . . 99.989999999999995 112.51 -177.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.683 ' HG ' ' H ' ' A' ' 116' ' ' GLN . 0.3 OUTLIER -169.85 91.72 0.21 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 111.555 -2.566 . . . . 99.989999999999995 106.236 177.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.513 ' CB ' ' ND2' ' A' ' 26' ' ' ASN . . . 43.35 21.59 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.221 -1.809 . . . . 99.989999999999995 109.503 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.78 ' O ' ' N ' ' A' ' 162' ' ' GLN . 0.5 OUTLIER -133.73 -84.05 0.45 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.189 -0.914 . . . . 99.989999999999995 109.585 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.734 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 1.2 m -53.66 46.86 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.725 0.641 . . . . 99.989999999999995 111.814 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.78 ' N ' ' O ' ' A' ' 160' ' ' LEU . 7.2 tt0 -80.44 9.39 5.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 104.656 -2.35 . . . . 99.989999999999995 104.656 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.655 ' H ' ' C ' ' A' ' 161' ' ' THR . 16.1 tttp -84.6 -5.41 59.3 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 112.781 -2.009 . . . . 99.989999999999995 108.435 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.671 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -129.9 -72.0 0.12 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 107.811 -2.115 . . . . 99.989999999999995 107.811 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 4.3 mm? -38.75 -15.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.776 -0.37 . . . . 99.989999999999995 111.245 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.9 tttt -84.14 -47.68 10.63 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.856 -0.794 . . . . 99.989999999999995 108.856 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 164' ' ' GLY . 18.6 p-10 -79.41 4.99 13.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.307 -0.86 . . . . 99.989999999999995 109.028 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 171' ' ' GLU . 24.4 t -84.1 -52.65 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.426 -0.807 . . . . 99.989999999999995 109.892 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -37.65 -48.17 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.21 -0.904 . . . . 99.989999999999995 110.501 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.418 ' O ' ' CG1' ' A' ' 173' ' ' ILE . 53.3 t0 -62.84 -37.52 87.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.283 -0.417 . . . . 99.989999999999995 110.85 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 168' ' ' VAL . 77.5 mm-40 -77.3 -30.07 54.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 99.989999999999995 111.196 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.42 -40.01 89.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 99.989999999999995 110.955 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 170' ' ' ASP . 21.1 pt -67.41 -29.73 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.157 -0.474 . . . . 99.989999999999995 110.67 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.69 -36.73 77.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 99.989999999999995 110.04 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.96 -21.28 66.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 99.989999999999995 110.555 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.54 74.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 99.989999999999995 110.609 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 41.8 tp -56.97 -36.05 69.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 99.989999999999995 110.405 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 99.989999999999995 110.559 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 . . . . . 0 C--O 1.228 -0.027 0 CA-C-O 121.03 0.443 . . . . 99.989999999999995 110.669 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.48 ' OG1' ' OG1' ' A' ' 52' ' ' THR . 0.7 OUTLIER -41.2 115.66 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 99.989999999999995 110.233 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.3 tt -122.97 146.46 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 99.989999999999995 110.957 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 30.6 mttm -104.47 163.29 12.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.039 -0.528 . . . . 99.989999999999995 110.853 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.4 136.98 26.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.564 . . . . 99.989999999999995 110.518 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.48 131.22 35.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.518 -0.549 . . . . 99.989999999999995 109.518 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.516 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 57.3 t -117.8 125.88 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 120.076 -0.65 . . . . 99.989999999999995 110.793 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 m -135.64 159.77 39.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 99.989999999999995 109.797 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.69 -177.09 36.24 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.56 -0.829 . . . . 99.989999999999995 111.273 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 12' ' ' GLY . 25.2 t70 -81.05 124.94 29.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.684 0.278 . . . . 99.989999999999995 110.463 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 36.03 39.56 0.31 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.847 -0.901 . . . . 99.989999999999995 110.847 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 55.2 124.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.052 0.453 . . . . 99.989999999999995 110.88 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' A' ' 16' ' ' LYS . 1.4 m -120.91 -168.33 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 99.989999999999995 109.889 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.58 49.64 0.01 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 121.428 -0.415 . . . . 99.989999999999995 112.408 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.617 ' N ' ' O ' ' A' ' 14' ' ' VAL . 23.2 pttt -57.4 -39.69 76.67 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.11 0.411 . . . . 99.989999999999995 112.11 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.455 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 54.1 p -65.49 -43.87 88.85 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.213 0.449 . . . . 99.989999999999995 112.213 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.1 m -53.9 -24.63 16.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.1 0.476 . . . . 99.989999999999995 111.026 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.57 -39.04 70.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.681 -0.69 . . . . 99.989999999999995 111.222 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.42 ' O ' ' OG1' ' A' ' 24' ' ' THR . 36.6 tp -63.29 -38.74 92.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.136 -0.484 . . . . 99.989999999999995 112.046 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.3 pt -87.5 5.23 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.211 0.448 . . . . 99.989999999999995 112.211 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.7 t -59.06 -75.5 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.108 -0.637 . . . . 99.989999999999995 110.695 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -67.18 -39.52 86.41 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 119.534 -0.866 . . . . 99.989999999999995 110.957 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -49.27 -45.7 45.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 99.989999999999995 110.992 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 t 179.42 75.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 110.624 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.591 ' ND2' ' OE1' ' A' ' 162' ' ' GLN . 2.3 p30 -60.15 113.52 2.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 99.989999999999995 110.224 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 28' ' ' LEU . 85.5 mttt -150.86 50.03 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.384 . . . . 99.989999999999995 111.295 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' A' ' 27' ' ' LYS . 3.9 mp 57.68 129.36 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.581 -0.281 . . . . 99.989999999999995 110.658 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.42 156.94 36.92 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.15 1.9 . . . . 99.989999999999995 111.905 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.9 m -117.07 146.96 42.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.289 -0.414 . . . . 99.989999999999995 110.328 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -56.51 -34.94 67.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 99.989999999999995 110.165 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -64.66 -33.51 76.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.942 -0.572 . . . . 99.989999999999995 110.544 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.7 t 48.18 69.54 2.63 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 99.989999999999995 110.431 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.494 ' O ' ' O ' ' A' ' 35' ' ' THR . 51.3 Cg_exo -50.56 -14.69 1.23 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.927 2.418 . . . . 99.989999999999995 112.16 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 50.03 171.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 99.989999999999995 110.702 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.0 142.43 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 99.989999999999995 110.29 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -49.07 -30.11 5.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 99.989999999999995 109.802 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -58.73 160.11 6.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.742 -0.663 . . . . 99.989999999999995 110.438 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.594 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 81.6 m-20 -133.21 -8.06 2.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.077 -0.51 . . . . 99.989999999999995 109.954 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER 163.85 28.45 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.78 -0.645 . . . . 99.989999999999995 109.929 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.77 108.06 5.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 99.989999999999995 110.935 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.8 t -130.0 130.18 66.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.813 -0.631 . . . . 99.989999999999995 109.793 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.31 106.22 14.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.958 0.409 . . . . 99.989999999999995 111.425 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.46 154.81 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.919 -0.582 . . . . 99.989999999999995 110.074 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.22 133.93 55.37 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.882 -0.327 . . . . 99.989999999999995 110.478 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.5 tt -129.65 126.89 63.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 99.989999999999995 110.523 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.18 25.93 60.66 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.854 -0.898 . . . . 99.989999999999995 110.854 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.32 50.05 7.79 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.711 -0.955 . . . . 99.989999999999995 110.711 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -130.43 79.03 73.17 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.741 0.305 . . . . 99.989999999999995 110.361 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.58 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 26.9 Cg_exo -58.77 108.87 0.44 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.883 2.389 . . . . 99.989999999999995 112.437 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 50' ' ' PRO . 64.3 m-85 -160.33 174.53 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.998 -0.546 . . . . 99.989999999999995 110.27 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.48 ' OG1' ' OG1' ' A' ' 3' ' ' THR . 3.7 p -133.55 142.01 47.98 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.537 -0.465 . . . . 99.989999999999995 111.676 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.5 tp -116.22 126.73 54.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.709 -0.678 . . . . 99.989999999999995 109.717 178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.09 134.43 11.68 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.643 -0.789 . . . . 99.989999999999995 111.277 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.455 ' HG ' ' H ' ' A' ' 57' ' ' ASP . 11.6 tp -113.79 119.89 38.9 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.777 -0.453 . . . . 99.989999999999995 109.777 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.708 ' O ' ' O ' ' A' ' 57' ' ' ASP . 63.2 t80 -91.26 8.83 33.97 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.26 0.467 . . . . 99.989999999999995 112.26 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.708 ' O ' ' O ' ' A' ' 56' ' ' PHE . 36.2 p30 30.47 177.26 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.058 1.132 . . . . 99.989999999999995 114.058 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.422 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 82.4 p -88.57 156.61 18.97 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.612 -0.68 . . . . 99.989999999999995 110.77 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.61 20.12 4.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 110.941 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.548 0 N-CA-C 110.603 -0.999 . . . . 99.989999999999995 110.603 179.837 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 5' ' ' LYS . 96.8 mt-30 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.914 0.388 . . . . 99.989999999999995 110.475 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.2 p -98.12 66.93 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 99.989999999999995 110.461 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -101.97 0.87 35.94 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.271 0.471 . . . . 99.989999999999995 112.271 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.28 110.66 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.274 -0.571 . . . . 99.989999999999995 111.408 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -70.81 134.81 47.67 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.046 -0.524 . . . . 99.989999999999995 111.228 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 tt -119.0 126.96 52.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 99.989999999999995 109.699 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.01 132.77 40.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 110.086 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 42.5 t -128.59 118.82 23.63 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.323 0.583 . . . . 99.989999999999995 111.675 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.479 ' CZ ' ' CE ' ' A' ' 94' ' ' LYS . 28.3 p90 -149.43 157.53 43.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.365 -0.834 . . . . 99.989999999999995 109.181 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.0 t -70.72 132.32 45.19 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.814 -0.754 . . . . 99.989999999999995 109.294 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 50.4 t -56.17 -9.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.761 -0.376 . . . . 99.989999999999995 111.306 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 86' ' ' SER . 27.1 m -127.18 169.47 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 99.989999999999995 110.508 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.646 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.5 OUTLIER -25.38 -68.16 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.643 -0.708 . . . . 99.989999999999995 112.826 -178.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.563 ' O ' ' CB ' ' A' ' 88' ' ' SER . 99.1 Cg_exo -28.09 74.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.841 3.027 . . . . 99.989999999999995 114.465 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 86' ' ' SER . 2.9 t 146.26 -11.46 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.624 0.577 . . . . 99.989999999999995 109.983 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 91' ' ' GLU . 0.7 OUTLIER 40.24 89.54 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.064 -0.717 . . . . 99.989999999999995 109.064 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' SER . 43.7 p90 -36.01 -26.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 99.989999999999995 109.824 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 89' ' ' SER . 97.2 mt-10 -62.05 -23.81 66.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.405 -0.816 . . . . 99.989999999999995 110.664 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.559 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 83.1 m-20 -80.23 -48.45 13.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.146 -0.622 . . . . 99.989999999999995 110.564 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 56.0 t -77.63 -68.68 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 113.425 0.898 . . . . 99.989999999999995 113.425 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.479 ' CE ' ' CZ ' ' A' ' 82' ' ' PHE . 87.9 mttt -61.56 -15.1 35.61 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.776 1.028 . . . . 99.989999999999995 113.776 -177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 78.1 mm-40 -129.06 -48.37 1.22 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.145 1.165 . . . . 99.989999999999995 114.145 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -77.78 -35.69 51.31 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.928 0.714 . . . . 99.989999999999995 112.928 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 69.1 m95 -99.13 -21.04 16.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.854 -0.738 . . . . 99.989999999999995 112.339 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -59.84 -41.79 87.45 Favored Pre-proline 0 C--N 1.333 -0.135 0 C-N-CA 120.119 -0.633 . . . . 99.989999999999995 109.955 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 4.1 Cg_exo -70.62 -38.42 5.93 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.703 2.269 . . . . 99.989999999999995 111.15 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -59.08 -39.03 80.87 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.009 -0.541 . . . . 99.989999999999995 110.63 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.01 -34.12 8.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.819 -0.353 . . . . 99.989999999999995 110.876 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' CYS . 76.2 m -60.22 -36.83 78.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 99.989999999999995 111.019 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.588 ' ND1' ' O ' ' A' ' 99' ' ' PRO . 37.7 m80 -50.5 -32.69 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 99.989999999999995 111.222 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -55.7 -45.57 77.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.559 -0.291 . . . . 99.989999999999995 111.411 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -143.55 160.7 50.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 99.989999999999995 110.984 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.479 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 8.0 Cg_endo -52.79 163.57 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.938 2.425 . . . . 99.989999999999995 111.935 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -64.86 131.47 46.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 99.989999999999995 110.861 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.85 161.21 33.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 99.989999999999995 110.158 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -46.38 146.15 5.22 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.261 1.974 . . . . 99.989999999999995 111.844 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.546 ' O ' ' N ' ' A' ' 152' ' ' VAL . 19.1 p90 -147.26 156.89 43.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 119.932 -0.707 . . . . 99.989999999999995 111.744 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.32 125.67 42.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.515 -0.766 . . . . 99.989999999999995 110.665 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 tp -96.21 122.61 39.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.418 -0.586 . . . . 99.989999999999995 109.418 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.469 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.3 t -130.24 150.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.053 0.454 . . . . 99.989999999999995 111.747 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.5 156.87 17.11 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 109.966 -1.254 . . . . 99.989999999999995 109.966 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.22 167.58 11.71 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.563 0.697 . . . . 99.989999999999995 111.978 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.603 ' O ' ' O ' ' A' ' 117' ' ' ILE . 97.0 mm-40 50.75 24.45 1.73 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.761 -1.109 . . . . 99.989999999999995 112.777 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.603 ' O ' ' O ' ' A' ' 116' ' ' GLN . 4.8 tt 30.62 -156.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.943 -0.392 . . . . 99.989999999999995 109.943 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.518 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 53.0 p30 -120.81 29.27 7.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.005 -0.739 . . . . 99.989999999999995 109.005 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.594 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 34.9 tp -137.31 -38.65 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.12 -0.945 . . . . 99.989999999999995 110.069 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? . . . . . 0 CA--C 1.518 -0.274 0 N-CA-C 108.47 -0.937 . . . . 99.989999999999995 108.47 179.184 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.533 ' O ' ' CG1' ' A' ' 137' ' ' ILE . 1.3 tt . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 120.763 0.316 . . . . 99.989999999999995 111.209 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.503 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -131.15 -65.66 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.174 0.435 . . . . 99.989999999999995 112.174 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.503 ' HD2' ' H ' ' A' ' 138' ' ' THR . 84.3 Cg_exo -23.92 -69.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.758 2.972 . . . . 99.989999999999995 114.489 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -113.37 -37.8 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.14 0.422 . . . . 99.989999999999995 112.14 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.6 m -52.57 -40.22 62.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.567 -0.288 . . . . 99.989999999999995 111.732 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.75 -28.87 62.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.672 0.272 . . . . 99.989999999999995 111.506 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.24 -38.24 88.47 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.131 0.419 . . . . 99.989999999999995 112.131 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -63.35 -46.19 87.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 99.989999999999995 110.897 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 65.3 mt -54.29 -33.47 58.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.954 -0.566 . . . . 99.989999999999995 111.051 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.77 81.73 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.682 -0.407 . . . . 99.989999999999995 110.064 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -60.42 -41.58 94.26 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.471 -0.786 . . . . 99.989999999999995 110.667 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -51.65 -31.98 27.69 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.416 -0.957 . . . . 99.989999999999995 108.416 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.4 mt -131.23 -115.58 0.23 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.845 -1.07 . . . . 99.989999999999995 108.459 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.569 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 63.5 mttm -134.96 -142.03 0.18 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.644 -0.707 . . . . 99.989999999999995 110.219 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 150.88 177.98 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.386 0.429 . . . . 99.989999999999995 111.059 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 110' ' ' PHE . 94.0 t -145.66 -59.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.63 -0.713 . . . . 99.989999999999995 109.567 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 154' ' ' TYR . 16.4 mmtt -100.81 170.56 8.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.161 -0.681 . . . . 99.989999999999995 109.161 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.505 ' CG ' ' C ' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -173.2 97.36 0.12 Allowed 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 119.668 -0.813 . . . . 99.989999999999995 109.321 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.58 ' CG2' ' H ' ' A' ' 156' ' ' GLU . 2.7 p -170.42 -167.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 119.547 -0.861 . . . . 99.989999999999995 111.165 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.58 ' H ' ' CG2' ' A' ' 155' ' ' VAL . 96.1 mt-10 -106.88 166.56 10.5 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.219 -1.03 . . . . 99.989999999999995 108.219 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.526 ' SG ' ' C ' ' A' ' 156' ' ' GLU . 0.5 OUTLIER -178.29 119.91 0.09 Allowed 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 114.491 1.293 . . . . 99.989999999999995 114.491 178.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 160' ' ' LEU . 16.4 t -156.77 94.77 1.48 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.508 -1.678 . . . . 99.989999999999995 107.022 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 35.12 28.57 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.319 -1.31 . . . . 99.989999999999995 109.565 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.768 ' O ' ' N ' ' A' ' 162' ' ' GLN . 41.9 mt -142.8 -78.89 0.23 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.397 -0.82 . . . . 99.989999999999995 111.238 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.744 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.6 m -44.09 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 114.043 1.127 . . . . 99.989999999999995 114.043 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.768 ' N ' ' O ' ' A' ' 160' ' ' LEU . 11.8 pt20 -72.07 10.25 0.78 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.212 -2.144 . . . . 99.989999999999995 105.212 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.744 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.1 tttm -62.14 -27.03 68.65 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.167 -1.379 . . . . 99.989999999999995 109.062 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.679 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -125.12 -63.62 0.18 Allowed Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 108.233 -1.947 . . . . 99.989999999999995 108.233 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.1 mt -39.19 -13.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.416 -0.513 . . . . 99.989999999999995 112.181 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 164' ' ' GLY . 43.4 tttm -81.29 -46.55 14.59 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.296 -1.001 . . . . 99.989999999999995 108.296 176.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' GLY . 2.7 m120 -83.33 6.56 19.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.513 -1.222 . . . . 99.989999999999995 110.102 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.8 t -86.41 -57.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 99.989999999999995 110.376 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -45.84 -45.78 15.18 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.239 -0.584 . . . . 99.989999999999995 110.247 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -69.69 -45.16 68.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 99.989999999999995 111.481 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.0 -25.41 64.5 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.935 0.346 . . . . 99.989999999999995 111.935 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.97 -36.11 80.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.694 -0.402 . . . . 99.989999999999995 110.348 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 8.5 mm -60.75 -37.03 75.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.406 -0.59 . . . . 99.989999999999995 109.406 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 36.9 tp -58.46 -35.87 72.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.695 -0.684 . . . . 99.989999999999995 109.879 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.88 -24.25 67.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.604 -0.726 . . . . 99.989999999999995 111.073 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.04 -36.25 79.08 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.816 -0.354 . . . . 99.989999999999995 110.695 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.3 mt -59.42 -32.98 70.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 99.989999999999995 110.411 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 99.989999999999995 110.641 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.452 ' O ' ' CB ' ' A' ' 176' ' ' ALA . 58.8 tp60 . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.875 0.369 . . . . 99.989999999999995 110.055 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.438 ' HG1' ' CG2' ' A' ' 52' ' ' THR . 0.7 OUTLIER -49.76 132.41 22.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 99.989999999999995 110.105 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.9 tp -126.13 145.91 32.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.246 -0.434 . . . . 99.989999999999995 110.937 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -91.28 142.18 27.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 99.989999999999995 110.732 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -138.61 130.69 28.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.613 -0.721 . . . . 99.989999999999995 110.621 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.0 t -98.24 135.28 33.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.759 -0.83 . . . . 99.989999999999995 108.759 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.607 ' CG1' ' SG ' ' A' ' 81' ' ' CYS . 62.6 t -99.03 131.53 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 119.898 -0.721 . . . . 99.989999999999995 110.979 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.0 136.23 59.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.549 -0.75 . . . . 99.989999999999995 110.063 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.94 -173.72 19.9 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.933 -0.867 . . . . 99.989999999999995 110.933 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 13' ' ' ALA . 54.6 t0 -80.3 118.3 21.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.136 -0.32 . . . . 99.989999999999995 110.136 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 29.87 -87.68 0.01 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.184 -0.766 . . . . 99.989999999999995 111.184 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -133.12 150.0 52.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 99.989999999999995 110.522 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.673 ' CG2' ' H ' ' A' ' 15' ' ' GLY . 8.5 m -153.7 -96.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 110.835 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.673 ' H ' ' CG2' ' A' ' 14' ' ' VAL . . . -137.76 19.52 3.32 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.679 -0.772 . . . . 99.989999999999995 112.037 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -39.13 -36.31 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.187 0.494 . . . . 99.989999999999995 111.832 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.0 p -65.31 -46.87 78.63 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.911 -0.316 . . . . 99.989999999999995 111.808 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -79.45 -35.87 39.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.453 . . . . 99.989999999999995 110.797 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.494 ' O ' ' OG ' ' A' ' 22' ' ' SER . 12.7 tp -58.32 -40.35 81.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.75 -0.659 . . . . 99.989999999999995 110.496 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.17 -37.81 78.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 99.989999999999995 110.368 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.473 ' O ' ' C ' ' A' ' 22' ' ' SER . 93.8 mt -70.19 -1.73 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.87 -0.605 . . . . 99.989999999999995 110.861 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.504 ' H ' ' HG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -29.36 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 111.634 -178.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.416 ' OH ' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -98.27 -12.33 21.69 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.561 -0.456 . . . . 99.989999999999995 111.546 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -48.61 -49.2 37.99 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.831 -0.348 . . . . 99.989999999999995 111.28 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.2 p -133.9 -16.01 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.821 -0.352 . . . . 99.989999999999995 110.532 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.589 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER 70.86 111.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.559 -0.534 . . . . 99.989999999999995 109.559 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 57.09 136.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 99.989999999999995 110.658 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 177.56 113.21 0.15 Allowed Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.016 -0.538 . . . . 99.989999999999995 110.245 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -46.51 149.18 2.96 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.981 1.787 . . . . 99.989999999999995 112.316 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.8 t -58.27 -18.55 27.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.807 -0.633 . . . . 99.989999999999995 110.952 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.65 -34.13 57.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.342 -0.39 . . . . 99.989999999999995 110.859 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -119.69 126.8 51.98 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.838 -0.345 . . . . 99.989999999999995 110.845 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.84 157.38 38.16 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.179 -0.464 . . . . 99.989999999999995 110.367 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.53 66.07 3.74 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.673 2.249 . . . . 99.989999999999995 111.915 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.3 p -76.47 -15.95 59.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 99.989999999999995 111.229 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.0 -44.62 95.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.876 -0.33 . . . . 99.989999999999995 110.837 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -175.26 124.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 99.989999999999995 110.685 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -73.66 144.33 45.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 99.989999999999995 110.755 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -111.46 168.63 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 99.989999999999995 111.004 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 40' ' ' TYR . 26.3 p90 -155.85 35.43 0.35 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.347 -0.612 . . . . 99.989999999999995 109.347 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.27 97.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.465 -0.789 . . . . 99.989999999999995 110.285 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.526 ' O ' ' OG1' ' A' ' 52' ' ' THR . 21.8 t -129.92 132.83 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 99.989999999999995 110.36 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 t -103.0 133.78 47.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.12 0.486 . . . . 99.989999999999995 111.219 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.416 ' CG1' ' OH ' ' A' ' 23' ' ' TYR . 19.1 m -132.44 156.48 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.593 -0.731 . . . . 99.989999999999995 109.951 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -113.37 123.93 51.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.74 -0.384 . . . . 99.989999999999995 110.985 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' GLY . 9.2 tp -134.6 137.63 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 99.989999999999995 110.103 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 34.09 28.29 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.428 -0.669 . . . . 99.989999999999995 111.428 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 82.53 47.03 6.16 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.628 -0.589 . . . . 99.989999999999995 111.628 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -128.22 83.6 65.64 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-O 120.872 0.368 . . . . 99.989999999999995 110.166 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 59.2 Cg_endo -78.84 99.88 1.31 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.45 2.1 . . . . 99.989999999999995 112.674 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' A' ' 50' ' ' PRO . 62.4 m-85 -156.36 177.85 10.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.891 -0.595 . . . . 99.989999999999995 110.491 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 9.2 t -139.96 150.04 44.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.675 0.62 . . . . 99.989999999999995 112.675 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.9 tp -118.11 128.39 54.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.327 -0.851 . . . . 99.989999999999995 108.86 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -86.31 138.02 15.52 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.347 -0.93 . . . . 99.989999999999995 111.813 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' A' ' 40' ' ' TYR . 81.2 mt -124.38 126.7 46.4 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.913 -0.315 . . . . 99.989999999999995 110.626 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.613 ' O ' ' O ' ' A' ' 57' ' ' ASP . 45.4 t80 -108.5 35.4 3.2 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 120.413 -0.515 . . . . 99.989999999999995 111.961 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 56' ' ' PHE . 90.6 m-20 36.79 178.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.663 0.986 . . . . 99.989999999999995 113.663 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.4 m -64.77 132.08 48.59 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 120.138 -0.625 . . . . 99.989999999999995 110.606 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.84 149.04 33.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.52 . . . . 99.989999999999995 110.643 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.682 0 N-CA-C 110.936 -0.866 . . . . 99.989999999999995 110.936 179.815 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.841 0.353 . . . . 99.989999999999995 110.506 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.8 t -141.72 155.98 45.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 99.989999999999995 110.459 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -122.76 -33.07 3.44 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.749 -0.38 . . . . 99.989999999999995 111.09 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.91 152.56 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.652 -0.419 . . . . 99.989999999999995 110.417 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.415 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 21.0 m-85 -120.83 160.53 23.22 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.015 -0.365 . . . . 99.989999999999995 110.015 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tt -119.15 123.25 43.93 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.731 -0.387 . . . . 99.989999999999995 110.246 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.9 m -102.27 133.49 45.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.925 -0.398 . . . . 99.989999999999995 109.925 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.607 ' SG ' ' CG1' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -134.07 134.82 42.78 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.261 0.553 . . . . 99.989999999999995 111.516 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 115' ' ' THR . 39.3 p90 -142.83 153.84 43.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.616 -0.72 . . . . 99.989999999999995 109.873 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.1 p -95.63 134.74 38.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.412 -0.588 . . . . 99.989999999999995 109.412 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.67 ' CG1' ' H ' ' A' ' 85' ' ' VAL . 5.4 p -49.23 -68.23 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 118.943 -1.103 . . . . 99.989999999999995 110.416 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.67 ' H ' ' CG1' ' A' ' 84' ' ' VAL . 7.6 p -56.17 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.295 -0.412 . . . . 99.989999999999995 110.533 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.0 OUTLIER 157.84 80.76 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 99.989999999999995 110.472 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -56.39 -36.13 96.94 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.506 2.137 . . . . 99.989999999999995 112.061 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 m -57.65 -38.02 74.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.898 -0.592 . . . . 99.989999999999995 111.192 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.3 p -71.21 -34.26 70.67 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.04 -0.264 . . . . 99.989999999999995 111.509 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -70.48 -43.79 69.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 99.989999999999995 111.41 -179.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 96.8 mt-10 -61.48 -34.09 74.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.264 -0.426 . . . . 99.989999999999995 111.595 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 96' ' ' LYS . 28.0 m120 -89.75 -63.33 1.3 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.612 -0.435 . . . . 99.989999999999995 111.983 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.2 t -36.04 -62.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 99.989999999999995 112.255 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -70.44 -19.47 62.97 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.805 1.039 . . . . 99.989999999999995 113.805 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.542 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 82.6 tt0 -124.87 -55.7 1.59 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.075 1.139 . . . . 99.989999999999995 114.075 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 92' ' ' ASN . 19.3 tttt -74.99 -16.3 60.63 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.61 0.967 . . . . 99.989999999999995 113.61 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -96.31 -50.32 4.83 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.551 -0.86 . . . . 99.989999999999995 112.123 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' O ' ' OG1' ' A' ' 102' ' ' THR . 0.1 OUTLIER -43.04 -46.69 13.84 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.147 -0.621 . . . . 99.989999999999995 111.251 -178.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.542 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 15.7 Cg_exo -65.69 -39.55 20.39 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.049 1.833 . . . . 99.989999999999995 112.338 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.56 -36.26 83.2 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.754 -0.378 . . . . 99.989999999999995 111.404 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.4 pt -89.83 -32.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.536 -0.466 . . . . 99.989999999999995 111.266 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 81.9 p -99.5 17.65 19.83 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.884 -0.326 . . . . 99.989999999999995 111.098 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -54.31 -46.45 72.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.566 -0.454 . . . . 99.989999999999995 110.494 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.66 -42.12 98.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 99.989999999999995 110.479 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.7 t -127.33 87.39 56.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 99.989999999999995 110.42 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.02 -27.98 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.312 2.008 . . . . 99.989999999999995 112.116 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -103.5 117.87 35.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 99.989999999999995 110.238 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.2 m -170.88 101.77 0.41 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.502 -0.317 . . . . 99.989999999999995 110.857 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.41 148.17 11.3 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.028 1.819 . . . . 99.989999999999995 112.008 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.551 ' CE1' ' CB ' ' A' ' 151' ' ' ALA . 21.0 p90 -148.31 162.93 38.53 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.49 -0.484 . . . . 99.989999999999995 111.618 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 7.3 mp -91.14 129.58 37.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 99.989999999999995 109.806 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.4 tp -95.08 121.83 37.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.037 -0.529 . . . . 99.989999999999995 110.304 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 114' ' ' GLY . 40.1 t -135.8 168.51 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.512 -0.767 . . . . 99.989999999999995 109.91 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.427 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -155.16 97.86 0.17 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.307 -0.949 . . . . 99.989999999999995 111.261 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 82' ' ' PHE . 2.6 p -51.47 177.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.92 0.39 . . . . 99.989999999999995 110.4 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.507 ' O ' ' C ' ' A' ' 117' ' ' ILE . 43.7 tp60 47.37 29.96 1.43 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 111.007 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 116' ' ' GLN . 13.0 tt 27.43 -142.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 122.404 0.282 . . . . 99.989999999999995 110.367 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 86.3 m-20 -88.24 3.32 49.91 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.279 -0.568 . . . . 99.989999999999995 109.882 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.573 ' CB ' ' O ' ' A' ' 118' ' ' ASP . 16.8 tp 137.34 90.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 124.572 1.17 . . . . 99.989999999999995 109.515 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.533 ' C ' ' O ' ' A' ' 119' ' ' LEU . 27.8 ttm180 . . . . . 0 N--CA 1.469 0.487 0 O-C-N 123.986 0.804 . . . . 99.989999999999995 111.161 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.9 tt . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 121.249 0.547 . . . . 99.989999999999995 111.044 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.596 ' O ' ' O ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -135.37 -66.06 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.508 -0.769 . . . . 99.989999999999995 111.256 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.696 ' C ' ' H ' ' A' ' 141' ' ' THR . 48.7 Cg_exo -19.42 151.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 124.1 3.2 . . . . 99.989999999999995 114.329 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -48.05 -2.76 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.721 -1.581 . . . . 99.989999999999995 110.508 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.696 ' H ' ' C ' ' A' ' 139' ' ' PRO . 58.6 p -82.14 -8.37 59.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.619 -0.264 . . . . 99.989999999999995 110.92 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.63 -48.56 59.52 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.134 -0.626 . . . . 99.989999999999995 110.161 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.76 -31.11 72.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.879 -0.601 . . . . 99.989999999999995 110.691 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -57.71 -41.53 81.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 99.989999999999995 110.106 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.0 mt -49.07 -35.15 15.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.893 -0.594 . . . . 99.989999999999995 109.944 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.13 -37.87 69.35 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.754 -0.461 . . . . 99.989999999999995 109.754 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -63.81 -38.2 90.2 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.462 -0.79 . . . . 99.989999999999995 110.753 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -49.25 -35.27 17.2 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.0 -1.111 . . . . 99.989999999999995 108.0 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.38 -113.35 0.31 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.609 -1.178 . . . . 99.989999999999995 109.003 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.583 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 43.1 tttp -132.4 -117.46 0.21 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.495 -0.775 . . . . 99.989999999999995 110.913 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 109.47 -162.96 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.133 0.895 . . . . 99.989999999999995 109.24 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 110' ' ' PHE . 50.7 t -149.26 -63.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.738 -0.385 . . . . 99.989999999999995 110.462 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.544 ' HZ2' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -86.89 -173.93 4.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.096 -0.705 . . . . 99.989999999999995 109.096 179.261 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.61 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 31.0 p90 -170.8 95.94 0.21 Allowed 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.835 -0.802 . . . . 99.989999999999995 108.835 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.522 ' CG1' ' N ' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -172.63 -169.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.551 -0.749 . . . . 99.989999999999995 111.167 -178.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.607 ' O ' ' OG1' ' A' ' 161' ' ' THR . 77.1 mt-10 -153.14 114.81 4.26 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.755 -1.111 . . . . 99.989999999999995 108.309 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.513 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -121.29 138.11 54.39 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 122.474 1.13 . . . . 99.989999999999995 112.595 -177.346 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.473 ' C ' ' N ' ' A' ' 160' ' ' LEU . 37.7 t -145.57 93.96 2.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.005 -1.907 . . . . 99.989999999999995 106.659 176.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 39.61 30.54 0.06 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.779 -1.1 . . . . 99.989999999999995 108.986 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.867 ' O ' ' N ' ' A' ' 162' ' ' GLN . 58.2 tp -145.52 -86.61 0.11 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.977 -1.01 . . . . 99.989999999999995 110.281 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.629 ' C ' ' H ' ' A' ' 163' ' ' LYS . 1.5 m -44.7 41.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.93 1.085 . . . . 99.989999999999995 113.93 -176.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.867 ' N ' ' O ' ' A' ' 160' ' ' LEU . 13.1 pt20 -69.4 -0.79 6.92 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.064 -2.199 . . . . 99.989999999999995 105.064 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.629 ' H ' ' C ' ' A' ' 161' ' ' THR . 63.9 mttp -56.84 -28.64 61.9 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 113.815 -1.539 . . . . 99.989999999999995 107.663 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.627 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -114.84 -65.21 0.41 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.947 -2.061 . . . . 99.989999999999995 107.947 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.52 -6.92 0.01 OUTLIER 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.897 0.703 . . . . 99.989999999999995 112.897 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' A' ' 164' ' ' GLY . 38.2 tttt -92.85 -44.47 8.46 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.387 -0.968 . . . . 99.989999999999995 108.387 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 164' ' ' GLY . 33.3 m120 -81.73 -1.72 48.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.168 -0.924 . . . . 99.989999999999995 109.013 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.544 ' CG2' ' HZ2' ' A' ' 153' ' ' LYS . 22.0 t -71.95 -52.28 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 109.434 -0.58 . . . . 99.989999999999995 109.434 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.409 ' CD2' ' CE1' ' A' ' 23' ' ' TYR . 38.9 m-85 -55.79 -40.73 73.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.618 -0.719 . . . . 99.989999999999995 110.335 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -47.8 64.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 99.989999999999995 111.497 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.56 -25.98 59.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.942 0.401 . . . . 99.989999999999995 111.215 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.03 -46.43 65.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.048 -0.524 . . . . 99.989999999999995 111.0 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 10.9 pt -66.2 -36.47 77.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.604 -0.517 . . . . 99.989999999999995 109.604 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.4 tp -61.37 -35.27 77.0 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.313 -0.625 . . . . 99.989999999999995 109.313 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.51 68.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.664 -0.698 . . . . 99.989999999999995 110.176 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -58.79 -30.68 67.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.151 -0.477 . . . . 99.989999999999995 109.871 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.0 tp -53.32 -37.51 62.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.624 -0.716 . . . . 99.989999999999995 110.483 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 99.989999999999995 110.665 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 121.015 0.436 . . . . 99.989999999999995 110.532 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.4 134.81 44.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.804 -0.635 . . . . 99.989999999999995 109.971 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.5 tp -126.45 152.22 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 99.989999999999995 110.609 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -104.15 149.02 25.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.201 0.524 . . . . 99.989999999999995 111.342 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 128.09 46.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.5 -0.773 . . . . 99.989999999999995 109.835 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.9 t -98.92 139.45 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.857 -0.337 . . . . 99.989999999999995 110.456 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.438 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 86.8 t -95.66 136.59 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 120.836 -0.346 . . . . 99.989999999999995 111.031 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.8 t -119.79 137.58 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 99.989999999999995 110.766 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 12' ' ' GLY . . . 81.85 -81.33 1.68 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.436 -0.665 . . . . 99.989999999999995 111.436 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 52.9 t0 63.8 -52.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.705 0.288 . . . . 99.989999999999995 110.614 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 10' ' ' GLY . . . 93.19 -9.42 74.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.746 -0.941 . . . . 99.989999999999995 110.746 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 90.88 -4.54 0.26 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.766 0.317 . . . . 99.989999999999995 110.698 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.4 146.04 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 99.989999999999995 110.813 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 17' ' ' THR . . . 122.04 -53.56 0.72 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.024 -0.608 . . . . 99.989999999999995 112.436 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.87 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.525 0.565 . . . . 99.989999999999995 112.525 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.615 ' N ' ' O ' ' A' ' 15' ' ' GLY . 58.3 p -61.99 -43.65 98.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.872 0.693 . . . . 99.989999999999995 112.872 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 20.8 m -127.11 0.53 6.49 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.398 -0.521 . . . . 99.989999999999995 112.382 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -93.43 -52.11 4.66 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.472 -0.491 . . . . 99.989999999999995 110.138 178.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.2 tp -52.08 -37.33 53.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.515 . . . . 99.989999999999995 110.046 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.9 tt -92.03 3.91 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.668 -0.696 . . . . 99.989999999999995 110.94 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.6 p -38.61 -80.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.266 0.469 . . . . 99.989999999999995 112.266 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -72.14 -29.25 63.86 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 119.603 1.092 . . . . 99.989999999999995 111.215 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.7 m -41.96 -47.38 4.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.158 -0.473 . . . . 99.989999999999995 110.924 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -119.58 -8.91 9.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 99.989999999999995 110.881 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.554 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 40.9 t-20 55.68 94.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 99.989999999999995 111.303 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 59.84 86.71 0.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 99.989999999999995 111.375 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.8 tp -127.94 68.86 76.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 99.989999999999995 110.996 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.38 128.94 16.14 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.287 1.992 . . . . 99.989999999999995 111.935 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -149.93 144.8 26.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 99.989999999999995 110.711 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.13 -34.07 76.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 99.989999999999995 110.464 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.49 140.41 49.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 99.989999999999995 110.391 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.69 79.51 62.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 99.989999999999995 110.918 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.1 141.99 67.43 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.601 2.201 . . . . 99.989999999999995 111.674 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 36' ' ' VAL . 69.6 p -69.3 -23.92 63.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 99.989999999999995 111.295 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' CG1' ' H ' ' A' ' 37' ' ' PHE . 9.7 t 37.69 -124.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 99.989999999999995 110.413 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.511 ' H ' ' CG1' ' A' ' 36' ' ' VAL . 95.7 m-85 -113.61 147.42 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 99.989999999999995 110.341 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -68.36 135.65 52.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.398 . . . . 99.989999999999995 110.4 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -105.58 138.35 41.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.049 -0.523 . . . . 99.989999999999995 110.972 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.551 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 13.0 p90 -175.51 4.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 99.989999999999995 110.095 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.38 99.63 2.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.617 -0.72 . . . . 99.989999999999995 109.609 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.89 138.11 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.32 -0.4 . . . . 99.989999999999995 110.631 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t -100.37 115.17 29.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.923 -0.58 . . . . 99.989999999999995 110.414 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -136.47 145.05 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 99.989999999999995 111.008 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 72.2 mtm -102.3 128.18 48.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.987 -0.551 . . . . 99.989999999999995 109.778 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.8 tt -124.18 125.53 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 99.989999999999995 110.469 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.14 24.71 44.82 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.785 -0.926 . . . . 99.989999999999995 110.785 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.9 56.55 5.3 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.43 -1.068 . . . . 99.989999999999995 110.43 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -141.76 91.29 8.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 110.274 -0.269 . . . . 99.989999999999995 110.274 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 30.5 Cg_exo -58.63 103.59 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.57 2.18 . . . . 99.989999999999995 112.683 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 50' ' ' PRO . 89.2 m-85 -159.86 161.19 34.39 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.408 -0.59 . . . . 99.989999999999995 109.408 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 p -132.31 143.67 50.04 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.136 -0.626 . . . . 99.989999999999995 110.885 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.2 tp -120.55 139.12 53.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 99.989999999999995 110.245 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -110.65 123.61 6.67 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.719 -0.753 . . . . 99.989999999999995 111.629 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.551 ' O ' ' CB ' ' A' ' 40' ' ' TYR . 62.0 mt -109.36 131.58 54.93 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.626 0.25 . . . . 99.989999999999995 110.478 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.602 ' CD2' ' O ' ' A' ' 56' ' ' PHE . 41.2 t80 -113.67 31.11 6.73 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.863 0.69 . . . . 99.989999999999995 112.863 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.573 ' CG ' ' H ' ' A' ' 58' ' ' THR . 33.0 t0 -54.06 -154.5 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.183 0.447 . . . . 99.989999999999995 110.937 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.573 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 11.3 m 65.56 -70.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.194 -0.457 . . . . 99.989999999999995 110.653 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . -67.45 146.57 53.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 99.989999999999995 110.523 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . . . . . . 0 CA--C 1.525 0.679 0 C-N-CA 120.826 -0.702 . . . . 99.989999999999995 111.396 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.899 0.38 . . . . 99.989999999999995 110.207 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.2 m -146.65 131.68 18.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 99.989999999999995 110.118 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 76' ' ' ASP . 46.4 p30 -115.07 6.56 15.22 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.442 -0.503 . . . . 99.989999999999995 111.506 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.47 110.5 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.523 -0.471 . . . . 99.989999999999995 110.964 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -87.26 120.42 28.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.02 0.438 . . . . 99.989999999999995 110.468 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tt -119.39 127.55 53.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.86 -0.609 . . . . 99.989999999999995 110.315 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.86 128.44 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.682 -0.488 . . . . 99.989999999999995 109.682 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.596 ' HG ' ' CG2' ' A' ' 115' ' ' THR . 0.0 OUTLIER -134.34 147.72 50.61 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.595 -0.442 . . . . 99.989999999999995 111.356 -179.296 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -170.63 146.55 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 99.989999999999995 110.205 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.489 ' O ' ' OG ' ' A' ' 89' ' ' SER . 30.4 t -62.86 127.25 30.36 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.532 -0.914 . . . . 99.989999999999995 108.532 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 137' ' ' ILE . 3.9 t -76.31 30.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 112.674 0.62 . . . . 99.989999999999995 112.674 -177.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 86' ' ' SER . 14.9 p -130.04 141.62 45.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.697 -0.401 . . . . 99.989999999999995 109.974 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER 83.99 142.16 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.356 -0.384 . . . . 99.989999999999995 110.492 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.08 -3.3 13.4 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.529 2.152 . . . . 99.989999999999995 112.563 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.9 m -91.64 -38.61 12.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.903 0.335 . . . . 99.989999999999995 111.903 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 83' ' ' SER . 93.7 p -60.91 -34.04 74.07 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.94 0.348 . . . . 99.989999999999995 111.94 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -82.78 -41.84 18.65 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.827 -0.349 . . . . 99.989999999999995 110.998 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 83.8 tt0 -60.26 -30.32 69.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.198 -0.456 . . . . 99.989999999999995 111.143 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.623 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 86.7 m-20 -66.24 -43.36 86.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.942 0.349 . . . . 99.989999999999995 111.942 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.24 -70.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 113.334 0.865 . . . . 99.989999999999995 113.334 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 142' ' ' ALA . 24.7 mttt -52.78 -16.19 0.93 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.858 0.688 . . . . 99.989999999999995 112.858 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 95.6 mt-10 -130.31 -52.88 1.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.364 1.246 . . . . 99.989999999999995 114.364 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -73.63 -47.43 40.15 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.218 1.192 . . . . 99.989999999999995 114.218 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.623 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 63.9 m95 -81.74 -30.19 32.57 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 119.554 -0.858 . . . . 99.989999999999995 111.134 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.5 t -44.78 -56.48 8.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.69 -0.404 . . . . 99.989999999999995 110.835 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.52 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 12.0 Cg_endo -57.39 -37.21 98.21 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.428 1.419 . . . . 99.989999999999995 110.915 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.44 -40.92 98.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.138 -0.483 . . . . 99.989999999999995 109.78 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 86.8 mt -68.21 -39.7 81.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.988 -0.551 . . . . 99.989999999999995 110.306 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 105' ' ' CYS . 47.8 m -54.81 -44.36 73.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 99.989999999999995 110.561 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -66.2 -41.11 90.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 99.989999999999995 110.973 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -58.03 -46.45 85.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 99.989999999999995 111.547 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -141.79 162.77 44.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.988 0.423 . . . . 99.989999999999995 111.072 -179.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.457 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 59.1 Cg_endo -73.61 -155.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.997 2.464 . . . . 99.989999999999995 111.783 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.524 ' NZ ' ' HZ3' ' A' ' 150' ' ' LYS . 26.0 mttm -81.36 120.95 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.827 0.346 . . . . 99.989999999999995 110.451 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.606 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -153.45 156.81 32.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 99.989999999999995 110.065 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.73 132.0 44.23 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.151 1.9 . . . . 99.989999999999995 111.483 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.747 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -133.55 132.11 40.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 99.989999999999995 110.52 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 7.9 mp -86.34 128.49 34.94 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.345 -0.542 . . . . 99.989999999999995 110.935 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.496 ' CD2' ' HZ2' ' A' ' 94' ' ' LYS . 34.9 tp -92.7 130.66 38.25 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.219 -0.659 . . . . 99.989999999999995 109.219 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.59 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 21.8 t -142.26 160.06 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.928 -0.709 . . . . 99.989999999999995 111.911 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.433 ' O ' ' SG ' ' A' ' 157' ' ' CYS . . . -136.09 165.66 24.85 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.278 -1.529 . . . . 99.989999999999995 109.278 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.596 ' CG2' ' HG ' ' A' ' 81' ' ' CYS . 1.0 OUTLIER -129.9 172.46 11.66 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.365 -0.534 . . . . 99.989999999999995 110.44 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.725 ' O ' ' N ' ' A' ' 118' ' ' ASP . 20.0 mt-30 50.15 24.2 1.37 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.729 -0.669 . . . . 99.989999999999995 110.472 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.594 ' O ' ' CB ' ' A' ' 118' ' ' ASP . 0.4 OUTLIER 21.36 32.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.097 0.777 . . . . 99.989999999999995 113.097 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 116' ' ' GLN . 15.7 t0 93.95 48.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.673 -0.642 . . . . 99.989999999999995 110.143 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 116' ' ' GLN . 0.5 OUTLIER 77.43 87.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.078 -0.965 . . . . 99.989999999999995 110.942 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' A' ' 119' ' ' LEU . 43.4 ptt85 . . . . . 0 N--CA 1.469 0.475 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 112.272 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.546 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 3.2 tt . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.384 0.135 . . . . 99.989999999999995 110.973 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.524 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -133.38 -69.23 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 113.111 0.782 . . . . 99.989999999999995 113.111 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 1.5 Cg_endo -38.61 -84.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 123.413 2.742 . . . . 99.989999999999995 113.939 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 144' ' ' LYS . 96.9 mt-10 -110.55 -36.12 5.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.237 -0.438 . . . . 99.989999999999995 111.387 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.4 p -44.87 -43.14 8.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.109 -0.496 . . . . 99.989999999999995 110.522 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.5 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -70.78 -58.18 3.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.821 -0.352 . . . . 99.989999999999995 111.57 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.6 -35.53 73.04 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.791 0.663 . . . . 99.989999999999995 112.791 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 140' ' ' GLU . 19.4 tttm -58.24 -43.91 88.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.907 0.336 . . . . 99.989999999999995 111.907 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 7.5 mp -66.85 -29.3 69.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.523 -0.308 . . . . 99.989999999999995 111.368 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.89 -30.94 67.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.707 0.289 . . . . 99.989999999999995 111.488 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 144' ' ' LYS . 60.1 mtm180 -59.62 -36.55 76.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.286 0.476 . . . . 99.989999999999995 112.286 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -119.56 -34.88 3.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.865 0.691 . . . . 99.989999999999995 112.865 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 150' ' ' LYS . 13.1 tp -67.02 -3.27 6.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.665 -0.414 . . . . 99.989999999999995 111.575 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 67.4 mttm 98.95 150.2 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.495 0.718 . . . . 99.989999999999995 109.685 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 157.08 -172.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 99.989999999999995 110.755 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 110' ' ' PHE . 28.7 t -144.68 -53.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.446 -0.946 . . . . 99.989999999999995 108.446 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.587 ' NZ ' ' OE1' ' A' ' 171' ' ' GLU . 15.6 mmtt -95.53 -177.21 4.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.527 -0.761 . . . . 99.989999999999995 109.131 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -168.12 93.82 0.37 Allowed 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.242 -1.392 . . . . 99.989999999999995 107.242 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.407 ' CG2' ' H ' ' A' ' 156' ' ' GLU . 0.8 OUTLIER -172.6 -167.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 114.688 -1.142 . . . . 99.989999999999995 109.383 -178.24 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.407 ' H ' ' CG2' ' A' ' 155' ' ' VAL . 41.9 mt-10 -139.34 -165.43 1.86 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.597 -0.728 . . . . 99.989999999999995 109.158 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.59 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.5 OUTLIER -174.95 120.0 0.2 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.139 0.971 . . . . 99.989999999999995 111.717 178.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 160' ' ' LEU . 42.6 t -165.99 91.08 0.46 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.093 -1.447 . . . . 99.989999999999995 107.093 177.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 33.67 30.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.092 -1.867 . . . . 99.989999999999995 109.085 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.654 ' C ' ' H ' ' A' ' 162' ' ' GLN . 16.0 tp -157.65 -74.73 0.09 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.956 -1.02 . . . . 99.989999999999995 110.48 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.736 ' C ' ' H ' ' A' ' 163' ' ' LYS . 7.4 m -64.54 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.664 -0.414 . . . . 99.989999999999995 111.126 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.654 ' H ' ' C ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -80.3 23.28 0.49 Allowed 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.016 -2.216 . . . . 99.989999999999995 105.016 175.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.736 ' H ' ' C ' ' A' ' 161' ' ' THR . 16.2 tttp -74.6 -4.38 36.8 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 112.665 -2.061 . . . . 99.989999999999995 108.297 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.715 ' O ' ' N ' ' A' ' 167' ' ' ASN . . . -120.71 -54.77 0.24 Allowed Glycine 0 C--O 1.221 -0.661 0 N-CA-C 107.643 -2.183 . . . . 99.989999999999995 107.643 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.516 ' CD2' ' H ' ' A' ' 165' ' ' LEU . 4.0 mm? -34.16 -23.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.654 0.264 . . . . 99.989999999999995 110.845 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.67 ' N ' ' O ' ' A' ' 164' ' ' GLY . 28.2 tttp -77.95 -46.99 19.62 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.429 -0.952 . . . . 99.989999999999995 108.429 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.715 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.8 m120 -79.65 10.68 3.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.047 -1.433 . . . . 99.989999999999995 109.051 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 171' ' ' GLU . 53.2 t -96.44 -63.25 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.731 -0.668 . . . . 99.989999999999995 110.048 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 168' ' ' VAL . 13.1 m-85 -38.9 -43.1 0.92 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 119.967 -0.693 . . . . 99.989999999999995 109.784 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 54.1 p-10 -68.88 -38.08 79.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 99.989999999999995 110.547 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.63 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 34.8 tt0 -68.67 -24.85 64.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.028 0.442 . . . . 99.989999999999995 110.144 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.83 -32.38 72.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.694 -0.685 . . . . 99.989999999999995 109.26 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.98 -39.17 79.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.367 -0.833 . . . . 99.989999999999995 109.651 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.9 -36.11 83.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.758 . . . . 99.989999999999995 110.668 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.36 77.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 99.989999999999995 110.621 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.82 -28.19 67.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 99.989999999999995 110.252 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.92 -35.88 71.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 110.517 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 99.989999999999995 110.503 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.347 . . . . 99.989999999999995 110.436 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.434 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -79.79 138.62 37.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.551 . . . . 99.989999999999995 110.119 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.2 tp -129.35 141.5 46.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 110.388 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -91.77 144.52 25.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.296 -0.411 . . . . 99.989999999999995 110.845 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.425 ' HG ' ' HB3' ' A' ' 56' ' ' PHE . 1.9 t -124.22 135.45 53.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.471 -0.566 . . . . 99.989999999999995 109.471 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.51 154.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.97 0.414 . . . . 99.989999999999995 111.898 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 56' ' ' PHE . 7.2 p -96.77 132.63 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.877 -0.601 . . . . 99.989999999999995 111.084 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.1 t -133.94 130.55 55.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.195 -0.668 . . . . 99.989999999999995 109.195 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.04 -163.89 37.58 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.101 -1.047 . . . . 99.989999999999995 111.778 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.7 t0 -87.42 117.84 26.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 99.989999999999995 111.263 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 32.11 33.67 0.01 OUTLIER Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.71 -0.677 . . . . 99.989999999999995 112.149 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.541 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 17.05 108.28 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.548 0.573 . . . . 99.989999999999995 112.548 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 16' ' ' LYS . 1.4 t -75.36 -138.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.247 -0.433 . . . . 99.989999999999995 111.74 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.411 ' H ' ' CG1' ' A' ' 14' ' ' VAL . . . -59.09 57.73 0.01 OUTLIER Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.725 -0.67 . . . . 99.989999999999995 112.476 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.721 ' NZ ' ' H ' ' A' ' 59' ' ' ALA . 1.1 pttt -64.66 -25.44 67.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.604 0.24 . . . . 99.989999999999995 111.372 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.0 m -66.38 -67.55 0.44 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.927 -0.309 . . . . 99.989999999999995 111.352 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.3 m -55.6 -28.78 57.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.544 0.688 . . . . 99.989999999999995 109.837 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.1 tp -60.71 -39.08 87.24 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.075 -0.966 . . . . 99.989999999999995 110.294 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.511 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -78.13 -30.36 49.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.553 . . . . 99.989999999999995 111.101 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 tt -58.49 -9.21 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.401 . . . . 99.989999999999995 110.876 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -48.24 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.923 -0.711 . . . . 99.989999999999995 110.81 -178.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -57.05 -38.27 72.99 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 119.501 -0.879 . . . . 99.989999999999995 110.675 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.75 -65.0 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 99.989999999999995 111.873 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.6 p -122.08 -18.98 6.75 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.702 -0.399 . . . . 99.989999999999995 111.399 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 22' ' ' SER . 69.2 m-80 60.94 42.99 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.448 -0.342 . . . . 99.989999999999995 110.819 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 179.0 152.27 0.35 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.413 -0.358 . . . . 99.989999999999995 110.629 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -40.45 148.48 0.35 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 99.989999999999995 110.139 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.15 144.86 99.24 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.41 2.074 . . . . 99.989999999999995 111.96 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.621 ' C ' ' H ' ' A' ' 32' ' ' TYR . 48.2 t -69.4 67.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 99.989999999999995 110.412 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 62.02 -17.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.01 -0.541 . . . . 99.989999999999995 111.523 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.621 ' H ' ' C ' ' A' ' 30' ' ' SER . 86.6 m-85 -120.97 145.8 47.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 99.989999999999995 110.848 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.31 66.35 32.96 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 99.989999999999995 110.047 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.77 156.62 65.25 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.621 2.214 . . . . 99.989999999999995 112.667 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.1 p -116.74 170.37 8.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.804 -0.634 . . . . 99.989999999999995 110.378 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.89 157.86 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 99.989999999999995 110.891 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -58.05 -37.0 73.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 99.989999999999995 111.056 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -72.09 123.57 23.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.877 0.37 . . . . 99.989999999999995 110.835 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -59.88 -36.96 78.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 99.989999999999995 110.815 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.708 ' CB ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -158.08 -22.32 0.08 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.287 -0.415 . . . . 99.989999999999995 110.544 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.63 98.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.177 0.513 . . . . 99.989999999999995 111.13 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.5 t -131.14 132.33 63.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.365 -0.834 . . . . 99.989999999999995 110.035 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 43' ' ' THR . 12.9 t -112.62 123.6 50.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.105 0.479 . . . . 99.989999999999995 111.107 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.9 m -134.32 154.72 38.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.687 -0.688 . . . . 99.989999999999995 109.953 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.3 pmm? -126.52 125.93 42.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.228 0.537 . . . . 99.989999999999995 110.491 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.3 mt -126.42 112.2 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.941 -0.762 . . . . 99.989999999999995 108.941 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 4.48 85.87 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.771 -1.332 . . . . 99.989999999999995 109.771 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.93 5.49 59.7 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.426 -0.67 . . . . 99.989999999999995 111.426 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -83.06 115.07 56.95 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 121.029 -0.268 . . . . 99.989999999999995 110.93 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.29 109.26 2.09 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.127 1.885 . . . . 99.989999999999995 112.682 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -151.77 171.13 18.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.897 -0.592 . . . . 99.989999999999995 109.684 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.434 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.1 p -143.67 126.74 16.45 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.08 -0.648 . . . . 99.989999999999995 111.945 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.3 tp -109.98 130.34 55.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.081 -0.509 . . . . 99.989999999999995 110.169 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.62 147.13 41.49 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.22 -1.152 . . . . 99.989999999999995 110.22 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.708 ' H ' ' CB ' ' A' ' 40' ' ' TYR . 49.2 mt -83.08 98.83 9.51 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 119.565 -0.854 . . . . 99.989999999999995 111.161 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.518 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 11.0 p90 -57.04 -40.94 77.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.312 -0.858 . . . . 99.989999999999995 110.593 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -43.02 165.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.892 -0.594 . . . . 99.989999999999995 111.187 -179.407 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.523 ' H ' ' CG ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 77.19 95.98 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.573 -0.451 . . . . 99.989999999999995 110.868 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.721 ' H ' ' NZ ' ' A' ' 16' ' ' LYS . . . -176.83 -124.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 99.989999999999995 110.338 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.682 0 N-CA-C 111.125 -0.79 . . . . 99.989999999999995 111.125 179.747 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.707 0.289 . . . . 99.989999999999995 110.817 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.8 p -123.42 154.28 39.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 99.989999999999995 110.71 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -115.93 0.08 12.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.228 -0.442 . . . . 99.989999999999995 111.078 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.42 101.52 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.721 -0.392 . . . . 99.989999999999995 110.364 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.674 ' CE2' ' SG ' ' A' ' 105' ' ' CYS . 87.9 m-85 -73.84 118.96 17.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.185 0.517 . . . . 99.989999999999995 111.13 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tt -116.68 128.19 55.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.478 -0.783 . . . . 99.989999999999995 110.766 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.579 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 40.6 t -94.03 130.95 42.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.013 -0.54 . . . . 99.989999999999995 109.952 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 42.8 t -123.61 127.42 48.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.023 0.44 . . . . 99.989999999999995 111.152 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.431 ' H ' ' HA2' ' A' ' 114' ' ' GLY . 33.9 p90 -171.23 139.24 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 99.989999999999995 111.091 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -62.37 132.69 53.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.331 -0.989 . . . . 99.989999999999995 108.331 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.53 15.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 119.745 -0.782 . . . . 99.989999999999995 111.612 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -138.86 26.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.272 0.558 . . . . 99.989999999999995 109.894 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -121.31 86.82 43.95 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.611 -0.722 . . . . 99.989999999999995 110.06 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.56 -29.3 18.58 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.403 2.068 . . . . 99.989999999999995 112.352 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.1 m -70.45 -41.46 72.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.989 0.424 . . . . 99.989999999999995 110.484 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.547 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 49.5 m -73.97 -53.45 10.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.922 -0.581 . . . . 99.989999999999995 111.765 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.38 -46.2 72.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.396 -0.366 . . . . 99.989999999999995 111.449 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -66.19 -28.15 68.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.08 -0.509 . . . . 99.989999999999995 111.531 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.582 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 24.2 m120 -102.64 -3.4 26.69 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.126 -0.629 . . . . 99.989999999999995 111.076 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.579 ' CG1' ' CG1' ' A' ' 80' ' ' VAL . 38.5 t -89.53 -71.6 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.703 -0.399 . . . . 99.989999999999995 111.831 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -70.69 -20.21 62.7 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.174 0.435 . . . . 99.989999999999995 112.174 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -112.64 -10.59 13.64 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.556 1.317 . . . . 99.989999999999995 114.556 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -129.61 -29.04 2.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.452 -0.899 . . . . 99.989999999999995 113.03 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.582 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 53.8 m95 -98.26 -31.38 12.09 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.643 -0.823 . . . . 99.989999999999995 110.827 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.552 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -67.85 -44.27 40.74 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 120.678 -0.409 . . . . 99.989999999999995 110.751 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 17.0 Cg_exo -63.51 -36.67 52.85 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.315 2.01 . . . . 99.989999999999995 111.757 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.31 -41.41 96.95 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.769 -0.372 . . . . 99.989999999999995 110.962 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.1 pt -83.19 -34.28 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.73 -0.388 . . . . 99.989999999999995 111.04 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 40.8 m -61.25 -40.7 95.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.294 -0.412 . . . . 99.989999999999995 111.486 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -58.67 -43.86 90.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.488 -0.324 . . . . 99.989999999999995 111.435 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -82.3 -15.02 54.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.418 -0.356 . . . . 99.989999999999995 111.101 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.674 ' SG ' ' CE2' ' A' ' 78' ' ' PHE . 1.7 t -114.66 108.77 48.74 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.859 -0.337 . . . . 99.989999999999995 111.316 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.01 163.1 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.947 1.764 . . . . 99.989999999999995 111.337 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -48.34 118.28 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 99.989999999999995 110.75 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.617 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -151.84 156.74 34.44 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 99.989999999999995 110.027 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.18 132.41 47.86 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.259 1.973 . . . . 99.989999999999995 112.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.723 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -130.9 130.35 43.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.154 0.502 . . . . 99.989999999999995 110.504 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 7.4 mp -92.73 131.58 37.68 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.302 -0.559 . . . . 99.989999999999995 110.914 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 tp -93.35 123.53 36.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 99.989999999999995 109.622 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 80' ' ' VAL . 42.1 t -143.3 152.17 16.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.569 -0.452 . . . . 99.989999999999995 111.299 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.431 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -141.15 -179.06 18.08 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.611 -0.995 . . . . 99.989999999999995 110.611 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 p -124.74 174.23 8.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.23 0.538 . . . . 99.989999999999995 110.848 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 117' ' ' ILE . 52.4 mt-30 48.5 28.97 1.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.317 -0.856 . . . . 99.989999999999995 111.904 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.667 ' CG2' ' H ' ' A' ' 119' ' ' LEU . 3.8 tt 31.23 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 109.932 -0.396 . . . . 99.989999999999995 109.932 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.523 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 27.4 p-10 -109.66 9.07 25.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.312 0.577 . . . . 99.989999999999995 110.254 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.667 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 77.1 mt -123.15 4.32 9.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.111 -0.95 . . . . 99.989999999999995 108.78 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.551 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.553 0 CA-C-N 114.754 -1.112 . . . . 99.989999999999995 110.336 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.717 ' CG2' ' H ' ' A' ' 138' ' ' THR . 94.6 mt . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 121.216 0.531 . . . . 99.989999999999995 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.717 ' H ' ' CG2' ' A' ' 137' ' ' ILE . 49.8 p -133.33 37.75 0.39 Allowed Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.242 -0.89 . . . . 99.989999999999995 111.612 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 138' ' ' THR . 87.8 Cg_exo -23.63 -39.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.384 2.723 . . . . 99.989999999999995 112.663 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 138' ' ' THR . 97.3 mt-10 -66.02 -47.68 73.64 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.49 -0.484 . . . . 99.989999999999995 110.138 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 143' ' ' GLU . 84.4 m -54.37 -71.56 0.08 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.626 -0.43 . . . . 99.989999999999995 110.601 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 141' ' ' THR . . . -28.06 -31.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.054 0.761 . . . . 99.989999999999995 113.054 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 141' ' ' THR . 78.6 mm-40 -60.62 -39.91 89.94 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.96 -0.696 . . . . 99.989999999999995 110.834 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' THR . 20.8 tttt -98.04 -19.3 18.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 99.989999999999995 110.786 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -32.35 73.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 99.989999999999995 110.099 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -80.24 -39.83 28.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 99.989999999999995 110.922 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.04 -36.73 77.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 99.989999999999995 111.476 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 59.3 t0 -98.36 -16.44 19.31 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.361 0.504 . . . . 99.989999999999995 112.361 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 3.8 tp -117.46 34.4 5.15 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.292 -0.563 . . . . 99.989999999999995 112.051 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 23.2 mttm 80.85 149.41 0.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.282 0.563 . . . . 99.989999999999995 110.895 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 156.34 -177.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.209 -0.905 . . . . 99.989999999999995 110.762 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 110' ' ' PHE . 24.4 t -141.63 -52.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.706 -0.679 . . . . 99.989999999999995 109.846 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.584 ' NZ ' ' OD1' ' A' ' 167' ' ' ASN . 5.6 tttm -119.77 -172.54 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.726 -0.67 . . . . 99.989999999999995 109.553 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.616 ' CG ' ' O ' ' A' ' 154' ' ' TYR . 29.9 p90 -154.28 96.77 1.96 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.387 -1.338 . . . . 99.989999999999995 107.387 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.81 138.48 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 122.118 0.961 . . . . 99.989999999999995 111.848 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.746 ' O ' ' OG1' ' A' ' 161' ' ' THR . 88.7 mt-10 -123.62 98.33 5.78 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.553 -1.647 . . . . 99.989999999999995 106.553 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -114.62 146.11 41.21 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 123.188 1.471 . . . . 99.989999999999995 113.167 -176.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.514 ' N ' ' SG ' ' A' ' 157' ' ' CYS . 15.2 t -169.9 93.23 0.24 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 111.629 -2.532 . . . . 99.989999999999995 107.201 176.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 42.92 28.09 0.12 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.976 -1.466 . . . . 99.989999999999995 110.215 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 162' ' ' GLN . 21.4 mt -145.65 -81.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.303 -0.862 . . . . 99.989999999999995 110.488 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.746 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -57.39 52.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.164 0.507 . . . . 99.989999999999995 111.481 -178.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.706 ' N ' ' O ' ' A' ' 160' ' ' LEU . 5.4 pp0? -82.62 15.52 2.55 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.42 -2.067 . . . . 99.989999999999995 105.42 176.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.649 ' H ' ' C ' ' A' ' 161' ' ' THR . 25.5 mttt -89.47 0.63 56.74 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 113.14 -1.845 . . . . 99.989999999999995 108.752 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.622 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.04 -72.76 0.11 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 108.369 -1.893 . . . . 99.989999999999995 108.369 177.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 164' ' ' GLY . 11.1 mp -40.22 -19.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.564 -0.854 . . . . 99.989999999999995 110.686 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.622 ' N ' ' O ' ' A' ' 164' ' ' GLY . 28.4 tttt -80.06 -49.78 11.29 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.487 -0.931 . . . . 99.989999999999995 108.487 177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 164' ' ' GLY . 17.6 p-10 -77.9 4.53 11.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.604 -1.18 . . . . 99.989999999999995 109.791 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 171' ' ' GLU . 17.6 t -81.25 -58.11 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.214 -0.448 . . . . 99.989999999999995 110.243 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 168' ' ' VAL . 40.0 m-85 -39.31 -39.88 0.7 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.051 -0.659 . . . . 99.989999999999995 109.705 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -65.89 -47.66 74.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.057 0.456 . . . . 99.989999999999995 110.022 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 168' ' ' VAL . 77.1 mm-40 -67.76 -18.92 65.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.937 -0.574 . . . . 99.989999999999995 110.153 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.35 -38.62 91.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 99.989999999999995 110.821 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 15.0 tt -62.11 -31.79 52.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.751 -0.379 . . . . 99.989999999999995 110.482 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.1 tp -63.36 -38.1 89.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 99.989999999999995 110.464 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.69 -22.92 66.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 110.867 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.19 68.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 99.989999999999995 110.427 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 38.9 tp -56.61 -36.77 69.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 99.989999999999995 110.57 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 99.989999999999995 110.583 -179.763 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.538 ' N ' ' C ' ' A' ' 176' ' ' ALA . 65.0 mtt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.526 -0.546 . . . . 99.989999999999995 109.526 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 3' ' ' THR . 90.5 mt-30 -115.68 164.64 14.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 99.989999999999995 110.819 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 52' ' ' THR . 1.8 t -39.93 142.19 0.37 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.021 -0.536 . . . . 99.989999999999995 109.876 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.3 tp -128.57 149.68 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.623 -0.431 . . . . 99.989999999999995 110.953 -178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -95.93 141.09 29.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 99.989999999999995 111.019 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.524 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -134.76 147.49 50.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.75 -0.659 . . . . 99.989999999999995 109.825 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.421 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 28.4 m -131.9 147.28 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.304 -0.558 . . . . 99.989999999999995 111.14 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -109.0 124.45 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.158 0.504 . . . . 99.989999999999995 110.942 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -127.25 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.417 -0.81 . . . . 99.989999999999995 109.849 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.71 -164.36 11.44 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.576 -0.821 . . . . 99.989999999999995 111.611 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.7 t0 -78.62 126.53 30.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.802 0.334 . . . . 99.989999999999995 110.833 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.14 -88.62 0.01 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.423 -0.671 . . . . 99.989999999999995 111.423 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -136.6 127.7 27.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.78 0.324 . . . . 99.989999999999995 110.167 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.464 ' O ' ' C ' ' A' ' 15' ' ' GLY . 8.6 m -140.64 150.8 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 99.989999999999995 111.305 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.782 ' H ' ' HG1' ' A' ' 115' ' ' THR . . . 23.76 54.24 0.04 OUTLIER Glycine 0 N--CA 1.471 1.015 0 CA-C-N 115.708 -0.678 . . . . 99.989999999999995 112.888 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.5 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 85.1 mttt -35.12 -58.85 0.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.825 0.305 . . . . 99.989999999999995 111.825 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 20' ' ' LEU . 4.0 m -130.37 -55.94 1.09 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.4 0.518 . . . . 99.989999999999995 112.4 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 17' ' ' THR . 87.7 m -34.84 -28.58 0.01 OUTLIER 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.045 0.45 . . . . 99.989999999999995 111.049 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 17' ' ' THR . 4.2 tt -76.3 -43.39 41.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.057 -0.52 . . . . 99.989999999999995 111.432 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 17' ' ' THR . 96.0 mt -59.33 -35.96 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 99.989999999999995 111.089 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.638 ' C ' ' HG1' ' A' ' 24' ' ' THR . 12.8 pt -90.14 8.19 3.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.021 -0.536 . . . . 99.989999999999995 111.766 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.464 ' OG ' ' SG ' ' A' ' 157' ' ' CYS . 0.4 OUTLIER -39.85 -77.83 0.02 OUTLIER 'General case' 0 C--O 1.241 0.611 0 C-N-CA 119.885 -0.726 . . . . 99.989999999999995 110.504 -179.177 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.603 ' C ' ' H ' ' A' ' 25' ' ' THR . 14.9 p90 -39.93 -34.72 0.3 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 118.226 0.466 . . . . 99.989999999999995 111.499 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.638 ' HG1' ' C ' ' A' ' 21' ' ' ILE . 1.1 m -45.95 -14.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.936 -0.764 . . . . 99.989999999999995 108.936 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.603 ' H ' ' C ' ' A' ' 23' ' ' TYR . 55.7 m 50.53 37.31 15.68 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.546 -0.752 . . . . 99.989999999999995 109.705 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.498 ' O ' ' O ' ' A' ' 27' ' ' LYS . 91.7 m-20 -63.12 -40.37 97.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 99.989999999999995 111.168 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' ' O ' ' A' ' 26' ' ' ASN . 36.8 mttt 57.84 131.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.886 0.374 . . . . 99.989999999999995 110.457 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.606 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.8 mt -39.6 -55.84 3.24 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.156 -0.475 . . . . 99.989999999999995 111.984 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 28' ' ' LEU . 85.0 Cg_exo -38.64 -15.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.65 2.233 . . . . 99.989999999999995 113.048 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 28' ' ' LEU . 23.0 t -104.32 131.29 51.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.663 -0.415 . . . . 99.989999999999995 110.573 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.54 -29.36 68.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 99.989999999999995 111.104 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -53.91 122.04 9.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.75 0.31 . . . . 99.989999999999995 110.806 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.484 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 14.8 p -178.18 50.73 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.925 -0.579 . . . . 99.989999999999995 110.543 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 14.7 Cg_endo -59.68 131.42 40.0 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.626 2.217 . . . . 99.989999999999995 112.002 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 p -119.55 5.39 11.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 99.989999999999995 110.672 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.1 t -62.11 -40.59 88.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 99.989999999999995 110.808 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -109.79 132.94 53.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 111.204 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -84.67 124.02 31.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 99.989999999999995 109.796 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -99.37 144.99 27.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.046 0.45 . . . . 99.989999999999995 111.205 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.524 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 20.4 p90 -167.13 19.6 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.713 -0.676 . . . . 99.989999999999995 109.45 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.62 100.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.259 -0.882 . . . . 99.989999999999995 109.58 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 t -137.38 134.03 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 99.989999999999995 110.977 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 43' ' ' THR . 8.9 t -103.62 108.21 19.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 99.989999999999995 110.603 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -135.17 144.2 34.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 99.989999999999995 110.219 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.5 ptp -111.46 146.03 37.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 99.989999999999995 110.545 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 47' ' ' GLY . 39.1 mm -118.73 125.7 74.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 99.989999999999995 110.127 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 32.12 45.51 0.19 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.527 -0.629 . . . . 99.989999999999995 111.527 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.51 47.76 5.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.093 -0.575 . . . . 99.989999999999995 111.742 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 2.8 mt-10 -133.46 77.48 65.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.359 . . . . 99.989999999999995 110.108 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.29 106.85 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.965 2.443 . . . . 99.989999999999995 112.959 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.552 ' CE1' ' O ' ' A' ' 169' ' ' PHE . 30.7 p90 -155.84 166.27 34.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.564 -0.532 . . . . 99.989999999999995 109.564 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.486 ' O ' ' OG1' ' A' ' 3' ' ' THR . 1.0 OUTLIER -131.3 127.18 37.19 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.599 -0.44 . . . . 99.989999999999995 110.955 179.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.5 tp -119.35 127.79 53.49 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.491 -0.322 . . . . 99.989999999999995 111.019 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -93.1 144.17 16.9 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 109.733 -1.347 . . . . 99.989999999999995 109.733 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.524 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 64.9 mt -137.29 129.74 29.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.471 -0.491 . . . . 99.989999999999995 112.201 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -97.3 -164.27 1.13 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.736 -0.468 . . . . 99.989999999999995 109.736 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 58' ' ' THR . 49.1 p30 -162.33 -162.38 0.82 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.948 -0.301 . . . . 99.989999999999995 111.401 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.667 ' CG2' ' H ' ' A' ' 59' ' ' ALA . 4.4 t -8.25 -112.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.039 0.837 . . . . 99.989999999999995 112.803 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.667 ' H ' ' CG2' ' A' ' 58' ' ' THR . . . 39.81 83.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 99.989999999999995 110.42 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -40.84 -89.4 0.01 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.195 -0.762 . . . . 99.989999999999995 111.195 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.479 ' OE1' ' O ' ' A' ' 63' ' ' ASP . 46.6 tt0 -59.75 -15.37 19.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.679 0.276 . . . . 99.989999999999995 110.757 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 58.79 21.07 8.56 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.573 -1.269 . . . . 99.989999999999995 107.573 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 60.5 t0 176.58 45.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.926 -1.488 . . . . 99.989999999999995 108.498 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.439 ' C ' ' O ' ' A' ' 63' ' ' ASP . 98.9 m-85 -33.25 -40.75 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.654 -0.703 . . . . 99.989999999999995 111.133 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 88.1 m-20 -83.8 116.99 22.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 99.989999999999995 111.089 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -65.54 -28.37 69.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 99.989999999999995 110.886 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.73 -38.41 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 99.989999999999995 110.49 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -63.04 152.64 83.43 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.845 -0.342 . . . . 99.989999999999995 110.407 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.93 136.59 62.3 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.648 2.232 . . . . 99.989999999999995 112.526 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.55 1.33 53.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 99.989999999999995 110.621 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.565 ' O ' ' CB ' ' A' ' 72' ' ' TYR . 49.3 m -121.26 157.69 29.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 99.989999999999995 111.122 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.565 ' CB ' ' O ' ' A' ' 71' ' ' SER . 6.6 t80 91.39 71.17 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 115.774 -0.648 . . . . 99.989999999999995 110.922 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.52 133.6 59.03 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.704 2.269 . . . . 99.989999999999995 111.765 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -104.18 14.12 31.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 99.989999999999995 110.124 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -136.65 151.15 48.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 99.989999999999995 110.538 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -112.1 -19.61 12.23 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.671 -0.412 . . . . 99.989999999999995 110.924 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.7 t -122.24 120.43 61.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.486 -0.325 . . . . 99.989999999999995 110.144 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -87.53 122.18 30.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.128 0.489 . . . . 99.989999999999995 111.548 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.505 ' CD2' ' SG ' ' A' ' 6' ' ' CYS . 10.6 mp -111.73 114.2 27.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.512 -0.767 . . . . 99.989999999999995 110.002 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.4 m -98.59 129.23 49.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.224 -0.658 . . . . 99.989999999999995 109.224 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.451 ' HG ' ' CD1' ' A' ' 19' ' ' LEU . 6.8 t -129.86 135.86 48.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.499 0.666 . . . . 99.989999999999995 112.042 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -142.24 144.92 33.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.143 -0.935 . . . . 99.989999999999995 109.372 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.6 t -66.55 130.69 44.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.896 -0.779 . . . . 99.989999999999995 108.896 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.515 ' CG1' ' OG1' ' A' ' 138' ' ' THR . 10.7 t -63.64 4.24 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 113.368 0.877 . . . . 99.989999999999995 113.368 -177.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' SER . 14.7 p -129.99 144.1 39.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 118.557 0.617 . . . . 99.989999999999995 109.556 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.599 ' C ' ' H ' ' A' ' 88' ' ' SER . 0.7 OUTLIER 83.65 92.16 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.79 -0.448 . . . . 99.989999999999995 109.79 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -48.11 -0.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.648 2.232 . . . . 99.989999999999995 113.113 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.599 ' H ' ' C ' ' A' ' 86' ' ' SER . 19.9 m -66.19 -61.52 1.98 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.54 -0.464 . . . . 99.989999999999995 110.888 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.8 p -64.94 -35.02 79.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.191 -0.458 . . . . 99.989999999999995 111.525 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -69.01 -50.52 48.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.056 0.391 . . . . 99.989999999999995 112.056 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -64.12 -24.16 67.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.28 -0.418 . . . . 99.989999999999995 111.851 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 96' ' ' LYS . 14.0 m120 -86.99 -64.09 1.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.766 -0.374 . . . . 99.989999999999995 111.858 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.416 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 30.1 t -41.07 -61.92 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.611 0.597 . . . . 99.989999999999995 112.611 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 142' ' ' ALA . 43.5 mtpt -67.96 -21.26 65.1 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.913 0.708 . . . . 99.989999999999995 112.913 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 68.3 tt0 -106.11 -63.24 1.28 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.166 0.802 . . . . 99.989999999999995 113.166 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 92' ' ' ASN . 17.4 mttp -67.19 -35.95 80.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.298 1.221 . . . . 99.989999999999995 114.298 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 97' ' ' TRP . 29.7 m95 -84.82 -33.93 22.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.982 -0.687 . . . . 99.989999999999995 111.899 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.471 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -44.69 -54.34 13.01 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.704 -0.398 . . . . 99.989999999999995 111.267 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 16.6 Cg_endo -60.46 -36.49 86.28 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.568 1.512 . . . . 99.989999999999995 111.61 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.84 -40.51 97.66 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.357 -0.537 . . . . 99.989999999999995 110.096 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 83.7 mt -73.8 -38.52 50.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 99.989999999999995 110.869 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.8 p -61.42 -37.42 83.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 99.989999999999995 111.562 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -56.69 -36.99 70.25 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.911 -0.316 . . . . 99.989999999999995 111.22 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -55.19 -44.74 75.57 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.899 -0.32 . . . . 99.989999999999995 111.268 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.5 153.8 29.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.689 -0.404 . . . . 99.989999999999995 110.735 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -43.34 -76.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.293 1.995 . . . . 99.989999999999995 112.141 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -140.47 142.85 35.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 99.989999999999995 110.844 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.587 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -152.79 156.57 33.09 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 99.989999999999995 110.09 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.29 128.73 31.23 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.209 1.94 . . . . 99.989999999999995 110.91 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.727 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -124.0 123.5 40.51 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.46 -0.496 . . . . 99.989999999999995 111.72 -178.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 8.8 mp -97.68 129.86 44.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 110.44 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -96.76 129.32 44.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.333 -0.394 . . . . 99.989999999999995 110.561 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.489 ' CG1' ' N ' ' A' ' 114' ' ' GLY . 51.5 t -147.38 168.12 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 99.989999999999995 111.347 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.489 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -135.51 166.63 24.46 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.538 -1.025 . . . . 99.989999999999995 110.538 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.782 ' HG1' ' H ' ' A' ' 15' ' ' GLY . 11.2 t -123.56 174.58 7.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.109 0.48 . . . . 99.989999999999995 112.017 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.56 ' O ' ' C ' ' A' ' 117' ' ' ILE . 33.1 mt-30 34.16 31.04 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.361 -0.836 . . . . 99.989999999999995 110.232 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.605 ' CG2' ' N ' ' A' ' 118' ' ' ASP . 7.7 tt 24.84 -138.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 O-C-N 123.944 0.777 . . . . 99.989999999999995 109.452 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.605 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 61.8 m-20 -84.87 71.93 10.83 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.348 -0.541 . . . . 99.989999999999995 109.573 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.602 ' O ' ' N ' ' A' ' 121' ' ' ASP . 5.9 tt 66.1 91.42 0.08 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.596 -0.729 . . . . 99.989999999999995 110.631 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 119' ' ' LEU . 56.9 ttp180 5.72 62.39 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 124.259 0.974 . . . . 99.989999999999995 111.181 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' A' ' 119' ' ' LEU . 0.6 OUTLIER 168.54 -96.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.476 -0.784 . . . . 99.989999999999995 110.606 -179.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.606 ' H ' ' CG2' ' A' ' 125' ' ' THR . 39.7 t0 108.08 -43.5 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 123.487 0.715 . . . . 99.989999999999995 111.116 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.432 ' CD ' ' C ' ' A' ' 121' ' ' ASP . 56.3 Cg_endo -91.75 -37.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 121.501 1.467 . . . . 99.989999999999995 112.179 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.7 p -99.04 -0.86 41.06 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.066 -0.654 . . . . 99.989999999999995 111.93 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.606 ' CG2' ' H ' ' A' ' 122' ' ' ASP . 13.2 t -111.71 -13.72 13.7 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.493 -0.483 . . . . 99.989999999999995 110.778 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.486 ' CG2' ' N ' ' A' ' 127' ' ' GLU . 16.3 tt -86.19 -42.78 16.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.331 -0.618 . . . . 99.989999999999995 109.331 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 126' ' ' ILE . 96.5 mt-10 -73.81 -34.48 64.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.666 -0.697 . . . . 99.989999999999995 111.041 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -74.12 -32.28 63.13 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.356 -0.384 . . . . 99.989999999999995 111.48 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.596 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 4.6 mp -66.97 -33.11 74.87 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.756 0.65 . . . . 99.989999999999995 112.756 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.596 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . 109.08 130.6 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.703 -0.851 . . . . 99.989999999999995 108.703 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.3 mttp -48.54 -37.74 18.57 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.479 -0.782 . . . . 99.989999999999995 111.732 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -82.84 -3.09 56.36 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.598 -0.441 . . . . 99.989999999999995 111.322 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -110.3 -9.15 14.66 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.815 -0.354 . . . . 99.989999999999995 111.165 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' A' ' 135' ' ' LYS . 91.1 mt-30 -52.37 -40.91 62.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.543 -0.463 . . . . 99.989999999999995 110.81 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 134' ' ' GLN . 41.0 mttp 26.71 59.94 0.53 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 116.068 -0.515 . . . . 99.989999999999995 112.141 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.86 143.04 78.4 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.441 2.094 . . . . 99.989999999999995 111.363 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -133.02 47.41 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 120.161 -0.616 . . . . 99.989999999999995 111.814 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.515 ' OG1' ' CG1' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -133.23 -65.29 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 112.241 0.46 . . . . 99.989999999999995 112.241 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.491 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.6 Cg_exo -20.54 -73.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 124.001 3.134 . . . . 99.989999999999995 113.983 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -114.82 -31.05 6.25 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.573 -0.451 . . . . 99.989999999999995 111.496 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 40.2 m -55.78 -42.61 75.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.451 -0.341 . . . . 99.989999999999995 111.305 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.513 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -69.55 -38.22 77.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.8 -0.36 . . . . 99.989999999999995 111.526 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.59 -35.27 79.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.561 -0.29 . . . . 99.989999999999995 111.316 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.97 -50.41 72.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.51 -0.314 . . . . 99.989999999999995 111.319 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.05 -33.04 74.85 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.849 -0.34 . . . . 99.989999999999995 111.684 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.502 ' N ' ' HZ1' ' A' ' 94' ' ' LYS . . . -69.78 -41.4 75.18 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.96 -0.756 . . . . 99.989999999999995 108.96 178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 -62.43 -35.11 78.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.747 -1.115 . . . . 99.989999999999995 109.468 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -47.39 -30.83 3.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.739 -1.208 . . . . 99.989999999999995 107.739 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.1 mt -123.48 -117.67 0.29 Allowed 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.625 -1.25 . . . . 99.989999999999995 107.625 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 151' ' ' ALA . 76.9 tttt -177.46 69.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.905 -0.589 . . . . 99.989999999999995 111.219 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -53.13 -121.94 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.666 0.746 . . . . 99.989999999999995 111.093 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.437 ' N ' ' O ' ' A' ' 110' ' ' PHE . 71.6 t -155.02 -61.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.051 -0.977 . . . . 99.989999999999995 109.213 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.527 ' C ' ' CG ' ' A' ' 154' ' ' TYR . 18.5 mttp -101.76 -173.65 2.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.204 -0.453 . . . . 99.989999999999995 109.815 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -170.03 95.5 0.26 Allowed 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.386 -1.339 . . . . 99.989999999999995 107.386 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.609 ' CG2' ' H ' ' A' ' 156' ' ' GLU . 3.6 p -171.92 -167.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 114.799 -1.091 . . . . 99.989999999999995 109.399 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.609 ' H ' ' CG2' ' A' ' 155' ' ' VAL . 27.9 mp0 -130.66 -170.62 2.38 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.032 -0.986 . . . . 99.989999999999995 109.313 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.477 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -171.76 121.13 0.48 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.878 0.847 . . . . 99.989999999999995 109.508 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.64 ' O ' ' N ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -173.88 92.74 0.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.237 -0.892 . . . . 99.989999999999995 109.097 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 31.34 31.25 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.774 -1.557 . . . . 99.989999999999995 109.578 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.64 ' N ' ' O ' ' A' ' 158' ' ' SER . 21.7 tp -164.76 -77.45 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.767 -1.106 . . . . 99.989999999999995 109.805 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.82 ' C ' ' H ' ' A' ' 163' ' ' LYS . 2.8 m -58.98 3.45 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.295 -0.562 . . . . 99.989999999999995 110.132 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.623 ' H ' ' C ' ' A' ' 160' ' ' LEU . 13.9 pt20 -64.8 30.38 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 107.954 -1.128 . . . . 99.989999999999995 107.954 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.82 ' H ' ' C ' ' A' ' 161' ' ' THR . 94.2 mttt -90.89 3.95 53.17 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.563 -1.643 . . . . 99.989999999999995 106.563 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -118.2 -70.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 107.685 -2.166 . . . . 99.989999999999995 107.685 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.435 ' CD1' ' SG ' ' A' ' 157' ' ' CYS . 7.3 mt -41.03 -14.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 120.667 -0.413 . . . . 99.989999999999995 110.899 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 164' ' ' GLY . 60.0 tttp -82.93 -50.58 8.43 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.928 -1.138 . . . . 99.989999999999995 107.928 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 164' ' ' GLY . 29.9 m120 -77.61 3.73 13.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.499 -1.228 . . . . 99.989999999999995 109.487 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 171' ' ' GLU . 33.2 t -84.04 -51.76 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 116.098 -0.501 . . . . 99.989999999999995 109.759 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.552 ' O ' ' CE1' ' A' ' 51' ' ' TYR . 6.7 m-85 -37.69 -42.36 0.56 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.288 -0.565 . . . . 99.989999999999995 109.808 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -67.52 -40.64 85.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.386 -0.37 . . . . 99.989999999999995 110.35 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 168' ' ' VAL . 76.7 mm-40 -67.03 -23.31 65.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.05 0.453 . . . . 99.989999999999995 109.951 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.5 85.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.623 . . . . 99.989999999999995 110.903 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 14.0 tt -60.58 -31.69 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.407 -0.517 . . . . 99.989999999999995 109.625 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.1 tp -65.7 -38.56 89.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 99.989999999999995 110.139 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.47 -33.8 76.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.868 -0.606 . . . . 99.989999999999995 110.833 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.538 ' C ' ' N ' ' A' ' 1' ' ' MET . . . -59.14 -32.5 69.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.391 -0.368 . . . . 99.989999999999995 110.501 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.64 -36.01 69.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 99.989999999999995 110.386 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 99.989999999999995 110.641 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.1 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.237 -0.653 . . . . 99.989999999999995 109.237 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 3' ' ' THR . 91.6 mt-30 49.68 -148.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.372 -0.376 . . . . 99.989999999999995 110.135 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.715 ' CB ' ' HG1' ' A' ' 52' ' ' THR . 2.0 t -36.83 135.07 0.46 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.241 0.543 . . . . 99.989999999999995 110.737 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 tp -127.27 150.76 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.26 -0.882 . . . . 99.989999999999995 110.282 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -114.05 157.91 21.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.214 0.53 . . . . 99.989999999999995 111.623 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.23 153.35 47.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.424 -0.807 . . . . 99.989999999999995 109.388 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.8 t -122.48 133.09 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.539 -0.465 . . . . 99.989999999999995 112.027 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 10.5 p -50.02 120.86 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 115.789 -0.641 . . . . 99.989999999999995 111.166 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' O ' ' N ' ' A' ' 81' ' ' CYS . 47.9 t -127.63 131.49 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.339 -0.615 . . . . 99.989999999999995 109.339 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.19 -169.91 37.56 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.591 -0.814 . . . . 99.989999999999995 111.314 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 92' ' ' ASN . 58.5 t0 -123.29 139.63 53.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.923 0.392 . . . . 99.989999999999995 110.677 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 63.42 -117.19 10.5 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.847 -0.901 . . . . 99.989999999999995 110.847 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.95 128.83 10.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.822 0.344 . . . . 99.989999999999995 110.421 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.524 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 24.2 m -136.53 164.33 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 99.989999999999995 110.552 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.483 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -74.65 80.76 0.89 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 120.945 -0.645 . . . . 99.989999999999995 112.118 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.564 ' H ' ' CD ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -81.46 -1.16 44.83 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.469 -0.43 . . . . 99.989999999999995 110.914 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.3 p -68.42 -53.32 24.47 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.562 -0.455 . . . . 99.989999999999995 111.107 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.586 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 93.2 m -69.25 -22.42 63.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.69 0.757 . . . . 99.989999999999995 109.811 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.47 -56.06 16.67 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.103 -0.953 . . . . 99.989999999999995 110.626 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 22' ' ' SER . 14.3 tp -69.11 -34.09 74.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.596 -0.729 . . . . 99.989999999999995 111.027 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 tp -55.17 -10.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 110.818 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 97.3 p -42.21 -80.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.491 -0.484 . . . . 99.989999999999995 111.076 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.539 ' N ' ' OG ' ' A' ' 22' ' ' SER . 79.7 t80 -62.08 -33.37 74.3 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.352 -0.539 . . . . 99.989999999999995 111.482 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.7 m -47.86 -45.14 29.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.22 -0.445 . . . . 99.989999999999995 111.819 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -151.9 -12.53 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.322 -0.551 . . . . 99.989999999999995 111.804 -179.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 25' ' ' THR . 47.9 t30 53.98 119.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.73 0.3 . . . . 99.989999999999995 111.18 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 mttm 61.08 62.87 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.272 -0.422 . . . . 99.989999999999995 110.567 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -116.19 89.66 26.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 99.989999999999995 111.074 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.05 158.91 1.15 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.375 2.05 . . . . 99.989999999999995 111.691 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.2 m -55.13 141.89 33.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.99 0.424 . . . . 99.989999999999995 110.931 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.637 ' C ' ' H ' ' A' ' 33' ' ' VAL . 84.0 tt0 -178.56 88.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.624 -0.716 . . . . 99.989999999999995 109.633 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' O ' ' C ' ' A' ' 33' ' ' VAL . 56.6 t80 64.77 -13.2 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 99.989999999999995 110.17 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.637 ' H ' ' C ' ' A' ' 31' ' ' GLU . 39.0 t 36.17 61.83 2.94 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 99.989999999999995 111.426 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.58 133.52 32.36 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.362 2.041 . . . . 99.989999999999995 111.562 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 p -128.63 163.11 25.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 99.989999999999995 111.029 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -118.98 132.36 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.539 . . . . 99.989999999999995 109.953 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.97 -3.3 24.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.847 -0.341 . . . . 99.989999999999995 111.124 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -60.82 -48.5 81.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.582 -0.447 . . . . 99.989999999999995 110.575 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -176.8 172.87 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 99.989999999999995 110.417 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 55' ' ' LEU . 82.8 m-85 -125.66 15.94 8.13 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.284 -0.636 . . . . 99.989999999999995 109.284 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.86 98.02 5.46 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.633 -0.712 . . . . 99.989999999999995 110.602 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.22 135.8 52.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.022 -0.99 . . . . 99.989999999999995 109.628 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 51' ' ' TYR . 2.1 t -107.83 138.87 43.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.173 0.511 . . . . 99.989999999999995 111.71 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.2 144.62 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.439 -0.801 . . . . 99.989999999999995 109.861 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.1 mtm -112.11 136.46 51.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.883 -0.327 . . . . 99.989999999999995 110.713 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.88 99.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.31 -0.405 . . . . 99.989999999999995 110.553 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.02 56.76 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.583 -0.607 . . . . 99.989999999999995 111.583 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.47 41.69 24.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.919 -0.872 . . . . 99.989999999999995 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.02 76.87 75.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 99.989999999999995 110.68 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.433 ' C ' ' CD2' ' A' ' 51' ' ' TYR . 82.1 Cg_endo -86.0 117.68 1.65 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.113 2.542 . . . . 99.989999999999995 112.563 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.492 ' O ' ' OG1' ' A' ' 43' ' ' THR . 97.8 m-85 -154.49 174.04 15.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 99.989999999999995 109.777 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.715 ' HG1' ' CB ' ' A' ' 3' ' ' THR . 0.7 OUTLIER -121.75 126.97 50.11 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.668 -0.413 . . . . 99.989999999999995 110.499 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.646 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -109.9 123.41 49.55 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.676 -0.409 . . . . 99.989999999999995 110.264 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -93.76 135.51 12.6 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.894 -1.282 . . . . 99.989999999999995 109.894 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.538 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 5.8 mp -142.58 108.89 5.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.013 -0.675 . . . . 99.989999999999995 112.091 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.416 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 75.3 m-85 -80.26 168.99 18.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.798 -0.816 . . . . 99.989999999999995 108.798 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 58' ' ' THR . 51.9 p30 -138.11 -179.4 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.256 -0.276 . . . . 99.989999999999995 110.256 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.551 ' O ' ' CB ' ' A' ' 59' ' ' ALA . 13.4 m 48.62 174.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 99.989999999999995 110.857 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . 87.06 124.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.616 . . . . 99.989999999999995 110.704 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.97 6.52 0.03 OUTLIER Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.958 -0.639 . . . . 99.989999999999995 111.578 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -96.18 159.33 15.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.256 0.551 . . . . 99.989999999999995 110.01 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.98 -42.72 99.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.257 -0.883 . . . . 99.989999999999995 110.743 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -108.93 32.41 4.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 99.989999999999995 109.89 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -50.87 -44.42 59.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 99.989999999999995 111.16 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 66' ' ' ARG . 42.3 t0 -167.02 168.41 13.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 99.989999999999995 111.022 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.516 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.5 mtm180 -59.19 146.39 39.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.1 -0.5 . . . . 99.989999999999995 110.659 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.565 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 3.4 mm? -63.22 -38.28 90.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 99.989999999999995 111.007 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 40.61 70.64 1.47 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.842 0.353 . . . . 99.989999999999995 110.373 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -51.53 138.39 48.29 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.821 2.348 . . . . 99.989999999999995 112.369 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.3 mt -106.63 140.32 39.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.048 -0.524 . . . . 99.989999999999995 110.49 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -59.36 -36.56 75.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 99.989999999999995 110.763 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -148.18 103.62 3.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 99.989999999999995 110.556 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -47.99 132.5 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.056 1.837 . . . . 99.989999999999995 112.111 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -100.8 26.31 7.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.902 -0.59 . . . . 99.989999999999995 111.027 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 t -133.99 157.36 46.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.693 0.282 . . . . 99.989999999999995 110.348 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.487 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 59.9 t0 -150.17 -10.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.615 -0.434 . . . . 99.989999999999995 111.396 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.8 t -119.03 106.22 19.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 120.509 -0.476 . . . . 99.989999999999995 111.285 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -81.16 129.96 34.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 99.989999999999995 111.013 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.4 tp -114.21 113.09 24.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.852 -0.613 . . . . 99.989999999999995 110.6 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.73 132.56 33.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.05 -0.352 . . . . 99.989999999999995 110.05 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' VAL . 49.4 t -132.81 116.71 16.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.094 0.473 . . . . 99.989999999999995 111.287 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.432 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 39.6 p90 -153.53 155.72 36.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 99.989999999999995 109.792 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.472 ' OG ' ' OD2' ' A' ' 121' ' ' ASP . 30.1 t -71.85 128.85 37.07 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.18 -0.608 . . . . 99.989999999999995 109.479 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.77 -2.17 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.503 0.557 . . . . 99.989999999999995 112.503 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 85' ' ' VAL . 7.2 p -127.75 30.98 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.554 -0.458 . . . . 99.989999999999995 110.461 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.493 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 5.2 p -122.51 82.94 47.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 99.989999999999995 110.472 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -51.44 -30.29 34.29 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.667 2.245 . . . . 99.989999999999995 112.286 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.477 ' O ' ' OD1' ' A' ' 92' ' ' ASN . 22.5 m -67.72 -47.65 68.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 99.989999999999995 110.444 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.493 ' OG ' ' OG ' ' A' ' 86' ' ' SER . 97.0 p -67.87 -35.22 78.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 110.151 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.46 -47.51 85.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.529 -0.759 . . . . 99.989999999999995 110.802 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -71.49 -18.52 62.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.776 -0.647 . . . . 99.989999999999995 111.609 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 88' ' ' SER . 11.3 m120 -93.17 -67.08 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.164 0.431 . . . . 99.989999999999995 112.164 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 89' ' ' SER . 31.0 m -45.23 -50.1 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.454 0.539 . . . . 99.989999999999995 112.454 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 59.5 mttm -70.71 -32.27 69.42 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.796 0.665 . . . . 99.989999999999995 112.796 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 83.5 tt0 -107.6 -60.92 1.64 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.28 0.844 . . . . 99.989999999999995 113.28 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 92' ' ' ASN . 75.4 mttt -63.44 -34.92 78.81 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.278 1.214 . . . . 99.989999999999995 114.278 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.419 ' CE3' ' OE1' ' A' ' 100' ' ' GLU . 49.8 m95 -86.26 -29.4 23.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.847 -0.741 . . . . 99.989999999999995 111.523 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.496 ' O ' ' OG1' ' A' ' 102' ' ' THR . 2.1 t -44.77 -53.98 14.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.332 -0.547 . . . . 99.989999999999995 110.853 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 29.1 Cg_endo -65.14 -33.13 51.04 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.615 1.543 . . . . 99.989999999999995 111.474 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.419 ' OE1' ' CE3' ' A' ' 97' ' ' TRP . 84.6 tt0 -59.76 -37.73 79.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.972 -0.558 . . . . 99.989999999999995 110.8 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.1 pt -94.91 -29.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.881 -0.328 . . . . 99.989999999999995 111.329 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 55.1 m -52.33 -40.72 62.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.853 -0.339 . . . . 99.989999999999995 110.62 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -53.78 -33.33 55.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 99.989999999999995 110.871 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -54.55 -43.56 72.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 99.989999999999995 111.119 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -152.3 152.88 30.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.848 -0.341 . . . . 99.989999999999995 110.769 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.69 -42.87 2.17 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.664 2.243 . . . . 99.989999999999995 112.651 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 13.3 tttm -138.34 130.19 28.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 99.989999999999995 111.084 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 t -165.66 147.45 6.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.053 -0.521 . . . . 99.989999999999995 110.262 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.39 135.57 58.43 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.187 1.925 . . . . 99.989999999999995 111.427 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.695 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -116.52 119.28 35.1 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.473 -0.491 . . . . 99.989999999999995 111.005 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -94.64 119.37 33.18 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.496 -0.482 . . . . 99.989999999999995 110.445 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 46.0 mt -90.94 130.19 36.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 99.989999999999995 109.592 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.555 ' CG1' ' N ' ' A' ' 114' ' ' GLY . 52.0 t -153.22 162.49 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.368 0.604 . . . . 99.989999999999995 112.122 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.555 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -137.08 170.37 23.55 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.612 -1.395 . . . . 99.989999999999995 109.612 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 9.8 t -136.06 167.03 22.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.343 0.572 . . . . 99.989999999999995 111.776 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.534 ' O ' ' O ' ' A' ' 117' ' ' ILE . 40.7 mt-30 55.6 25.76 8.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.995 -0.548 . . . . 99.989999999999995 109.881 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.692 ' N ' ' OG ' ' A' ' 158' ' ' SER . 6.3 tt 30.28 -151.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.867 -0.606 . . . . 99.989999999999995 110.304 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.569 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 52.9 p30 -122.86 29.76 6.69 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.649 -0.871 . . . . 99.989999999999995 108.649 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.619 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 7.7 tt -139.78 -43.02 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.736 -1.12 . . . . 99.989999999999995 110.242 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 122' ' ' ASP . 25.7 mmt180 -52.86 -58.72 5.99 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.355 -0.98 . . . . 99.989999999999995 108.355 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 122' ' ' ASP . 93.4 m-20 -44.28 -14.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.433 -0.507 . . . . 99.989999999999995 109.962 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -0.56 -68.44 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 O-C-N 124.036 0.835 . . . . 99.989999999999995 112.054 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.551 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 53.1 Cg_exo -32.71 -33.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.291 1.327 . . . . 99.989999999999995 111.727 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 122' ' ' ASP . 1.9 m -111.49 -39.44 4.65 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.252 -0.431 . . . . 99.989999999999995 111.901 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 m -73.66 -36.26 65.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.276 0.56 . . . . 99.989999999999995 110.578 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.02 -47.65 16.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.239 -0.891 . . . . 99.989999999999995 110.982 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.21 -36.0 74.61 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.949 -0.3 . . . . 99.989999999999995 111.51 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -97.08 -68.14 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.794 -0.362 . . . . 99.989999999999995 111.324 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 130' ' ' ALA . 42.9 mt -85.17 45.51 1.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.341 -0.391 . . . . 99.989999999999995 111.153 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 129' ' ' LEU . . . -46.53 -99.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.706 -0.479 . . . . 99.989999999999995 109.706 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -150.22 92.64 1.9 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.457 0.646 . . . . 99.989999999999995 109.751 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -155.04 60.25 0.65 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.808 -1.087 . . . . 99.989999999999995 108.21 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 49.0 mttp 62.6 42.82 8.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.325 -0.852 . . . . 99.989999999999995 108.988 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -121.03 136.99 54.86 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.826 -0.625 . . . . 99.989999999999995 110.357 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.55 161.63 55.74 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.96 0.41 . . . . 99.989999999999995 111.377 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.17 161.96 40.54 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 123.205 2.604 . . . . 99.989999999999995 112.556 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.447 ' C ' ' OG1' ' A' ' 141' ' ' THR . 7.7 tt -101.93 51.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.175 -0.466 . . . . 99.989999999999995 111.019 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.503 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.99 -65.77 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.21 0.448 . . . . 99.989999999999995 112.21 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.503 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.2 Cg_exo -24.27 -68.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 123.7 2.933 . . . . 99.989999999999995 114.38 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -109.12 -35.13 6.39 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.653 -0.419 . . . . 99.989999999999995 112.102 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.447 ' OG1' ' C ' ' A' ' 137' ' ' ILE . 61.0 p -56.42 -38.2 71.24 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.966 -0.294 . . . . 99.989999999999995 111.344 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.3 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.745 0.307 . . . . 99.989999999999995 111.18 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.48 -37.52 81.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 99.989999999999995 112.007 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -59.88 -50.4 73.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 99.989999999999995 110.879 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 80.4 mt -58.87 -28.91 66.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.871 -0.604 . . . . 99.989999999999995 111.795 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.48 -38.74 87.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.533 -0.467 . . . . 99.989999999999995 110.058 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -58.47 -40.39 82.59 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.64 -0.709 . . . . 99.989999999999995 110.296 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -53.88 -29.59 42.3 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.532 -0.914 . . . . 99.989999999999995 108.532 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 146' ' ' ALA . 81.8 mt -137.76 -112.02 0.17 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.92 -1.036 . . . . 99.989999999999995 109.045 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.568 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 59.9 mttm -143.78 -136.87 0.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.816 -0.629 . . . . 99.989999999999995 111.094 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 153.89 -160.85 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 O-C-N 123.319 0.387 . . . . 99.989999999999995 110.229 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 88.2 t -155.88 -68.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.454 -0.573 . . . . 99.989999999999995 109.454 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -101.94 177.97 4.75 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.618 -0.512 . . . . 99.989999999999995 109.618 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.603 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 27.3 p90 -169.11 94.11 0.3 Allowed 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.435 -1.321 . . . . 99.989999999999995 107.435 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.468 ' CG2' ' C ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -170.72 -167.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.673 -1.149 . . . . 99.989999999999995 109.409 -177.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -126.37 -172.3 2.59 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.594 -1.185 . . . . 99.989999999999995 109.33 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.538 ' SG ' ' O ' ' A' ' 114' ' ' GLY . 1.2 p -171.71 117.2 0.4 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.547 -0.909 . . . . 99.989999999999995 108.547 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.692 ' OG ' ' N ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -173.14 93.75 0.11 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.216 -0.902 . . . . 99.989999999999995 108.974 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.626 ' H ' ' NE2' ' A' ' 162' ' ' GLN . . . 31.51 32.69 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.34 -1.755 . . . . 99.989999999999995 109.722 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.64 ' C ' ' H ' ' A' ' 162' ' ' GLN . 5.6 tt -165.98 -77.5 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 114.748 -1.115 . . . . 99.989999999999995 109.995 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.827 ' C ' ' H ' ' A' ' 163' ' ' LYS . 2.4 m -59.3 5.6 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.643 -0.423 . . . . 99.989999999999995 110.18 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.64 ' H ' ' C ' ' A' ' 160' ' ' LEU . 87.4 mt-30 -65.77 30.96 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.883 -1.154 . . . . 99.989999999999995 107.883 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.827 ' H ' ' C ' ' A' ' 161' ' ' THR . 99.5 mttt -90.57 5.43 47.89 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 106.921 -1.511 . . . . 99.989999999999995 106.921 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -128.41 -71.4 0.15 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 108.184 -1.966 . . . . 99.989999999999995 108.184 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 164' ' ' GLY . 3.9 mm? -37.45 -21.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.052 0.453 . . . . 99.989999999999995 110.341 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.634 ' N ' ' O ' ' A' ' 164' ' ' GLY . 16.7 tttm -78.98 -52.56 8.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.613 -0.884 . . . . 99.989999999999995 108.613 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 164' ' ' GLY . 14.7 t-20 -78.98 4.06 15.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.431 -1.259 . . . . 99.989999999999995 109.907 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 171' ' ' GLU . 2.9 t -76.57 -58.2 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 116.141 -0.482 . . . . 99.989999999999995 110.9 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.468 ' C ' ' O ' ' A' ' 168' ' ' VAL . 71.6 m-85 -35.48 -37.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.482 -0.487 . . . . 99.989999999999995 109.73 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 168' ' ' VAL . 76.4 m-20 -71.28 -45.16 63.79 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.996 -0.547 . . . . 99.989999999999995 110.622 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 168' ' ' VAL . 97.1 mt-10 -69.37 -27.47 65.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.206 -0.452 . . . . 99.989999999999995 110.988 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.3 -30.79 71.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.114 -0.494 . . . . 99.989999999999995 110.56 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.2 pp -66.08 -27.1 39.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.486 -0.561 . . . . 99.989999999999995 109.486 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.73 -37.38 78.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 99.989999999999995 109.526 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.01 -19.54 64.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.67 -0.696 . . . . 99.989999999999995 110.462 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.85 -35.76 75.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 99.989999999999995 110.27 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 62.0 mt -59.44 -33.47 71.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 99.989999999999995 110.19 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 99.989999999999995 110.426 -179.845 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' H2 ' ' H ' ' A' ' 2' ' ' GLN . 25.3 ttt . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 99.989999999999995 109.416 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.425 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 91.0 mt-30 -111.67 -138.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.147 -0.479 . . . . 99.989999999999995 110.574 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -40.5 114.93 0.5 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.446 -0.343 . . . . 99.989999999999995 110.388 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.7 tp -117.59 144.38 25.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.191 -0.458 . . . . 99.989999999999995 110.207 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -91.99 140.1 29.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 99.989999999999995 110.612 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -141.01 151.26 43.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.992 -0.549 . . . . 99.989999999999995 110.711 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.431 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 29.3 m -127.2 142.86 42.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.089 -0.505 . . . . 99.989999999999995 110.585 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.613 ' CG1' ' HG ' ' A' ' 81' ' ' CYS . 43.3 t -111.19 124.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.199 0.523 . . . . 99.989999999999995 110.895 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.6 m -133.42 161.51 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.39 -0.823 . . . . 99.989999999999995 109.938 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.684 ' N ' ' NZ ' ' A' ' 16' ' ' LYS . . . -172.75 -168.76 34.5 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.603 -0.808 . . . . 99.989999999999995 111.584 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.596 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 42.9 t0 -80.35 121.86 26.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 99.989999999999995 110.817 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.567 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . -45.72 98.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.038 -0.825 . . . . 99.989999999999995 111.038 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 151.34 20.58 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.663 0.273 . . . . 99.989999999999995 111.522 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.63 135.97 58.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.514 -0.474 . . . . 99.989999999999995 111.037 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.71 88.76 0.74 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.62 -0.592 . . . . 99.989999999999995 111.62 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.684 ' NZ ' ' N ' ' A' ' 10' ' ' GLY . 84.7 mttt -81.65 -0.21 41.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.664 0.269 . . . . 99.989999999999995 110.79 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.4 m -80.49 -70.29 0.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.463 -0.335 . . . . 99.989999999999995 111.163 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 18.0 m -50.91 -25.25 4.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.62 0.724 . . . . 99.989999999999995 109.345 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.61 ' CD2' ' SG ' ' A' ' 81' ' ' CYS . 62.4 tp -55.05 -55.0 35.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.595 -1.184 . . . . 99.989999999999995 111.375 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' A' ' 22' ' ' SER . 82.1 mt -69.96 -32.66 71.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 99.989999999999995 110.813 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 93.2 mt -62.06 -1.8 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.825 -0.625 . . . . 99.989999999999995 110.966 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.699 ' HG ' ' N ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -56.35 -75.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.395 -0.522 . . . . 99.989999999999995 111.059 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.699 ' N ' ' HG ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -62.5 -28.64 69.98 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 119.921 -0.712 . . . . 99.989999999999995 111.165 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.651 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 2.6 m -54.46 -48.5 71.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.258 0.466 . . . . 99.989999999999995 112.258 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.8 p -131.52 -21.84 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.543 -0.463 . . . . 99.989999999999995 111.474 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 22' ' ' SER . 83.0 m-20 61.43 114.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 99.989999999999995 111.131 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' N ' ' NE2' ' A' ' 162' ' ' GLN . 75.0 mttt 61.92 59.21 1.76 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.037 -0.529 . . . . 99.989999999999995 111.093 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 tp -125.34 66.85 54.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.742 -0.383 . . . . 99.989999999999995 111.026 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.51 145.06 37.08 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.595 2.197 . . . . 99.989999999999995 111.877 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 32' ' ' TYR . 89.1 p -138.2 153.34 49.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.868 0.366 . . . . 99.989999999999995 110.759 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.48 -32.62 74.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 99.989999999999995 110.474 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.488 ' O ' ' OG ' ' A' ' 30' ' ' SER . 63.5 t80 -115.37 156.44 25.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 99.989999999999995 109.927 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 t -118.56 83.83 22.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.833 -0.347 . . . . 99.989999999999995 111.825 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -63.89 144.41 88.18 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.666 2.244 . . . . 99.989999999999995 111.508 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.0 p -123.97 156.9 35.57 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.771 -0.372 . . . . 99.989999999999995 110.946 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -123.16 131.34 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 99.989999999999995 110.461 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 78.1 t80 -97.42 -9.28 27.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 99.989999999999995 110.886 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.41 -70.96 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.889 -0.325 . . . . 99.989999999999995 111.111 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -173.8 174.06 3.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 99.989999999999995 110.669 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.0 23.83 2.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.506 -0.553 . . . . 99.989999999999995 109.506 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.51 98.62 10.22 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.637 -0.71 . . . . 99.989999999999995 110.446 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.486 ' O ' ' OG1' ' A' ' 52' ' ' THR . 15.6 m -115.55 158.16 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.063 -0.971 . . . . 99.989999999999995 110.219 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.6 t -123.22 140.92 52.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.015 0.436 . . . . 99.989999999999995 111.225 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.2 p -149.04 152.49 12.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.7 . . . . 99.989999999999995 110.968 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.7 mtm -101.3 123.35 45.26 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.128 -0.693 . . . . 99.989999999999995 109.128 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.1 tt -134.17 136.79 52.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.204 -0.599 . . . . 99.989999999999995 111.217 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.19 28.06 4.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.374 -0.69 . . . . 99.989999999999995 111.374 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.5 49.04 16.05 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.681 -0.968 . . . . 99.989999999999995 110.681 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -131.45 78.13 72.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.753 0.311 . . . . 99.989999999999995 110.329 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.598 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 20.6 Cg_exo -61.62 99.37 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.736 2.291 . . . . 99.989999999999995 112.143 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 83.5 m-85 -161.12 -179.38 7.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.015 -0.538 . . . . 99.989999999999995 110.508 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 4.8 t -144.43 144.15 31.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.648 -0.421 . . . . 99.989999999999995 110.37 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.1 mm? -111.64 127.32 55.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.618 -0.433 . . . . 99.989999999999995 110.526 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -83.1 122.67 5.83 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 109.241 -1.544 . . . . 99.989999999999995 109.241 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.419 ' CD2' ' SG ' ' A' ' 6' ' ' CYS . 86.5 mt -127.55 145.6 50.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.297 0.57 . . . . 99.989999999999995 112.254 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.488 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 39.7 t80 -119.55 -168.39 1.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.568 -1.271 . . . . 99.989999999999995 107.568 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 59' ' ' ALA . 52.0 p30 -174.11 -162.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.574 0.624 . . . . 99.989999999999995 110.327 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 60' ' ' GLY . 81.7 p 43.23 -93.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 99.989999999999995 110.7 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 43.6 17.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 99.989999999999995 110.717 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 58' ' ' THR . . . -56.94 -29.64 59.28 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.533 -0.627 . . . . 99.989999999999995 111.533 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 94.2 mt-30 -79.77 99.86 7.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.145 0.498 . . . . 99.989999999999995 110.453 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.0 -35.51 64.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.54 -0.754 . . . . 99.989999999999995 109.934 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 64' ' ' TYR . 60.7 t0 -91.81 11.53 24.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.715 -0.675 . . . . 99.989999999999995 109.436 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.691 ' CD2' ' NH2' ' A' ' 68' ' ' ARG . 40.7 m-85 23.97 -120.19 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.269 -0.878 . . . . 99.989999999999995 111.327 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -139.42 141.17 37.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 99.989999999999995 110.24 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.3 mtt85 -58.09 147.29 30.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.343 -0.389 . . . . 99.989999999999995 110.563 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp 49.7 79.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 99.989999999999995 110.383 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.691 ' NH2' ' CD2' ' A' ' 64' ' ' TYR . 16.4 mtt180 -65.91 143.64 98.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 99.989999999999995 110.323 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.75 -30.82 26.8 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.285 1.99 . . . . 99.989999999999995 112.402 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.9 mt -100.46 140.79 34.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 99.989999999999995 110.907 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 72' ' ' TYR . 51.7 p -77.09 162.42 27.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.013 -0.54 . . . . 99.989999999999995 110.473 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -30.59 93.88 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.101 -0.499 . . . . 99.989999999999995 111.026 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.453 ' N ' ' O ' ' A' ' 71' ' ' SER . 27.8 Cg_exo -58.53 142.95 98.55 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.38 2.053 . . . . 99.989999999999995 112.297 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.506 ' O ' ' C ' ' A' ' 75' ' ' THR . 95.7 mt-30 -62.41 -33.66 75.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.489 . . . . 99.989999999999995 110.924 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.506 ' C ' ' O ' ' A' ' 74' ' ' GLN . 2.1 t 23.19 61.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.603 0.564 . . . . 99.989999999999995 111.439 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -65.01 -39.22 93.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 99.989999999999995 110.957 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.88 104.11 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.404 -0.362 . . . . 99.989999999999995 110.54 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -78.92 125.15 28.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.162 0.506 . . . . 99.989999999999995 111.87 -177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.46 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 10.5 mp -112.59 128.43 56.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.53 -0.759 . . . . 99.989999999999995 109.974 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.0 m -109.88 136.84 44.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.541 -0.54 . . . . 99.989999999999995 109.541 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.613 ' HG ' ' CG1' ' A' ' 8' ' ' VAL . 1.3 m -112.36 127.23 55.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.075 0.464 . . . . 99.989999999999995 111.43 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 113' ' ' VAL . 48.7 p90 -149.73 115.75 5.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.66 -0.7 . . . . 99.989999999999995 110.419 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.483 ' O ' ' OG ' ' A' ' 89' ' ' SER . 35.5 t -58.59 139.78 55.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.089 -0.708 . . . . 99.989999999999995 109.089 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 84' ' ' VAL . 11.1 p -101.01 38.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 119.81 -0.756 . . . . 99.989999999999995 111.544 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 85' ' ' VAL . 1.9 p -129.3 -7.38 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.836 -0.346 . . . . 99.989999999999995 110.832 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.1 154.71 55.92 Favored Pre-proline 0 C--N 1.331 -0.218 0 C-N-CA 120.878 -0.329 . . . . 99.989999999999995 110.733 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.594 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 57.8 Cg_endo -73.04 -40.79 1.58 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.667 2.245 . . . . 99.989999999999995 112.758 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.4 p -82.86 -7.94 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.379 -0.373 . . . . 99.989999999999995 111.31 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 83' ' ' SER . 84.2 p -60.63 -41.1 94.2 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.772 -0.371 . . . . 99.989999999999995 111.177 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.594 ' CE1' ' O ' ' A' ' 87' ' ' PRO . 22.6 p90 -89.35 -41.25 12.24 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.89 -0.324 . . . . 99.989999999999995 111.181 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.2 tt0 -57.7 -32.81 67.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.365 -0.379 . . . . 99.989999999999995 111.116 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 90.5 m-20 -77.34 -39.38 47.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.724 -0.39 . . . . 99.989999999999995 111.326 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 t -84.8 -66.87 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 113.299 0.851 . . . . 99.989999999999995 113.299 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.43 -17.67 55.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.441 0.904 . . . . 99.989999999999995 113.441 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.528 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 95.3 mt-10 -125.72 -48.44 1.65 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.185 1.18 . . . . 99.989999999999995 114.185 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -78.53 -41.01 33.39 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.247 0.832 . . . . 99.989999999999995 113.247 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.606 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 57.6 m95 -92.61 -25.53 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.381 -0.928 . . . . 99.989999999999995 112.29 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.539 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -56.34 -45.37 99.93 Favored Pre-proline 0 CA--C 1.527 0.092 0 C-N-CA 119.951 -0.699 . . . . 99.989999999999995 110.118 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 25.7 Cg_exo -57.46 -43.92 47.03 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.119 1.88 . . . . 99.989999999999995 110.76 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -57.4 -42.52 82.4 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 119.714 -0.794 . . . . 99.989999999999995 109.555 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.7 mt -69.79 -36.34 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.986 -0.552 . . . . 99.989999999999995 109.908 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 105' ' ' CYS . 49.8 m -57.11 -31.68 65.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.486 -0.779 . . . . 99.989999999999995 111.178 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -46.85 -45.54 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.717 -0.393 . . . . 99.989999999999995 110.063 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -59.9 -33.47 71.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 99.989999999999995 109.953 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' THR . 5.1 t 70.79 58.9 0.46 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.773 -0.649 . . . . 99.989999999999995 110.847 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.49 120.44 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.731 2.287 . . . . 99.989999999999995 112.057 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.7 0.29 57.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.391 . . . . 99.989999999999995 110.437 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.436 ' H ' ' HG1' ' A' ' 108' ' ' THR . 0.6 OUTLIER -77.3 157.4 80.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.963 -0.562 . . . . 99.989999999999995 110.419 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -50.08 144.61 21.79 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.606 2.204 . . . . 99.989999999999995 111.662 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.734 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -118.8 119.18 33.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.193 0.521 . . . . 99.989999999999995 110.577 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 8.5 mp -97.63 130.89 44.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.992 -0.549 . . . . 99.989999999999995 111.38 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 92.3 mt -94.58 129.04 41.56 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.172 -0.677 . . . . 99.989999999999995 109.172 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.603 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 30.5 t -136.33 153.64 31.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.205 -0.452 . . . . 99.989999999999995 111.146 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.455 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -134.96 168.28 23.73 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.377 -0.689 . . . . 99.989999999999995 111.377 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 117' ' ' ILE . 3.4 p -124.81 177.44 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.167 0.508 . . . . 99.989999999999995 110.794 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.55 ' O ' ' C ' ' A' ' 117' ' ' ILE . 16.4 tt0 36.55 30.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.5 -0.773 . . . . 99.989999999999995 111.158 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 118' ' ' ASP . 6.0 tt 19.94 -138.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 O-C-N 123.602 0.564 . . . . 99.989999999999995 110.012 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.596 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 1.0 OUTLIER -93.27 55.5 2.3 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.626 -0.829 . . . . 99.989999999999995 109.846 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 120' ' ' ARG . 2.3 tt 85.93 77.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.479 -0.328 . . . . 99.989999999999995 110.824 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.54 ' C ' ' O ' ' A' ' 119' ' ' LEU . 45.2 mtm180 17.63 57.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.944 0.778 . . . . 99.989999999999995 110.817 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.569 ' O ' ' CB ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER 164.21 -91.63 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.698 -0.401 . . . . 99.989999999999995 110.989 -179.086 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 40.5 t0 107.68 -46.23 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 124.021 0.826 . . . . 99.989999999999995 110.671 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' CD ' ' C ' ' A' ' 121' ' ' ASP . 49.3 Cg_endo -92.93 -33.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.416 1.411 . . . . 99.989999999999995 111.868 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.9 m -98.75 2.22 46.78 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 120.189 -0.605 . . . . 99.989999999999995 111.038 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.446 ' O ' ' CB ' ' A' ' 129' ' ' LEU . 8.8 t -105.74 -19.0 13.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.98 -0.378 . . . . 99.989999999999995 109.98 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.409 ' CD1' ' O ' ' A' ' 122' ' ' ASP . 73.4 mt -80.67 -50.3 17.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.342 -0.543 . . . . 99.989999999999995 110.87 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -74.66 -39.97 61.73 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.155 0.798 . . . . 99.989999999999995 113.155 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -79.0 -37.66 38.66 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.006 0.743 . . . . 99.989999999999995 113.006 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.591 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 15.9 tp -73.15 -39.65 65.51 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.81 -0.356 . . . . 99.989999999999995 111.635 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.591 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . 136.69 115.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.446 -0.946 . . . . 99.989999999999995 108.446 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.06 -37.58 77.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.08 -0.509 . . . . 99.989999999999995 111.936 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -81.69 3.91 23.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.614 -0.434 . . . . 99.989999999999995 111.15 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -108.49 -34.62 6.7 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.791 -0.364 . . . . 99.989999999999995 110.99 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 79.8 mm-40 -89.86 120.62 31.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.135 0.493 . . . . 99.989999999999995 111.169 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.78 78.3 75.2 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.528 -0.76 . . . . 99.989999999999995 109.619 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.66 134.84 41.11 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.609 2.206 . . . . 99.989999999999995 112.213 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.442 ' CG2' ' OG1' ' A' ' 141' ' ' THR . 73.3 mt -116.07 89.9 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.534 . . . . 99.989999999999995 110.037 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.643 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -131.38 -39.66 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.08 0.77 . . . . 99.989999999999995 113.08 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.643 ' CD ' ' H ' ' A' ' 138' ' ' THR . 69.4 Cg_endo -88.93 -48.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.126 1.884 . . . . 99.989999999999995 114.591 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' CB ' ' HZ2' ' A' ' 144' ' ' LYS . 97.3 mt-10 -66.67 -52.74 41.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.355 0.872 . . . . 99.989999999999995 113.355 -177.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.442 ' OG1' ' CG2' ' A' ' 137' ' ' ILE . 30.9 p -83.32 -10.74 58.31 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.821 1.045 . . . . 99.989999999999995 113.821 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -83.93 -63.07 1.41 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.339 -0.944 . . . . 99.989999999999995 111.365 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.15 -39.1 93.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.408 -0.36 . . . . 99.989999999999995 111.97 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.412 ' HZ2' ' CB ' ' A' ' 140' ' ' GLU . 26.6 mttt -66.34 -57.07 8.26 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.694 -0.402 . . . . 99.989999999999995 111.361 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.38 -33.8 71.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.502 -0.317 . . . . 99.989999999999995 111.322 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.53 -38.67 87.66 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.127 -0.694 . . . . 99.989999999999995 109.127 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -61.4 -40.58 94.89 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.235 -0.893 . . . . 99.989999999999995 110.065 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -51.95 -32.42 33.2 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.988 -1.115 . . . . 99.989999999999995 107.988 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 146' ' ' ALA . 75.6 mt -130.59 -116.61 0.23 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.602 -1.181 . . . . 99.989999999999995 108.178 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.561 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 53.2 mmtt -133.32 -145.32 0.24 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.622 -0.717 . . . . 99.989999999999995 111.041 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 151.41 -166.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.816 -0.629 . . . . 99.989999999999995 110.894 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 41.2 t -159.16 -66.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.843 -0.617 . . . . 99.989999999999995 110.68 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 2.5 tttm -105.58 -176.83 3.19 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.241 -0.436 . . . . 99.989999999999995 110.079 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 153' ' ' LYS . 13.8 m-85 -161.13 95.95 1.07 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.643 -1.614 . . . . 99.989999999999995 106.643 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.6 p -143.82 144.46 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-O 121.925 0.869 . . . . 99.989999999999995 111.956 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.658 ' O ' ' OG1' ' A' ' 161' ' ' THR . 8.3 mm-40 -126.75 98.57 5.42 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 105.907 -1.886 . . . . 99.989999999999995 105.907 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.425 ' SG ' ' N ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -113.95 144.21 43.45 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 123.127 1.441 . . . . 99.989999999999995 113.609 -175.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 160' ' ' LEU . 38.2 t -158.38 93.6 1.22 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 111.793 -2.458 . . . . 99.989999999999995 106.621 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 37.23 29.71 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.257 -1.338 . . . . 99.989999999999995 109.587 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.773 ' O ' ' N ' ' A' ' 162' ' ' GLN . 77.2 mt -145.32 -82.05 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.013 -0.994 . . . . 99.989999999999995 110.425 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.724 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -53.6 44.25 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.504 0.502 . . . . 99.989999999999995 112.341 -177.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.773 ' N ' ' O ' ' A' ' 160' ' ' LEU . 2.2 pt20 -75.72 14.72 0.6 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.86 -1.904 . . . . 99.989999999999995 105.86 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.724 ' H ' ' C ' ' A' ' 161' ' ' THR . 89.8 mttt -78.33 -4.91 50.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.822 -1.536 . . . . 99.989999999999995 107.434 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.7 -70.99 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 107.754 -2.139 . . . . 99.989999999999995 107.754 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -38.25 -19.1 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.733 -0.387 . . . . 99.989999999999995 111.447 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 164' ' ' GLY . 60.2 tttm -84.12 -48.33 9.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.342 -0.984 . . . . 99.989999999999995 108.342 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 164' ' ' GLY . 77.8 m-20 -78.53 6.53 8.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.685 -1.143 . . . . 99.989999999999995 109.029 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 169' ' ' PHE . 5.7 t -83.26 -60.09 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 115.652 -0.704 . . . . 99.989999999999995 110.196 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.689 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 57.8 m-85 -40.34 -47.8 2.58 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.033 -0.667 . . . . 99.989999999999995 110.355 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -67.13 -43.17 83.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 99.989999999999995 110.845 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.56 -27.04 66.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.033 -0.531 . . . . 99.989999999999995 111.325 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.68 -33.25 75.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.333 -0.394 . . . . 99.989999999999995 110.096 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.76 -37.81 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.954 -0.566 . . . . 99.989999999999995 109.578 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 174' ' ' LEU . 3.5 mm? -64.27 -31.92 73.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.743 -0.662 . . . . 99.989999999999995 110.049 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.2 -27.4 68.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.84 -0.618 . . . . 99.989999999999995 110.807 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.79 -32.6 74.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 99.989999999999995 110.206 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.81 -35.76 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.856 -0.611 . . . . 99.989999999999995 110.618 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.369 -0.378 . . . . 99.989999999999995 110.683 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.278 -0.638 . . . . 99.989999999999995 109.278 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 3' ' ' THR . 25.3 mt-30 -123.62 174.94 7.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 99.989999999999995 110.543 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -37.76 128.34 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 99.989999999999995 110.055 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.7 tt -122.2 135.73 61.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.664 . . . . 99.989999999999995 110.425 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -77.15 145.93 37.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.049 0.452 . . . . 99.989999999999995 111.517 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -139.65 136.73 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.674 -0.694 . . . . 99.989999999999995 110.033 179.585 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m -130.48 148.15 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.364 . . . . 99.989999999999995 111.485 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.554 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 47.1 t -115.95 120.78 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.263 0.554 . . . . 99.989999999999995 111.078 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.95 158.27 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.275 -0.875 . . . . 99.989999999999995 110.095 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.596 ' N ' ' HZ3' ' A' ' 16' ' ' LYS . . . -164.49 -174.65 34.49 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.974 -0.851 . . . . 99.989999999999995 110.974 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.609 ' H ' ' CG2' ' A' ' 93' ' ' VAL . 23.5 t70 -81.2 121.94 26.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.019 0.438 . . . . 99.989999999999995 110.588 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . 43.75 64.6 1.83 Allowed Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.248 -0.741 . . . . 99.989999999999995 111.248 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.524 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . -16.98 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.854 0.359 . . . . 99.989999999999995 111.948 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.422 ' CG1' ' OE1' ' A' ' 116' ' ' GLN . 99.5 t -66.32 -55.78 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.045 -0.525 . . . . 99.989999999999995 110.94 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.76 59.63 0.31 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.716 -0.755 . . . . 99.989999999999995 111.902 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HZ3' ' N ' ' A' ' 10' ' ' GLY . 17.8 mttt -77.25 -7.2 55.54 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.659 -0.318 . . . . 99.989999999999995 110.838 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.673 ' HG1' ' CG1' ' A' ' 33' ' ' VAL . 70.7 p -63.17 -44.69 94.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.595 -0.275 . . . . 99.989999999999995 111.582 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.5 m -84.64 -14.04 49.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.59 0.71 . . . . 99.989999999999995 110.167 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.498 ' CD2' ' SG ' ' A' ' 81' ' ' CYS . 14.0 tp -73.58 -42.99 60.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.031 -0.986 . . . . 99.989999999999995 110.847 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.7 tp -65.45 -39.14 91.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.409 -0.814 . . . . 99.989999999999995 112.429 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.622 ' C ' ' HG1' ' A' ' 24' ' ' THR . 10.5 pt -76.38 -3.51 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.633 0.605 . . . . 99.989999999999995 112.633 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 21' ' ' ILE . 2.0 m -42.14 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.394 -0.923 . . . . 99.989999999999995 110.768 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.607 ' C ' ' H ' ' A' ' 25' ' ' THR . 40.0 t80 -54.31 -39.94 67.46 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.029 0.377 . . . . 99.989999999999995 111.96 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.622 ' HG1' ' C ' ' A' ' 21' ' ' ILE . 23.0 p -49.57 -9.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.492 -0.483 . . . . 99.989999999999995 110.013 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.607 ' H ' ' C ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER 76.5 95.52 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.781 -0.645 . . . . 99.989999999999995 110.749 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -141.11 -69.56 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.912 -0.585 . . . . 99.989999999999995 110.4 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.705 ' H ' ' NE2' ' A' ' 162' ' ' GLN . 30.9 tttt 48.22 53.09 12.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.929 -0.397 . . . . 99.989999999999995 109.929 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mt -147.0 87.24 6.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 99.989999999999995 111.036 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.42 134.08 55.89 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.056 1.838 . . . . 99.989999999999995 111.378 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -125.02 145.08 50.07 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.762 -0.375 . . . . 99.989999999999995 110.872 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.37 -31.65 72.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 99.989999999999995 110.519 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -123.03 146.25 47.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.084 -0.507 . . . . 99.989999999999995 110.037 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.673 ' CG1' ' HG1' ' A' ' 17' ' ' THR . 15.9 m -119.79 88.13 39.2 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.975 -0.29 . . . . 99.989999999999995 111.31 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -53.77 148.06 38.38 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.639 2.226 . . . . 99.989999999999995 112.316 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.6 m -76.68 142.92 40.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 99.989999999999995 110.762 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.45 163.29 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 99.989999999999995 110.68 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -115.97 156.96 25.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 99.989999999999995 110.522 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 0.8 OUTLIER 51.73 -146.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 99.989999999999995 109.993 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 15.6 t-20 81.66 64.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 99.989999999999995 110.56 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.608 ' CD2' ' O ' ' A' ' 40' ' ' TYR . 26.6 p90 -157.0 38.53 0.31 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.064 -0.717 . . . . 99.989999999999995 109.064 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.14 98.35 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.008 -0.996 . . . . 99.989999999999995 109.612 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.507 ' O ' ' OG1' ' A' ' 52' ' ' THR . 18.5 t -135.66 130.45 49.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.736 -0.665 . . . . 99.989999999999995 110.318 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 t -94.54 133.94 37.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.26 -0.427 . . . . 99.989999999999995 110.685 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -135.25 142.86 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 99.989999999999995 110.608 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.3 mtm -113.15 130.27 56.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 99.989999999999995 110.298 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 48' ' ' GLY . 7.7 tp -131.96 136.2 57.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.507 -0.315 . . . . 99.989999999999995 110.636 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 31.14 35.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-N 116.129 -0.487 . . . . 99.989999999999995 111.889 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 79.63 65.37 1.78 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.902 -0.666 . . . . 99.989999999999995 111.572 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -151.26 88.09 4.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.154 -0.313 . . . . 99.989999999999995 110.154 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.59 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 42.7 Cg_endo -76.04 112.55 3.52 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.09 1.86 . . . . 99.989999999999995 112.575 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 95.9 m-85 -162.59 166.95 24.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.072 -0.714 . . . . 99.989999999999995 109.072 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 6.8 t -138.04 148.4 45.05 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.125 -0.63 . . . . 99.989999999999995 111.217 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.74 133.3 54.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.345 -0.389 . . . . 99.989999999999995 110.748 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -73.0 148.15 40.8 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.262 -1.135 . . . . 99.989999999999995 110.262 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.463 ' H ' ' CA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -132.52 119.11 20.11 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 120.09 -0.644 . . . . 99.989999999999995 112.33 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.554 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 17.2 t80 -107.9 -176.34 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.759 -0.83 . . . . 99.989999999999995 108.759 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 52.7 p30 -176.86 -165.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.371 . . . . 99.989999999999995 111.065 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 57' ' ' ASP . 31.5 p 36.59 -148.86 0.01 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.011 -0.54 . . . . 99.989999999999995 111.073 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 54.75 172.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 99.989999999999995 110.322 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.31 8.42 0.08 OUTLIER Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.196 -0.762 . . . . 99.989999999999995 111.196 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -73.74 116.57 14.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.361 0.6 . . . . 99.989999999999995 110.042 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.83 -32.64 67.8 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.149 -0.932 . . . . 99.989999999999995 110.461 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 64' ' ' TYR . 88.3 m-20 -93.7 7.5 44.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.916 -0.584 . . . . 99.989999999999995 109.991 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.507 ' O ' ' O ' ' A' ' 63' ' ' ASP . 66.0 m-85 34.26 -158.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.839 -0.618 . . . . 99.989999999999995 110.881 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.88 130.41 35.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 99.989999999999995 110.308 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -59.48 -36.72 76.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.941 0.4 . . . . 99.989999999999995 110.397 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.9 mt -64.3 -36.6 84.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.966 -0.561 . . . . 99.989999999999995 111.099 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -130.65 76.29 77.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.505 -0.316 . . . . 99.989999999999995 111.237 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.05 -10.71 23.02 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.353 2.035 . . . . 99.989999999999995 111.545 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 36.8 tp -58.12 -35.72 71.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 99.989999999999995 110.902 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t 64.53 -176.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 99.989999999999995 110.101 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.1 71.73 76.1 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 120.667 -0.413 . . . . 99.989999999999995 111.232 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.77 0.02 10.3 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.912 2.408 . . . . 99.989999999999995 111.465 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.61 -29.64 64.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.706 -0.679 . . . . 99.989999999999995 111.219 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.448 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 10.3 t -41.18 135.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.831 0.348 . . . . 99.989999999999995 110.685 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -91.95 -24.37 19.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 99.989999999999995 110.725 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 t -119.14 110.02 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 99.989999999999995 110.216 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.448 ' CE1' ' CG2' ' A' ' 75' ' ' THR . 96.8 m-85 -86.33 126.65 34.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.165 0.507 . . . . 99.989999999999995 112.006 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 79' ' ' LEU . 7.3 mp -106.38 110.01 22.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.528 -0.76 . . . . 99.989999999999995 109.367 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 113' ' ' VAL . 39.0 t -74.53 129.0 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.944 -0.391 . . . . 99.989999999999995 109.944 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.498 ' SG ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -122.27 129.89 52.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.113 0.482 . . . . 99.989999999999995 112.003 -179.03 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 82' ' ' PHE . 4.0 p90 -166.42 125.75 1.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.294 -0.866 . . . . 99.989999999999995 109.36 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.502 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 84.2 p -52.89 146.36 10.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.81 -0.756 . . . . 99.989999999999995 109.319 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.58 4.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.194 -0.602 . . . . 99.989999999999995 112.493 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.576 ' O ' ' CB ' ' A' ' 86' ' ' SER . 80.3 t -127.79 148.86 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.73 -0.388 . . . . 99.989999999999995 110.25 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.586 ' C ' ' H ' ' A' ' 88' ' ' SER . 1.9 t 93.24 96.24 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.244 0 O-C-N 123.643 0.589 . . . . 99.989999999999995 110.328 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.446 ' O ' ' CE2' ' A' ' 90' ' ' PHE . 61.9 Cg_exo -48.97 -2.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.67 2.247 . . . . 99.989999999999995 112.72 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.586 ' H ' ' C ' ' A' ' 86' ' ' SER . 2.2 t -97.48 -34.73 10.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.886 -0.326 . . . . 99.989999999999995 110.998 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -57.01 -40.74 77.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.37 -0.377 . . . . 99.989999999999995 111.702 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.461 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 2.4 p90 -82.29 -32.8 29.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 99.989999999999995 110.319 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.1 tt0 -54.3 -28.67 43.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.646 -0.707 . . . . 99.989999999999995 110.925 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' LYS . 72.1 m-20 -90.51 -64.79 1.08 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.299 -0.56 . . . . 99.989999999999995 110.578 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.609 ' CG2' ' H ' ' A' ' 11' ' ' ASP . 54.7 t -50.12 -60.59 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.012 -0.54 . . . . 99.989999999999995 112.35 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.479 ' CE ' ' CE1' ' A' ' 82' ' ' PHE . 26.6 mttt -71.57 -9.83 58.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.524 0.565 . . . . 99.989999999999995 112.524 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -126.32 -62.02 1.18 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.962 0.727 . . . . 99.989999999999995 112.962 -178.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 92' ' ' ASN . 20.0 tptm -64.77 -34.6 78.73 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.251 0.834 . . . . 99.989999999999995 113.251 -178.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.4 ' O ' ' C ' ' A' ' 98' ' ' VAL . 51.1 m95 -81.94 -34.95 29.57 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.917 -0.713 . . . . 99.989999999999995 110.681 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.452 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -39.21 -55.21 3.16 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.44 -0.346 . . . . 99.989999999999995 111.184 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 17.2 Cg_endo -60.0 -37.19 86.58 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 121.553 1.502 . . . . 99.989999999999995 111.175 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.476 ' OE2' ' OH ' ' A' ' 64' ' ' TYR . 84.9 tt0 -61.75 -42.68 99.28 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.406 -0.518 . . . . 99.989999999999995 110.162 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.92 -39.68 67.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.122 -0.49 . . . . 99.989999999999995 110.793 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.418 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 44.1 p -62.71 -12.71 25.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.915 -0.584 . . . . 99.989999999999995 111.05 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -54.18 -41.59 68.73 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.871 -0.332 . . . . 99.989999999999995 110.173 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -87.85 -15.41 36.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 99.989999999999995 110.482 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 102' ' ' THR . 22.2 m 55.35 58.59 10.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 99.989999999999995 110.916 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -78.17 124.09 6.45 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.644 2.229 . . . . 99.989999999999995 112.01 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -92.27 2.97 56.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.406 . . . . 99.989999999999995 110.729 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.483 ' H ' ' HG1' ' A' ' 108' ' ' THR . 0.6 OUTLIER -72.35 155.18 91.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 99.989999999999995 110.88 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.33 149.11 57.58 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.96 2.44 . . . . 99.989999999999995 112.115 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.737 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -130.72 139.14 50.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.272 0.558 . . . . 99.989999999999995 110.521 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.43 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 7.0 mp -104.76 136.16 44.78 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.366 -0.533 . . . . 99.989999999999995 110.558 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 18.3 tp -88.11 128.43 35.43 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.15 -0.685 . . . . 99.989999999999995 109.15 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' VAL . 1.9 t -142.29 151.89 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 119.85 -0.74 . . . . 99.989999999999995 111.682 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.433 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -134.46 171.54 22.22 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.645 -0.982 . . . . 99.989999999999995 110.645 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.4 ' H ' ' HA ' ' A' ' 83' ' ' SER . 1.5 p -119.82 173.73 6.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.97 0.414 . . . . 99.989999999999995 110.461 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.604 ' O ' ' O ' ' A' ' 117' ' ' ILE . 33.8 mt-30 37.8 34.0 0.05 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 118.826 -0.607 . . . . 99.989999999999995 111.24 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.623 ' CG2' ' N ' ' A' ' 118' ' ' ASP . 2.5 tt 19.96 -143.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 123.595 0.559 . . . . 99.989999999999995 110.485 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.623 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 59.5 t0 -59.98 -2.92 0.47 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.723 -0.791 . . . . 99.989999999999995 110.726 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' A' ' 121' ' ' ASP . 59.2 tp 132.52 92.01 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.182 0.926 . . . . 99.989999999999995 110.105 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' C ' ' O ' ' A' ' 119' ' ' LEU . 41.7 ptt85 15.01 50.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.201 0.938 . . . . 99.989999999999995 111.625 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 119' ' ' LEU . 0.8 OUTLIER 169.65 -95.94 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.538 -0.755 . . . . 99.989999999999995 110.1 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 10.9 t0 109.08 -44.9 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 O-C-N 123.876 0.735 . . . . 99.989999999999995 110.483 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.423 ' CD ' ' C ' ' A' ' 121' ' ' ASP . 83.6 Cg_endo -88.91 -36.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.481 1.454 . . . . 99.989999999999995 110.524 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 52.5 p -98.38 -6.97 29.6 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 120.546 -0.462 . . . . 99.989999999999995 110.793 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.553 ' OG1' ' CD2' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -85.66 -23.19 27.56 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.223 -0.658 . . . . 99.989999999999995 109.223 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.515 ' CG2' ' N ' ' A' ' 127' ' ' GLU . 10.4 tt -80.08 -43.35 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.743 -0.662 . . . . 99.989999999999995 109.792 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.515 ' N ' ' CG2' ' A' ' 126' ' ' ILE . 98.3 mt-10 -61.91 -33.59 74.52 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.198 -0.456 . . . . 99.989999999999995 110.084 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 130' ' ' ALA . 69.9 tttt -58.68 -35.96 73.43 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.569 -0.9 . . . . 99.989999999999995 108.569 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.682 ' O ' ' N ' ' A' ' 131' ' ' LYS . 26.6 mt -90.18 22.52 3.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.666 -1.152 . . . . 99.989999999999995 108.544 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 129' ' ' LEU . . . -4.82 63.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 O-C-N 125.072 1.483 . . . . 99.989999999999995 111.977 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.682 ' N ' ' O ' ' A' ' 129' ' ' LEU . 80.3 mttt 47.3 75.97 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.922 -0.581 . . . . 99.989999999999995 109.767 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -126.82 57.13 1.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.215 -0.661 . . . . 99.989999999999995 109.215 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 65.1 tttt 67.07 43.18 2.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.714 -0.675 . . . . 99.989999999999995 109.556 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.444 ' NE2' ' CG1' ' A' ' 126' ' ' ILE . 26.2 mt-30 -58.07 137.68 56.69 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.096 -0.502 . . . . 99.989999999999995 110.532 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.96 66.88 9.84 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 99.989999999999995 111.178 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.03 152.53 50.88 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.665 2.243 . . . . 99.989999999999995 111.497 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.1 mm -107.19 101.15 12.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.33 -0.548 . . . . 99.989999999999995 110.84 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.408 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.91 -53.89 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 99.989999999999995 111.57 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.408 ' CD ' ' H ' ' A' ' 138' ' ' THR . 66.1 Cg_endo -92.87 -36.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.559 2.173 . . . . 99.989999999999995 113.294 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.53 -70.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.637 0.606 . . . . 99.989999999999995 112.637 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 43.3 p -123.11 4.42 9.27 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.043 0.757 . . . . 99.989999999999995 113.043 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.45 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -79.84 -71.08 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.72 -0.792 . . . . 99.989999999999995 110.829 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.41 ' OE1' ' CD1' ' A' ' 154' ' ' TYR . 77.7 mm-40 -73.24 -31.46 64.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 99.989999999999995 111.191 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -56.97 -38.26 72.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 99.989999999999995 111.69 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.46 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 9.9 mp -86.06 -6.91 58.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.852 0.358 . . . . 99.989999999999995 110.99 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -91.17 -61.56 1.63 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.672 -0.411 . . . . 99.989999999999995 111.129 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -61.07 -37.8 83.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.971 -0.558 . . . . 99.989999999999995 112.192 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.67 -12.61 23.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.849 0.685 . . . . 99.989999999999995 112.849 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 0.6 OUTLIER -124.71 29.4 6.24 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.102 -0.639 . . . . 99.989999999999995 112.485 -178.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 49.0 mttp 95.01 143.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.375 0.67 . . . . 99.989999999999995 111.454 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 152.88 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.25 -0.886 . . . . 99.989999999999995 110.104 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' A' ' 110' ' ' PHE . 89.1 t -159.32 -59.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.912 -0.585 . . . . 99.989999999999995 110.232 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 12.3 mmtm -104.69 -170.94 1.83 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.495 -0.32 . . . . 99.989999999999995 110.605 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 153' ' ' LYS . 18.5 m-85 -153.67 96.4 2.0 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.75 -1.204 . . . . 99.989999999999995 107.75 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 13.2 m -134.79 98.49 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-O 121.36 0.6 . . . . 99.989999999999995 110.559 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.583 ' O ' ' OG1' ' A' ' 161' ' ' THR . 91.1 mt-10 -103.16 99.06 8.9 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 106.517 -1.66 . . . . 99.989999999999995 106.517 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.569 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -119.0 155.68 30.96 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 123.306 1.527 . . . . 99.989999999999995 114.362 -175.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' LEU . 47.0 t -164.07 94.73 0.75 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 111.341 -2.663 . . . . 99.989999999999995 106.858 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 39.54 26.58 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.303 -1.317 . . . . 99.989999999999995 109.647 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.737 ' O ' ' N ' ' A' ' 162' ' ' GLN . 76.0 mt -142.05 -81.17 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.284 -0.871 . . . . 99.989999999999995 110.169 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -57.19 45.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 O-C-N 123.36 0.412 . . . . 99.989999999999995 110.778 -178.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.737 ' N ' ' O ' ' A' ' 160' ' ' LEU . 77.2 mt-30 -85.73 14.67 5.53 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 105.268 -2.123 . . . . 99.989999999999995 105.268 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.626 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.8 mttt -88.95 1.75 54.96 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 112.613 -2.085 . . . . 99.989999999999995 107.115 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.61 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -129.74 -73.6 0.14 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 108.739 -1.744 . . . . 99.989999999999995 108.739 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 164' ' ' GLY . 12.4 mt -41.72 -17.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.48 -0.888 . . . . 99.989999999999995 111.017 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.61 ' N ' ' O ' ' A' ' 164' ' ' GLY . 22.3 tttp -83.06 -48.47 10.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.055 -1.091 . . . . 99.989999999999995 108.055 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' GLY . 21.2 m120 -75.1 2.38 10.85 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.541 -1.209 . . . . 99.989999999999995 109.225 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 169' ' ' PHE . 24.7 t -84.1 -53.72 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 115.826 -0.624 . . . . 99.989999999999995 110.628 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 168' ' ' VAL . 6.0 m-85 -37.31 -52.78 1.1 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.804 -0.635 . . . . 99.989999999999995 111.207 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 53.1 p-10 -65.8 -39.23 90.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.545 -0.462 . . . . 99.989999999999995 111.199 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.615 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 99.2 mt-10 -70.67 -22.05 62.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.767 0.318 . . . . 99.989999999999995 110.7 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.21 77.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.628 -0.508 . . . . 99.989999999999995 109.628 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.49 -37.45 70.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.835 -0.621 . . . . 99.989999999999995 109.333 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.6 tp -57.25 -34.51 68.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.579 -0.737 . . . . 99.989999999999995 109.541 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.51 -23.69 67.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.632 -0.713 . . . . 99.989999999999995 111.152 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -63.95 -30.96 72.0 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.722 -0.391 . . . . 99.989999999999995 110.328 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.39 -35.54 70.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 99.989999999999995 110.607 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 99.989999999999995 110.679 -179.816 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.349 -0.612 . . . . 99.989999999999995 109.349 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 3' ' ' THR . 89.7 mt-30 -116.03 167.21 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 99.989999999999995 110.264 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -39.39 140.77 0.42 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.939 -0.393 . . . . 99.989999999999995 109.939 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp -130.35 152.43 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.938 -0.574 . . . . 99.989999999999995 110.955 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -102.5 162.79 12.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.293 0.568 . . . . 99.989999999999995 111.567 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.53 157.2 46.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.146 -0.933 . . . . 99.989999999999995 109.329 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.5 t -122.16 134.81 64.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.711 -0.396 . . . . 99.989999999999995 111.54 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 8' ' ' VAL . 9.3 p -50.05 125.73 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.963 -0.562 . . . . 99.989999999999995 110.223 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.04 133.44 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.681 -0.408 . . . . 99.989999999999995 110.424 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.544 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . 106.06 -67.99 0.24 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.178 -0.769 . . . . 99.989999999999995 111.178 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 60' ' ' GLY . 81.7 m-20 58.53 -82.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.581 0.229 . . . . 99.989999999999995 111.377 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 40.57 33.75 0.62 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.737 -0.945 . . . . 99.989999999999995 110.737 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 47.88 101.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.789 0.328 . . . . 99.989999999999995 110.564 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.678 ' CG2' ' H ' ' A' ' 15' ' ' GLY . 26.4 m -135.5 -111.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 99.989999999999995 111.057 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.678 ' H ' ' CG2' ' A' ' 14' ' ' VAL . . . -169.12 63.64 0.18 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.883 -0.887 . . . . 99.989999999999995 110.883 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -73.11 -2.9 23.28 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.088 -0.245 . . . . 99.989999999999995 111.215 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.8 p -61.43 -41.33 97.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.539 -0.3 . . . . 99.989999999999995 111.295 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 99.2 m -95.81 -7.57 36.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.054 0.454 . . . . 99.989999999999995 111.013 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.561 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 24.9 tp -66.7 -68.25 0.39 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.036 -0.529 . . . . 99.989999999999995 111.109 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.461 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 67.4 mt -65.66 -26.48 67.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.768 -0.651 . . . . 99.989999999999995 111.615 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 tt -58.86 -18.93 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.453 -0.499 . . . . 99.989999999999995 110.697 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.586 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -66.53 -75.95 0.09 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.384 -0.927 . . . . 99.989999999999995 111.397 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.688 ' CZ ' ' CZ ' ' A' ' 169' ' ' PHE . 1.9 p90 -41.24 -31.8 0.24 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 119.541 -0.864 . . . . 99.989999999999995 109.659 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.466 ' N ' ' CG ' ' A' ' 23' ' ' TYR . 2.5 m -57.12 -46.68 82.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.719 -0.673 . . . . 99.989999999999995 111.272 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.445 ' OG1' ' C ' ' A' ' 24' ' ' THR . 0.0 OUTLIER 175.99 -6.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.819 -0.352 . . . . 99.989999999999995 111.524 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 59.1 t-20 57.3 87.13 0.07 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.644 -0.422 . . . . 99.989999999999995 110.756 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -89.93 8.18 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 99.989999999999995 111.103 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 62.79 148.93 0.1 OUTLIER Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.535 -0.302 . . . . 99.989999999999995 110.288 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -42.04 143.18 1.32 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.247 1.965 . . . . 99.989999999999995 112.413 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.1 p -130.9 154.89 47.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 99.989999999999995 110.305 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' OE2' ' CE2' ' A' ' 32' ' ' TYR . 22.1 pt-20 -71.28 -15.65 62.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 99.989999999999995 110.854 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' CE2' ' OE2' ' A' ' 31' ' ' GLU . 69.3 m-85 -112.51 138.35 49.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 99.989999999999995 110.647 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.7 77.67 69.58 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 99.989999999999995 110.063 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.22 140.01 34.41 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.715 2.277 . . . . 99.989999999999995 112.334 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.7 p -116.6 25.68 10.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 99.989999999999995 110.271 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 m -124.05 160.49 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 99.989999999999995 110.628 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.449 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 80.9 t80 59.78 72.04 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 99.989999999999995 110.522 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -65.01 147.71 52.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 99.989999999999995 110.348 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.509 ' O ' ' O ' ' A' ' 55' ' ' LEU . 10.3 m120 -89.49 144.96 25.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 99.989999999999995 110.383 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.1 p90 -175.57 -4.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.376 . . . . 99.989999999999995 110.556 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.98 99.8 3.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.406 -0.361 . . . . 99.989999999999995 110.889 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.5 ' O ' ' OG1' ' A' ' 52' ' ' THR . 21.8 t -140.78 133.45 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 99.989999999999995 110.17 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.9 111.92 24.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.419 . . . . 99.989999999999995 110.825 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.7 t -137.43 145.83 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.919 -0.582 . . . . 99.989999999999995 111.154 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.657 ' N ' ' SD ' ' A' ' 45' ' ' MET . 2.3 mmt -97.08 132.93 42.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.668 -0.493 . . . . 99.989999999999995 109.668 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mt -120.66 127.0 75.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.74 -0.384 . . . . 99.989999999999995 111.141 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.73 31.12 5.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.218 -0.753 . . . . 99.989999999999995 111.218 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.05 52.13 6.48 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.898 -0.881 . . . . 99.989999999999995 110.898 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -138.75 79.07 29.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.047 -0.353 . . . . 99.989999999999995 110.047 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 36.1 Cg_exo -52.82 103.96 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.941 2.427 . . . . 99.989999999999995 112.965 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 76.6 m-85 -159.99 169.66 22.97 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.394 -0.595 . . . . 99.989999999999995 109.394 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 10.1 t -140.32 135.91 32.68 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.851 -0.74 . . . . 99.989999999999995 111.61 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -115.39 132.86 56.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.937 -0.574 . . . . 99.989999999999995 110.122 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 40' ' ' TYR . . . -107.77 126.41 8.31 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.431 -1.467 . . . . 99.989999999999995 109.431 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 39' ' ' ASN . 4.0 mp -136.3 125.97 25.46 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.953 -0.699 . . . . 99.989999999999995 111.845 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.431 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 69.7 m-85 -77.39 160.69 28.57 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.19 -0.67 . . . . 99.989999999999995 109.19 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 58' ' ' THR . 55.9 p30 -166.26 174.73 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.35 -0.241 . . . . 99.989999999999995 110.35 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.604 ' OG1' ' N ' ' A' ' 59' ' ' ALA . 1.7 t 147.63 -140.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.826 0.704 . . . . 99.989999999999995 109.568 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.604 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -140.37 135.55 32.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.49 -0.323 . . . . 99.989999999999995 110.132 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' ' OD2' ' A' ' 11' ' ' ASP . . . 76.52 -163.65 52.91 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.672 -0.971 . . . . 99.989999999999995 110.672 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.491 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 65.9 tp60 -63.81 -26.83 68.8 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.785 -0.244 . . . . 99.989999999999995 110.678 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 61' ' ' GLN . 37.5 mt-10 139.74 -105.5 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.707 1.254 . . . . 99.989999999999995 108.693 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.584 ' C ' ' H ' ' A' ' 65' ' ' ASP . 93.0 m-20 -78.94 -3.88 47.04 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.716 -0.476 . . . . 99.989999999999995 109.716 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.2 t80 66.18 -10.67 0.24 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.609 -0.723 . . . . 99.989999999999995 110.516 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.584 ' H ' ' C ' ' A' ' 63' ' ' ASP . 83.4 m-20 -73.82 140.77 46.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 99.989999999999995 110.164 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -95.09 4.27 53.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.517 -0.31 . . . . 99.989999999999995 110.733 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 mt -60.38 -33.57 72.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 99.989999999999995 110.485 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -123.56 77.42 55.24 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 99.989999999999995 110.616 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -77.53 -8.32 17.11 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.631 2.221 . . . . 99.989999999999995 112.261 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 74.5 mt -88.17 143.14 27.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 99.989999999999995 110.65 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.1 t -113.55 142.37 46.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 99.989999999999995 110.265 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -60.97 116.94 21.1 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.349 -0.387 . . . . 99.989999999999995 110.342 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.29 6.7 4.54 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.245 1.963 . . . . 99.989999999999995 112.409 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -55.91 -37.18 68.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.467 -0.333 . . . . 99.989999999999995 111.114 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.491 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 5.5 p -85.05 159.9 20.11 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.94 -0.304 . . . . 99.989999999999995 110.469 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 75' ' ' THR . 97.0 m-20 -139.96 3.2 2.0 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.82 -0.352 . . . . 99.989999999999995 111.83 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.26 109.71 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.428 -0.509 . . . . 99.989999999999995 110.615 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -78.44 122.5 25.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 111.399 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.408 ' C ' ' CD2' ' A' ' 79' ' ' LEU . 7.4 tt -121.52 116.73 25.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.712 -0.677 . . . . 99.989999999999995 110.379 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.472 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 41.4 t -90.37 130.19 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.161 -0.472 . . . . 99.989999999999995 110.268 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 118.84 26.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 99.989999999999995 110.901 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -144.69 163.91 32.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.729 -0.669 . . . . 99.989999999999995 109.74 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 85' ' ' VAL . 35.6 t -85.83 134.22 33.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.32 -0.622 . . . . 99.989999999999995 109.32 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.0 t -41.81 -17.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 120.229 -0.588 . . . . 99.989999999999995 112.103 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.556 ' O ' ' CB ' ' A' ' 86' ' ' SER . 38.9 t -135.22 131.81 52.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.167 -0.613 . . . . 99.989999999999995 110.731 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 2.9 m 151.94 81.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 99.989999999999995 110.19 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -52.75 -29.61 42.97 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.385 2.056 . . . . 99.989999999999995 111.855 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.0 m -71.08 -49.98 38.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 99.989999999999995 109.796 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.6 p -62.02 -30.91 71.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 99.989999999999995 110.318 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -57.8 -50.71 72.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 99.989999999999995 111.498 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -79.09 -18.79 52.72 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.708 -0.397 . . . . 99.989999999999995 111.164 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 25.4 m120 -93.78 -10.42 34.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.242 -0.583 . . . . 99.989999999999995 110.344 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.472 ' CG1' ' CG1' ' A' ' 80' ' ' VAL . 52.3 t -104.4 -71.25 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.392 0.615 . . . . 99.989999999999995 112.241 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.533 ' O ' ' CG2' ' A' ' 98' ' ' VAL . 78.8 mttt -69.67 -21.3 63.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.498 -0.774 . . . . 99.989999999999995 112.272 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.544 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 97.4 mt-10 -106.07 -38.4 6.31 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.434 0.901 . . . . 99.989999999999995 113.434 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -76.21 -30.66 58.06 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 119.351 -0.94 . . . . 99.989999999999995 111.881 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 23.3 m95 -89.57 -42.61 11.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.458 . . . . 99.989999999999995 111.299 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 2.2 t -40.22 -54.38 4.67 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 120.639 -0.424 . . . . 99.989999999999995 111.249 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.544 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 27.9 Cg_endo -64.2 -37.84 39.07 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.649 1.566 . . . . 99.989999999999995 112.162 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.57 -37.94 89.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.384 -0.371 . . . . 99.989999999999995 111.257 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 22.8 pt -86.29 -28.22 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.687 -0.405 . . . . 99.989999999999995 111.127 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 105' ' ' CYS . 86.3 m -59.99 -36.47 77.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.488 -0.324 . . . . 99.989999999999995 110.922 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -56.18 -37.69 69.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.41 -0.359 . . . . 99.989999999999995 110.88 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -55.99 -46.32 78.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.397 -0.365 . . . . 99.989999999999995 110.935 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 102' ' ' THR . 1.3 m -146.83 155.39 48.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.478 -0.328 . . . . 99.989999999999995 110.693 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.76 -60.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.482 2.122 . . . . 99.989999999999995 111.872 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -125.31 128.47 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 99.989999999999995 110.529 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.596 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -157.42 152.39 21.31 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.11 -0.495 . . . . 99.989999999999995 110.079 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -56.73 126.01 20.89 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.028 1.819 . . . . 99.989999999999995 111.39 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.691 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -116.58 111.29 19.68 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.356 -0.538 . . . . 99.989999999999995 110.453 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 7.7 mp -86.54 123.14 31.42 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.217 -0.593 . . . . 99.989999999999995 111.053 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.7 tp -100.94 123.58 45.34 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.904 -0.776 . . . . 99.989999999999995 108.904 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.7 t -136.18 147.47 28.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.455 -0.498 . . . . 99.989999999999995 111.47 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.478 ' O ' ' CD1' ' A' ' 19' ' ' LEU . . . -121.14 153.01 16.69 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.416 -1.074 . . . . 99.989999999999995 110.416 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 p -114.3 172.49 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.168 0.509 . . . . 99.989999999999995 110.804 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.578 ' O ' ' O ' ' A' ' 117' ' ' ILE . 31.5 mt-30 48.73 21.29 0.41 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.43 -0.805 . . . . 99.989999999999995 111.164 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.578 ' O ' ' O ' ' A' ' 116' ' ' GLN . 0.3 OUTLIER 36.32 -160.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.401 0 N-CA-C 108.284 -1.006 . . . . 99.989999999999995 108.284 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.563 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 19.1 m-20 -69.07 75.42 0.33 Allowed 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 118.788 -1.165 . . . . 99.989999999999995 109.463 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 121' ' ' ASP . 98.0 mt 64.86 85.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.111 -0.949 . . . . 99.989999999999995 110.832 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 119' ' ' LEU . 57.1 ttm-85 8.8 59.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.108 0.88 . . . . 99.989999999999995 111.132 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 119' ' ' LEU . 0.5 OUTLIER 167.12 -90.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.369 -0.832 . . . . 99.989999999999995 110.249 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 11.4 t0 109.93 -46.45 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 O-C-N 123.99 0.806 . . . . 99.989999999999995 110.339 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -92.78 -37.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 121.447 1.431 . . . . 99.989999999999995 111.794 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.2 m -98.38 -1.99 40.28 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.091 -0.643 . . . . 99.989999999999995 112.307 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -110.47 -12.09 14.42 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.007 -0.677 . . . . 99.989999999999995 110.958 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.535 ' CD1' ' O ' ' A' ' 122' ' ' ASP . 67.7 mt -85.78 -46.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.109 -0.7 . . . . 99.989999999999995 109.109 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.31 -32.1 69.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.592 -0.731 . . . . 99.989999999999995 110.273 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -61.98 -29.22 70.1 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.098 -0.501 . . . . 99.989999999999995 111.125 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.48 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 44.0 mt -54.58 -38.57 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.896 -0.322 . . . . 99.989999999999995 111.007 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . 78.23 9.52 2.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.618 -0.433 . . . . 99.989999999999995 111.191 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.492 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 51.9 mttp 56.9 83.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.068 0.461 . . . . 99.989999999999995 110.248 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 131' ' ' LYS . 87.8 m-20 -141.02 -25.91 0.73 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 99.989999999999995 109.094 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -178.75 45.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.115 -0.948 . . . . 99.989999999999995 110.22 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 135' ' ' LYS . 93.2 mt-30 -50.75 -38.31 47.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.905 0.383 . . . . 99.989999999999995 110.129 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.45 ' C ' ' O ' ' A' ' 134' ' ' GLN . 11.9 mmtm 31.75 61.05 1.25 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.62 . . . . 99.989999999999995 111.751 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.23 144.16 99.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.203 1.935 . . . . 99.989999999999995 111.185 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.81 45.93 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.557 -0.457 . . . . 99.989999999999995 111.153 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.43 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -118.69 -50.28 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 113.638 0.977 . . . . 99.989999999999995 113.638 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.43 ' HD2' ' H ' ' A' ' 138' ' ' THR . 72.9 Cg_endo -81.87 -83.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.127 1.885 . . . . 99.989999999999995 114.464 -176.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.51 -43.8 98.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 99.989999999999995 111.701 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.451 ' HG1' ' N ' ' A' ' 142' ' ' ALA . 81.9 p -60.56 -40.96 93.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.125 0.417 . . . . 99.989999999999995 112.125 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.451 ' N ' ' HG1' ' A' ' 141' ' ' THR . . . -77.31 -36.46 54.02 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.839 -0.344 . . . . 99.989999999999995 111.601 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.66 -42.33 96.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 99.989999999999995 111.755 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -66.4 -46.57 76.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.804 0.335 . . . . 99.989999999999995 110.986 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.4 tt -53.72 -35.16 60.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.133 -0.485 . . . . 99.989999999999995 111.06 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.03 -38.38 88.27 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 120.699 -0.4 . . . . 99.989999999999995 110.39 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -62.91 -39.78 95.6 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.749 -0.66 . . . . 99.989999999999995 110.789 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -52.31 -32.56 38.34 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.08 -1.081 . . . . 99.989999999999995 108.08 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 146' ' ' ALA . 62.6 mt -133.29 -113.41 0.22 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.577 -1.192 . . . . 99.989999999999995 108.479 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.563 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 51.3 mttp -143.83 -132.94 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 99.989999999999995 110.464 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 156.09 -165.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.866 0.365 . . . . 99.989999999999995 110.448 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 19.8 t -143.83 -51.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.39 -0.596 . . . . 99.989999999999995 109.39 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 3.5 tttm -143.62 -169.92 3.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.176 -0.465 . . . . 99.989999999999995 109.847 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -166.18 96.02 0.59 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.569 -0.9 . . . . 99.989999999999995 108.569 179.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 114' ' ' GLY . 16.5 m -136.14 153.61 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 115.621 -0.718 . . . . 99.989999999999995 110.474 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.594 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -133.11 94.0 3.27 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.542 -1.281 . . . . 99.989999999999995 107.542 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.618 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.5 OUTLIER -110.87 148.1 33.14 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 123.155 1.455 . . . . 99.989999999999995 113.504 -176.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.47 ' C ' ' N ' ' A' ' 160' ' ' LEU . 8.8 t -155.3 91.29 1.32 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 111.576 -2.556 . . . . 99.989999999999995 105.224 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.484 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . 42.03 28.16 0.09 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.984 -1.462 . . . . 99.989999999999995 108.739 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.623 ' O ' ' N ' ' A' ' 162' ' ' GLN . 47.0 mt -139.52 -74.02 0.37 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.619 -0.719 . . . . 99.989999999999995 111.841 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.747 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.1 m -57.82 44.12 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 120.918 0.39 . . . . 99.989999999999995 112.05 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.623 ' N ' ' O ' ' A' ' 160' ' ' LEU . 38.4 tt0 -74.83 19.32 0.14 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.122 -1.807 . . . . 99.989999999999995 106.122 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.747 ' H ' ' C ' ' A' ' 161' ' ' THR . 56.8 mttp -108.14 -1.49 20.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.583 -1.644 . . . . 99.989999999999995 107.779 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.17 -38.07 0.23 Allowed Glycine 0 C--O 1.225 -0.46 0 N-CA-C 109.599 -1.4 . . . . 99.989999999999995 109.599 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.9 tp -73.62 -22.99 59.84 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.034 0.445 . . . . 99.989999999999995 110.53 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -61.86 -34.15 75.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 99.989999999999995 109.231 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.597 ' O ' ' N ' ' A' ' 170' ' ' ASP . 7.9 m120 -72.29 -59.07 2.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.096 -1.446 . . . . 99.989999999999995 107.096 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.501 ' C ' ' O ' ' A' ' 167' ' ' ASN . 59.0 t -29.25 -55.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.693 -1.14 . . . . 99.989999999999995 110.446 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.688 ' CZ ' ' CZ ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -56.9 -48.76 77.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.254 -0.978 . . . . 99.989999999999995 110.316 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 167' ' ' ASN . 56.0 t0 -67.63 -47.44 69.6 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.783 0.325 . . . . 99.989999999999995 111.477 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.51 -29.05 70.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.444 . . . . 99.989999999999995 111.324 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.43 -32.49 66.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.096 -0.705 . . . . 99.989999999999995 109.096 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.32 -37.09 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.482 -0.781 . . . . 99.989999999999995 109.741 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.8 -37.73 77.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.621 -0.718 . . . . 99.989999999999995 110.426 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.54 -28.05 69.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.972 -0.558 . . . . 99.989999999999995 110.589 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -57.26 -37.1 71.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 99.989999999999995 110.979 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 177' ' ' LEU . 8.0 mp -60.04 -32.18 70.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.422 -0.354 . . . . 99.989999999999995 110.669 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.381 -0.372 . . . . 99.989999999999995 110.504 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.359 -0.608 . . . . 99.989999999999995 109.359 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -90.98 -69.52 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 99.989999999999995 110.305 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.5 t -40.37 125.59 2.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.87 -0.605 . . . . 99.989999999999995 110.392 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.49 149.93 22.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.03 -0.532 . . . . 99.989999999999995 109.894 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -105.08 147.3 28.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.223 0.535 . . . . 99.989999999999995 112.002 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -132.61 145.23 50.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.351 -0.84 . . . . 99.989999999999995 109.393 179.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 t -127.4 135.9 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.507 -0.477 . . . . 99.989999999999995 111.548 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 56' ' ' PHE . 5.2 t -74.81 120.81 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 120.257 -0.577 . . . . 99.989999999999995 110.443 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.5 130.66 74.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.104 -0.498 . . . . 99.989999999999995 109.875 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' HA3' ' HZ2' ' A' ' 16' ' ' LYS . . . 177.51 -162.01 29.67 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.595 -1.002 . . . . 99.989999999999995 110.595 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' ALA . 44.7 t0 -148.85 -117.09 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.992 0.425 . . . . 99.989999999999995 111.084 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . -29.83 -29.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.436 -0.802 . . . . 99.989999999999995 112.657 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -38.18 136.65 0.61 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.421 0.611 . . . . 99.989999999999995 110.046 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.88 27.48 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 99.989999999999995 111.77 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' CA ' ' NE2' ' A' ' 116' ' ' GLN . . . -143.22 36.87 1.54 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.512 -0.852 . . . . 99.989999999999995 112.053 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.566 ' CB ' ' H ' ' A' ' 58' ' ' THR . 26.8 mttt -74.59 -7.58 53.61 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.8 -0.36 . . . . 99.989999999999995 111.043 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.598 ' C ' ' H ' ' A' ' 19' ' ' LEU . 85.7 m -78.38 -69.63 0.54 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.821 -0.352 . . . . 99.989999999999995 110.897 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 32.4 m -61.75 0.16 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.357 0.598 . . . . 99.989999999999995 109.913 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.598 ' H ' ' C ' ' A' ' 17' ' ' THR . 7.8 tt -69.72 -52.29 26.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.091 -0.959 . . . . 99.989999999999995 110.989 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.63 -32.45 64.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.647 -0.706 . . . . 99.989999999999995 111.144 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.4 mt -55.03 -20.26 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.501 . . . . 99.989999999999995 110.929 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.489 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 5.2 m -50.62 -74.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.602 -0.439 . . . . 99.989999999999995 111.457 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.707 ' CZ ' ' CZ ' ' A' ' 169' ' ' PHE . 23.9 p90 -63.03 -28.08 69.85 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 120.566 -0.454 . . . . 99.989999999999995 111.141 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.4 m -51.17 -46.03 61.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 99.989999999999995 111.562 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.9 m -157.44 -19.46 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 99.989999999999995 110.41 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 22' ' ' SER . 1.4 m-80 64.16 133.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.934 -0.575 . . . . 99.989999999999995 110.904 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' NZ ' ' NE2' ' A' ' 162' ' ' GLN . 40.6 mttp 66.71 59.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.876 -0.602 . . . . 99.989999999999995 111.734 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 tp -128.87 67.28 77.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.4 0.619 . . . . 99.989999999999995 110.295 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -79.55 6.52 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.147 2.564 . . . . 99.989999999999995 112.533 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.6 m -49.18 137.21 14.03 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.666 -0.414 . . . . 99.989999999999995 110.384 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.26 -34.81 78.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 99.989999999999995 110.799 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -59.03 -40.85 86.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.356 -0.384 . . . . 99.989999999999995 110.527 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.8 t 52.39 77.84 0.43 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 99.989999999999995 110.573 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.07 141.73 36.88 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.603 2.202 . . . . 99.989999999999995 112.038 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.5 m -126.26 149.61 48.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 99.989999999999995 110.674 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.15 157.63 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 99.989999999999995 110.396 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -57.25 -41.03 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 99.989999999999995 111.52 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.35 130.15 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.978 0.418 . . . . 99.989999999999995 111.042 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LEU . 87.4 m-20 -123.9 14.95 9.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 99.989999999999995 110.516 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.547 ' CB ' ' CE1' ' A' ' 56' ' ' PHE . 22.3 p90 -175.73 12.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 99.989999999999995 109.9 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.22 99.9 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.638 -0.71 . . . . 99.989999999999995 109.844 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.6 t -144.68 140.57 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 99.989999999999995 110.889 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.6 t -124.51 132.01 53.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 110.343 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.8 t -133.69 138.9 49.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 99.989999999999995 110.762 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.9 mtm -113.49 120.92 42.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.154 -0.476 . . . . 99.989999999999995 110.153 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.8 pp -128.15 154.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.825 -0.35 . . . . 99.989999999999995 110.936 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.491 ' O ' ' OE1' ' A' ' 49' ' ' GLU . . . 32.81 27.95 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.597 -0.601 . . . . 99.989999999999995 111.597 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 74.19 50.22 10.83 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.956 -0.858 . . . . 99.989999999999995 110.956 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.491 ' OE1' ' O ' ' A' ' 47' ' ' GLY . 4.1 mp0 -130.4 96.53 24.16 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 110.026 -0.361 . . . . 99.989999999999995 110.026 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' C ' ' CD1' ' A' ' 51' ' ' TYR . 57.7 Cg_endo -76.8 108.65 2.69 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.05 1.833 . . . . 99.989999999999995 113.033 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.44 ' CD1' ' C ' ' A' ' 50' ' ' PRO . 93.7 m-85 -150.55 165.44 33.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.799 -0.637 . . . . 99.989999999999995 109.957 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.21 125.78 30.14 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.427 -0.509 . . . . 99.989999999999995 111.709 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.8 tp -113.1 125.4 54.33 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.243 -0.435 . . . . 99.989999999999995 110.813 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -89.43 136.42 13.54 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.572 -1.411 . . . . 99.989999999999995 109.572 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 39' ' ' ASN . 29.2 tp -137.11 125.69 23.7 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.744 -0.783 . . . . 99.989999999999995 112.85 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CE1' ' CB ' ' A' ' 40' ' ' TYR . 26.3 m-85 -97.93 -177.93 3.92 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.471 -0.936 . . . . 99.989999999999995 108.471 177.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' O ' ' OG1' ' A' ' 58' ' ' THR . 50.8 p30 -171.49 -174.89 1.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.379 -0.23 . . . . 99.989999999999995 110.379 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.566 ' H ' ' CB ' ' A' ' 16' ' ' LYS . 29.3 p 56.89 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.087 0.47 . . . . 99.989999999999995 111.664 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.566 ' CB ' ' HZ1' ' A' ' 16' ' ' LYS . . . -177.77 149.35 0.59 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.636 -0.711 . . . . 99.989999999999995 110.075 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.0 60.72 8.3 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.34 -1.104 . . . . 99.989999999999995 110.34 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -106.5 -47.47 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 99.989999999999995 111.064 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 64' ' ' TYR . 84.7 tt0 -140.44 133.82 29.88 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.052 -0.522 . . . . 99.989999999999995 109.608 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.556 ' C ' ' O ' ' A' ' 62' ' ' GLU . 51.2 p30 8.94 57.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.259 0.975 . . . . 99.989999999999995 111.731 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER 9.68 100.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.979 0.799 . . . . 99.989999999999995 112.188 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.5 p30 -78.9 86.78 4.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.054 0.454 . . . . 99.989999999999995 110.835 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -61.41 -32.71 72.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.621 . . . . 99.989999999999995 111.269 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.5 tp -52.19 -37.5 54.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.398 -0.365 . . . . 99.989999999999995 111.333 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -54.25 151.62 13.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.626 -0.429 . . . . 99.989999999999995 110.365 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.71 138.28 78.64 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.744 2.296 . . . . 99.989999999999995 112.483 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.2 mt -111.72 142.3 44.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.051 -0.522 . . . . 99.989999999999995 110.503 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.9 p -128.56 158.09 39.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 99.989999999999995 110.687 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -129.62 76.45 78.53 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 99.989999999999995 110.884 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.3 179.11 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.941 2.428 . . . . 99.989999999999995 111.812 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -56.36 -41.65 76.52 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.791 -0.364 . . . . 99.989999999999995 110.714 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.4 p 48.66 46.48 21.3 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.939 -0.304 . . . . 99.989999999999995 110.96 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -62.03 -37.81 86.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 99.989999999999995 110.381 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.532 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -119.34 99.79 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 99.989999999999995 110.345 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -71.14 127.76 33.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.978 -0.556 . . . . 99.989999999999995 111.958 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.532 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 9.1 mp -114.69 137.13 52.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.474 -0.785 . . . . 99.989999999999995 109.766 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 113' ' ' VAL . 62.3 t -104.75 132.4 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.986 -0.376 . . . . 99.989999999999995 109.986 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.452 ' SG ' ' CD1' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -114.38 123.81 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 99.989999999999995 111.54 -179.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.464 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 44.1 p90 -150.78 128.53 11.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.648 -0.705 . . . . 99.989999999999995 110.047 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -62.64 126.32 26.92 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.874 -0.787 . . . . 99.989999999999995 108.874 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.69 -20.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.564 -0.454 . . . . 99.989999999999995 111.675 -178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 85' ' ' VAL . 7.7 p -105.79 11.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.442 -0.503 . . . . 99.989999999999995 111.183 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.14 84.42 45.79 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 99.989999999999995 110.416 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -52.84 -27.38 34.48 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.457 2.104 . . . . 99.989999999999995 112.491 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.8 m -64.91 -44.84 88.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.806 -0.358 . . . . 99.989999999999995 111.199 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.561 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 83.8 p -70.71 -24.91 62.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 99.989999999999995 110.995 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.452 ' CD1' ' C ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -73.4 -40.45 64.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.007 -0.542 . . . . 99.989999999999995 111.44 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.09 -37.33 84.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.196 -0.456 . . . . 99.989999999999995 112.148 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -93.01 -39.82 10.89 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.963 -0.695 . . . . 99.989999999999995 112.071 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.561 ' CG2' ' O ' ' A' ' 89' ' ' SER . 37.4 t -51.68 -64.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.41 . . . . 99.989999999999995 111.573 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -72.61 -8.58 55.98 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.651 -0.42 . . . . 99.989999999999995 112.031 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.545 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 81.0 tt0 -103.77 -71.99 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.194 1.183 . . . . 99.989999999999995 114.194 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -88.07 -9.13 54.29 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.493 1.294 . . . . 99.989999999999995 114.493 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -97.4 -41.24 8.32 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.558 -0.857 . . . . 99.989999999999995 110.135 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -53.1 -54.64 42.15 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.117 -0.492 . . . . 99.989999999999995 110.996 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.545 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 17.9 Cg_endo -60.47 -34.05 93.34 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.674 1.583 . . . . 99.989999999999995 112.283 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -57.96 -37.56 74.4 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.688 -0.405 . . . . 99.989999999999995 110.954 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.1 pt -95.37 -31.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.465 -0.334 . . . . 99.989999999999995 111.495 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 28.7 m -51.08 -37.86 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.316 . . . . 99.989999999999995 110.948 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -50.63 -31.84 17.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 99.989999999999995 110.994 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.662 ' ND1' ' SG ' ' A' ' 105' ' ' CYS . 50.4 t-80 -57.33 -45.58 84.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.487 -0.324 . . . . 99.989999999999995 111.346 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.662 ' SG ' ' ND1' ' A' ' 104' ' ' HIS . 0.8 OUTLIER -174.59 82.74 0.34 Allowed Pre-proline 0 C--O 1.233 0.188 0 C-N-CA 120.746 -0.381 . . . . 99.989999999999995 110.962 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -63.13 -16.78 56.64 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.921 2.414 . . . . 99.989999999999995 112.808 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -77.64 -3.19 39.67 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.02 -0.272 . . . . 99.989999999999995 111.633 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 105' ' ' CYS . 13.9 p -94.8 150.31 37.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.984 -0.286 . . . . 99.989999999999995 110.826 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.95 142.69 93.82 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.437 2.091 . . . . 99.989999999999995 111.274 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.705 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -119.98 125.83 49.34 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.548 0.69 . . . . 99.989999999999995 111.404 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -99.92 133.69 43.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.463 -0.789 . . . . 99.989999999999995 110.777 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.8 mt -99.99 124.86 45.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.654 -0.703 . . . . 99.989999999999995 109.444 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 80' ' ' VAL . 41.5 t -128.05 129.44 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.516 -0.474 . . . . 99.989999999999995 111.302 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -106.47 142.54 15.65 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.032 -1.227 . . . . 99.989999999999995 110.032 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.32 169.1 8.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.12 0.486 . . . . 99.989999999999995 110.339 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.915 ' O ' ' N ' ' A' ' 118' ' ' ASP . 56.8 mm-40 52.1 23.52 2.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.727 -0.67 . . . . 99.989999999999995 110.918 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.592 ' CG2' ' H ' ' A' ' 119' ' ' LEU . 15.8 tt 27.66 -46.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 115.773 1.768 . . . . 99.989999999999995 115.773 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.915 ' N ' ' O ' ' A' ' 116' ' ' GLN . 47.0 t0 120.69 6.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.401 1.081 . . . . 99.989999999999995 108.505 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.592 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 8.9 tp -133.13 -24.74 1.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.913 -1.039 . . . . 99.989999999999995 109.8 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.751 HH21 ' NE2' ' A' ' 116' ' ' GLN . 65.5 ttp85 -71.33 -60.99 1.93 Allowed 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.534 -0.913 . . . . 99.989999999999995 108.534 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 123' ' ' PRO . 38.0 m-20 -43.93 -29.16 0.53 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.726 -0.67 . . . . 99.989999999999995 110.253 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 124' ' ' SER . 5.2 m-20 10.11 -73.9 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 N-CA-C 112.622 0.601 . . . . 99.989999999999995 112.622 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' A' ' 121' ' ' ASP . 57.3 Cg_exo -34.83 -26.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 120.928 1.085 . . . . 99.989999999999995 111.415 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.629 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.5 OUTLIER -107.74 -34.1 7.07 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.085 -0.507 . . . . 99.989999999999995 111.657 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.97 -33.99 18.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.125 0.488 . . . . 99.989999999999995 110.848 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -79.8 -46.2 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.535 -0.757 . . . . 99.989999999999995 110.941 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.403 ' CD ' ' O ' ' A' ' 123' ' ' PRO . 96.8 mt-10 -65.7 -34.47 78.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.468 -0.333 . . . . 99.989999999999995 111.597 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -95.86 -69.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.833 -0.347 . . . . 99.989999999999995 111.584 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' ALA . 61.9 mt -85.7 40.26 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 99.989999999999995 111.415 -178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.542 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -38.57 -91.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.705 -0.48 . . . . 99.989999999999995 109.705 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -148.16 91.37 1.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.387 0.613 . . . . 99.989999999999995 109.626 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 30.8 p-10 -145.61 36.26 1.07 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.978 -1.01 . . . . 99.989999999999995 108.318 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 27.0 ttmt 87.34 55.28 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.858 -1.065 . . . . 99.989999999999995 109.095 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 130' ' ' ALA . 50.8 mt-30 -59.22 149.35 28.7 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.907 -0.588 . . . . 99.989999999999995 110.365 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -132.54 70.08 79.6 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 121.006 0.431 . . . . 99.989999999999995 110.92 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.8 145.55 97.12 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.644 2.229 . . . . 99.989999999999995 111.962 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.31 78.14 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.438 -0.578 . . . . 99.989999999999995 109.438 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.435 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -132.31 -52.48 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.19 0 N-CA-C 114.412 1.264 . . . . 99.989999999999995 114.412 -178.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 143' ' ' GLU . 86.1 Cg_endo -83.87 -93.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.975 1.783 . . . . 99.989999999999995 114.585 -175.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.0 -38.83 76.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.358 -0.837 . . . . 99.989999999999995 111.554 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.435 ' HG1' ' N ' ' A' ' 142' ' ' ALA . 64.2 p -69.59 -34.55 74.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.362 -0.381 . . . . 99.989999999999995 111.602 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.435 ' N ' ' HG1' ' A' ' 141' ' ' THR . . . -91.96 -42.3 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.54 -0.464 . . . . 99.989999999999995 110.361 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 139' ' ' PRO . 84.2 tt0 -60.98 -39.67 90.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 99.989999999999995 111.001 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -63.53 -43.92 95.73 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.763 -0.375 . . . . 99.989999999999995 111.171 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 145' ' ' LEU . 3.1 mm? -79.23 -7.16 58.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.455 -0.339 . . . . 99.989999999999995 111.913 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.03 -66.43 0.9 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.232 -0.587 . . . . 99.989999999999995 111.581 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -59.77 -37.56 79.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.935 -0.575 . . . . 99.989999999999995 112.491 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -93.66 -13.82 27.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.909 0.707 . . . . 99.989999999999995 112.909 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.8 tp -134.75 51.09 2.13 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 119.582 -0.847 . . . . 99.989999999999995 112.249 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 67.7 mttm 65.11 158.7 0.1 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.205 0.526 . . . . 99.989999999999995 111.311 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 158.06 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.35 -0.841 . . . . 99.989999999999995 111.444 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 72.6 t -142.5 -66.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.695 -0.684 . . . . 99.989999999999995 109.379 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -136.42 -167.75 2.12 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.773 -0.649 . . . . 99.989999999999995 110.411 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -150.27 97.15 2.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.706 -0.85 . . . . 99.989999999999995 108.706 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 155' ' ' VAL . 21.1 m -116.2 97.96 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.669 -0.696 . . . . 99.989999999999995 110.147 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.661 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -95.33 98.75 10.81 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.512 -1.662 . . . . 99.989999999999995 106.512 178.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.535 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -125.61 149.31 48.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 123.007 1.384 . . . . 99.989999999999995 113.098 -176.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.731 ' HG ' ' HE ' ' A' ' 120' ' ' ARG . 22.3 t -157.03 92.76 1.29 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 111.906 -2.406 . . . . 99.989999999999995 106.289 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 42.27 27.42 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.095 -1.411 . . . . 99.989999999999995 109.242 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.676 ' O ' ' N ' ' A' ' 162' ' ' GLN . 19.8 mt -144.57 -73.37 0.26 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.809 -0.632 . . . . 99.989999999999995 112.125 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.661 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 2.2 m -57.06 65.31 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.315 0.578 . . . . 99.989999999999995 111.8 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.676 ' N ' ' O ' ' A' ' 160' ' ' LEU . 7.9 pt20 -82.68 15.07 2.77 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.066 -2.198 . . . . 99.989999999999995 105.066 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.66 ' H ' ' C ' ' A' ' 161' ' ' THR . 24.9 tttt -86.44 -6.53 58.89 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 113.421 -1.718 . . . . 99.989999999999995 108.486 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 167' ' ' ASN . . . -131.4 -74.73 0.12 Allowed Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 109.111 -1.596 . . . . 99.989999999999995 109.111 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 14.8 mt -41.49 -22.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.993 -0.683 . . . . 99.989999999999995 111.746 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.6 tttt -77.85 -46.59 21.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.823 -1.177 . . . . 99.989999999999995 107.823 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 164' ' ' GLY . 32.4 m120 -76.03 -0.45 21.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.856 -1.52 . . . . 99.989999999999995 109.784 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 171' ' ' GLU . 46.7 t -83.91 -60.14 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 116.489 -0.323 . . . . 99.989999999999995 110.762 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.707 ' CZ ' ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -43.05 -45.64 5.32 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.001 -0.68 . . . . 99.989999999999995 110.018 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.653 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 32.6 p30 -70.03 -30.56 67.88 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.291 -0.564 . . . . 99.989999999999995 109.779 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.653 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 85.5 tt0 -64.72 -31.38 72.58 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.486 -0.325 . . . . 99.989999999999995 110.133 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.12 -29.43 68.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.158 -0.682 . . . . 99.989999999999995 109.158 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 77.3 mt -52.41 -39.75 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.989 -1.115 . . . . 99.989999999999995 107.989 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.14 -37.79 88.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.988 -1.005 . . . . 99.989999999999995 109.589 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -76.78 -13.03 60.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.636 -0.711 . . . . 99.989999999999995 110.708 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.14 -29.21 69.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.916 0.388 . . . . 99.989999999999995 110.15 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.65 -35.27 70.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.033 -0.53 . . . . 99.989999999999995 110.431 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 99.989999999999995 110.575 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.565 ' N ' ' O ' ' A' ' 176' ' ' ALA . 64.1 mtt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.274 -0.639 . . . . 99.989999999999995 109.274 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -110.31 -113.83 0.31 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 99.989999999999995 110.459 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.9 p -42.73 113.68 0.5 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 99.989999999999995 110.384 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.8 tt -117.28 138.97 46.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.145 -0.48 . . . . 99.989999999999995 110.133 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -96.47 150.85 20.15 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.136 0.493 . . . . 99.989999999999995 111.106 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.52 ' SG ' ' CD2' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -143.1 137.03 28.87 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.808 -0.633 . . . . 99.989999999999995 111.013 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 p -106.61 139.66 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.961 -0.563 . . . . 99.989999999999995 109.692 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.6 t -115.63 131.35 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 120.287 -0.565 . . . . 99.989999999999995 111.592 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 t -128.58 138.69 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.539 -0.755 . . . . 99.989999999999995 109.839 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 60' ' ' GLY . . . -135.4 -177.33 14.89 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.785 -0.721 . . . . 99.989999999999995 111.497 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 53.8 p30 -72.25 -123.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.345 . . . . 99.989999999999995 111.221 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.582 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . -151.21 72.51 0.28 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.929 -0.868 . . . . 99.989999999999995 110.929 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 152.23 27.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.58 0.224 . . . . 99.989999999999995 111.398 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.4 ' CG1' ' H ' ' A' ' 83' ' ' SER . 16.8 m -125.28 133.85 68.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.659 -0.416 . . . . 99.989999999999995 110.412 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.3 93.59 1.86 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.264 -0.493 . . . . 99.989999999999995 112.429 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -73.27 -8.53 56.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.013 0.435 . . . . 99.989999999999995 110.102 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -59.27 -55.12 38.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 99.989999999999995 111.029 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -58.91 -36.19 74.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.701 . . . . 99.989999999999995 109.317 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 4.0 tt -65.71 -54.09 32.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.002 -0.999 . . . . 99.989999999999995 110.699 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.529 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -59.78 -32.53 70.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.063 0.459 . . . . 99.989999999999995 110.207 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.488 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 33.7 mt -62.36 -9.6 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.694 . . . . 99.989999999999995 111.378 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -53.43 -82.16 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.182 -1.007 . . . . 99.989999999999995 110.936 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -52.62 -31.61 37.45 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 120.268 -0.573 . . . . 99.989999999999995 110.851 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.403 ' HG1' ' HA ' ' A' ' 21' ' ' ILE . 10.3 m -47.18 -39.63 14.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.355 -0.609 . . . . 99.989999999999995 109.355 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -140.98 -87.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.662 -0.699 . . . . 99.989999999999995 109.985 178.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.559 ' N ' ' OG1' ' A' ' 25' ' ' THR . 2.1 t-20 156.58 83.94 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.993 -0.743 . . . . 99.989999999999995 108.993 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' H ' ' NE2' ' A' ' 162' ' ' GLN . 24.7 tttt 65.53 91.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 99.989999999999995 110.646 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 tp -125.14 85.64 57.84 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.984 -0.553 . . . . 99.989999999999995 110.45 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.61 47.18 2.25 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.85 2.367 . . . . 99.989999999999995 112.692 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.9 m -64.13 152.67 39.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.329 -0.396 . . . . 99.989999999999995 110.349 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -59.41 -39.57 83.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.382 -0.372 . . . . 99.989999999999995 110.555 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.6 ' CE2' ' O ' ' A' ' 33' ' ' VAL . 81.7 t80 -137.38 136.27 37.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.273 -0.422 . . . . 99.989999999999995 110.416 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 17.1 m -78.03 148.78 75.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 99.989999999999995 110.387 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.97 -162.4 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.386 2.057 . . . . 99.989999999999995 112.059 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.3 p -76.11 164.88 25.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 99.989999999999995 110.166 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -126.56 158.0 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.407 . . . . 99.989999999999995 110.805 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -117.93 161.04 20.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.917 -0.583 . . . . 99.989999999999995 110.363 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 51.5 p30 -77.92 4.29 12.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.974 0.416 . . . . 99.989999999999995 110.454 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -127.28 132.17 50.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 99.989999999999995 110.14 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -125.7 15.71 8.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.453 -0.573 . . . . 99.989999999999995 109.453 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.0 97.69 10.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.696 -0.684 . . . . 99.989999999999995 110.225 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.7 t -111.91 143.36 21.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.903 -1.044 . . . . 99.989999999999995 110.084 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 43' ' ' THR . 14.2 t -118.84 121.49 40.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 99.989999999999995 110.756 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.1 m -136.11 166.41 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.62 . . . . 99.989999999999995 110.59 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.2 mtm -111.82 128.51 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 99.989999999999995 110.028 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 tt -130.63 123.57 55.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.709 -0.396 . . . . 99.989999999999995 110.442 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.26 28.55 54.89 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.008 -0.837 . . . . 99.989999999999995 111.008 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.87 51.34 7.91 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.499 -1.04 . . . . 99.989999999999995 110.499 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -130.52 89.54 43.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 110.378 -0.23 . . . . 99.989999999999995 110.378 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.597 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 41.9 Cg_endo -74.72 103.9 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.135 1.89 . . . . 99.989999999999995 112.707 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 53.2 m-85 -162.01 174.81 12.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.838 -0.619 . . . . 99.989999999999995 109.564 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 t -145.94 141.67 27.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.109 -0.636 . . . . 99.989999999999995 110.908 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.2 tp -107.84 129.24 55.09 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.264 -0.426 . . . . 99.989999999999995 110.607 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -96.48 119.58 6.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.845 -0.902 . . . . 99.989999999999995 110.845 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.411 ' CD2' ' SG ' ' A' ' 6' ' ' CYS . 71.7 mt -115.99 153.31 31.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 99.989999999999995 110.644 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 56' ' ' PHE . 46.2 t80 -135.52 32.66 3.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 99.989999999999995 111.446 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' O ' ' OG1' ' A' ' 58' ' ' THR . 49.5 p30 -80.44 -173.59 4.16 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.742 0.306 . . . . 99.989999999999995 111.247 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 57' ' ' ASP . 1.2 m 168.74 -58.06 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.201 -0.454 . . . . 99.989999999999995 110.371 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.588 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . 164.02 139.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.072 -0.513 . . . . 99.989999999999995 110.204 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 10' ' ' GLY . . . 53.47 -82.03 0.01 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.177 -1.169 . . . . 99.989999999999995 110.177 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 59' ' ' ALA . 47.4 mt-30 67.43 17.92 10.1 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 111.773 0.286 . . . . 99.989999999999995 111.773 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.19 -72.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.314 -0.624 . . . . 99.989999999999995 109.314 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 65' ' ' ASP . 48.3 p30 -93.72 4.87 53.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 99.989999999999995 109.732 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.507 ' C ' ' O ' ' A' ' 63' ' ' ASP . 66.1 t80 18.54 -80.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.169 -0.923 . . . . 99.989999999999995 111.797 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 63' ' ' ASP . 21.3 t70 -141.63 151.33 42.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.24 -0.436 . . . . 99.989999999999995 110.538 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -56.75 -34.57 67.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 99.989999999999995 110.572 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.3 mt -91.23 136.73 32.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 99.989999999999995 110.232 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -128.54 69.5 79.23 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.302 -0.408 . . . . 99.989999999999995 110.737 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.13 146.99 25.92 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.769 2.312 . . . . 99.989999999999995 112.273 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.3 mt -60.63 -33.13 72.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.412 . . . . 99.989999999999995 110.446 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.3 t 36.44 37.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.5 . . . . 99.989999999999995 111.388 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 54.43 85.64 0.18 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.999 -0.28 . . . . 99.989999999999995 110.802 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.81 -63.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.557 2.171 . . . . 99.989999999999995 112.214 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 41.25 82.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 99.989999999999995 110.448 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.0 p -129.82 158.43 39.48 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.652 -0.499 . . . . 99.989999999999995 109.652 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.41 ' OD2' ' OE2' ' A' ' 178' ' ' GLU . 93.3 m-20 -121.84 -23.79 5.4 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.533 -0.467 . . . . 99.989999999999995 111.221 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.3 t -131.16 124.27 55.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.26 -0.576 . . . . 99.989999999999995 111.526 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -89.8 127.38 35.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 99.989999999999995 110.94 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.52 ' CD2' ' SG ' ' A' ' 6' ' ' CYS . 10.6 mp -104.64 135.58 45.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.703 -0.68 . . . . 99.989999999999995 110.814 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.83 131.94 69.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.951 -0.568 . . . . 99.989999999999995 109.794 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.64 135.82 53.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.306 0.574 . . . . 99.989999999999995 111.315 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.491 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 41.2 p90 -160.41 132.29 6.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.298 -0.865 . . . . 99.989999999999995 109.758 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.4 ' H ' ' CG1' ' A' ' 14' ' ' VAL . 75.7 p -59.0 135.98 57.8 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.817 -0.753 . . . . 99.989999999999995 109.447 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.0 p -114.76 23.64 5.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 119.874 -0.73 . . . . 99.989999999999995 110.197 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.7 p -63.6 -38.06 81.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.464 -0.789 . . . . 99.989999999999995 110.273 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.77 155.78 80.05 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 99.989999999999995 110.562 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -59.79 -13.59 23.02 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.897 2.398 . . . . 99.989999999999995 112.684 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 m -66.16 -67.06 0.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.926 -0.31 . . . . 99.989999999999995 111.004 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.3 m -60.61 -38.16 83.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.357 -0.383 . . . . 99.989999999999995 110.693 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.443 ' CZ ' ' OG1' ' A' ' 141' ' ' THR . 0.3 OUTLIER -60.03 -36.27 76.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.898 -0.592 . . . . 99.989999999999995 111.121 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' OE2' ' OE1' ' A' ' 95' ' ' GLU . 45.0 tp10 -81.91 -23.42 36.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.441 . . . . 99.989999999999995 111.848 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.62 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 80.3 m-20 -85.84 5.46 32.6 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 112.68 0.622 . . . . 99.989999999999995 112.68 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.461 ' CG1' ' CG ' ' A' ' 82' ' ' PHE . 1.5 p -119.07 -65.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.164 -0.614 . . . . 99.989999999999995 111.689 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.537 ' HZ1' ' CD2' ' A' ' 112' ' ' LEU . 74.0 mttt -54.8 -19.69 6.97 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.406 -0.518 . . . . 99.989999999999995 110.467 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' OE1' ' OE2' ' A' ' 91' ' ' GLU . 85.2 tt0 -113.89 -27.63 7.68 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.635 0.976 . . . . 99.989999999999995 113.635 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -113.01 -40.31 3.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.188 1.181 . . . . 99.989999999999995 114.188 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.62 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 47.4 m95 -90.63 -51.1 5.56 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.301 -0.96 . . . . 99.989999999999995 111.484 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.437 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 3.0 t -50.28 -58.9 8.27 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.479 -0.328 . . . . 99.989999999999995 111.414 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.4 Cg_endo -51.84 -39.13 68.61 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.652 1.568 . . . . 99.989999999999995 112.013 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.99 -43.79 98.32 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.368 -0.533 . . . . 99.989999999999995 110.015 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.2 mt -70.28 -36.56 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 99.989999999999995 110.494 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 105' ' ' CYS . 56.8 m -53.19 -43.33 67.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.838 -0.619 . . . . 99.989999999999995 110.852 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -63.39 -42.98 98.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 99.989999999999995 110.841 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.07 -42.39 98.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 99.989999999999995 111.63 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -103.97 161.57 22.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 99.989999999999995 111.204 -179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 41.5 Cg_endo -70.23 -157.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.856 2.371 . . . . 99.989999999999995 112.381 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -86.18 9.07 18.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 99.989999999999995 110.915 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.88 156.07 0.76 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.48 -0.327 . . . . 99.989999999999995 110.464 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.51 143.71 54.57 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.683 2.255 . . . . 99.989999999999995 111.821 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.752 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -129.72 114.84 16.48 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.558 -0.457 . . . . 99.989999999999995 110.852 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.95 122.72 27.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.604 . . . . 99.989999999999995 109.424 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.537 ' CD2' ' HZ1' ' A' ' 94' ' ' LYS . 27.5 tp -85.53 133.05 34.09 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.767 -0.373 . . . . 99.989999999999995 110.015 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.491 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -142.47 163.73 17.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.525 -0.47 . . . . 99.989999999999995 111.418 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.499 ' O ' ' CD1' ' A' ' 19' ' ' LEU . . . -146.4 176.59 25.24 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.486 -1.046 . . . . 99.989999999999995 110.486 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 116' ' ' GLN . 9.2 p -127.94 179.93 5.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 117.191 0.496 . . . . 99.989999999999995 109.87 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.538 ' O ' ' C ' ' A' ' 117' ' ' ILE . 9.5 mt-30 37.36 33.64 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.456 . . . . 99.989999999999995 110.487 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.538 ' C ' ' O ' ' A' ' 116' ' ' GLN . 1.0 OUTLIER 23.82 -141.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.236 0 O-C-N 123.506 0.503 . . . . 99.989999999999995 111.149 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.513 ' OD2' ' CG2' ' A' ' 138' ' ' THR . 86.7 m-20 -86.65 -2.48 58.55 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.203 -0.599 . . . . 99.989999999999995 112.568 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.472 ' O ' ' CG2' ' A' ' 125' ' ' THR . 6.0 tp 178.11 45.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.677 0.275 . . . . 99.989999999999995 111.18 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 57.7 ttp180 26.34 69.53 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.816 0.673 . . . . 99.989999999999995 112.816 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.6 ' O ' ' C ' ' A' ' 122' ' ' ASP . 18.0 t0 94.25 15.01 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.762 1.023 . . . . 99.989999999999995 113.762 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.6 ' C ' ' O ' ' A' ' 121' ' ' ASP . 0.2 OUTLIER -4.11 -64.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.45 0 O-C-N 123.456 0.472 . . . . 99.989999999999995 111.284 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.598 ' N ' ' O ' ' A' ' 121' ' ' ASP . 14.7 Cg_exo -30.76 -61.83 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.282 1.988 . . . . 99.989999999999995 112.6 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.4 p -108.36 -3.02 18.67 Favored 'General case' 0 C--N 1.337 0.055 0 C-N-CA 120.172 -0.611 . . . . 99.989999999999995 111.869 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 120' ' ' ARG . 1.1 m -96.29 -24.96 15.96 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.094 -0.706 . . . . 99.989999999999995 109.094 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.548 ' CG2' ' N ' ' A' ' 127' ' ' GLU . 11.6 tt -73.25 -47.02 48.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.842 -0.617 . . . . 99.989999999999995 109.903 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.548 ' N ' ' CG2' ' A' ' 126' ' ' ILE . 97.8 mt-10 -66.59 -37.83 85.72 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.438 -0.505 . . . . 99.989999999999995 111.483 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.68 -38.83 73.78 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.391 0.515 . . . . 99.989999999999995 112.391 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.572 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 17.4 mt -52.26 -56.0 17.6 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.706 -0.397 . . . . 99.989999999999995 111.775 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . 149.62 1.43 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.292 0.37 . . . . 99.989999999999995 110.743 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 134' ' ' GLN . 51.3 mttp 71.7 -63.87 0.41 Allowed 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 122.895 0.478 . . . . 99.989999999999995 110.294 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -59.38 -25.17 64.04 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.313 -0.555 . . . . 99.989999999999995 110.731 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -89.33 1.25 56.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.161 0.8 . . . . 99.989999999999995 113.161 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.415 ' CG ' ' O ' ' A' ' 131' ' ' LYS . 1.3 pp0? -82.72 127.99 33.94 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 119.696 -0.802 . . . . 99.989999999999995 111.392 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.69 68.99 59.63 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.127 -0.488 . . . . 99.989999999999995 110.516 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.26 139.35 11.64 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 123.091 2.527 . . . . 99.989999999999995 113.042 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.1 tt -127.96 112.67 28.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.178 -0.465 . . . . 99.989999999999995 110.161 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.591 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -131.12 -45.74 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.648 0.61 . . . . 99.989999999999995 112.648 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.591 ' CD ' ' H ' ' A' ' 138' ' ' THR . 56.9 Cg_endo -88.2 -62.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.585 2.19 . . . . 99.989999999999995 114.389 -177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 139' ' ' PRO . 95.9 mt-10 -29.76 -72.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.528 0.566 . . . . 99.989999999999995 112.528 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.443 ' OG1' ' CZ ' ' A' ' 90' ' ' PHE . 23.1 p -127.8 7.92 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.462 0.912 . . . . 99.989999999999995 113.462 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.499 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -83.5 -70.64 0.55 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.694 -0.803 . . . . 99.989999999999995 110.754 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -74.1 -40.58 62.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 99.989999999999995 111.632 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -62.13 -36.48 81.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.38 . . . . 99.989999999999995 111.445 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 35.6 tp -72.26 -22.47 61.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.185 -0.461 . . . . 99.989999999999995 111.232 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.65 -33.26 75.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.089 0.471 . . . . 99.989999999999995 110.81 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -59.89 -45.93 90.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 99.989999999999995 110.336 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -84.94 -29.53 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 99.989999999999995 110.736 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 55.5 tp -43.21 -28.46 0.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.002 -0.545 . . . . 99.989999999999995 112.268 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.527 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 63.0 mttm 88.17 -0.13 0.42 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.647 0.379 . . . . 99.989999999999995 110.009 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.46 -132.49 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.194 0.521 . . . . 99.989999999999995 111.518 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 110' ' ' PHE . 3.7 t -151.84 -54.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.499 -0.773 . . . . 99.989999999999995 110.336 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.416 ' HG3' ' H ' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -107.25 -167.76 1.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.458 -0.337 . . . . 99.989999999999995 110.348 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.616 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 34.2 p90 -161.95 97.13 1.03 Allowed 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.835 -0.802 . . . . 99.989999999999995 108.835 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.61 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.957 0.884 . . . . 99.989999999999995 111.613 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.645 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -153.39 96.93 2.09 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.305 -1.739 . . . . 99.989999999999995 106.305 178.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.419 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -112.83 145.49 40.56 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 123.274 1.511 . . . . 99.989999999999995 113.157 -176.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.437 ' HB2' ' N ' ' A' ' 116' ' ' GLN . 13.6 t -173.35 90.19 0.08 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 111.707 -2.497 . . . . 99.989999999999995 107.168 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 57.07 29.38 16.41 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.801 -1.545 . . . . 99.989999999999995 111.695 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.666 ' C ' ' H ' ' A' ' 162' ' ' GLN . 21.2 tp -156.18 -85.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.413 -0.588 . . . . 99.989999999999995 109.413 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.768 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.9 OUTLIER -46.41 -9.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.313 -0.625 . . . . 99.989999999999995 109.313 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.666 ' H ' ' C ' ' A' ' 160' ' ' LEU . 19.4 mt-30 -51.35 -1.58 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.094 -0.706 . . . . 99.989999999999995 109.094 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.768 ' H ' ' C ' ' A' ' 161' ' ' THR . 43.0 mttm -82.01 -2.69 52.47 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.721 -1.585 . . . . 99.989999999999995 106.721 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -116.45 -70.13 0.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 108.322 -1.911 . . . . 99.989999999999995 108.322 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 19' ' ' LEU . 43.1 tp -39.81 -16.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.478 -0.489 . . . . 99.989999999999995 110.826 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 164' ' ' GLY . 79.3 tttt -80.99 -53.51 6.37 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.964 -1.124 . . . . 99.989999999999995 107.964 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 164' ' ' GLY . 40.1 t-20 -71.15 -2.51 16.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.582 -1.19 . . . . 99.989999999999995 109.667 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 171' ' ' GLU . 29.6 t -78.3 -47.45 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.14 -0.482 . . . . 99.989999999999995 110.016 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 168' ' ' VAL . 63.0 t80 -39.12 -43.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.732 -0.667 . . . . 99.989999999999995 109.533 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.7 -37.82 88.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 99.989999999999995 110.36 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 168' ' ' VAL . 96.8 mt-10 -72.71 -20.82 61.15 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.049 0.452 . . . . 99.989999999999995 110.132 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.66 -36.73 85.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.614 -0.721 . . . . 99.989999999999995 110.742 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.425 ' CG1' ' N ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -62.04 -36.45 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.463 -0.569 . . . . 99.989999999999995 109.463 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.425 ' N ' ' CG1' ' A' ' 173' ' ' ILE . 45.3 tp -61.39 -35.01 76.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.712 -0.676 . . . . 99.989999999999995 110.016 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.55 -29.66 69.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.673 . . . . 99.989999999999995 110.852 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 1' ' ' MET . . . -65.98 -31.62 72.63 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.943 0.401 . . . . 99.989999999999995 110.285 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 32.8 tp -57.17 -35.86 70.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 99.989999999999995 110.671 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.41 ' OE2' ' OD2' ' A' ' 76' ' ' ASP . 97.0 mt-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 99.989999999999995 110.44 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.487 -0.56 . . . . 99.989999999999995 109.487 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 176' ' ' ALA . 91.2 mt-30 73.23 45.39 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.917 -0.583 . . . . 99.989999999999995 110.667 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.4 ' HB ' ' H ' ' A' ' 52' ' ' THR . 11.4 p -84.01 157.22 21.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.382 -0.826 . . . . 99.989999999999995 109.117 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.1 tt -134.12 152.9 34.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.454 -0.498 . . . . 99.989999999999995 110.821 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -103.04 146.79 27.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.036 0.445 . . . . 99.989999999999995 111.186 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -139.51 158.35 44.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.825 -0.625 . . . . 99.989999999999995 110.018 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.492 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 12.2 p -127.6 134.4 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.516 -0.311 . . . . 99.989999999999995 110.771 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.6 t -110.98 133.81 55.31 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 C-N-CA 120.367 -0.533 . . . . 99.989999999999995 110.812 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.3 t -114.62 132.47 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.003 -0.544 . . . . 99.989999999999995 110.225 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' A' ' 59' ' ' ALA . . . -103.37 123.34 7.76 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.086 -0.806 . . . . 99.989999999999995 111.086 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 13' ' ' ALA . 25.5 t70 -82.76 121.48 26.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.602 0.239 . . . . 99.989999999999995 110.397 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 56.75 -0.82 0.14 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.599 -0.6 . . . . 99.989999999999995 111.599 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.56 ' H ' ' C ' ' A' ' 11' ' ' ASP . . . 82.12 125.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.661 -0.496 . . . . 99.989999999999995 109.661 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.743 ' H ' ' HZ1' ' A' ' 16' ' ' LYS . 1.8 m -142.27 -88.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.571 -0.452 . . . . 99.989999999999995 111.816 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.49 ' H ' ' CG2' ' A' ' 14' ' ' VAL . . . -159.59 55.51 0.34 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.718 -0.753 . . . . 99.989999999999995 111.997 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.743 ' HZ1' ' H ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -63.71 -34.64 78.31 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.673 -0.31 . . . . 99.989999999999995 111.339 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.1 m -52.18 -43.84 64.36 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.901 0.334 . . . . 99.989999999999995 111.901 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.429 ' SG ' ' CD2' ' A' ' 28' ' ' LEU . 74.2 m -61.14 -26.97 68.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.168 0.509 . . . . 99.989999999999995 110.667 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.53 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -78.96 -35.91 42.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.726 -0.67 . . . . 99.989999999999995 111.173 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.416 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 81.4 mt -63.82 -36.09 82.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.303 . . . . 99.989999999999995 111.487 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.409 ' HA ' ' HG1' ' A' ' 24' ' ' THR . 17.9 pt -98.78 12.85 5.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.86 -0.336 . . . . 99.989999999999995 111.616 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.587 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 13.1 p -48.36 -77.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.248 -0.581 . . . . 99.989999999999995 110.893 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -62.77 -38.06 89.11 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 119.021 -1.072 . . . . 99.989999999999995 110.582 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.409 ' HG1' ' HA ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -48.68 -44.69 38.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 99.989999999999995 110.265 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER 171.2 77.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.787 -0.642 . . . . 99.989999999999995 109.796 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.512 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -58.05 83.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 99.989999999999995 110.521 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 25' ' ' THR . 24.1 mttm -148.17 60.26 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 99.989999999999995 110.712 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.559 ' H ' ' CB ' ' A' ' 159' ' ' ALA . 11.0 tp -123.34 68.56 39.06 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.467 -0.493 . . . . 99.989999999999995 110.89 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.78 -14.0 26.89 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.561 2.174 . . . . 99.989999999999995 112.246 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.9 p -67.78 120.8 14.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.945 0.403 . . . . 99.989999999999995 110.628 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -67.8 -32.67 73.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 99.989999999999995 111.145 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -56.66 -41.47 77.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.368 -0.378 . . . . 99.989999999999995 111.03 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.1 t 54.06 70.38 1.75 Allowed Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.777 -0.369 . . . . 99.989999999999995 110.432 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -53.93 137.45 68.65 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.817 2.345 . . . . 99.989999999999995 112.61 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.0 m -128.45 140.36 51.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 99.989999999999995 110.6 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 37' ' ' PHE . 9.1 p -159.75 -52.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.45 -0.341 . . . . 99.989999999999995 110.789 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.501 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 66.9 t80 -100.07 130.79 46.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.374 -0.376 . . . . 99.989999999999995 110.845 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 89.9 m-20 -75.83 136.9 40.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 99.989999999999995 110.495 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -111.48 148.27 33.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 99.989999999999995 110.784 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -176.14 -7.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.947 -0.569 . . . . 99.989999999999995 109.98 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.79 103.25 4.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.899 -0.591 . . . . 99.989999999999995 110.393 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.6 131.82 62.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 99.989999999999995 110.641 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -105.64 123.03 47.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.47 . . . . 99.989999999999995 110.744 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.78 157.3 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.546 . . . . 99.989999999999995 110.473 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 66.1 mtm -129.97 132.0 46.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 99.989999999999995 110.338 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.6 tt -135.17 131.77 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.734 -0.386 . . . . 99.989999999999995 110.97 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.37 26.57 51.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.552 -0.619 . . . . 99.989999999999995 111.552 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.55 58.43 3.86 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.838 -0.905 . . . . 99.989999999999995 110.838 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -136.23 101.36 10.21 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.286 -0.264 . . . . 99.989999999999995 110.286 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.43 103.19 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 122.266 1.977 . . . . 99.989999999999995 113.004 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -154.12 169.7 22.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 99.989999999999995 109.832 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.4 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.0 OUTLIER -136.11 125.47 24.89 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 119.942 -0.703 . . . . 99.989999999999995 112.093 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.5 tp -107.86 121.16 44.18 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.215 -0.448 . . . . 99.989999999999995 110.221 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -94.42 134.41 12.01 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.294 -1.123 . . . . 99.989999999999995 110.294 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -140.95 117.96 11.18 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.275 -0.57 . . . . 99.989999999999995 111.493 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.422 ' H ' ' HA ' ' A' ' 7' ' ' VAL . 10.9 t80 -65.97 -158.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.7 -0.852 . . . . 99.989999999999995 108.7 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 58' ' ' THR . 50.2 p30 -166.88 172.76 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.652 0.263 . . . . 99.989999999999995 110.63 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' A' ' 59' ' ' ALA . 0.3 OUTLIER 35.31 -157.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 99.989999999999995 110.836 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 58' ' ' THR . . . 158.23 -50.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.888 -0.597 . . . . 99.989999999999995 110.271 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 61' ' ' GLN . . . -85.11 -175.78 50.63 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.611 -0.996 . . . . 99.989999999999995 110.611 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 60' ' ' GLY . 92.9 mt-30 35.31 -158.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 99.989999999999995 110.542 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' A' ' 64' ' ' TYR . 85.3 tt0 54.68 81.63 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 99.989999999999995 110.346 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 57.1 t0 55.11 -1.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 99.989999999999995 111.129 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.611 ' H ' ' C ' ' A' ' 62' ' ' GLU . 58.0 t80 61.05 111.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.36 . . . . 99.989999999999995 110.133 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -82.53 123.27 29.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 99.989999999999995 111.184 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -67.35 153.1 44.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 99.989999999999995 110.318 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 mt -73.23 147.78 44.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 99.989999999999995 110.541 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -122.93 80.75 50.25 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 99.989999999999995 110.617 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -52.33 -11.65 1.22 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.777 2.318 . . . . 99.989999999999995 112.205 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.2 146.33 39.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 99.989999999999995 110.667 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 72' ' ' TYR . 40.1 p -85.23 6.46 25.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 99.989999999999995 111.039 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.45 ' C ' ' O ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -34.39 -59.16 0.59 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.42 -0.355 . . . . 99.989999999999995 110.983 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 72' ' ' TYR . 37.0 Cg_endo -68.09 135.86 36.01 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.154 1.903 . . . . 99.989999999999995 111.885 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -121.6 122.01 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.285 -0.416 . . . . 99.989999999999995 110.797 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.1 m -126.65 127.51 45.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 99.989999999999995 110.529 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -83.63 -36.22 24.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 99.989999999999995 110.546 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.68 122.86 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.985 -0.552 . . . . 99.989999999999995 110.291 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -84.97 123.3 30.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.365 0.602 . . . . 99.989999999999995 111.377 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 tt -115.39 130.76 56.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.139 -0.937 . . . . 99.989999999999995 109.754 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -118.4 135.53 58.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.807 -0.357 . . . . 99.989999999999995 110.152 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.413 ' SG ' ' CD2' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -130.79 132.07 45.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 99.989999999999995 110.893 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.444 ' H ' ' HA2' ' A' ' 114' ' ' GLY . 44.5 p90 -152.84 143.89 23.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.592 -0.731 . . . . 99.989999999999995 110.173 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.577 ' N ' ' HG1' ' A' ' 115' ' ' THR . 14.0 t -53.12 132.22 37.91 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.577 -0.527 . . . . 99.989999999999995 109.577 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.51 24.18 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.999 -0.546 . . . . 99.989999999999995 111.755 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.8 7.82 7.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.025 -0.534 . . . . 99.989999999999995 110.659 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.632 ' HG ' ' HG ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -124.29 150.01 62.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 99.989999999999995 110.124 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.93 -38.31 3.02 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.43 2.087 . . . . 99.989999999999995 113.345 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.1 p -85.67 -18.62 32.67 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.403 0.52 . . . . 99.989999999999995 112.403 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.632 ' HG ' ' HG ' ' A' ' 86' ' ' SER . 50.6 m -59.09 -35.2 72.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.88 -0.328 . . . . 99.989999999999995 111.746 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 90' ' ' PHE . 2.1 p90 -89.77 -29.25 18.81 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.795 -0.362 . . . . 99.989999999999995 111.381 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.73 -31.93 73.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.521 -0.308 . . . . 99.989999999999995 111.714 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -80.56 -38.09 30.21 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.443 -0.503 . . . . 99.989999999999995 111.939 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -68.39 -62.78 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.321 0.86 . . . . 99.989999999999995 113.321 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.493 ' NZ ' ' CB ' ' A' ' 142' ' ' ALA . 19.7 mttt -70.69 -7.12 42.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.01 0.744 . . . . 99.989999999999995 113.01 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 76.7 tt0 -131.37 -52.97 1.02 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.559 0.948 . . . . 99.989999999999995 113.559 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -74.34 -42.54 59.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.033 0.753 . . . . 99.989999999999995 113.033 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.538 ' NE1' ' OD1' ' A' ' 11' ' ' ASP . 96.5 m95 -88.58 -32.77 17.96 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.852 0.686 . . . . 99.989999999999995 112.852 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.518 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -53.22 -45.03 98.54 Favored Pre-proline 0 N--CA 1.466 0.364 0 C-N-CA 120.564 -0.454 . . . . 99.989999999999995 111.526 -178.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 12.8 Cg_exo -64.0 -45.12 10.97 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.259 1.973 . . . . 99.989999999999995 111.515 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.64 -40.78 80.05 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.106 -0.638 . . . . 99.989999999999995 109.793 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.22 -35.38 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 99.989999999999995 110.418 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.2 m -52.75 -39.46 62.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 99.989999999999995 111.162 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.22 -46.43 79.5 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.875 -0.33 . . . . 99.989999999999995 110.625 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -61.14 -44.95 96.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 99.989999999999995 110.908 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.9 87.57 48.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 99.989999999999995 110.531 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -51.59 -34.84 54.35 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.312 2.008 . . . . 99.989999999999995 112.212 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -143.55 112.31 6.54 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.738 -0.385 . . . . 99.989999999999995 110.602 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.606 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -171.08 151.81 3.3 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.329 -0.396 . . . . 99.989999999999995 110.292 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.62 142.49 98.01 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.308 2.005 . . . . 99.989999999999995 111.257 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.725 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -135.92 137.4 41.32 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.413 -0.515 . . . . 99.989999999999995 111.39 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.46 130.27 42.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.083 -0.508 . . . . 99.989999999999995 110.828 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 34.2 tp -97.05 127.45 43.03 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.157 -0.683 . . . . 99.989999999999995 109.157 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.7 t -146.29 167.46 7.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.236 -0.586 . . . . 99.989999999999995 111.655 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.444 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -142.59 170.92 24.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.069 -1.212 . . . . 99.989999999999995 110.069 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.577 ' HG1' ' N ' ' A' ' 83' ' ' SER . 3.1 p -122.9 177.6 5.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.182 0.515 . . . . 99.989999999999995 110.115 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.701 ' O ' ' N ' ' A' ' 118' ' ' ASP . 83.2 mt-30 57.78 11.28 1.3 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.517 -0.765 . . . . 99.989999999999995 111.402 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.703 ' CG2' ' H ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 35.57 19.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.342 0 CA-C-O 120.979 0.419 . . . . 99.989999999999995 111.178 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 116' ' ' GLN . 2.4 p30 50.48 13.82 0.14 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.906 -0.588 . . . . 99.989999999999995 111.692 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.9 tp -144.12 -36.1 0.35 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 119.804 -0.758 . . . . 99.989999999999995 112.816 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.703 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 8.0 tpm_? -63.25 -53.75 48.07 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.938 0.347 . . . . 99.989999999999995 111.938 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 125' ' ' THR . 81.2 m-20 -88.05 -11.28 47.64 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.441 -0.504 . . . . 99.989999999999995 111.167 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.467 ' C ' ' N ' ' A' ' 124' ' ' SER . 0.9 OUTLIER -43.82 -61.76 1.8 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 120.95 -0.3 . . . . 99.989999999999995 110.903 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 122' ' ' ASP . 1.6 Cg_endo -46.32 -20.12 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.159 1.24 . . . . 99.989999999999995 109.846 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.467 ' N ' ' C ' ' A' ' 122' ' ' ASP . 0.4 OUTLIER -103.93 -64.2 1.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.132 -0.94 . . . . 99.989999999999995 110.478 179.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 121' ' ' ASP . 41.3 m -62.04 -41.4 98.08 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 121.092 -0.243 . . . . 99.989999999999995 110.694 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -76.44 -46.16 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.497 0.554 . . . . 99.989999999999995 112.497 -179.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -55.2 -38.32 68.23 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.699 -0.4 . . . . 99.989999999999995 112.015 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -63.29 -38.16 90.07 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.334 -0.546 . . . . 99.989999999999995 111.212 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.558 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 50.2 mt -47.73 -48.52 29.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.577 -0.283 . . . . 99.989999999999995 111.557 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . 86.67 22.68 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.33 -0.618 . . . . 99.989999999999995 109.33 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -133.97 77.48 1.71 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.284 -0.871 . . . . 99.989999999999995 110.712 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -51.98 -28.14 15.81 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.052 -1.092 . . . . 99.989999999999995 108.052 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -55.59 -34.41 64.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.843 -1.072 . . . . 99.989999999999995 109.348 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -54.71 144.32 22.49 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.163 -0.615 . . . . 99.989999999999995 110.344 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.81 158.79 55.62 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 120.936 0.398 . . . . 99.989999999999995 111.187 -179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -62.88 150.38 88.55 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.967 2.445 . . . . 99.989999999999995 111.983 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' A' ' 137' ' ' ILE . 15.5 tt -136.15 48.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.467 -0.493 . . . . 99.989999999999995 111.072 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.714 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 6.8 m -128.56 -30.5 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.707 1.003 . . . . 99.989999999999995 113.707 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.714 ' CD ' ' H ' ' A' ' 138' ' ' THR . 79.7 Cg_exo -44.41 -59.7 1.03 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.691 1.594 . . . . 99.989999999999995 112.754 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -122.07 -35.14 3.21 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.721 -0.392 . . . . 99.989999999999995 111.73 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.7 m -53.98 -40.42 66.87 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.935 -0.306 . . . . 99.989999999999995 111.061 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.493 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . . . -80.18 -37.37 33.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.665 0.269 . . . . 99.989999999999995 111.265 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.2 -41.44 83.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.306 -0.406 . . . . 99.989999999999995 111.409 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.14 -42.42 99.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 99.989999999999995 110.513 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 89.3 mt -64.23 -34.12 77.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.796 -0.638 . . . . 99.989999999999995 111.326 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.73 -30.59 62.92 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.885 -0.326 . . . . 99.989999999999995 111.472 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -54.43 -38.26 66.07 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.487 0.551 . . . . 99.989999999999995 112.487 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 149' ' ' LEU . 55.0 p30 -123.27 -26.56 4.27 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.957 0.725 . . . . 99.989999999999995 112.957 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.59 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 5.9 tp -74.94 2.35 10.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.408 -0.517 . . . . 99.989999999999995 111.315 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.546 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 47.7 mttt 100.44 147.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.624 0.77 . . . . 99.989999999999995 110.384 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 155.25 -173.27 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.902 -0.59 . . . . 99.989999999999995 111.08 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 110' ' ' PHE . 46.3 t -150.35 -57.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.188 -0.914 . . . . 99.989999999999995 109.281 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -98.76 -176.36 3.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.763 -0.653 . . . . 99.989999999999995 109.656 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.619 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 31.6 p90 -170.62 97.13 0.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.823 -0.751 . . . . 99.989999999999995 109.958 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -161.3 -176.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.406 -0.815 . . . . 99.989999999999995 110.186 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.747 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.4 OUTLIER -148.18 96.08 2.57 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.086 -0.961 . . . . 99.989999999999995 108.838 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.487 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -108.64 147.26 32.13 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 123.129 1.443 . . . . 99.989999999999995 113.058 -178.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.514 ' HB2' ' N ' ' A' ' 116' ' ' GLN . 5.3 t -165.94 90.98 0.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 111.64 -2.527 . . . . 99.989999999999995 106.102 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.559 ' CB ' ' H ' ' A' ' 28' ' ' LEU . . . 48.5 31.6 2.94 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.261 -1.791 . . . . 99.989999999999995 109.962 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.816 ' O ' ' N ' ' A' ' 162' ' ' GLN . 1.9 mt -153.46 -76.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.517 -0.765 . . . . 99.989999999999995 111.886 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.75 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.1 m -51.78 44.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 112.838 0.681 . . . . 99.989999999999995 112.838 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.816 ' N ' ' O ' ' A' ' 160' ' ' LEU . 36.2 tt0 -72.7 8.47 1.46 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 104.839 -2.282 . . . . 99.989999999999995 104.839 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.75 ' H ' ' C ' ' A' ' 161' ' ' THR . 26.4 mttt -81.24 -6.31 58.73 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.196 -1.82 . . . . 99.989999999999995 108.16 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -126.89 -67.84 0.16 Allowed Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 106.648 -2.581 . . . . 99.989999999999995 106.648 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.457 ' CD1' ' SG ' ' A' ' 157' ' ' CYS . 4.7 mt -41.68 -7.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.025 -0.67 . . . . 99.989999999999995 112.652 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 164' ' ' GLY . 48.7 tttt -83.51 -45.49 13.53 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.455 -0.942 . . . . 99.989999999999995 108.455 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 164' ' ' GLY . 24.4 m120 -81.22 4.75 19.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.031 -0.986 . . . . 99.989999999999995 109.29 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.406 ' CG2' ' HA ' ' A' ' 165' ' ' LEU . 58.2 t -86.8 -62.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.514 -0.766 . . . . 99.989999999999995 110.765 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -45.19 -40.44 7.21 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 119.641 -0.824 . . . . 99.989999999999995 109.217 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -68.04 -42.96 79.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.075 -0.511 . . . . 99.989999999999995 110.203 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.99 -27.85 69.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 99.989999999999995 109.973 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.76 -32.29 73.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.636 -0.711 . . . . 99.989999999999995 110.92 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.1 pp -64.61 -27.21 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.658 -0.417 . . . . 99.989999999999995 110.338 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.84 -35.02 79.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 99.989999999999995 110.569 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.46 -28.93 62.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.119 -0.491 . . . . 99.989999999999995 111.839 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -59.46 -42.18 91.41 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.808 0.299 . . . . 99.989999999999995 111.808 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.85 -25.93 66.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.411 . . . . 99.989999999999995 110.483 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 99.989999999999995 110.52 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 176' ' ' ALA . 63.7 mtt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.24 -0.652 . . . . 99.989999999999995 109.24 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' THR . 90.4 mt-30 -122.63 167.17 13.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 99.989999999999995 110.581 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -40.52 134.96 1.65 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.676 -0.49 . . . . 99.989999999999995 109.676 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.2 tp -123.79 144.6 32.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.091 -0.504 . . . . 99.989999999999995 110.727 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -100.88 153.83 19.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.272 0.558 . . . . 99.989999999999995 111.365 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -135.65 160.38 38.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.814 . . . . 99.989999999999995 109.892 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.537 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 33.1 m -125.4 157.47 34.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.786 -0.366 . . . . 99.989999999999995 110.458 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.47 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 21.6 t -108.76 126.65 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 120.377 -0.529 . . . . 99.989999999999995 111.294 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.9 t -133.66 129.26 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 99.989999999999995 109.651 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.602 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . -164.59 -143.09 3.6 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.226 -0.988 . . . . 99.989999999999995 111.444 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.5 t0 -83.42 111.63 19.2 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.652 -0.499 . . . . 99.989999999999995 109.652 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 28.2 -90.3 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.986 -0.846 . . . . 99.989999999999995 110.986 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -131.23 126.8 36.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.071 0.462 . . . . 99.989999999999995 111.56 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.55 ' C ' ' H ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -136.52 -174.4 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.7 -0.682 . . . . 99.989999999999995 109.303 178.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -65.08 42.24 0.11 Allowed Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.218 -0.753 . . . . 99.989999999999995 111.218 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 59' ' ' ALA . 37.1 mttt -62.05 -36.4 81.5 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.586 0.217 . . . . 99.989999999999995 111.586 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.7 m -66.04 -48.85 69.71 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.109 0.411 . . . . 99.989999999999995 112.109 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -62.37 -29.92 70.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.152 0.501 . . . . 99.989999999999995 110.727 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.7 tp -57.29 -41.36 79.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.416 -0.811 . . . . 99.989999999999995 110.858 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tt -66.99 -37.93 85.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 99.989999999999995 110.672 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.454 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 93.4 mt -70.31 3.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.613 -0.721 . . . . 99.989999999999995 111.195 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.483 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 10.5 t -62.38 -74.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.765 -0.374 . . . . 99.989999999999995 111.864 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.614 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 0.7 OUTLIER -59.93 -31.06 69.49 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 119.73 -0.788 . . . . 99.989999999999995 110.234 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 6.7 m -52.04 -43.36 63.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.666 -0.697 . . . . 99.989999999999995 111.489 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -163.14 -38.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.601 -0.439 . . . . 99.989999999999995 111.377 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 22' ' ' SER . 2.6 p-10 43.55 95.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.759 -0.46 . . . . 99.989999999999995 109.759 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -152.92 13.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 99.989999999999995 111.4 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 tp 61.24 60.64 3.07 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.213 0.53 . . . . 99.989999999999995 110.519 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.35 -168.43 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.862 2.375 . . . . 99.989999999999995 112.003 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 m -56.71 151.04 14.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 110.455 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.76 -34.74 74.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 99.989999999999995 111.069 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -115.54 132.21 56.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.426 -0.352 . . . . 99.989999999999995 110.737 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.05 70.64 82.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 110.394 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.07 9.53 3.02 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.994 2.463 . . . . 99.989999999999995 112.678 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.1 m -51.5 -38.92 56.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 99.989999999999995 110.65 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.7 p -130.09 141.8 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.398 . . . . 99.989999999999995 110.252 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -58.2 -49.5 76.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.368 -0.378 . . . . 99.989999999999995 110.279 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 51.3 p30 -176.14 157.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 99.989999999999995 110.544 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' LEU . 38.0 t-20 -124.45 169.27 12.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 99.989999999999995 110.55 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.456 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -178.36 11.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 99.989999999999995 110.172 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.24 100.31 3.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.857 -0.61 . . . . 99.989999999999995 109.857 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.411 ' CG1' ' OH ' ' A' ' 23' ' ' TYR . 42.2 t -134.87 134.17 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 99.989999999999995 111.217 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.8 t -119.44 126.64 51.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.941 -0.572 . . . . 99.989999999999995 110.422 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.76 144.88 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 99.989999999999995 110.676 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 73.8 mtm -105.76 123.53 48.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.527 . . . . 99.989999999999995 110.14 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.4 mt -132.72 117.11 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.867 -0.333 . . . . 99.989999999999995 110.804 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.35 70.96 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.116 -0.793 . . . . 99.989999999999995 111.116 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.07 43.9 15.46 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.78 -0.928 . . . . 99.989999999999995 110.78 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' OE1' ' OD1' ' A' ' 170' ' ' ASP . 64.8 mt-10 -123.2 86.01 51.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 110.509 -0.182 . . . . 99.989999999999995 110.509 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.467 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 50.2 Cg_endo -76.9 102.02 1.57 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.211 1.941 . . . . 99.989999999999995 112.423 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 88.9 m-85 -155.46 170.39 22.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.728 -0.669 . . . . 99.989999999999995 109.965 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.402 ' H ' ' HB ' ' A' ' 3' ' ' THR . 3.4 p -134.8 142.83 46.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.248 -0.581 . . . . 99.989999999999995 111.159 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.0 tp -122.36 126.85 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 99.989999999999995 109.954 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -98.07 130.72 10.33 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.557 -0.83 . . . . 99.989999999999995 111.695 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 39' ' ' ASN . 66.6 mt -116.76 123.41 47.09 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.079 -0.341 . . . . 99.989999999999995 110.079 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.532 ' O ' ' O ' ' A' ' 57' ' ' ASP . 34.9 t80 -91.15 32.13 1.05 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.5 -0.48 . . . . 99.989999999999995 111.961 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 56' ' ' PHE . 50.5 p30 -36.24 168.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.062 0.458 . . . . 99.989999999999995 112.059 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.515 ' H ' ' CB ' ' A' ' 16' ' ' LYS . 46.4 m 59.8 53.67 4.72 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.052 -0.522 . . . . 99.989999999999995 111.174 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.595 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . . . -141.36 157.34 45.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.391 . . . . 99.989999999999995 110.429 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 167.54 -42.73 0.24 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.44 -0.664 . . . . 99.989999999999995 111.44 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.41 -87.37 0.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.967 0.413 . . . . 99.989999999999995 111.204 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -64.0 -46.97 82.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 99.989999999999995 109.906 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -87.7 5.54 39.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.669 -0.696 . . . . 99.989999999999995 109.328 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -45.8 -43.79 13.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.817 -0.629 . . . . 99.989999999999995 110.133 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 52.6 p30 -175.93 154.45 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 99.989999999999995 110.375 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -107.35 -73.4 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 99.989999999999995 110.071 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -99.38 134.86 41.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 99.989999999999995 110.164 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -110.22 131.74 21.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.362 . . . . 99.989999999999995 110.271 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.63 135.95 27.19 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.022 1.815 . . . . 99.989999999999995 112.128 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.8 -37.87 86.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.266 -0.424 . . . . 99.989999999999995 110.125 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.4 p -155.15 163.28 40.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 99.989999999999995 110.523 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 54.59 79.18 0.35 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 99.989999999999995 110.752 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.22 148.74 17.8 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.749 2.299 . . . . 99.989999999999995 111.945 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -83.55 8.61 13.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 99.989999999999995 110.978 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.7 t -131.09 150.63 52.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.231 -0.285 . . . . 99.989999999999995 110.231 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD2' ' OE2' ' A' ' 178' ' ' GLU . 88.1 m-20 -127.37 -15.69 5.08 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.58 -0.448 . . . . 99.989999999999995 111.639 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.12 107.56 13.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.493 -0.483 . . . . 99.989999999999995 110.941 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -74.04 135.29 43.06 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.424 -0.511 . . . . 99.989999999999995 110.721 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tt -117.47 125.26 50.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.788 -0.642 . . . . 99.989999999999995 109.966 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.7 m -100.66 132.27 46.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.513 -0.475 . . . . 99.989999999999995 109.949 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.7 t -125.91 128.46 47.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.398 0.618 . . . . 99.989999999999995 111.675 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.486 ' CZ ' ' CE ' ' A' ' 94' ' ' LYS . 12.8 p90 -153.44 157.63 40.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.394 -0.821 . . . . 99.989999999999995 109.511 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.52 ' OG ' ' CB ' ' A' ' 89' ' ' SER . 16.3 p -66.42 132.33 48.06 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.151 -1.055 . . . . 99.989999999999995 108.151 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -78.71 32.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 119.795 -0.762 . . . . 99.989999999999995 112.934 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' A' ' 119' ' ' LEU . 32.6 m -121.62 160.78 22.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.075 0.464 . . . . 99.989999999999995 110.347 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -42.22 -58.61 3.34 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 113.143 0.794 . . . . 99.989999999999995 113.143 -179.199 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 89' ' ' SER . 20.0 Cg_exo -22.69 65.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 124.634 3.556 . . . . 99.989999999999995 115.984 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 86' ' ' SER . 50.5 m 34.02 10.76 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.305 1.224 . . . . 99.989999999999995 114.305 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 87' ' ' PRO . 88.5 p -69.46 -33.67 73.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.388 0.54 . . . . 99.989999999999995 110.806 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.6 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 5.8 p90 -89.12 -41.38 12.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 99.989999999999995 111.202 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.6 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.7 tt0 -55.98 -34.17 65.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.94 -0.573 . . . . 99.989999999999995 112.267 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 96' ' ' LYS . 73.4 m-20 -85.75 -64.4 1.16 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.486 -0.485 . . . . 99.989999999999995 112.123 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 52.7 t -49.67 -52.97 11.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.714 0.635 . . . . 99.989999999999995 112.714 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.486 ' CE ' ' CZ ' ' A' ' 82' ' ' PHE . 23.3 mttm -67.37 -20.08 65.51 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.734 0.642 . . . . 99.989999999999995 112.734 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 84.4 tt0 -126.61 -58.54 1.32 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.228 0.825 . . . . 99.989999999999995 113.228 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 92' ' ' ASN . 14.7 tptp -60.49 -35.2 75.36 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.937 0.718 . . . . 99.989999999999995 112.937 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 10' ' ' GLY . 42.2 m95 -84.16 -35.0 23.9 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.032 -0.667 . . . . 99.989999999999995 111.006 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 97' ' ' TRP . 2.3 t -37.45 -54.53 2.1 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.779 -0.368 . . . . 99.989999999999995 111.162 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.431 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 20.0 Cg_endo -63.64 -36.5 52.4 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 121.271 1.314 . . . . 99.989999999999995 110.979 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 97' ' ' TRP . 48.2 tp10 -61.45 -43.91 98.04 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.384 -0.526 . . . . 99.989999999999995 110.042 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.9 mt -74.74 -35.3 36.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 99.989999999999995 110.812 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 42.7 m -50.49 -41.7 53.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 99.989999999999995 111.023 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -57.7 -39.9 78.24 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.81 -0.356 . . . . 99.989999999999995 110.363 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -58.37 -44.9 89.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 99.989999999999995 111.003 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.483 ' O ' ' OG1' ' A' ' 108' ' ' THR . 8.6 t -167.48 108.61 0.61 Allowed Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.917 -0.313 . . . . 99.989999999999995 110.925 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.49 150.56 22.09 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.199 1.933 . . . . 99.989999999999995 112.419 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 60.41 49.37 6.91 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.208 -0.451 . . . . 99.989999999999995 110.972 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -121.42 108.81 35.34 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.35 -0.387 . . . . 99.989999999999995 110.814 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -47.82 148.29 6.39 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.993 1.796 . . . . 99.989999999999995 111.441 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 152' ' ' VAL . 20.3 p90 -151.02 161.63 42.37 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.453 -0.899 . . . . 99.989999999999995 112.824 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.3 mp -96.6 127.51 42.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.013 -0.994 . . . . 99.989999999999995 110.347 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.9 tp -88.77 119.86 29.64 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.49 -0.93 . . . . 99.989999999999995 108.49 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 114' ' ' GLY . 40.0 t -136.3 165.3 29.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 99.989999999999995 111.815 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -142.15 174.36 23.29 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.817 -1.313 . . . . 99.989999999999995 109.817 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 12.5 t -137.79 161.14 37.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.949 0.404 . . . . 99.989999999999995 110.451 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.542 ' O ' ' C ' ' A' ' 117' ' ' ILE . 2.8 mm100 54.55 33.19 18.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.066 -0.516 . . . . 99.989999999999995 110.773 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.634 ' CG2' ' N ' ' A' ' 118' ' ' ASP . 7.2 tt 21.84 -138.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.424 0 O-C-N 123.544 0.527 . . . . 99.989999999999995 110.812 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.634 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 23.7 p30 -87.07 83.49 7.46 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.9 -0.72 . . . . 99.989999999999995 109.277 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.589 ' N ' ' CG1' ' A' ' 85' ' ' VAL . 16.6 tp 56.75 42.5 26.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.354 -0.839 . . . . 99.989999999999995 109.023 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.605 ' O ' ' C ' ' A' ' 121' ' ' ASP . 50.6 ttm-85 51.03 65.79 1.37 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.586 -0.734 . . . . 99.989999999999995 109.152 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.618 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 59.3 t0 5.82 66.67 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.328 1.061 . . . . 99.989999999999995 109.979 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.651 ' O ' ' N ' ' A' ' 124' ' ' SER . 0.4 OUTLIER -107.15 -179.39 0.7 Allowed Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 113.097 -1.865 . . . . 99.989999999999995 107.861 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.427 ' O ' ' HB3' ' A' ' 127' ' ' GLU . 30.3 Cg_exo -59.62 35.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 121.257 1.304 . . . . 99.989999999999995 111.114 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.651 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.5 OUTLIER -115.53 -57.54 2.23 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.161 -0.616 . . . . 99.989999999999995 109.484 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.465 ' CG2' ' OD2' ' A' ' 118' ' ' ASP . 17.4 m -66.73 -33.63 76.06 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.83 -1.544 . . . . 99.989999999999995 106.83 177.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 52.7 mt -88.95 -70.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 113.613 -1.63 . . . . 99.989999999999995 114.363 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 123' ' ' PRO . 76.9 tt0 -65.73 -32.16 73.55 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.734 1.013 . . . . 99.989999999999995 113.734 -175.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -91.9 -68.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.769 -0.772 . . . . 99.989999999999995 111.158 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 4.1 mm? -58.13 -33.17 68.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 111.433 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . 99.09 122.64 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.882 -0.784 . . . . 99.989999999999995 108.882 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -50.1 -35.83 27.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.54 -0.754 . . . . 99.989999999999995 111.749 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -86.86 5.55 36.26 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.637 -0.425 . . . . 99.989999999999995 111.905 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 134' ' ' GLN . 35.0 tttp -134.34 -6.6 2.6 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.464 -0.494 . . . . 99.989999999999995 110.959 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 133' ' ' LYS . 92.1 mt-30 -14.4 -71.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.533 0.521 . . . . 99.989999999999995 111.862 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.7 tptt 54.41 60.7 10.36 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 99.989999999999995 110.825 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.418 ' C ' ' H ' ' A' ' 138' ' ' THR . 8.7 Cg_endo -53.64 154.42 16.1 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.374 2.049 . . . . 99.989999999999995 111.41 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.1 tt -76.77 43.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.305 -0.558 . . . . 99.989999999999995 110.226 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.519 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.49 -64.34 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.761 -0.376 . . . . 99.989999999999995 111.802 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.519 ' HD2' ' H ' ' A' ' 138' ' ' THR . 72.1 Cg_exo -22.52 -72.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 123.495 2.797 . . . . 99.989999999999995 113.485 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -102.45 -44.28 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.538 -0.465 . . . . 99.989999999999995 112.047 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 41.9 m -51.39 -46.26 62.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.428 0.529 . . . . 99.989999999999995 112.428 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.425 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . . . -76.73 -38.57 54.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.496 -0.482 . . . . 99.989999999999995 111.825 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.444 ' CD ' ' O ' ' A' ' 139' ' ' PRO . 97.7 mt-10 -60.21 -39.47 86.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.555 -0.458 . . . . 99.989999999999995 111.255 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.96 -49.62 75.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 99.989999999999995 109.96 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 91.1 mt -57.56 -31.93 66.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 99.989999999999995 111.475 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.69 75.73 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.503 -0.479 . . . . 99.989999999999995 109.942 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -59.75 -35.38 74.47 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.614 -0.721 . . . . 99.989999999999995 109.611 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -49.56 -31.17 9.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.94 -1.133 . . . . 99.989999999999995 107.94 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.6 mt -126.68 -114.64 0.28 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.816 -1.084 . . . . 99.989999999999995 108.633 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -175.9 71.85 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.132 -0.485 . . . . 99.989999999999995 111.87 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.415 ' CB ' ' CE1' ' A' ' 110' ' ' PHE . . . -61.01 -138.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.841 0.353 . . . . 99.989999999999995 110.628 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 110' ' ' PHE . 54.9 t -154.16 -50.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 110.829 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.56 ' NZ ' ' OE1' ' A' ' 171' ' ' GLU . 1.1 mmtm -114.41 -175.62 2.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 121.093 -0.243 . . . . 99.989999999999995 110.651 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.653 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -170.7 96.21 0.22 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.832 -1.173 . . . . 99.989999999999995 107.832 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.4 p -143.51 142.95 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.515 0.674 . . . . 99.989999999999995 111.245 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.736 ' O ' ' OG1' ' A' ' 161' ' ' THR . 3.6 pt-20 -119.92 96.19 5.07 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.487 -1.301 . . . . 99.989999999999995 107.487 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.584 ' SG ' ' O ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -120.25 131.11 54.8 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 114.403 1.26 . . . . 99.989999999999995 114.403 -176.165 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 160' ' ' LEU . 77.1 p -119.83 87.94 2.84 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 103.929 -2.619 . . . . 99.989999999999995 103.929 173.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 37.02 26.93 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.245 -1.02 . . . . 99.989999999999995 108.245 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.865 ' O ' ' N ' ' A' ' 162' ' ' GLN . 34.9 tp -133.64 -79.25 0.47 Allowed 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 114.811 -1.086 . . . . 99.989999999999995 111.467 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 4.6 m -45.59 49.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.323 0.86 . . . . 99.989999999999995 113.323 -176.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.865 ' N ' ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -71.49 0.81 7.52 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 104.623 -2.362 . . . . 99.989999999999995 104.623 175.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.659 ' H ' ' C ' ' A' ' 161' ' ' THR . 8.7 mtmp? -58.86 -23.54 60.99 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 113.546 -1.661 . . . . 99.989999999999995 106.849 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -119.28 -65.99 0.29 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 107.387 -2.285 . . . . 99.989999999999995 107.387 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.41 ' CB ' ' OG ' ' A' ' 22' ' ' SER . 0.5 OUTLIER -40.67 -10.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.689 0.626 . . . . 99.989999999999995 112.689 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.647 ' N ' ' O ' ' A' ' 164' ' ' GLY . 41.8 tttp -91.52 -42.05 10.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.706 -1.22 . . . . 99.989999999999995 107.706 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.584 ' N ' ' O ' ' A' ' 164' ' ' GLY . 78.3 m-20 -81.98 -0.03 42.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.651 -1.159 . . . . 99.989999999999995 109.135 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.7 t -77.98 -57.82 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 109.495 -0.557 . . . . 99.989999999999995 109.495 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.614 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 46.8 m-85 -48.79 -43.54 38.16 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 119.816 -0.754 . . . . 99.989999999999995 109.686 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.494 ' OD1' ' OE1' ' A' ' 49' ' ' GLU . 62.6 t0 -67.12 -49.48 64.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.205 0.526 . . . . 99.989999999999995 109.913 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.56 ' OE1' ' NZ ' ' A' ' 153' ' ' LYS . 87.5 tt0 -59.06 -25.54 63.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.403 -0.591 . . . . 99.989999999999995 109.403 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.02 -32.2 61.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.813 -0.631 . . . . 99.989999999999995 109.314 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.413 ' CG2' ' O ' ' A' ' 170' ' ' ASP . 3.6 tt -59.13 -30.08 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.28 -0.637 . . . . 99.989999999999995 109.28 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.7 tp -57.42 -38.54 74.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.602 -0.726 . . . . 99.989999999999995 110.1 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.79 62.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 99.989999999999995 111.131 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 1' ' ' MET . . . -63.59 -32.28 73.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.828 0.346 . . . . 99.989999999999995 110.562 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.02 -34.04 71.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 99.989999999999995 110.456 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.483 ' OE2' ' OD2' ' A' ' 76' ' ' ASP . 96.9 mt-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 99.989999999999995 110.561 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.6 mtm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.006 -0.738 . . . . 99.989999999999995 109.006 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' THR . 92.6 mt-30 -124.38 174.69 7.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.746 -0.661 . . . . 99.989999999999995 110.53 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.6 OUTLIER -38.48 133.56 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 99.989999999999995 110.16 -179.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.5 tp -131.06 152.21 37.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.761 -0.654 . . . . 99.989999999999995 110.336 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 54' ' ' GLY . 25.2 mttm -109.26 161.26 15.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.198 0.523 . . . . 99.989999999999995 111.504 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -122.85 144.96 48.86 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.491 -0.777 . . . . 99.989999999999995 109.457 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.5 145.28 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.345 0.498 . . . . 99.989999999999995 112.345 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.0 128.12 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.495 -0.775 . . . . 99.989999999999995 112.05 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' ' N ' ' A' ' 81' ' ' CYS . 44.8 t -141.77 128.45 19.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.097 -0.956 . . . . 99.989999999999995 108.788 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.53 -174.96 38.13 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.884 -1.151 . . . . 99.989999999999995 112.106 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.404 ' H ' ' CG2' ' A' ' 93' ' ' VAL . 60.5 t0 -90.96 124.24 35.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.973 0.416 . . . . 99.989999999999995 110.755 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . -47.39 101.82 0.04 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.89 -0.884 . . . . 99.989999999999995 110.89 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 150.16 30.67 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.707 0.299 . . . . 99.989999999999995 110.871 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.2 m -127.47 132.84 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.685 -0.406 . . . . 99.989999999999995 111.024 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.53 97.75 2.27 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.169 -0.539 . . . . 99.989999999999995 112.555 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.428 ' HD2' ' H ' ' A' ' 58' ' ' THR . 23.4 mttm -83.0 -2.51 55.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.674 0.273 . . . . 99.989999999999995 110.964 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.2 m -65.93 -57.78 7.07 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.562 -0.29 . . . . 99.989999999999995 111.742 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.3 m -68.73 -25.95 65.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.489 0.661 . . . . 99.989999999999995 110.14 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 7.4 tp -50.94 -56.15 13.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.124 -0.944 . . . . 99.989999999999995 111.641 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 22' ' ' SER . 55.2 mt -71.19 -35.09 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.425 -0.352 . . . . 99.989999999999995 111.83 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 tt -47.7 -11.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.443 -0.503 . . . . 99.989999999999995 110.268 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.721 ' HG ' ' H ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -55.75 -76.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 119.686 -0.806 . . . . 99.989999999999995 110.318 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.721 ' H ' ' HG ' ' A' ' 22' ' ' SER . 49.7 t80 -56.59 -39.21 73.15 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 119.202 -0.999 . . . . 99.989999999999995 110.916 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -66.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.548 0.573 . . . . 99.989999999999995 112.548 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 73.6 p -111.72 -23.57 10.55 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.351 0.501 . . . . 99.989999999999995 112.351 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 25' ' ' THR . 31.6 t30 83.35 95.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.909 0.385 . . . . 99.989999999999995 110.658 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 26' ' ' ASN . 11.2 pttm 33.32 73.26 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.279 0.561 . . . . 99.989999999999995 111.574 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.26 79.45 70.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.906 -0.588 . . . . 99.989999999999995 110.414 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.89 146.69 77.82 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.912 2.408 . . . . 99.989999999999995 112.742 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -128.33 143.18 50.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 99.989999999999995 110.139 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.86 -36.61 72.58 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.828 -0.349 . . . . 99.989999999999995 110.734 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 33' ' ' VAL . 77.4 t80 -124.82 138.23 54.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.211 -0.45 . . . . 99.989999999999995 110.597 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.408 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 9.6 t -73.0 123.32 89.46 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.261 -0.427 . . . . 99.989999999999995 110.519 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.39 158.12 36.81 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.227 1.951 . . . . 99.989999999999995 112.057 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -76.97 157.03 31.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 99.989999999999995 110.437 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.38 156.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 99.989999999999995 110.835 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.83 156.83 29.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 99.989999999999995 110.186 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -73.94 88.57 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.947 0.403 . . . . 99.989999999999995 110.357 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -144.77 108.73 4.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 110.347 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.65 ' CB ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -101.2 -24.71 14.21 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.858 -0.423 . . . . 99.989999999999995 109.858 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.27 95.53 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 120.12 -0.632 . . . . 99.989999999999995 109.352 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.4 t -134.81 137.59 50.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.037 -0.983 . . . . 99.989999999999995 111.232 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.8 t -120.41 133.98 55.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 99.989999999999995 110.726 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.408 ' CG1' ' CZ ' ' A' ' 51' ' ' TYR . 8.8 p -141.31 141.8 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 99.989999999999995 110.408 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.9 mtm -110.5 118.84 37.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.451 -0.34 . . . . 99.989999999999995 110.435 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.0 mt -129.14 119.57 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.334 -0.394 . . . . 99.989999999999995 110.554 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.94 25.85 73.22 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.046 -0.822 . . . . 99.989999999999995 111.046 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.22 48.54 14.6 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.742 -0.943 . . . . 99.989999999999995 110.742 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -131.87 105.27 14.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 110.38 -0.23 . . . . 99.989999999999995 110.38 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.59 100.09 1.2 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.132 1.888 . . . . 99.989999999999995 112.479 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.479 ' CD1' ' CD1' ' A' ' 173' ' ' ILE . 33.5 p90 -142.08 165.58 27.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.458 . . . . 99.989999999999995 110.317 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.29 127.49 35.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.067 0.461 . . . . 99.989999999999995 111.812 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.8 tp -107.36 138.08 44.22 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.833 -0.621 . . . . 99.989999999999995 109.842 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -81.6 147.6 26.9 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.365 -1.094 . . . . 99.989999999999995 110.365 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.65 ' H ' ' CB ' ' A' ' 40' ' ' TYR . 48.3 mt -99.51 98.52 9.41 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 119.623 -0.831 . . . . 99.989999999999995 111.243 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 57' ' ' ASP . 7.9 p90 -55.54 -27.36 48.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.747 -1.115 . . . . 99.989999999999995 111.51 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 58' ' ' THR . 63.6 t0 -17.09 139.88 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.947 0.779 . . . . 99.989999999999995 112.578 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.54 ' CB ' ' O ' ' A' ' 57' ' ' ASP . 1.1 m 155.33 149.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.832 -0.622 . . . . 99.989999999999995 110.304 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.12 151.96 20.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.309 -0.405 . . . . 99.989999999999995 110.543 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.55 -174.06 38.19 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.655 -0.978 . . . . 99.989999999999995 110.655 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 62' ' ' GLU . 34.6 tt0 69.46 -132.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.13 -0.322 . . . . 99.989999999999995 110.13 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 77.2 tt0 36.47 51.36 0.86 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.578 -0.897 . . . . 99.989999999999995 108.578 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 38.8 t0 100.95 93.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.269 -1.332 . . . . 99.989999999999995 107.723 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -58.19 -33.93 69.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.021 -0.536 . . . . 99.989999999999995 110.877 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.36 145.34 55.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 99.989999999999995 110.637 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -118.71 153.53 34.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 99.989999999999995 110.537 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.8 tp -94.91 136.62 35.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.005 -0.543 . . . . 99.989999999999995 110.846 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.07 83.31 19.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 110.222 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.36 148.37 19.53 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.786 2.324 . . . . 99.989999999999995 112.549 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.37 -31.54 70.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.912 -0.586 . . . . 99.989999999999995 110.611 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.7 p -61.53 165.41 4.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 99.989999999999995 110.884 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -51.16 159.63 1.02 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 99.989999999999995 110.614 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.41 152.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.847 2.364 . . . . 99.989999999999995 112.181 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.503 ' O ' ' O ' ' A' ' 75' ' ' THR . 97.4 mt-30 -73.74 142.79 46.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 99.989999999999995 111.031 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 74' ' ' GLN . 59.8 p 44.43 -178.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.888 -0.596 . . . . 99.989999999999995 111.208 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -123.3 -26.96 4.19 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.345 -0.389 . . . . 99.989999999999995 111.636 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.34 110.67 31.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 120.473 -0.491 . . . . 99.989999999999995 110.941 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -76.13 132.19 39.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.088 0.471 . . . . 99.989999999999995 111.52 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.488 ' CD2' ' CE1' ' A' ' 56' ' ' PHE . 4.1 mp -109.1 99.64 8.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.611 -0.722 . . . . 99.989999999999995 110.699 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 17.4 t -65.38 134.74 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.008 -0.542 . . . . 99.989999999999995 109.734 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' VAL . 19.0 t -123.85 130.32 52.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.427 . . . . 99.989999999999995 111.093 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.46 ' CG ' ' O ' ' A' ' 82' ' ' PHE . 39.0 p90 -167.87 129.17 1.44 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.738 -0.665 . . . . 99.989999999999995 110.347 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.452 ' HA ' ' H ' ' A' ' 115' ' ' THR . 90.1 p -56.69 134.24 54.58 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.724 -1.213 . . . . 99.989999999999995 107.724 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.526 ' CG1' ' OG1' ' A' ' 138' ' ' THR . 6.3 t -90.38 8.2 3.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 120.011 -0.676 . . . . 99.989999999999995 112.446 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.26 20.39 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.943 0.402 . . . . 99.989999999999995 110.163 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 t -139.61 137.7 19.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.57 . . . . 99.989999999999995 110.196 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.494 ' O ' ' CD1' ' A' ' 90' ' ' PHE . 61.0 Cg_endo -73.76 -27.04 12.94 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.197 1.932 . . . . 99.989999999999995 113.224 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.2 p -81.6 -29.38 33.32 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.138 0.422 . . . . 99.989999999999995 112.138 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -62.25 -37.42 85.36 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.872 -0.331 . . . . 99.989999999999995 111.612 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.528 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 2.0 p90 -91.25 -36.95 13.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.884 0.373 . . . . 99.989999999999995 111.328 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 85.6 tt0 -56.56 -38.43 71.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.028 -0.533 . . . . 99.989999999999995 112.182 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 96' ' ' LYS . 9.6 m120 -90.0 -47.39 7.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.883 -0.727 . . . . 99.989999999999995 111.211 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.458 ' CG1' ' CG1' ' A' ' 80' ' ' VAL . 42.9 t -57.31 -56.09 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.84 0.681 . . . . 99.989999999999995 112.84 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -71.32 -11.44 60.91 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.083 0.401 . . . . 99.989999999999995 112.083 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -125.73 -65.78 0.98 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.852 0.686 . . . . 99.989999999999995 112.852 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 92' ' ' ASN . 81.1 mttt -61.17 -33.31 73.22 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.411 0.893 . . . . 99.989999999999995 113.411 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -83.2 -31.47 27.06 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.973 -0.691 . . . . 99.989999999999995 110.777 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.483 ' O ' ' OG1' ' A' ' 102' ' ' THR . 2.2 t -40.77 -54.28 5.36 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.608 -0.437 . . . . 99.989999999999995 110.977 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 33.1 Cg_endo -66.11 -32.03 44.24 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.667 1.578 . . . . 99.989999999999995 111.51 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -61.62 -38.52 87.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.014 -0.539 . . . . 99.989999999999995 110.984 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.0 pt -94.42 -30.7 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 120.872 -0.331 . . . . 99.989999999999995 111.515 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' CYS . 55.4 m -60.28 -41.08 92.57 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.869 -0.332 . . . . 99.989999999999995 110.928 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -60.62 -39.13 87.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.349 -0.387 . . . . 99.989999999999995 110.556 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -57.26 -44.03 83.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 99.989999999999995 111.014 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -150.53 159.93 33.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 99.989999999999995 110.876 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.48 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 9.6 Cg_endo -55.32 155.86 18.89 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.877 2.385 . . . . 99.989999999999995 111.851 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -62.93 130.05 43.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.407 -0.36 . . . . 99.989999999999995 110.317 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.99 158.83 54.95 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 99.989999999999995 110.502 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.47 143.91 10.92 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.166 1.911 . . . . 99.989999999999995 112.064 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 152' ' ' VAL . 21.2 p90 -147.62 156.83 43.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.691 -0.804 . . . . 99.989999999999995 112.103 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 129.61 48.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.018 -0.992 . . . . 99.989999999999995 110.421 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 85.8 mt -84.26 132.12 34.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.285 -0.566 . . . . 99.989999999999995 109.498 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.3 t -144.69 151.47 15.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.28 -0.418 . . . . 99.989999999999995 111.048 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.494 ' O ' ' CD1' ' A' ' 19' ' ' LEU . . . -145.36 176.21 24.5 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.628 -0.796 . . . . 99.989999999999995 111.625 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.452 ' H ' ' HA ' ' A' ' 83' ' ' SER . 9.2 p -121.66 179.13 4.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.852 -0.425 . . . . 99.989999999999995 109.852 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.572 ' N ' ' CB ' ' A' ' 158' ' ' SER . 98.7 mm-40 36.44 37.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.018 -0.537 . . . . 99.989999999999995 111.049 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.595 ' CG2' ' H ' ' A' ' 119' ' ' LEU . 5.8 tt 29.42 -150.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.435 0 O-C-N 123.071 0.232 . . . . 99.989999999999995 110.512 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.582 ' N ' ' OD1' ' A' ' 118' ' ' ASP . 0.0 OUTLIER -108.76 11.09 26.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.433 -0.507 . . . . 99.989999999999995 110.991 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.595 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 5.7 mp -139.22 12.19 2.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.893 -0.594 . . . . 99.989999999999995 110.981 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 25.4 ptt180 28.65 65.22 0.11 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.204 0.315 . . . . 99.989999999999995 110.18 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 120' ' ' ARG . 13.8 m-20 149.51 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.762 0.664 . . . . 99.989999999999995 111.111 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 121' ' ' ASP . 0.1 OUTLIER 94.37 -67.24 0.0 OUTLIER Pre-proline 0 C--O 1.222 -0.393 0 O-C-N 125.589 1.805 . . . . 99.989999999999995 109.706 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.497 ' CD ' ' O ' ' A' ' 121' ' ' ASP . 31.7 Cg_exo -57.48 -28.41 80.56 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 CA-C-N 121.32 1.507 . . . . 99.989999999999995 110.47 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.603 ' C ' ' H ' ' A' ' 126' ' ' ILE . 36.0 p -78.82 -67.69 0.72 Allowed 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 120.347 -0.541 . . . . 99.989999999999995 109.912 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.556 ' N ' ' OG ' ' A' ' 124' ' ' SER . 32.5 p -50.3 -11.57 0.07 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.651 0.739 . . . . 99.989999999999995 109.353 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.603 ' H ' ' C ' ' A' ' 124' ' ' SER . 13.5 mt -86.76 -70.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.378 -1.283 . . . . 99.989999999999995 110.294 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -76.9 -41.01 45.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.052 0.453 . . . . 99.989999999999995 111.107 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' SER . 21.8 tttp -64.95 -15.83 62.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.89 -0.595 . . . . 99.989999999999995 110.834 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.8 tp -155.15 -82.41 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.387 -0.525 . . . . 99.989999999999995 111.327 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 125' ' ' THR . . . 168.91 -102.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.884 -0.598 . . . . 99.989999999999995 109.579 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.1 pttp 174.03 2.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.368 0.418 . . . . 99.989999999999995 111.967 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -80.13 -39.13 30.08 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.172 -0.611 . . . . 99.989999999999995 110.936 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -70.35 -44.19 68.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 99.989999999999995 111.679 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.473 ' O ' ' C ' ' A' ' 135' ' ' LYS . 99.6 mm-40 -55.94 -37.95 69.65 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.805 -0.358 . . . . 99.989999999999995 111.201 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER 32.99 87.95 0.1 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.518 -0.31 . . . . 99.989999999999995 110.74 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.4 139.98 28.06 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.363 2.042 . . . . 99.989999999999995 111.908 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.421 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 15.3 tt -98.83 38.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.897 0.38 . . . . 99.989999999999995 110.596 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.612 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -119.6 -41.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 112.916 0.71 . . . . 99.989999999999995 112.916 -178.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.612 ' CD ' ' H ' ' A' ' 138' ' ' THR . 73.2 Cg_exo -47.97 -64.04 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.215 1.944 . . . . 99.989999999999995 113.262 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -105.9 -44.69 4.55 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.393 0.516 . . . . 99.989999999999995 112.393 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.5 m -51.85 -43.3 63.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.952 -0.299 . . . . 99.989999999999995 111.762 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.77 -28.01 33.48 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.584 -0.446 . . . . 99.989999999999995 110.912 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.25 -44.13 95.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 99.989999999999995 111.03 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -63.86 -41.61 97.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 99.989999999999995 110.37 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 87.2 mt -61.31 -31.44 71.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.863 -0.608 . . . . 99.989999999999995 111.268 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.31 -40.49 70.78 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.244 -0.582 . . . . 99.989999999999995 109.46 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -56.48 -37.06 69.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.375 -0.829 . . . . 99.989999999999995 109.405 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.74 -25.35 10.87 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.054 -1.091 . . . . 99.989999999999995 108.054 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.3 mt -134.73 -115.12 0.2 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.456 -1.247 . . . . 99.989999999999995 107.844 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 151' ' ' ALA . 37.9 pttt 178.42 75.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.076 -0.511 . . . . 99.989999999999995 111.46 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.498 ' CB ' ' CE1' ' A' ' 110' ' ' PHE . . . -56.04 -145.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.975 0.417 . . . . 99.989999999999995 111.843 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 110' ' ' PHE . 75.1 t -136.69 -56.03 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.558 -0.746 . . . . 99.989999999999995 110.978 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 24.6 tttt -125.46 -167.68 1.72 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.635 -0.257 . . . . 99.989999999999995 110.793 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.455 ' CD1' ' C ' ' A' ' 153' ' ' LYS . 51.0 m-85 -156.67 96.71 1.66 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.691 -1.225 . . . . 99.989999999999995 107.691 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.32 139.52 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 122.148 0.975 . . . . 99.989999999999995 111.515 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.742 ' O ' ' OG1' ' A' ' 161' ' ' THR . 10.4 pt-20 -122.36 98.0 5.72 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.539 -1.664 . . . . 99.989999999999995 106.613 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.469 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -123.94 145.75 48.94 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 123.18 1.467 . . . . 99.989999999999995 113.112 -175.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.572 ' CB ' ' N ' ' A' ' 116' ' ' GLN . 10.0 t -173.22 93.89 0.1 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 112.013 -2.358 . . . . 99.989999999999995 107.831 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 50.21 38.74 18.08 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.642 -1.163 . . . . 99.989999999999995 110.332 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.72 ' O ' ' N ' ' A' ' 162' ' ' GLN . 22.1 tp -165.09 -82.17 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.866 -0.606 . . . . 99.989999999999995 111.031 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.742 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.8 OUTLIER -52.37 55.54 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.418 0.525 . . . . 99.989999999999995 112.418 -177.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.72 ' N ' ' O ' ' A' ' 160' ' ' LEU . 2.3 pp0? -80.42 15.8 1.52 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 105.692 -1.966 . . . . 99.989999999999995 105.692 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.645 ' H ' ' C ' ' A' ' 161' ' ' THR . 99.5 mttt -84.65 -3.44 58.51 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 113.751 -1.568 . . . . 99.989999999999995 108.426 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.45 -72.62 0.1 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.276 -1.93 . . . . 99.989999999999995 108.276 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -40.61 -16.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.333 -0.547 . . . . 99.989999999999995 111.366 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' A' ' 164' ' ' GLY . 81.2 tttt -84.57 -49.53 8.5 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.415 -0.957 . . . . 99.989999999999995 108.415 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 164' ' ' GLY . 81.3 m-20 -78.16 4.5 12.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.806 -1.088 . . . . 99.989999999999995 109.371 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.29 -58.73 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.885 -0.598 . . . . 99.989999999999995 110.2 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.477 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 94.4 m-85 -44.41 -44.7 8.57 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.032 -0.667 . . . . 99.989999999999995 109.521 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.404 ' N ' ' HH ' ' A' ' 51' ' ' TYR . 60.0 t0 -69.38 -44.41 71.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.401 -0.363 . . . . 99.989999999999995 110.398 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.99 -25.17 68.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.22 -0.446 . . . . 99.989999999999995 110.15 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.46 -35.58 68.07 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.261 -0.644 . . . . 99.989999999999995 109.261 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.479 ' CD1' ' CD1' ' A' ' 51' ' ' TYR . 91.6 mt -55.19 -43.09 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.616 -0.883 . . . . 99.989999999999995 108.616 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 8.0 mp -70.28 -36.18 74.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.296 -0.865 . . . . 99.989999999999995 110.002 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.63 -32.97 74.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.891 -0.595 . . . . 99.989999999999995 110.393 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.59 72.76 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.784 -0.45 . . . . 99.989999999999995 109.784 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.2 tp -59.32 -35.25 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.928 -0.578 . . . . 99.989999999999995 109.684 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 99.989999999999995 110.53 179.912 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.421 -0.585 . . . . 99.989999999999995 109.421 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -82.61 -48.09 11.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.288 0.566 . . . . 99.989999999999995 110.062 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.402 ' HB ' ' HG1' ' A' ' 52' ' ' THR . 0.6 OUTLIER -107.83 150.27 27.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.551 -0.75 . . . . 99.989999999999995 110.6 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp -127.36 147.25 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 99.989999999999995 110.526 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -86.0 135.38 33.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.872 0.368 . . . . 99.989999999999995 110.539 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -135.94 130.9 34.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.0 -0.545 . . . . 99.989999999999995 110.283 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.9 134.75 44.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.221 -0.659 . . . . 99.989999999999995 109.221 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' CG1' ' OD1' ' A' ' 57' ' ' ASP . 75.1 t -114.09 125.83 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 120.194 -0.602 . . . . 99.989999999999995 111.302 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 p -136.94 146.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.339 -0.846 . . . . 99.989999999999995 109.486 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . -117.66 -157.44 10.68 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.663 -0.78 . . . . 99.989999999999995 111.558 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 11' ' ' ASP . 51.3 p30 -74.09 24.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.067 0.46 . . . . 99.989999999999995 110.029 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 125.34 -77.32 0.38 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.557 -1.017 . . . . 99.989999999999995 110.557 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.86 94.9 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 99.989999999999995 110.472 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.04 169.56 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 99.989999999999995 110.389 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.589 ' C ' ' HG1' ' A' ' 115' ' ' THR . . . -69.05 56.46 0.57 Allowed Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.958 -0.457 . . . . 99.989999999999995 111.958 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -81.03 0.81 34.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.883 0.373 . . . . 99.989999999999995 110.255 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.8 p -69.16 -38.83 78.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.038 -0.528 . . . . 99.989999999999995 111.469 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 98.3 m -90.85 -14.54 31.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.136 0.494 . . . . 99.989999999999995 110.603 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.419 ' CD2' ' SG ' ' A' ' 81' ' ' CYS . 22.1 tp -59.8 -45.36 92.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.593 -0.731 . . . . 99.989999999999995 111.375 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pp -74.07 -33.77 63.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 99.989999999999995 111.333 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.75 -5.72 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.194 -0.457 . . . . 99.989999999999995 110.346 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.492 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 43.7 t -44.82 -80.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.428 -0.509 . . . . 99.989999999999995 111.315 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -55.78 -38.33 69.77 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 120.361 -0.536 . . . . 99.989999999999995 110.535 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.592 ' O ' ' CB ' ' A' ' 25' ' ' THR . 3.7 m -44.54 -34.12 2.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.453 -0.794 . . . . 99.989999999999995 110.208 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' THR . 13.3 m 107.78 92.14 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.32 1.012 . . . . 99.989999999999995 109.839 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.513 ' ND2' ' CB ' ' A' ' 159' ' ' ALA . 27.8 t30 -110.22 -75.93 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 99.989999999999995 110.308 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt 57.95 43.42 21.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.999 -0.546 . . . . 99.989999999999995 111.246 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp 41.33 68.8 2.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.873 0.368 . . . . 99.989999999999995 110.248 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.48 157.15 22.11 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 123.014 2.476 . . . . 99.989999999999995 112.596 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.575 ' C ' ' H ' ' A' ' 32' ' ' TYR . 20.2 m -56.91 -27.95 61.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 99.989999999999995 110.315 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -57.82 -2.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 99.989999999999995 110.265 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.575 ' H ' ' C ' ' A' ' 30' ' ' SER . 41.4 m-85 70.43 -116.01 0.1 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.765 -0.652 . . . . 99.989999999999995 111.145 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.28 79.45 66.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.859 -0.336 . . . . 99.989999999999995 111.482 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.53 154.08 44.41 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.663 2.242 . . . . 99.989999999999995 111.323 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -130.01 147.35 51.75 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.525 -0.47 . . . . 99.989999999999995 110.967 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.6 t -131.01 140.18 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.668 -0.696 . . . . 99.989999999999995 109.948 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -95.62 134.87 38.02 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.745 -0.382 . . . . 99.989999999999995 110.798 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 59.32 45.21 14.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.922 -0.581 . . . . 99.989999999999995 111.213 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LEU . 51.6 t-20 -97.79 124.03 41.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.346 . . . . 99.989999999999995 110.532 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.631 ' CG ' ' N ' ' A' ' 41' ' ' ALA . 17.4 p90 -165.28 -48.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.96 -0.564 . . . . 99.989999999999995 109.488 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.631 ' N ' ' CG ' ' A' ' 40' ' ' TYR . . . -77.99 104.36 8.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.769 -0.65 . . . . 99.989999999999995 110.635 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.75 126.2 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.281 -0.872 . . . . 99.989999999999995 109.324 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.6 t -82.6 127.38 33.3 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.259 0.552 . . . . 99.989999999999995 111.583 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.05 142.42 35.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.31 -0.859 . . . . 99.989999999999995 110.553 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.5 ptp -143.71 140.59 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 99.989999999999995 110.049 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.611 ' O ' ' N ' ' A' ' 48' ' ' GLY . 42.7 mm -119.81 102.85 13.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.754 -0.378 . . . . 99.989999999999995 110.238 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 20.98 43.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.719 0 O-C-N 123.784 0.678 . . . . 99.989999999999995 111.844 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -151.12 -76.64 0.02 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.383 -0.687 . . . . 99.989999999999995 111.383 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' OE1' ' OH ' ' A' ' 51' ' ' TYR . 6.5 mt-10 -153.8 161.83 28.23 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 121.0 -0.28 . . . . 99.989999999999995 110.367 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -84.45 139.26 7.84 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 C-N-CA 122.806 2.337 . . . . 99.989999999999995 113.197 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' OH ' ' OE1' ' A' ' 49' ' ' GLU . 42.4 m-85 -152.36 159.85 43.38 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.034 -1.099 . . . . 99.989999999999995 108.034 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.402 ' HG1' ' HB ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -135.45 140.39 44.83 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 119.566 -0.854 . . . . 99.989999999999995 111.746 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.465 ' O ' ' O ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -109.86 139.18 45.22 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.565 -0.532 . . . . 99.989999999999995 109.565 178.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.557 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -92.75 120.13 6.07 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.896 -0.669 . . . . 99.989999999999995 111.937 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.485 ' H ' ' CA ' ' A' ' 40' ' ' TYR . 57.9 mt -114.87 124.92 52.95 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.926 -0.398 . . . . 99.989999999999995 109.926 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 57' ' ' ASP . 25.3 t80 -115.48 34.44 4.91 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.744 0.646 . . . . 99.989999999999995 112.744 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.545 ' OD1' ' CG1' ' A' ' 8' ' ' VAL . 72.2 m-20 -45.75 -177.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.147 0.499 . . . . 99.989999999999995 111.496 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.502 ' OG1' ' O ' ' A' ' 57' ' ' ASP . 1.7 p 76.59 147.98 0.1 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.524 -0.762 . . . . 99.989999999999995 110.936 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.05 -173.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.9 -0.591 . . . . 99.989999999999995 111.118 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 148.36 -3.35 0.75 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.845 -0.902 . . . . 99.989999999999995 110.845 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.475 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 47.8 tt0 -179.33 76.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.244 -0.28 . . . . 99.989999999999995 110.244 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.581 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 149.93 -121.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.92 -0.77 . . . . 99.989999999999995 108.92 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 52.6 p30 -70.18 57.51 0.16 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.55 -0.537 . . . . 99.989999999999995 109.55 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 88.2 m-85 -35.98 -45.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.575 -0.739 . . . . 99.989999999999995 110.283 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 67' ' ' LEU . 52.9 p30 -171.22 166.8 7.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.059 -0.519 . . . . 99.989999999999995 110.507 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -58.7 -31.91 68.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.313 -0.403 . . . . 99.989999999999995 110.807 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.508 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 69.9 mt -79.43 148.08 32.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.343 -0.39 . . . . 99.989999999999995 110.628 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 157.07 82.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 99.989999999999995 110.667 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.18 -11.74 20.23 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.85 2.366 . . . . 99.989999999999995 112.115 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 41.6 tp -53.47 -35.91 61.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 99.989999999999995 110.939 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.6 p -62.11 155.69 23.56 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.749 -0.38 . . . . 99.989999999999995 110.181 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -131.97 78.07 70.41 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.037 0.446 . . . . 99.989999999999995 111.021 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.31 142.64 78.81 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.561 2.174 . . . . 99.989999999999995 111.471 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -108.72 133.93 52.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.79 -0.364 . . . . 99.989999999999995 110.747 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.2 t -135.98 153.42 51.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 99.989999999999995 110.977 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -117.72 -19.28 9.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 99.989999999999995 110.47 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.0 t -127.2 114.56 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.266 -0.425 . . . . 99.989999999999995 110.556 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.15 126.0 34.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.293 0.568 . . . . 99.989999999999995 112.182 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.41 ' CD2' ' C ' ' A' ' 79' ' ' LEU . 6.8 tt -124.59 126.41 45.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.156 -0.929 . . . . 99.989999999999995 109.799 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.67 136.45 54.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.564 -0.289 . . . . 99.989999999999995 110.234 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.496 ' SG ' ' C ' ' A' ' 114' ' ' GLY . 17.7 t -130.62 129.64 42.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.364 0.602 . . . . 99.989999999999995 111.906 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.527 ' H ' ' HA2' ' A' ' 114' ' ' GLY . 42.3 p90 -139.15 154.14 48.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.448 -0.796 . . . . 99.989999999999995 110.028 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 32.0 t -67.98 134.0 49.99 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.56 -0.456 . . . . 99.989999999999995 110.204 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 48.5 t -96.26 26.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.991 -0.683 . . . . 99.989999999999995 111.719 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.469 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 62.9 t -122.58 12.87 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 99.989999999999995 110.953 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.2 m -137.34 145.32 49.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.529 . . . . 99.989999999999995 110.009 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.436 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 60.4 Cg_endo -73.75 -20.79 19.64 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.26 1.973 . . . . 99.989999999999995 112.76 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.8 m -91.52 -25.22 19.36 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.916 -0.313 . . . . 99.989999999999995 111.771 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.3 m -64.03 -40.97 97.52 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.876 -0.329 . . . . 99.989999999999995 111.712 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 87' ' ' PRO . 2.7 p90 -85.13 -29.36 24.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.097 0.475 . . . . 99.989999999999995 110.808 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.94 -28.14 64.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.697 -0.683 . . . . 99.989999999999995 111.587 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 93' ' ' VAL . 11.0 m120 -87.53 -70.17 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.579 0.585 . . . . 99.989999999999995 112.579 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -31.95 -64.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.507 0.558 . . . . 99.989999999999995 112.507 -178.351 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HZ1' ' HA ' ' A' ' 142' ' ' ALA . 16.0 mttp -64.49 -33.27 75.5 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.543 0.942 . . . . 99.989999999999995 113.543 -177.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 88.7 mt-10 -107.73 -63.59 1.29 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.049 1.129 . . . . 99.989999999999995 114.049 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -62.02 -38.93 90.53 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.117 1.155 . . . . 99.989999999999995 114.117 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.573 ' CZ2' ' O ' ' A' ' 10' ' ' GLY . 74.1 m95 -77.0 -30.58 55.98 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.988 -0.685 . . . . 99.989999999999995 111.376 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.4 t -45.72 -55.33 12.82 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.874 0.324 . . . . 99.989999999999995 111.874 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 19.4 Cg_endo -60.03 -36.94 87.82 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.733 1.622 . . . . 99.989999999999995 111.717 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.486 ' OE1' ' CE3' ' A' ' 97' ' ' TRP . 85.2 tt0 -59.59 -44.29 93.41 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.217 -0.593 . . . . 99.989999999999995 109.724 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.4 mt -76.38 -31.37 20.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.981 -0.554 . . . . 99.989999999999995 110.204 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 105' ' ' CYS . 37.1 m -52.85 -37.63 60.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.717 -0.674 . . . . 99.989999999999995 110.999 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -49.58 -40.07 37.29 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.708 -0.397 . . . . 99.989999999999995 110.21 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.563 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 80.5 m80 -78.6 -20.54 50.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 99.989999999999995 110.052 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 6.8 p 39.13 58.6 6.01 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.929 -0.578 . . . . 99.989999999999995 110.791 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.79 133.36 12.6 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.794 2.329 . . . . 99.989999999999995 112.145 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -89.5 -1.13 57.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.957 0.408 . . . . 99.989999999999995 110.167 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.82 155.79 84.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.918 -0.583 . . . . 99.989999999999995 110.744 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.96 150.04 58.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.761 2.307 . . . . 99.989999999999995 111.98 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.729 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -129.65 131.15 46.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.894 -0.41 . . . . 99.989999999999995 109.894 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 7.3 mp -93.96 130.54 40.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.117 0.484 . . . . 99.989999999999995 111.877 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 50.4 tp -102.11 130.4 48.7 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.738 -0.838 . . . . 99.989999999999995 108.738 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.46 179.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.073 -0.651 . . . . 99.989999999999995 111.529 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.527 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -149.04 178.9 26.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.82 -0.912 . . . . 99.989999999999995 110.82 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.589 ' HG1' ' C ' ' A' ' 15' ' ' GLY . 13.0 t -128.27 163.74 24.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.811 0.339 . . . . 99.989999999999995 110.298 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.683 ' H ' ' HG ' ' A' ' 158' ' ' SER . 96.9 mt-30 56.49 18.19 3.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.016 -0.538 . . . . 99.989999999999995 110.272 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.674 ' CG1' ' H ' ' A' ' 120' ' ' ARG . 15.7 pt 33.94 -150.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.565 -0.289 . . . . 99.989999999999995 110.363 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 118' ' ' ASP . 50.9 p30 -118.32 17.28 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.718 -0.393 . . . . 99.989999999999995 110.403 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.437 ' O ' ' CG ' ' A' ' 122' ' ' ASP . 0.1 OUTLIER -144.72 -36.14 0.32 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.115 -0.493 . . . . 99.989999999999995 112.245 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.674 ' H ' ' CG1' ' A' ' 117' ' ' ILE . 65.3 ttp85 -56.19 -48.96 75.34 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 119.53 -0.868 . . . . 99.989999999999995 109.812 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.573 ' O ' ' N ' ' A' ' 123' ' ' PRO . 10.9 t0 -43.64 -17.77 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.726 -0.842 . . . . 99.989999999999995 108.726 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 120' ' ' ARG . 5.3 m-20 13.38 -76.82 0.0 OUTLIER Pre-proline 0 C--O 1.222 -0.345 0 O-C-N 124.257 0.973 . . . . 99.989999999999995 112.395 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.573 ' N ' ' O ' ' A' ' 121' ' ' ASP . 78.4 Cg_exo -33.83 -30.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 CA-C-N 120.224 1.116 . . . . 99.989999999999995 111.589 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 122' ' ' ASP . 14.7 m -100.5 -33.38 10.36 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.885 0.698 . . . . 99.989999999999995 112.885 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.8 t -100.58 -23.3 14.71 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 119.947 -0.701 . . . . 99.989999999999995 111.218 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 tt -82.49 -36.8 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.572 -0.451 . . . . 99.989999999999995 109.856 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -76.26 -35.85 58.75 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 120.727 0.299 . . . . 99.989999999999995 111.09 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.02 -65.79 0.94 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.527 -0.306 . . . . 99.989999999999995 111.406 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.562 ' CD2' ' NE2' ' A' ' 134' ' ' GLN . 39.4 mt -78.0 46.03 0.56 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.966 -0.294 . . . . 99.989999999999995 110.886 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.37 51.46 1.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.994 0.426 . . . . 99.989999999999995 110.066 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.6 mttp 63.87 72.39 0.47 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.389 0.614 . . . . 99.989999999999995 110.004 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -118.38 46.06 1.89 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.999 -1.001 . . . . 99.989999999999995 108.961 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 77.7 mttt 63.44 37.26 10.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.418 -0.81 . . . . 99.989999999999995 110.0 -178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.562 ' NE2' ' CD2' ' A' ' 129' ' ' LEU . 21.3 pt20 -158.82 162.78 37.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.122 -0.49 . . . . 99.989999999999995 110.232 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.71 155.35 80.51 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.733 -0.387 . . . . 99.989999999999995 111.002 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -49.91 173.88 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.426 2.084 . . . . 99.989999999999995 112.084 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 82.6 mt -91.43 78.4 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.568 -0.53 . . . . 99.989999999999995 109.568 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.557 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -129.98 -48.19 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.29 0.478 . . . . 99.989999999999995 112.29 -178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.557 ' CD ' ' H ' ' A' ' 138' ' ' THR . 59.7 Cg_endo -87.66 -67.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.416 2.078 . . . . 99.989999999999995 114.598 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 139' ' ' PRO . 77.7 mm-40 -31.55 -72.88 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.993 0.738 . . . . 99.989999999999995 112.993 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.2 p -116.79 4.38 12.99 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.877 1.066 . . . . 99.989999999999995 113.877 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.402 ' HA ' ' HZ1' ' A' ' 94' ' ' LYS . . . -94.2 -65.2 1.0 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.486 -0.886 . . . . 99.989999999999995 110.512 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' THR . 84.2 tt0 -69.79 -41.49 75.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.442 -0.345 . . . . 99.989999999999995 111.219 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -66.68 -38.16 86.23 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.832 0.349 . . . . 99.989999999999995 111.462 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 23.3 tp -74.73 -19.97 60.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.241 -0.436 . . . . 99.989999999999995 111.582 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.14 -36.71 77.74 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.178 0.513 . . . . 99.989999999999995 110.833 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -58.83 -41.16 86.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.542 -0.754 . . . . 99.989999999999995 110.236 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -89.96 -27.06 20.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 99.989999999999995 110.663 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 54.3 tp -44.52 -25.98 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 119.143 -0.456 . . . . 99.989999999999995 112.113 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.604 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 55.5 mttp 91.54 -0.93 0.17 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.898 0.479 . . . . 99.989999999999995 110.407 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -59.04 -136.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.327 0.584 . . . . 99.989999999999995 111.789 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -159.92 -36.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.364 -0.835 . . . . 99.989999999999995 110.278 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -110.31 -179.07 3.67 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.292 -0.633 . . . . 99.989999999999995 109.292 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.623 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 34.7 p90 -169.82 97.43 0.3 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 119.798 -0.761 . . . . 99.989999999999995 109.798 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.467 ' O ' ' CD ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -161.15 171.94 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 115.243 -0.89 . . . . 99.989999999999995 109.98 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.734 ' O ' ' OG1' ' A' ' 161' ' ' THR . 20.1 mm-40 -138.81 96.51 3.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.404 -1.332 . . . . 99.989999999999995 107.404 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.466 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -107.02 147.75 29.55 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 123.17 1.462 . . . . 99.989999999999995 112.51 -177.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.683 ' HG ' ' H ' ' A' ' 116' ' ' GLN . 0.3 OUTLIER -169.85 91.72 0.21 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 111.555 -2.566 . . . . 99.989999999999995 106.236 177.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.513 ' CB ' ' ND2' ' A' ' 26' ' ' ASN . . . 43.35 21.59 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.221 -1.809 . . . . 99.989999999999995 109.503 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.78 ' O ' ' N ' ' A' ' 162' ' ' GLN . 0.5 OUTLIER -133.73 -84.05 0.45 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.189 -0.914 . . . . 99.989999999999995 109.585 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.734 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 1.2 m -53.66 46.86 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.725 0.641 . . . . 99.989999999999995 111.814 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.78 ' N ' ' O ' ' A' ' 160' ' ' LEU . 7.2 tt0 -80.44 9.39 5.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 104.656 -2.35 . . . . 99.989999999999995 104.656 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.655 ' H ' ' C ' ' A' ' 161' ' ' THR . 16.1 tttp -84.6 -5.41 59.3 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 112.781 -2.009 . . . . 99.989999999999995 108.435 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.671 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -129.9 -72.0 0.12 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 107.811 -2.115 . . . . 99.989999999999995 107.811 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 4.3 mm? -38.75 -15.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.776 -0.37 . . . . 99.989999999999995 111.245 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.9 tttt -84.14 -47.68 10.63 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.856 -0.794 . . . . 99.989999999999995 108.856 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 164' ' ' GLY . 18.6 p-10 -79.41 4.99 13.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.307 -0.86 . . . . 99.989999999999995 109.028 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 171' ' ' GLU . 24.4 t -84.1 -52.65 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.426 -0.807 . . . . 99.989999999999995 109.892 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -37.65 -48.17 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.21 -0.904 . . . . 99.989999999999995 110.501 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.418 ' O ' ' CG1' ' A' ' 173' ' ' ILE . 53.3 t0 -62.84 -37.52 87.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.283 -0.417 . . . . 99.989999999999995 110.85 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 168' ' ' VAL . 77.5 mm-40 -77.3 -30.07 54.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 99.989999999999995 111.196 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.42 -40.01 89.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 99.989999999999995 110.955 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.418 ' CG1' ' O ' ' A' ' 170' ' ' ASP . 21.1 pt -67.41 -29.73 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.157 -0.474 . . . . 99.989999999999995 110.67 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.69 -36.73 77.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 99.989999999999995 110.04 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.96 -21.28 66.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 99.989999999999995 110.555 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.54 74.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 99.989999999999995 110.609 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 41.8 tp -56.97 -36.05 69.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 99.989999999999995 110.405 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 99.989999999999995 110.559 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.39 -0.596 . . . . 99.989999999999995 109.39 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 42.28 -119.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 99.989999999999995 110.669 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.48 ' OG1' ' OG1' ' A' ' 52' ' ' THR . 0.7 OUTLIER -41.2 115.66 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 99.989999999999995 110.233 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.3 tt -122.97 146.46 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 99.989999999999995 110.957 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 30.6 mttm -104.47 163.29 12.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.039 -0.528 . . . . 99.989999999999995 110.853 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.4 136.98 26.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.564 . . . . 99.989999999999995 110.518 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.48 131.22 35.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.518 -0.549 . . . . 99.989999999999995 109.518 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.516 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 57.3 t -117.8 125.88 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 120.076 -0.65 . . . . 99.989999999999995 110.793 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 m -135.64 159.77 39.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 99.989999999999995 109.797 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.69 -177.09 36.24 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.56 -0.829 . . . . 99.989999999999995 111.273 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 12' ' ' GLY . 25.2 t70 -81.05 124.94 29.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.684 0.278 . . . . 99.989999999999995 110.463 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 36.03 39.56 0.31 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.847 -0.901 . . . . 99.989999999999995 110.847 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 55.2 124.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.052 0.453 . . . . 99.989999999999995 110.88 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' A' ' 16' ' ' LYS . 1.4 m -120.91 -168.33 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 99.989999999999995 109.889 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.58 49.64 0.01 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 121.428 -0.415 . . . . 99.989999999999995 112.408 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.617 ' N ' ' O ' ' A' ' 14' ' ' VAL . 23.2 pttt -57.4 -39.69 76.67 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.11 0.411 . . . . 99.989999999999995 112.11 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.455 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 54.1 p -65.49 -43.87 88.85 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.213 0.449 . . . . 99.989999999999995 112.213 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.1 m -53.9 -24.63 16.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.1 0.476 . . . . 99.989999999999995 111.026 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.57 -39.04 70.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.681 -0.69 . . . . 99.989999999999995 111.222 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.42 ' O ' ' OG1' ' A' ' 24' ' ' THR . 36.6 tp -63.29 -38.74 92.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.136 -0.484 . . . . 99.989999999999995 112.046 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.3 pt -87.5 5.23 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.211 0.448 . . . . 99.989999999999995 112.211 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.7 t -59.06 -75.5 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.108 -0.637 . . . . 99.989999999999995 110.695 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -67.18 -39.52 86.41 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 119.534 -0.866 . . . . 99.989999999999995 110.957 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -49.27 -45.7 45.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 99.989999999999995 110.992 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 t 179.42 75.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 110.624 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.591 ' ND2' ' OE1' ' A' ' 162' ' ' GLN . 2.3 p30 -60.15 113.52 2.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 99.989999999999995 110.224 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 28' ' ' LEU . 85.5 mttt -150.86 50.03 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.384 . . . . 99.989999999999995 111.295 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.501 ' O ' ' O ' ' A' ' 27' ' ' LYS . 3.9 mp 57.68 129.36 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.581 -0.281 . . . . 99.989999999999995 110.658 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.42 156.94 36.92 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.15 1.9 . . . . 99.989999999999995 111.905 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.9 m -117.07 146.96 42.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.289 -0.414 . . . . 99.989999999999995 110.328 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -56.51 -34.94 67.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 99.989999999999995 110.165 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -64.66 -33.51 76.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.942 -0.572 . . . . 99.989999999999995 110.544 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.7 t 48.18 69.54 2.63 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 99.989999999999995 110.431 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.494 ' O ' ' O ' ' A' ' 35' ' ' THR . 51.3 Cg_exo -50.56 -14.69 1.23 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.927 2.418 . . . . 99.989999999999995 112.16 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 50.03 171.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 99.989999999999995 110.702 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.5 t -121.0 142.43 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 99.989999999999995 110.29 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -49.07 -30.11 5.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 99.989999999999995 109.802 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -58.73 160.11 6.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.742 -0.663 . . . . 99.989999999999995 110.438 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.594 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 81.6 m-20 -133.21 -8.06 2.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.077 -0.51 . . . . 99.989999999999995 109.954 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER 163.85 28.45 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.78 -0.645 . . . . 99.989999999999995 109.929 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.77 108.06 5.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 99.989999999999995 110.935 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.8 t -130.0 130.18 66.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.813 -0.631 . . . . 99.989999999999995 109.793 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.31 106.22 14.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.958 0.409 . . . . 99.989999999999995 111.425 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.46 154.81 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.919 -0.582 . . . . 99.989999999999995 110.074 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.22 133.93 55.37 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.882 -0.327 . . . . 99.989999999999995 110.478 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.5 tt -129.65 126.89 63.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 99.989999999999995 110.523 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.18 25.93 60.66 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.854 -0.898 . . . . 99.989999999999995 110.854 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.32 50.05 7.79 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.711 -0.955 . . . . 99.989999999999995 110.711 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -130.43 79.03 73.17 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.741 0.305 . . . . 99.989999999999995 110.361 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.58 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 26.9 Cg_exo -58.77 108.87 0.44 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.883 2.389 . . . . 99.989999999999995 112.437 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 50' ' ' PRO . 64.3 m-85 -160.33 174.53 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.998 -0.546 . . . . 99.989999999999995 110.27 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.48 ' OG1' ' OG1' ' A' ' 3' ' ' THR . 3.7 p -133.55 142.01 47.98 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.537 -0.465 . . . . 99.989999999999995 111.676 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.5 tp -116.22 126.73 54.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.709 -0.678 . . . . 99.989999999999995 109.717 178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.09 134.43 11.68 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.643 -0.789 . . . . 99.989999999999995 111.277 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.455 ' HG ' ' H ' ' A' ' 57' ' ' ASP . 11.6 tp -113.79 119.89 38.9 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.777 -0.453 . . . . 99.989999999999995 109.777 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.708 ' O ' ' O ' ' A' ' 57' ' ' ASP . 63.2 t80 -91.26 8.83 33.97 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.26 0.467 . . . . 99.989999999999995 112.26 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.708 ' O ' ' O ' ' A' ' 56' ' ' PHE . 36.2 p30 30.47 177.26 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.058 1.132 . . . . 99.989999999999995 114.058 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.422 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 82.4 p -88.57 156.61 18.97 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.612 -0.68 . . . . 99.989999999999995 110.77 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 61' ' ' GLN . . . -132.61 20.12 4.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 110.941 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.33 -1.67 2.49 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.603 -0.999 . . . . 99.989999999999995 110.603 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 59' ' ' ALA . 95.6 mt-30 -141.72 -172.18 3.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.442 . . . . 99.989999999999995 111.103 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 77.2 mm-40 43.5 55.16 5.03 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.001 -0.741 . . . . 99.989999999999995 109.001 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 18.9 t0 84.84 103.09 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.114 -1.439 . . . . 99.989999999999995 107.114 -177.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -56.5 164.05 1.55 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.354 -0.538 . . . . 99.989999999999995 110.303 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -82.25 115.78 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.499 -0.319 . . . . 99.989999999999995 110.893 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -108.29 -1.68 19.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 99.989999999999995 110.586 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.404 ' C ' ' CG ' ' A' ' 68' ' ' ARG . 51.9 mt -103.25 137.43 41.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.375 . . . . 99.989999999999995 110.638 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.667 ' H ' ' CD ' ' A' ' 69' ' ' PRO . 3.2 mtt180 -152.61 -43.2 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.315 -0.402 . . . . 99.989999999999995 111.737 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.667 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 17.0 Cg_exo -65.2 -19.86 62.66 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.37 2.047 . . . . 99.989999999999995 112.517 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.18 120.3 35.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.843 0.354 . . . . 99.989999999999995 110.256 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 79.5 p -150.86 163.58 38.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 99.989999999999995 110.525 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -127.53 159.78 63.99 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 99.989999999999995 110.269 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' O ' ' CG ' ' A' ' 76' ' ' ASP . 11.6 Cg_endo -57.69 -26.57 73.56 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.766 2.311 . . . . 99.989999999999995 112.088 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 5' ' ' LYS . 96.8 mt-30 -61.42 -29.18 69.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 99.989999999999995 110.475 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.2 p -98.12 66.93 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 99.989999999999995 110.461 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 73' ' ' PRO . 88.8 m-20 -101.97 0.87 35.94 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.271 0.471 . . . . 99.989999999999995 112.271 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.28 110.66 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.274 -0.571 . . . . 99.989999999999995 111.408 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -70.81 134.81 47.67 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.046 -0.524 . . . . 99.989999999999995 111.228 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.3 tt -119.0 126.96 52.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 99.989999999999995 109.699 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.7 t -97.01 132.77 40.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 110.086 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 42.5 t -128.59 118.82 23.63 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.323 0.583 . . . . 99.989999999999995 111.675 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.479 ' CZ ' ' CE ' ' A' ' 94' ' ' LYS . 28.3 p90 -149.43 157.53 43.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.365 -0.834 . . . . 99.989999999999995 109.181 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.0 t -70.72 132.32 45.19 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.814 -0.754 . . . . 99.989999999999995 109.294 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 50.4 t -56.17 -9.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.761 -0.376 . . . . 99.989999999999995 111.306 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 86' ' ' SER . 27.1 m -127.18 169.47 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 99.989999999999995 110.508 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.646 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.5 OUTLIER -25.38 -68.16 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.643 -0.708 . . . . 99.989999999999995 112.826 -178.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.563 ' O ' ' CB ' ' A' ' 88' ' ' SER . 99.1 Cg_exo -28.09 74.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.841 3.027 . . . . 99.989999999999995 114.465 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 86' ' ' SER . 2.9 t 146.26 -11.46 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.624 0.577 . . . . 99.989999999999995 109.983 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 91' ' ' GLU . 0.7 OUTLIER 40.24 89.54 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.064 -0.717 . . . . 99.989999999999995 109.064 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' SER . 43.7 p90 -36.01 -26.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 99.989999999999995 109.824 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 89' ' ' SER . 97.2 mt-10 -62.05 -23.81 66.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.405 -0.816 . . . . 99.989999999999995 110.664 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.559 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 83.1 m-20 -80.23 -48.45 13.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.146 -0.622 . . . . 99.989999999999995 110.564 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 56.0 t -77.63 -68.68 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 113.425 0.898 . . . . 99.989999999999995 113.425 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.479 ' CE ' ' CZ ' ' A' ' 82' ' ' PHE . 87.9 mttt -61.56 -15.1 35.61 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.776 1.028 . . . . 99.989999999999995 113.776 -177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 78.1 mm-40 -129.06 -48.37 1.22 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.145 1.165 . . . . 99.989999999999995 114.145 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -77.78 -35.69 51.31 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.928 0.714 . . . . 99.989999999999995 112.928 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 69.1 m95 -99.13 -21.04 16.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.854 -0.738 . . . . 99.989999999999995 112.339 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -59.84 -41.79 87.45 Favored Pre-proline 0 C--N 1.333 -0.135 0 C-N-CA 120.119 -0.633 . . . . 99.989999999999995 109.955 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 4.1 Cg_exo -70.62 -38.42 5.93 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.703 2.269 . . . . 99.989999999999995 111.15 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.579 ' OE2' ' NH1' ' A' ' 68' ' ' ARG . 48.1 tp10 -59.08 -39.03 80.87 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.009 -0.541 . . . . 99.989999999999995 110.63 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.01 -34.12 8.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.819 -0.353 . . . . 99.989999999999995 110.876 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' CYS . 76.2 m -60.22 -36.83 78.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 99.989999999999995 111.019 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.588 ' ND1' ' O ' ' A' ' 99' ' ' PRO . 37.7 m80 -50.5 -32.69 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 99.989999999999995 111.222 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 68' ' ' ARG . 55.8 t-80 -55.7 -45.57 77.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.559 -0.291 . . . . 99.989999999999995 111.411 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -143.55 160.7 50.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 99.989999999999995 110.984 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.479 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 8.0 Cg_endo -52.79 163.57 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.938 2.425 . . . . 99.989999999999995 111.935 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -64.86 131.47 46.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 99.989999999999995 110.861 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.85 161.21 33.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 99.989999999999995 110.158 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -46.38 146.15 5.22 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.261 1.974 . . . . 99.989999999999995 111.844 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.546 ' O ' ' N ' ' A' ' 152' ' ' VAL . 19.1 p90 -147.26 156.89 43.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 119.932 -0.707 . . . . 99.989999999999995 111.744 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.32 125.67 42.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.515 -0.766 . . . . 99.989999999999995 110.665 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 16.1 tp -96.21 122.61 39.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.418 -0.586 . . . . 99.989999999999995 109.418 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.469 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.3 t -130.24 150.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.053 0.454 . . . . 99.989999999999995 111.747 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.5 156.87 17.11 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 109.966 -1.254 . . . . 99.989999999999995 109.966 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.22 167.58 11.71 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.563 0.697 . . . . 99.989999999999995 111.978 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.603 ' O ' ' O ' ' A' ' 117' ' ' ILE . 97.0 mm-40 50.75 24.45 1.73 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.761 -1.109 . . . . 99.989999999999995 112.777 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.603 ' O ' ' O ' ' A' ' 116' ' ' GLN . 4.8 tt 30.62 -156.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.943 -0.392 . . . . 99.989999999999995 109.943 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.518 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 53.0 p30 -120.81 29.27 7.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.005 -0.739 . . . . 99.989999999999995 109.005 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.594 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 34.9 tp -137.31 -38.65 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.12 -0.945 . . . . 99.989999999999995 110.069 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? -59.29 -63.56 1.26 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.47 -0.937 . . . . 99.989999999999995 108.47 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 123' ' ' PRO . 72.3 m-20 -48.34 -32.69 7.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 99.989999999999995 110.343 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.53 ' C ' ' O ' ' A' ' 121' ' ' ASP . 2.0 t0 7.08 -72.26 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 123.807 0.692 . . . . 99.989999999999995 112.675 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 121' ' ' ASP . 52.2 Cg_exo -35.04 -39.43 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.069 1.18 . . . . 99.989999999999995 111.484 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.2 p -115.88 -0.12 12.94 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.769 -0.372 . . . . 99.989999999999995 111.565 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.408 ' HB ' ' N ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -107.83 -29.6 8.98 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.567 -0.453 . . . . 99.989999999999995 111.101 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.16 -18.74 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.155 -0.475 . . . . 99.989999999999995 111.07 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -107.98 -32.69 7.46 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.993 -0.683 . . . . 99.989999999999995 112.752 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 129' ' ' LEU . 82.1 tttt -66.63 -42.61 86.5 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.954 0.797 . . . . 99.989999999999995 111.094 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.578 ' O ' ' CB ' ' A' ' 130' ' ' ALA . 10.8 mp -41.24 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.335 -0.546 . . . . 99.989999999999995 109.719 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . 94.7 12.58 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.132 -0.692 . . . . 99.989999999999995 109.132 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' A' ' 134' ' ' GLN . 76.2 mttt -141.52 81.22 1.76 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.107 -0.952 . . . . 99.989999999999995 110.352 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -46.54 -29.79 1.95 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.752 -1.203 . . . . 99.989999999999995 107.752 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.414 ' N ' ' C ' ' A' ' 131' ' ' LYS . 57.5 tttp -58.42 -36.45 73.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.83 -1.077 . . . . 99.989999999999995 109.666 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 131' ' ' LYS . 85.6 mm-40 -63.18 153.19 35.23 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.066 0.46 . . . . 99.989999999999995 111.294 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.59 ' H ' ' CD ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -126.37 162.06 48.66 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 115.761 -0.654 . . . . 99.989999999999995 110.117 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.65 157.16 12.93 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.725 2.284 . . . . 99.989999999999995 112.326 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.533 ' O ' ' CG1' ' A' ' 137' ' ' ILE . 1.3 tt -104.92 46.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.252 -0.431 . . . . 99.989999999999995 111.209 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.503 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -131.15 -65.66 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.174 0.435 . . . . 99.989999999999995 112.174 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.503 ' HD2' ' H ' ' A' ' 138' ' ' THR . 84.3 Cg_exo -23.92 -69.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.758 2.972 . . . . 99.989999999999995 114.489 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -113.37 -37.8 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.14 0.422 . . . . 99.989999999999995 112.14 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.6 m -52.57 -40.22 62.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.567 -0.288 . . . . 99.989999999999995 111.732 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.75 -28.87 62.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.672 0.272 . . . . 99.989999999999995 111.506 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.24 -38.24 88.47 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.131 0.419 . . . . 99.989999999999995 112.131 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -63.35 -46.19 87.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 99.989999999999995 110.897 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 65.3 mt -54.29 -33.47 58.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.954 -0.566 . . . . 99.989999999999995 111.051 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.77 81.73 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.682 -0.407 . . . . 99.989999999999995 110.064 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -60.42 -41.58 94.26 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.471 -0.786 . . . . 99.989999999999995 110.667 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -51.65 -31.98 27.69 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.416 -0.957 . . . . 99.989999999999995 108.416 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.4 mt -131.23 -115.58 0.23 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.845 -1.07 . . . . 99.989999999999995 108.459 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.569 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 63.5 mttm -134.96 -142.03 0.18 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.644 -0.707 . . . . 99.989999999999995 110.219 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 150.88 177.98 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.386 0.429 . . . . 99.989999999999995 111.059 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 110' ' ' PHE . 94.0 t -145.66 -59.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.63 -0.713 . . . . 99.989999999999995 109.567 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 154' ' ' TYR . 16.4 mmtt -100.81 170.56 8.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.161 -0.681 . . . . 99.989999999999995 109.161 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.505 ' CG ' ' C ' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -173.2 97.36 0.12 Allowed 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 119.668 -0.813 . . . . 99.989999999999995 109.321 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.58 ' CG2' ' H ' ' A' ' 156' ' ' GLU . 2.7 p -170.42 -167.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 119.547 -0.861 . . . . 99.989999999999995 111.165 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.58 ' H ' ' CG2' ' A' ' 155' ' ' VAL . 96.1 mt-10 -106.88 166.56 10.5 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.219 -1.03 . . . . 99.989999999999995 108.219 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.526 ' SG ' ' C ' ' A' ' 156' ' ' GLU . 0.5 OUTLIER -178.29 119.91 0.09 Allowed 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 114.491 1.293 . . . . 99.989999999999995 114.491 178.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 160' ' ' LEU . 16.4 t -156.77 94.77 1.48 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.508 -1.678 . . . . 99.989999999999995 107.022 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 35.12 28.57 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.319 -1.31 . . . . 99.989999999999995 109.565 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.768 ' O ' ' N ' ' A' ' 162' ' ' GLN . 41.9 mt -142.8 -78.89 0.23 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.397 -0.82 . . . . 99.989999999999995 111.238 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.744 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.6 m -44.09 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 114.043 1.127 . . . . 99.989999999999995 114.043 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.768 ' N ' ' O ' ' A' ' 160' ' ' LEU . 11.8 pt20 -72.07 10.25 0.78 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.212 -2.144 . . . . 99.989999999999995 105.212 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.744 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.1 tttm -62.14 -27.03 68.65 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.167 -1.379 . . . . 99.989999999999995 109.062 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.679 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -125.12 -63.62 0.18 Allowed Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 108.233 -1.947 . . . . 99.989999999999995 108.233 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.1 mt -39.19 -13.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.416 -0.513 . . . . 99.989999999999995 112.181 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 164' ' ' GLY . 43.4 tttm -81.29 -46.55 14.59 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.296 -1.001 . . . . 99.989999999999995 108.296 176.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' GLY . 2.7 m120 -83.33 6.56 19.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.513 -1.222 . . . . 99.989999999999995 110.102 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.8 t -86.41 -57.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 99.989999999999995 110.376 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -45.84 -45.78 15.18 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.239 -0.584 . . . . 99.989999999999995 110.247 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -69.69 -45.16 68.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 99.989999999999995 111.481 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.0 -25.41 64.5 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.935 0.346 . . . . 99.989999999999995 111.935 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.97 -36.11 80.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.694 -0.402 . . . . 99.989999999999995 110.348 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 8.5 mm -60.75 -37.03 75.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.406 -0.59 . . . . 99.989999999999995 109.406 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 36.9 tp -58.46 -35.87 72.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.695 -0.684 . . . . 99.989999999999995 109.879 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.88 -24.25 67.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.604 -0.726 . . . . 99.989999999999995 111.073 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -61.04 -36.25 79.08 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.816 -0.354 . . . . 99.989999999999995 110.695 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.3 mt -59.42 -32.98 70.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 99.989999999999995 110.411 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 99.989999999999995 110.641 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttm . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.505 -0.554 . . . . 99.989999999999995 109.505 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.452 ' O ' ' CB ' ' A' ' 176' ' ' ALA . 58.8 tp60 -56.23 -38.82 71.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 99.989999999999995 110.055 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.438 ' HG1' ' CG2' ' A' ' 52' ' ' THR . 0.7 OUTLIER -49.76 132.41 22.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 99.989999999999995 110.105 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.9 tp -126.13 145.91 32.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.246 -0.434 . . . . 99.989999999999995 110.937 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -91.28 142.18 27.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 99.989999999999995 110.732 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -138.61 130.69 28.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.613 -0.721 . . . . 99.989999999999995 110.621 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.0 t -98.24 135.28 33.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.759 -0.83 . . . . 99.989999999999995 108.759 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.607 ' CG1' ' SG ' ' A' ' 81' ' ' CYS . 62.6 t -99.03 131.53 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 119.898 -0.721 . . . . 99.989999999999995 110.979 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.0 136.23 59.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.549 -0.75 . . . . 99.989999999999995 110.063 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.94 -173.72 19.9 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.933 -0.867 . . . . 99.989999999999995 110.933 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 13' ' ' ALA . 54.6 t0 -80.3 118.3 21.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.136 -0.32 . . . . 99.989999999999995 110.136 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 29.87 -87.68 0.01 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.184 -0.766 . . . . 99.989999999999995 111.184 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -133.12 150.0 52.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 99.989999999999995 110.522 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.673 ' CG2' ' H ' ' A' ' 15' ' ' GLY . 8.5 m -153.7 -96.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 110.835 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.673 ' H ' ' CG2' ' A' ' 14' ' ' VAL . . . -137.76 19.52 3.32 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.679 -0.772 . . . . 99.989999999999995 112.037 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -39.13 -36.31 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.187 0.494 . . . . 99.989999999999995 111.832 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.0 p -65.31 -46.87 78.63 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.911 -0.316 . . . . 99.989999999999995 111.808 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -79.45 -35.87 39.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.453 . . . . 99.989999999999995 110.797 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.494 ' O ' ' OG ' ' A' ' 22' ' ' SER . 12.7 tp -58.32 -40.35 81.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.75 -0.659 . . . . 99.989999999999995 110.496 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.17 -37.81 78.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 99.989999999999995 110.368 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.473 ' O ' ' C ' ' A' ' 22' ' ' SER . 93.8 mt -70.19 -1.73 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.87 -0.605 . . . . 99.989999999999995 110.861 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.504 ' H ' ' HG ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -29.36 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 111.634 -178.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.416 ' OH ' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -98.27 -12.33 21.69 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.561 -0.456 . . . . 99.989999999999995 111.546 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -48.61 -49.2 37.99 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.831 -0.348 . . . . 99.989999999999995 111.28 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.2 p -133.9 -16.01 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.821 -0.352 . . . . 99.989999999999995 110.532 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.589 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER 70.86 111.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.559 -0.534 . . . . 99.989999999999995 109.559 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 57.09 136.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 99.989999999999995 110.658 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 177.56 113.21 0.15 Allowed Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.016 -0.538 . . . . 99.989999999999995 110.245 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -46.51 149.18 2.96 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.981 1.787 . . . . 99.989999999999995 112.316 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.8 t -58.27 -18.55 27.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.807 -0.633 . . . . 99.989999999999995 110.952 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.65 -34.13 57.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.342 -0.39 . . . . 99.989999999999995 110.859 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -119.69 126.8 51.98 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.838 -0.345 . . . . 99.989999999999995 110.845 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.84 157.38 38.16 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.179 -0.464 . . . . 99.989999999999995 110.367 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.53 66.07 3.74 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.673 2.249 . . . . 99.989999999999995 111.915 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.3 p -76.47 -15.95 59.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 99.989999999999995 111.229 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.0 -44.62 95.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.876 -0.33 . . . . 99.989999999999995 110.837 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -175.26 124.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 99.989999999999995 110.685 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -73.66 144.33 45.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 99.989999999999995 110.755 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -111.46 168.63 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 99.989999999999995 111.004 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 40' ' ' TYR . 26.3 p90 -155.85 35.43 0.35 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.347 -0.612 . . . . 99.989999999999995 109.347 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.27 97.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.465 -0.789 . . . . 99.989999999999995 110.285 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.526 ' O ' ' OG1' ' A' ' 52' ' ' THR . 21.8 t -129.92 132.83 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 99.989999999999995 110.36 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 t -103.0 133.78 47.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.12 0.486 . . . . 99.989999999999995 111.219 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.416 ' CG1' ' OH ' ' A' ' 23' ' ' TYR . 19.1 m -132.44 156.48 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.593 -0.731 . . . . 99.989999999999995 109.951 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -113.37 123.93 51.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.74 -0.384 . . . . 99.989999999999995 110.985 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' GLY . 9.2 tp -134.6 137.63 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 99.989999999999995 110.103 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 34.09 28.29 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.428 -0.669 . . . . 99.989999999999995 111.428 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 82.53 47.03 6.16 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.628 -0.589 . . . . 99.989999999999995 111.628 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -128.22 83.6 65.64 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-O 120.872 0.368 . . . . 99.989999999999995 110.166 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 59.2 Cg_endo -78.84 99.88 1.31 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.45 2.1 . . . . 99.989999999999995 112.674 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' A' ' 50' ' ' PRO . 62.4 m-85 -156.36 177.85 10.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.891 -0.595 . . . . 99.989999999999995 110.491 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 9.2 t -139.96 150.04 44.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.675 0.62 . . . . 99.989999999999995 112.675 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.9 tp -118.11 128.39 54.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.327 -0.851 . . . . 99.989999999999995 108.86 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -86.31 138.02 15.52 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.347 -0.93 . . . . 99.989999999999995 111.813 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' A' ' 40' ' ' TYR . 81.2 mt -124.38 126.7 46.4 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.913 -0.315 . . . . 99.989999999999995 110.626 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.613 ' O ' ' O ' ' A' ' 57' ' ' ASP . 45.4 t80 -108.5 35.4 3.2 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 120.413 -0.515 . . . . 99.989999999999995 111.961 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 56' ' ' PHE . 90.6 m-20 36.79 178.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.663 0.986 . . . . 99.989999999999995 113.663 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.4 m -64.77 132.08 48.59 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 120.138 -0.625 . . . . 99.989999999999995 110.606 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.84 149.04 33.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.52 . . . . 99.989999999999995 110.643 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.84 157.69 7.28 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.936 -0.866 . . . . 99.989999999999995 110.936 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 43.28 -120.37 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.716 0.293 . . . . 99.989999999999995 110.433 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.578 ' C ' ' H ' ' A' ' 64' ' ' TYR . 78.4 mm-40 45.69 85.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.788 -0.449 . . . . 99.989999999999995 109.788 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' OD2' ' OD2' ' A' ' 65' ' ' ASP . 36.6 t0 63.69 -4.5 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.505 . . . . 99.989999999999995 109.958 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.584 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 65.3 t80 52.72 14.97 0.47 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.949 -0.569 . . . . 99.989999999999995 110.561 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.497 ' OD2' ' OD2' ' A' ' 63' ' ' ASP . 86.0 m-20 -65.16 155.12 35.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 99.989999999999995 110.533 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.446 HH21 ' H ' ' A' ' 70' ' ' LEU . 73.5 mtp180 53.75 96.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 110.882 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.547 ' CD1' ' HH ' ' A' ' 64' ' ' TYR . 39.0 tp -59.25 -37.57 77.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 99.989999999999995 110.332 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 -139.9 155.94 70.83 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.116 -0.493 . . . . 99.989999999999995 110.566 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.92 152.1 83.46 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.734 2.289 . . . . 99.989999999999995 112.28 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.446 ' H ' HH21 ' A' ' 66' ' ' ARG . 90.6 mt -58.3 -32.66 68.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 99.989999999999995 110.576 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 73.65 -8.4 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 99.989999999999995 110.676 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.602 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -58.46 -41.92 91.8 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 99.989999999999995 110.673 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 24.5 Cg_exo -60.42 147.87 92.57 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.452 2.101 . . . . 99.989999999999995 111.868 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -94.34 121.49 35.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.324 -0.398 . . . . 99.989999999999995 110.506 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.8 t -141.72 155.98 45.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 99.989999999999995 110.459 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -122.76 -33.07 3.44 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.749 -0.38 . . . . 99.989999999999995 111.09 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.91 152.56 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.652 -0.419 . . . . 99.989999999999995 110.417 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.415 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 21.0 m-85 -120.83 160.53 23.22 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.015 -0.365 . . . . 99.989999999999995 110.015 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.9 tt -119.15 123.25 43.93 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.731 -0.387 . . . . 99.989999999999995 110.246 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.9 m -102.27 133.49 45.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.925 -0.398 . . . . 99.989999999999995 109.925 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.607 ' SG ' ' CG1' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -134.07 134.82 42.78 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.261 0.553 . . . . 99.989999999999995 111.516 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 115' ' ' THR . 39.3 p90 -142.83 153.84 43.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.616 -0.72 . . . . 99.989999999999995 109.873 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.1 p -95.63 134.74 38.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.412 -0.588 . . . . 99.989999999999995 109.412 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.67 ' CG1' ' H ' ' A' ' 85' ' ' VAL . 5.4 p -49.23 -68.23 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 118.943 -1.103 . . . . 99.989999999999995 110.416 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.67 ' H ' ' CG1' ' A' ' 84' ' ' VAL . 7.6 p -56.17 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.295 -0.412 . . . . 99.989999999999995 110.533 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.0 OUTLIER 157.84 80.76 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 99.989999999999995 110.472 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -56.39 -36.13 96.94 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.506 2.137 . . . . 99.989999999999995 112.061 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 m -57.65 -38.02 74.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.898 -0.592 . . . . 99.989999999999995 111.192 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.3 p -71.21 -34.26 70.67 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.04 -0.264 . . . . 99.989999999999995 111.509 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -70.48 -43.79 69.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 99.989999999999995 111.41 -179.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 96.8 mt-10 -61.48 -34.09 74.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.264 -0.426 . . . . 99.989999999999995 111.595 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 96' ' ' LYS . 28.0 m120 -89.75 -63.33 1.3 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.612 -0.435 . . . . 99.989999999999995 111.983 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.2 t -36.04 -62.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 99.989999999999995 112.255 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -70.44 -19.47 62.97 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.805 1.039 . . . . 99.989999999999995 113.805 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.542 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 82.6 tt0 -124.87 -55.7 1.59 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.075 1.139 . . . . 99.989999999999995 114.075 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 92' ' ' ASN . 19.3 tttt -74.99 -16.3 60.63 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.61 0.967 . . . . 99.989999999999995 113.61 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -96.31 -50.32 4.83 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.551 -0.86 . . . . 99.989999999999995 112.123 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' O ' ' OG1' ' A' ' 102' ' ' THR . 0.1 OUTLIER -43.04 -46.69 13.84 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.147 -0.621 . . . . 99.989999999999995 111.251 -178.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.542 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 15.7 Cg_exo -65.69 -39.55 20.39 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.049 1.833 . . . . 99.989999999999995 112.338 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.56 -36.26 83.2 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.754 -0.378 . . . . 99.989999999999995 111.404 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.4 pt -89.83 -32.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.536 -0.466 . . . . 99.989999999999995 111.266 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 81.9 p -99.5 17.65 19.83 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.884 -0.326 . . . . 99.989999999999995 111.098 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -54.31 -46.45 72.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.566 -0.454 . . . . 99.989999999999995 110.494 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.66 -42.12 98.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 99.989999999999995 110.479 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.7 t -127.33 87.39 56.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 99.989999999999995 110.42 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.02 -27.98 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.312 2.008 . . . . 99.989999999999995 112.116 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -103.5 117.87 35.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 99.989999999999995 110.238 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 3.2 m -170.88 101.77 0.41 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.502 -0.317 . . . . 99.989999999999995 110.857 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.41 148.17 11.3 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.028 1.819 . . . . 99.989999999999995 112.008 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.551 ' CE1' ' CB ' ' A' ' 151' ' ' ALA . 21.0 p90 -148.31 162.93 38.53 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.49 -0.484 . . . . 99.989999999999995 111.618 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 7.3 mp -91.14 129.58 37.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 99.989999999999995 109.806 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.4 tp -95.08 121.83 37.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.037 -0.529 . . . . 99.989999999999995 110.304 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 114' ' ' GLY . 40.1 t -135.8 168.51 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.512 -0.767 . . . . 99.989999999999995 109.91 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.427 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -155.16 97.86 0.17 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.307 -0.949 . . . . 99.989999999999995 111.261 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 82' ' ' PHE . 2.6 p -51.47 177.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.92 0.39 . . . . 99.989999999999995 110.4 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.507 ' O ' ' C ' ' A' ' 117' ' ' ILE . 43.7 tp60 47.37 29.96 1.43 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 111.007 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.507 ' C ' ' O ' ' A' ' 116' ' ' GLN . 13.0 tt 27.43 -142.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 122.404 0.282 . . . . 99.989999999999995 110.367 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 86.3 m-20 -88.24 3.32 49.91 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.279 -0.568 . . . . 99.989999999999995 109.882 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.573 ' CB ' ' O ' ' A' ' 118' ' ' ASP . 16.8 tp 137.34 90.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 124.572 1.17 . . . . 99.989999999999995 109.515 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.533 ' C ' ' O ' ' A' ' 119' ' ' LEU . 27.8 ttm180 15.44 58.88 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.986 0.804 . . . . 99.989999999999995 111.161 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER 165.12 -91.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 99.989999999999995 110.713 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 11.8 t0 105.68 -45.31 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 O-C-N 124.124 0.89 . . . . 99.989999999999995 111.219 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.427 ' CD ' ' C ' ' A' ' 121' ' ' ASP . 71.3 Cg_endo -90.78 -34.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 121.227 1.284 . . . . 99.989999999999995 110.432 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.427 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 46.6 p -98.35 1.47 47.03 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.141 -0.482 . . . . 99.989999999999995 110.051 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.06 -27.02 13.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.073 -0.512 . . . . 99.989999999999995 110.094 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 62.3 mt -71.77 -42.47 70.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.117 -0.492 . . . . 99.989999999999995 109.697 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -75.84 -32.61 59.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 99.989999999999995 110.529 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -74.36 -42.5 59.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.28 -0.418 . . . . 99.989999999999995 111.011 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 131' ' ' LYS . 13.3 mt -50.32 -53.55 27.91 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.395 -0.366 . . . . 99.989999999999995 110.479 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 43.24 13.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 99.989999999999995 110.665 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mmtt -56.87 -72.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 99.989999999999995 110.494 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 45.0 t30 94.48 -39.33 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 106.439 -1.689 . . . . 99.989999999999995 106.439 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.574 ' O ' ' O ' ' A' ' 134' ' ' GLN . 28.1 mttt -99.51 -15.23 18.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.387 -1.279 . . . . 99.989999999999995 108.427 176.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.574 ' O ' ' O ' ' A' ' 133' ' ' LYS . 98.3 mt-30 34.32 -170.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.218 -0.901 . . . . 99.989999999999995 112.8 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.696 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 0.3 OUTLIER -145.05 -44.19 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.449 -0.796 . . . . 99.989999999999995 110.635 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.696 ' CD ' ' H ' ' A' ' 135' ' ' LYS . 1.8 Cg_endo -80.81 -157.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.108 2.539 . . . . 99.989999999999995 111.998 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.9 tt -114.14 112.78 41.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.249 0.547 . . . . 99.989999999999995 111.044 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.596 ' O ' ' O ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -135.37 -66.06 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.508 -0.769 . . . . 99.989999999999995 111.256 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.696 ' C ' ' H ' ' A' ' 141' ' ' THR . 48.7 Cg_exo -19.42 151.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 124.1 3.2 . . . . 99.989999999999995 114.329 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -48.05 -2.76 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.721 -1.581 . . . . 99.989999999999995 110.508 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.696 ' H ' ' C ' ' A' ' 139' ' ' PRO . 58.6 p -82.14 -8.37 59.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.619 -0.264 . . . . 99.989999999999995 110.92 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.63 -48.56 59.52 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.134 -0.626 . . . . 99.989999999999995 110.161 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.76 -31.11 72.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.879 -0.601 . . . . 99.989999999999995 110.691 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -57.71 -41.53 81.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 99.989999999999995 110.106 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.0 mt -49.07 -35.15 15.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.893 -0.594 . . . . 99.989999999999995 109.944 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.13 -37.87 69.35 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.754 -0.461 . . . . 99.989999999999995 109.754 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -63.81 -38.2 90.2 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.462 -0.79 . . . . 99.989999999999995 110.753 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -49.25 -35.27 17.2 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.0 -1.111 . . . . 99.989999999999995 108.0 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.38 -113.35 0.31 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.609 -1.178 . . . . 99.989999999999995 109.003 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.583 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 43.1 tttp -132.4 -117.46 0.21 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.495 -0.775 . . . . 99.989999999999995 110.913 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 109.47 -162.96 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.133 0.895 . . . . 99.989999999999995 109.24 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 110' ' ' PHE . 50.7 t -149.26 -63.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.738 -0.385 . . . . 99.989999999999995 110.462 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.544 ' HZ2' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -86.89 -173.93 4.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.096 -0.705 . . . . 99.989999999999995 109.096 179.261 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.61 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 31.0 p90 -170.8 95.94 0.21 Allowed 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.835 -0.802 . . . . 99.989999999999995 108.835 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.522 ' CG1' ' N ' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -172.63 -169.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.551 -0.749 . . . . 99.989999999999995 111.167 -178.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.607 ' O ' ' OG1' ' A' ' 161' ' ' THR . 77.1 mt-10 -153.14 114.81 4.26 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.755 -1.111 . . . . 99.989999999999995 108.309 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.513 ' HA ' ' HG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -121.29 138.11 54.39 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 122.474 1.13 . . . . 99.989999999999995 112.595 -177.346 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.473 ' C ' ' N ' ' A' ' 160' ' ' LEU . 37.7 t -145.57 93.96 2.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.005 -1.907 . . . . 99.989999999999995 106.659 176.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 39.61 30.54 0.06 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.779 -1.1 . . . . 99.989999999999995 108.986 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.867 ' O ' ' N ' ' A' ' 162' ' ' GLN . 58.2 tp -145.52 -86.61 0.11 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.977 -1.01 . . . . 99.989999999999995 110.281 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.629 ' C ' ' H ' ' A' ' 163' ' ' LYS . 1.5 m -44.7 41.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.93 1.085 . . . . 99.989999999999995 113.93 -176.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.867 ' N ' ' O ' ' A' ' 160' ' ' LEU . 13.1 pt20 -69.4 -0.79 6.92 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.064 -2.199 . . . . 99.989999999999995 105.064 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.629 ' H ' ' C ' ' A' ' 161' ' ' THR . 63.9 mttp -56.84 -28.64 61.9 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 113.815 -1.539 . . . . 99.989999999999995 107.663 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.627 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -114.84 -65.21 0.41 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.947 -2.061 . . . . 99.989999999999995 107.947 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.52 -6.92 0.01 OUTLIER 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.897 0.703 . . . . 99.989999999999995 112.897 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' A' ' 164' ' ' GLY . 38.2 tttt -92.85 -44.47 8.46 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.387 -0.968 . . . . 99.989999999999995 108.387 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 164' ' ' GLY . 33.3 m120 -81.73 -1.72 48.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.168 -0.924 . . . . 99.989999999999995 109.013 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.544 ' CG2' ' HZ2' ' A' ' 153' ' ' LYS . 22.0 t -71.95 -52.28 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 109.434 -0.58 . . . . 99.989999999999995 109.434 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.409 ' CD2' ' CE1' ' A' ' 23' ' ' TYR . 38.9 m-85 -55.79 -40.73 73.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.618 -0.719 . . . . 99.989999999999995 110.335 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -47.8 64.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 99.989999999999995 111.497 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.56 -25.98 59.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.942 0.401 . . . . 99.989999999999995 111.215 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.03 -46.43 65.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.048 -0.524 . . . . 99.989999999999995 111.0 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 10.9 pt -66.2 -36.47 77.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.604 -0.517 . . . . 99.989999999999995 109.604 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.4 tp -61.37 -35.27 77.0 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.313 -0.625 . . . . 99.989999999999995 109.313 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.51 68.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.664 -0.698 . . . . 99.989999999999995 110.176 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -58.79 -30.68 67.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.151 -0.477 . . . . 99.989999999999995 109.871 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.0 tp -53.32 -37.51 62.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.624 -0.716 . . . . 99.989999999999995 110.483 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 99.989999999999995 110.665 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' H3 ' ' H ' ' A' ' 2' ' ' GLN . 86.3 mtp . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.409 -0.589 . . . . 99.989999999999995 109.409 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.437 ' H ' ' H3 ' ' A' ' 1' ' ' MET . 98.8 mt-30 -85.71 -75.28 0.38 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 99.989999999999995 110.532 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.4 134.81 44.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.804 -0.635 . . . . 99.989999999999995 109.971 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.5 tp -126.45 152.22 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 99.989999999999995 110.609 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -104.15 149.02 25.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.201 0.524 . . . . 99.989999999999995 111.342 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 128.09 46.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.5 -0.773 . . . . 99.989999999999995 109.835 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 84.9 t -98.92 139.45 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.857 -0.337 . . . . 99.989999999999995 110.456 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.438 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 86.8 t -95.66 136.59 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 120.836 -0.346 . . . . 99.989999999999995 111.031 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.8 t -119.79 137.58 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 99.989999999999995 110.766 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 12' ' ' GLY . . . 81.85 -81.33 1.68 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.436 -0.665 . . . . 99.989999999999995 111.436 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 52.9 t0 63.8 -52.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.705 0.288 . . . . 99.989999999999995 110.614 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 10' ' ' GLY . . . 93.19 -9.42 74.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.746 -0.941 . . . . 99.989999999999995 110.746 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 90.88 -4.54 0.26 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.766 0.317 . . . . 99.989999999999995 110.698 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.4 146.04 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 99.989999999999995 110.813 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 17' ' ' THR . . . 122.04 -53.56 0.72 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.024 -0.608 . . . . 99.989999999999995 112.436 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -41.87 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.525 0.565 . . . . 99.989999999999995 112.525 -178.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.615 ' N ' ' O ' ' A' ' 15' ' ' GLY . 58.3 p -61.99 -43.65 98.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.872 0.693 . . . . 99.989999999999995 112.872 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 20.8 m -127.11 0.53 6.49 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.398 -0.521 . . . . 99.989999999999995 112.382 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' C ' ' CD1' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -93.43 -52.11 4.66 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.472 -0.491 . . . . 99.989999999999995 110.138 178.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.2 tp -52.08 -37.33 53.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.515 . . . . 99.989999999999995 110.046 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.9 tt -92.03 3.91 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.668 -0.696 . . . . 99.989999999999995 110.94 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.6 p -38.61 -80.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.266 0.469 . . . . 99.989999999999995 112.266 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -72.14 -29.25 63.86 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 119.603 1.092 . . . . 99.989999999999995 111.215 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.7 m -41.96 -47.38 4.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.158 -0.473 . . . . 99.989999999999995 110.924 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -119.58 -8.91 9.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 99.989999999999995 110.881 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.554 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 40.9 t-20 55.68 94.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 99.989999999999995 111.303 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 59.84 86.71 0.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 99.989999999999995 111.375 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.8 tp -127.94 68.86 76.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 99.989999999999995 110.996 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.38 128.94 16.14 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.287 1.992 . . . . 99.989999999999995 111.935 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -149.93 144.8 26.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 99.989999999999995 110.711 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.13 -34.07 76.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 99.989999999999995 110.464 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.49 140.41 49.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 99.989999999999995 110.391 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.3 t -124.69 79.51 62.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 99.989999999999995 110.918 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.1 141.99 67.43 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.601 2.201 . . . . 99.989999999999995 111.674 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 36' ' ' VAL . 69.6 p -69.3 -23.92 63.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 99.989999999999995 111.295 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' CG1' ' H ' ' A' ' 37' ' ' PHE . 9.7 t 37.69 -124.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 99.989999999999995 110.413 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.511 ' H ' ' CG1' ' A' ' 36' ' ' VAL . 95.7 m-85 -113.61 147.42 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 99.989999999999995 110.341 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -68.36 135.65 52.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.398 . . . . 99.989999999999995 110.4 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -105.58 138.35 41.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.049 -0.523 . . . . 99.989999999999995 110.972 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.551 ' CB ' ' O ' ' A' ' 55' ' ' LEU . 13.0 p90 -175.51 4.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 99.989999999999995 110.095 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.38 99.63 2.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.617 -0.72 . . . . 99.989999999999995 109.609 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.89 138.11 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.32 -0.4 . . . . 99.989999999999995 110.631 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t -100.37 115.17 29.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.923 -0.58 . . . . 99.989999999999995 110.414 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -136.47 145.05 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 99.989999999999995 111.008 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 72.2 mtm -102.3 128.18 48.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.987 -0.551 . . . . 99.989999999999995 109.778 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.8 tt -124.18 125.53 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 99.989999999999995 110.469 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.14 24.71 44.82 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.785 -0.926 . . . . 99.989999999999995 110.785 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.9 56.55 5.3 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.43 -1.068 . . . . 99.989999999999995 110.43 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -141.76 91.29 8.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 110.274 -0.269 . . . . 99.989999999999995 110.274 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 30.5 Cg_exo -58.63 103.59 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.57 2.18 . . . . 99.989999999999995 112.683 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 50' ' ' PRO . 89.2 m-85 -159.86 161.19 34.39 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.408 -0.59 . . . . 99.989999999999995 109.408 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.7 p -132.31 143.67 50.04 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.136 -0.626 . . . . 99.989999999999995 110.885 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 59.2 tp -120.55 139.12 53.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 99.989999999999995 110.245 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -110.65 123.61 6.67 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.719 -0.753 . . . . 99.989999999999995 111.629 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.551 ' O ' ' CB ' ' A' ' 40' ' ' TYR . 62.0 mt -109.36 131.58 54.93 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.626 0.25 . . . . 99.989999999999995 110.478 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.602 ' CD2' ' O ' ' A' ' 56' ' ' PHE . 41.2 t80 -113.67 31.11 6.73 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.863 0.69 . . . . 99.989999999999995 112.863 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.573 ' CG ' ' H ' ' A' ' 58' ' ' THR . 33.0 t0 -54.06 -154.5 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.183 0.447 . . . . 99.989999999999995 110.937 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.573 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 11.3 m 65.56 -70.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.194 -0.457 . . . . 99.989999999999995 110.653 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . -67.45 146.57 53.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 99.989999999999995 110.523 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . 151.18 38.55 0.03 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.826 -0.702 . . . . 99.989999999999995 111.396 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -116.46 -178.68 3.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.721 -0.474 . . . . 99.989999999999995 109.721 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 83.9 tt0 -110.42 128.29 55.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.36 -0.978 . . . . 99.989999999999995 108.36 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 21.2 t0 92.61 -4.85 0.16 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.718 -0.845 . . . . 99.989999999999995 108.718 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.455 ' C ' ' O ' ' A' ' 63' ' ' ASP . 51.3 m-85 30.95 96.47 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.235 -0.893 . . . . 99.989999999999995 111.136 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.8 -35.38 74.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.952 0.406 . . . . 99.989999999999995 110.327 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 37.3 mtm105 -56.63 147.05 23.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 99.989999999999995 110.707 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.3 mt -89.79 139.16 30.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 99.989999999999995 110.297 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 51.66 65.53 6.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 99.989999999999995 110.274 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -55.43 143.05 79.04 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.835 2.357 . . . . 99.989999999999995 112.638 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.1 mt -101.52 139.77 36.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 99.989999999999995 109.962 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.3 p -121.11 150.45 41.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 99.989999999999995 110.795 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -131.97 68.76 80.63 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.972 -0.558 . . . . 99.989999999999995 110.772 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.38 -19.84 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.94 1.76 . . . . 99.989999999999995 112.257 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.94 71.93 6.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.899 0.38 . . . . 99.989999999999995 110.207 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 26.2 m -146.65 131.68 18.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 99.989999999999995 110.118 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 76' ' ' ASP . 46.4 p30 -115.07 6.56 15.22 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.442 -0.503 . . . . 99.989999999999995 111.506 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.6 t -121.47 110.5 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.523 -0.471 . . . . 99.989999999999995 110.964 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -87.26 120.42 28.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.02 0.438 . . . . 99.989999999999995 110.468 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tt -119.39 127.55 53.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.86 -0.609 . . . . 99.989999999999995 110.315 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.86 128.44 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.682 -0.488 . . . . 99.989999999999995 109.682 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.596 ' HG ' ' CG2' ' A' ' 115' ' ' THR . 0.0 OUTLIER -134.34 147.72 50.61 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.595 -0.442 . . . . 99.989999999999995 111.356 -179.296 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -170.63 146.55 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 99.989999999999995 110.205 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.489 ' O ' ' OG ' ' A' ' 89' ' ' SER . 30.4 t -62.86 127.25 30.36 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.532 -0.914 . . . . 99.989999999999995 108.532 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 137' ' ' ILE . 3.9 t -76.31 30.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 112.674 0.62 . . . . 99.989999999999995 112.674 -177.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 86' ' ' SER . 14.9 p -130.04 141.62 45.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.697 -0.401 . . . . 99.989999999999995 109.974 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER 83.99 142.16 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.356 -0.384 . . . . 99.989999999999995 110.492 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.08 -3.3 13.4 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.529 2.152 . . . . 99.989999999999995 112.563 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.9 m -91.64 -38.61 12.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.903 0.335 . . . . 99.989999999999995 111.903 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 83' ' ' SER . 93.7 p -60.91 -34.04 74.07 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.94 0.348 . . . . 99.989999999999995 111.94 -178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -82.78 -41.84 18.65 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.827 -0.349 . . . . 99.989999999999995 110.998 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 83.8 tt0 -60.26 -30.32 69.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.198 -0.456 . . . . 99.989999999999995 111.143 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.623 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 86.7 m-20 -66.24 -43.36 86.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.942 0.349 . . . . 99.989999999999995 111.942 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.24 -70.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 113.334 0.865 . . . . 99.989999999999995 113.334 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 142' ' ' ALA . 24.7 mttt -52.78 -16.19 0.93 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.858 0.688 . . . . 99.989999999999995 112.858 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 95.6 mt-10 -130.31 -52.88 1.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.364 1.246 . . . . 99.989999999999995 114.364 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -73.63 -47.43 40.15 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.218 1.192 . . . . 99.989999999999995 114.218 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.623 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 63.9 m95 -81.74 -30.19 32.57 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 119.554 -0.858 . . . . 99.989999999999995 111.134 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.5 t -44.78 -56.48 8.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.69 -0.404 . . . . 99.989999999999995 110.835 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.52 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 12.0 Cg_endo -57.39 -37.21 98.21 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.428 1.419 . . . . 99.989999999999995 110.915 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.44 -40.92 98.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.138 -0.483 . . . . 99.989999999999995 109.78 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 86.8 mt -68.21 -39.7 81.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.988 -0.551 . . . . 99.989999999999995 110.306 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 105' ' ' CYS . 47.8 m -54.81 -44.36 73.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 99.989999999999995 110.561 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -66.2 -41.11 90.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 99.989999999999995 110.973 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -58.03 -46.45 85.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 99.989999999999995 111.547 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -141.79 162.77 44.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.988 0.423 . . . . 99.989999999999995 111.072 -179.471 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.457 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 59.1 Cg_endo -73.61 -155.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.997 2.464 . . . . 99.989999999999995 111.783 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.524 ' NZ ' ' HZ3' ' A' ' 150' ' ' LYS . 26.0 mttm -81.36 120.95 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.827 0.346 . . . . 99.989999999999995 110.451 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.606 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -153.45 156.81 32.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 99.989999999999995 110.065 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.73 132.0 44.23 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.151 1.9 . . . . 99.989999999999995 111.483 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.747 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -133.55 132.11 40.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 99.989999999999995 110.52 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.419 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 7.9 mp -86.34 128.49 34.94 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.345 -0.542 . . . . 99.989999999999995 110.935 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.496 ' CD2' ' HZ2' ' A' ' 94' ' ' LYS . 34.9 tp -92.7 130.66 38.25 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.219 -0.659 . . . . 99.989999999999995 109.219 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.59 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 21.8 t -142.26 160.06 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.928 -0.709 . . . . 99.989999999999995 111.911 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.433 ' O ' ' SG ' ' A' ' 157' ' ' CYS . . . -136.09 165.66 24.85 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.278 -1.529 . . . . 99.989999999999995 109.278 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.596 ' CG2' ' HG ' ' A' ' 81' ' ' CYS . 1.0 OUTLIER -129.9 172.46 11.66 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.365 -0.534 . . . . 99.989999999999995 110.44 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.725 ' O ' ' N ' ' A' ' 118' ' ' ASP . 20.0 mt-30 50.15 24.2 1.37 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.729 -0.669 . . . . 99.989999999999995 110.472 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.594 ' O ' ' CB ' ' A' ' 118' ' ' ASP . 0.4 OUTLIER 21.36 32.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.097 0.777 . . . . 99.989999999999995 113.097 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 116' ' ' GLN . 15.7 t0 93.95 48.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.673 -0.642 . . . . 99.989999999999995 110.143 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 121' ' ' ASP . 0.5 OUTLIER 77.43 87.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.078 -0.965 . . . . 99.989999999999995 110.942 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' A' ' 119' ' ' LEU . 43.4 ptt85 7.72 56.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 O-C-N 124.321 1.013 . . . . 99.989999999999995 112.272 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' A' ' 119' ' ' LEU . 0.5 OUTLIER 173.97 -91.53 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.706 -0.679 . . . . 99.989999999999995 110.834 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 8.7 t0 104.22 -46.41 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 123.999 0.812 . . . . 99.989999999999995 110.876 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.482 ' CD ' ' H ' ' A' ' 124' ' ' SER . 52.5 Cg_endo -92.32 -41.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 121.727 1.618 . . . . 99.989999999999995 109.955 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.482 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 75.8 m -89.78 -1.0 57.89 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.924 -0.769 . . . . 99.989999999999995 108.924 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 122' ' ' ASP . 1.1 m -85.32 -35.23 21.57 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.303 -0.862 . . . . 99.989999999999995 109.29 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 mm -67.04 -42.12 88.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.127 -0.942 . . . . 99.989999999999995 109.473 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -72.49 -33.0 66.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.366 -0.833 . . . . 99.989999999999995 110.856 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -72.0 -45.41 61.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.867 0.365 . . . . 99.989999999999995 111.04 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.45 -40.15 90.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 99.989999999999995 110.881 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.68 24.33 8.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.604 -0.271 . . . . 99.989999999999995 110.885 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.505 ' O ' ' N ' ' A' ' 134' ' ' GLN . 33.6 mttm -127.44 77.22 1.73 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.015 0.436 . . . . 99.989999999999995 110.906 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -49.66 -28.08 5.47 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.167 -1.42 . . . . 99.989999999999995 107.167 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.42 ' N ' ' C ' ' A' ' 131' ' ' LYS . 22.1 mttt -61.45 -17.99 56.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.36 -1.291 . . . . 99.989999999999995 110.203 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 131' ' ' LYS . 34.8 mm-40 -60.76 157.18 15.39 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.139 -0.624 . . . . 99.989999999999995 110.033 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -120.49 75.42 25.11 Favored Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 120.848 -0.341 . . . . 99.989999999999995 111.139 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.87 156.34 39.13 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.665 2.243 . . . . 99.989999999999995 111.873 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.546 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 3.2 tt -125.12 92.84 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.654 -0.418 . . . . 99.989999999999995 110.973 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.524 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -133.38 -69.23 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 113.111 0.782 . . . . 99.989999999999995 113.111 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 1.5 Cg_endo -38.61 -84.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 123.413 2.742 . . . . 99.989999999999995 113.939 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 144' ' ' LYS . 96.9 mt-10 -110.55 -36.12 5.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.237 -0.438 . . . . 99.989999999999995 111.387 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.4 p -44.87 -43.14 8.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.109 -0.496 . . . . 99.989999999999995 110.522 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.5 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -70.78 -58.18 3.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.821 -0.352 . . . . 99.989999999999995 111.57 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.6 -35.53 73.04 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.791 0.663 . . . . 99.989999999999995 112.791 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 140' ' ' GLU . 19.4 tttm -58.24 -43.91 88.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.907 0.336 . . . . 99.989999999999995 111.907 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 7.5 mp -66.85 -29.3 69.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.523 -0.308 . . . . 99.989999999999995 111.368 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.89 -30.94 67.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.707 0.289 . . . . 99.989999999999995 111.488 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.401 HH21 ' HG3' ' A' ' 144' ' ' LYS . 60.1 mtm180 -59.62 -36.55 76.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.286 0.476 . . . . 99.989999999999995 112.286 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -119.56 -34.88 3.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.865 0.691 . . . . 99.989999999999995 112.865 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 150' ' ' LYS . 13.1 tp -67.02 -3.27 6.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.665 -0.414 . . . . 99.989999999999995 111.575 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 67.4 mttm 98.95 150.2 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.495 0.718 . . . . 99.989999999999995 109.685 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 157.08 -172.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 99.989999999999995 110.755 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 110' ' ' PHE . 28.7 t -144.68 -53.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.446 -0.946 . . . . 99.989999999999995 108.446 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.587 ' NZ ' ' OE1' ' A' ' 171' ' ' GLU . 15.6 mmtt -95.53 -177.21 4.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.527 -0.761 . . . . 99.989999999999995 109.131 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -168.12 93.82 0.37 Allowed 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.242 -1.392 . . . . 99.989999999999995 107.242 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.407 ' CG2' ' H ' ' A' ' 156' ' ' GLU . 0.8 OUTLIER -172.6 -167.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 114.688 -1.142 . . . . 99.989999999999995 109.383 -178.24 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.407 ' H ' ' CG2' ' A' ' 155' ' ' VAL . 41.9 mt-10 -139.34 -165.43 1.86 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.597 -0.728 . . . . 99.989999999999995 109.158 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.59 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.5 OUTLIER -174.95 120.0 0.2 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.139 0.971 . . . . 99.989999999999995 111.717 178.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 160' ' ' LEU . 42.6 t -165.99 91.08 0.46 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.093 -1.447 . . . . 99.989999999999995 107.093 177.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 33.67 30.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.092 -1.867 . . . . 99.989999999999995 109.085 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.654 ' C ' ' H ' ' A' ' 162' ' ' GLN . 16.0 tp -157.65 -74.73 0.09 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.956 -1.02 . . . . 99.989999999999995 110.48 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.736 ' C ' ' H ' ' A' ' 163' ' ' LYS . 7.4 m -64.54 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.664 -0.414 . . . . 99.989999999999995 111.126 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.654 ' H ' ' C ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -80.3 23.28 0.49 Allowed 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.016 -2.216 . . . . 99.989999999999995 105.016 175.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.736 ' H ' ' C ' ' A' ' 161' ' ' THR . 16.2 tttp -74.6 -4.38 36.8 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 112.665 -2.061 . . . . 99.989999999999995 108.297 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.715 ' O ' ' N ' ' A' ' 167' ' ' ASN . . . -120.71 -54.77 0.24 Allowed Glycine 0 C--O 1.221 -0.661 0 N-CA-C 107.643 -2.183 . . . . 99.989999999999995 107.643 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.516 ' CD2' ' H ' ' A' ' 165' ' ' LEU . 4.0 mm? -34.16 -23.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.654 0.264 . . . . 99.989999999999995 110.845 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.67 ' N ' ' O ' ' A' ' 164' ' ' GLY . 28.2 tttp -77.95 -46.99 19.62 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.429 -0.952 . . . . 99.989999999999995 108.429 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.715 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.8 m120 -79.65 10.68 3.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.047 -1.433 . . . . 99.989999999999995 109.051 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 171' ' ' GLU . 53.2 t -96.44 -63.25 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.731 -0.668 . . . . 99.989999999999995 110.048 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 168' ' ' VAL . 13.1 m-85 -38.9 -43.1 0.92 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 119.967 -0.693 . . . . 99.989999999999995 109.784 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 54.1 p-10 -68.88 -38.08 79.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 99.989999999999995 110.547 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.63 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 34.8 tt0 -68.67 -24.85 64.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.028 0.442 . . . . 99.989999999999995 110.144 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.83 -32.38 72.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.694 -0.685 . . . . 99.989999999999995 109.26 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.98 -39.17 79.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.367 -0.833 . . . . 99.989999999999995 109.651 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.9 -36.11 83.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.758 . . . . 99.989999999999995 110.668 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.36 77.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 99.989999999999995 110.621 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.82 -28.19 67.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 99.989999999999995 110.252 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.92 -35.88 71.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 99.989999999999995 110.517 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 99.989999999999995 110.503 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.482 -0.562 . . . . 99.989999999999995 109.482 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -85.82 -63.52 1.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 99.989999999999995 110.436 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.434 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -79.79 138.62 37.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.551 . . . . 99.989999999999995 110.119 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.2 tp -129.35 141.5 46.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 110.388 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -91.77 144.52 25.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.296 -0.411 . . . . 99.989999999999995 110.845 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.425 ' HG ' ' HB3' ' A' ' 56' ' ' PHE . 1.9 t -124.22 135.45 53.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.471 -0.566 . . . . 99.989999999999995 109.471 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.51 154.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.97 0.414 . . . . 99.989999999999995 111.898 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 56' ' ' PHE . 7.2 p -96.77 132.63 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.877 -0.601 . . . . 99.989999999999995 111.084 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.1 t -133.94 130.55 55.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.195 -0.668 . . . . 99.989999999999995 109.195 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.04 -163.89 37.58 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.101 -1.047 . . . . 99.989999999999995 111.778 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.7 t0 -87.42 117.84 26.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 99.989999999999995 111.263 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 32.11 33.67 0.01 OUTLIER Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.71 -0.677 . . . . 99.989999999999995 112.149 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.541 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 17.05 108.28 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.548 0.573 . . . . 99.989999999999995 112.548 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 16' ' ' LYS . 1.4 t -75.36 -138.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.247 -0.433 . . . . 99.989999999999995 111.74 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.411 ' H ' ' CG1' ' A' ' 14' ' ' VAL . . . -59.09 57.73 0.01 OUTLIER Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.725 -0.67 . . . . 99.989999999999995 112.476 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.721 ' NZ ' ' H ' ' A' ' 59' ' ' ALA . 1.1 pttt -64.66 -25.44 67.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.604 0.24 . . . . 99.989999999999995 111.372 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.0 m -66.38 -67.55 0.44 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.927 -0.309 . . . . 99.989999999999995 111.352 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 92.3 m -55.6 -28.78 57.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.544 0.688 . . . . 99.989999999999995 109.837 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.1 tp -60.71 -39.08 87.24 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.075 -0.966 . . . . 99.989999999999995 110.294 178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.511 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -78.13 -30.36 49.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.553 . . . . 99.989999999999995 111.101 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.6 tt -58.49 -9.21 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.401 . . . . 99.989999999999995 110.876 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -48.24 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.923 -0.711 . . . . 99.989999999999995 110.81 -178.441 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -57.05 -38.27 72.99 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 119.501 -0.879 . . . . 99.989999999999995 110.675 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.75 -65.0 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 99.989999999999995 111.873 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.6 p -122.08 -18.98 6.75 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.702 -0.399 . . . . 99.989999999999995 111.399 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 22' ' ' SER . 69.2 m-80 60.94 42.99 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.448 -0.342 . . . . 99.989999999999995 110.819 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 179.0 152.27 0.35 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.413 -0.358 . . . . 99.989999999999995 110.629 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -40.45 148.48 0.35 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 99.989999999999995 110.139 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.15 144.86 99.24 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.41 2.074 . . . . 99.989999999999995 111.96 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.621 ' C ' ' H ' ' A' ' 32' ' ' TYR . 48.2 t -69.4 67.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 99.989999999999995 110.412 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 62.02 -17.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.01 -0.541 . . . . 99.989999999999995 111.523 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.621 ' H ' ' C ' ' A' ' 30' ' ' SER . 86.6 m-85 -120.97 145.8 47.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 99.989999999999995 110.848 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.1 t -123.31 66.35 32.96 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 99.989999999999995 110.047 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.77 156.62 65.25 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.621 2.214 . . . . 99.989999999999995 112.667 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.1 p -116.74 170.37 8.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.804 -0.634 . . . . 99.989999999999995 110.378 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.89 157.86 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 99.989999999999995 110.891 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -58.05 -37.0 73.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 99.989999999999995 111.056 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -72.09 123.57 23.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.877 0.37 . . . . 99.989999999999995 110.835 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -59.88 -36.96 78.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 99.989999999999995 110.815 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.708 ' CB ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -158.08 -22.32 0.08 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.287 -0.415 . . . . 99.989999999999995 110.544 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.63 98.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.177 0.513 . . . . 99.989999999999995 111.13 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.5 t -131.14 132.33 63.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.365 -0.834 . . . . 99.989999999999995 110.035 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 43' ' ' THR . 12.9 t -112.62 123.6 50.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.105 0.479 . . . . 99.989999999999995 111.107 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.9 m -134.32 154.72 38.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.687 -0.688 . . . . 99.989999999999995 109.953 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.3 pmm? -126.52 125.93 42.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.228 0.537 . . . . 99.989999999999995 110.491 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.3 mt -126.42 112.2 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.941 -0.762 . . . . 99.989999999999995 108.941 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 4.48 85.87 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.771 -1.332 . . . . 99.989999999999995 109.771 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.93 5.49 59.7 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.426 -0.67 . . . . 99.989999999999995 111.426 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -83.06 115.07 56.95 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 121.029 -0.268 . . . . 99.989999999999995 110.93 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.29 109.26 2.09 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.127 1.885 . . . . 99.989999999999995 112.682 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -151.77 171.13 18.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.897 -0.592 . . . . 99.989999999999995 109.684 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.434 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.1 p -143.67 126.74 16.45 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.08 -0.648 . . . . 99.989999999999995 111.945 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 48.3 tp -109.98 130.34 55.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.081 -0.509 . . . . 99.989999999999995 110.169 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.62 147.13 41.49 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.22 -1.152 . . . . 99.989999999999995 110.22 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.708 ' H ' ' CB ' ' A' ' 40' ' ' TYR . 49.2 mt -83.08 98.83 9.51 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 119.565 -0.854 . . . . 99.989999999999995 111.161 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.518 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 11.0 p90 -57.04 -40.94 77.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.312 -0.858 . . . . 99.989999999999995 110.593 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -43.02 165.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.892 -0.594 . . . . 99.989999999999995 111.187 -179.407 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.523 ' H ' ' CG ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 77.19 95.98 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.573 -0.451 . . . . 99.989999999999995 110.868 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.721 ' H ' ' NZ ' ' A' ' 16' ' ' LYS . . . -176.83 -124.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 99.989999999999995 110.338 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.11 37.72 24.33 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.125 -0.79 . . . . 99.989999999999995 111.125 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 64' ' ' TYR . 94.9 mt-30 -136.75 98.92 3.9 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.048 0.452 . . . . 99.989999999999995 110.115 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 61' ' ' GLN . 97.8 mt-10 -40.96 -35.68 0.56 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.756 -0.831 . . . . 99.989999999999995 108.756 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -98.28 50.97 1.01 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.686 -1.143 . . . . 99.989999999999995 108.151 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 61' ' ' GLN . 61.6 m-85 -43.58 -43.73 5.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.679 -0.691 . . . . 99.989999999999995 110.873 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 65' ' ' ASP . 51.4 p30 -159.09 -176.16 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 99.989999999999995 110.568 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -120.37 150.35 40.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 99.989999999999995 110.573 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.5 mt 56.28 78.67 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.49 . . . . 99.989999999999995 110.859 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -88.41 153.06 50.63 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 99.989999999999995 110.242 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.9 123.02 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.324 2.016 . . . . 99.989999999999995 112.13 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.19 -36.71 83.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 99.989999999999995 110.554 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -125.43 151.61 45.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.19 -0.459 . . . . 99.989999999999995 110.933 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 58.26 70.47 1.23 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.063 -0.517 . . . . 99.989999999999995 110.827 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -51.11 152.48 10.61 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.905 2.404 . . . . 99.989999999999995 112.06 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -53.49 -38.37 63.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 99.989999999999995 110.817 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.8 p -123.42 154.28 39.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 99.989999999999995 110.71 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -115.93 0.08 12.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.228 -0.442 . . . . 99.989999999999995 111.078 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.42 101.52 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.721 -0.392 . . . . 99.989999999999995 110.364 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.674 ' CE2' ' SG ' ' A' ' 105' ' ' CYS . 87.9 m-85 -73.84 118.96 17.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.185 0.517 . . . . 99.989999999999995 111.13 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tt -116.68 128.19 55.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.478 -0.783 . . . . 99.989999999999995 110.766 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.579 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 40.6 t -94.03 130.95 42.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.013 -0.54 . . . . 99.989999999999995 109.952 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 42.8 t -123.61 127.42 48.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.023 0.44 . . . . 99.989999999999995 111.152 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.431 ' H ' ' HA2' ' A' ' 114' ' ' GLY . 33.9 p90 -171.23 139.24 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 99.989999999999995 111.091 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -62.37 132.69 53.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.331 -0.989 . . . . 99.989999999999995 108.331 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.53 15.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 119.745 -0.782 . . . . 99.989999999999995 111.612 -178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.4 t -138.86 26.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.272 0.558 . . . . 99.989999999999995 109.894 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -121.31 86.82 43.95 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.611 -0.722 . . . . 99.989999999999995 110.06 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.56 -29.3 18.58 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.403 2.068 . . . . 99.989999999999995 112.352 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.1 m -70.45 -41.46 72.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.989 0.424 . . . . 99.989999999999995 110.484 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.547 ' O ' ' CG2' ' A' ' 93' ' ' VAL . 49.5 m -73.97 -53.45 10.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.922 -0.581 . . . . 99.989999999999995 111.765 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -54.38 -46.2 72.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.396 -0.366 . . . . 99.989999999999995 111.449 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -66.19 -28.15 68.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.08 -0.509 . . . . 99.989999999999995 111.531 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.582 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 24.2 m120 -102.64 -3.4 26.69 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.126 -0.629 . . . . 99.989999999999995 111.076 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.579 ' CG1' ' CG1' ' A' ' 80' ' ' VAL . 38.5 t -89.53 -71.6 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.703 -0.399 . . . . 99.989999999999995 111.831 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -70.69 -20.21 62.7 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.174 0.435 . . . . 99.989999999999995 112.174 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -112.64 -10.59 13.64 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.556 1.317 . . . . 99.989999999999995 114.556 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -129.61 -29.04 2.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.452 -0.899 . . . . 99.989999999999995 113.03 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.582 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 53.8 m95 -98.26 -31.38 12.09 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.643 -0.823 . . . . 99.989999999999995 110.827 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.552 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -67.85 -44.27 40.74 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 120.678 -0.409 . . . . 99.989999999999995 110.751 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 17.0 Cg_exo -63.51 -36.67 52.85 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.315 2.01 . . . . 99.989999999999995 111.757 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.31 -41.41 96.95 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.769 -0.372 . . . . 99.989999999999995 110.962 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 39.1 pt -83.19 -34.28 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.73 -0.388 . . . . 99.989999999999995 111.04 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 40.8 m -61.25 -40.7 95.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.294 -0.412 . . . . 99.989999999999995 111.486 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -58.67 -43.86 90.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.488 -0.324 . . . . 99.989999999999995 111.435 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -82.3 -15.02 54.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.418 -0.356 . . . . 99.989999999999995 111.101 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.674 ' SG ' ' CE2' ' A' ' 78' ' ' PHE . 1.7 t -114.66 108.77 48.74 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.859 -0.337 . . . . 99.989999999999995 111.316 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.01 163.1 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.947 1.764 . . . . 99.989999999999995 111.337 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -48.34 118.28 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 99.989999999999995 110.75 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.617 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -151.84 156.74 34.44 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 99.989999999999995 110.027 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.18 132.41 47.86 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.259 1.973 . . . . 99.989999999999995 112.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.723 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -130.9 130.35 43.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.154 0.502 . . . . 99.989999999999995 110.504 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 7.4 mp -92.73 131.58 37.68 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.302 -0.559 . . . . 99.989999999999995 110.914 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.0 tp -93.35 123.53 36.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 99.989999999999995 109.622 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 80' ' ' VAL . 42.1 t -143.3 152.17 16.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.569 -0.452 . . . . 99.989999999999995 111.299 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.431 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -141.15 -179.06 18.08 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.611 -0.995 . . . . 99.989999999999995 110.611 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 p -124.74 174.23 8.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.23 0.538 . . . . 99.989999999999995 110.848 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 117' ' ' ILE . 52.4 mt-30 48.5 28.97 1.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.317 -0.856 . . . . 99.989999999999995 111.904 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.667 ' CG2' ' H ' ' A' ' 119' ' ' LEU . 3.8 tt 31.23 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 109.932 -0.396 . . . . 99.989999999999995 109.932 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.523 ' N ' ' CG2' ' A' ' 117' ' ' ILE . 27.4 p-10 -109.66 9.07 25.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.312 0.577 . . . . 99.989999999999995 110.254 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.667 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 77.1 mt -123.15 4.32 9.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.111 -0.95 . . . . 99.989999999999995 108.78 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.551 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 30.99 66.48 0.14 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 114.754 -1.112 . . . . 99.989999999999995 110.336 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 120' ' ' ARG . 89.7 m-20 31.09 45.96 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.543 -0.463 . . . . 99.989999999999995 110.388 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -31.73 -62.56 0.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.962 -0.563 . . . . 99.989999999999995 111.957 -179.13 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.489 ' C ' ' O ' ' A' ' 122' ' ' ASP . 82.6 Cg_exo -31.57 -34.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.113 1.875 . . . . 99.989999999999995 111.1 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 122' ' ' ASP . 2.5 p -107.91 -53.24 2.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.611 -0.722 . . . . 99.989999999999995 111.11 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 129' ' ' LEU . 12.0 m -59.58 -45.91 90.5 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.996 -0.681 . . . . 99.989999999999995 109.665 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.72 -48.67 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 120.378 -0.529 . . . . 99.989999999999995 110.679 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -44.42 -40.53 5.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.334 -0.547 . . . . 99.989999999999995 110.58 -178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -110.52 -49.2 3.07 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.538 0.94 . . . . 99.989999999999995 113.538 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' A' ' 125' ' ' THR . 18.3 tp -55.5 -45.2 77.07 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.472 1.286 . . . . 99.989999999999995 114.472 -176.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . 97.66 125.57 0.01 OUTLIER 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.65 -0.87 . . . . 99.989999999999995 108.65 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -52.78 -44.38 66.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.691 -0.686 . . . . 99.989999999999995 111.393 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -62.27 -27.66 69.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.308 -0.405 . . . . 99.989999999999995 111.725 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -88.2 -3.29 58.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.942 0.719 . . . . 99.989999999999995 112.942 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.416 ' HB3' HH21 ' A' ' 120' ' ' ARG . 42.3 mt-30 -65.82 -41.48 91.8 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 119.967 -0.693 . . . . 99.989999999999995 111.52 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt 59.19 61.23 4.58 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.342 -0.39 . . . . 99.989999999999995 110.499 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.81 146.19 96.28 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.75 2.3 . . . . 99.989999999999995 112.315 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.717 ' CG2' ' H ' ' A' ' 138' ' ' THR . 94.6 mt -88.99 -119.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.216 0.531 . . . . 99.989999999999995 110.93 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.717 ' H ' ' CG2' ' A' ' 137' ' ' ILE . 49.8 p -133.33 37.75 0.39 Allowed Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.242 -0.89 . . . . 99.989999999999995 111.612 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 138' ' ' THR . 87.8 Cg_exo -23.63 -39.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.384 2.723 . . . . 99.989999999999995 112.663 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 138' ' ' THR . 97.3 mt-10 -66.02 -47.68 73.64 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.49 -0.484 . . . . 99.989999999999995 110.138 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 143' ' ' GLU . 84.4 m -54.37 -71.56 0.08 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.626 -0.43 . . . . 99.989999999999995 110.601 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 141' ' ' THR . . . -28.06 -31.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.054 0.761 . . . . 99.989999999999995 113.054 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 141' ' ' THR . 78.6 mm-40 -60.62 -39.91 89.94 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.96 -0.696 . . . . 99.989999999999995 110.834 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' THR . 20.8 tttt -98.04 -19.3 18.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 99.989999999999995 110.786 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -32.35 73.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 99.989999999999995 110.099 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -80.24 -39.83 28.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 99.989999999999995 110.922 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.04 -36.73 77.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 99.989999999999995 111.476 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 59.3 t0 -98.36 -16.44 19.31 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.361 0.504 . . . . 99.989999999999995 112.361 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 3.8 tp -117.46 34.4 5.15 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.292 -0.563 . . . . 99.989999999999995 112.051 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.522 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 23.2 mttm 80.85 149.41 0.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.282 0.563 . . . . 99.989999999999995 110.895 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 156.34 -177.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.209 -0.905 . . . . 99.989999999999995 110.762 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 110' ' ' PHE . 24.4 t -141.63 -52.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.706 -0.679 . . . . 99.989999999999995 109.846 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.584 ' NZ ' ' OD1' ' A' ' 167' ' ' ASN . 5.6 tttm -119.77 -172.54 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.726 -0.67 . . . . 99.989999999999995 109.553 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.616 ' CG ' ' O ' ' A' ' 154' ' ' TYR . 29.9 p90 -154.28 96.77 1.96 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.387 -1.338 . . . . 99.989999999999995 107.387 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -140.81 138.48 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 122.118 0.961 . . . . 99.989999999999995 111.848 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.746 ' O ' ' OG1' ' A' ' 161' ' ' THR . 88.7 mt-10 -123.62 98.33 5.78 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.553 -1.647 . . . . 99.989999999999995 106.553 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -114.62 146.11 41.21 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 123.188 1.471 . . . . 99.989999999999995 113.167 -176.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.514 ' N ' ' SG ' ' A' ' 157' ' ' CYS . 15.2 t -169.9 93.23 0.24 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 111.629 -2.532 . . . . 99.989999999999995 107.201 176.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 42.92 28.09 0.12 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.976 -1.466 . . . . 99.989999999999995 110.215 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 162' ' ' GLN . 21.4 mt -145.65 -81.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.303 -0.862 . . . . 99.989999999999995 110.488 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.746 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -57.39 52.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.164 0.507 . . . . 99.989999999999995 111.481 -178.234 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.706 ' N ' ' O ' ' A' ' 160' ' ' LEU . 5.4 pp0? -82.62 15.52 2.55 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.42 -2.067 . . . . 99.989999999999995 105.42 176.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.649 ' H ' ' C ' ' A' ' 161' ' ' THR . 25.5 mttt -89.47 0.63 56.74 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 113.14 -1.845 . . . . 99.989999999999995 108.752 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.622 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.04 -72.76 0.11 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 108.369 -1.893 . . . . 99.989999999999995 108.369 177.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 164' ' ' GLY . 11.1 mp -40.22 -19.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.564 -0.854 . . . . 99.989999999999995 110.686 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.622 ' N ' ' O ' ' A' ' 164' ' ' GLY . 28.4 tttt -80.06 -49.78 11.29 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.487 -0.931 . . . . 99.989999999999995 108.487 177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 164' ' ' GLY . 17.6 p-10 -77.9 4.53 11.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.604 -1.18 . . . . 99.989999999999995 109.791 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 171' ' ' GLU . 17.6 t -81.25 -58.11 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.214 -0.448 . . . . 99.989999999999995 110.243 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.45 ' C ' ' O ' ' A' ' 168' ' ' VAL . 40.0 m-85 -39.31 -39.88 0.7 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.051 -0.659 . . . . 99.989999999999995 109.705 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -65.89 -47.66 74.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.057 0.456 . . . . 99.989999999999995 110.022 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 168' ' ' VAL . 77.1 mm-40 -67.76 -18.92 65.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.937 -0.574 . . . . 99.989999999999995 110.153 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.35 -38.62 91.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 99.989999999999995 110.821 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 15.0 tt -62.11 -31.79 52.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.751 -0.379 . . . . 99.989999999999995 110.482 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.1 tp -63.36 -38.1 89.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 99.989999999999995 110.464 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.69 -22.92 66.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.95 -0.568 . . . . 99.989999999999995 110.867 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.19 68.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 99.989999999999995 110.427 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 38.9 tp -56.61 -36.77 69.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 99.989999999999995 110.57 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 99.989999999999995 110.583 -179.763 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.557 ' O ' ' HB1' ' A' ' 176' ' ' ALA . 90.5 mt-30 . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.894 0.378 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 2' ' ' GLN . 1.8 t -39.93 142.19 0.37 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.876 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.91 HD11 ' OD2' ' A' ' 76' ' ' ASP . 8.3 tp -128.57 149.68 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.953 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -95.93 141.09 29.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.795 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -134.76 147.49 50.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.825 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.476 ' HA ' ' H ' ' A' ' 56' ' ' PHE . 28.4 m -131.9 147.28 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.14 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.417 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 55.3 t -109.0 124.45 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.158 0.504 . . . . 0.0 110.942 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -127.25 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.849 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.528 ' HA3' HG21 ' A' ' 14' ' ' VAL . . . -148.71 -164.36 11.44 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.611 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.7 t0 -78.62 126.53 30.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 110.833 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.14 -88.62 0.01 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -136.6 127.7 27.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.78 0.324 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.528 HG21 ' HA3' ' A' ' 10' ' ' GLY . 8.6 m -140.64 150.8 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.305 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.596 ' CA ' ' OG1' ' A' ' 115' ' ' THR . . . 23.76 54.24 0.04 OUTLIER Glycine 0 N--CA 1.471 1.015 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.888 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.5 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 85.1 mttt -35.12 -58.85 0.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 20' ' ' LEU . 4.0 m -130.37 -55.94 1.09 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 17' ' ' THR . 87.7 m -34.84 -28.58 0.01 OUTLIER 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.045 0.45 . . . . 0.0 111.049 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 17' ' ' THR . 4.2 tt -76.3 -43.39 41.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.432 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.791 HD21 ' O ' ' A' ' 56' ' ' PHE . 96.0 mt -59.33 -35.96 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.089 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.016 HD12 HD22 ' A' ' 26' ' ' ASN . 12.8 pt -90.14 8.19 3.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.766 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -39.85 -77.83 0.02 OUTLIER 'General case' 0 C--O 1.241 0.611 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.504 -179.177 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.585 ' C ' ' N ' ' A' ' 25' ' ' THR . 14.9 p90 -39.93 -34.72 0.3 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 118.226 0.466 . . . . 0.0 111.499 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.508 ' CB ' ' O ' ' A' ' 21' ' ' ILE . 1.1 m -45.95 -14.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 25' ' ' THR . 55.7 m 50.53 37.31 15.68 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.705 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 1.016 HD22 HD12 ' A' ' 21' ' ' ILE . 91.7 m-20 -63.12 -40.37 97.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' ' O ' ' A' ' 26' ' ' ASN . 36.8 mttt 57.84 131.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.886 0.374 . . . . 0.0 110.457 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.606 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.8 mt -39.6 -55.84 3.24 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.984 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 28' ' ' LEU . 85.0 Cg_exo -38.64 -15.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.65 2.233 . . . . 0.0 113.048 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 28' ' ' LEU . 23.0 t -104.32 131.29 51.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.573 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 33' ' ' VAL . 96.9 mt-10 -67.54 -29.36 68.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.104 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -53.91 122.04 9.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.75 0.31 . . . . 0.0 110.806 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 33' ' ' VAL . 14.8 p -178.18 50.73 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.543 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 14.7 Cg_endo -59.68 131.42 40.0 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.626 2.217 . . . . 0.0 112.002 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 p -119.55 5.39 11.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.672 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.1 t -62.11 -40.59 88.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -109.79 132.94 53.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.204 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -84.67 124.02 31.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.796 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -99.37 144.99 27.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.046 0.45 . . . . 0.0 111.205 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.606 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 20.4 p90 -167.13 19.6 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.45 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.62 100.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.58 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 t -137.38 134.03 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.977 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 43' ' ' THR . 8.9 t -103.62 108.21 19.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.603 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -135.17 144.2 34.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.219 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.5 ptp -111.46 146.03 37.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.545 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 47' ' ' GLY . 39.1 mm -118.73 125.7 74.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.127 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 32.12 45.51 0.19 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.51 47.76 5.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.742 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 2.8 mt-10 -133.46 77.48 65.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.359 . . . . 0.0 110.108 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.29 106.85 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.965 2.443 . . . . 0.0 112.959 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.552 ' CE1' ' O ' ' A' ' 169' ' ' PHE . 30.7 p90 -155.84 166.27 34.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.3 127.18 37.19 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.955 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.914 HD22 ' HB2' ' A' ' 172' ' ' ALA . 41.5 tp -119.35 127.79 53.49 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.019 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -93.1 144.17 16.9 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.671 HD23 ' SG ' ' A' ' 6' ' ' CYS . 64.9 mt -137.29 129.74 29.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.201 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.791 ' O ' HD21 ' A' ' 20' ' ' LEU . 1.9 t80 -97.3 -164.27 1.13 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 58' ' ' THR . 49.1 p30 -162.33 -162.38 0.82 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.401 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.796 HG23 ' H ' ' A' ' 59' ' ' ALA . 4.4 t -8.25 -112.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.039 0.837 . . . . 0.0 112.803 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.796 ' H ' HG23 ' A' ' 58' ' ' THR . . . 39.81 83.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.42 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.77 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 121.017 0.437 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -136.65 151.15 48.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.538 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.91 ' OD2' HD11 ' A' ' 4' ' ' ILE . 84.1 m-20 -112.1 -19.61 12.23 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.924 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.487 ' CG1' HD13 ' A' ' 111' ' ' LEU . 19.7 t -122.24 120.43 61.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.144 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.587 ' C ' HD12 ' A' ' 79' ' ' LEU . 98.3 m-85 -87.53 122.18 30.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.128 0.489 . . . . 0.0 111.548 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.795 HD22 ' SG ' ' A' ' 6' ' ' CYS . 10.6 mp -111.73 114.2 27.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.002 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.4 m -98.59 129.23 49.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 114' ' ' GLY . 6.8 t -129.86 135.86 48.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.499 0.666 . . . . 0.0 112.042 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.453 ' H ' ' HA2' ' A' ' 114' ' ' GLY . 49.9 p90 -142.24 144.92 33.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.372 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.6 t -66.55 130.69 44.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 84' ' ' VAL . 10.7 t -63.64 4.24 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' SER . 14.7 p -129.99 144.1 39.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 118.557 0.617 . . . . 0.0 109.556 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.7 OUTLIER 83.65 92.16 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -48.11 -0.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.648 2.232 . . . . 0.0 113.113 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.647 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 19.9 m -66.19 -61.52 1.98 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.888 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.8 p -64.94 -35.02 79.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.525 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.771 ' CZ ' HD22 ' A' ' 145' ' ' LEU . 78.5 t80 -69.01 -50.52 48.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -64.12 -24.16 67.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.851 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.647 ' ND2' ' O ' ' A' ' 88' ' ' SER . 67.9 m-20 -86.99 -64.09 1.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.858 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 30.1 t -41.07 -61.92 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 142' ' ' ALA . 43.5 mtpt -67.96 -21.26 65.1 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 68.3 tt0 -106.11 -63.24 1.28 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 92' ' ' ASN . 17.4 mttp -67.19 -35.95 80.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.46 ' CD1' ' HA ' ' A' ' 93' ' ' VAL . 29.7 m95 -84.82 -33.93 22.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.899 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.948 ' O ' HG23 ' A' ' 102' ' ' THR . 2.3 t -44.69 -54.34 13.01 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.267 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 16.6 Cg_endo -60.46 -36.49 86.28 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.568 1.512 . . . . 0.0 111.61 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.84 -40.51 97.66 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.096 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 83.7 mt -73.8 -38.52 50.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.948 HG23 ' O ' ' A' ' 98' ' ' VAL . 49.8 p -61.42 -37.42 83.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.562 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -56.69 -36.99 70.25 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.22 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -55.19 -44.74 75.57 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.268 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.5 153.8 29.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.735 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -43.34 -76.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.293 1.995 . . . . 0.0 112.141 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -140.47 142.85 35.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.587 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -152.79 156.57 33.09 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.09 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.29 128.73 31.23 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.209 1.94 . . . . 0.0 110.91 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.727 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -124.0 123.5 40.51 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.72 -178.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 111' ' ' LEU . 8.8 mp -97.68 129.86 44.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.44 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -96.76 129.32 44.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.561 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.673 HG12 ' N ' ' A' ' 114' ' ' GLY . 51.5 t -147.38 168.12 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.347 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.673 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -135.51 166.63 24.46 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.596 ' OG1' ' CA ' ' A' ' 15' ' ' GLY . 11.2 t -123.56 174.58 7.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.109 0.48 . . . . 0.0 112.017 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.56 ' O ' ' C ' ' A' ' 117' ' ' ILE . 33.1 mt-30 34.16 31.04 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.232 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.883 HG23 ' N ' ' A' ' 118' ' ' ASP . 7.7 tt 24.84 -138.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 O-C-N 123.944 0.777 . . . . 0.0 109.452 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.883 ' N ' HG23 ' A' ' 117' ' ' ILE . 61.8 m-20 -84.87 71.93 10.83 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.573 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 119' ' ' LEU . 5.9 tt 66.1 91.42 0.08 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.631 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 119' ' ' LEU . 56.9 ttp180 . . . . . 0 N--CA 1.469 0.479 0 O-C-N 124.259 0.974 . . . . 0.0 111.181 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 137' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.149 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.584 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -133.23 -65.29 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.6 Cg_exo -20.54 -73.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 124.001 3.134 . . . . 0.0 113.983 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -114.82 -31.05 6.25 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.496 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.472 HG21 ' CD1' ' A' ' 137' ' ' ILE . 40.2 m -55.78 -42.61 75.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.305 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.513 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -69.55 -38.22 77.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.526 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.59 -35.27 79.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.316 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.97 -50.41 72.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.319 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.771 HD22 ' CZ ' ' A' ' 90' ' ' PHE . 11.0 mp -64.05 -33.04 74.85 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.684 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.78 -41.4 75.18 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 -62.43 -35.11 78.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.468 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -47.39 -30.83 3.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.1 mt -123.48 -117.67 0.29 Allowed 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 151' ' ' ALA . 76.9 tttt -177.46 69.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.219 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -53.13 -121.94 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.666 0.746 . . . . 0.0 111.093 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.469 HG23 ' H ' ' A' ' 110' ' ' PHE . 71.6 t -155.02 -61.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.213 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.527 ' C ' ' CG ' ' A' ' 154' ' ' TYR . 18.5 mttp -101.76 -173.65 2.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.815 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.679 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -170.03 95.5 0.26 Allowed 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.926 HG22 ' H ' ' A' ' 156' ' ' GLU . 3.6 p -171.92 -167.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.399 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.926 ' H ' HG22 ' A' ' 155' ' ' VAL . 27.9 mp0 -130.66 -170.62 2.38 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.313 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.808 ' SG ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -171.76 121.13 0.48 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.878 0.847 . . . . 0.0 109.508 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.665 ' HB3' ' H ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -173.88 92.74 0.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.097 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 31.34 31.25 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.578 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.705 HD23 ' CD1' ' A' ' 117' ' ' ILE . 21.7 tp -164.76 -77.45 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.805 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.834 ' C ' ' H ' ' A' ' 163' ' ' LYS . 2.8 m -58.98 3.45 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.132 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.603 ' H ' ' C ' ' A' ' 160' ' ' LEU . 3.7 pt20 -64.8 30.38 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.834 ' H ' ' C ' ' A' ' 161' ' ' THR . 94.2 mttt -90.89 3.95 53.17 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -118.2 -70.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.808 HD12 ' SG ' ' A' ' 157' ' ' CYS . 7.3 mt -41.03 -14.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.899 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 164' ' ' GLY . 60.0 tttp -82.93 -50.58 8.43 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 164' ' ' GLY . 29.9 m120 -77.61 3.73 13.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.487 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 171' ' ' GLU . 33.2 t -84.04 -51.76 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.759 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.552 ' O ' ' CE1' ' A' ' 51' ' ' TYR . 6.7 m-85 -37.69 -42.36 0.56 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.808 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 173' ' ' ILE . 61.5 t0 -67.52 -40.64 85.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.35 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 168' ' ' VAL . 76.7 mm-40 -67.03 -23.31 65.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.05 0.453 . . . . 0.0 109.951 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.914 ' HB2' HD22 ' A' ' 53' ' ' LEU . . . -59.78 -39.5 85.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.903 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 170' ' ' ASP . 14.0 tt -60.58 -31.69 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.625 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.1 tp -65.7 -38.56 89.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.139 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.47 -33.8 76.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 2' ' ' GLN . . . -59.14 -32.5 69.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.64 -36.01 69.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.386 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 99.99 110.641 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 3' ' ' THR . 91.6 mt-30 . . . . . 0 C--O 1.231 0.09 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.486 ' CB ' ' HG1' ' A' ' 52' ' ' THR . 2.0 t -36.83 135.07 0.46 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.241 0.543 . . . . 0.0 110.737 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 tp -127.27 150.76 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.282 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -114.05 157.91 21.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.214 0.53 . . . . 0.0 111.623 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.23 153.35 47.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.388 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 9' ' ' VAL . 45.8 t -122.48 133.09 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.539 -0.465 . . . . 0.0 112.027 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.668 HG11 ' O ' ' A' ' 58' ' ' THR . 10.5 p -50.02 120.86 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.166 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 7' ' ' VAL . 47.9 t -127.63 131.49 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.19 -169.91 37.56 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.314 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.619 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 58.5 t0 -123.29 139.63 53.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.923 0.392 . . . . 0.0 110.677 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 63.42 -117.19 10.5 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.95 128.83 10.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 110.421 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.51 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 24.2 m -136.53 164.33 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.552 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -74.65 80.76 0.89 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.118 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.634 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -81.46 -1.16 44.83 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.469 -0.43 . . . . 0.0 110.914 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.3 p -68.42 -53.32 24.47 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.107 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' ILE . 93.2 m -69.25 -22.42 63.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.69 0.757 . . . . 0.0 109.811 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.47 -56.06 16.67 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.626 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.11 -34.09 74.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.027 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 18' ' ' CYS . 1.7 tp -55.17 -10.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.818 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 97.3 p -42.21 -80.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.076 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.539 ' N ' ' OG ' ' A' ' 22' ' ' SER . 79.7 t80 -62.08 -33.37 74.3 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.482 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.7 m -47.86 -45.14 29.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.819 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -151.9 -12.53 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.804 -179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 25' ' ' THR . 47.9 t30 53.98 119.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.73 0.3 . . . . 0.0 111.18 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.722 ' H ' ' NE2' ' A' ' 162' ' ' GLN . 17.2 mttm 61.08 62.87 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.567 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -116.19 89.66 26.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.05 158.91 1.15 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.375 2.05 . . . . 0.0 111.691 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.2 m -55.13 141.89 33.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.99 0.424 . . . . 0.0 110.931 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 33' ' ' VAL . 84.0 tt0 -178.56 88.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.633 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' O ' ' C ' ' A' ' 33' ' ' VAL . 56.6 t80 64.77 -13.2 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.17 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.615 ' H ' ' C ' ' A' ' 31' ' ' GLU . 39.0 t 36.17 61.83 2.94 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.426 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.58 133.52 32.36 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.362 2.041 . . . . 0.0 111.562 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 p -128.63 163.11 25.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 111.029 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 38' ' ' ASP . 41.0 t -118.98 132.36 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.953 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.97 -3.3 24.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.124 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.491 ' H ' HG12 ' A' ' 36' ' ' VAL . 91.7 m-20 -60.82 -48.5 81.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.575 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -176.8 172.87 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.417 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 55' ' ' LEU . 82.8 m-85 -125.66 15.94 8.13 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.86 98.02 5.46 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.602 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.22 135.8 52.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.628 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 51' ' ' TYR . 2.1 t -107.83 138.87 43.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.173 0.511 . . . . 0.0 111.71 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.2 144.62 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.861 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.1 mtm -112.11 136.46 51.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.713 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.617 HG21 ' CG ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER -150.88 99.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.553 178.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.02 56.76 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.47 41.69 24.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.02 76.87 75.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 110.68 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.433 ' C ' ' CD2' ' A' ' 51' ' ' TYR . 82.1 Cg_endo -86.0 117.68 1.65 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.113 2.542 . . . . 0.0 112.563 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' A' ' 50' ' ' PRO . 97.8 m-85 -154.49 174.04 15.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.777 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.532 ' C ' HD22 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -121.75 126.97 50.11 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.499 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.908 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -109.9 123.41 49.55 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.264 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.724 ' C ' HD12 ' A' ' 55' ' ' LEU . . . -93.76 135.51 12.6 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.724 HD12 ' C ' ' A' ' 54' ' ' GLY . 5.8 mp -142.58 108.89 5.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.091 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.454 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 75.3 m-85 -80.26 168.99 18.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 58' ' ' THR . 51.9 p30 -138.11 -179.4 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 13.4 m 48.62 174.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.857 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 58' ' ' THR . . . 87.06 124.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.704 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.578 -179.98 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.553 0.216 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 t -133.99 157.36 46.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.693 0.282 . . . . 0.0 110.348 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 59.9 t0 -150.17 -10.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.396 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.67 ' CG1' HD13 ' A' ' 111' ' ' LEU . 22.8 t -119.03 106.22 19.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.285 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -81.16 129.96 34.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.013 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.565 HD11 HG21 ' A' ' 113' ' ' VAL . 30.4 tp -114.21 113.09 24.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.6 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.73 132.56 33.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' VAL . 49.4 t -132.81 116.71 16.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.094 0.473 . . . . 0.0 111.287 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.432 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 39.6 p90 -153.53 155.72 36.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.792 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 86' ' ' SER . 30.1 t -71.85 128.85 37.07 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.479 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.749 HG11 ' OE2' ' A' ' 156' ' ' GLU . 2.1 t -59.77 -2.17 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 85' ' ' VAL . 7.2 p -127.75 30.98 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.461 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 83' ' ' SER . 5.2 p -122.51 82.94 47.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.472 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -51.44 -30.29 34.29 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.667 2.245 . . . . 0.0 112.286 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.632 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 22.5 m -67.72 -47.65 68.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.444 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.955 ' O ' HG22 ' A' ' 93' ' ' VAL . 97.0 p -67.87 -35.22 78.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.46 -47.51 85.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.802 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -71.49 -18.52 62.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.609 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 88' ' ' SER . 56.3 m-20 -93.17 -67.08 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.955 HG22 ' O ' ' A' ' 89' ' ' SER . 31.0 m -45.23 -50.1 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.495 ' N ' HG23 ' A' ' 93' ' ' VAL . 59.5 mttm -70.71 -32.27 69.42 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 83.5 tt0 -107.6 -60.92 1.64 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 92' ' ' ASN . 75.4 mttt -63.44 -34.92 78.81 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.419 ' CE3' ' OE1' ' A' ' 100' ' ' GLU . 49.8 m95 -86.26 -29.4 23.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.523 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -44.77 -53.98 14.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.853 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 29.1 Cg_endo -65.14 -33.13 51.04 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.615 1.543 . . . . 0.0 111.474 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.419 ' OE1' ' CE3' ' A' ' 97' ' ' TRP . 84.6 tt0 -59.76 -37.73 79.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.8 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.1 pt -94.91 -29.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.329 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 105' ' ' CYS . 55.1 m -52.33 -40.72 62.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.62 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -53.78 -33.33 55.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -54.55 -43.56 72.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.119 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -152.3 152.88 30.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.769 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.69 -42.87 2.17 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.664 2.243 . . . . 0.0 112.651 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 13.3 tttm -138.34 130.19 28.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 t -165.66 147.45 6.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.262 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.39 135.57 58.43 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.187 1.925 . . . . 0.0 111.427 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.695 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -116.52 119.28 35.1 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.005 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.67 HD13 ' CG1' ' A' ' 77' ' ' VAL . 10.0 mp -94.64 119.37 33.18 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.445 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 113' ' ' VAL . 46.0 mt -90.94 130.19 36.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.592 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 114' ' ' GLY . 52.0 t -153.22 162.49 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.368 0.604 . . . . 0.0 112.122 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.569 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -137.08 170.37 23.55 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 9.8 t -136.06 167.03 22.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.343 0.572 . . . . 0.0 111.776 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.534 ' O ' ' O ' ' A' ' 117' ' ' ILE . 63.2 mt-30 55.6 25.76 8.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.881 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.833 HG23 ' N ' ' A' ' 118' ' ' ASP . 6.3 tt 30.28 -151.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.304 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.833 ' N ' HG23 ' A' ' 117' ' ' ILE . 52.9 p30 -122.86 29.76 6.69 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.831 ' H ' HG23 ' A' ' 117' ' ' ILE . 7.7 tt -139.78 -43.02 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.242 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.593 ' H ' HG22 ' A' ' 117' ' ' ILE . 25.7 mmt180 . . . . . 0 CA--C 1.516 -0.348 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 137' ' ' ILE . 7.7 tt . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.696 0.284 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.604 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.99 -65.77 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.604 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.2 Cg_exo -24.27 -68.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 123.7 2.933 . . . . 0.0 114.38 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -109.12 -35.13 6.39 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.653 -0.419 . . . . 0.0 112.102 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.447 ' OG1' ' C ' ' A' ' 137' ' ' ILE . 61.0 p -56.42 -38.2 71.24 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.344 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.3 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.745 0.307 . . . . 0.0 111.18 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.48 -37.52 81.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.007 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -59.88 -50.4 73.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 80.4 mt -58.87 -28.91 66.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.795 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.48 -38.74 87.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.058 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -58.47 -40.39 82.59 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.296 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -53.88 -29.59 42.3 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 146' ' ' ALA . 81.8 mt -137.76 -112.02 0.17 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.045 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.73 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 59.9 mttm -143.78 -136.87 0.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.094 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 153.89 -160.85 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 O-C-N 123.319 0.387 . . . . 0.0 110.229 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 110' ' ' PHE . 88.2 t -155.88 -68.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.613 ' CE ' HD23 ' A' ' 111' ' ' LEU . 3.9 mtmp? -101.94 177.97 4.75 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.603 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 27.3 p90 -169.11 94.11 0.3 Allowed 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.601 HG22 ' C ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -170.72 -167.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.409 -177.789 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.749 ' OE2' HG11 ' A' ' 84' ' ' VAL . 57.8 mt-10 -126.37 -172.3 2.59 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.33 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.533 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 1.2 p -171.71 117.2 0.4 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.692 ' OG ' ' N ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -173.14 93.75 0.11 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.974 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 31.51 32.69 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.722 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.605 ' C ' ' H ' ' A' ' 162' ' ' GLN . 5.6 tt -165.98 -77.5 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.995 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.813 ' C ' ' H ' ' A' ' 163' ' ' LYS . 2.4 m -59.3 5.6 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.18 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.722 ' NE2' ' H ' ' A' ' 27' ' ' LYS . 24.5 mt-30 -65.77 30.96 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.813 ' H ' ' C ' ' A' ' 161' ' ' THR . 99.5 mttt -90.57 5.43 47.89 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -128.41 -71.4 0.15 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 164' ' ' GLY . 3.9 mm? -37.45 -21.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.052 0.453 . . . . 0.0 110.341 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.634 ' N ' ' O ' ' A' ' 164' ' ' GLY . 16.7 tttm -78.98 -52.56 8.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 164' ' ' GLY . 14.7 t-20 -78.98 4.06 15.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.907 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 171' ' ' GLU . 2.9 t -76.57 -58.2 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.468 ' C ' ' O ' ' A' ' 168' ' ' VAL . 71.6 m-85 -35.48 -37.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.73 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.617 ' CG ' HG21 ' A' ' 46' ' ' ILE . 76.4 m-20 -71.28 -45.16 63.79 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.622 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 168' ' ' VAL . 97.1 mt-10 -69.37 -27.47 65.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.988 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.609 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . . . -63.3 -30.79 71.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.56 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 176' ' ' ALA . 1.2 pp -66.08 -27.1 39.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.73 -37.38 78.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.526 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.01 -19.54 64.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.462 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -59.85 -35.76 75.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.27 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 62.0 mt -59.44 -33.47 71.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.19 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.426 -179.845 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 3' ' ' THR . 91.0 mt-30 . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.827 0.346 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -40.5 114.93 0.5 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.388 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.899 HD11 ' OD2' ' A' ' 76' ' ' ASP . 9.7 tp -117.59 144.38 25.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.207 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -91.99 140.1 29.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 110.612 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.87 ' SG ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -141.01 151.26 43.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.711 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.462 HG22 ' OG1' ' A' ' 75' ' ' THR . 29.3 m -127.2 142.86 42.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.585 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.491 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 43.3 t -111.19 124.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.199 0.523 . . . . 0.0 110.895 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.529 ' C ' ' HZ3' ' A' ' 16' ' ' LYS . 19.6 m -133.42 161.51 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.938 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.759 ' N ' ' HZ3' ' A' ' 16' ' ' LYS . . . -172.75 -168.76 34.5 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.584 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.596 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 42.9 t0 -80.35 121.86 26.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 110.817 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.688 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -45.72 98.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 151.34 20.58 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.663 0.273 . . . . 0.0 111.522 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.63 135.97 58.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.037 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.71 88.76 0.74 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HZ3' ' N ' ' A' ' 10' ' ' GLY . 84.7 mttt -81.65 -0.21 41.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.664 0.269 . . . . 0.0 110.79 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.81 HG21 ' O ' ' A' ' 34' ' ' PRO . 21.4 m -80.49 -70.29 0.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.163 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.652 ' HA ' HD12 ' A' ' 21' ' ' ILE . 18.0 m -50.91 -25.25 4.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.62 0.724 . . . . 0.0 109.345 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.61 ' CD2' ' SG ' ' A' ' 81' ' ' CYS . 62.4 tp -55.05 -55.0 35.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.375 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' SER . 82.1 mt -69.96 -32.66 71.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 18' ' ' CYS . 93.2 mt -62.06 -1.8 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.966 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.5 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -56.35 -75.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.059 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.689 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -62.5 -28.64 69.98 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.165 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.651 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 2.6 m -54.46 -48.5 71.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.8 p -131.52 -21.84 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.474 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 22' ' ' SER . 83.0 m-20 61.43 114.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.131 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.0 mttt 61.92 59.21 1.76 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.093 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 tp -125.34 66.85 54.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.026 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.51 145.06 37.08 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.595 2.197 . . . . 0.0 111.877 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 89.1 p -138.2 153.34 49.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.868 0.366 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.48 -32.62 74.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -115.37 156.44 25.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.927 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 t -118.56 83.83 22.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.825 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.81 ' O ' HG21 ' A' ' 17' ' ' THR . 13.1 Cg_exo -63.89 144.41 88.18 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.666 2.244 . . . . 0.0 111.508 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.0 p -123.97 156.9 35.57 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.946 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 38' ' ' ASP . 40.2 t -123.16 131.34 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 78.1 t80 -97.42 -9.28 27.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.886 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' H ' HG12 ' A' ' 36' ' ' VAL . 96.0 m-20 -69.41 -70.96 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.111 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 40' ' ' TYR . 40.3 t-20 -173.8 174.06 3.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.669 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.455 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -139.0 23.83 2.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.51 98.62 10.22 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.446 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.486 ' O ' ' OG1' ' A' ' 52' ' ' THR . 15.6 m -115.55 158.16 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.219 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.6 t -123.22 140.92 52.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.015 0.436 . . . . 0.0 111.225 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 45' ' ' MET . 13.2 p -149.04 152.49 12.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.968 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.403 ' N ' HG22 ' A' ' 44' ' ' VAL . 70.7 mtm -101.3 123.35 45.26 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.674 HD13 ' HB2' ' A' ' 170' ' ' ASP . 9.1 tt -134.17 136.79 52.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.217 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.19 28.06 4.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.5 49.04 16.05 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -131.45 78.13 72.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.753 0.311 . . . . 0.0 110.329 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.598 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 20.6 Cg_exo -61.62 99.37 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.736 2.291 . . . . 0.0 112.143 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 83.5 m-85 -161.12 -179.38 7.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.508 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.549 ' C ' HD22 ' A' ' 53' ' ' LEU . 4.8 t -144.43 144.15 31.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.37 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.908 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.1 mm? -111.64 127.32 55.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.526 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -83.1 122.67 5.83 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.591 HD23 ' SG ' ' A' ' 6' ' ' CYS . 86.5 mt -127.55 145.6 50.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.297 0.57 . . . . 0.0 112.254 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.491 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 39.7 t80 -119.55 -168.39 1.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 59' ' ' ALA . 52.0 p30 -174.11 -162.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.574 0.624 . . . . 0.0 110.327 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 60' ' ' GLY . 81.7 p 43.23 -93.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.7 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 43.6 17.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.717 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 58' ' ' THR . . . . . . . . 0 CA--C 1.528 0.87 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.506 ' O ' ' C ' ' A' ' 75' ' ' THR . 95.7 mt-30 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.349 0.118 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.506 ' C ' ' O ' ' A' ' 74' ' ' GLN . 2.1 t 23.19 61.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.603 0.564 . . . . 0.0 111.439 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.899 ' OD2' HD11 ' A' ' 4' ' ' ILE . 90.1 m-20 -65.01 -39.22 93.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 ' HB1' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -105.88 104.11 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.54 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.621 ' C ' HD12 ' A' ' 79' ' ' LEU . 96.8 m-85 -78.92 125.15 28.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.162 0.506 . . . . 0.0 111.87 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.87 HD13 ' SG ' ' A' ' 6' ' ' CYS . 10.5 mp -112.59 128.43 56.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.974 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.0 m -109.88 136.84 44.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.675 ' O ' HG21 ' A' ' 93' ' ' VAL . 1.3 m -112.36 127.23 55.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.075 0.464 . . . . 0.0 111.43 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 113' ' ' VAL . 48.7 p90 -149.73 115.75 5.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.419 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.664 ' OG ' HG12 ' A' ' 85' ' ' VAL . 35.5 t -58.59 139.78 55.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 84' ' ' VAL . 11.1 p -101.01 38.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.544 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.664 HG12 ' OG ' ' A' ' 83' ' ' SER . 1.9 p -129.3 -7.38 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.832 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.1 154.71 55.92 Favored Pre-proline 0 C--N 1.331 -0.218 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.733 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.594 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 57.8 Cg_endo -73.04 -40.79 1.58 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.667 2.245 . . . . 0.0 112.758 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.4 p -82.86 -7.94 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.31 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 83' ' ' SER . 84.2 p -60.63 -41.1 94.2 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.177 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.594 ' CE1' ' O ' ' A' ' 87' ' ' PRO . 22.6 p90 -89.35 -41.25 12.24 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.181 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.2 tt0 -57.7 -32.81 67.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.116 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 90.5 m-20 -77.34 -39.38 47.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.326 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.675 HG21 ' O ' ' A' ' 81' ' ' CYS . 9.6 t -84.8 -66.87 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 93' ' ' VAL . 92.9 mttt -61.43 -17.67 55.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.528 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 95.3 mt-10 -125.72 -48.44 1.65 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -78.53 -41.01 33.39 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.606 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 57.6 m95 -92.61 -25.53 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.381 -0.928 . . . . 0.0 112.29 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.539 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -56.34 -45.37 99.93 Favored Pre-proline 0 CA--C 1.527 0.092 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.118 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 25.7 Cg_exo -57.46 -43.92 47.03 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.119 1.88 . . . . 0.0 110.76 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -57.4 -42.52 82.4 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.555 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.7 mt -69.79 -36.34 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.908 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 105' ' ' CYS . 49.8 m -57.11 -31.68 65.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.178 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -46.85 -45.54 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.063 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -59.9 -33.47 71.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 109.953 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' THR . 5.1 t 70.79 58.9 0.46 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.49 120.44 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.731 2.287 . . . . 0.0 112.057 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.7 0.29 57.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.391 . . . . 0.0 110.437 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.3 157.4 80.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.419 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -50.08 144.61 21.79 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.606 2.204 . . . . 0.0 111.662 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.734 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -118.8 119.18 33.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.193 0.521 . . . . 0.0 110.577 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 111' ' ' LEU . 8.5 mp -97.63 130.89 44.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.38 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.421 HD12 ' CD1' ' A' ' 154' ' ' TYR . 92.3 mt -94.58 129.04 41.56 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.603 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 30.5 t -136.33 153.64 31.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.584 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -134.96 168.28 23.73 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.472 ' H ' ' HA ' ' A' ' 83' ' ' SER . 3.4 p -124.81 177.44 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.167 0.508 . . . . 0.0 110.794 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.55 ' O ' ' C ' ' A' ' 117' ' ' ILE . 16.4 tt0 36.55 30.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.158 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.875 HG23 ' N ' ' A' ' 118' ' ' ASP . 6.0 tt 19.94 -138.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 O-C-N 123.602 0.564 . . . . 0.0 110.012 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.875 ' N ' HG23 ' A' ' 117' ' ' ILE . 1.0 OUTLIER -93.27 55.5 2.3 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.626 -0.829 . . . . 0.0 109.846 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 120' ' ' ARG . 2.3 tt 85.93 77.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.824 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.54 ' C ' ' O ' ' A' ' 119' ' ' LEU . 45.2 mtm180 . . . . . 0 N--CA 1.47 0.551 0 O-C-N 123.944 0.778 . . . . 0.0 110.817 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.68 ' O ' HG23 ' A' ' 84' ' ' VAL . 73.3 mt . . . . . 0 C--O 1.231 0.107 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.754 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -131.38 -39.66 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.754 ' CD ' ' H ' ' A' ' 138' ' ' THR . 69.4 Cg_endo -88.93 -48.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.126 1.884 . . . . 0.0 114.591 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.67 -52.74 41.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.617 ' OG1' HG22 ' A' ' 137' ' ' ILE . 30.9 p -83.32 -10.74 58.31 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -83.93 -63.07 1.41 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.365 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.15 -39.1 93.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.97 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -66.34 -57.07 8.26 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.361 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.38 -33.8 71.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.322 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.53 -38.67 87.66 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -61.4 -40.58 94.89 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.065 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -51.95 -32.42 33.2 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 146' ' ' ALA . 75.6 mt -130.59 -116.61 0.23 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.178 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.701 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 53.2 mmtt -133.32 -145.32 0.24 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.041 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 151.41 -166.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.894 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 151' ' ' ALA . 41.2 t -159.16 -66.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.68 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 2.5 tttm -105.58 -176.83 3.19 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.079 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 153' ' ' LYS . 13.8 m-85 -161.13 95.95 1.07 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' A' ' 165' ' ' LEU . 9.6 p -143.82 144.46 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-O 121.925 0.869 . . . . 0.0 111.956 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.658 ' O ' ' OG1' ' A' ' 161' ' ' THR . 8.3 mm-40 -126.75 98.57 5.42 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.441 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.95 144.21 43.45 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 123.127 1.441 . . . . 0.0 113.609 -175.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 160' ' ' LEU . 38.2 t -158.38 93.6 1.22 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 111.793 -2.458 . . . . 0.0 106.621 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 37.23 29.71 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.587 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.773 ' O ' ' N ' ' A' ' 162' ' ' GLN . 77.2 mt -145.32 -82.05 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.425 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.673 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -53.6 44.25 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.504 0.502 . . . . 0.0 112.341 -177.423 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.773 ' N ' ' O ' ' A' ' 160' ' ' LEU . 11.9 pt20 -75.72 14.72 0.6 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.673 ' H ' ' C ' ' A' ' 161' ' ' THR . 89.8 mttt -78.33 -4.91 50.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.822 -1.536 . . . . 0.0 107.434 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.7 -70.99 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 107.754 -2.139 . . . . 0.0 107.754 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.43 ' CD2' HG11 ' A' ' 155' ' ' VAL . 2.2 mm? -38.25 -19.1 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.447 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 164' ' ' GLY . 60.2 tttm -84.12 -48.33 9.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 164' ' ' GLY . 77.8 m-20 -78.53 6.53 8.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.029 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 169' ' ' PHE . 5.7 t -83.26 -60.09 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.196 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.689 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 57.8 m-85 -40.34 -47.8 2.58 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.355 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.674 ' HB2' HD13 ' A' ' 46' ' ' ILE . 64.6 t0 -67.13 -43.17 83.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.845 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.56 -27.04 66.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.325 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.521 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . . . -63.68 -33.25 75.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.096 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.76 -37.81 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.578 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.633 HD22 ' N ' ' A' ' 174' ' ' LEU . 3.5 mm? -64.27 -31.92 73.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.049 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.448 ' HB1' HG13 ' A' ' 77' ' ' VAL . . . -62.2 -27.4 68.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.807 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.498 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . . . -63.79 -32.6 74.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 110.206 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.81 -35.76 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.618 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.369 -0.378 . . . . 99.99 110.683 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 3' ' ' THR . 81.0 mt-30 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.861 0.363 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -37.76 128.34 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.055 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 176' ' ' ALA . 19.7 tt -122.2 135.73 61.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.425 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -77.15 145.93 37.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.049 0.452 . . . . 0.0 111.517 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -139.65 136.73 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.033 179.585 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 56' ' ' PHE . 25.9 m -130.48 148.15 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.364 . . . . 0.0 111.485 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.574 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 47.1 t -115.95 120.78 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 111.078 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.95 158.27 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.095 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.49 -174.65 34.49 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.64 ' H ' ' CG2' ' A' ' 93' ' ' VAL . 23.5 t70 -81.2 121.94 26.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.019 0.438 . . . . 0.0 110.588 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . 43.75 64.6 1.83 Allowed Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.534 ' HB2' ' HZ2' ' A' ' 16' ' ' LYS . . . -16.98 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.854 0.359 . . . . 0.0 111.948 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.597 HG12 ' OE1' ' A' ' 116' ' ' GLN . 99.5 t -66.32 -55.78 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.94 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.76 59.63 0.31 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.716 -0.755 . . . . 0.0 111.902 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.534 ' HZ2' ' HB2' ' A' ' 13' ' ' ALA . 17.8 mttt -77.25 -7.2 55.54 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.659 -0.318 . . . . 0.0 110.838 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.7 p -63.17 -44.69 94.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.582 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.5 m -84.64 -14.04 49.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.59 0.71 . . . . 0.0 110.167 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.594 HD22 ' SG ' ' A' ' 81' ' ' CYS . 14.0 tp -73.58 -42.99 60.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.847 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.796 ' CD1' HD12 ' A' ' 55' ' ' LEU . 26.7 tp -65.45 -39.14 91.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.429 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.468 ' O ' ' OG1' ' A' ' 24' ' ' THR . 10.5 pt -76.38 -3.51 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 21' ' ' ILE . 2.0 m -42.14 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.768 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.569 ' C ' ' H ' ' A' ' 25' ' ' THR . 40.0 t80 -54.31 -39.94 67.46 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.029 0.377 . . . . 0.0 111.96 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 21' ' ' ILE . 23.0 p -49.57 -9.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.013 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.569 ' H ' ' C ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER 76.5 95.52 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.749 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.513 ' HB3' HE22 ' A' ' 162' ' ' GLN . 25.9 t30 -141.11 -69.56 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.4 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.773 ' H ' HE22 ' A' ' 162' ' ' GLN . 30.9 tttt 48.22 53.09 12.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mt -147.0 87.24 6.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.42 134.08 55.89 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.056 1.838 . . . . 0.0 111.378 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -125.02 145.08 50.07 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.872 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.37 -31.65 72.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.519 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -123.03 146.25 47.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.037 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 33' ' ' VAL . 15.9 m -119.79 88.13 39.2 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.31 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -53.77 148.06 38.38 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.639 2.226 . . . . 0.0 112.316 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.6 m -76.68 142.92 40.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.45 163.29 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.68 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -115.97 156.96 25.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.522 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 0.8 OUTLIER 51.73 -146.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.993 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 15.6 t-20 81.66 64.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 110.56 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.608 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 26.6 p90 -157.0 38.53 0.31 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.14 98.35 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.612 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.507 ' O ' ' OG1' ' A' ' 52' ' ' THR . 18.5 t -135.66 130.45 49.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.318 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 t -94.54 133.94 37.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.685 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -135.25 142.86 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.3 mtm -113.15 130.27 56.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.298 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 48' ' ' GLY . 7.7 tp -131.96 136.2 57.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.636 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 31.14 35.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.889 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 79.63 65.37 1.78 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.572 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -151.26 88.09 4.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.59 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 42.7 Cg_endo -76.04 112.55 3.52 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.09 1.86 . . . . 0.0 112.575 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 95.9 m-85 -162.59 166.95 24.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 6.8 t -138.04 148.4 45.05 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.217 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -122.74 133.3 54.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.748 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -73.0 148.15 40.8 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.796 HD12 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -132.52 119.11 20.11 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.33 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.574 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 17.2 t80 -107.9 -176.34 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.79 ' OD2' HD22 ' A' ' 20' ' ' LEU . 52.7 p30 -176.86 -165.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.065 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.508 ' H ' ' HB2' ' A' ' 16' ' ' LYS . 31.5 p 36.59 -148.86 0.01 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.073 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 54.75 172.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.322 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.724 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.466 0.174 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.448 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 10.3 t -41.18 135.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 110.685 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -91.95 -24.37 19.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.725 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.411 HG12 HD13 ' A' ' 111' ' ' LEU . 4.2 t -119.14 110.02 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.216 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.547 ' C ' HD12 ' A' ' 79' ' ' LEU . 96.8 m-85 -86.33 126.65 34.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.165 0.507 . . . . 0.0 112.006 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.3 mp -106.38 110.01 22.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.367 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 113' ' ' VAL . 39.0 t -74.53 129.0 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.739 ' O ' HG21 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -122.27 129.89 52.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.113 0.482 . . . . 0.0 112.003 -179.03 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.613 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 4.0 p90 -166.42 125.75 1.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.36 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.546 ' HB3' HG11 ' A' ' 14' ' ' VAL . 84.2 p -52.89 146.36 10.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.319 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.58 4.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.493 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 119' ' ' LEU . 80.3 t -127.79 148.86 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.25 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.9 t 93.24 96.24 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.244 0 O-C-N 123.643 0.589 . . . . 0.0 110.328 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.446 ' O ' ' CE2' ' A' ' 90' ' ' PHE . 61.9 Cg_exo -48.97 -2.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.67 2.247 . . . . 0.0 112.72 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 86' ' ' SER . 2.2 t -97.48 -34.73 10.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -57.01 -40.74 77.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.702 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.461 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 2.4 p90 -82.29 -32.8 29.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.319 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.1 tt0 -54.3 -28.67 43.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.925 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' LYS . 72.1 m-20 -90.51 -64.79 1.08 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.578 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.739 HG21 ' O ' ' A' ' 81' ' ' CYS . 54.7 t -50.12 -60.59 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.35 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.733 ' HZ3' HD11 ' A' ' 112' ' ' LEU . 26.6 mttt -71.57 -9.83 58.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -126.32 -62.02 1.18 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 92' ' ' ASN . 20.0 tptm -64.77 -34.6 78.73 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.4 ' O ' ' C ' ' A' ' 98' ' ' VAL . 51.1 m95 -81.94 -34.95 29.57 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.924 ' O ' HG23 ' A' ' 102' ' ' THR . 2.3 t -39.21 -55.21 3.16 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.184 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 17.2 Cg_endo -60.0 -37.19 86.58 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 121.553 1.502 . . . . 0.0 111.175 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -61.75 -42.68 99.28 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.162 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.92 -39.68 67.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.793 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 98' ' ' VAL . 44.1 p -62.71 -12.71 25.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.05 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -54.18 -41.59 68.73 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -87.85 -15.41 36.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.482 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.2 m 55.35 58.59 10.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.916 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -78.17 124.09 6.45 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.644 2.229 . . . . 0.0 112.01 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -92.27 2.97 56.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.729 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.35 155.18 91.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.88 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.33 149.11 57.58 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.96 2.44 . . . . 0.0 112.115 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.737 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -130.72 139.14 50.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.272 0.558 . . . . 0.0 110.521 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.0 mp -104.76 136.16 44.78 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.558 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.733 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 18.3 tp -88.11 128.43 35.43 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 155' ' ' VAL . 1.9 t -142.29 151.89 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.682 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.534 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -134.46 171.54 22.22 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.475 ' H ' ' HA ' ' A' ' 83' ' ' SER . 1.5 p -119.82 173.73 6.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.97 0.414 . . . . 0.0 110.461 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.604 ' O ' ' O ' ' A' ' 117' ' ' ILE . 33.8 mt-30 37.8 34.0 0.05 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.24 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.888 HG23 ' N ' ' A' ' 118' ' ' ASP . 2.5 tt 19.96 -143.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 123.595 0.559 . . . . 0.0 110.485 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.888 ' N ' HG23 ' A' ' 117' ' ' ILE . 59.5 t0 -59.98 -2.92 0.47 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.726 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.682 ' HB2' HG21 ' A' ' 85' ' ' VAL . 59.2 tp 132.52 92.01 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.182 0.926 . . . . 0.0 110.105 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.522 ' C ' ' O ' ' A' ' 119' ' ' LEU . 41.7 ptt85 . . . . . 0 N--CA 1.471 0.604 0 O-C-N 124.201 0.938 . . . . 0.0 111.625 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.1 mm . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.913 0.387 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.954 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.0 OUTLIER -130.91 -53.89 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.57 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 138' ' ' THR . 66.1 Cg_endo -92.87 -36.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.559 2.173 . . . . 0.0 113.294 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.53 -70.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.47 ' O ' HD13 ' A' ' 145' ' ' LEU . 43.3 p -123.11 4.42 9.27 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.954 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -79.84 -71.08 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.829 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.41 ' OE1' ' CD1' ' A' ' 154' ' ' TYR . 77.7 mm-40 -73.24 -31.46 64.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -56.97 -38.26 72.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.69 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 145' ' ' LEU . 9.9 mp -86.06 -6.91 58.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -91.17 -61.56 1.63 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.129 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -61.07 -37.8 83.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.192 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.67 -12.61 23.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 0.6 OUTLIER -124.71 29.4 6.24 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.485 -178.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 49.0 mttp 95.01 143.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.375 0.67 . . . . 0.0 111.454 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 152.88 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.104 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 151' ' ' ALA . 89.1 t -159.32 -59.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.232 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 12.3 mmtm -104.69 -170.94 1.83 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.605 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 153' ' ' LYS . 18.5 m-85 -153.67 96.4 2.0 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.707 ' O ' HG13 ' A' ' 113' ' ' VAL . 13.2 m -134.79 98.49 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-O 121.36 0.6 . . . . 0.0 110.559 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.561 ' O ' ' OG1' ' A' ' 161' ' ' THR . 91.1 mt-10 -103.16 99.06 8.9 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.534 ' SG ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -119.0 155.68 30.96 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 123.306 1.527 . . . . 0.0 114.362 -175.294 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' LEU . 47.0 t -164.07 94.73 0.75 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 111.341 -2.663 . . . . 0.0 106.858 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 39.54 26.58 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.647 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.737 ' O ' ' N ' ' A' ' 162' ' ' GLN . 76.0 mt -142.05 -81.17 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.169 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.561 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -57.19 45.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 O-C-N 123.36 0.412 . . . . 0.0 110.778 -178.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.773 HE22 ' H ' ' A' ' 27' ' ' LYS . 77.2 mt-30 -85.73 14.67 5.53 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.8 mttt -88.95 1.75 54.96 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 112.613 -2.085 . . . . 0.0 107.115 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.61 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -129.74 -73.6 0.14 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.534 HD12 ' SG ' ' A' ' 157' ' ' CYS . 12.4 mt -41.72 -17.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.017 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.61 ' N ' ' O ' ' A' ' 164' ' ' GLY . 22.3 tttp -83.06 -48.47 10.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' GLY . 75.2 m-20 -75.1 2.38 10.85 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.225 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 169' ' ' PHE . 24.7 t -84.1 -53.72 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.628 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 168' ' ' VAL . 6.0 m-85 -37.31 -52.78 1.1 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.207 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 53.1 p-10 -65.8 -39.23 90.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.199 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.615 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 99.2 mt-10 -70.67 -22.05 62.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.767 0.318 . . . . 0.0 110.7 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.581 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -63.41 -34.21 77.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.49 -37.45 70.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.333 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.6 tp -57.25 -34.51 68.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.541 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 172' ' ' ALA . . . -63.51 -23.69 67.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.152 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 4' ' ' ILE . . . -63.95 -30.96 72.0 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.328 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.39 -35.54 70.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.607 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.679 -179.816 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 3' ' ' THR . 89.7 mt-30 . . . . . 0 C--O 1.227 -0.107 0 CA-C-O 120.684 0.278 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 3' ' ' THR . 0.5 OUTLIER -39.39 140.77 0.42 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 11.0 tp -130.35 152.43 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.955 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.463 ' CB ' HG22 ' A' ' 75' ' ' THR . 55.7 mttp -102.5 162.79 12.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.293 0.568 . . . . 0.0 111.567 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.53 157.2 46.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.329 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.75 ' O ' HG23 ' A' ' 9' ' ' VAL . 61.5 t -122.16 134.81 64.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.54 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.3 p -50.05 125.73 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.223 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 7' ' ' VAL . 21.4 t -127.04 133.44 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.424 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.581 ' HA3' HG13 ' A' ' 93' ' ' VAL . . . 106.06 -67.99 0.24 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 60' ' ' GLY . 81.7 m-20 58.53 -82.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.581 0.229 . . . . 0.0 111.377 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 40.57 33.75 0.62 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 47.88 101.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.789 0.328 . . . . 0.0 110.564 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.79 HG23 ' H ' ' A' ' 15' ' ' GLY . 26.4 m -135.5 -111.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.057 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.79 ' H ' HG23 ' A' ' 14' ' ' VAL . . . -169.12 63.64 0.18 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' HD2' ' H ' ' A' ' 58' ' ' THR . 16.2 mttp -73.11 -2.9 23.28 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.215 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.8 p -61.43 -41.33 97.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.295 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' ILE . 99.2 m -95.81 -7.57 36.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.054 0.454 . . . . 0.0 111.013 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.905 HD11 HG12 ' A' ' 113' ' ' VAL . 24.9 tp -66.7 -68.25 0.39 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.109 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.461 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 67.4 mt -65.66 -26.48 67.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.615 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 18' ' ' CYS . 3.6 tt -58.86 -18.93 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.697 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -66.53 -75.95 0.09 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.397 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.735 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.9 p90 -41.24 -31.8 0.24 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.659 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.466 ' N ' ' CG ' ' A' ' 23' ' ' TYR . 2.5 m -57.12 -46.68 82.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.272 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.445 ' OG1' ' C ' ' A' ' 24' ' ' THR . 0.0 OUTLIER 175.99 -6.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.524 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 59.1 t-20 57.3 87.13 0.07 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.756 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -89.93 8.18 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.414 ' N ' ' HB1' ' A' ' 159' ' ' ALA . 0.8 OUTLIER 62.79 148.93 0.1 OUTLIER Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.288 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -42.04 143.18 1.32 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.247 1.965 . . . . 0.0 112.413 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.1 p -130.9 154.89 47.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.305 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' OE2' ' CE2' ' A' ' 32' ' ' TYR . 22.1 pt-20 -71.28 -15.65 62.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.854 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.422 ' CE2' ' OE2' ' A' ' 31' ' ' GLU . 69.3 m-85 -112.51 138.35 49.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.647 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.7 77.67 69.58 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.063 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.22 140.01 34.41 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.715 2.277 . . . . 0.0 112.334 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.7 p -116.6 25.68 10.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.271 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 m -124.05 160.49 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.628 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.449 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 80.9 t80 59.78 72.04 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.522 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -65.01 147.71 52.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.348 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.509 ' O ' ' O ' ' A' ' 55' ' ' LEU . 54.1 m-20 -89.49 144.96 25.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.383 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.1 p90 -175.57 -4.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.556 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.98 99.8 3.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG21 ' OH ' ' A' ' 23' ' ' TYR . 21.8 t -140.78 133.45 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.17 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.9 111.92 24.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.419 . . . . 0.0 110.825 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.419 HG23 HG12 ' A' ' 42' ' ' VAL . 58.7 t -137.43 145.83 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.154 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.657 ' SD ' ' N ' ' A' ' 45' ' ' MET . 2.3 mmt -97.08 132.93 42.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 170' ' ' ASP . 4.8 mt -120.66 127.0 75.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.141 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.73 31.12 5.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.05 52.13 6.48 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -138.75 79.07 29.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 36.1 Cg_exo -52.82 103.96 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.941 2.427 . . . . 0.0 112.965 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 76.6 m-85 -159.99 169.66 22.97 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.589 ' C ' HD22 ' A' ' 53' ' ' LEU . 10.1 t -140.32 135.91 32.68 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.61 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.861 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -115.39 132.86 56.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.122 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 40' ' ' TYR . . . -107.77 126.41 8.31 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 55' ' ' LEU . 4.0 mp -136.3 125.97 25.46 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.845 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.468 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 69.7 m-85 -77.39 160.69 28.57 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.611 ' C ' HG22 ' A' ' 58' ' ' THR . 55.9 p30 -166.26 174.73 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.643 ' OG1' ' N ' ' A' ' 59' ' ' ALA . 1.7 t 147.63 -140.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.826 0.704 . . . . 0.0 109.568 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.643 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -140.37 135.55 32.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.132 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' ' OD2' ' A' ' 11' ' ' ASP . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.518 0.199 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.675 ' OG1' HG23 ' A' ' 7' ' ' VAL . 5.5 p -85.05 159.9 20.11 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.469 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 75' ' ' THR . 97.0 m-20 -139.96 3.2 2.0 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.83 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.451 HG12 HD13 ' A' ' 111' ' ' LEU . 2.4 t -109.26 109.71 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.615 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -78.44 122.5 25.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.399 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.651 ' C ' HD23 ' A' ' 79' ' ' LEU . 7.4 tt -121.52 116.73 25.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.379 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.472 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 41.4 t -90.37 130.19 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.268 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 118.84 26.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.72 ' HA ' HG11 ' A' ' 14' ' ' VAL . 36.8 p90 -144.69 163.91 32.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.74 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 85' ' ' VAL . 35.6 t -85.83 134.22 33.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.621 HG13 ' CG2' ' A' ' 138' ' ' THR . 71.0 t -41.81 -17.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.103 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.594 ' HB ' HD21 ' A' ' 119' ' ' LEU . 38.9 t -135.22 131.81 52.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.731 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 2.9 m 151.94 81.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.19 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -52.75 -29.61 42.97 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.385 2.056 . . . . 0.0 111.855 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.0 m -71.08 -49.98 38.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 109.796 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 93' ' ' VAL . 59.6 p -62.02 -30.91 71.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.467 ' CG ' HD11 ' A' ' 137' ' ' ILE . 91.0 t80 -57.8 -50.71 72.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.498 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -79.09 -18.79 52.72 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.164 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 25.4 m120 -93.78 -10.42 34.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.344 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.581 HG13 ' HA3' ' A' ' 10' ' ' GLY . 52.3 t -104.4 -71.25 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.392 0.615 . . . . 0.0 112.241 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.675 ' HE2' HD11 ' A' ' 112' ' ' LEU . 78.8 mttt -69.67 -21.3 63.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.272 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.544 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 97.4 mt-10 -106.07 -38.4 6.31 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -76.21 -30.66 58.06 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.881 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 23.3 m95 -89.57 -42.61 11.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.299 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 2.2 t -40.22 -54.38 4.67 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.249 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.544 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 27.9 Cg_endo -64.2 -37.84 39.07 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.649 1.566 . . . . 0.0 112.162 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.57 -37.94 89.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.257 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 101' ' ' ILE . 22.8 pt -86.29 -28.22 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.127 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 105' ' ' CYS . 86.3 m -59.99 -36.47 77.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.922 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -56.18 -37.69 69.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.88 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -55.99 -46.32 78.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.935 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 102' ' ' THR . 1.3 m -146.83 155.39 48.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.693 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.76 -60.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.482 2.122 . . . . 0.0 111.872 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -125.31 128.47 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.529 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.596 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -157.42 152.39 21.31 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.079 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -56.73 126.01 20.89 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.028 1.819 . . . . 0.0 111.39 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.691 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -116.58 111.29 19.68 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.453 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.7 mp -86.54 123.14 31.42 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.053 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.675 HD11 ' HE2' ' A' ' 94' ' ' LYS . 23.7 tp -100.94 123.58 45.34 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.905 HG12 HD11 ' A' ' 19' ' ' LEU . 4.7 t -136.18 147.47 28.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.47 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.495 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -121.14 153.01 16.69 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 p -114.3 172.49 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.168 0.509 . . . . 0.0 110.804 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.578 ' O ' ' O ' ' A' ' 117' ' ' ILE . 61.3 mt-30 48.73 21.29 0.41 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.164 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.793 HG23 ' N ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER 36.32 -160.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.401 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.793 ' N ' HG23 ' A' ' 117' ' ' ILE . 19.1 m-20 -69.07 75.42 0.33 Allowed 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.463 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 85' ' ' VAL . 98.0 mt 64.86 85.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.832 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 119' ' ' LEU . 57.1 ttm-85 . . . . . 0 N--CA 1.472 0.646 0 O-C-N 124.108 0.88 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 137' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.548 0.213 . . . . 0.0 111.153 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.621 ' CG2' HG13 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -118.69 -50.28 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 138' ' ' THR . 72.9 Cg_endo -81.87 -83.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.127 1.885 . . . . 0.0 114.464 -176.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.51 -43.8 98.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.701 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 137' ' ' ILE . 81.9 p -60.56 -40.96 93.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -77.31 -36.46 54.02 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.601 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.66 -42.33 96.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.755 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -66.4 -46.57 76.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.804 0.335 . . . . 0.0 110.986 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.4 tt -53.72 -35.16 60.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.06 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.03 -38.38 88.27 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.39 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -62.91 -39.78 95.6 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.789 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -52.31 -32.56 38.34 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 146' ' ' ALA . 62.6 mt -133.29 -113.41 0.22 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.479 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.718 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 51.3 mttp -143.83 -132.94 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.464 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 156.09 -165.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.866 0.365 . . . . 0.0 110.448 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.615 HG23 ' H ' ' A' ' 110' ' ' PHE . 19.8 t -143.83 -51.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 3.5 tttm -143.62 -169.92 3.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.847 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -166.18 96.02 0.59 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.175 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 114' ' ' GLY . 16.5 m -136.14 153.61 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.474 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.594 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -133.11 94.0 3.27 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.562 ' SG ' HD22 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -110.87 148.1 33.14 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 123.155 1.455 . . . . 0.0 113.504 -176.232 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.47 ' C ' ' N ' ' A' ' 160' ' ' LEU . 8.8 t -155.3 91.29 1.32 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 111.576 -2.556 . . . . 0.0 105.224 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.484 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . 42.03 28.16 0.09 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.739 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.702 ' O ' ' N ' ' A' ' 162' ' ' GLN . 47.0 mt -139.52 -74.02 0.37 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.841 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.71 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.1 m -57.82 44.12 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 120.918 0.39 . . . . 0.0 112.05 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.702 ' N ' ' O ' ' A' ' 160' ' ' LEU . 38.4 tt0 -74.83 19.32 0.14 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.71 ' H ' ' C ' ' A' ' 161' ' ' THR . 56.8 mttp -108.14 -1.49 20.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.779 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 168' ' ' VAL . . . -133.17 -38.07 0.23 Allowed Glycine 0 C--O 1.225 -0.46 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.735 HD23 ' H ' ' A' ' 23' ' ' TYR . 9.9 tp -73.62 -22.99 59.84 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.034 0.445 . . . . 0.0 110.53 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -61.86 -34.15 75.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.597 ' O ' ' N ' ' A' ' 170' ' ' ASP . 7.9 m120 -72.29 -59.07 2.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 165' ' ' LEU . 59.0 t -29.25 -55.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.446 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.688 ' CZ ' ' CZ ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -56.9 -48.76 77.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.316 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.609 ' HB2' HG21 ' A' ' 46' ' ' ILE . 56.0 t0 -67.63 -47.44 69.6 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 111.477 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.51 -29.05 70.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.324 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.61 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . . . -57.43 -32.49 66.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.32 -37.09 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.741 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.8 -37.73 77.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.426 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.54 -28.05 69.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.589 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.461 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . . . -57.26 -37.1 71.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.979 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 177' ' ' LEU . 8.0 mp -60.04 -32.18 70.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.669 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.381 -0.372 . . . . 99.99 110.504 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 121.029 0.442 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 3' ' ' THR . 3.5 t -40.37 125.59 2.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.392 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.49 149.93 22.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.894 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -105.08 147.3 28.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.223 0.535 . . . . 0.0 112.002 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.592 ' SG ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -132.61 145.23 50.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.393 179.106 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.407 HG13 ' CD1' ' A' ' 56' ' ' PHE . 16.6 t -127.4 135.9 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.548 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 56' ' ' PHE . 5.2 t -74.81 120.81 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.443 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.648 HG11 HD13 ' A' ' 101' ' ' ILE . 38.9 t -120.5 130.66 74.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.875 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.51 -162.01 29.67 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' ALA . 44.7 t0 -148.85 -117.09 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.992 0.425 . . . . 0.0 111.084 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.571 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -29.83 -29.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.657 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -38.18 136.65 0.61 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.421 0.611 . . . . 0.0 110.046 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 12' ' ' GLY . 31.5 m -125.88 27.48 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.77 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.53 ' CA ' HE21 ' A' ' 116' ' ' GLN . . . -143.22 36.87 1.54 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.053 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.704 ' NZ ' ' HB3' ' A' ' 59' ' ' ALA . 26.8 mttt -74.59 -7.58 53.61 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.043 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 19' ' ' LEU . 85.7 m -78.38 -69.63 0.54 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.897 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.694 ' HA ' HD12 ' A' ' 21' ' ' ILE . 32.4 m -61.75 0.16 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.357 0.598 . . . . 0.0 109.913 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.756 ' O ' HD13 ' A' ' 165' ' ' LEU . 7.8 tt -69.72 -52.29 26.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.989 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.63 -32.45 64.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.144 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 18' ' ' CYS . 77.4 mt -55.03 -20.26 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.929 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.489 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 5.2 m -50.62 -74.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.457 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.707 ' CZ ' ' CZ ' ' A' ' 169' ' ' PHE . 23.9 p90 -63.03 -28.08 69.85 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.141 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.4 m -51.17 -46.03 61.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.562 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.9 m -157.44 -19.46 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 110.41 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 22' ' ' SER . 1.4 m-80 64.16 133.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.904 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.713 ' HG3' HE22 ' A' ' 162' ' ' GLN . 40.6 mttp 66.71 59.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.734 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 21' ' ' ILE . 1.3 tp -128.87 67.28 77.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.4 0.619 . . . . 0.0 110.295 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -79.55 6.52 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.147 2.564 . . . . 0.0 112.533 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.6 m -49.18 137.21 14.03 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.384 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.26 -34.81 78.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.799 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -59.03 -40.85 86.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.527 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 33' ' ' VAL . 70.8 t 52.39 77.84 0.43 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.573 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.07 141.73 36.88 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.603 2.202 . . . . 0.0 112.038 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.5 m -126.26 149.61 48.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.15 157.63 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.396 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -57.25 -41.03 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.52 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.35 130.15 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.978 0.418 . . . . 0.0 111.042 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LEU . 87.4 m-20 -123.9 14.95 9.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.516 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.547 ' CB ' ' CE1' ' A' ' 56' ' ' PHE . 22.3 p90 -175.73 12.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.9 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.22 99.9 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.844 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.6 t -144.68 140.57 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.889 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 43' ' ' THR . 7.6 t -124.51 132.01 53.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.343 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.8 t -133.69 138.9 49.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.762 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.9 mtm -113.49 120.92 42.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.153 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.8 pp -128.15 154.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.936 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.491 ' O ' ' OE1' ' A' ' 49' ' ' GLU . . . 32.81 27.95 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 74.19 50.22 10.83 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.491 ' OE1' ' O ' ' A' ' 47' ' ' GLY . 4.1 mp0 -130.4 96.53 24.16 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' C ' ' CD1' ' A' ' 51' ' ' TYR . 57.7 Cg_endo -76.8 108.65 2.69 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.05 1.833 . . . . 0.0 113.033 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.583 ' CE1' HG23 ' A' ' 173' ' ' ILE . 93.7 m-85 -150.55 165.44 33.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.957 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.21 125.78 30.14 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.709 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.562 HD13 ' HB1' ' A' ' 172' ' ' ALA . 51.8 tp -113.1 125.4 54.33 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.813 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -89.43 136.42 13.54 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.544 HD12 ' SG ' ' A' ' 6' ' ' CYS . 29.2 tp -137.11 125.69 23.7 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.85 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CE1' ' CB ' ' A' ' 40' ' ' TYR . 26.3 m-85 -97.93 -177.93 3.92 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 177.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' O ' ' OG1' ' A' ' 58' ' ' THR . 50.8 p30 -171.49 -174.89 1.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.629 ' H ' ' CB ' ' A' ' 16' ' ' LYS . 29.3 p 56.89 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.087 0.47 . . . . 0.0 111.664 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.704 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . . . -177.77 149.35 0.59 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.075 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.662 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.56 0.219 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.4 p 48.66 46.48 21.3 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.96 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -62.03 -37.81 86.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.381 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.532 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -119.34 99.79 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.345 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.579 ' C ' HD12 ' A' ' 79' ' ' LEU . 98.2 m-85 -71.14 127.76 33.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.958 -177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.592 HD13 ' SG ' ' A' ' 6' ' ' CYS . 9.1 mp -114.69 137.13 52.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.766 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 113' ' ' VAL . 62.3 t -104.75 132.4 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.578 ' SG ' HD13 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -114.38 123.81 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 111.54 -179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.464 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 44.1 p90 -150.78 128.53 11.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.047 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -62.64 126.32 26.92 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 156' ' ' GLU . 21.5 t -66.69 -20.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.675 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 85' ' ' VAL . 7.7 p -105.79 11.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.183 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.14 84.42 45.79 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 0.0 110.416 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -52.84 -27.38 34.48 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.457 2.104 . . . . 0.0 112.491 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.8 m -64.91 -44.84 88.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.199 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.691 ' O ' HG23 ' A' ' 93' ' ' VAL . 83.8 p -70.71 -24.91 62.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 0.0 110.995 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.482 ' CG ' HG21 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -73.4 -40.45 64.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.44 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.09 -37.33 84.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.148 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -93.01 -39.82 10.89 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.071 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 89' ' ' SER . 37.4 t -51.68 -64.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.41 . . . . 0.0 111.573 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -72.61 -8.58 55.98 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.031 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.545 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 81.0 tt0 -103.77 -71.99 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -88.07 -9.13 54.29 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.41 ' CE2' ' HB2' ' A' ' 11' ' ' ASP . 93.0 m95 -97.4 -41.24 8.32 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.135 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -53.1 -54.64 42.15 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.545 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 17.9 Cg_endo -60.47 -34.05 93.34 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.674 1.583 . . . . 0.0 112.283 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -57.96 -37.56 74.4 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.954 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.648 HD13 HG11 ' A' ' 9' ' ' VAL . 44.1 pt -95.37 -31.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.495 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.487 HG22 ' HG3' ' A' ' 106' ' ' PRO . 28.7 m -51.08 -37.86 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.316 . . . . 0.0 110.948 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -50.63 -31.84 17.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.994 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.632 ' ND1' ' SG ' ' A' ' 105' ' ' CYS . 50.4 t-80 -57.33 -45.58 84.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.346 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.632 ' SG ' ' ND1' ' A' ' 104' ' ' HIS . 0.8 OUTLIER -174.59 82.74 0.34 Allowed Pre-proline 0 C--O 1.233 0.188 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.962 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.487 ' HG3' HG22 ' A' ' 102' ' ' THR . 18.0 Cg_exo -63.13 -16.78 56.64 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.921 2.414 . . . . 0.0 112.808 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -77.64 -3.19 39.67 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.633 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 105' ' ' CYS . 13.9 p -94.8 150.31 37.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.826 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.95 142.69 93.82 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.437 2.091 . . . . 0.0 111.274 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.705 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -119.98 125.83 49.34 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.548 0.69 . . . . 0.0 111.404 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -99.92 133.69 43.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.777 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.8 mt -99.99 124.86 45.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.444 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 80' ' ' VAL . 41.5 t -128.05 129.44 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.302 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -106.47 142.54 15.65 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.431 HG21 ' HB1' ' A' ' 13' ' ' ALA . 0.6 OUTLIER -102.32 169.1 8.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.339 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.915 ' O ' ' N ' ' A' ' 118' ' ' ASP . 56.8 mm-40 52.1 23.52 2.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.918 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.921 HG23 ' H ' ' A' ' 119' ' ' LEU . 15.8 tt 27.66 -46.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.915 ' N ' ' O ' ' A' ' 116' ' ' GLN . 47.0 t0 120.69 6.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.401 1.081 . . . . 0.0 108.505 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.921 ' H ' HG23 ' A' ' 117' ' ' ILE . 8.9 tp -133.13 -24.74 1.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.8 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.768 HH21 ' NE2' ' A' ' 116' ' ' GLN . 65.5 ttp85 . . . . . 0 CA--C 1.516 -0.345 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.482 HG21 ' CG ' ' A' ' 90' ' ' PHE . 4.8 mp . . . . . 0 C--O 1.232 0.133 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.805 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -132.31 -52.48 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.19 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.1 Cg_endo -83.87 -93.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.975 1.783 . . . . 0.0 114.585 -175.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.0 -38.83 76.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.554 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.2 p -69.59 -34.55 74.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.602 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -91.96 -42.3 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.361 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 139' ' ' PRO . 84.2 tt0 -60.98 -39.67 90.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.001 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -63.53 -43.92 95.73 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.171 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.621 ' N ' HD22 ' A' ' 145' ' ' LEU . 3.1 mm? -79.23 -7.16 58.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.913 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.03 -66.43 0.9 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.581 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -59.77 -37.56 79.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.491 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -93.66 -13.82 27.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.8 tp -134.75 51.09 2.13 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.249 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.702 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 67.7 mttm 65.11 158.7 0.1 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.205 0.526 . . . . 0.0 111.311 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 158.06 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.444 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.648 HG12 ' HG3' ' A' ' 153' ' ' LYS . 72.6 t -142.5 -66.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.379 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.648 ' HG3' HG12 ' A' ' 152' ' ' VAL . 25.0 mttm -136.42 -167.75 2.12 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.411 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -150.27 97.15 2.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.737 ' O ' HG23 ' A' ' 155' ' ' VAL . 21.1 m -116.2 97.96 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.147 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.647 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -95.33 98.75 10.81 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.683 ' HB2' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -125.61 149.31 48.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 123.007 1.384 . . . . 0.0 113.098 -176.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.607 ' OG ' ' NE ' ' A' ' 120' ' ' ARG . 22.3 t -157.03 92.76 1.29 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 111.906 -2.406 . . . . 0.0 106.289 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 42.27 27.42 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.242 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.676 ' O ' ' N ' ' A' ' 162' ' ' GLN . 19.8 mt -144.57 -73.37 0.26 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.125 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.647 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 2.2 m -57.06 65.31 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.315 0.578 . . . . 0.0 111.8 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.713 HE22 ' HG3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -82.68 15.07 2.77 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 175.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.592 ' H ' ' C ' ' A' ' 161' ' ' THR . 24.9 tttt -86.44 -6.53 58.89 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 113.421 -1.718 . . . . 0.0 108.486 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 167' ' ' ASN . . . -131.4 -74.73 0.12 Allowed Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.756 HD13 ' O ' ' A' ' 19' ' ' LEU . 14.8 mt -41.49 -22.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.746 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.6 tttt -77.85 -46.59 21.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 164' ' ' GLY . 78.4 m-20 -76.03 -0.45 21.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.784 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 171' ' ' GLU . 46.7 t -83.91 -60.14 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.762 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.707 ' CZ ' ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -43.05 -45.64 5.32 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.018 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.653 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 32.6 p30 -70.03 -30.56 67.88 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.779 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.653 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 85.5 tt0 -64.72 -31.38 72.58 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.133 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.562 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -60.12 -29.43 68.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.583 HG23 ' CE1' ' A' ' 51' ' ' TYR . 77.3 mt -52.41 -39.75 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.14 -37.79 88.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.589 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -76.78 -13.03 60.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.708 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -66.14 -29.21 69.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.916 0.388 . . . . 0.0 110.15 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.65 -35.27 70.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.431 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.575 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.754 HG22 HG22 ' A' ' 52' ' ' THR . 40.9 p -42.73 113.68 0.5 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.384 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 176' ' ' ALA . 17.8 tt -117.28 138.97 46.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.133 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -96.47 150.85 20.15 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.136 0.493 . . . . 0.0 111.106 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.886 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -143.1 137.03 28.87 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.013 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 p -106.61 139.66 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.692 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 79' ' ' LEU . 57.6 t -115.63 131.35 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.592 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 t -128.58 138.69 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.839 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 60' ' ' GLY . . . -135.4 -177.33 14.89 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.497 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 53.8 p30 -72.25 -123.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.345 . . . . 0.0 111.221 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.711 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -151.21 72.51 0.28 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 152.23 27.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.58 0.224 . . . . 0.0 111.398 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.57 HG11 ' H ' ' A' ' 83' ' ' SER . 16.8 m -125.28 133.85 68.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.412 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.3 93.59 1.86 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.429 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -73.27 -8.53 56.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.013 0.435 . . . . 0.0 110.102 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -59.27 -55.12 38.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.029 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HA ' HD12 ' A' ' 21' ' ' ILE . 82.6 m -58.91 -36.19 74.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.701 . . . . 0.0 109.317 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.659 ' O ' HD23 ' A' ' 165' ' ' LEU . 4.0 tt -65.71 -54.09 32.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.699 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.803 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -59.78 -32.53 70.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.063 0.459 . . . . 0.0 110.207 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 21' ' ' ILE . 33.7 mt -62.36 -9.6 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.378 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.462 ' CB ' HD23 ' A' ' 165' ' ' LEU . 23.3 t -53.43 -82.16 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.936 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -52.62 -31.61 37.45 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.851 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.3 m -47.18 -39.63 14.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -140.98 -87.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.985 178.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.559 ' N ' ' OG1' ' A' ' 25' ' ' THR . 2.1 t-20 156.58 83.94 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.798 ' H ' HE21 ' A' ' 162' ' ' GLN . 24.7 tttt 65.53 91.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.646 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 tp -125.14 85.64 57.84 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.45 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.61 47.18 2.25 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.85 2.367 . . . . 0.0 112.692 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.9 m -64.13 152.67 39.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.349 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -59.41 -39.57 83.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.555 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.6 ' CE2' ' O ' ' A' ' 33' ' ' VAL . 81.7 t80 -137.38 136.27 37.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.416 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 17.1 m -78.03 148.78 75.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.387 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.97 -162.4 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.386 2.057 . . . . 0.0 112.059 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.3 p -76.11 164.88 25.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -126.56 158.0 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.407 . . . . 0.0 110.805 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -117.93 161.04 20.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.363 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 51.5 p30 -77.92 4.29 12.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.974 0.416 . . . . 0.0 110.454 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -127.28 132.17 50.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.14 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -125.7 15.71 8.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.0 97.69 10.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.225 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.7 t -111.91 143.36 21.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 43' ' ' THR . 14.2 t -118.84 121.49 40.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.756 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 169' ' ' PHE . 33.1 m -136.11 166.41 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.59 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.2 mtm -111.82 128.51 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.028 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 46' ' ' ILE . 10.9 tt -130.63 123.57 55.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.442 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.26 28.55 54.89 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.87 51.34 7.91 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -130.52 89.54 43.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.597 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 41.9 Cg_endo -74.72 103.9 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.135 1.89 . . . . 0.0 112.707 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 53.2 m-85 -162.01 174.81 12.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.564 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.754 HG22 HG22 ' A' ' 3' ' ' THR . 4.2 t -145.94 141.67 27.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.908 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.98 HD13 ' HB1' ' A' ' 172' ' ' ALA . 59.2 tp -107.84 129.24 55.09 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.607 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -96.48 119.58 6.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.596 HD23 ' SG ' ' A' ' 6' ' ' CYS . 71.7 mt -115.99 153.31 31.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.644 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.585 ' O ' ' CD2' ' A' ' 56' ' ' PHE . 46.2 t80 -135.52 32.66 3.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.446 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' O ' ' OG1' ' A' ' 58' ' ' THR . 49.5 p30 -80.44 -173.59 4.16 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.638 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 1.2 m 168.74 -58.06 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.371 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . 164.02 139.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.204 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 10' ' ' GLY . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 . . . . . 0 CA--C 1.523 -0.06 0 CA-C-O 120.783 0.325 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.0 p -129.82 158.43 39.48 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.564 ' HB2' HD11 ' A' ' 4' ' ' ILE . 93.3 m-20 -121.84 -23.79 5.4 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.221 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.548 HG21 ' HB1' ' A' ' 175' ' ' ALA . 21.3 t -131.16 124.27 55.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.526 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.498 ' C ' HD12 ' A' ' 79' ' ' LEU . 97.5 m-85 -89.8 127.38 35.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.886 HD22 ' SG ' ' A' ' 6' ' ' CYS . 10.6 mp -104.64 135.58 45.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.814 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.554 HG11 HG23 ' A' ' 98' ' ' VAL . 41.3 t -117.83 131.94 69.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.794 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.64 135.82 53.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.306 0.574 . . . . 0.0 111.315 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.989 ' CG ' HG11 ' A' ' 93' ' ' VAL . 41.2 p90 -160.41 132.29 6.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.758 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.57 ' H ' HG11 ' A' ' 14' ' ' VAL . 75.7 p -59.0 135.98 57.8 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.447 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 84' ' ' VAL . 9.0 p -114.76 23.64 5.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.197 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.678 HG23 HD12 ' A' ' 119' ' ' LEU . 8.7 p -63.6 -38.06 81.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.273 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -133.77 155.78 80.05 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.562 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -59.79 -13.59 23.02 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.897 2.398 . . . . 0.0 112.684 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 m -66.16 -67.06 0.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.004 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.542 ' O ' HG12 ' A' ' 93' ' ' VAL . 59.3 m -60.61 -38.16 83.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.693 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' CZ ' ' OG1' ' A' ' 141' ' ' THR . 0.3 OUTLIER -60.03 -36.27 76.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.121 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.476 ' OE2' ' OE1' ' A' ' 95' ' ' GLU . 45.0 tp10 -81.91 -23.42 36.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.848 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.62 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 80.3 m-20 -85.84 5.46 32.6 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.989 HG11 ' CG ' ' A' ' 82' ' ' PHE . 1.5 p -119.07 -65.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.689 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.726 ' H ' HG13 ' A' ' 93' ' ' VAL . 74.0 mttt -54.8 -19.69 6.97 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.467 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.476 ' OE1' ' OE2' ' A' ' 91' ' ' GLU . 85.2 tt0 -113.89 -27.63 7.68 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -113.01 -40.31 3.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.62 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 47.4 m95 -90.63 -51.1 5.56 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.484 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.554 HG23 HG11 ' A' ' 80' ' ' VAL . 3.0 t -50.28 -58.9 8.27 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.4 Cg_endo -51.84 -39.13 68.61 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.652 1.568 . . . . 0.0 112.013 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.99 -43.79 98.32 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.015 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.2 mt -70.28 -36.56 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.494 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 105' ' ' CYS . 56.8 m -53.19 -43.33 67.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.852 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -63.39 -42.98 98.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.841 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.07 -42.39 98.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.63 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -103.97 161.57 22.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 0.0 111.204 -179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.469 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 41.5 Cg_endo -70.23 -157.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.856 2.371 . . . . 0.0 112.381 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -86.18 9.07 18.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.88 156.07 0.76 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.464 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.51 143.71 54.57 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.683 2.255 . . . . 0.0 111.821 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.752 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -129.72 114.84 16.48 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.852 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.95 122.72 27.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.424 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.603 HD13 ' CD2' ' A' ' 149' ' ' LEU . 27.5 tp -85.53 133.05 34.09 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.015 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.491 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -142.47 163.73 17.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.418 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.541 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -146.4 176.59 25.24 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 116' ' ' GLN . 9.2 p -127.94 179.93 5.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 117.191 0.496 . . . . 0.0 109.87 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.538 ' O ' ' C ' ' A' ' 117' ' ' ILE . 43.4 mt-30 37.36 33.64 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.687 HD12 ' H ' ' A' ' 118' ' ' ASP . 1.0 OUTLIER 23.82 -141.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.236 0 O-C-N 123.506 0.503 . . . . 0.0 111.149 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.687 ' H ' HD12 ' A' ' 117' ' ' ILE . 86.7 m-20 -86.65 -2.48 58.55 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.568 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.678 HD12 HG23 ' A' ' 85' ' ' VAL . 6.0 tp 178.11 45.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.677 0.275 . . . . 0.0 111.18 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' C ' ' O ' ' A' ' 119' ' ' LEU . 57.7 ttp180 . . . . . 0 C--N 1.326 -0.414 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 137' ' ' ILE . 10.1 tt . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.874 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.2 OUTLIER -131.12 -45.74 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.684 ' CD ' ' H ' ' A' ' 138' ' ' THR . 56.9 Cg_endo -88.2 -62.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.585 2.19 . . . . 0.0 114.389 -177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 139' ' ' PRO . 95.9 mt-10 -29.76 -72.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.422 ' OG1' ' CZ ' ' A' ' 90' ' ' PHE . 23.1 p -127.8 7.92 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.874 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -83.5 -70.64 0.55 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.754 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -74.1 -40.58 62.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.632 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -62.13 -36.48 81.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.38 . . . . 0.0 111.445 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 145' ' ' LEU . 35.6 tp -72.26 -22.47 61.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.232 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.65 -33.26 75.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.089 0.471 . . . . 0.0 110.81 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -59.89 -45.93 90.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.336 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -84.94 -29.53 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.736 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.603 ' CD2' HD13 ' A' ' 112' ' ' LEU . 55.5 tp -43.21 -28.46 0.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.268 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.527 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 63.0 mttm 88.17 -0.13 0.42 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.647 0.379 . . . . 0.0 110.009 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.46 -132.49 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.194 0.521 . . . . 0.0 111.518 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 110' ' ' PHE . 3.7 t -151.84 -54.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.336 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -107.25 -167.76 1.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.348 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.616 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 34.2 p90 -161.95 97.13 1.03 Allowed 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.61 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.957 0.884 . . . . 0.0 111.613 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.562 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -153.39 96.93 2.09 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.572 ' HA ' HG22 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -112.83 145.49 40.56 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 123.274 1.511 . . . . 0.0 113.157 -176.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.673 ' HB3' HG23 ' A' ' 117' ' ' ILE . 13.6 t -173.35 90.19 0.08 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 111.707 -2.497 . . . . 0.0 107.168 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 57.07 29.38 16.41 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.619 ' C ' ' H ' ' A' ' 162' ' ' GLN . 21.2 tp -156.18 -85.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.693 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.9 OUTLIER -46.41 -9.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.798 HE21 ' H ' ' A' ' 27' ' ' LYS . 19.4 mt-30 -51.35 -1.58 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.693 ' H ' ' C ' ' A' ' 161' ' ' THR . 43.0 mttm -82.01 -2.69 52.47 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -116.45 -70.13 0.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 19' ' ' LEU . 43.1 tp -39.81 -16.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.826 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 164' ' ' GLY . 79.3 tttt -80.99 -53.51 6.37 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 164' ' ' GLY . 40.1 t-20 -71.15 -2.51 16.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.667 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 171' ' ' GLU . 29.6 t -78.3 -47.45 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.016 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 168' ' ' VAL . 63.0 t80 -39.12 -43.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.533 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.7 -37.82 88.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.36 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 168' ' ' VAL . 96.8 mt-10 -72.71 -20.82 61.15 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.049 0.452 . . . . 0.0 110.132 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.98 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -64.66 -36.73 85.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.742 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.425 ' CG1' ' N ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -62.04 -36.45 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.425 ' N ' ' CG1' ' A' ' 173' ' ' ILE . 45.3 tp -61.39 -35.01 76.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.016 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.548 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -60.55 -29.66 69.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.852 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.753 ' HA ' HD12 ' A' ' 4' ' ' ILE . . . -65.98 -31.62 72.63 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.943 0.401 . . . . 0.0 110.285 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 32.8 tp -57.17 -35.86 70.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.671 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.41 ' OE2' ' OD2' ' A' ' 76' ' ' ASP . 97.0 mt-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.44 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 176' ' ' ALA . 91.2 mt-30 . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 121.17 0.509 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.668 HG22 ' HA ' ' A' ' 51' ' ' TYR . 11.4 p -84.01 157.22 21.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.117 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 76' ' ' ASP . 20.1 tt -134.12 152.9 34.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.821 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -103.04 146.79 27.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.036 0.445 . . . . 0.0 111.186 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -139.51 158.35 44.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.018 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.808 HG12 HG21 ' A' ' 75' ' ' THR . 12.2 p -127.6 134.4 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.771 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.665 HG11 HD21 ' A' ' 19' ' ' LEU . 13.6 t -110.98 133.81 55.31 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.812 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.3 t -114.62 132.47 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.225 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.37 123.34 7.76 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.538 ' OD1' ' NE1' ' A' ' 97' ' ' TRP . 25.5 t70 -82.76 121.48 26.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.602 0.239 . . . . 0.0 110.397 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.706 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 56.75 -0.82 0.14 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 82.12 125.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.745 HG23 ' H ' ' A' ' 15' ' ' GLY . 1.8 m -142.27 -88.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.816 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.745 ' H ' HG23 ' A' ' 14' ' ' VAL . . . -159.59 55.51 0.34 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.997 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.715 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.71 -34.64 78.31 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.673 -0.31 . . . . 0.0 111.339 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.1 m -52.18 -43.84 64.36 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.901 ' SG ' HD23 ' A' ' 28' ' ' LEU . 74.2 m -61.14 -26.97 68.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.168 0.509 . . . . 0.0 110.667 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.812 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -78.96 -35.91 42.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.173 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.64 HD11 ' HB3' ' A' ' 57' ' ' ASP . 81.4 mt -63.82 -36.09 82.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.487 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 28' ' ' LEU . 17.9 pt -98.78 12.85 5.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.616 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.579 ' CB ' HD13 ' A' ' 165' ' ' LEU . 13.1 p -48.36 -77.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.893 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.405 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 80.1 t80 -62.77 -38.06 89.11 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.582 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.424 ' C ' HG22 ' A' ' 25' ' ' THR . 0.6 OUTLIER -48.68 -44.69 38.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.265 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER 171.2 77.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.796 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -58.05 83.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 25' ' ' THR . 24.1 mttm -148.17 60.26 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.901 HD23 ' SG ' ' A' ' 18' ' ' CYS . 11.0 tp -123.34 68.56 39.06 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.78 -14.0 26.89 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.561 2.174 . . . . 0.0 112.246 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.9 p -67.78 120.8 14.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.945 0.403 . . . . 0.0 110.628 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -67.8 -32.67 73.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.145 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -56.66 -41.47 77.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.03 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 33' ' ' VAL . 65.1 t 54.06 70.38 1.75 Allowed Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.432 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -53.93 137.45 68.65 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.817 2.345 . . . . 0.0 112.61 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.0 m -128.45 140.36 51.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.6 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.66 HG13 ' N ' ' A' ' 37' ' ' PHE . 9.1 p -159.75 -52.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.789 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.66 ' N ' HG13 ' A' ' 36' ' ' VAL . 66.9 t80 -100.07 130.79 46.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.845 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 89.9 m-20 -75.83 136.9 40.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.495 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -111.48 148.27 33.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.784 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.421 ' H ' ' H ' ' A' ' 41' ' ' ALA . 26.8 p90 -176.14 -7.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.98 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.421 ' H ' ' H ' ' A' ' 40' ' ' TYR . . . -138.79 103.25 4.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.393 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.6 131.82 62.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.641 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 43' ' ' THR . 15.3 t -105.64 123.03 47.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.744 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.78 157.3 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.473 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 66.1 mtm -129.97 132.0 46.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.338 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.446 HG21 ' HB2' ' A' ' 170' ' ' ASP . 17.6 tt -135.17 131.77 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.97 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.37 26.57 51.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.55 58.43 3.86 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -136.23 101.36 10.21 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.43 103.19 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 122.266 1.977 . . . . 0.0 113.004 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.668 ' HA ' HG22 ' A' ' 3' ' ' THR . 52.6 p90 -154.12 169.7 22.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.832 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.495 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.0 OUTLIER -136.11 125.47 24.89 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.093 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.84 HD13 ' HB1' ' A' ' 172' ' ' ALA . 43.5 tp -107.86 121.16 44.18 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.221 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -94.42 134.41 12.01 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.956 HD12 ' H ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -140.95 117.96 11.18 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.493 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.542 ' HB2' HG23 ' A' ' 7' ' ' VAL . 10.9 t80 -65.97 -158.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.64 ' HB3' HD11 ' A' ' 20' ' ' LEU . 50.2 p30 -166.88 172.76 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.652 0.263 . . . . 0.0 110.63 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.702 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 0.3 OUTLIER 35.31 -157.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 110.836 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . 158.23 -50.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.271 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.655 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.729 0.299 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.808 HG21 HG12 ' A' ' 7' ' ' VAL . 54.1 m -126.65 127.51 45.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.529 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.512 ' CB ' HD11 ' A' ' 4' ' ' ILE . 85.4 m-20 -83.63 -36.22 24.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.68 122.86 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.291 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -84.97 123.3 30.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.365 0.602 . . . . 0.0 111.377 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.553 HD22 HG22 ' A' ' 8' ' ' VAL . 7.4 tt -115.39 130.76 56.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.754 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -118.4 135.53 58.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.152 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.741 ' SG ' HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -130.79 132.07 45.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 110.893 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.795 ' CD1' HG21 ' A' ' 93' ' ' VAL . 44.5 p90 -152.84 143.89 23.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.173 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.631 ' H ' HG11 ' A' ' 14' ' ' VAL . 14.0 t -53.12 132.22 37.91 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 138' ' ' THR . 0.0 OUTLIER -99.51 24.18 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.755 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -113.8 7.82 7.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.659 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.43 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -124.29 150.01 62.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.124 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.93 -38.31 3.02 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.43 2.087 . . . . 0.0 113.345 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.1 p -85.67 -18.62 32.67 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.43 ' OG ' ' OG ' ' A' ' 86' ' ' SER . 50.6 m -59.09 -35.2 72.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.746 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 90' ' ' PHE . 2.1 p90 -89.77 -29.25 18.81 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.381 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 90' ' ' PHE . 98.7 mt-10 -63.73 -31.93 73.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.714 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -80.56 -38.09 30.21 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.939 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.795 HG21 ' CD1' ' A' ' 82' ' ' PHE . 76.5 t -68.39 -62.78 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.554 ' HE2' HD21 ' A' ' 112' ' ' LEU . 19.7 mttt -70.69 -7.12 42.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 76.7 tt0 -131.37 -52.97 1.02 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -74.34 -42.54 59.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.538 ' NE1' ' OD1' ' A' ' 11' ' ' ASP . 96.5 m95 -88.58 -32.77 17.96 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.518 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -53.22 -45.03 98.54 Favored Pre-proline 0 N--CA 1.466 0.364 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.526 -178.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 12.8 Cg_exo -64.0 -45.12 10.97 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.259 1.973 . . . . 0.0 111.515 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.64 -40.78 80.05 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.793 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.22 -35.38 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.418 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.2 m -52.75 -39.46 62.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.162 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.22 -46.43 79.5 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.625 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -61.14 -44.95 96.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.908 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.9 87.57 48.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.531 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -51.59 -34.84 54.35 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.312 2.008 . . . . 0.0 112.212 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -143.55 112.31 6.54 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.602 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.606 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -171.08 151.81 3.3 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.292 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.62 142.49 98.01 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.308 2.005 . . . . 0.0 111.257 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.725 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -135.92 137.4 41.32 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.39 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 111' ' ' LEU . 6.6 mp -95.46 130.27 42.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.74 HD22 ' HB2' ' A' ' 146' ' ' ALA . 34.2 tp -97.05 127.45 43.03 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.7 t -146.29 167.46 7.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.655 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -142.59 170.92 24.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.499 ' O ' HG22 ' A' ' 84' ' ' VAL . 3.1 p -122.9 177.6 5.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.182 0.515 . . . . 0.0 110.115 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.701 ' O ' ' N ' ' A' ' 118' ' ' ASP . 83.2 mt-30 57.78 11.28 1.3 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.402 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.742 ' CG2' ' H ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 35.57 19.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.342 0 CA-C-O 120.979 0.419 . . . . 0.0 111.178 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 116' ' ' GLN . 2.4 p30 50.48 13.82 0.14 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.692 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.9 tp -144.12 -36.1 0.35 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 119.804 -0.758 . . . . 0.0 112.816 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.742 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 8.0 tpm_? . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.686 ' O ' HG23 ' A' ' 137' ' ' ILE . 15.5 tt . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.811 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 6.8 m -128.56 -30.5 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.811 ' CD ' ' H ' ' A' ' 138' ' ' THR . 79.7 Cg_exo -44.41 -59.7 1.03 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.691 1.594 . . . . 0.0 112.754 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -122.07 -35.14 3.21 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.73 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.7 m -53.98 -40.42 66.87 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.061 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.549 ' HB1' ' NZ ' ' A' ' 94' ' ' LYS . . . -80.18 -37.37 33.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.665 0.269 . . . . 0.0 111.265 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.2 -41.44 83.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.409 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.14 -42.42 99.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 110.513 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 89.3 mt -64.23 -34.12 77.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.326 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.74 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -73.73 -30.59 62.92 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.472 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -54.43 -38.26 66.07 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 149' ' ' LEU . 55.0 p30 -123.27 -26.56 4.27 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.59 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 5.9 tp -74.94 2.35 10.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.315 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.703 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 47.7 mttt 100.44 147.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.624 0.77 . . . . 0.0 110.384 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 155.25 -173.27 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.08 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 110' ' ' PHE . 46.3 t -150.35 -57.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.281 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -98.76 -176.36 3.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.656 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.619 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 31.6 p90 -170.62 97.13 0.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.958 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.461 HG22 ' C ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -161.3 -176.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.186 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.746 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.4 OUTLIER -148.18 96.08 2.57 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.838 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.721 ' SG ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -108.64 147.26 32.13 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 123.129 1.443 . . . . 0.0 113.058 -178.274 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.534 ' HB2' ' N ' ' A' ' 116' ' ' GLN . 5.3 t -165.94 90.98 0.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 111.64 -2.527 . . . . 0.0 106.102 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.813 ' HB1' ' H ' ' A' ' 28' ' ' LEU . . . 48.5 31.6 2.94 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.962 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.816 ' O ' ' N ' ' A' ' 162' ' ' GLN . 1.9 mt -153.46 -76.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.886 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.746 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 3.1 m -51.78 44.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.816 ' N ' ' O ' ' A' ' 160' ' ' LEU . 36.2 tt0 -72.7 8.47 1.46 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.707 ' H ' ' C ' ' A' ' 161' ' ' THR . 26.4 mttt -81.24 -6.31 58.73 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.16 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -126.89 -67.84 0.16 Allowed Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 106.648 -2.581 . . . . 0.0 106.648 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.721 HD12 ' SG ' ' A' ' 157' ' ' CYS . 4.7 mt -41.68 -7.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.652 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 164' ' ' GLY . 48.7 tttt -83.51 -45.49 13.53 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 164' ' ' GLY . 24.4 m120 -81.22 4.75 19.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.29 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 165' ' ' LEU . 58.2 t -86.8 -62.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.765 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 23' ' ' TYR . 78.4 m-85 -45.19 -40.44 7.21 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.217 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 46' ' ' ILE . 59.5 t0 -68.04 -42.96 79.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.203 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.99 -27.85 69.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.973 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.84 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -62.76 -32.29 73.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.92 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.513 HG22 ' CG ' ' A' ' 51' ' ' TYR . 1.1 pp -64.61 -27.21 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.338 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.84 -35.02 79.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.569 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.46 -28.93 62.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.839 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -59.46 -42.18 91.41 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.85 -25.93 66.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.411 . . . . 0.0 110.483 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 99.99 110.52 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' THR . 90.4 mt-30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.871 0.367 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -40.52 134.96 1.65 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.739 HD11 ' OD2' ' A' ' 76' ' ' ASP . 5.2 tp -123.79 144.6 32.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.727 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HA ' ' H ' ' A' ' 54' ' ' GLY . 91.2 mttt -100.88 153.83 19.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.272 0.558 . . . . 0.0 111.365 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -135.65 160.38 38.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.892 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.537 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 33.1 m -125.4 157.47 34.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.458 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.477 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 21.6 t -108.76 126.65 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.294 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.9 t -133.66 129.26 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.651 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.602 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . -164.59 -143.09 3.6 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.444 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.5 t0 -83.42 111.63 19.2 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 28.2 -90.3 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -131.23 126.8 36.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.071 0.462 . . . . 0.0 111.56 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -136.52 -174.4 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.303 178.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.471 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -65.08 42.24 0.11 Allowed Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 59' ' ' ALA . 37.1 mttt -62.05 -36.4 81.5 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.7 m -66.04 -48.85 69.71 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -62.37 -29.92 70.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.152 0.501 . . . . 0.0 110.727 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.597 HD21 HG11 ' A' ' 113' ' ' VAL . 57.7 tp -57.29 -41.36 79.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.858 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tt -66.99 -37.93 85.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 0.0 110.672 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 21' ' ' ILE . 93.4 mt -70.31 3.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.195 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.576 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 10.5 t -62.38 -74.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.864 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.614 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 0.7 OUTLIER -59.93 -31.06 69.49 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.234 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 6.7 m -52.04 -43.36 63.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.489 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -163.14 -38.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.377 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 22' ' ' SER . 1.8 p30 43.55 95.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -152.92 13.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.4 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.691 HD11 ' HG3' ' A' ' 120' ' ' ARG . 5.1 tp 61.24 60.64 3.07 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.213 0.53 . . . . 0.0 110.519 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.35 -168.43 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.862 2.375 . . . . 0.0 112.003 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 m -56.71 151.04 14.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.455 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.76 -34.74 74.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -115.54 132.21 56.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.737 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.05 70.64 82.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.394 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.07 9.53 3.02 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.994 2.463 . . . . 0.0 112.678 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.1 m -51.5 -38.92 56.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.65 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.7 p -130.09 141.8 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.252 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -58.2 -49.5 76.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.279 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 51.3 p30 -176.14 157.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.544 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' LEU . 38.0 t-20 -124.45 169.27 12.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.55 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.492 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -178.36 11.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.172 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.24 100.31 3.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.857 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.413 HG11 ' OH ' ' A' ' 23' ' ' TYR . 42.2 t -134.87 134.17 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.217 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 43' ' ' THR . 14.8 t -119.44 126.64 51.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.422 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.76 144.88 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.676 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 73.8 mtm -105.76 123.53 48.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.14 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.4 mt -132.72 117.11 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.804 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.35 70.96 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.07 43.9 15.46 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.494 ' OE1' ' OD1' ' A' ' 170' ' ' ASP . 64.8 mt-10 -123.2 86.01 51.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.467 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 50.2 Cg_endo -76.9 102.02 1.57 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.211 1.941 . . . . 0.0 112.423 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 88.9 m-85 -155.46 170.39 22.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.965 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.492 ' H ' ' HB ' ' A' ' 3' ' ' THR . 3.4 p -134.8 142.83 46.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.159 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.785 HD22 ' HB2' ' A' ' 172' ' ' ALA . 46.0 tp -122.36 126.85 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.954 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -98.07 130.72 10.33 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.695 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.492 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 66.6 mt -116.76 123.41 47.09 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.532 ' O ' ' O ' ' A' ' 57' ' ' ASP . 34.9 t80 -91.15 32.13 1.05 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.961 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 56' ' ' PHE . 50.5 p30 -36.24 168.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.062 0.458 . . . . 0.0 112.059 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 58' ' ' THR . 46.4 m 59.8 53.67 4.72 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.174 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.595 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . . . -141.36 157.34 45.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.429 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.738 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.898 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.537 0.208 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.7 t -131.09 150.63 52.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.739 ' OD2' HD11 ' A' ' 4' ' ' ILE . 88.1 m-20 -127.37 -15.69 5.08 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.639 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.12 107.56 13.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.941 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -74.04 135.29 43.06 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.721 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.468 HD11 HG21 ' A' ' 113' ' ' VAL . 7.9 tt -117.47 125.26 50.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.621 HG21 HD12 ' A' ' 112' ' ' LEU . 10.7 m -100.66 132.27 46.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.949 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.7 t -125.91 128.46 47.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.398 0.618 . . . . 0.0 111.675 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' HB3' HG21 ' A' ' 93' ' ' VAL . 12.8 p90 -153.44 157.63 40.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.511 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.52 ' OG ' ' CB ' ' A' ' 89' ' ' SER . 16.3 p -66.42 132.33 48.06 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -78.71 32.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.934 -177.341 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' A' ' 119' ' ' LEU . 32.6 m -121.62 160.78 22.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.075 0.464 . . . . 0.0 110.347 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -42.22 -58.61 3.34 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 89' ' ' SER . 20.0 Cg_exo -22.69 65.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 124.634 3.556 . . . . 0.0 115.984 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 86' ' ' SER . 50.5 m 34.02 10.76 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 87' ' ' PRO . 88.5 p -69.46 -33.67 73.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.388 0.54 . . . . 0.0 110.806 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.6 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 5.8 p90 -89.12 -41.38 12.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.202 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.6 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.7 tt0 -55.98 -34.17 65.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.267 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 96' ' ' LYS . 73.4 m-20 -85.75 -64.4 1.16 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.123 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 82' ' ' PHE . 52.7 t -49.67 -52.97 11.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.707 ' NZ ' HD21 ' A' ' 112' ' ' LEU . 23.3 mttm -67.37 -20.08 65.51 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 84.4 tt0 -126.61 -58.54 1.32 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 92' ' ' ASN . 14.7 tptp -60.49 -35.2 75.36 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 10' ' ' GLY . 42.2 m95 -84.16 -35.0 23.9 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.006 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -37.45 -54.53 2.1 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 20.0 Cg_endo -63.64 -36.5 52.4 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 121.271 1.314 . . . . 0.0 110.979 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 97' ' ' TRP . 48.2 tp10 -61.45 -43.91 98.04 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.042 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.9 mt -74.74 -35.3 36.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.812 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.7 m -50.49 -41.7 53.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.023 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -57.7 -39.9 78.24 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.363 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -58.37 -44.9 89.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.483 ' O ' ' OG1' ' A' ' 108' ' ' THR . 8.6 t -167.48 108.61 0.61 Allowed Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.49 150.56 22.09 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.199 1.933 . . . . 0.0 112.419 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 60.41 49.37 6.91 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.972 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -121.42 108.81 35.34 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.814 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -47.82 148.29 6.39 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.993 1.796 . . . . 0.0 111.441 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 152' ' ' VAL . 20.3 p90 -151.02 161.63 42.37 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.824 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.3 mp -96.6 127.51 42.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.347 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.707 HD21 ' NZ ' ' A' ' 94' ' ' LYS . 16.9 tp -88.77 119.86 29.64 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.643 HG12 ' N ' ' A' ' 114' ' ' GLY . 40.0 t -136.3 165.3 29.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 0.0 111.815 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.643 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -142.15 174.36 23.29 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 12.5 t -137.79 161.14 37.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.949 0.404 . . . . 0.0 110.451 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.648 HE22 ' NH2' ' A' ' 120' ' ' ARG . 44.8 mm-40 54.55 33.19 18.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.773 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.889 HG23 ' N ' ' A' ' 118' ' ' ASP . 7.2 tt 21.84 -138.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.424 0 O-C-N 123.544 0.527 . . . . 0.0 110.812 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.889 ' N ' HG23 ' A' ' 117' ' ' ILE . 23.7 p30 -87.07 83.49 7.46 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.277 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.589 ' N ' ' CG1' ' A' ' 85' ' ' VAL . 16.6 tp 56.75 42.5 26.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.023 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.691 ' HG3' HD11 ' A' ' 28' ' ' LEU . 50.6 ttm-85 . . . . . 0 CA--C 1.519 -0.238 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.152 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 84' ' ' VAL . 6.1 tt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.849 0.356 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.609 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.49 -64.34 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.802 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 138' ' ' THR . 72.1 Cg_exo -22.52 -72.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 123.495 2.797 . . . . 0.0 113.485 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -102.45 -44.28 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.047 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.567 HG21 HG13 ' A' ' 137' ' ' ILE . 41.9 m -51.39 -46.26 62.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.518 ' HB1' ' NZ ' ' A' ' 94' ' ' LYS . . . -76.73 -38.57 54.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.825 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.444 ' CD ' ' O ' ' A' ' 139' ' ' PRO . 97.7 mt-10 -60.21 -39.47 86.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.255 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.96 -49.62 75.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 109.96 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 91.1 mt -57.56 -31.93 66.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.475 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.69 75.73 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.942 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -59.75 -35.38 74.47 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.611 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -49.56 -31.17 9.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.6 mt -126.68 -114.64 0.28 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.633 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -175.9 71.85 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.87 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . . . -61.01 -138.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.841 0.353 . . . . 0.0 110.628 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 110' ' ' PHE . 54.9 t -154.16 -50.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.829 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.541 ' NZ ' ' OE1' ' A' ' 171' ' ' GLU . 1.1 mmtm -114.41 -175.62 2.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.651 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.653 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -170.7 96.21 0.22 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.497 HG11 ' CD2' ' A' ' 165' ' ' LEU . 9.4 p -143.51 142.95 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.515 0.674 . . . . 0.0 111.245 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.736 ' O ' ' OG1' ' A' ' 161' ' ' THR . 3.6 pt-20 -119.92 96.19 5.07 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -120.25 131.11 54.8 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -176.165 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 160' ' ' LEU . 77.1 p -119.83 87.94 2.84 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 173.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 37.02 26.93 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.865 ' O ' ' N ' ' A' ' 162' ' ' GLN . 34.9 tp -133.64 -79.25 0.47 Allowed 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.467 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 4.6 m -45.59 49.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.865 ' N ' ' O ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -71.49 0.81 7.52 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 175.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.6 ' H ' ' C ' ' A' ' 161' ' ' THR . 8.7 mtmp? -58.86 -23.54 60.99 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 113.546 -1.661 . . . . 0.0 106.849 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -119.28 -65.99 0.29 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.497 ' CD2' HG11 ' A' ' 155' ' ' VAL . 0.5 OUTLIER -40.67 -10.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.647 ' N ' ' O ' ' A' ' 164' ' ' GLY . 41.8 tttp -91.52 -42.05 10.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.584 ' N ' ' O ' ' A' ' 164' ' ' GLY . 78.3 m-20 -81.98 -0.03 42.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.135 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.7 t -77.98 -57.82 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.614 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 46.8 m-85 -48.79 -43.54 38.16 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.686 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.763 ' O ' HG22 ' A' ' 173' ' ' ILE . 62.6 t0 -67.12 -49.48 64.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.205 0.526 . . . . 0.0 109.913 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.541 ' OE1' ' NZ ' ' A' ' 153' ' ' LYS . 87.5 tt0 -59.06 -25.54 63.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.785 ' HB2' HD22 ' A' ' 53' ' ' LEU . . . -55.02 -32.2 61.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.314 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 170' ' ' ASP . 3.6 tt -59.13 -30.08 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.7 tp -57.42 -38.54 74.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.1 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.528 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -71.8 -15.79 62.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -63.59 -32.28 73.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 110.562 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.02 -34.04 71.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.456 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.483 ' OE2' ' OD2' ' A' ' 76' ' ' ASP . 96.9 mt-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.561 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' THR . 92.6 mt-30 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.827 0.346 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.46 ' H ' HG23 ' A' ' 3' ' ' THR . 0.6 OUTLIER -38.48 133.56 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.16 -179.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.663 HD11 ' OD2' ' A' ' 76' ' ' ASP . 4.5 tp -131.06 152.21 37.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.336 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.507 ' HA ' ' H ' ' A' ' 54' ' ' GLY . 25.2 mttm -109.26 161.26 15.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.198 0.523 . . . . 0.0 111.504 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -122.85 144.96 48.86 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.457 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.5 145.28 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG23 ' NZ ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -68.0 128.12 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.05 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.524 HG11 HD13 ' A' ' 101' ' ' ILE . 44.8 t -141.77 128.45 19.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.788 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.53 -174.96 38.13 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.884 -1.151 . . . . 0.0 112.106 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.467 ' N ' HG22 ' A' ' 93' ' ' VAL . 60.5 t0 -90.96 124.24 35.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.973 0.416 . . . . 0.0 110.755 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -47.39 101.82 0.04 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 150.16 30.67 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.707 0.299 . . . . 0.0 110.871 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 82' ' ' PHE . 29.2 m -127.47 132.84 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.024 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.53 97.75 2.27 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.555 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.497 ' NZ ' HG23 ' A' ' 8' ' ' VAL . 23.4 mttm -83.0 -2.51 55.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.674 0.273 . . . . 0.0 110.964 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.2 m -65.93 -57.78 7.07 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.742 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.439 ' O ' HG22 ' A' ' 21' ' ' ILE . 92.3 m -68.73 -25.95 65.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.489 0.661 . . . . 0.0 110.14 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.668 HD12 ' SG ' ' A' ' 157' ' ' CYS . 7.4 tp -50.94 -56.15 13.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.641 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.539 HD13 HD22 ' A' ' 55' ' ' LEU . 55.2 mt -71.19 -35.09 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.83 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 18' ' ' CYS . 2.0 tt -47.7 -11.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.268 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.572 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -55.75 -76.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.318 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.572 ' N ' ' OG ' ' A' ' 22' ' ' SER . 49.7 t80 -56.59 -39.21 73.15 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.916 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -66.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 73.6 p -111.72 -23.57 10.55 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 25' ' ' THR . 31.6 t30 83.35 95.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.909 0.385 . . . . 0.0 110.658 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 26' ' ' ASN . 11.2 pttm 33.32 73.26 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.279 0.561 . . . . 0.0 111.574 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.26 79.45 70.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.414 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.89 146.69 77.82 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.912 2.408 . . . . 0.0 112.742 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -128.33 143.18 50.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.139 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.86 -36.61 72.58 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.734 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 33' ' ' VAL . 77.4 t80 -124.82 138.23 54.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.597 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.408 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 9.6 t -73.0 123.32 89.46 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.519 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.39 158.12 36.81 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.227 1.951 . . . . 0.0 112.057 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -76.97 157.03 31.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.437 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.38 156.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.83 156.83 29.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.186 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -73.94 88.57 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 110.357 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -144.77 108.73 4.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.673 ' CB ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -101.2 -24.71 14.21 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.27 95.53 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.352 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.654 HG21 HD11 ' A' ' 55' ' ' LEU . 55.4 t -134.81 137.59 50.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.232 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 43' ' ' THR . 6.8 t -120.41 133.98 55.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.726 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.428 HG21 ' CZ ' ' A' ' 23' ' ' TYR . 8.8 p -141.31 141.8 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.408 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.9 mtm -110.5 118.84 37.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.435 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.0 mt -129.14 119.57 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.554 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.94 25.85 73.22 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.22 48.54 14.6 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -131.87 105.27 14.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.59 100.09 1.2 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.132 1.888 . . . . 0.0 112.479 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.854 ' CD1' HD11 ' A' ' 173' ' ' ILE . 33.5 p90 -142.08 165.58 27.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.317 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.29 127.49 35.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.067 0.461 . . . . 0.0 111.812 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.678 HD13 ' HB1' ' A' ' 172' ' ' ALA . 62.8 tp -107.36 138.08 44.22 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.842 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -81.6 147.6 26.9 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.673 ' H ' ' CB ' ' A' ' 40' ' ' TYR . 48.3 mt -99.51 98.52 9.41 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.243 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 57' ' ' ASP . 7.9 p90 -55.54 -27.36 48.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.51 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 58' ' ' THR . 63.6 t0 -17.09 139.88 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.947 0.779 . . . . 0.0 112.578 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.54 ' CB ' ' O ' ' A' ' 57' ' ' ASP . 1.1 m 155.33 149.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.304 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.12 151.96 20.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.543 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.654 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.503 ' O ' ' O ' ' A' ' 75' ' ' THR . 97.4 mt-30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.866 0.365 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 74' ' ' GLN . 59.8 p 44.43 -178.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.208 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.663 ' OD2' HD11 ' A' ' 4' ' ' ILE . 92.9 m-20 -123.3 -26.96 4.19 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.636 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.521 HG21 ' HB1' ' A' ' 175' ' ' ALA . 6.6 t -118.34 110.67 31.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.941 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -76.13 132.19 39.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.088 0.471 . . . . 0.0 111.52 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.488 ' CD2' ' CE1' ' A' ' 56' ' ' PHE . 4.1 mp -109.1 99.64 8.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.699 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 17.4 t -65.38 134.74 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.734 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.453 ' HB2' ' HZ3' ' A' ' 16' ' ' LYS . 19.0 t -123.85 130.32 52.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.427 . . . . 0.0 111.093 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.546 ' HA ' HG11 ' A' ' 14' ' ' VAL . 39.0 p90 -167.87 129.17 1.44 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.347 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.509 ' HA ' ' H ' ' A' ' 115' ' ' THR . 90.1 p -56.69 134.24 54.58 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.652 HG21 ' CB ' ' A' ' 156' ' ' GLU . 6.3 t -90.38 8.2 3.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.446 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.662 HG21 ' HG2' ' A' ' 120' ' ' ARG . 11.0 p -114.26 20.39 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.943 0.402 . . . . 0.0 110.163 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 t -139.61 137.7 19.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.196 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.494 ' O ' ' CD1' ' A' ' 90' ' ' PHE . 61.0 Cg_endo -73.76 -27.04 12.94 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.197 1.932 . . . . 0.0 113.224 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.2 p -81.6 -29.38 33.32 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -62.25 -37.42 85.36 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.612 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.528 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 2.0 p90 -91.25 -36.95 13.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.884 0.373 . . . . 0.0 111.328 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 85.6 tt0 -56.56 -38.43 71.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.182 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 96' ' ' LYS . 47.5 m-20 -90.0 -47.39 7.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.211 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 11' ' ' ASP . 42.9 t -57.31 -56.09 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.448 ' NZ ' HD13 ' A' ' 112' ' ' LEU . 35.0 mttm -71.32 -11.44 60.91 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -125.73 -65.78 0.98 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 92' ' ' ASN . 81.1 mttt -61.17 -33.31 73.22 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.412 ' CZ2' ' HA ' ' A' ' 11' ' ' ASP . 48.5 m95 -83.2 -31.47 27.06 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.777 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.2 t -40.77 -54.28 5.36 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.977 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 33.1 Cg_endo -66.11 -32.03 44.24 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.667 1.578 . . . . 0.0 111.51 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -61.62 -38.52 87.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.524 HD13 HG11 ' A' ' 9' ' ' VAL . 27.0 pt -94.42 -30.7 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.515 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' CYS . 55.4 m -60.28 -41.08 92.57 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.928 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -60.62 -39.13 87.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.556 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -57.26 -44.03 83.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.014 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -150.53 159.93 33.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 110.876 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.48 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 9.6 Cg_endo -55.32 155.86 18.89 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.877 2.385 . . . . 0.0 111.851 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -62.93 130.05 43.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.317 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.99 158.83 54.95 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.502 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.47 143.91 10.92 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.166 1.911 . . . . 0.0 112.064 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 151' ' ' ALA . 21.2 p90 -147.62 156.83 43.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.691 -0.804 . . . . 0.0 112.103 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 129.61 48.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.421 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.575 HD12 ' CD2' ' A' ' 154' ' ' TYR . 85.8 mt -84.26 132.12 34.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.498 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.615 HG11 HD21 ' A' ' 19' ' ' LEU . 44.3 t -144.69 151.47 15.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.048 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.502 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -145.36 176.21 24.5 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.625 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.509 ' H ' ' HA ' ' A' ' 83' ' ' SER . 9.2 p -121.66 179.13 4.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.572 ' N ' ' CB ' ' A' ' 158' ' ' SER . 98.7 mm-40 36.44 37.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.845 HG23 ' H ' ' A' ' 119' ' ' LEU . 5.8 tt 29.42 -150.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.435 0 O-C-N 123.071 0.232 . . . . 0.0 110.512 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.764 ' N ' HG23 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -108.76 11.09 26.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.845 ' H ' HG23 ' A' ' 117' ' ' ILE . 5.7 mp -139.22 12.19 2.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.981 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.662 ' HG2' HG21 ' A' ' 85' ' ' VAL . 25.4 ptt180 . . . . . 0 N--CA 1.467 0.392 0 O-C-N 123.204 0.315 . . . . 0.0 110.18 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 137' ' ' ILE . 15.3 tt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.897 0.38 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.698 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -119.6 -41.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.698 ' CD ' ' H ' ' A' ' 138' ' ' THR . 73.2 Cg_exo -47.97 -64.04 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.215 1.944 . . . . 0.0 113.262 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -105.9 -44.69 4.55 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.519 HG21 ' CG1' ' A' ' 137' ' ' ILE . 44.5 m -51.85 -43.3 63.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.762 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.77 -28.01 33.48 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.912 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.25 -44.13 95.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.03 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -63.86 -41.61 97.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.37 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 87.2 mt -61.31 -31.44 71.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.268 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.31 -40.49 70.78 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.46 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -56.48 -37.06 69.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.405 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.74 -25.35 10.87 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.3 mt -134.73 -115.12 0.2 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.844 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 151' ' ' ALA . 37.9 pttt 178.42 75.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.46 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.641 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . . . -56.04 -145.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.975 0.417 . . . . 0.0 111.843 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 110' ' ' PHE . 75.1 t -136.69 -56.03 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.978 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.455 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 24.6 tttt -125.46 -167.68 1.72 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.793 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.575 ' CD2' HD12 ' A' ' 112' ' ' LEU . 51.0 m-85 -156.67 96.71 1.66 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.32 139.52 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 122.148 0.975 . . . . 0.0 111.515 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.727 ' O ' ' OG1' ' A' ' 161' ' ' THR . 10.4 pt-20 -122.36 98.0 5.72 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.539 -1.664 . . . . 0.0 106.613 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.668 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -123.94 145.75 48.94 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 123.18 1.467 . . . . 0.0 113.112 -175.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.572 ' CB ' ' N ' ' A' ' 116' ' ' GLN . 10.0 t -173.22 93.89 0.1 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 112.013 -2.358 . . . . 0.0 107.831 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 50.21 38.74 18.08 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.332 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.742 ' O ' ' N ' ' A' ' 162' ' ' GLN . 22.1 tp -165.09 -82.17 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.031 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.727 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.8 OUTLIER -52.37 55.54 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.742 ' N ' ' O ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -80.42 15.8 1.52 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.545 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.605 ' H ' ' C ' ' A' ' 161' ' ' THR . 99.5 mttt -84.65 -3.44 58.51 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 113.751 -1.568 . . . . 0.0 108.426 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.45 -72.62 0.1 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -40.61 -16.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.366 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' A' ' 164' ' ' GLY . 81.2 tttt -84.57 -49.53 8.5 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 164' ' ' GLY . 81.3 m-20 -78.16 4.5 12.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.371 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.29 -58.73 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.2 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.477 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 94.4 m-85 -44.41 -44.7 8.57 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.521 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -69.38 -44.41 71.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.398 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.99 -25.17 68.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.15 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.678 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -56.46 -35.58 68.07 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.854 HD11 ' CD1' ' A' ' 51' ' ' TYR . 91.6 mt -55.19 -43.09 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 174' ' ' LEU . 8.0 mp -70.28 -36.18 74.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.002 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -63.63 -32.97 74.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.393 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.59 72.76 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.2 tp -59.32 -35.25 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.684 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 99.99 110.53 179.912 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 121.288 0.566 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.436 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.6 OUTLIER -107.83 150.27 27.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.6 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.693 HD11 ' OD2' ' A' ' 76' ' ' ASP . 11.0 tp -127.36 147.25 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.526 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -86.0 135.38 33.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.872 0.368 . . . . 0.0 110.539 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -135.94 130.9 34.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.283 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.423 HG23 ' HB ' ' A' ' 75' ' ' THR . 59.2 t -103.9 134.75 44.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.765 HG11 ' OD1' ' A' ' 57' ' ' ASP . 75.1 t -114.09 125.83 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.302 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.467 HG21 ' CZ3' ' A' ' 97' ' ' TRP . 13.3 p -136.94 146.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.486 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . -117.66 -157.44 10.68 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' HA ' ' HE1' ' A' ' 97' ' ' TRP . 51.3 p30 -74.09 24.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.067 0.46 . . . . 0.0 110.029 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 125.34 -77.32 0.38 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.86 94.9 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 110.472 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.406 HG11 ' H ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -120.04 169.56 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.389 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -69.05 56.46 0.57 Allowed Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -81.03 0.81 34.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.883 0.373 . . . . 0.0 110.255 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.8 p -69.16 -38.83 78.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.469 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.862 ' SG ' HG23 ' A' ' 33' ' ' VAL . 98.3 m -90.85 -14.54 31.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.136 0.494 . . . . 0.0 110.603 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.896 HD12 ' SG ' ' A' ' 157' ' ' CYS . 22.1 tp -59.8 -45.36 92.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.375 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD23 ' OD2' ' A' ' 57' ' ' ASP . 1.4 pp -74.07 -33.77 63.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 111.333 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 18' ' ' CYS . 52.6 mt -61.75 -5.72 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.346 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.492 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 43.7 t -44.82 -80.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.315 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -55.78 -38.33 69.77 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.535 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.592 ' O ' ' CB ' ' A' ' 25' ' ' THR . 3.7 m -44.54 -34.12 2.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.208 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' THR . 13.3 m 107.78 92.14 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.32 1.012 . . . . 0.0 109.839 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.634 ' ND2' ' HB2' ' A' ' 159' ' ' ALA . 27.8 t30 -110.22 -75.93 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.308 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt 57.95 43.42 21.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.246 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp 41.33 68.8 2.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.873 0.368 . . . . 0.0 110.248 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.48 157.15 22.11 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 123.014 2.476 . . . . 0.0 112.596 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 32' ' ' TYR . 20.2 m -56.91 -27.95 61.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.315 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -57.82 -2.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.265 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.539 ' H ' ' C ' ' A' ' 30' ' ' SER . 41.4 m-85 70.43 -116.01 0.1 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.145 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.862 HG23 ' SG ' ' A' ' 18' ' ' CYS . 7.1 p -125.28 79.45 66.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.482 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.53 154.08 44.41 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.663 2.242 . . . . 0.0 111.323 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -130.01 147.35 51.75 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.6 t -131.01 140.18 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.948 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -95.62 134.87 38.02 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.798 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 59.32 45.21 14.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.213 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LEU . 51.6 t-20 -97.79 124.03 41.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.346 . . . . 0.0 110.532 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.631 ' CG ' ' N ' ' A' ' 41' ' ' ALA . 17.4 p90 -165.28 -48.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.488 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.631 ' N ' ' CG ' ' A' ' 40' ' ' TYR . . . -77.99 104.36 8.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.635 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.75 126.2 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.324 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 43' ' ' THR . 12.6 t -82.6 127.38 33.3 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.259 0.552 . . . . 0.0 111.583 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.05 142.42 35.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.553 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.5 ptp -143.71 140.59 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.049 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.611 ' O ' ' N ' ' A' ' 48' ' ' GLY . 42.7 mm -119.81 102.85 13.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.238 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 20.98 43.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.719 0 O-C-N 123.784 0.678 . . . . 0.0 111.844 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -151.12 -76.64 0.02 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' OE1' ' OH ' ' A' ' 51' ' ' TYR . 6.5 mt-10 -153.8 161.83 28.23 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.367 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -84.45 139.26 7.84 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 C-N-CA 122.806 2.337 . . . . 0.0 113.197 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.561 ' HB2' HG21 ' A' ' 173' ' ' ILE . 42.4 m-85 -152.36 159.85 43.38 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.436 ' H ' ' HB ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -135.45 140.39 44.83 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.746 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.649 HD21 ' CD2' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -109.86 139.18 45.22 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.557 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -92.75 120.13 6.07 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.937 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.529 ' H ' ' CA ' ' A' ' 40' ' ' TYR . 57.9 mt -114.87 124.92 52.95 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 57' ' ' ASP . 25.3 t80 -115.48 34.44 4.91 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.765 ' OD1' HG11 ' A' ' 8' ' ' VAL . 72.2 m-20 -45.75 -177.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.147 0.499 . . . . 0.0 111.496 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.677 HG23 ' C ' ' A' ' 57' ' ' ASP . 1.7 p 76.59 147.98 0.1 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.936 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.05 -173.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.118 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.739 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.83 0.348 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.423 ' HB ' HG23 ' A' ' 7' ' ' VAL . 6.2 t -135.98 153.42 51.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.977 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.693 ' OD2' HD11 ' A' ' 4' ' ' ILE . 85.5 m-20 -117.72 -19.28 9.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.47 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.437 HG12 HD13 ' A' ' 111' ' ' LEU . 23.0 t -127.2 114.56 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.556 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.15 126.0 34.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.293 0.568 . . . . 0.0 112.182 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 80' ' ' VAL . 6.8 tt -124.59 126.41 45.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.799 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.655 ' N ' HD23 ' A' ' 79' ' ' LEU . 22.7 t -117.67 136.45 54.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.863 ' SG ' HD22 ' A' ' 19' ' ' LEU . 17.7 t -130.62 129.64 42.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.364 0.602 . . . . 0.0 111.906 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.906 ' CD1' HG11 ' A' ' 93' ' ' VAL . 42.3 p90 -139.15 154.14 48.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.028 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.406 ' H ' HG11 ' A' ' 14' ' ' VAL . 32.0 t -67.98 134.0 49.99 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.204 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.792 ' O ' HG12 ' A' ' 84' ' ' VAL . 48.5 t -96.26 26.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.991 -0.683 . . . . 0.0 111.719 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.704 ' O ' HG12 ' A' ' 85' ' ' VAL . 62.9 t -122.58 12.87 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 0.0 110.953 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.2 m -137.34 145.32 49.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.009 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.436 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 60.4 Cg_endo -73.75 -20.79 19.64 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.26 1.973 . . . . 0.0 112.76 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.8 m -91.52 -25.22 19.36 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.916 -0.313 . . . . 0.0 111.771 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.3 m -64.03 -40.97 97.52 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.712 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 87' ' ' PRO . 2.7 p90 -85.13 -29.36 24.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.097 0.475 . . . . 0.0 110.808 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.94 -28.14 64.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.587 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 93' ' ' VAL . 11.0 m120 -87.53 -70.17 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.906 HG11 ' CD1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -31.95 -64.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.351 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.688 ' H ' HG13 ' A' ' 93' ' ' VAL . 16.0 mttp -64.49 -33.27 75.5 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -177.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 88.7 mt-10 -107.73 -63.59 1.29 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -62.02 -38.93 90.53 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.573 ' CZ2' ' O ' ' A' ' 10' ' ' GLY . 74.1 m95 -77.0 -30.58 55.98 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.376 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.469 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.4 t -45.72 -55.33 12.82 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 19.4 Cg_endo -60.03 -36.94 87.82 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.733 1.622 . . . . 0.0 111.717 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.486 ' OE1' ' CE3' ' A' ' 97' ' ' TRP . 85.2 tt0 -59.59 -44.29 93.41 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.724 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.4 mt -76.38 -31.37 20.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.204 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 105' ' ' CYS . 37.1 m -52.85 -37.63 60.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.999 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -49.58 -40.07 37.29 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.21 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.533 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 80.5 m80 -78.6 -20.54 50.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.052 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 6.8 p 39.13 58.6 6.01 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.791 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.79 133.36 12.6 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.794 2.329 . . . . 0.0 112.145 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -89.5 -1.13 57.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.957 0.408 . . . . 0.0 110.167 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.82 155.79 84.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.744 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.96 150.04 58.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.761 2.307 . . . . 0.0 111.98 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.729 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -129.65 131.15 46.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.3 mp -93.96 130.54 40.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.117 0.484 . . . . 0.0 111.877 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.464 HD13 ' CD2' ' A' ' 149' ' ' LEU . 50.4 tp -102.11 130.4 48.7 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.46 179.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.529 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.586 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -149.04 178.9 26.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 13.0 t -128.27 163.74 24.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.811 0.339 . . . . 0.0 110.298 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.602 ' N ' ' OG ' ' A' ' 158' ' ' SER . 96.9 mt-30 56.49 18.19 3.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.272 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.744 HG13 ' H ' ' A' ' 119' ' ' LEU . 15.7 pt 33.94 -150.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.363 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.452 ' OD1' ' C ' ' A' ' 118' ' ' ASP . 50.9 p30 -118.32 17.28 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.403 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.744 ' H ' HG13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -144.72 -36.14 0.32 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.245 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.737 ' H ' ' CG1' ' A' ' 117' ' ' ILE . 65.3 ttp85 . . . . . 0 CA--C 1.515 -0.368 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.812 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.478 ' O ' HG13 ' A' ' 84' ' ' VAL . 82.6 mt . . . . . 0 N--CA 1.461 0.084 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.852 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -129.98 -48.19 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.646 ' CD ' ' H ' ' A' ' 138' ' ' THR . 59.7 Cg_endo -87.66 -67.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.416 2.078 . . . . 0.0 114.598 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 139' ' ' PRO . 77.7 mm-40 -31.55 -72.88 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.2 p -116.79 4.38 12.99 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.852 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -94.2 -65.2 1.0 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.512 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' THR . 84.2 tt0 -69.79 -41.49 75.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.219 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -66.68 -38.16 86.23 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.832 0.349 . . . . 0.0 111.462 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 145' ' ' LEU . 23.3 tp -74.73 -19.97 60.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.582 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.14 -36.71 77.74 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.178 0.513 . . . . 0.0 110.833 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -58.83 -41.16 86.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.236 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -89.96 -27.06 20.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.663 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 54.3 tp -44.52 -25.98 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.113 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.604 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 55.5 mttp 91.54 -0.93 0.17 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.898 0.479 . . . . 0.0 110.407 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -59.04 -136.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.327 0.584 . . . . 0.0 111.789 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -159.92 -36.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.278 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -110.31 -179.07 3.67 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.623 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 34.7 p90 -169.82 97.43 0.3 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.798 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.467 ' O ' ' CD ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -161.15 171.94 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.98 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.733 ' O ' ' OG1' ' A' ' 161' ' ' THR . 20.1 mm-40 -138.81 96.51 3.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.896 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -107.02 147.75 29.55 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 123.17 1.462 . . . . 0.0 112.51 -177.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.602 ' OG ' ' N ' ' A' ' 116' ' ' GLN . 0.3 OUTLIER -169.85 91.72 0.21 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 111.555 -2.566 . . . . 0.0 106.236 177.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.634 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . . . 43.35 21.59 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.221 -1.809 . . . . 0.0 109.503 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.78 ' O ' ' N ' ' A' ' 162' ' ' GLN . 0.5 OUTLIER -133.73 -84.05 0.45 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.585 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.733 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 1.2 m -53.66 46.86 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.725 0.641 . . . . 0.0 111.814 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.78 ' N ' ' O ' ' A' ' 160' ' ' LEU . 7.2 tt0 -80.44 9.39 5.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.594 ' H ' ' C ' ' A' ' 161' ' ' THR . 16.1 tttp -84.6 -5.41 59.3 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 112.781 -2.009 . . . . 0.0 108.435 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.671 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -129.9 -72.0 0.12 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 107.811 -2.115 . . . . 0.0 107.811 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.417 ' N ' HD22 ' A' ' 165' ' ' LEU . 4.3 mm? -38.75 -15.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.245 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.9 tttt -84.14 -47.68 10.63 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 164' ' ' GLY . 18.6 p-10 -79.41 4.99 13.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.028 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 171' ' ' GLU . 24.4 t -84.1 -52.65 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.892 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.649 ' CD2' HD21 ' A' ' 53' ' ' LEU . 4.4 m-85 -37.65 -48.17 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.501 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.418 ' O ' ' CG1' ' A' ' 173' ' ' ILE . 53.3 t0 -62.84 -37.52 87.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 168' ' ' VAL . 77.5 mm-40 -77.3 -30.07 54.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.196 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.42 -40.01 89.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.955 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.561 HG21 ' HB2' ' A' ' 51' ' ' TYR . 21.1 pt -67.41 -29.73 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.67 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.69 -36.73 77.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.04 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.96 -21.28 66.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -65.01 -32.54 74.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.609 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 41.8 tp -56.97 -36.05 69.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.405 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.559 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.584 ' O ' ' HB2' ' A' ' 176' ' ' ALA . 94.6 mt-30 . . . . . 0 C--O 1.228 -0.027 0 CA-C-O 121.03 0.443 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -41.2 115.66 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.233 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 176' ' ' ALA . 18.3 tt -122.97 146.46 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.957 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 30.6 mttm -104.47 163.29 12.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.853 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.4 136.98 26.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.518 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.531 HG23 ' HB ' ' A' ' 75' ' ' THR . 57.4 t -77.48 131.22 35.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 79' ' ' LEU . 57.3 t -117.8 125.88 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.793 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 101' ' ' ILE . 21.9 m -135.64 159.77 39.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.797 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.69 -177.09 36.24 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.273 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB2' HG23 ' A' ' 93' ' ' VAL . 25.2 t70 -81.05 124.94 29.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.684 0.278 . . . . 0.0 110.463 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 36.03 39.56 0.31 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 55.2 124.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.629 HG23 ' SG ' ' A' ' 81' ' ' CYS . 1.4 m -120.91 -168.33 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.889 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.58 49.64 0.01 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 121.428 -0.415 . . . . 0.0 112.408 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.617 ' N ' ' O ' ' A' ' 14' ' ' VAL . 23.2 pttt -57.4 -39.69 76.67 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.455 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 54.1 p -65.49 -43.87 88.85 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.1 m -53.9 -24.63 16.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.1 0.476 . . . . 0.0 111.026 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.57 -39.04 70.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.222 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 42' ' ' VAL . 36.6 tp -63.29 -38.74 92.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.046 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.3 pt -87.5 5.23 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.788 ' CB ' HD13 ' A' ' 165' ' ' LEU . 38.7 t -59.06 -75.5 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.695 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -67.18 -39.52 86.41 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.957 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -49.27 -45.7 45.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.992 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 t 179.42 75.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.624 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 26' ' ' ASN . 6.8 p-10 -60.15 113.52 2.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.224 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 28' ' ' LEU . 85.5 mttt -150.86 50.03 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.295 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.632 HD12 HD21 ' A' ' 160' ' ' LEU . 3.9 mp 57.68 129.36 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.658 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 159' ' ' ALA . 73.6 Cg_endo -76.42 156.94 36.92 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.15 1.9 . . . . 0.0 111.905 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.9 m -117.07 146.96 42.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.328 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -56.51 -34.94 67.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.165 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -64.66 -33.51 76.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.544 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.7 t 48.18 69.54 2.63 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.431 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.494 ' O ' ' O ' ' A' ' 35' ' ' THR . 51.3 Cg_exo -50.56 -14.69 1.23 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.927 2.418 . . . . 0.0 112.16 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 50.03 171.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.702 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 38' ' ' ASP . 22.5 t -121.0 142.43 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.29 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -49.07 -30.11 5.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 109.802 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.548 ' H ' HG12 ' A' ' 36' ' ' VAL . 90.0 m-20 -58.73 160.11 6.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.438 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.594 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 81.6 m-20 -133.21 -8.06 2.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.954 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER 163.85 28.45 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.929 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.77 108.06 5.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 20' ' ' LEU . 22.8 t -130.0 130.18 66.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.793 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.31 106.22 14.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.958 0.409 . . . . 0.0 111.425 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.46 154.81 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.074 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.22 133.93 55.37 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.478 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.543 HG21 ' HB2' ' A' ' 170' ' ' ASP . 13.5 tt -129.65 126.89 63.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.523 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.18 25.93 60.66 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.32 50.05 7.79 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -130.43 79.03 73.17 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.741 0.305 . . . . 0.0 110.361 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.58 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 26.9 Cg_exo -58.77 108.87 0.44 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.883 2.389 . . . . 0.0 112.437 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 50' ' ' PRO . 64.3 m-85 -160.33 174.53 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.27 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 p -133.55 142.01 47.98 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.676 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.665 HD13 ' CB ' ' A' ' 172' ' ' ALA . 66.5 tp -116.22 126.73 54.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.717 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.09 134.43 11.68 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.277 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.532 ' HG ' ' H ' ' A' ' 57' ' ' ASP . 11.6 tp -113.79 119.89 38.9 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.708 ' O ' ' O ' ' A' ' 57' ' ' ASP . 63.2 t80 -91.26 8.83 33.97 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.708 ' O ' ' O ' ' A' ' 56' ' ' PHE . 36.2 p30 30.47 177.26 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.468 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 82.4 p -88.57 156.61 18.97 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.612 -0.68 . . . . 0.0 110.77 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.61 20.12 4.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.548 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.837 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 5' ' ' LYS . 96.8 mt-30 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.914 0.388 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.531 ' HB ' HG23 ' A' ' 7' ' ' VAL . 48.2 p -98.12 66.93 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.461 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -101.97 0.87 35.94 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.519 ' CG1' HD13 ' A' ' 111' ' ' LEU . 45.5 t -125.28 110.66 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.408 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -70.81 134.81 47.67 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.228 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.596 ' HB3' HG22 ' A' ' 8' ' ' VAL . 8.3 tt -119.0 126.96 52.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.699 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 112' ' ' LEU . 24.7 t -97.01 132.77 40.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.086 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.629 ' SG ' HG23 ' A' ' 14' ' ' VAL . 42.5 t -128.59 118.82 23.63 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.323 0.583 . . . . 0.0 111.675 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 115' ' ' THR . 28.3 p90 -149.43 157.53 43.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.181 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.0 t -70.72 132.32 45.19 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.294 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 84' ' ' VAL . 50.4 t -56.17 -9.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.306 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 86' ' ' SER . 27.1 m -127.18 169.47 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.508 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.646 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.5 OUTLIER -25.38 -68.16 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.826 -178.593 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.563 ' O ' ' CB ' ' A' ' 88' ' ' SER . 99.1 Cg_exo -28.09 74.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.841 3.027 . . . . 0.0 114.465 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 86' ' ' SER . 2.9 t 146.26 -11.46 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.624 0.577 . . . . 0.0 109.983 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 91' ' ' GLU . 0.7 OUTLIER 40.24 89.54 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' SER . 43.7 p90 -36.01 -26.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.824 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 89' ' ' SER . 97.2 mt-10 -62.05 -23.81 66.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.664 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.559 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 83.1 m-20 -80.23 -48.45 13.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.564 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 11' ' ' ASP . 56.0 t -77.63 -68.68 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.58 ' HE2' HD11 ' A' ' 112' ' ' LEU . 87.9 mttt -61.56 -15.1 35.61 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 78.1 mm-40 -129.06 -48.37 1.22 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -77.78 -35.69 51.31 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 69.1 m95 -99.13 -21.04 16.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.339 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -59.84 -41.79 87.45 Favored Pre-proline 0 C--N 1.333 -0.135 0 C-N-CA 120.119 -0.633 . . . . 0.0 109.955 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 4.1 Cg_exo -70.62 -38.42 5.93 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.703 2.269 . . . . 0.0 111.15 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -59.08 -39.03 80.87 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.63 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 9' ' ' VAL . 34.3 pt -85.01 -34.12 8.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' CYS . 76.2 m -60.22 -36.83 78.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.019 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.588 ' ND1' ' O ' ' A' ' 99' ' ' PRO . 37.7 m80 -50.5 -32.69 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.222 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -55.7 -45.57 77.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.411 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -143.55 160.7 50.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 110.984 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.479 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 8.0 Cg_endo -52.79 163.57 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.938 2.425 . . . . 0.0 111.935 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -64.86 131.47 46.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.861 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.85 161.21 33.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.158 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -46.38 146.15 5.22 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.261 1.974 . . . . 0.0 111.844 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.546 ' O ' ' N ' ' A' ' 152' ' ' VAL . 19.1 p90 -147.26 156.89 43.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.744 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.519 HD13 ' CG1' ' A' ' 77' ' ' VAL . 8.0 mp -97.32 125.67 42.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.665 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.58 HD11 ' HE2' ' A' ' 94' ' ' LYS . 16.1 tp -96.21 122.61 39.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.469 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.3 t -130.24 150.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.053 0.454 . . . . 0.0 111.747 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.5 156.87 17.11 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -119.22 167.58 11.71 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.563 0.697 . . . . 0.0 111.978 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.603 ' O ' ' O ' ' A' ' 117' ' ' ILE . 97.0 mm-40 50.75 24.45 1.73 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.777 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.838 HG23 ' H ' ' A' ' 119' ' ' LEU . 4.8 tt 30.62 -156.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.79 ' N ' HG23 ' A' ' 117' ' ' ILE . 53.0 p30 -120.81 29.27 7.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.838 ' H ' HG23 ' A' ' 117' ' ' ILE . 34.9 tp -137.31 -38.65 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.069 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.559 ' H ' HG22 ' A' ' 117' ' ' ILE . 6.9 tpm_? . . . . . 0 CA--C 1.518 -0.274 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 137' ' ' ILE . 1.3 tt . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 120.763 0.316 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.593 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -131.15 -65.66 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.593 ' HD2' ' H ' ' A' ' 138' ' ' THR . 84.3 Cg_exo -23.92 -69.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.758 2.972 . . . . 0.0 114.489 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -113.37 -37.8 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.6 m -52.57 -40.22 62.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.732 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.423 ' CB ' ' HZ3' ' A' ' 94' ' ' LYS . . . -72.75 -28.87 62.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.672 0.272 . . . . 0.0 111.506 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.24 -38.24 88.47 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -63.35 -46.19 87.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 110.897 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 65.3 mt -54.29 -33.47 58.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.051 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.77 81.73 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.064 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -60.42 -41.58 94.26 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.667 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -51.65 -31.98 27.69 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.4 mt -131.23 -115.58 0.23 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.459 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.701 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 63.5 mttm -134.96 -142.03 0.18 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.219 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 150.88 177.98 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.386 0.429 . . . . 0.0 111.059 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 110' ' ' PHE . 94.0 t -145.66 -59.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.567 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 154' ' ' TYR . 16.4 mmtt -100.81 170.56 8.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.505 ' CG ' ' C ' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -173.2 97.36 0.12 Allowed 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.321 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.899 HG22 ' H ' ' A' ' 156' ' ' GLU . 2.7 p -170.42 -167.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.165 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.899 ' H ' HG22 ' A' ' 155' ' ' VAL . 96.1 mt-10 -106.88 166.56 10.5 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.578 ' HB2' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -178.29 119.91 0.09 Allowed 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 178.061 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 160' ' ' LEU . 16.4 t -156.77 94.77 1.48 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.508 -1.678 . . . . 0.0 107.022 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.566 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . 35.12 28.57 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.565 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.768 ' O ' ' N ' ' A' ' 162' ' ' GLN . 41.9 mt -142.8 -78.89 0.23 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.238 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.705 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.6 m -44.09 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.768 ' N ' ' O ' ' A' ' 160' ' ' LEU . 11.8 pt20 -72.07 10.25 0.78 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.705 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.1 tttm -62.14 -27.03 68.65 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.062 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.679 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -125.12 -63.62 0.18 Allowed Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.788 HD13 ' CB ' ' A' ' 22' ' ' SER . 4.1 mt -39.19 -13.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.416 -0.513 . . . . 0.0 112.181 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 164' ' ' GLY . 43.4 tttm -81.29 -46.55 14.59 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' GLY . 32.6 m-20 -83.33 6.56 19.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.102 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 165' ' ' LEU . 54.8 t -86.41 -57.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.376 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.659 ' HA ' HD22 ' A' ' 53' ' ' LEU . 27.2 m-85 -45.84 -45.78 15.18 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.247 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.543 ' HB2' HG21 ' A' ' 46' ' ' ILE . 55.8 t0 -69.69 -45.16 68.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.481 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.0 -25.41 64.5 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.665 ' CB ' HD13 ' A' ' 53' ' ' LEU . . . -61.97 -36.11 80.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.348 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 8.5 mm -60.75 -37.03 75.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 36.9 tp -58.46 -35.87 72.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.879 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.475 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -63.88 -24.25 67.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.073 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -61.04 -36.25 79.08 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.695 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.3 mt -59.42 -32.98 70.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.411 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.641 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.452 ' O ' ' CB ' ' A' ' 176' ' ' ALA . 8.3 tp-100 . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.875 0.369 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.7 OUTLIER -49.76 132.41 22.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.105 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.677 HD11 ' OD2' ' A' ' 76' ' ' ASP . 3.9 tp -126.13 145.91 32.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.937 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -91.28 142.18 27.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.732 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -138.61 130.69 28.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.621 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG13 ' CB ' ' A' ' 56' ' ' PHE . 44.0 t -98.24 135.28 33.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.754 HG22 ' HB3' ' A' ' 79' ' ' LEU . 62.6 t -99.03 131.53 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.979 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.0 136.23 59.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.063 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.566 ' CA ' HG23 ' A' ' 58' ' ' THR . . . -148.94 -173.72 19.9 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 13' ' ' ALA . 54.6 t0 -80.3 118.3 21.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 29.87 -87.68 0.01 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -133.12 150.0 52.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.914 HG23 ' H ' ' A' ' 15' ' ' GLY . 8.5 m -153.7 -96.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.914 ' H ' HG23 ' A' ' 14' ' ' VAL . . . -137.76 19.52 3.32 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.037 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -39.13 -36.31 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.187 0.494 . . . . 0.0 111.832 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.0 p -65.31 -46.87 78.63 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.808 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -79.45 -35.87 39.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.453 . . . . 0.0 110.797 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.725 HD12 ' SG ' ' A' ' 157' ' ' CYS . 12.7 tp -58.32 -40.35 81.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.496 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.17 -37.81 78.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.368 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 21' ' ' ILE . 93.8 mt -70.19 -1.73 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.726 ' CB ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -29.36 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.634 -178.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.539 ' CE2' HG11 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -98.27 -12.33 21.69 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.546 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -48.61 -49.2 37.99 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.28 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.496 ' OG1' HD12 ' A' ' 28' ' ' LEU . 73.2 p -133.9 -16.01 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.532 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.585 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER 70.86 111.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 57.09 136.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.658 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.685 HD23 ' HD2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER 177.56 113.21 0.15 Allowed Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.245 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.685 ' HD2' HD23 ' A' ' 28' ' ' LEU . 66.6 Cg_exo -46.51 149.18 2.96 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.981 1.787 . . . . 0.0 112.316 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.8 t -58.27 -18.55 27.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.65 -34.13 57.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.859 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -119.69 126.8 51.98 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.845 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.84 157.38 38.16 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.53 66.07 3.74 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.673 2.249 . . . . 0.0 111.915 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.3 p -76.47 -15.95 59.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.229 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.0 -44.62 95.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.837 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -175.26 124.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 0.0 110.685 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -73.66 144.33 45.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.755 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -111.46 168.63 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.004 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.598 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 26.3 p90 -155.85 35.43 0.35 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.27 97.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.285 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.521 ' O ' ' OG1' ' A' ' 52' ' ' THR . 21.8 t -129.92 132.83 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.36 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 t -103.0 133.78 47.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.12 0.486 . . . . 0.0 111.219 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.539 HG11 ' CE2' ' A' ' 23' ' ' TYR . 19.1 m -132.44 156.48 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.951 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -113.37 123.93 51.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.985 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' GLY . 9.2 tp -134.6 137.63 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.103 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 34.09 28.29 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 82.53 47.03 6.16 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -128.22 83.6 65.64 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.166 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 59.2 Cg_endo -78.84 99.88 1.31 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.45 2.1 . . . . 0.0 112.674 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' A' ' 50' ' ' PRO . 62.4 m-85 -156.36 177.85 10.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.491 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.521 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 9.2 t -139.96 150.04 44.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.901 HD22 ' CB ' ' A' ' 172' ' ' ALA . 19.9 tp -118.11 128.39 54.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.86 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -86.31 138.02 15.52 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.813 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' A' ' 40' ' ' TYR . 81.2 mt -124.38 126.7 46.4 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.626 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.613 ' O ' ' O ' ' A' ' 57' ' ' ASP . 45.4 t80 -108.5 35.4 3.2 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.961 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 56' ' ' PHE . 90.6 m-20 36.79 178.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.566 HG23 ' CA ' ' A' ' 10' ' ' GLY . 98.4 m -64.77 132.08 48.59 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.606 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.84 149.04 33.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.643 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.682 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.815 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.841 0.353 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.5 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 5.8 t -141.72 155.98 45.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.459 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.677 ' OD2' HD11 ' A' ' 4' ' ' ILE . 91.2 m-20 -122.76 -33.07 3.44 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.09 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.91 152.56 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.417 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 75' ' ' THR . 21.0 m-85 -120.83 160.53 23.22 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.754 ' HB3' HG22 ' A' ' 8' ' ' VAL . 7.9 tt -119.15 123.25 43.93 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.246 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.9 m -102.27 133.49 45.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.607 ' SG ' ' CG1' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -134.07 134.82 42.78 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 111.516 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 115' ' ' THR . 39.3 p90 -142.83 153.84 43.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.873 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.1 p -95.63 134.74 38.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.928 HG13 ' H ' ' A' ' 85' ' ' VAL . 5.4 p -49.23 -68.23 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.416 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.928 ' H ' HG13 ' A' ' 84' ' ' VAL . 7.6 p -56.17 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.533 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.0 OUTLIER 157.84 80.76 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.472 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -56.39 -36.13 96.94 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.506 2.137 . . . . 0.0 112.061 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 m -57.65 -38.02 74.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.192 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.3 p -71.21 -34.26 70.67 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.509 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.545 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -70.48 -43.79 69.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 0.0 111.41 -179.315 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 96.8 mt-10 -61.48 -34.09 74.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.595 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 96' ' ' LYS . 28.0 m120 -89.75 -63.33 1.3 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.983 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.2 t -36.04 -62.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.255 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -70.44 -19.47 62.97 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.542 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 82.6 tt0 -124.87 -55.7 1.59 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 92' ' ' ASN . 19.3 tttt -74.99 -16.3 60.63 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -96.31 -50.32 4.83 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.123 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.47 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -43.04 -46.69 13.84 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.251 -178.78 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.542 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 15.7 Cg_exo -65.69 -39.55 20.39 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.049 1.833 . . . . 0.0 112.338 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.56 -36.26 83.2 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.404 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.631 HG13 HG23 ' A' ' 102' ' ' THR . 20.4 pt -89.83 -32.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.266 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.631 HG23 HG13 ' A' ' 101' ' ' ILE . 81.9 p -99.5 17.65 19.83 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.098 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -54.31 -46.45 72.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.494 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.66 -42.12 98.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.479 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.7 t -127.33 87.39 56.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.42 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.02 -27.98 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.312 2.008 . . . . 0.0 112.116 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -103.5 117.87 35.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.238 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 108' ' ' THR . 3.2 m -170.88 101.77 0.41 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.857 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.41 148.17 11.3 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.028 1.819 . . . . 0.0 112.008 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 151' ' ' ALA . 21.0 p90 -148.31 162.93 38.53 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.618 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.3 mp -91.14 129.58 37.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.806 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.4 tp -95.08 121.83 37.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.661 HG11 HD11 ' A' ' 19' ' ' LEU . 40.1 t -135.8 168.51 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.91 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.631 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -155.16 97.86 0.17 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.261 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 82' ' ' PHE . 2.6 p -51.47 177.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.92 0.39 . . . . 0.0 110.4 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.507 ' O ' ' C ' ' A' ' 117' ' ' ILE . 43.7 tp60 47.37 29.96 1.43 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.007 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.774 ' CD1' HD23 ' A' ' 160' ' ' LEU . 13.0 tt 27.43 -142.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 122.404 0.282 . . . . 0.0 110.367 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.744 ' N ' HG23 ' A' ' 117' ' ' ILE . 86.3 m-20 -88.24 3.32 49.91 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.882 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.617 ' H ' HG23 ' A' ' 117' ' ' ILE . 16.8 tp 137.34 90.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 124.572 1.17 . . . . 0.0 109.515 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.533 ' C ' ' O ' ' A' ' 119' ' ' LEU . 27.8 ttm180 . . . . . 0 N--CA 1.469 0.487 0 O-C-N 123.986 0.804 . . . . 0.0 111.161 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.533 HG21 ' HB2' ' A' ' 90' ' ' PHE . 4.9 tt . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 121.249 0.547 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.628 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -135.37 -66.06 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.256 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 141' ' ' THR . 48.7 Cg_exo -19.42 151.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 124.1 3.2 . . . . 0.0 114.329 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -48.05 -2.76 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.508 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.654 ' H ' ' C ' ' A' ' 139' ' ' PRO . 58.6 p -82.14 -8.37 59.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.92 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.63 -48.56 59.52 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.161 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.76 -31.11 72.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.691 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -57.71 -41.53 81.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.106 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.0 mt -49.07 -35.15 15.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.944 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.13 -37.87 69.35 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -63.81 -38.2 90.2 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.753 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -49.25 -35.27 17.2 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.38 -113.35 0.31 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.003 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.583 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 43.1 tttp -132.4 -117.46 0.21 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.913 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.587 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . . . 109.47 -162.96 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.133 0.895 . . . . 0.0 109.24 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 110' ' ' PHE . 50.7 t -149.26 -63.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.462 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.42 ' HZ2' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -86.89 -173.93 4.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.261 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.61 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 31.0 p90 -170.8 95.94 0.21 Allowed 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.743 HG13 ' N ' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -172.63 -169.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.167 -178.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.743 ' N ' HG13 ' A' ' 155' ' ' VAL . 77.1 mt-10 -153.14 114.81 4.26 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.309 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.725 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -121.29 138.11 54.39 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 122.474 1.13 . . . . 0.0 112.595 -177.346 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.473 ' C ' ' N ' ' A' ' 160' ' ' LEU . 37.7 t -145.57 93.96 2.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.005 -1.907 . . . . 0.0 106.659 176.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 39.61 30.54 0.06 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.986 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.867 ' O ' ' N ' ' A' ' 162' ' ' GLN . 58.2 tp -145.52 -86.61 0.11 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.281 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.563 ' C ' ' H ' ' A' ' 163' ' ' LYS . 1.5 m -44.7 41.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -176.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.867 ' N ' ' O ' ' A' ' 160' ' ' LEU . 13.1 pt20 -69.4 -0.79 6.92 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 161' ' ' THR . 63.9 mttp -56.84 -28.64 61.9 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 113.815 -1.539 . . . . 0.0 107.663 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.627 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -114.84 -65.21 0.41 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.726 HD12 ' CB ' ' A' ' 22' ' ' SER . 0.5 OUTLIER -42.52 -6.92 0.01 OUTLIER 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' A' ' 164' ' ' GLY . 38.2 tttt -92.85 -44.47 8.46 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 164' ' ' GLY . 33.3 m120 -81.73 -1.72 48.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.013 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.427 HG21 HD22 ' A' ' 165' ' ' LEU . 22.0 t -71.95 -52.28 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.449 ' CZ ' HD11 ' A' ' 55' ' ' LEU . 38.9 m-85 -55.79 -40.73 73.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.335 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.469 ' OD1' HG21 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -69.01 -47.8 64.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.497 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.56 -25.98 59.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.942 0.401 . . . . 0.0 111.215 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.901 ' CB ' HD22 ' A' ' 53' ' ' LEU . . . -52.03 -46.43 65.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.0 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.434 HG21 ' HB2' ' A' ' 51' ' ' TYR . 10.9 pt -66.2 -36.47 77.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.4 tp -61.37 -35.27 77.0 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.51 68.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.176 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -58.79 -30.68 67.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.871 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.0 tp -53.32 -37.51 62.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.483 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.665 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 121.015 0.436 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.451 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.5 OUTLIER -73.4 134.81 44.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.971 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.433 ' HA ' HD12 ' A' ' 4' ' ' ILE . 10.5 tp -126.45 152.22 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.609 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 75' ' ' THR . 25.0 mttm -104.15 149.02 25.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.201 0.524 . . . . 0.0 111.342 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 128.09 46.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.835 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.72 HG23 HG21 ' A' ' 75' ' ' THR . 84.9 t -98.92 139.45 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.456 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.48 HG21 ' CA ' ' A' ' 57' ' ' ASP . 86.8 t -95.66 136.59 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.031 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.571 HG11 ' CG1' ' A' ' 101' ' ' ILE . 22.8 t -119.79 137.58 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 12' ' ' GLY . . . 81.85 -81.33 1.68 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 52.9 t0 63.8 -52.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.705 0.288 . . . . 0.0 110.614 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.694 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 93.19 -9.42 74.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 90.88 -4.54 0.26 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.766 0.317 . . . . 0.0 110.698 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.4 146.04 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.813 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 17' ' ' THR . . . 122.04 -53.56 0.72 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.436 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HD3' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -41.87 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.615 ' N ' ' O ' ' A' ' 15' ' ' GLY . 58.3 p -61.99 -43.65 98.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.412 ' HB3' ' H ' ' A' ' 159' ' ' ALA . 20.8 m -127.11 0.53 6.49 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.382 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.011 HD13 ' SG ' ' A' ' 157' ' ' CYS . 0.3 OUTLIER -93.43 -52.11 4.66 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.138 178.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 20' ' ' LEU . 47.2 tp -52.08 -37.33 53.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.046 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.9 tt -92.03 3.91 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.94 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.6 p -38.61 -80.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -72.14 -29.25 63.86 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 119.603 1.092 . . . . 0.0 111.215 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.7 m -41.96 -47.38 4.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.924 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.551 HG21 HD13 ' A' ' 28' ' ' LEU . 85.9 m -119.58 -8.91 9.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.881 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.554 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 40.9 t-20 55.68 94.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.303 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 59.84 86.71 0.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.375 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.551 HD13 HG21 ' A' ' 25' ' ' THR . 30.8 tp -127.94 68.86 76.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.996 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.38 128.94 16.14 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.287 1.992 . . . . 0.0 111.935 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -149.93 144.8 26.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.711 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.13 -34.07 76.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.464 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.49 140.41 49.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.391 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG11 ' HB ' ' A' ' 17' ' ' THR . 48.3 t -124.69 79.51 62.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.1 141.99 67.43 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.601 2.201 . . . . 0.0 111.674 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 36' ' ' VAL . 69.6 p -69.3 -23.92 63.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.295 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 37' ' ' PHE . 9.7 t 37.69 -124.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.413 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.563 ' N ' HG12 ' A' ' 36' ' ' VAL . 95.7 m-85 -113.61 147.42 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.341 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -68.36 135.65 52.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.398 . . . . 0.0 110.4 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -105.58 138.35 41.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.972 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.583 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 13.0 p90 -175.51 4.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.095 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.38 99.63 2.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.609 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.89 138.11 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.631 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t -100.37 115.17 29.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.414 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -136.47 145.05 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.008 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 72.2 mtm -102.3 128.18 48.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.778 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 170' ' ' ASP . 12.8 tt -124.18 125.53 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.469 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.14 24.71 44.82 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.9 56.55 5.3 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -141.76 91.29 8.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 30.5 Cg_exo -58.63 103.59 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.57 2.18 . . . . 0.0 112.683 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' CD2' HD13 ' A' ' 173' ' ' ILE . 89.2 m-85 -159.86 161.19 34.39 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.451 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.7 p -132.31 143.67 50.04 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.885 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.8 HD13 ' HB1' ' A' ' 172' ' ' ALA . 59.2 tp -120.55 139.12 53.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -110.65 123.61 6.67 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.629 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.583 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 62.0 mt -109.36 131.58 54.93 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.626 0.25 . . . . 0.0 110.478 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.602 ' O ' ' CD2' ' A' ' 56' ' ' PHE . 41.2 t80 -113.67 31.11 6.73 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.556 ' CG ' ' H ' ' A' ' 58' ' ' THR . 33.0 t0 -54.06 -154.5 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.183 0.447 . . . . 0.0 110.937 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.556 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 11.3 m 65.56 -70.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.653 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . -67.45 146.57 53.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.523 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . . . . . . 0 CA--C 1.525 0.679 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.396 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.899 0.38 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 5' ' ' LYS . 26.2 m -146.65 131.68 18.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.118 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.8 ' OD1' HG23 ' A' ' 77' ' ' VAL . 46.4 p30 -115.07 6.56 15.22 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.506 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.8 HG23 ' OD1' ' A' ' 76' ' ' ASP . 40.6 t -121.47 110.5 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.964 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -87.26 120.42 28.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 110.468 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tt -119.39 127.55 53.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.315 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.86 128.44 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.474 ' SG ' ' CG2' ' A' ' 115' ' ' THR . 0.0 OUTLIER -134.34 147.72 50.61 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.356 -179.296 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.49 ' CG ' HG21 ' A' ' 93' ' ' VAL . 24.9 p90 -170.63 146.55 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.672 ' OG ' HG12 ' A' ' 85' ' ' VAL . 30.4 t -62.86 127.25 30.36 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.618 HG21 ' CD ' ' A' ' 156' ' ' GLU . 3.9 t -76.31 30.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.672 HG12 ' OG ' ' A' ' 83' ' ' SER . 14.9 p -130.04 141.62 45.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.974 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER 83.99 142.16 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.492 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.08 -3.3 13.4 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.529 2.152 . . . . 0.0 112.563 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.9 m -91.64 -38.61 12.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.7 p -60.91 -34.04 74.07 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -82.78 -41.84 18.65 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.998 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 83.8 tt0 -60.26 -30.32 69.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.623 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 86.7 m-20 -66.24 -43.36 86.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -92.24 -70.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -177.786 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.708 ' O ' HD21 ' A' ' 149' ' ' LEU . 24.7 mttt -52.78 -16.19 0.93 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 95.6 mt-10 -130.31 -52.88 1.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -73.63 -47.43 40.15 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.623 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 63.9 m95 -81.74 -30.19 32.57 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.134 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 93' ' ' VAL . 2.5 t -44.78 -56.48 8.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.835 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.52 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 12.0 Cg_endo -57.39 -37.21 98.21 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.428 1.419 . . . . 0.0 110.915 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.44 -40.92 98.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.78 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.571 ' CG1' HG11 ' A' ' 9' ' ' VAL . 86.8 mt -68.21 -39.7 81.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 105' ' ' CYS . 47.8 m -54.81 -44.36 73.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.561 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -66.2 -41.11 90.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.973 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -58.03 -46.45 85.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.547 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -141.79 162.77 44.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 111.072 -179.471 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.457 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 59.1 Cg_endo -73.61 -155.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.997 2.464 . . . . 0.0 111.783 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -81.36 120.95 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.827 0.346 . . . . 0.0 110.451 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.606 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -153.45 156.81 32.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.065 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.73 132.0 44.23 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.151 1.9 . . . . 0.0 111.483 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.747 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -133.55 132.11 40.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.9 mp -86.34 128.49 34.94 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.935 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.885 HD22 ' HB2' ' A' ' 146' ' ' ALA . 34.9 tp -92.7 130.66 38.25 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.59 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 21.8 t -142.26 160.06 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.911 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.532 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -136.09 165.66 24.85 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.474 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 1.0 OUTLIER -129.9 172.46 11.66 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.44 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.725 ' O ' ' N ' ' A' ' 118' ' ' ASP . 67.6 mt-30 50.15 24.2 1.37 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.472 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.594 ' O ' ' CB ' ' A' ' 118' ' ' ASP . 0.4 OUTLIER 21.36 32.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 116' ' ' GLN . 15.7 t0 93.95 48.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.673 -0.642 . . . . 0.0 110.143 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 116' ' ' GLN . 0.5 OUTLIER 77.43 87.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.942 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' A' ' 119' ' ' LEU . 43.4 ptt85 . . . . . 0 N--CA 1.469 0.475 0 O-C-N 124.321 1.013 . . . . 0.0 112.272 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.546 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 3.2 tt . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.384 0.135 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.524 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -133.38 -69.23 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 1.5 Cg_endo -38.61 -84.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 123.413 2.742 . . . . 0.0 113.939 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 144' ' ' LYS . 96.9 mt-10 -110.55 -36.12 5.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.387 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.435 ' O ' HD13 ' A' ' 145' ' ' LEU . 8.4 p -44.87 -43.14 8.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.522 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.5 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -70.78 -58.18 3.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.57 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.6 -35.53 73.04 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 140' ' ' GLU . 19.4 tttm -58.24 -43.91 88.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 7.5 mp -66.85 -29.3 69.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.368 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.885 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -70.89 -30.94 67.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.707 0.289 . . . . 0.0 111.488 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.438 HH21 ' HG3' ' A' ' 144' ' ' LYS . 60.1 mtm180 -59.62 -36.55 76.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -119.56 -34.88 3.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.708 HD21 ' O ' ' A' ' 94' ' ' LYS . 13.1 tp -67.02 -3.27 6.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.575 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.729 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 67.4 mttm 98.95 150.2 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.495 0.718 . . . . 0.0 109.685 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 157.08 -172.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.755 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.686 HG23 ' H ' ' A' ' 110' ' ' PHE . 28.7 t -144.68 -53.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.605 ' NZ ' ' OE1' ' A' ' 171' ' ' GLU . 15.6 mmtt -95.53 -177.21 4.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.131 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.608 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -168.12 93.82 0.37 Allowed 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.704 HG22 ' H ' ' A' ' 156' ' ' GLU . 0.8 OUTLIER -172.6 -167.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.383 -178.24 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.704 ' H ' HG22 ' A' ' 155' ' ' VAL . 41.9 mt-10 -139.34 -165.43 1.86 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.158 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 1.011 ' SG ' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -174.95 120.0 0.2 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.139 0.971 . . . . 0.0 111.717 178.723 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 160' ' ' LEU . 42.6 t -165.99 91.08 0.46 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 33.67 30.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.092 -1.867 . . . . 0.0 109.085 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.614 ' C ' ' H ' ' A' ' 162' ' ' GLN . 16.0 tp -157.65 -74.73 0.09 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.48 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.721 ' C ' ' H ' ' A' ' 163' ' ' LYS . 7.4 m -64.54 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.126 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.614 ' H ' ' C ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -80.3 23.28 0.49 Allowed 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 175.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.721 ' H ' ' C ' ' A' ' 161' ' ' THR . 16.2 tttp -74.6 -4.38 36.8 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 112.665 -2.061 . . . . 0.0 108.297 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.715 ' O ' ' N ' ' A' ' 167' ' ' ASN . . . -120.71 -54.77 0.24 Allowed Glycine 0 C--O 1.221 -0.661 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.565 ' H ' ' CD2' ' A' ' 165' ' ' LEU . 4.0 mm? -34.16 -23.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.654 0.264 . . . . 0.0 110.845 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.67 ' N ' ' O ' ' A' ' 164' ' ' GLY . 28.2 tttp -77.95 -46.99 19.62 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.715 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.8 m120 -79.65 10.68 3.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.051 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 171' ' ' GLU . 53.2 t -96.44 -63.25 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.048 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 168' ' ' VAL . 13.1 m-85 -38.9 -43.1 0.92 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.784 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 54.1 p-10 -68.88 -38.08 79.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.547 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.63 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 34.8 tt0 -68.67 -24.85 64.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.028 0.442 . . . . 0.0 110.144 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.8 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -61.83 -32.38 72.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.26 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.491 HD13 ' CD2' ' A' ' 51' ' ' TYR . 61.9 mt -59.98 -39.17 79.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.651 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.9 -36.11 83.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.668 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.36 77.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.621 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.82 -28.19 67.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.252 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.92 -35.88 71.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.503 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.347 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.509 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -79.79 138.62 37.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.119 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.759 ' O ' HD12 ' A' ' 53' ' ' LEU . 11.2 tp -129.35 141.5 46.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.388 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -91.77 144.52 25.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.845 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 t -124.22 135.45 53.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.439 ' HB ' HG21 ' A' ' 75' ' ' THR . 6.2 p -110.51 154.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 111.898 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 81' ' ' CYS . 7.2 p -96.77 132.63 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.084 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.678 HG11 HD13 ' A' ' 101' ' ' ILE . 43.1 t -133.94 130.55 55.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.04 -163.89 37.58 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.778 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.7 t0 -87.42 117.84 26.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 111.263 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 32.11 33.67 0.01 OUTLIER Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.149 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.541 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 17.05 108.28 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 16' ' ' LYS . 1.4 t -75.36 -138.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.74 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.414 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -59.09 57.73 0.01 OUTLIER Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.476 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.763 ' NZ ' ' H ' ' A' ' 59' ' ' ALA . 1.1 pttt -64.66 -25.44 67.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.604 0.24 . . . . 0.0 111.372 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.658 HG21 ' CG1' ' A' ' 33' ' ' VAL . 38.0 m -66.38 -67.55 0.44 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.352 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' ILE . 92.3 m -55.6 -28.78 57.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.544 0.688 . . . . 0.0 109.837 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 165' ' ' LEU . 24.1 tp -60.71 -39.08 87.24 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.294 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -78.13 -30.36 49.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.101 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 18' ' ' CYS . 1.6 tt -58.49 -9.21 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.876 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -48.24 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.81 -178.441 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -57.05 -38.27 72.99 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.675 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.75 -65.0 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.873 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.6 p -122.08 -18.98 6.75 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.399 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 22' ' ' SER . 69.2 m-80 60.94 42.99 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.819 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 179.0 152.27 0.35 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.629 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -40.45 148.48 0.35 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.139 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.15 144.86 99.24 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.41 2.074 . . . . 0.0 111.96 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 32' ' ' TYR . 48.2 t -69.4 67.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.412 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 62.02 -17.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.523 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.609 ' H ' ' C ' ' A' ' 30' ' ' SER . 86.6 m-85 -120.97 145.8 47.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.658 ' CG1' HG21 ' A' ' 17' ' ' THR . 22.1 t -123.31 66.35 32.96 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.047 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.77 156.62 65.25 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.621 2.214 . . . . 0.0 112.667 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.1 p -116.74 170.37 8.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.378 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.89 157.86 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.891 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -58.05 -37.0 73.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.056 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -72.09 123.57 23.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.877 0.37 . . . . 0.0 110.835 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -59.88 -36.96 78.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.738 ' CB ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -158.08 -22.32 0.08 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.544 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.63 98.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.177 0.513 . . . . 0.0 111.13 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.563 HG21 HD11 ' A' ' 55' ' ' LEU . 64.5 t -131.14 132.33 63.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.035 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 43' ' ' THR . 12.9 t -112.62 123.6 50.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.105 0.479 . . . . 0.0 111.107 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.9 m -134.32 154.72 38.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.953 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 45' ' ' MET . 1.3 pmm? -126.52 125.93 42.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.228 0.537 . . . . 0.0 110.491 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.3 mt -126.42 112.2 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 4.48 85.87 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.93 5.49 59.7 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -83.06 115.07 56.95 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.93 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.29 109.26 2.09 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.127 1.885 . . . . 0.0 112.682 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -151.77 171.13 18.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.509 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.1 p -143.67 126.74 16.45 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.945 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.759 HD12 ' O ' ' A' ' 4' ' ' ILE . 48.3 tp -109.98 130.34 55.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.169 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.62 147.13 41.49 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.738 ' H ' ' CB ' ' A' ' 40' ' ' TYR . 49.2 mt -83.08 98.83 9.51 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.161 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.518 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 11.0 p90 -57.04 -40.94 77.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.593 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -43.02 165.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.187 -179.407 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.584 ' H ' ' CG ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 77.19 95.98 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.868 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.763 ' H ' ' NZ ' ' A' ' 16' ' ' LYS . . . -176.83 -124.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.338 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.682 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.747 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.707 0.289 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.439 HG21 ' HB ' ' A' ' 7' ' ' VAL . 40.8 p -123.42 154.28 39.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.71 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -115.93 0.08 12.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.534 ' CG1' HD13 ' A' ' 111' ' ' LEU . 21.8 t -115.42 101.52 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CZ ' ' SG ' ' A' ' 105' ' ' CYS . 87.9 m-85 -73.84 118.96 17.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.185 0.517 . . . . 0.0 111.13 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.518 HD11 HG21 ' A' ' 113' ' ' VAL . 8.0 tt -116.68 128.19 55.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.766 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.579 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 40.6 t -94.03 130.95 42.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.952 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.566 ' HB2' HG23 ' A' ' 8' ' ' VAL . 42.8 t -123.61 127.42 48.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.023 0.44 . . . . 0.0 111.152 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.737 ' HB3' HG21 ' A' ' 93' ' ' VAL . 33.9 p90 -171.23 139.24 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.091 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -62.37 132.69 53.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 156' ' ' GLU . 2.9 t -74.53 15.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.612 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.712 HG11 ' HE ' ' A' ' 120' ' ' ARG . 19.4 t -138.86 26.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.272 0.558 . . . . 0.0 109.894 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.424 ' C ' HD11 ' A' ' 137' ' ' ILE . 8.0 t -121.31 86.82 43.95 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.06 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.56 -29.3 18.58 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.403 2.068 . . . . 0.0 112.352 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.1 m -70.45 -41.46 72.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.989 0.424 . . . . 0.0 110.484 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.869 ' O ' HG23 ' A' ' 93' ' ' VAL . 49.5 m -73.97 -53.45 10.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.765 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.493 ' CB ' HD13 ' A' ' 137' ' ' ILE . 87.2 t80 -54.38 -46.2 72.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.449 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -66.19 -28.15 68.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.531 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.582 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 24.2 m120 -102.64 -3.4 26.69 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.126 -0.629 . . . . 0.0 111.076 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 89' ' ' SER . 38.5 t -89.53 -71.6 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.831 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HZ1' ' N ' ' A' ' 146' ' ' ALA . 46.9 mtpt -70.69 -20.21 62.7 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -112.64 -10.59 13.64 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -129.61 -29.04 2.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.452 -0.899 . . . . 0.0 113.03 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.582 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 53.8 m95 -98.26 -31.38 12.09 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.827 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.552 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -67.85 -44.27 40.74 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.751 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 17.0 Cg_exo -63.51 -36.67 52.85 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.315 2.01 . . . . 0.0 111.757 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.31 -41.41 96.95 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.962 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.678 HD13 HG11 ' A' ' 9' ' ' VAL . 39.1 pt -83.19 -34.28 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.04 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.8 m -61.25 -40.7 95.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.486 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -58.67 -43.86 90.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.435 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -82.3 -15.02 54.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.101 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.612 ' SG ' ' CZ ' ' A' ' 78' ' ' PHE . 1.7 t -114.66 108.77 48.74 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.316 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.01 163.1 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.947 1.764 . . . . 0.0 111.337 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -48.34 118.28 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.75 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.617 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -151.84 156.74 34.44 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.027 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.18 132.41 47.86 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.259 1.973 . . . . 0.0 112.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.745 ' H ' HG23 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -130.9 130.35 43.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.154 0.502 . . . . 0.0 110.504 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.4 mp -92.73 131.58 37.68 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.914 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.679 HD22 ' HB2' ' A' ' 146' ' ' ALA . 36.0 tp -93.35 123.53 36.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.622 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.518 HG21 HD11 ' A' ' 79' ' ' LEU . 42.1 t -143.3 152.17 16.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.299 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.499 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -141.15 -179.06 18.08 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 p -124.74 174.23 8.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.23 0.538 . . . . 0.0 110.848 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 117' ' ' ILE . 52.4 mt-30 48.5 28.97 1.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.904 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.955 HG23 ' H ' ' A' ' 119' ' ' LEU . 3.8 tt 31.23 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.78 ' N ' HG23 ' A' ' 117' ' ' ILE . 27.4 p-10 -109.66 9.07 25.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.312 0.577 . . . . 0.0 110.254 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.955 ' H ' HG23 ' A' ' 117' ' ' ILE . 77.1 mt -123.15 4.32 9.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.78 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.712 ' HE ' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.553 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.336 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.872 HG22 ' N ' ' A' ' 138' ' ' THR . 94.6 mt . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 121.216 0.531 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.872 ' N ' HG22 ' A' ' 137' ' ' ILE . 49.8 p -133.33 37.75 0.39 Allowed Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.612 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 138' ' ' THR . 87.8 Cg_exo -23.63 -39.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.384 2.723 . . . . 0.0 112.663 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 138' ' ' THR . 97.3 mt-10 -66.02 -47.68 73.64 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.138 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 143' ' ' GLU . 84.4 m -54.37 -71.56 0.08 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.601 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 141' ' ' THR . . . -28.06 -31.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 141' ' ' THR . 78.6 mm-40 -60.62 -39.91 89.94 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.834 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 141' ' ' THR . 20.8 tttt -98.04 -19.3 18.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.786 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -64.12 -32.35 73.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.099 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.716 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -80.24 -39.83 28.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.922 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.04 -36.73 77.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.476 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 148' ' ' ASP . 59.3 t0 -98.36 -16.44 19.31 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 3.8 tp -117.46 34.4 5.15 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.051 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 23.2 mttm 80.85 149.41 0.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.282 0.563 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.716 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . 156.34 -177.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.762 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.745 HG23 ' H ' ' A' ' 110' ' ' PHE . 24.4 t -141.63 -52.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.846 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.475 ' HZ1' ' CG ' ' A' ' 167' ' ' ASN . 5.6 tttm -119.77 -172.54 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.553 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.616 ' CG ' ' O ' ' A' ' 154' ' ' TYR . 29.9 p90 -154.28 96.77 1.96 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 165' ' ' LEU . 7.8 p -140.81 138.48 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 122.118 0.961 . . . . 0.0 111.848 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.744 ' O ' ' OG1' ' A' ' 161' ' ' THR . 88.7 mt-10 -123.62 98.33 5.78 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.518 ' SG ' HD22 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -114.62 146.11 41.21 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 123.188 1.471 . . . . 0.0 113.167 -176.176 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.514 ' N ' ' SG ' ' A' ' 157' ' ' CYS . 15.2 t -169.9 93.23 0.24 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 111.629 -2.532 . . . . 0.0 107.201 176.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 42.92 28.09 0.12 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.976 -1.466 . . . . 0.0 110.215 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 162' ' ' GLN . 21.4 mt -145.65 -81.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.488 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.744 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -57.39 52.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.164 0.507 . . . . 0.0 111.481 -178.234 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.706 ' N ' ' O ' ' A' ' 160' ' ' LEU . 5.4 pp0? -82.62 15.52 2.55 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 176.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.585 ' H ' ' C ' ' A' ' 161' ' ' THR . 25.5 mttt -89.47 0.63 56.74 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.752 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.622 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.04 -72.76 0.11 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 177.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 19' ' ' LEU . 11.1 mp -40.22 -19.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.686 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.622 ' N ' ' O ' ' A' ' 164' ' ' GLY . 28.4 tttt -80.06 -49.78 11.29 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 164' ' ' GLY . 17.6 p-10 -77.9 4.53 11.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.791 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 171' ' ' GLU . 17.6 t -81.25 -58.11 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.243 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 40.0 m-85 -39.31 -39.88 0.7 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.705 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.685 ' O ' HG22 ' A' ' 173' ' ' ILE . 58.2 t0 -65.89 -47.66 74.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.057 0.456 . . . . 0.0 110.022 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 168' ' ' VAL . 77.1 mm-40 -67.76 -18.92 65.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.153 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.643 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -63.35 -38.62 91.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.821 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 170' ' ' ASP . 15.0 tt -62.11 -31.79 52.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.1 tp -63.36 -38.1 89.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.464 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.69 -22.92 66.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.19 68.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.427 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 38.9 tp -56.61 -36.77 69.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.57 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.583 -179.763 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.538 ' N ' ' C ' ' A' ' 176' ' ' ALA . 65.0 mtt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.557 ' O ' ' HB1' ' A' ' 176' ' ' ALA . 90.5 mt-30 -115.68 164.64 14.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.819 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 2' ' ' GLN . 1.8 t -39.93 142.19 0.37 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.876 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.91 HD11 ' OD2' ' A' ' 76' ' ' ASP . 8.3 tp -128.57 149.68 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.953 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -95.93 141.09 29.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.795 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -134.76 147.49 50.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.825 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.476 ' HA ' ' H ' ' A' ' 56' ' ' PHE . 28.4 m -131.9 147.28 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.14 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.417 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 55.3 t -109.0 124.45 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.158 0.504 . . . . 0.0 110.942 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -127.25 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.849 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.528 ' HA3' HG21 ' A' ' 14' ' ' VAL . . . -148.71 -164.36 11.44 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.611 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.7 t0 -78.62 126.53 30.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 110.833 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.14 -88.62 0.01 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -136.6 127.7 27.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.78 0.324 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.528 HG21 ' HA3' ' A' ' 10' ' ' GLY . 8.6 m -140.64 150.8 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.305 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.596 ' CA ' ' OG1' ' A' ' 115' ' ' THR . . . 23.76 54.24 0.04 OUTLIER Glycine 0 N--CA 1.471 1.015 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.888 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.5 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 85.1 mttt -35.12 -58.85 0.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 20' ' ' LEU . 4.0 m -130.37 -55.94 1.09 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 17' ' ' THR . 87.7 m -34.84 -28.58 0.01 OUTLIER 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.045 0.45 . . . . 0.0 111.049 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 17' ' ' THR . 4.2 tt -76.3 -43.39 41.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.432 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.791 HD21 ' O ' ' A' ' 56' ' ' PHE . 96.0 mt -59.33 -35.96 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.089 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.016 HD12 HD22 ' A' ' 26' ' ' ASN . 12.8 pt -90.14 8.19 3.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.766 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -39.85 -77.83 0.02 OUTLIER 'General case' 0 C--O 1.241 0.611 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.504 -179.177 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.585 ' C ' ' N ' ' A' ' 25' ' ' THR . 14.9 p90 -39.93 -34.72 0.3 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 118.226 0.466 . . . . 0.0 111.499 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.508 ' CB ' ' O ' ' A' ' 21' ' ' ILE . 1.1 m -45.95 -14.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 25' ' ' THR . 55.7 m 50.53 37.31 15.68 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.705 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 1.016 HD22 HD12 ' A' ' 21' ' ' ILE . 91.7 m-20 -63.12 -40.37 97.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.498 ' O ' ' O ' ' A' ' 26' ' ' ASN . 36.8 mttt 57.84 131.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.886 0.374 . . . . 0.0 110.457 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.606 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.8 mt -39.6 -55.84 3.24 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.984 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 28' ' ' LEU . 85.0 Cg_exo -38.64 -15.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.65 2.233 . . . . 0.0 113.048 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 28' ' ' LEU . 23.0 t -104.32 131.29 51.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.573 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 33' ' ' VAL . 96.9 mt-10 -67.54 -29.36 68.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.104 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -53.91 122.04 9.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.75 0.31 . . . . 0.0 110.806 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 33' ' ' VAL . 14.8 p -178.18 50.73 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.543 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 14.7 Cg_endo -59.68 131.42 40.0 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.626 2.217 . . . . 0.0 112.002 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 p -119.55 5.39 11.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.672 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.1 t -62.11 -40.59 88.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -109.79 132.94 53.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.204 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -84.67 124.02 31.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.796 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -99.37 144.99 27.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.046 0.45 . . . . 0.0 111.205 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.606 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 20.4 p90 -167.13 19.6 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.45 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.62 100.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.58 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 t -137.38 134.03 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.977 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 43' ' ' THR . 8.9 t -103.62 108.21 19.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.603 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -135.17 144.2 34.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.219 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.5 ptp -111.46 146.03 37.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.545 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 47' ' ' GLY . 39.1 mm -118.73 125.7 74.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.127 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 32.12 45.51 0.19 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.51 47.76 5.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.742 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 2.8 mt-10 -133.46 77.48 65.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.359 . . . . 0.0 110.108 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.29 106.85 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.965 2.443 . . . . 0.0 112.959 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.552 ' CE1' ' O ' ' A' ' 169' ' ' PHE . 30.7 p90 -155.84 166.27 34.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.3 127.18 37.19 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.955 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.914 HD22 ' HB2' ' A' ' 172' ' ' ALA . 41.5 tp -119.35 127.79 53.49 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.019 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -93.1 144.17 16.9 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.671 HD23 ' SG ' ' A' ' 6' ' ' CYS . 64.9 mt -137.29 129.74 29.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.201 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.791 ' O ' HD21 ' A' ' 20' ' ' LEU . 1.9 t80 -97.3 -164.27 1.13 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 58' ' ' THR . 49.1 p30 -162.33 -162.38 0.82 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.401 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.796 HG23 ' H ' ' A' ' 59' ' ' ALA . 4.4 t -8.25 -112.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.039 0.837 . . . . 0.0 112.803 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.796 ' H ' HG23 ' A' ' 58' ' ' THR . . . 39.81 83.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.42 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -40.84 -89.4 0.01 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.479 ' OE1' ' O ' ' A' ' 63' ' ' ASP . 46.6 tt0 -59.75 -15.37 19.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.679 0.276 . . . . 0.0 110.757 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 65.2 tt0 58.79 21.07 8.56 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 60.5 t0 176.58 45.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.498 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.439 ' C ' ' O ' ' A' ' 63' ' ' ASP . 98.9 m-85 -33.25 -40.75 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.133 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 88.1 m-20 -83.8 116.99 22.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 111.089 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -65.54 -28.37 69.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.886 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.623 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -46.73 -38.41 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.49 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -63.04 152.64 83.43 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.407 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.93 136.59 62.3 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.648 2.232 . . . . 0.0 112.526 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.55 1.33 53.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.621 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.565 ' O ' ' CB ' ' A' ' 72' ' ' TYR . 49.3 m -121.26 157.69 29.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.122 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.565 ' CB ' ' O ' ' A' ' 71' ' ' SER . 6.6 t80 91.39 71.17 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.922 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.52 133.6 59.03 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.704 2.269 . . . . 0.0 111.765 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -104.18 14.12 31.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 0.0 110.124 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -136.65 151.15 48.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.538 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.91 ' OD2' HD11 ' A' ' 4' ' ' ILE . 84.1 m-20 -112.1 -19.61 12.23 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.924 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.487 ' CG1' HD13 ' A' ' 111' ' ' LEU . 19.7 t -122.24 120.43 61.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.144 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.587 ' C ' HD12 ' A' ' 79' ' ' LEU . 98.3 m-85 -87.53 122.18 30.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.128 0.489 . . . . 0.0 111.548 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.795 HD22 ' SG ' ' A' ' 6' ' ' CYS . 10.6 mp -111.73 114.2 27.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.002 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.4 m -98.59 129.23 49.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 114' ' ' GLY . 6.8 t -129.86 135.86 48.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.499 0.666 . . . . 0.0 112.042 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.453 ' H ' ' HA2' ' A' ' 114' ' ' GLY . 49.9 p90 -142.24 144.92 33.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.372 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.6 t -66.55 130.69 44.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 84' ' ' VAL . 10.7 t -63.64 4.24 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' SER . 14.7 p -129.99 144.1 39.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 118.557 0.617 . . . . 0.0 109.556 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.7 OUTLIER 83.65 92.16 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -48.11 -0.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.648 2.232 . . . . 0.0 113.113 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.647 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 19.9 m -66.19 -61.52 1.98 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.888 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.8 p -64.94 -35.02 79.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.525 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.771 ' CZ ' HD22 ' A' ' 145' ' ' LEU . 78.5 t80 -69.01 -50.52 48.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -64.12 -24.16 67.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.851 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.647 ' ND2' ' O ' ' A' ' 88' ' ' SER . 67.9 m-20 -86.99 -64.09 1.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.858 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 30.1 t -41.07 -61.92 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 142' ' ' ALA . 43.5 mtpt -67.96 -21.26 65.1 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 68.3 tt0 -106.11 -63.24 1.28 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 92' ' ' ASN . 17.4 mttp -67.19 -35.95 80.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.46 ' CD1' ' HA ' ' A' ' 93' ' ' VAL . 29.7 m95 -84.82 -33.93 22.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.899 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.948 ' O ' HG23 ' A' ' 102' ' ' THR . 2.3 t -44.69 -54.34 13.01 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.267 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 16.6 Cg_endo -60.46 -36.49 86.28 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.568 1.512 . . . . 0.0 111.61 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.84 -40.51 97.66 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.096 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 83.7 mt -73.8 -38.52 50.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.948 HG23 ' O ' ' A' ' 98' ' ' VAL . 49.8 p -61.42 -37.42 83.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.562 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -56.69 -36.99 70.25 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.22 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -55.19 -44.74 75.57 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.268 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.5 153.8 29.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.735 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -43.34 -76.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.293 1.995 . . . . 0.0 112.141 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -140.47 142.85 35.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.587 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -152.79 156.57 33.09 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.09 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.29 128.73 31.23 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.209 1.94 . . . . 0.0 110.91 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.727 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -124.0 123.5 40.51 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.72 -178.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 111' ' ' LEU . 8.8 mp -97.68 129.86 44.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.44 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -96.76 129.32 44.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.561 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.673 HG12 ' N ' ' A' ' 114' ' ' GLY . 51.5 t -147.38 168.12 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.347 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.673 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -135.51 166.63 24.46 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.596 ' OG1' ' CA ' ' A' ' 15' ' ' GLY . 11.2 t -123.56 174.58 7.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.109 0.48 . . . . 0.0 112.017 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.56 ' O ' ' C ' ' A' ' 117' ' ' ILE . 33.1 mt-30 34.16 31.04 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.232 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.883 HG23 ' N ' ' A' ' 118' ' ' ASP . 7.7 tt 24.84 -138.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 O-C-N 123.944 0.777 . . . . 0.0 109.452 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.883 ' N ' HG23 ' A' ' 117' ' ' ILE . 61.8 m-20 -84.87 71.93 10.83 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.573 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.646 HD13 ' OG1' ' A' ' 125' ' ' THR . 5.9 tt 66.1 91.42 0.08 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.631 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 119' ' ' LEU . 56.9 ttp180 5.72 62.39 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 124.259 0.974 . . . . 0.0 111.181 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' A' ' 119' ' ' LEU . 0.6 OUTLIER 168.54 -96.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.606 -179.266 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.913 ' H ' HG22 ' A' ' 125' ' ' THR . 39.7 t0 108.08 -43.5 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 123.487 0.715 . . . . 0.0 111.116 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.432 ' CD ' ' C ' ' A' ' 121' ' ' ASP . 56.3 Cg_endo -91.75 -37.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 121.501 1.467 . . . . 0.0 112.179 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.7 p -99.04 -0.86 41.06 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.93 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.936 ' O ' HD13 ' A' ' 129' ' ' LEU . 13.2 t -111.71 -13.72 13.7 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.778 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 127' ' ' GLU . 16.3 tt -86.19 -42.78 16.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.494 ' N ' HG23 ' A' ' 126' ' ' ILE . 96.5 mt-10 -73.81 -34.48 64.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.041 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -74.12 -32.28 63.13 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.48 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 125' ' ' THR . 4.6 mp -66.97 -33.11 74.87 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.596 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . 109.08 130.6 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.3 mttp -48.54 -37.74 18.57 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.732 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -82.84 -3.09 56.36 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.322 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -110.3 -9.15 14.66 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.165 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' A' ' 135' ' ' LYS . 91.1 mt-30 -52.37 -40.91 62.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.81 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 134' ' ' GLN . 41.0 mttp 26.71 59.94 0.53 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.141 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.86 143.04 78.4 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.441 2.094 . . . . 0.0 111.363 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 137' ' ' ILE . 0.6 OUTLIER -133.02 47.41 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.814 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.584 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -133.23 -65.29 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.6 Cg_exo -20.54 -73.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 124.001 3.134 . . . . 0.0 113.983 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -114.82 -31.05 6.25 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.496 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.472 HG21 ' CD1' ' A' ' 137' ' ' ILE . 40.2 m -55.78 -42.61 75.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.305 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.513 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -69.55 -38.22 77.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.526 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.59 -35.27 79.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.316 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.97 -50.41 72.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.319 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.771 HD22 ' CZ ' ' A' ' 90' ' ' PHE . 11.0 mp -64.05 -33.04 74.85 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.684 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.78 -41.4 75.18 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 -62.43 -35.11 78.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.468 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -47.39 -30.83 3.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.1 mt -123.48 -117.67 0.29 Allowed 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 151' ' ' ALA . 76.9 tttt -177.46 69.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.219 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -53.13 -121.94 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.666 0.746 . . . . 0.0 111.093 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.469 HG23 ' H ' ' A' ' 110' ' ' PHE . 71.6 t -155.02 -61.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.213 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.527 ' C ' ' CG ' ' A' ' 154' ' ' TYR . 18.5 mttp -101.76 -173.65 2.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.815 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.679 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -170.03 95.5 0.26 Allowed 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.926 HG22 ' H ' ' A' ' 156' ' ' GLU . 3.6 p -171.92 -167.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.399 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.926 ' H ' HG22 ' A' ' 155' ' ' VAL . 27.9 mp0 -130.66 -170.62 2.38 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.313 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.808 ' SG ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -171.76 121.13 0.48 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.878 0.847 . . . . 0.0 109.508 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.665 ' HB3' ' H ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -173.88 92.74 0.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.097 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 31.34 31.25 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.578 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.705 HD23 ' CD1' ' A' ' 117' ' ' ILE . 21.7 tp -164.76 -77.45 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.805 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.834 ' C ' ' H ' ' A' ' 163' ' ' LYS . 2.8 m -58.98 3.45 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.132 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.603 ' H ' ' C ' ' A' ' 160' ' ' LEU . 3.7 pt20 -64.8 30.38 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.834 ' H ' ' C ' ' A' ' 161' ' ' THR . 94.2 mttt -90.89 3.95 53.17 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -118.2 -70.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.808 HD12 ' SG ' ' A' ' 157' ' ' CYS . 7.3 mt -41.03 -14.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.899 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 164' ' ' GLY . 60.0 tttp -82.93 -50.58 8.43 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 164' ' ' GLY . 29.9 m120 -77.61 3.73 13.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.487 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 171' ' ' GLU . 33.2 t -84.04 -51.76 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.759 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.552 ' O ' ' CE1' ' A' ' 51' ' ' TYR . 6.7 m-85 -37.69 -42.36 0.56 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.808 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 173' ' ' ILE . 61.5 t0 -67.52 -40.64 85.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.35 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 168' ' ' VAL . 76.7 mm-40 -67.03 -23.31 65.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.05 0.453 . . . . 0.0 109.951 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.914 ' HB2' HD22 ' A' ' 53' ' ' LEU . . . -59.78 -39.5 85.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.903 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 170' ' ' ASP . 14.0 tt -60.58 -31.69 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.625 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.1 tp -65.7 -38.56 89.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.139 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.47 -33.8 76.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 2' ' ' GLN . . . -59.14 -32.5 69.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.64 -36.01 69.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.386 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 99.99 110.641 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.1 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 3' ' ' THR . 91.6 mt-30 49.68 -148.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.135 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.486 ' CB ' ' HG1' ' A' ' 52' ' ' THR . 2.0 t -36.83 135.07 0.46 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.241 0.543 . . . . 0.0 110.737 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 tp -127.27 150.76 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.282 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -114.05 157.91 21.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.214 0.53 . . . . 0.0 111.623 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.23 153.35 47.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.388 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 9' ' ' VAL . 45.8 t -122.48 133.09 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.539 -0.465 . . . . 0.0 112.027 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.668 HG11 ' O ' ' A' ' 58' ' ' THR . 10.5 p -50.02 120.86 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.166 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 7' ' ' VAL . 47.9 t -127.63 131.49 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.19 -169.91 37.56 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.314 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.619 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 58.5 t0 -123.29 139.63 53.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.923 0.392 . . . . 0.0 110.677 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 63.42 -117.19 10.5 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.95 128.83 10.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 110.421 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.51 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 24.2 m -136.53 164.33 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.552 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -74.65 80.76 0.89 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.118 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.634 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -81.46 -1.16 44.83 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.469 -0.43 . . . . 0.0 110.914 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.3 p -68.42 -53.32 24.47 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.107 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' ILE . 93.2 m -69.25 -22.42 63.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.69 0.757 . . . . 0.0 109.811 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.47 -56.06 16.67 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.626 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.11 -34.09 74.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.027 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 18' ' ' CYS . 1.7 tp -55.17 -10.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.818 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 97.3 p -42.21 -80.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.076 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.539 ' N ' ' OG ' ' A' ' 22' ' ' SER . 79.7 t80 -62.08 -33.37 74.3 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.482 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.7 m -47.86 -45.14 29.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.819 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -151.9 -12.53 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.804 -179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 25' ' ' THR . 47.9 t30 53.98 119.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.73 0.3 . . . . 0.0 111.18 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.722 ' H ' ' NE2' ' A' ' 162' ' ' GLN . 17.2 mttm 61.08 62.87 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.567 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -116.19 89.66 26.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.05 158.91 1.15 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.375 2.05 . . . . 0.0 111.691 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.2 m -55.13 141.89 33.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.99 0.424 . . . . 0.0 110.931 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 33' ' ' VAL . 84.0 tt0 -178.56 88.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.633 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' O ' ' C ' ' A' ' 33' ' ' VAL . 56.6 t80 64.77 -13.2 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.17 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.615 ' H ' ' C ' ' A' ' 31' ' ' GLU . 39.0 t 36.17 61.83 2.94 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.426 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.58 133.52 32.36 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.362 2.041 . . . . 0.0 111.562 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 p -128.63 163.11 25.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 111.029 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 38' ' ' ASP . 41.0 t -118.98 132.36 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.953 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.97 -3.3 24.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.124 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.491 ' H ' HG12 ' A' ' 36' ' ' VAL . 91.7 m-20 -60.82 -48.5 81.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.575 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -176.8 172.87 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.417 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 55' ' ' LEU . 82.8 m-85 -125.66 15.94 8.13 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.86 98.02 5.46 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.602 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.22 135.8 52.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.628 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 51' ' ' TYR . 2.1 t -107.83 138.87 43.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.173 0.511 . . . . 0.0 111.71 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.2 144.62 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.861 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.1 mtm -112.11 136.46 51.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.713 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.617 HG21 ' CG ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER -150.88 99.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.553 178.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.02 56.76 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.47 41.69 24.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.02 76.87 75.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 110.68 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.433 ' C ' ' CD2' ' A' ' 51' ' ' TYR . 82.1 Cg_endo -86.0 117.68 1.65 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.113 2.542 . . . . 0.0 112.563 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' A' ' 50' ' ' PRO . 97.8 m-85 -154.49 174.04 15.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.777 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.532 ' C ' HD22 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -121.75 126.97 50.11 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.499 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.908 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -109.9 123.41 49.55 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.264 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.724 ' C ' HD12 ' A' ' 55' ' ' LEU . . . -93.76 135.51 12.6 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.724 HD12 ' C ' ' A' ' 54' ' ' GLY . 5.8 mp -142.58 108.89 5.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.091 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.454 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 75.3 m-85 -80.26 168.99 18.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 58' ' ' THR . 51.9 p30 -138.11 -179.4 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 13.4 m 48.62 174.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.857 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 58' ' ' THR . . . 87.06 124.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.704 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.97 6.52 0.03 OUTLIER Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.578 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -96.18 159.33 15.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.256 0.551 . . . . 0.0 110.01 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.98 -42.72 99.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.743 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -108.93 32.41 4.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.89 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.447 ' CE2' ' HB2' ' A' ' 59' ' ' ALA . 87.3 t80 -50.87 -44.42 59.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.16 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 66' ' ' ARG . 42.3 t0 -167.02 168.41 13.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 111.022 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.516 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.5 mtm180 -59.19 146.39 39.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.659 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.598 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.4 mm? -63.22 -38.28 90.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.007 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 40.61 70.64 1.47 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.842 0.353 . . . . 0.0 110.373 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -51.53 138.39 48.29 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.821 2.348 . . . . 0.0 112.369 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.3 mt -106.63 140.32 39.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.49 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -59.36 -36.56 75.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -148.18 103.62 3.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.556 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -47.99 132.5 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.056 1.837 . . . . 0.0 112.111 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -100.8 26.31 7.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.027 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 t -133.99 157.36 46.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.693 0.282 . . . . 0.0 110.348 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 76' ' ' ASP . 59.9 t0 -150.17 -10.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.396 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.67 ' CG1' HD13 ' A' ' 111' ' ' LEU . 22.8 t -119.03 106.22 19.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.285 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -81.16 129.96 34.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.013 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.565 HD11 HG21 ' A' ' 113' ' ' VAL . 30.4 tp -114.21 113.09 24.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.6 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.73 132.56 33.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' VAL . 49.4 t -132.81 116.71 16.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.094 0.473 . . . . 0.0 111.287 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.432 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 39.6 p90 -153.53 155.72 36.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.792 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.458 ' OG ' ' OD2' ' A' ' 121' ' ' ASP . 30.1 t -71.85 128.85 37.07 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.479 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.749 HG11 ' OE2' ' A' ' 156' ' ' GLU . 2.1 t -59.77 -2.17 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 85' ' ' VAL . 7.2 p -127.75 30.98 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.461 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 83' ' ' SER . 5.2 p -122.51 82.94 47.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.472 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -51.44 -30.29 34.29 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.667 2.245 . . . . 0.0 112.286 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.632 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 22.5 m -67.72 -47.65 68.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.444 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.955 ' O ' HG22 ' A' ' 93' ' ' VAL . 97.0 p -67.87 -35.22 78.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.46 -47.51 85.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.802 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -71.49 -18.52 62.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.609 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 88' ' ' SER . 56.3 m-20 -93.17 -67.08 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.955 HG22 ' O ' ' A' ' 89' ' ' SER . 31.0 m -45.23 -50.1 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.495 ' N ' HG23 ' A' ' 93' ' ' VAL . 59.5 mttm -70.71 -32.27 69.42 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 83.5 tt0 -107.6 -60.92 1.64 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 92' ' ' ASN . 75.4 mttt -63.44 -34.92 78.81 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.419 ' CE3' ' OE1' ' A' ' 100' ' ' GLU . 49.8 m95 -86.26 -29.4 23.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.523 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -44.77 -53.98 14.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.853 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 29.1 Cg_endo -65.14 -33.13 51.04 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.615 1.543 . . . . 0.0 111.474 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.419 ' OE1' ' CE3' ' A' ' 97' ' ' TRP . 84.6 tt0 -59.76 -37.73 79.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.8 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.1 pt -94.91 -29.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.329 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 105' ' ' CYS . 55.1 m -52.33 -40.72 62.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.62 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -53.78 -33.33 55.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -54.55 -43.56 72.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.119 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -152.3 152.88 30.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.769 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.69 -42.87 2.17 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.664 2.243 . . . . 0.0 112.651 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 13.3 tttm -138.34 130.19 28.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 t -165.66 147.45 6.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.262 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.39 135.57 58.43 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.187 1.925 . . . . 0.0 111.427 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.695 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -116.52 119.28 35.1 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.005 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.67 HD13 ' CG1' ' A' ' 77' ' ' VAL . 10.0 mp -94.64 119.37 33.18 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.445 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 113' ' ' VAL . 46.0 mt -90.94 130.19 36.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.592 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 114' ' ' GLY . 52.0 t -153.22 162.49 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.368 0.604 . . . . 0.0 112.122 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.569 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -137.08 170.37 23.55 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 9.8 t -136.06 167.03 22.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.343 0.572 . . . . 0.0 111.776 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.534 ' O ' ' O ' ' A' ' 117' ' ' ILE . 40.7 mt-30 55.6 25.76 8.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.881 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.833 HG23 ' N ' ' A' ' 118' ' ' ASP . 6.3 tt 30.28 -151.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.304 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.833 ' N ' HG23 ' A' ' 117' ' ' ILE . 52.9 p30 -122.86 29.76 6.69 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.831 ' H ' HG23 ' A' ' 117' ' ' ILE . 7.7 tt -139.78 -43.02 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.242 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.593 ' H ' HG22 ' A' ' 117' ' ' ILE . 25.7 mmt180 -52.86 -58.72 5.99 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 122' ' ' ASP . 93.4 m-20 -44.28 -14.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.962 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -0.56 -68.44 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 O-C-N 124.036 0.835 . . . . 0.0 112.054 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.551 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 53.1 Cg_exo -32.71 -33.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.291 1.327 . . . . 0.0 111.727 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 122' ' ' ASP . 1.9 m -111.49 -39.44 4.65 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.901 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.674 ' OG1' HG11 ' A' ' 85' ' ' VAL . 75.2 m -73.66 -36.26 65.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.276 0.56 . . . . 0.0 110.578 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.02 -47.65 16.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.982 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.21 -36.0 74.61 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.51 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -97.08 -68.14 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.324 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 130' ' ' ALA . 42.9 mt -85.17 45.51 1.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.153 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 129' ' ' LEU . . . -46.53 -99.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -150.22 92.64 1.9 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.457 0.646 . . . . 0.0 109.751 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -155.04 60.25 0.65 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.21 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 49.0 mttp 62.6 42.82 8.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.988 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.468 ' OE1' HD23 ' A' ' 129' ' ' LEU . 42.3 mt-30 -121.03 136.99 54.86 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.357 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.55 161.63 55.74 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.96 0.41 . . . . 0.0 111.377 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.17 161.96 40.54 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 123.205 2.604 . . . . 0.0 112.556 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 137' ' ' ILE . 7.7 tt -101.93 51.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.019 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.604 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.99 -65.77 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.604 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.2 Cg_exo -24.27 -68.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 123.7 2.933 . . . . 0.0 114.38 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -109.12 -35.13 6.39 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.653 -0.419 . . . . 0.0 112.102 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.447 ' OG1' ' C ' ' A' ' 137' ' ' ILE . 61.0 p -56.42 -38.2 71.24 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.344 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.3 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.745 0.307 . . . . 0.0 111.18 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.48 -37.52 81.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.007 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -59.88 -50.4 73.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 80.4 mt -58.87 -28.91 66.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.795 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.48 -38.74 87.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.058 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -58.47 -40.39 82.59 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.296 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -53.88 -29.59 42.3 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 146' ' ' ALA . 81.8 mt -137.76 -112.02 0.17 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.045 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.73 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 59.9 mttm -143.78 -136.87 0.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.094 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 153.89 -160.85 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 O-C-N 123.319 0.387 . . . . 0.0 110.229 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 110' ' ' PHE . 88.2 t -155.88 -68.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.613 ' CE ' HD23 ' A' ' 111' ' ' LEU . 3.9 mtmp? -101.94 177.97 4.75 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.603 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 27.3 p90 -169.11 94.11 0.3 Allowed 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.601 HG22 ' C ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -170.72 -167.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.409 -177.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.749 ' OE2' HG11 ' A' ' 84' ' ' VAL . 57.8 mt-10 -126.37 -172.3 2.59 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.33 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.533 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 1.2 p -171.71 117.2 0.4 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.692 ' OG ' ' N ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -173.14 93.75 0.11 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.974 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 31.51 32.69 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.722 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.605 ' C ' ' H ' ' A' ' 162' ' ' GLN . 5.6 tt -165.98 -77.5 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.995 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.813 ' C ' ' H ' ' A' ' 163' ' ' LYS . 2.4 m -59.3 5.6 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.18 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.722 ' NE2' ' H ' ' A' ' 27' ' ' LYS . 24.5 mt-30 -65.77 30.96 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.813 ' H ' ' C ' ' A' ' 161' ' ' THR . 99.5 mttt -90.57 5.43 47.89 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -128.41 -71.4 0.15 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 164' ' ' GLY . 3.9 mm? -37.45 -21.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.052 0.453 . . . . 0.0 110.341 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.634 ' N ' ' O ' ' A' ' 164' ' ' GLY . 16.7 tttm -78.98 -52.56 8.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 164' ' ' GLY . 14.7 t-20 -78.98 4.06 15.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.907 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 171' ' ' GLU . 2.9 t -76.57 -58.2 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.468 ' C ' ' O ' ' A' ' 168' ' ' VAL . 71.6 m-85 -35.48 -37.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.73 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.617 ' CG ' HG21 ' A' ' 46' ' ' ILE . 76.4 m-20 -71.28 -45.16 63.79 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.622 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 168' ' ' VAL . 97.1 mt-10 -69.37 -27.47 65.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.988 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.609 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . . . -63.3 -30.79 71.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.56 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 176' ' ' ALA . 1.2 pp -66.08 -27.1 39.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.73 -37.38 78.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.526 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.01 -19.54 64.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.462 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -59.85 -35.76 75.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.27 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 62.0 mt -59.44 -33.47 71.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.19 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 99.99 110.426 -179.845 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 3' ' ' THR . 91.0 mt-30 -111.67 -138.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.574 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -40.5 114.93 0.5 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.388 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.899 HD11 ' OD2' ' A' ' 76' ' ' ASP . 9.7 tp -117.59 144.38 25.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.207 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -91.99 140.1 29.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 110.612 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.87 ' SG ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -141.01 151.26 43.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.711 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.462 HG22 ' OG1' ' A' ' 75' ' ' THR . 29.3 m -127.2 142.86 42.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.585 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.491 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 43.3 t -111.19 124.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.199 0.523 . . . . 0.0 110.895 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.529 ' C ' ' HZ3' ' A' ' 16' ' ' LYS . 19.6 m -133.42 161.51 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.938 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.759 ' N ' ' HZ3' ' A' ' 16' ' ' LYS . . . -172.75 -168.76 34.5 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.584 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.596 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 42.9 t0 -80.35 121.86 26.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 110.817 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.688 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -45.72 98.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 151.34 20.58 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.663 0.273 . . . . 0.0 111.522 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.63 135.97 58.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.037 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.71 88.76 0.74 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HZ3' ' N ' ' A' ' 10' ' ' GLY . 84.7 mttt -81.65 -0.21 41.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.664 0.269 . . . . 0.0 110.79 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.81 HG21 ' O ' ' A' ' 34' ' ' PRO . 21.4 m -80.49 -70.29 0.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.163 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.652 ' HA ' HD12 ' A' ' 21' ' ' ILE . 18.0 m -50.91 -25.25 4.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.62 0.724 . . . . 0.0 109.345 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.61 ' CD2' ' SG ' ' A' ' 81' ' ' CYS . 62.4 tp -55.05 -55.0 35.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.375 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' SER . 82.1 mt -69.96 -32.66 71.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 18' ' ' CYS . 93.2 mt -62.06 -1.8 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.966 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.5 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -56.35 -75.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.059 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.689 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -62.5 -28.64 69.98 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.165 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.651 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 2.6 m -54.46 -48.5 71.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.8 p -131.52 -21.84 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.474 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 22' ' ' SER . 83.0 m-20 61.43 114.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.131 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.0 mttt 61.92 59.21 1.76 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.093 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 tp -125.34 66.85 54.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.026 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.51 145.06 37.08 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.595 2.197 . . . . 0.0 111.877 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 89.1 p -138.2 153.34 49.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.868 0.366 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.48 -32.62 74.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -115.37 156.44 25.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.927 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 t -118.56 83.83 22.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.825 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.81 ' O ' HG21 ' A' ' 17' ' ' THR . 13.1 Cg_exo -63.89 144.41 88.18 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.666 2.244 . . . . 0.0 111.508 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.0 p -123.97 156.9 35.57 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.946 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 38' ' ' ASP . 40.2 t -123.16 131.34 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 78.1 t80 -97.42 -9.28 27.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.886 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' H ' HG12 ' A' ' 36' ' ' VAL . 96.0 m-20 -69.41 -70.96 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.111 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 40' ' ' TYR . 40.3 t-20 -173.8 174.06 3.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.669 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.455 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -139.0 23.83 2.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.51 98.62 10.22 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.446 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.486 ' O ' ' OG1' ' A' ' 52' ' ' THR . 15.6 m -115.55 158.16 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.219 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.6 t -123.22 140.92 52.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.015 0.436 . . . . 0.0 111.225 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 45' ' ' MET . 13.2 p -149.04 152.49 12.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.968 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.403 ' N ' HG22 ' A' ' 44' ' ' VAL . 70.7 mtm -101.3 123.35 45.26 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.674 HD13 ' HB2' ' A' ' 170' ' ' ASP . 9.1 tt -134.17 136.79 52.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.217 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.19 28.06 4.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.5 49.04 16.05 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -131.45 78.13 72.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.753 0.311 . . . . 0.0 110.329 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.598 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 20.6 Cg_exo -61.62 99.37 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.736 2.291 . . . . 0.0 112.143 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 83.5 m-85 -161.12 -179.38 7.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.508 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.549 ' C ' HD22 ' A' ' 53' ' ' LEU . 4.8 t -144.43 144.15 31.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.37 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.908 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.1 mm? -111.64 127.32 55.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.526 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -83.1 122.67 5.83 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.591 HD23 ' SG ' ' A' ' 6' ' ' CYS . 86.5 mt -127.55 145.6 50.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.297 0.57 . . . . 0.0 112.254 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.491 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 39.7 t80 -119.55 -168.39 1.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 59' ' ' ALA . 52.0 p30 -174.11 -162.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.574 0.624 . . . . 0.0 110.327 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 60' ' ' GLY . 81.7 p 43.23 -93.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.7 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 43.6 17.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.717 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 58' ' ' THR . . . -56.94 -29.64 59.28 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 94.2 mt-30 -79.77 99.86 7.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.145 0.498 . . . . 0.0 110.453 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.0 -35.51 64.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.934 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 64' ' ' TYR . 60.7 t0 -91.81 11.53 24.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.436 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.691 ' CD2' ' NH2' ' A' ' 68' ' ' ARG . 40.7 m-85 23.97 -120.19 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.327 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -139.42 141.17 37.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.24 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.3 mtt85 -58.09 147.29 30.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.563 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp 49.7 79.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.383 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.691 ' NH2' ' CD2' ' A' ' 64' ' ' TYR . 16.4 mtt180 -65.91 143.64 98.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.323 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.75 -30.82 26.8 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.285 1.99 . . . . 0.0 112.402 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.9 mt -100.46 140.79 34.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 72' ' ' TYR . 51.7 p -77.09 162.42 27.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.473 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -30.59 93.88 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.026 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 75' ' ' THR . 27.8 Cg_exo -58.53 142.95 98.55 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.38 2.053 . . . . 0.0 112.297 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.506 ' O ' ' C ' ' A' ' 75' ' ' THR . 95.7 mt-30 -62.41 -33.66 75.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.506 ' C ' ' O ' ' A' ' 74' ' ' GLN . 2.1 t 23.19 61.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.603 0.564 . . . . 0.0 111.439 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.899 ' OD2' HD11 ' A' ' 4' ' ' ILE . 90.1 m-20 -65.01 -39.22 93.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 ' HB1' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -105.88 104.11 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.54 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.621 ' C ' HD12 ' A' ' 79' ' ' LEU . 96.8 m-85 -78.92 125.15 28.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.162 0.506 . . . . 0.0 111.87 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.87 HD13 ' SG ' ' A' ' 6' ' ' CYS . 10.5 mp -112.59 128.43 56.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.974 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.0 m -109.88 136.84 44.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.675 ' O ' HG21 ' A' ' 93' ' ' VAL . 1.3 m -112.36 127.23 55.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.075 0.464 . . . . 0.0 111.43 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 113' ' ' VAL . 48.7 p90 -149.73 115.75 5.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.419 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.664 ' OG ' HG12 ' A' ' 85' ' ' VAL . 35.5 t -58.59 139.78 55.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 84' ' ' VAL . 11.1 p -101.01 38.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.544 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.664 HG12 ' OG ' ' A' ' 83' ' ' SER . 1.9 p -129.3 -7.38 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.832 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.1 154.71 55.92 Favored Pre-proline 0 C--N 1.331 -0.218 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.733 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.594 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 57.8 Cg_endo -73.04 -40.79 1.58 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.667 2.245 . . . . 0.0 112.758 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.4 p -82.86 -7.94 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.31 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 83' ' ' SER . 84.2 p -60.63 -41.1 94.2 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.177 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.594 ' CE1' ' O ' ' A' ' 87' ' ' PRO . 22.6 p90 -89.35 -41.25 12.24 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.181 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.2 tt0 -57.7 -32.81 67.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.116 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 90.5 m-20 -77.34 -39.38 47.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.326 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.675 HG21 ' O ' ' A' ' 81' ' ' CYS . 9.6 t -84.8 -66.87 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 93' ' ' VAL . 92.9 mttt -61.43 -17.67 55.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.528 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 95.3 mt-10 -125.72 -48.44 1.65 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -78.53 -41.01 33.39 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.606 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 57.6 m95 -92.61 -25.53 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.381 -0.928 . . . . 0.0 112.29 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.539 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -56.34 -45.37 99.93 Favored Pre-proline 0 CA--C 1.527 0.092 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.118 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 25.7 Cg_exo -57.46 -43.92 47.03 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.119 1.88 . . . . 0.0 110.76 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -57.4 -42.52 82.4 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.555 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.7 mt -69.79 -36.34 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.908 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 105' ' ' CYS . 49.8 m -57.11 -31.68 65.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.178 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -46.85 -45.54 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.063 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -59.9 -33.47 71.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 109.953 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' THR . 5.1 t 70.79 58.9 0.46 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.49 120.44 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.731 2.287 . . . . 0.0 112.057 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.7 0.29 57.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.391 . . . . 0.0 110.437 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.3 157.4 80.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.419 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -50.08 144.61 21.79 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.606 2.204 . . . . 0.0 111.662 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.734 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -118.8 119.18 33.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.193 0.521 . . . . 0.0 110.577 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 111' ' ' LEU . 8.5 mp -97.63 130.89 44.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.38 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.421 HD12 ' CD1' ' A' ' 154' ' ' TYR . 92.3 mt -94.58 129.04 41.56 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.603 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 30.5 t -136.33 153.64 31.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.584 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -134.96 168.28 23.73 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.472 ' H ' ' HA ' ' A' ' 83' ' ' SER . 3.4 p -124.81 177.44 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.167 0.508 . . . . 0.0 110.794 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.55 ' O ' ' C ' ' A' ' 117' ' ' ILE . 16.4 tt0 36.55 30.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.158 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.875 HG23 ' N ' ' A' ' 118' ' ' ASP . 6.0 tt 19.94 -138.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 O-C-N 123.602 0.564 . . . . 0.0 110.012 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.875 ' N ' HG23 ' A' ' 117' ' ' ILE . 1.0 OUTLIER -93.27 55.5 2.3 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.626 -0.829 . . . . 0.0 109.846 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.857 HD13 ' OG1' ' A' ' 125' ' ' THR . 2.3 tt 85.93 77.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.824 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.54 ' C ' ' O ' ' A' ' 119' ' ' LEU . 45.2 mtm180 17.63 57.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.944 0.778 . . . . 0.0 110.817 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.569 ' O ' ' CB ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER 164.21 -91.63 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.989 -179.086 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 40.5 t0 107.68 -46.23 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 124.021 0.826 . . . . 0.0 110.671 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' CD ' ' C ' ' A' ' 121' ' ' ASP . 49.3 Cg_endo -92.93 -33.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.416 1.411 . . . . 0.0 111.868 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.9 m -98.75 2.22 46.78 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.038 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.857 ' OG1' HD13 ' A' ' 119' ' ' LEU . 8.8 t -105.74 -19.0 13.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 122' ' ' ASP . 73.4 mt -80.67 -50.3 17.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.87 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -74.66 -39.97 61.73 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -79.0 -37.66 38.66 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.712 HD22 ' CD1' ' A' ' 119' ' ' LEU . 15.9 tp -73.15 -39.65 65.51 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.635 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.591 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . 136.69 115.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.06 -37.58 77.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.936 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -81.69 3.91 23.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.15 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -108.49 -34.62 6.7 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.99 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.402 ' HG2' HD23 ' A' ' 129' ' ' LEU . 24.4 mm100 -89.86 120.62 31.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.78 78.3 75.2 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.619 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.66 134.84 41.11 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.609 2.206 . . . . 0.0 112.213 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.68 ' O ' HG23 ' A' ' 84' ' ' VAL . 73.3 mt -116.07 89.9 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.037 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.754 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -131.38 -39.66 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.754 ' CD ' ' H ' ' A' ' 138' ' ' THR . 69.4 Cg_endo -88.93 -48.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.126 1.884 . . . . 0.0 114.591 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.67 -52.74 41.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.617 ' OG1' HG22 ' A' ' 137' ' ' ILE . 30.9 p -83.32 -10.74 58.31 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -83.93 -63.07 1.41 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.365 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.15 -39.1 93.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.97 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -66.34 -57.07 8.26 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.361 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.38 -33.8 71.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.322 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.53 -38.67 87.66 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -61.4 -40.58 94.89 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.065 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -51.95 -32.42 33.2 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 146' ' ' ALA . 75.6 mt -130.59 -116.61 0.23 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.178 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.701 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 53.2 mmtt -133.32 -145.32 0.24 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.041 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 151.41 -166.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.894 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 151' ' ' ALA . 41.2 t -159.16 -66.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.68 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 2.5 tttm -105.58 -176.83 3.19 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.079 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 153' ' ' LYS . 13.8 m-85 -161.13 95.95 1.07 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' A' ' 165' ' ' LEU . 9.6 p -143.82 144.46 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-O 121.925 0.869 . . . . 0.0 111.956 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.658 ' O ' ' OG1' ' A' ' 161' ' ' THR . 8.3 mm-40 -126.75 98.57 5.42 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.441 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.95 144.21 43.45 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 123.127 1.441 . . . . 0.0 113.609 -175.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 160' ' ' LEU . 38.2 t -158.38 93.6 1.22 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 111.793 -2.458 . . . . 0.0 106.621 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 37.23 29.71 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.587 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.773 ' O ' ' N ' ' A' ' 162' ' ' GLN . 77.2 mt -145.32 -82.05 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.425 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.673 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -53.6 44.25 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.504 0.502 . . . . 0.0 112.341 -177.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.773 ' N ' ' O ' ' A' ' 160' ' ' LEU . 11.9 pt20 -75.72 14.72 0.6 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.673 ' H ' ' C ' ' A' ' 161' ' ' THR . 89.8 mttt -78.33 -4.91 50.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.822 -1.536 . . . . 0.0 107.434 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.7 -70.99 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 107.754 -2.139 . . . . 0.0 107.754 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.43 ' CD2' HG11 ' A' ' 155' ' ' VAL . 2.2 mm? -38.25 -19.1 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.447 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 164' ' ' GLY . 60.2 tttm -84.12 -48.33 9.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 164' ' ' GLY . 77.8 m-20 -78.53 6.53 8.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.029 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 169' ' ' PHE . 5.7 t -83.26 -60.09 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.196 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.689 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 57.8 m-85 -40.34 -47.8 2.58 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.355 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.674 ' HB2' HD13 ' A' ' 46' ' ' ILE . 64.6 t0 -67.13 -43.17 83.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.845 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.56 -27.04 66.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.325 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.521 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . . . -63.68 -33.25 75.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.096 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.76 -37.81 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.578 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.633 HD22 ' N ' ' A' ' 174' ' ' LEU . 3.5 mm? -64.27 -31.92 73.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.049 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.448 ' HB1' HG13 ' A' ' 77' ' ' VAL . . . -62.2 -27.4 68.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.807 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.498 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . . . -63.79 -32.6 74.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 110.206 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.81 -35.76 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.618 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.369 -0.378 . . . . 99.99 110.683 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 3' ' ' THR . 81.0 mt-30 -123.62 174.94 7.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.543 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -37.76 128.34 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.055 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 176' ' ' ALA . 19.7 tt -122.2 135.73 61.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.425 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -77.15 145.93 37.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.049 0.452 . . . . 0.0 111.517 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -139.65 136.73 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.033 179.585 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 56' ' ' PHE . 25.9 m -130.48 148.15 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.364 . . . . 0.0 111.485 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.574 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 47.1 t -115.95 120.78 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 111.078 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.95 158.27 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.095 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.49 -174.65 34.49 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.64 ' H ' ' CG2' ' A' ' 93' ' ' VAL . 23.5 t70 -81.2 121.94 26.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.019 0.438 . . . . 0.0 110.588 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . 43.75 64.6 1.83 Allowed Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.534 ' HB2' ' HZ2' ' A' ' 16' ' ' LYS . . . -16.98 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.854 0.359 . . . . 0.0 111.948 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.597 HG12 ' OE1' ' A' ' 116' ' ' GLN . 99.5 t -66.32 -55.78 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.94 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.76 59.63 0.31 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.716 -0.755 . . . . 0.0 111.902 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.534 ' HZ2' ' HB2' ' A' ' 13' ' ' ALA . 17.8 mttt -77.25 -7.2 55.54 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.659 -0.318 . . . . 0.0 110.838 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.7 p -63.17 -44.69 94.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.582 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.5 m -84.64 -14.04 49.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.59 0.71 . . . . 0.0 110.167 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.594 HD22 ' SG ' ' A' ' 81' ' ' CYS . 14.0 tp -73.58 -42.99 60.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.847 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.796 ' CD1' HD12 ' A' ' 55' ' ' LEU . 26.7 tp -65.45 -39.14 91.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.429 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.468 ' O ' ' OG1' ' A' ' 24' ' ' THR . 10.5 pt -76.38 -3.51 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 21' ' ' ILE . 2.0 m -42.14 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.768 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.569 ' C ' ' H ' ' A' ' 25' ' ' THR . 40.0 t80 -54.31 -39.94 67.46 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.029 0.377 . . . . 0.0 111.96 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 21' ' ' ILE . 23.0 p -49.57 -9.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.013 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.569 ' H ' ' C ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER 76.5 95.52 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.749 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.513 ' HB3' HE22 ' A' ' 162' ' ' GLN . 25.9 t30 -141.11 -69.56 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.4 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.773 ' H ' HE22 ' A' ' 162' ' ' GLN . 30.9 tttt 48.22 53.09 12.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mt -147.0 87.24 6.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.42 134.08 55.89 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.056 1.838 . . . . 0.0 111.378 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -125.02 145.08 50.07 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.872 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.37 -31.65 72.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.519 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -123.03 146.25 47.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.037 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 33' ' ' VAL . 15.9 m -119.79 88.13 39.2 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.31 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -53.77 148.06 38.38 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.639 2.226 . . . . 0.0 112.316 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.6 m -76.68 142.92 40.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.45 163.29 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.68 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -115.97 156.96 25.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.522 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 0.8 OUTLIER 51.73 -146.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.993 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 15.6 t-20 81.66 64.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 110.56 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.608 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 26.6 p90 -157.0 38.53 0.31 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.14 98.35 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.612 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.507 ' O ' ' OG1' ' A' ' 52' ' ' THR . 18.5 t -135.66 130.45 49.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.318 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 t -94.54 133.94 37.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.685 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -135.25 142.86 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.3 mtm -113.15 130.27 56.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.298 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 48' ' ' GLY . 7.7 tp -131.96 136.2 57.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.636 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 31.14 35.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.889 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 79.63 65.37 1.78 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.572 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -151.26 88.09 4.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.59 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 42.7 Cg_endo -76.04 112.55 3.52 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.09 1.86 . . . . 0.0 112.575 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 95.9 m-85 -162.59 166.95 24.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 6.8 t -138.04 148.4 45.05 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.217 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -122.74 133.3 54.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.748 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -73.0 148.15 40.8 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.796 HD12 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -132.52 119.11 20.11 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.33 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.574 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 17.2 t80 -107.9 -176.34 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.79 ' OD2' HD22 ' A' ' 20' ' ' LEU . 52.7 p30 -176.86 -165.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.065 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.508 ' H ' ' HB2' ' A' ' 16' ' ' LYS . 31.5 p 36.59 -148.86 0.01 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.073 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 54.75 172.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.322 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.31 8.42 0.08 OUTLIER Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -73.74 116.57 14.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.361 0.6 . . . . 0.0 110.042 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.83 -32.64 67.8 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.461 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 64' ' ' TYR . 88.3 m-20 -93.7 7.5 44.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.991 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.507 ' O ' ' O ' ' A' ' 63' ' ' ASP . 66.0 m-85 34.26 -158.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.881 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.88 130.41 35.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.308 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -59.48 -36.72 76.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.941 0.4 . . . . 0.0 110.397 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.9 mt -64.3 -36.6 84.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.099 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -130.65 76.29 77.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.237 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.05 -10.71 23.02 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.353 2.035 . . . . 0.0 111.545 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 36.8 tp -58.12 -35.72 71.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t 64.53 -176.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.101 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.1 71.73 76.1 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.232 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.77 0.02 10.3 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.912 2.408 . . . . 0.0 111.465 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.61 -29.64 64.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.219 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.448 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 10.3 t -41.18 135.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 110.685 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -91.95 -24.37 19.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.725 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.411 HG12 HD13 ' A' ' 111' ' ' LEU . 4.2 t -119.14 110.02 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.216 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.547 ' C ' HD12 ' A' ' 79' ' ' LEU . 96.8 m-85 -86.33 126.65 34.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.165 0.507 . . . . 0.0 112.006 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.3 mp -106.38 110.01 22.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.367 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 113' ' ' VAL . 39.0 t -74.53 129.0 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.739 ' O ' HG21 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -122.27 129.89 52.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.113 0.482 . . . . 0.0 112.003 -179.03 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.613 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 4.0 p90 -166.42 125.75 1.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.36 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.546 ' HB3' HG11 ' A' ' 14' ' ' VAL . 84.2 p -52.89 146.36 10.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.319 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.58 4.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.493 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 119' ' ' LEU . 80.3 t -127.79 148.86 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.25 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.9 t 93.24 96.24 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.244 0 O-C-N 123.643 0.589 . . . . 0.0 110.328 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.446 ' O ' ' CE2' ' A' ' 90' ' ' PHE . 61.9 Cg_exo -48.97 -2.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.67 2.247 . . . . 0.0 112.72 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 86' ' ' SER . 2.2 t -97.48 -34.73 10.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -57.01 -40.74 77.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.702 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.461 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 2.4 p90 -82.29 -32.8 29.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.319 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.1 tt0 -54.3 -28.67 43.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.925 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' LYS . 72.1 m-20 -90.51 -64.79 1.08 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.578 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.739 HG21 ' O ' ' A' ' 81' ' ' CYS . 54.7 t -50.12 -60.59 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.35 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.733 ' HZ3' HD11 ' A' ' 112' ' ' LEU . 26.6 mttt -71.57 -9.83 58.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -126.32 -62.02 1.18 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 92' ' ' ASN . 20.0 tptm -64.77 -34.6 78.73 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.4 ' O ' ' C ' ' A' ' 98' ' ' VAL . 51.1 m95 -81.94 -34.95 29.57 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.924 ' O ' HG23 ' A' ' 102' ' ' THR . 2.3 t -39.21 -55.21 3.16 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.184 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 17.2 Cg_endo -60.0 -37.19 86.58 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 121.553 1.502 . . . . 0.0 111.175 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -61.75 -42.68 99.28 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.162 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.92 -39.68 67.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.793 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 98' ' ' VAL . 44.1 p -62.71 -12.71 25.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.05 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -54.18 -41.59 68.73 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -87.85 -15.41 36.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.482 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.2 m 55.35 58.59 10.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.916 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -78.17 124.09 6.45 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.644 2.229 . . . . 0.0 112.01 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -92.27 2.97 56.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.729 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.35 155.18 91.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.88 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.33 149.11 57.58 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.96 2.44 . . . . 0.0 112.115 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.737 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -130.72 139.14 50.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.272 0.558 . . . . 0.0 110.521 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.0 mp -104.76 136.16 44.78 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.558 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.733 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 18.3 tp -88.11 128.43 35.43 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 155' ' ' VAL . 1.9 t -142.29 151.89 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.682 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.534 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -134.46 171.54 22.22 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.475 ' H ' ' HA ' ' A' ' 83' ' ' SER . 1.5 p -119.82 173.73 6.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.97 0.414 . . . . 0.0 110.461 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.604 ' O ' ' O ' ' A' ' 117' ' ' ILE . 33.8 mt-30 37.8 34.0 0.05 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.24 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.888 HG23 ' N ' ' A' ' 118' ' ' ASP . 2.5 tt 19.96 -143.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 123.595 0.559 . . . . 0.0 110.485 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.888 ' N ' HG23 ' A' ' 117' ' ' ILE . 59.5 t0 -59.98 -2.92 0.47 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.726 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.861 HD23 ' OG1' ' A' ' 125' ' ' THR . 59.2 tp 132.52 92.01 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.182 0.926 . . . . 0.0 110.105 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' C ' ' O ' ' A' ' 119' ' ' LEU . 41.7 ptt85 15.01 50.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.201 0.938 . . . . 0.0 111.625 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 119' ' ' LEU . 0.8 OUTLIER 169.65 -95.94 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.1 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 10.9 t0 109.08 -44.9 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 O-C-N 123.876 0.735 . . . . 0.0 110.483 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.423 ' CD ' ' C ' ' A' ' 121' ' ' ASP . 83.6 Cg_endo -88.91 -36.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.481 1.454 . . . . 0.0 110.524 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 52.5 p -98.38 -6.97 29.6 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.793 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.861 ' OG1' HD23 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -85.66 -23.19 27.56 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.687 HG12 HE22 ' A' ' 134' ' ' GLN . 10.4 tt -80.08 -43.35 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.792 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.515 ' N ' ' CG2' ' A' ' 126' ' ' ILE . 98.3 mt-10 -61.91 -33.59 74.52 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.084 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -58.68 -35.96 73.43 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.682 ' O ' ' N ' ' A' ' 131' ' ' LYS . 26.6 mt -90.18 22.52 3.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.544 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 129' ' ' LEU . . . -4.82 63.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 O-C-N 125.072 1.483 . . . . 0.0 111.977 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.682 ' N ' ' O ' ' A' ' 129' ' ' LEU . 80.3 mttt 47.3 75.97 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.767 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -126.82 57.13 1.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 65.1 tttt 67.07 43.18 2.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.556 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.687 HE22 HG12 ' A' ' 126' ' ' ILE . 84.0 mt-30 -58.07 137.68 56.69 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.532 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.96 66.88 9.84 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.03 152.53 50.88 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.665 2.243 . . . . 0.0 111.497 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.1 mm -107.19 101.15 12.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.954 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.0 OUTLIER -130.91 -53.89 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.57 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 138' ' ' THR . 66.1 Cg_endo -92.87 -36.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.559 2.173 . . . . 0.0 113.294 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.53 -70.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.47 ' O ' HD13 ' A' ' 145' ' ' LEU . 43.3 p -123.11 4.42 9.27 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.954 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -79.84 -71.08 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.829 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.41 ' OE1' ' CD1' ' A' ' 154' ' ' TYR . 77.7 mm-40 -73.24 -31.46 64.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -56.97 -38.26 72.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.69 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 145' ' ' LEU . 9.9 mp -86.06 -6.91 58.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -91.17 -61.56 1.63 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.129 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -61.07 -37.8 83.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.192 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.67 -12.61 23.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 0.6 OUTLIER -124.71 29.4 6.24 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.485 -178.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 49.0 mttp 95.01 143.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.375 0.67 . . . . 0.0 111.454 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 152.88 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.104 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 151' ' ' ALA . 89.1 t -159.32 -59.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.232 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 12.3 mmtm -104.69 -170.94 1.83 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.605 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 153' ' ' LYS . 18.5 m-85 -153.67 96.4 2.0 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.707 ' O ' HG13 ' A' ' 113' ' ' VAL . 13.2 m -134.79 98.49 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-O 121.36 0.6 . . . . 0.0 110.559 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.561 ' O ' ' OG1' ' A' ' 161' ' ' THR . 91.1 mt-10 -103.16 99.06 8.9 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.534 ' SG ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -119.0 155.68 30.96 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 123.306 1.527 . . . . 0.0 114.362 -175.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' LEU . 47.0 t -164.07 94.73 0.75 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 111.341 -2.663 . . . . 0.0 106.858 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 39.54 26.58 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.647 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.737 ' O ' ' N ' ' A' ' 162' ' ' GLN . 76.0 mt -142.05 -81.17 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.169 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.561 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -57.19 45.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 O-C-N 123.36 0.412 . . . . 0.0 110.778 -178.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.773 HE22 ' H ' ' A' ' 27' ' ' LYS . 77.2 mt-30 -85.73 14.67 5.53 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.8 mttt -88.95 1.75 54.96 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 112.613 -2.085 . . . . 0.0 107.115 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.61 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -129.74 -73.6 0.14 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.534 HD12 ' SG ' ' A' ' 157' ' ' CYS . 12.4 mt -41.72 -17.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.017 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.61 ' N ' ' O ' ' A' ' 164' ' ' GLY . 22.3 tttp -83.06 -48.47 10.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' GLY . 75.2 m-20 -75.1 2.38 10.85 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.225 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 169' ' ' PHE . 24.7 t -84.1 -53.72 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.628 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 168' ' ' VAL . 6.0 m-85 -37.31 -52.78 1.1 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.207 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 53.1 p-10 -65.8 -39.23 90.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.199 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.615 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 99.2 mt-10 -70.67 -22.05 62.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.767 0.318 . . . . 0.0 110.7 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.581 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -63.41 -34.21 77.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.49 -37.45 70.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.333 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.6 tp -57.25 -34.51 68.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.541 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 172' ' ' ALA . . . -63.51 -23.69 67.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.152 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 4' ' ' ILE . . . -63.95 -30.96 72.0 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.328 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.39 -35.54 70.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.607 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 99.99 110.679 -179.816 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 3' ' ' THR . 89.7 mt-30 -116.03 167.21 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.264 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 3' ' ' THR . 0.5 OUTLIER -39.39 140.77 0.42 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 11.0 tp -130.35 152.43 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.955 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' CB ' HG22 ' A' ' 75' ' ' THR . 55.7 mttp -102.5 162.79 12.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.293 0.568 . . . . 0.0 111.567 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.53 157.2 46.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.329 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.75 ' O ' HG23 ' A' ' 9' ' ' VAL . 61.5 t -122.16 134.81 64.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.54 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.3 p -50.05 125.73 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.223 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 7' ' ' VAL . 21.4 t -127.04 133.44 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.424 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.581 ' HA3' HG13 ' A' ' 93' ' ' VAL . . . 106.06 -67.99 0.24 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 60' ' ' GLY . 81.7 m-20 58.53 -82.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.581 0.229 . . . . 0.0 111.377 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 40.57 33.75 0.62 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 47.88 101.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.789 0.328 . . . . 0.0 110.564 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.79 HG23 ' H ' ' A' ' 15' ' ' GLY . 26.4 m -135.5 -111.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.057 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.79 ' H ' HG23 ' A' ' 14' ' ' VAL . . . -169.12 63.64 0.18 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' HD2' ' H ' ' A' ' 58' ' ' THR . 16.2 mttp -73.11 -2.9 23.28 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.215 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.8 p -61.43 -41.33 97.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.295 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' ILE . 99.2 m -95.81 -7.57 36.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.054 0.454 . . . . 0.0 111.013 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.905 HD11 HG12 ' A' ' 113' ' ' VAL . 24.9 tp -66.7 -68.25 0.39 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.109 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.461 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 67.4 mt -65.66 -26.48 67.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.615 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 18' ' ' CYS . 3.6 tt -58.86 -18.93 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.697 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -66.53 -75.95 0.09 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.397 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.735 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.9 p90 -41.24 -31.8 0.24 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.659 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.466 ' N ' ' CG ' ' A' ' 23' ' ' TYR . 2.5 m -57.12 -46.68 82.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.272 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.445 ' OG1' ' C ' ' A' ' 24' ' ' THR . 0.0 OUTLIER 175.99 -6.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.524 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 59.1 t-20 57.3 87.13 0.07 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.756 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -89.93 8.18 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.414 ' N ' ' HB1' ' A' ' 159' ' ' ALA . 0.8 OUTLIER 62.79 148.93 0.1 OUTLIER Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.288 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -42.04 143.18 1.32 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.247 1.965 . . . . 0.0 112.413 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.1 p -130.9 154.89 47.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.305 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' OE2' ' CE2' ' A' ' 32' ' ' TYR . 22.1 pt-20 -71.28 -15.65 62.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.854 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' CE2' ' OE2' ' A' ' 31' ' ' GLU . 69.3 m-85 -112.51 138.35 49.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.647 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.7 77.67 69.58 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.063 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.22 140.01 34.41 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.715 2.277 . . . . 0.0 112.334 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.7 p -116.6 25.68 10.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.271 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 m -124.05 160.49 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.628 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.449 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 80.9 t80 59.78 72.04 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.522 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -65.01 147.71 52.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.348 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.509 ' O ' ' O ' ' A' ' 55' ' ' LEU . 54.1 m-20 -89.49 144.96 25.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.383 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.1 p90 -175.57 -4.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.556 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.98 99.8 3.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG21 ' OH ' ' A' ' 23' ' ' TYR . 21.8 t -140.78 133.45 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.17 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.9 111.92 24.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.419 . . . . 0.0 110.825 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.419 HG23 HG12 ' A' ' 42' ' ' VAL . 58.7 t -137.43 145.83 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.154 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.657 ' SD ' ' N ' ' A' ' 45' ' ' MET . 2.3 mmt -97.08 132.93 42.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 170' ' ' ASP . 4.8 mt -120.66 127.0 75.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.141 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.73 31.12 5.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.05 52.13 6.48 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -138.75 79.07 29.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 36.1 Cg_exo -52.82 103.96 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.941 2.427 . . . . 0.0 112.965 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 76.6 m-85 -159.99 169.66 22.97 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.589 ' C ' HD22 ' A' ' 53' ' ' LEU . 10.1 t -140.32 135.91 32.68 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.61 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.861 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -115.39 132.86 56.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.122 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 40' ' ' TYR . . . -107.77 126.41 8.31 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 55' ' ' LEU . 4.0 mp -136.3 125.97 25.46 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.845 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.468 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 69.7 m-85 -77.39 160.69 28.57 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.611 ' C ' HG22 ' A' ' 58' ' ' THR . 55.9 p30 -166.26 174.73 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.643 ' OG1' ' N ' ' A' ' 59' ' ' ALA . 1.7 t 147.63 -140.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.826 0.704 . . . . 0.0 109.568 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.643 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -140.37 135.55 32.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.132 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' ' OD2' ' A' ' 11' ' ' ASP . . . 76.52 -163.65 52.91 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.491 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 65.9 tp60 -63.81 -26.83 68.8 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.785 -0.244 . . . . 0.0 110.678 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 61' ' ' GLN . 37.5 mt-10 139.74 -105.5 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.707 1.254 . . . . 0.0 108.693 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 65' ' ' ASP . 93.0 m-20 -78.94 -3.88 47.04 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.2 t80 66.18 -10.67 0.24 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.516 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.552 ' H ' ' C ' ' A' ' 63' ' ' ASP . 83.4 m-20 -73.82 140.77 46.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.164 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -95.09 4.27 53.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.733 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 mt -60.38 -33.57 72.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.485 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -123.56 77.42 55.24 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.616 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -77.53 -8.32 17.11 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.631 2.221 . . . . 0.0 112.261 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 74.5 mt -88.17 143.14 27.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.65 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.1 t -113.55 142.37 46.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.265 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -60.97 116.94 21.1 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.342 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.29 6.7 4.54 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.245 1.963 . . . . 0.0 112.409 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -55.91 -37.18 68.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.114 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.675 ' OG1' HG23 ' A' ' 7' ' ' VAL . 5.5 p -85.05 159.9 20.11 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.469 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 75' ' ' THR . 97.0 m-20 -139.96 3.2 2.0 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.83 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.451 HG12 HD13 ' A' ' 111' ' ' LEU . 2.4 t -109.26 109.71 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.615 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -78.44 122.5 25.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.399 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.651 ' C ' HD23 ' A' ' 79' ' ' LEU . 7.4 tt -121.52 116.73 25.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.379 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.472 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 41.4 t -90.37 130.19 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.268 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 118.84 26.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.72 ' HA ' HG11 ' A' ' 14' ' ' VAL . 36.8 p90 -144.69 163.91 32.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.74 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 85' ' ' VAL . 35.6 t -85.83 134.22 33.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.621 HG13 ' CG2' ' A' ' 138' ' ' THR . 71.0 t -41.81 -17.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.103 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.594 ' HB ' HD21 ' A' ' 119' ' ' LEU . 38.9 t -135.22 131.81 52.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.731 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 2.9 m 151.94 81.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.19 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -52.75 -29.61 42.97 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.385 2.056 . . . . 0.0 111.855 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.0 m -71.08 -49.98 38.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 109.796 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 93' ' ' VAL . 59.6 p -62.02 -30.91 71.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.467 ' CG ' HD11 ' A' ' 137' ' ' ILE . 91.0 t80 -57.8 -50.71 72.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.498 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -79.09 -18.79 52.72 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.164 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 25.4 m120 -93.78 -10.42 34.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.344 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.581 HG13 ' HA3' ' A' ' 10' ' ' GLY . 52.3 t -104.4 -71.25 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.392 0.615 . . . . 0.0 112.241 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.675 ' HE2' HD11 ' A' ' 112' ' ' LEU . 78.8 mttt -69.67 -21.3 63.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.272 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.544 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 97.4 mt-10 -106.07 -38.4 6.31 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -76.21 -30.66 58.06 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.881 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 23.3 m95 -89.57 -42.61 11.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.299 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 2.2 t -40.22 -54.38 4.67 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.249 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.544 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 27.9 Cg_endo -64.2 -37.84 39.07 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.649 1.566 . . . . 0.0 112.162 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.57 -37.94 89.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.257 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 101' ' ' ILE . 22.8 pt -86.29 -28.22 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.127 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 105' ' ' CYS . 86.3 m -59.99 -36.47 77.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.922 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -56.18 -37.69 69.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.88 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -55.99 -46.32 78.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.935 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 102' ' ' THR . 1.3 m -146.83 155.39 48.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.693 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.76 -60.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.482 2.122 . . . . 0.0 111.872 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -125.31 128.47 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.529 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.596 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -157.42 152.39 21.31 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.079 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -56.73 126.01 20.89 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.028 1.819 . . . . 0.0 111.39 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.691 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -116.58 111.29 19.68 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.453 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.7 mp -86.54 123.14 31.42 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.053 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.675 HD11 ' HE2' ' A' ' 94' ' ' LYS . 23.7 tp -100.94 123.58 45.34 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.905 HG12 HD11 ' A' ' 19' ' ' LEU . 4.7 t -136.18 147.47 28.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.47 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.495 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -121.14 153.01 16.69 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 p -114.3 172.49 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.168 0.509 . . . . 0.0 110.804 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.578 ' O ' ' O ' ' A' ' 117' ' ' ILE . 61.3 mt-30 48.73 21.29 0.41 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.164 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.793 HG23 ' N ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER 36.32 -160.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.401 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.793 ' N ' HG23 ' A' ' 117' ' ' ILE . 19.1 m-20 -69.07 75.42 0.33 Allowed 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.463 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 85' ' ' VAL . 98.0 mt 64.86 85.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.832 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 119' ' ' LEU . 57.1 ttm-85 8.8 59.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.108 0.88 . . . . 0.0 111.132 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 119' ' ' LEU . 0.5 OUTLIER 167.12 -90.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.249 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.714 ' O ' HD12 ' A' ' 126' ' ' ILE . 11.4 t0 109.93 -46.45 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 O-C-N 123.99 0.806 . . . . 0.0 110.339 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -92.78 -37.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 121.447 1.431 . . . . 0.0 111.794 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.2 m -98.38 -1.99 40.28 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.307 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -110.47 -12.09 14.42 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.958 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.714 HD12 ' O ' ' A' ' 122' ' ' ASP . 67.7 mt -85.78 -46.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.31 -32.1 69.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.273 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -61.98 -29.22 70.1 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.125 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.663 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 44.0 mt -54.58 -38.57 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.007 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . 78.23 9.52 2.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.191 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.492 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 51.9 mttp 56.9 83.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.068 0.461 . . . . 0.0 110.248 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 131' ' ' LYS . 87.8 m-20 -141.02 -25.91 0.73 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.094 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -178.75 45.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.22 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.483 ' HG2' HD13 ' A' ' 129' ' ' LEU . 93.2 mt-30 -50.75 -38.31 47.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.905 0.383 . . . . 0.0 110.129 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.45 ' C ' ' O ' ' A' ' 134' ' ' GLN . 11.9 mmtm 31.75 61.05 1.25 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.751 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.23 144.16 99.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.203 1.935 . . . . 0.0 111.185 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 137' ' ' ILE . 0.5 OUTLIER -144.81 45.93 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.153 -179.084 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.621 ' CG2' HG13 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -118.69 -50.28 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 138' ' ' THR . 72.9 Cg_endo -81.87 -83.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.127 1.885 . . . . 0.0 114.464 -176.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.51 -43.8 98.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.701 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 137' ' ' ILE . 81.9 p -60.56 -40.96 93.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -77.31 -36.46 54.02 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.601 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.66 -42.33 96.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.755 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -66.4 -46.57 76.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.804 0.335 . . . . 0.0 110.986 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.4 tt -53.72 -35.16 60.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.06 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.03 -38.38 88.27 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.39 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -62.91 -39.78 95.6 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.789 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -52.31 -32.56 38.34 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 146' ' ' ALA . 62.6 mt -133.29 -113.41 0.22 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.479 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.718 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 51.3 mttp -143.83 -132.94 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.464 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 156.09 -165.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.866 0.365 . . . . 0.0 110.448 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.615 HG23 ' H ' ' A' ' 110' ' ' PHE . 19.8 t -143.83 -51.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 3.5 tttm -143.62 -169.92 3.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.847 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -166.18 96.02 0.59 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.175 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 114' ' ' GLY . 16.5 m -136.14 153.61 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.474 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.594 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -133.11 94.0 3.27 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.562 ' SG ' HD22 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -110.87 148.1 33.14 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 123.155 1.455 . . . . 0.0 113.504 -176.232 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.47 ' C ' ' N ' ' A' ' 160' ' ' LEU . 8.8 t -155.3 91.29 1.32 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 111.576 -2.556 . . . . 0.0 105.224 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.484 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . 42.03 28.16 0.09 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.739 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.702 ' O ' ' N ' ' A' ' 162' ' ' GLN . 47.0 mt -139.52 -74.02 0.37 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.841 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.71 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.1 m -57.82 44.12 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 120.918 0.39 . . . . 0.0 112.05 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.702 ' N ' ' O ' ' A' ' 160' ' ' LEU . 38.4 tt0 -74.83 19.32 0.14 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.71 ' H ' ' C ' ' A' ' 161' ' ' THR . 56.8 mttp -108.14 -1.49 20.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.779 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 168' ' ' VAL . . . -133.17 -38.07 0.23 Allowed Glycine 0 C--O 1.225 -0.46 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.735 HD23 ' H ' ' A' ' 23' ' ' TYR . 9.9 tp -73.62 -22.99 59.84 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.034 0.445 . . . . 0.0 110.53 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -61.86 -34.15 75.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.597 ' O ' ' N ' ' A' ' 170' ' ' ASP . 7.9 m120 -72.29 -59.07 2.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 165' ' ' LEU . 59.0 t -29.25 -55.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.446 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.688 ' CZ ' ' CZ ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -56.9 -48.76 77.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.316 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.609 ' HB2' HG21 ' A' ' 46' ' ' ILE . 56.0 t0 -67.63 -47.44 69.6 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 111.477 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.51 -29.05 70.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.324 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.61 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . . . -57.43 -32.49 66.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.32 -37.09 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.741 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.8 -37.73 77.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.426 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.54 -28.05 69.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.589 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.461 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . . . -57.26 -37.1 71.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.979 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 177' ' ' LEU . 8.0 mp -60.04 -32.18 70.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.669 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.381 -0.372 . . . . 99.99 110.504 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -90.98 -69.52 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.305 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 3' ' ' THR . 3.5 t -40.37 125.59 2.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.392 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.49 149.93 22.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.894 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -105.08 147.3 28.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.223 0.535 . . . . 0.0 112.002 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.592 ' SG ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -132.61 145.23 50.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.393 179.106 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.407 HG13 ' CD1' ' A' ' 56' ' ' PHE . 16.6 t -127.4 135.9 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.548 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 56' ' ' PHE . 5.2 t -74.81 120.81 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.443 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.648 HG11 HD13 ' A' ' 101' ' ' ILE . 38.9 t -120.5 130.66 74.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.875 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.51 -162.01 29.67 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' ALA . 44.7 t0 -148.85 -117.09 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.992 0.425 . . . . 0.0 111.084 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.571 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -29.83 -29.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.657 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -38.18 136.65 0.61 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.421 0.611 . . . . 0.0 110.046 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 12' ' ' GLY . 31.5 m -125.88 27.48 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.77 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.53 ' CA ' HE21 ' A' ' 116' ' ' GLN . . . -143.22 36.87 1.54 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.053 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.704 ' NZ ' ' HB3' ' A' ' 59' ' ' ALA . 26.8 mttt -74.59 -7.58 53.61 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.043 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 19' ' ' LEU . 85.7 m -78.38 -69.63 0.54 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.897 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.694 ' HA ' HD12 ' A' ' 21' ' ' ILE . 32.4 m -61.75 0.16 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.357 0.598 . . . . 0.0 109.913 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.756 ' O ' HD13 ' A' ' 165' ' ' LEU . 7.8 tt -69.72 -52.29 26.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.989 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.63 -32.45 64.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.144 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 18' ' ' CYS . 77.4 mt -55.03 -20.26 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.929 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.489 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 5.2 m -50.62 -74.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.457 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.707 ' CZ ' ' CZ ' ' A' ' 169' ' ' PHE . 23.9 p90 -63.03 -28.08 69.85 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.141 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.4 m -51.17 -46.03 61.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.562 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.9 m -157.44 -19.46 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 110.41 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 22' ' ' SER . 1.4 m-80 64.16 133.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.904 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.713 ' HG3' HE22 ' A' ' 162' ' ' GLN . 40.6 mttp 66.71 59.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.734 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 21' ' ' ILE . 1.3 tp -128.87 67.28 77.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.4 0.619 . . . . 0.0 110.295 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -79.55 6.52 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.147 2.564 . . . . 0.0 112.533 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.6 m -49.18 137.21 14.03 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.384 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.26 -34.81 78.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.799 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -59.03 -40.85 86.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.527 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.559 HG12 ' O ' ' A' ' 33' ' ' VAL . 70.8 t 52.39 77.84 0.43 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.573 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.07 141.73 36.88 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.603 2.202 . . . . 0.0 112.038 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.5 m -126.26 149.61 48.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.15 157.63 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.396 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -57.25 -41.03 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.52 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.35 130.15 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.978 0.418 . . . . 0.0 111.042 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LEU . 87.4 m-20 -123.9 14.95 9.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.516 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.547 ' CB ' ' CE1' ' A' ' 56' ' ' PHE . 22.3 p90 -175.73 12.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.9 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.22 99.9 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.844 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.6 t -144.68 140.57 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.889 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 43' ' ' THR . 7.6 t -124.51 132.01 53.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.343 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.8 t -133.69 138.9 49.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.762 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.9 mtm -113.49 120.92 42.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.153 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.8 pp -128.15 154.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.936 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.491 ' O ' ' OE1' ' A' ' 49' ' ' GLU . . . 32.81 27.95 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 74.19 50.22 10.83 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.491 ' OE1' ' O ' ' A' ' 47' ' ' GLY . 4.1 mp0 -130.4 96.53 24.16 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' C ' ' CD1' ' A' ' 51' ' ' TYR . 57.7 Cg_endo -76.8 108.65 2.69 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.05 1.833 . . . . 0.0 113.033 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.583 ' CE1' HG23 ' A' ' 173' ' ' ILE . 93.7 m-85 -150.55 165.44 33.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.957 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.21 125.78 30.14 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.709 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.562 HD13 ' HB1' ' A' ' 172' ' ' ALA . 51.8 tp -113.1 125.4 54.33 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.813 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -89.43 136.42 13.54 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.544 HD12 ' SG ' ' A' ' 6' ' ' CYS . 29.2 tp -137.11 125.69 23.7 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.85 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CE1' ' CB ' ' A' ' 40' ' ' TYR . 26.3 m-85 -97.93 -177.93 3.92 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 177.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' O ' ' OG1' ' A' ' 58' ' ' THR . 50.8 p30 -171.49 -174.89 1.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.629 ' H ' ' CB ' ' A' ' 16' ' ' LYS . 29.3 p 56.89 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.087 0.47 . . . . 0.0 111.664 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.704 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . . . -177.77 149.35 0.59 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.075 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.0 60.72 8.3 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -106.5 -47.47 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.064 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 64' ' ' TYR . 84.7 tt0 -140.44 133.82 29.88 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.608 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.556 ' C ' ' O ' ' A' ' 62' ' ' GLU . 51.2 p30 8.94 57.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.259 0.975 . . . . 0.0 111.731 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER 9.68 100.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.979 0.799 . . . . 0.0 112.188 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.501 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 30.5 p30 -78.9 86.78 4.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.054 0.454 . . . . 0.0 110.835 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -61.41 -32.71 72.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.269 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.5 tp -52.19 -37.5 54.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.333 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -54.25 151.62 13.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.365 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.71 138.28 78.64 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.744 2.296 . . . . 0.0 112.483 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.2 mt -111.72 142.3 44.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.503 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.9 p -128.56 158.09 39.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.687 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -129.62 76.45 78.53 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.3 179.11 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.941 2.428 . . . . 0.0 111.812 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -56.36 -41.65 76.52 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.714 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.4 p 48.66 46.48 21.3 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.96 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -62.03 -37.81 86.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.381 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.532 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -119.34 99.79 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.345 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.579 ' C ' HD12 ' A' ' 79' ' ' LEU . 98.2 m-85 -71.14 127.76 33.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.958 -177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.592 HD13 ' SG ' ' A' ' 6' ' ' CYS . 9.1 mp -114.69 137.13 52.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.766 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 113' ' ' VAL . 62.3 t -104.75 132.4 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.578 ' SG ' HD13 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -114.38 123.81 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 111.54 -179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.464 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 44.1 p90 -150.78 128.53 11.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.047 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -62.64 126.32 26.92 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 156' ' ' GLU . 21.5 t -66.69 -20.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.675 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.769 HG22 ' O ' ' A' ' 85' ' ' VAL . 7.7 p -105.79 11.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.183 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.14 84.42 45.79 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 0.0 110.416 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -52.84 -27.38 34.48 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.457 2.104 . . . . 0.0 112.491 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.8 m -64.91 -44.84 88.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.199 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.691 ' O ' HG23 ' A' ' 93' ' ' VAL . 83.8 p -70.71 -24.91 62.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 0.0 110.995 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.482 ' CG ' HG21 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -73.4 -40.45 64.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.44 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.09 -37.33 84.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.148 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -93.01 -39.82 10.89 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.071 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 89' ' ' SER . 37.4 t -51.68 -64.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.41 . . . . 0.0 111.573 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -72.61 -8.58 55.98 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.031 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.545 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 81.0 tt0 -103.77 -71.99 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -88.07 -9.13 54.29 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.41 ' CE2' ' HB2' ' A' ' 11' ' ' ASP . 93.0 m95 -97.4 -41.24 8.32 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.135 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -53.1 -54.64 42.15 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.545 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 17.9 Cg_endo -60.47 -34.05 93.34 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.674 1.583 . . . . 0.0 112.283 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -57.96 -37.56 74.4 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.954 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.648 HD13 HG11 ' A' ' 9' ' ' VAL . 44.1 pt -95.37 -31.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.495 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.487 HG22 ' HG3' ' A' ' 106' ' ' PRO . 28.7 m -51.08 -37.86 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.316 . . . . 0.0 110.948 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -50.63 -31.84 17.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.994 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.632 ' ND1' ' SG ' ' A' ' 105' ' ' CYS . 50.4 t-80 -57.33 -45.58 84.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.346 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.632 ' SG ' ' ND1' ' A' ' 104' ' ' HIS . 0.8 OUTLIER -174.59 82.74 0.34 Allowed Pre-proline 0 C--O 1.233 0.188 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.962 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.487 ' HG3' HG22 ' A' ' 102' ' ' THR . 18.0 Cg_exo -63.13 -16.78 56.64 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.921 2.414 . . . . 0.0 112.808 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -77.64 -3.19 39.67 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.633 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 105' ' ' CYS . 13.9 p -94.8 150.31 37.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.826 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.95 142.69 93.82 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.437 2.091 . . . . 0.0 111.274 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.705 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -119.98 125.83 49.34 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.548 0.69 . . . . 0.0 111.404 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -99.92 133.69 43.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.777 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.8 mt -99.99 124.86 45.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.444 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 80' ' ' VAL . 41.5 t -128.05 129.44 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.302 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -106.47 142.54 15.65 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.431 HG21 ' HB1' ' A' ' 13' ' ' ALA . 0.6 OUTLIER -102.32 169.1 8.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.339 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.915 ' O ' ' N ' ' A' ' 118' ' ' ASP . 56.8 mm-40 52.1 23.52 2.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.918 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.921 HG23 ' H ' ' A' ' 119' ' ' LEU . 15.8 tt 27.66 -46.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.915 ' N ' ' O ' ' A' ' 116' ' ' GLN . 47.0 t0 120.69 6.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.401 1.081 . . . . 0.0 108.505 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.921 ' H ' HG23 ' A' ' 117' ' ' ILE . 8.9 tp -133.13 -24.74 1.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.8 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.768 HH21 ' NE2' ' A' ' 116' ' ' GLN . 65.5 ttp85 -71.33 -60.99 1.93 Allowed 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 123' ' ' PRO . 38.0 m-20 -43.93 -29.16 0.53 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 124' ' ' SER . 5.2 m-20 10.11 -73.9 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' A' ' 121' ' ' ASP . 57.3 Cg_exo -34.83 -26.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 120.928 1.085 . . . . 0.0 111.415 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.629 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.5 OUTLIER -107.74 -34.1 7.07 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.657 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.502 HG22 HG21 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -87.97 -33.99 18.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.125 0.488 . . . . 0.0 110.848 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.44 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.7 OUTLIER -79.8 -46.2 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.941 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.403 ' CD ' ' O ' ' A' ' 123' ' ' PRO . 96.8 mt-10 -65.7 -34.47 78.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.597 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -95.86 -69.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.584 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' ALA . 61.9 mt -85.7 40.26 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.415 -178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.542 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -38.57 -91.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -148.16 91.37 1.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.387 0.613 . . . . 0.0 109.626 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 30.8 p-10 -145.61 36.26 1.07 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.318 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 27.0 ttmt 87.34 55.28 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.095 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 130' ' ' ALA . 50.8 mt-30 -59.22 149.35 28.7 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.365 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -132.54 70.08 79.6 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 121.006 0.431 . . . . 0.0 110.92 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.8 145.55 97.12 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.644 2.229 . . . . 0.0 111.962 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 137' ' ' ILE . 4.8 mp -86.31 78.14 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.805 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -132.31 -52.48 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.19 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.1 Cg_endo -83.87 -93.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.975 1.783 . . . . 0.0 114.585 -175.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.0 -38.83 76.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.554 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.2 p -69.59 -34.55 74.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.602 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -91.96 -42.3 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.361 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 139' ' ' PRO . 84.2 tt0 -60.98 -39.67 90.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.001 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -63.53 -43.92 95.73 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.171 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.621 ' N ' HD22 ' A' ' 145' ' ' LEU . 3.1 mm? -79.23 -7.16 58.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.913 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.03 -66.43 0.9 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.581 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -59.77 -37.56 79.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.491 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -93.66 -13.82 27.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.8 tp -134.75 51.09 2.13 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.249 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.702 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 67.7 mttm 65.11 158.7 0.1 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.205 0.526 . . . . 0.0 111.311 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 158.06 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.444 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.648 HG12 ' HG3' ' A' ' 153' ' ' LYS . 72.6 t -142.5 -66.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.379 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.648 ' HG3' HG12 ' A' ' 152' ' ' VAL . 25.0 mttm -136.42 -167.75 2.12 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.411 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.594 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -150.27 97.15 2.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.737 ' O ' HG23 ' A' ' 155' ' ' VAL . 21.1 m -116.2 97.96 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.147 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.647 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -95.33 98.75 10.81 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.683 ' HB2' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -125.61 149.31 48.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 123.007 1.384 . . . . 0.0 113.098 -176.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.607 ' OG ' ' NE ' ' A' ' 120' ' ' ARG . 22.3 t -157.03 92.76 1.29 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 111.906 -2.406 . . . . 0.0 106.289 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 42.27 27.42 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.242 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.676 ' O ' ' N ' ' A' ' 162' ' ' GLN . 19.8 mt -144.57 -73.37 0.26 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.125 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.647 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 2.2 m -57.06 65.31 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.315 0.578 . . . . 0.0 111.8 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.713 HE22 ' HG3' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -82.68 15.07 2.77 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 175.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.592 ' H ' ' C ' ' A' ' 161' ' ' THR . 24.9 tttt -86.44 -6.53 58.89 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 113.421 -1.718 . . . . 0.0 108.486 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 167' ' ' ASN . . . -131.4 -74.73 0.12 Allowed Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.756 HD13 ' O ' ' A' ' 19' ' ' LEU . 14.8 mt -41.49 -22.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.746 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.6 tttt -77.85 -46.59 21.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 164' ' ' GLY . 78.4 m-20 -76.03 -0.45 21.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.784 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 171' ' ' GLU . 46.7 t -83.91 -60.14 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.762 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.707 ' CZ ' ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -43.05 -45.64 5.32 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.018 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.653 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 32.6 p30 -70.03 -30.56 67.88 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.779 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.653 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 85.5 tt0 -64.72 -31.38 72.58 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.133 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.562 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -60.12 -29.43 68.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.583 HG23 ' CE1' ' A' ' 51' ' ' TYR . 77.3 mt -52.41 -39.75 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.14 -37.79 88.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.589 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -76.78 -13.03 60.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.708 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -66.14 -29.21 69.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.916 0.388 . . . . 0.0 110.15 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.65 -35.27 70.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.431 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 99.99 110.575 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.565 ' N ' ' O ' ' A' ' 176' ' ' ALA . 64.1 mtt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -110.31 -113.83 0.31 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.754 HG22 HG22 ' A' ' 52' ' ' THR . 40.9 p -42.73 113.68 0.5 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.384 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 176' ' ' ALA . 17.8 tt -117.28 138.97 46.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.133 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -96.47 150.85 20.15 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.136 0.493 . . . . 0.0 111.106 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.886 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -143.1 137.03 28.87 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.013 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 p -106.61 139.66 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.692 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 79' ' ' LEU . 57.6 t -115.63 131.35 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.592 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 t -128.58 138.69 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.839 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 60' ' ' GLY . . . -135.4 -177.33 14.89 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.497 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 53.8 p30 -72.25 -123.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.345 . . . . 0.0 111.221 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.711 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -151.21 72.51 0.28 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 152.23 27.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.58 0.224 . . . . 0.0 111.398 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.57 HG11 ' H ' ' A' ' 83' ' ' SER . 16.8 m -125.28 133.85 68.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.412 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.3 93.59 1.86 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.429 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -73.27 -8.53 56.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.013 0.435 . . . . 0.0 110.102 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -59.27 -55.12 38.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.029 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HA ' HD12 ' A' ' 21' ' ' ILE . 82.6 m -58.91 -36.19 74.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.701 . . . . 0.0 109.317 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.659 ' O ' HD23 ' A' ' 165' ' ' LEU . 4.0 tt -65.71 -54.09 32.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.699 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.803 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -59.78 -32.53 70.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.063 0.459 . . . . 0.0 110.207 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 21' ' ' ILE . 33.7 mt -62.36 -9.6 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.378 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.462 ' CB ' HD23 ' A' ' 165' ' ' LEU . 23.3 t -53.43 -82.16 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.936 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -52.62 -31.61 37.45 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.851 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.3 m -47.18 -39.63 14.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -140.98 -87.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.985 178.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.559 ' N ' ' OG1' ' A' ' 25' ' ' THR . 2.1 t-20 156.58 83.94 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.798 ' H ' HE21 ' A' ' 162' ' ' GLN . 24.7 tttt 65.53 91.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.646 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 tp -125.14 85.64 57.84 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.45 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.61 47.18 2.25 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.85 2.367 . . . . 0.0 112.692 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.9 m -64.13 152.67 39.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.349 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -59.41 -39.57 83.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.555 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.6 ' CE2' ' O ' ' A' ' 33' ' ' VAL . 81.7 t80 -137.38 136.27 37.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.416 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 17.1 m -78.03 148.78 75.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.387 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.97 -162.4 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.386 2.057 . . . . 0.0 112.059 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.3 p -76.11 164.88 25.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -126.56 158.0 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.407 . . . . 0.0 110.805 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -117.93 161.04 20.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.363 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 51.5 p30 -77.92 4.29 12.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.974 0.416 . . . . 0.0 110.454 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -127.28 132.17 50.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.14 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -125.7 15.71 8.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.0 97.69 10.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.225 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.7 t -111.91 143.36 21.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 43' ' ' THR . 14.2 t -118.84 121.49 40.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.756 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 169' ' ' PHE . 33.1 m -136.11 166.41 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.59 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.2 mtm -111.82 128.51 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.028 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 46' ' ' ILE . 10.9 tt -130.63 123.57 55.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.442 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.26 28.55 54.89 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.87 51.34 7.91 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -130.52 89.54 43.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.597 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 41.9 Cg_endo -74.72 103.9 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.135 1.89 . . . . 0.0 112.707 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 53.2 m-85 -162.01 174.81 12.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.564 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.754 HG22 HG22 ' A' ' 3' ' ' THR . 4.2 t -145.94 141.67 27.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.908 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.98 HD13 ' HB1' ' A' ' 172' ' ' ALA . 59.2 tp -107.84 129.24 55.09 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.607 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -96.48 119.58 6.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.596 HD23 ' SG ' ' A' ' 6' ' ' CYS . 71.7 mt -115.99 153.31 31.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.644 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.585 ' O ' ' CD2' ' A' ' 56' ' ' PHE . 46.2 t80 -135.52 32.66 3.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.446 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' O ' ' OG1' ' A' ' 58' ' ' THR . 49.5 p30 -80.44 -173.59 4.16 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.638 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 1.2 m 168.74 -58.06 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.371 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . 164.02 139.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.204 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 10' ' ' GLY . . . 53.47 -82.03 0.01 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 59' ' ' ALA . 39.2 mt-30 67.43 17.92 10.1 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.19 -72.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 65' ' ' ASP . 48.3 p30 -93.72 4.87 53.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.732 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.507 ' C ' ' O ' ' A' ' 63' ' ' ASP . 66.1 t80 18.54 -80.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.797 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 63' ' ' ASP . 21.3 t70 -141.63 151.33 42.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.538 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -56.75 -34.57 67.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.572 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.3 mt -91.23 136.73 32.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.232 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -128.54 69.5 79.23 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.737 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.13 146.99 25.92 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.769 2.312 . . . . 0.0 112.273 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.3 mt -60.63 -33.13 72.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.446 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.3 t 36.44 37.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.388 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 54.43 85.64 0.18 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.802 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.81 -63.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.557 2.171 . . . . 0.0 112.214 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 41.25 82.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.0 p -129.82 158.43 39.48 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.564 ' HB2' HD11 ' A' ' 4' ' ' ILE . 93.3 m-20 -121.84 -23.79 5.4 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.221 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.548 HG21 ' HB1' ' A' ' 175' ' ' ALA . 21.3 t -131.16 124.27 55.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.526 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.498 ' C ' HD12 ' A' ' 79' ' ' LEU . 97.5 m-85 -89.8 127.38 35.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.886 HD22 ' SG ' ' A' ' 6' ' ' CYS . 10.6 mp -104.64 135.58 45.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.814 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.554 HG11 HG23 ' A' ' 98' ' ' VAL . 41.3 t -117.83 131.94 69.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.794 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.64 135.82 53.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.306 0.574 . . . . 0.0 111.315 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.989 ' CG ' HG11 ' A' ' 93' ' ' VAL . 41.2 p90 -160.41 132.29 6.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.758 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.57 ' H ' HG11 ' A' ' 14' ' ' VAL . 75.7 p -59.0 135.98 57.8 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.447 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 84' ' ' VAL . 9.0 p -114.76 23.64 5.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.197 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.678 HG23 HD12 ' A' ' 119' ' ' LEU . 8.7 p -63.6 -38.06 81.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.273 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -133.77 155.78 80.05 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.562 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -59.79 -13.59 23.02 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.897 2.398 . . . . 0.0 112.684 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 m -66.16 -67.06 0.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.004 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.542 ' O ' HG12 ' A' ' 93' ' ' VAL . 59.3 m -60.61 -38.16 83.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.693 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' CZ ' ' OG1' ' A' ' 141' ' ' THR . 0.3 OUTLIER -60.03 -36.27 76.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.121 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' OE2' ' OE1' ' A' ' 95' ' ' GLU . 45.0 tp10 -81.91 -23.42 36.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.848 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.62 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 80.3 m-20 -85.84 5.46 32.6 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.989 HG11 ' CG ' ' A' ' 82' ' ' PHE . 1.5 p -119.07 -65.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.689 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.726 ' H ' HG13 ' A' ' 93' ' ' VAL . 74.0 mttt -54.8 -19.69 6.97 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.467 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' OE1' ' OE2' ' A' ' 91' ' ' GLU . 85.2 tt0 -113.89 -27.63 7.68 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -113.01 -40.31 3.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.62 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 47.4 m95 -90.63 -51.1 5.56 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.484 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.554 HG23 HG11 ' A' ' 80' ' ' VAL . 3.0 t -50.28 -58.9 8.27 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.4 Cg_endo -51.84 -39.13 68.61 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.652 1.568 . . . . 0.0 112.013 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.99 -43.79 98.32 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.015 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.2 mt -70.28 -36.56 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.494 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 105' ' ' CYS . 56.8 m -53.19 -43.33 67.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.852 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -63.39 -42.98 98.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.841 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.07 -42.39 98.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.63 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -103.97 161.57 22.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 0.0 111.204 -179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 41.5 Cg_endo -70.23 -157.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.856 2.371 . . . . 0.0 112.381 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -86.18 9.07 18.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.88 156.07 0.76 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.464 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.51 143.71 54.57 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.683 2.255 . . . . 0.0 111.821 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.752 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -129.72 114.84 16.48 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.852 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.95 122.72 27.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.424 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.603 HD13 ' CD2' ' A' ' 149' ' ' LEU . 27.5 tp -85.53 133.05 34.09 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.015 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.491 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -142.47 163.73 17.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.418 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.541 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -146.4 176.59 25.24 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 116' ' ' GLN . 9.2 p -127.94 179.93 5.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 117.191 0.496 . . . . 0.0 109.87 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.538 ' O ' ' C ' ' A' ' 117' ' ' ILE . 43.4 mt-30 37.36 33.64 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.687 HD12 ' H ' ' A' ' 118' ' ' ASP . 1.0 OUTLIER 23.82 -141.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.236 0 O-C-N 123.506 0.503 . . . . 0.0 111.149 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.687 ' H ' HD12 ' A' ' 117' ' ' ILE . 86.7 m-20 -86.65 -2.48 58.55 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.568 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.678 HD12 HG23 ' A' ' 85' ' ' VAL . 6.0 tp 178.11 45.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.677 0.275 . . . . 0.0 111.18 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 57.7 ttp180 26.34 69.53 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.6 ' O ' ' C ' ' A' ' 122' ' ' ASP . 18.0 t0 94.25 15.01 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.731 ' OD1' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -4.11 -64.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.45 0 O-C-N 123.456 0.472 . . . . 0.0 111.284 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.598 ' N ' ' O ' ' A' ' 121' ' ' ASP . 14.7 Cg_exo -30.76 -61.83 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.282 1.988 . . . . 0.0 112.6 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.4 p -108.36 -3.02 18.67 Favored 'General case' 0 C--N 1.337 0.055 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.869 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.572 HG21 ' O ' ' A' ' 119' ' ' LEU . 1.1 m -96.29 -24.96 15.96 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.731 HD12 ' OD1' ' A' ' 122' ' ' ASP . 11.6 tt -73.25 -47.02 48.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.903 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.548 ' N ' ' CG2' ' A' ' 126' ' ' ILE . 97.8 mt-10 -66.59 -37.83 85.72 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.483 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.68 -38.83 73.78 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.701 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 17.4 mt -52.26 -56.0 17.6 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.775 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 129' ' ' LEU . . . 149.62 1.43 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.292 0.37 . . . . 0.0 110.743 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 134' ' ' GLN . 51.3 mttp 71.7 -63.87 0.41 Allowed 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 122.895 0.478 . . . . 0.0 110.294 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -59.38 -25.17 64.04 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.731 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -89.33 1.25 56.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.468 ' OE1' HD11 ' A' ' 126' ' ' ILE . 1.3 pp0? -82.72 127.99 33.94 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.392 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.69 68.99 59.63 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.516 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.26 139.35 11.64 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 123.091 2.527 . . . . 0.0 113.042 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.537 ' O ' HG23 ' A' ' 137' ' ' ILE . 10.1 tt -127.96 112.67 28.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.161 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.874 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.2 OUTLIER -131.12 -45.74 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.684 ' CD ' ' H ' ' A' ' 138' ' ' THR . 56.9 Cg_endo -88.2 -62.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.585 2.19 . . . . 0.0 114.389 -177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 139' ' ' PRO . 95.9 mt-10 -29.76 -72.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.422 ' OG1' ' CZ ' ' A' ' 90' ' ' PHE . 23.1 p -127.8 7.92 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.874 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -83.5 -70.64 0.55 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.754 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -74.1 -40.58 62.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.632 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -62.13 -36.48 81.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.38 . . . . 0.0 111.445 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 145' ' ' LEU . 35.6 tp -72.26 -22.47 61.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.232 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.65 -33.26 75.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.089 0.471 . . . . 0.0 110.81 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -59.89 -45.93 90.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.336 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -84.94 -29.53 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.736 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.603 ' CD2' HD13 ' A' ' 112' ' ' LEU . 55.5 tp -43.21 -28.46 0.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.268 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.527 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 63.0 mttm 88.17 -0.13 0.42 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.647 0.379 . . . . 0.0 110.009 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.46 -132.49 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.194 0.521 . . . . 0.0 111.518 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 110' ' ' PHE . 3.7 t -151.84 -54.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.336 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -107.25 -167.76 1.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.348 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.616 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 34.2 p90 -161.95 97.13 1.03 Allowed 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.61 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.957 0.884 . . . . 0.0 111.613 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.562 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -153.39 96.93 2.09 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.572 ' HA ' HG22 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -112.83 145.49 40.56 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 123.274 1.511 . . . . 0.0 113.157 -176.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.673 ' HB3' HG23 ' A' ' 117' ' ' ILE . 13.6 t -173.35 90.19 0.08 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 111.707 -2.497 . . . . 0.0 107.168 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 57.07 29.38 16.41 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.619 ' C ' ' H ' ' A' ' 162' ' ' GLN . 21.2 tp -156.18 -85.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.693 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.9 OUTLIER -46.41 -9.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.798 HE21 ' H ' ' A' ' 27' ' ' LYS . 19.4 mt-30 -51.35 -1.58 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.693 ' H ' ' C ' ' A' ' 161' ' ' THR . 43.0 mttm -82.01 -2.69 52.47 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -116.45 -70.13 0.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 19' ' ' LEU . 43.1 tp -39.81 -16.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.826 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 164' ' ' GLY . 79.3 tttt -80.99 -53.51 6.37 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 164' ' ' GLY . 40.1 t-20 -71.15 -2.51 16.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.667 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 171' ' ' GLU . 29.6 t -78.3 -47.45 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.016 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 168' ' ' VAL . 63.0 t80 -39.12 -43.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.533 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.7 -37.82 88.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.36 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 168' ' ' VAL . 96.8 mt-10 -72.71 -20.82 61.15 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.049 0.452 . . . . 0.0 110.132 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.98 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -64.66 -36.73 85.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.742 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.425 ' CG1' ' N ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -62.04 -36.45 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.425 ' N ' ' CG1' ' A' ' 173' ' ' ILE . 45.3 tp -61.39 -35.01 76.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.016 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.548 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -60.55 -29.66 69.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.852 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.753 ' HA ' HD12 ' A' ' 4' ' ' ILE . . . -65.98 -31.62 72.63 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.943 0.401 . . . . 0.0 110.285 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 32.8 tp -57.17 -35.86 70.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.671 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.41 ' OE2' ' OD2' ' A' ' 76' ' ' ASP . 97.0 mt-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 99.99 110.44 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 176' ' ' ALA . 91.2 mt-30 73.23 45.39 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.667 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.668 HG22 ' HA ' ' A' ' 51' ' ' TYR . 11.4 p -84.01 157.22 21.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.117 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 76' ' ' ASP . 20.1 tt -134.12 152.9 34.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.821 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -103.04 146.79 27.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.036 0.445 . . . . 0.0 111.186 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -139.51 158.35 44.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.018 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.808 HG12 HG21 ' A' ' 75' ' ' THR . 12.2 p -127.6 134.4 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.771 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.665 HG11 HD21 ' A' ' 19' ' ' LEU . 13.6 t -110.98 133.81 55.31 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.812 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.3 t -114.62 132.47 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.225 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.37 123.34 7.76 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.538 ' OD1' ' NE1' ' A' ' 97' ' ' TRP . 25.5 t70 -82.76 121.48 26.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.602 0.239 . . . . 0.0 110.397 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.706 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 56.75 -0.82 0.14 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 82.12 125.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.745 HG23 ' H ' ' A' ' 15' ' ' GLY . 1.8 m -142.27 -88.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.816 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.745 ' H ' HG23 ' A' ' 14' ' ' VAL . . . -159.59 55.51 0.34 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.997 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.715 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.71 -34.64 78.31 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.673 -0.31 . . . . 0.0 111.339 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.1 m -52.18 -43.84 64.36 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.901 ' SG ' HD23 ' A' ' 28' ' ' LEU . 74.2 m -61.14 -26.97 68.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.168 0.509 . . . . 0.0 110.667 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.812 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -78.96 -35.91 42.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.173 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.64 HD11 ' HB3' ' A' ' 57' ' ' ASP . 81.4 mt -63.82 -36.09 82.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.487 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 28' ' ' LEU . 17.9 pt -98.78 12.85 5.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.616 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.579 ' CB ' HD13 ' A' ' 165' ' ' LEU . 13.1 p -48.36 -77.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.893 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.405 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 80.1 t80 -62.77 -38.06 89.11 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.582 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.424 ' C ' HG22 ' A' ' 25' ' ' THR . 0.6 OUTLIER -48.68 -44.69 38.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.265 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER 171.2 77.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.796 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -58.05 83.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 25' ' ' THR . 24.1 mttm -148.17 60.26 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.901 HD23 ' SG ' ' A' ' 18' ' ' CYS . 11.0 tp -123.34 68.56 39.06 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.78 -14.0 26.89 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.561 2.174 . . . . 0.0 112.246 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.9 p -67.78 120.8 14.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.945 0.403 . . . . 0.0 110.628 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -67.8 -32.67 73.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.145 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -56.66 -41.47 77.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.03 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 33' ' ' VAL . 65.1 t 54.06 70.38 1.75 Allowed Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.432 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -53.93 137.45 68.65 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.817 2.345 . . . . 0.0 112.61 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.0 m -128.45 140.36 51.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.6 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.66 HG13 ' N ' ' A' ' 37' ' ' PHE . 9.1 p -159.75 -52.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.789 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.66 ' N ' HG13 ' A' ' 36' ' ' VAL . 66.9 t80 -100.07 130.79 46.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.845 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 89.9 m-20 -75.83 136.9 40.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.495 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -111.48 148.27 33.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.784 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.421 ' H ' ' H ' ' A' ' 41' ' ' ALA . 26.8 p90 -176.14 -7.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.98 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' H ' ' H ' ' A' ' 40' ' ' TYR . . . -138.79 103.25 4.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.393 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.6 131.82 62.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.641 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 43' ' ' THR . 15.3 t -105.64 123.03 47.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.744 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.78 157.3 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.473 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 66.1 mtm -129.97 132.0 46.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.338 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.446 HG21 ' HB2' ' A' ' 170' ' ' ASP . 17.6 tt -135.17 131.77 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.97 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.37 26.57 51.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.55 58.43 3.86 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -136.23 101.36 10.21 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.43 103.19 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 122.266 1.977 . . . . 0.0 113.004 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.668 ' HA ' HG22 ' A' ' 3' ' ' THR . 52.6 p90 -154.12 169.7 22.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.832 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.495 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.0 OUTLIER -136.11 125.47 24.89 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.093 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.84 HD13 ' HB1' ' A' ' 172' ' ' ALA . 43.5 tp -107.86 121.16 44.18 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.221 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -94.42 134.41 12.01 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.956 HD12 ' H ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -140.95 117.96 11.18 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.493 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.542 ' HB2' HG23 ' A' ' 7' ' ' VAL . 10.9 t80 -65.97 -158.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.64 ' HB3' HD11 ' A' ' 20' ' ' LEU . 50.2 p30 -166.88 172.76 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.652 0.263 . . . . 0.0 110.63 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.702 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 0.3 OUTLIER 35.31 -157.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 110.836 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . 158.23 -50.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.271 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 61' ' ' GLN . . . -85.11 -175.78 50.63 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 60' ' ' GLY . 92.9 mt-30 35.31 -158.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 0.0 110.542 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.57 ' C ' ' H ' ' A' ' 64' ' ' TYR . 85.3 tt0 54.68 81.63 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.346 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 57.1 t0 55.11 -1.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.129 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.57 ' H ' ' C ' ' A' ' 62' ' ' GLU . 58.0 t80 61.05 111.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.36 . . . . 0.0 110.133 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -82.53 123.27 29.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.184 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -67.35 153.1 44.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.318 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 mt -73.23 147.78 44.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.541 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -122.93 80.75 50.25 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.617 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -52.33 -11.65 1.22 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.777 2.318 . . . . 0.0 112.205 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.2 146.33 39.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.667 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 72' ' ' TYR . 40.1 p -85.23 6.46 25.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.039 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.45 ' C ' ' O ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -34.39 -59.16 0.59 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.983 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 72' ' ' TYR . 37.0 Cg_endo -68.09 135.86 36.01 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.154 1.903 . . . . 0.0 111.885 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -121.6 122.01 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.797 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.808 HG21 HG12 ' A' ' 7' ' ' VAL . 54.1 m -126.65 127.51 45.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.529 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.512 ' CB ' HD11 ' A' ' 4' ' ' ILE . 85.4 m-20 -83.63 -36.22 24.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.68 122.86 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.291 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -84.97 123.3 30.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.365 0.602 . . . . 0.0 111.377 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.553 HD22 HG22 ' A' ' 8' ' ' VAL . 7.4 tt -115.39 130.76 56.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.754 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -118.4 135.53 58.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.152 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.741 ' SG ' HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -130.79 132.07 45.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 110.893 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.795 ' CD1' HG21 ' A' ' 93' ' ' VAL . 44.5 p90 -152.84 143.89 23.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.173 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.631 ' H ' HG11 ' A' ' 14' ' ' VAL . 14.0 t -53.12 132.22 37.91 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 138' ' ' THR . 0.0 OUTLIER -99.51 24.18 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.755 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -113.8 7.82 7.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.659 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.43 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -124.29 150.01 62.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.124 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.93 -38.31 3.02 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.43 2.087 . . . . 0.0 113.345 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.1 p -85.67 -18.62 32.67 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.43 ' OG ' ' OG ' ' A' ' 86' ' ' SER . 50.6 m -59.09 -35.2 72.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.746 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 90' ' ' PHE . 2.1 p90 -89.77 -29.25 18.81 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.381 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 90' ' ' PHE . 98.7 mt-10 -63.73 -31.93 73.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.714 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -80.56 -38.09 30.21 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.939 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.795 HG21 ' CD1' ' A' ' 82' ' ' PHE . 76.5 t -68.39 -62.78 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.554 ' HE2' HD21 ' A' ' 112' ' ' LEU . 19.7 mttt -70.69 -7.12 42.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 76.7 tt0 -131.37 -52.97 1.02 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -74.34 -42.54 59.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.538 ' NE1' ' OD1' ' A' ' 11' ' ' ASP . 96.5 m95 -88.58 -32.77 17.96 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.518 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -53.22 -45.03 98.54 Favored Pre-proline 0 N--CA 1.466 0.364 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.526 -178.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 12.8 Cg_exo -64.0 -45.12 10.97 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.259 1.973 . . . . 0.0 111.515 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.64 -40.78 80.05 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.793 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.22 -35.38 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.418 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.2 m -52.75 -39.46 62.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.162 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.22 -46.43 79.5 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.625 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -61.14 -44.95 96.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.908 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.9 87.57 48.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.531 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -51.59 -34.84 54.35 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.312 2.008 . . . . 0.0 112.212 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -143.55 112.31 6.54 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.602 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.606 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -171.08 151.81 3.3 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.292 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.62 142.49 98.01 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.308 2.005 . . . . 0.0 111.257 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.725 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -135.92 137.4 41.32 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.39 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 111' ' ' LEU . 6.6 mp -95.46 130.27 42.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.74 HD22 ' HB2' ' A' ' 146' ' ' ALA . 34.2 tp -97.05 127.45 43.03 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.7 t -146.29 167.46 7.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.655 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -142.59 170.92 24.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.499 ' O ' HG22 ' A' ' 84' ' ' VAL . 3.1 p -122.9 177.6 5.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.182 0.515 . . . . 0.0 110.115 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.701 ' O ' ' N ' ' A' ' 118' ' ' ASP . 83.2 mt-30 57.78 11.28 1.3 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.402 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.742 ' CG2' ' H ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 35.57 19.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.342 0 CA-C-O 120.979 0.419 . . . . 0.0 111.178 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 116' ' ' GLN . 2.4 p30 50.48 13.82 0.14 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.692 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.9 tp -144.12 -36.1 0.35 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 119.804 -0.758 . . . . 0.0 112.816 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.742 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 8.0 tpm_? -63.25 -53.75 48.07 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 125' ' ' THR . 81.2 m-20 -88.05 -11.28 47.64 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.167 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.813 ' OD2' HD12 ' A' ' 126' ' ' ILE . 0.9 OUTLIER -43.82 -61.76 1.8 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.903 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 122' ' ' ASP . 1.6 Cg_endo -46.32 -20.12 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.159 1.24 . . . . 0.0 109.846 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.467 ' N ' ' C ' ' A' ' 122' ' ' ASP . 0.4 OUTLIER -103.93 -64.2 1.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.478 179.05 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 121' ' ' ASP . 41.3 m -62.04 -41.4 98.08 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.694 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.813 HD12 ' OD2' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -76.44 -46.16 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.478 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.453 ' N ' HG22 ' A' ' 126' ' ' ILE . 84.8 tt0 -55.2 -38.32 68.23 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.699 -0.4 . . . . 0.0 112.015 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -63.29 -38.16 90.07 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.212 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.72 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 50.2 mt -47.73 -48.52 29.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.557 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . 86.67 22.68 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -133.97 77.48 1.71 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.712 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -51.98 -28.14 15.81 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -55.59 -34.41 64.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.348 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -54.71 144.32 22.49 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.344 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.459 ' H ' ' HD2' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -143.81 158.79 55.62 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 120.936 0.398 . . . . 0.0 111.187 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -62.88 150.38 88.55 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.967 2.445 . . . . 0.0 111.983 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.686 ' O ' HG23 ' A' ' 137' ' ' ILE . 15.5 tt -136.15 48.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.072 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.811 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 6.8 m -128.56 -30.5 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.811 ' CD ' ' H ' ' A' ' 138' ' ' THR . 79.7 Cg_exo -44.41 -59.7 1.03 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.691 1.594 . . . . 0.0 112.754 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -122.07 -35.14 3.21 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.73 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.7 m -53.98 -40.42 66.87 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.061 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.549 ' HB1' ' NZ ' ' A' ' 94' ' ' LYS . . . -80.18 -37.37 33.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.665 0.269 . . . . 0.0 111.265 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.2 -41.44 83.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.409 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.14 -42.42 99.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 110.513 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 89.3 mt -64.23 -34.12 77.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.326 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.74 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -73.73 -30.59 62.92 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.472 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -54.43 -38.26 66.07 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 149' ' ' LEU . 55.0 p30 -123.27 -26.56 4.27 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.59 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 5.9 tp -74.94 2.35 10.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.315 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.703 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 47.7 mttt 100.44 147.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.624 0.77 . . . . 0.0 110.384 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 155.25 -173.27 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.08 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 110' ' ' PHE . 46.3 t -150.35 -57.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.281 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -98.76 -176.36 3.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.656 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.619 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 31.6 p90 -170.62 97.13 0.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.958 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.461 HG22 ' C ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -161.3 -176.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.186 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.746 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.4 OUTLIER -148.18 96.08 2.57 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.838 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.721 ' SG ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -108.64 147.26 32.13 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 123.129 1.443 . . . . 0.0 113.058 -178.274 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.534 ' HB2' ' N ' ' A' ' 116' ' ' GLN . 5.3 t -165.94 90.98 0.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 111.64 -2.527 . . . . 0.0 106.102 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.813 ' HB1' ' H ' ' A' ' 28' ' ' LEU . . . 48.5 31.6 2.94 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.962 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.816 ' O ' ' N ' ' A' ' 162' ' ' GLN . 1.9 mt -153.46 -76.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.886 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.746 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 3.1 m -51.78 44.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.816 ' N ' ' O ' ' A' ' 160' ' ' LEU . 36.2 tt0 -72.7 8.47 1.46 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.707 ' H ' ' C ' ' A' ' 161' ' ' THR . 26.4 mttt -81.24 -6.31 58.73 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.16 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -126.89 -67.84 0.16 Allowed Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 106.648 -2.581 . . . . 0.0 106.648 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.721 HD12 ' SG ' ' A' ' 157' ' ' CYS . 4.7 mt -41.68 -7.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.652 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 164' ' ' GLY . 48.7 tttt -83.51 -45.49 13.53 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 164' ' ' GLY . 24.4 m120 -81.22 4.75 19.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.29 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 165' ' ' LEU . 58.2 t -86.8 -62.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.765 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 23' ' ' TYR . 78.4 m-85 -45.19 -40.44 7.21 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.217 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 46' ' ' ILE . 59.5 t0 -68.04 -42.96 79.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.203 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.99 -27.85 69.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.973 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.84 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -62.76 -32.29 73.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.92 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.513 HG22 ' CG ' ' A' ' 51' ' ' TYR . 1.1 pp -64.61 -27.21 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.338 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.84 -35.02 79.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.569 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.46 -28.93 62.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.839 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -59.46 -42.18 91.41 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.85 -25.93 66.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.411 . . . . 0.0 110.483 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 99.99 110.52 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 176' ' ' ALA . 63.7 mtt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' THR . 90.4 mt-30 -122.63 167.17 13.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.581 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -40.52 134.96 1.65 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.739 HD11 ' OD2' ' A' ' 76' ' ' ASP . 5.2 tp -123.79 144.6 32.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.727 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HA ' ' H ' ' A' ' 54' ' ' GLY . 91.2 mttt -100.88 153.83 19.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.272 0.558 . . . . 0.0 111.365 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -135.65 160.38 38.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.892 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.537 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 33.1 m -125.4 157.47 34.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.458 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.477 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 21.6 t -108.76 126.65 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.294 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.9 t -133.66 129.26 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.651 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.602 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . -164.59 -143.09 3.6 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.444 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.5 t0 -83.42 111.63 19.2 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 28.2 -90.3 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -131.23 126.8 36.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.071 0.462 . . . . 0.0 111.56 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -136.52 -174.4 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.303 178.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.471 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -65.08 42.24 0.11 Allowed Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 59' ' ' ALA . 37.1 mttt -62.05 -36.4 81.5 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.7 m -66.04 -48.85 69.71 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -62.37 -29.92 70.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.152 0.501 . . . . 0.0 110.727 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.597 HD21 HG11 ' A' ' 113' ' ' VAL . 57.7 tp -57.29 -41.36 79.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.858 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tt -66.99 -37.93 85.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 0.0 110.672 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 21' ' ' ILE . 93.4 mt -70.31 3.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.195 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.576 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 10.5 t -62.38 -74.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.864 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.614 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 0.7 OUTLIER -59.93 -31.06 69.49 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.234 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 6.7 m -52.04 -43.36 63.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.489 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -163.14 -38.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.377 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' A' ' 22' ' ' SER . 1.8 p30 43.55 95.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -152.92 13.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.4 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.691 HD11 ' HG3' ' A' ' 120' ' ' ARG . 5.1 tp 61.24 60.64 3.07 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.213 0.53 . . . . 0.0 110.519 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.35 -168.43 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.862 2.375 . . . . 0.0 112.003 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 m -56.71 151.04 14.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.455 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.76 -34.74 74.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -115.54 132.21 56.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.737 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.05 70.64 82.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.394 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.07 9.53 3.02 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.994 2.463 . . . . 0.0 112.678 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.1 m -51.5 -38.92 56.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.65 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.7 p -130.09 141.8 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.252 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -58.2 -49.5 76.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.279 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 51.3 p30 -176.14 157.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.544 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' LEU . 38.0 t-20 -124.45 169.27 12.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.55 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.492 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -178.36 11.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.172 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.24 100.31 3.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.857 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.413 HG11 ' OH ' ' A' ' 23' ' ' TYR . 42.2 t -134.87 134.17 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.217 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 43' ' ' THR . 14.8 t -119.44 126.64 51.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.422 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.76 144.88 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.676 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 73.8 mtm -105.76 123.53 48.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.14 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.4 mt -132.72 117.11 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.804 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.35 70.96 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.07 43.9 15.46 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' OE1' ' OD1' ' A' ' 170' ' ' ASP . 64.8 mt-10 -123.2 86.01 51.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.467 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 50.2 Cg_endo -76.9 102.02 1.57 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.211 1.941 . . . . 0.0 112.423 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 88.9 m-85 -155.46 170.39 22.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.965 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.492 ' H ' ' HB ' ' A' ' 3' ' ' THR . 3.4 p -134.8 142.83 46.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.159 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.785 HD22 ' HB2' ' A' ' 172' ' ' ALA . 46.0 tp -122.36 126.85 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.954 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -98.07 130.72 10.33 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.695 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.492 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 66.6 mt -116.76 123.41 47.09 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.532 ' O ' ' O ' ' A' ' 57' ' ' ASP . 34.9 t80 -91.15 32.13 1.05 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.961 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 56' ' ' PHE . 50.5 p30 -36.24 168.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.062 0.458 . . . . 0.0 112.059 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 58' ' ' THR . 46.4 m 59.8 53.67 4.72 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.174 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.595 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . . . -141.36 157.34 45.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.429 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' A' ' 64' ' ' TYR . . . 167.54 -42.73 0.24 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.41 -87.37 0.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.967 0.413 . . . . 0.0 111.204 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -64.0 -46.97 82.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.906 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -87.7 5.54 39.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.328 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.411 ' HA ' ' H ' ' A' ' 60' ' ' GLY . 76.2 t80 -45.8 -43.79 13.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.133 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 52.6 p30 -175.93 154.45 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.375 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.552 ' C ' HD22 ' A' ' 67' ' ' LEU . 93.7 mtt180 -107.35 -73.4 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.071 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.7 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -99.38 134.86 41.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.164 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -110.22 131.74 21.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.271 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.63 135.95 27.19 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.022 1.815 . . . . 0.0 112.128 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.8 -37.87 86.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.125 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.4 p -155.15 163.28 40.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.523 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 54.59 79.18 0.35 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.752 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.22 148.74 17.8 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.749 2.299 . . . . 0.0 111.945 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -83.55 8.61 13.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.978 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.7 t -131.09 150.63 52.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.739 ' OD2' HD11 ' A' ' 4' ' ' ILE . 88.1 m-20 -127.37 -15.69 5.08 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.639 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.12 107.56 13.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.941 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -74.04 135.29 43.06 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.721 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.468 HD11 HG21 ' A' ' 113' ' ' VAL . 7.9 tt -117.47 125.26 50.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.621 HG21 HD12 ' A' ' 112' ' ' LEU . 10.7 m -100.66 132.27 46.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.949 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.7 t -125.91 128.46 47.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.398 0.618 . . . . 0.0 111.675 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.549 ' HB3' HG21 ' A' ' 93' ' ' VAL . 12.8 p90 -153.44 157.63 40.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.511 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.52 ' OG ' ' CB ' ' A' ' 89' ' ' SER . 16.3 p -66.42 132.33 48.06 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -78.71 32.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.934 -177.341 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' A' ' 119' ' ' LEU . 32.6 m -121.62 160.78 22.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.075 0.464 . . . . 0.0 110.347 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -42.22 -58.61 3.34 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.199 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 89' ' ' SER . 20.0 Cg_exo -22.69 65.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 124.634 3.556 . . . . 0.0 115.984 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 86' ' ' SER . 50.5 m 34.02 10.76 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 87' ' ' PRO . 88.5 p -69.46 -33.67 73.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.388 0.54 . . . . 0.0 110.806 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.6 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 5.8 p90 -89.12 -41.38 12.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.202 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.6 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.7 tt0 -55.98 -34.17 65.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.267 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 96' ' ' LYS . 73.4 m-20 -85.75 -64.4 1.16 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.123 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 82' ' ' PHE . 52.7 t -49.67 -52.97 11.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.707 ' NZ ' HD21 ' A' ' 112' ' ' LEU . 23.3 mttm -67.37 -20.08 65.51 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 84.4 tt0 -126.61 -58.54 1.32 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 92' ' ' ASN . 14.7 tptp -60.49 -35.2 75.36 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 10' ' ' GLY . 42.2 m95 -84.16 -35.0 23.9 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.006 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -37.45 -54.53 2.1 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 20.0 Cg_endo -63.64 -36.5 52.4 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 121.271 1.314 . . . . 0.0 110.979 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 97' ' ' TRP . 48.2 tp10 -61.45 -43.91 98.04 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.042 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.9 mt -74.74 -35.3 36.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.812 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.7 m -50.49 -41.7 53.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.023 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -57.7 -39.9 78.24 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.363 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -58.37 -44.9 89.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.483 ' O ' ' OG1' ' A' ' 108' ' ' THR . 8.6 t -167.48 108.61 0.61 Allowed Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.49 150.56 22.09 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.199 1.933 . . . . 0.0 112.419 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 60.41 49.37 6.91 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.972 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -121.42 108.81 35.34 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.814 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -47.82 148.29 6.39 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.993 1.796 . . . . 0.0 111.441 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 152' ' ' VAL . 20.3 p90 -151.02 161.63 42.37 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.824 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.3 mp -96.6 127.51 42.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.347 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.707 HD21 ' NZ ' ' A' ' 94' ' ' LYS . 16.9 tp -88.77 119.86 29.64 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.643 HG12 ' N ' ' A' ' 114' ' ' GLY . 40.0 t -136.3 165.3 29.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 0.0 111.815 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.643 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -142.15 174.36 23.29 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 12.5 t -137.79 161.14 37.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.949 0.404 . . . . 0.0 110.451 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.648 HE22 ' NH2' ' A' ' 120' ' ' ARG . 44.8 mm-40 54.55 33.19 18.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.773 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.889 HG23 ' N ' ' A' ' 118' ' ' ASP . 7.2 tt 21.84 -138.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.424 0 O-C-N 123.544 0.527 . . . . 0.0 110.812 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.929 ' OD2' HG21 ' A' ' 125' ' ' THR . 23.7 p30 -87.07 83.49 7.46 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.277 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.667 HD23 ' CB ' ' A' ' 124' ' ' SER . 16.6 tp 56.75 42.5 26.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.023 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.691 ' HG3' HD11 ' A' ' 28' ' ' LEU . 50.6 ttm-85 51.03 65.79 1.37 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.152 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.642 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 59.3 t0 5.82 66.67 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.328 1.061 . . . . 0.0 109.979 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.654 ' O ' ' N ' ' A' ' 124' ' ' SER . 0.4 OUTLIER -107.15 -179.39 0.7 Allowed Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 113.097 -1.865 . . . . 0.0 107.861 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 127' ' ' GLU . 30.3 Cg_exo -59.62 35.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 121.257 1.304 . . . . 0.0 111.114 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.667 ' CB ' HD23 ' A' ' 119' ' ' LEU . 0.5 OUTLIER -115.53 -57.54 2.23 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.484 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.929 HG21 ' OD2' ' A' ' 118' ' ' ASP . 17.4 m -66.73 -33.63 76.06 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 127' ' ' GLU . 52.7 mt -88.95 -70.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 113.613 -1.63 . . . . 0.0 114.363 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 126' ' ' ILE . 76.9 tt0 -65.73 -32.16 73.55 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -91.9 -68.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.647 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 4.1 mm? -58.13 -33.17 68.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.433 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . 99.09 122.64 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -50.1 -35.83 27.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.749 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -86.86 5.55 36.26 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.905 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 134' ' ' GLN . 35.0 tttp -134.34 -6.6 2.6 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.959 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.571 ' HG2' HG22 ' A' ' 125' ' ' THR . 92.1 mt-30 -14.4 -71.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.533 0.521 . . . . 0.0 111.862 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.7 tptt 54.41 60.7 10.36 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.825 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -53.64 154.42 16.1 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.374 2.049 . . . . 0.0 111.41 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 84' ' ' VAL . 6.1 tt -76.77 43.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.609 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.49 -64.34 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.802 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 138' ' ' THR . 72.1 Cg_exo -22.52 -72.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 123.495 2.797 . . . . 0.0 113.485 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -102.45 -44.28 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.047 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.567 HG21 HG13 ' A' ' 137' ' ' ILE . 41.9 m -51.39 -46.26 62.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.518 ' HB1' ' NZ ' ' A' ' 94' ' ' LYS . . . -76.73 -38.57 54.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.825 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.444 ' CD ' ' O ' ' A' ' 139' ' ' PRO . 97.7 mt-10 -60.21 -39.47 86.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.255 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.96 -49.62 75.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 109.96 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 91.1 mt -57.56 -31.93 66.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.475 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.69 75.73 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.942 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -59.75 -35.38 74.47 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.611 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -49.56 -31.17 9.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.6 mt -126.68 -114.64 0.28 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.633 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -175.9 71.85 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.87 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . . . -61.01 -138.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.841 0.353 . . . . 0.0 110.628 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 110' ' ' PHE . 54.9 t -154.16 -50.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.829 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.541 ' NZ ' ' OE1' ' A' ' 171' ' ' GLU . 1.1 mmtm -114.41 -175.62 2.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.651 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.653 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -170.7 96.21 0.22 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.497 HG11 ' CD2' ' A' ' 165' ' ' LEU . 9.4 p -143.51 142.95 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.515 0.674 . . . . 0.0 111.245 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.736 ' O ' ' OG1' ' A' ' 161' ' ' THR . 3.6 pt-20 -119.92 96.19 5.07 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -120.25 131.11 54.8 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -176.165 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 160' ' ' LEU . 77.1 p -119.83 87.94 2.84 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 173.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 37.02 26.93 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.865 ' O ' ' N ' ' A' ' 162' ' ' GLN . 34.9 tp -133.64 -79.25 0.47 Allowed 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.467 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 4.6 m -45.59 49.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.865 ' N ' ' O ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -71.49 0.81 7.52 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 175.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.6 ' H ' ' C ' ' A' ' 161' ' ' THR . 8.7 mtmp? -58.86 -23.54 60.99 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 113.546 -1.661 . . . . 0.0 106.849 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -119.28 -65.99 0.29 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.497 ' CD2' HG11 ' A' ' 155' ' ' VAL . 0.5 OUTLIER -40.67 -10.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.647 ' N ' ' O ' ' A' ' 164' ' ' GLY . 41.8 tttp -91.52 -42.05 10.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.584 ' N ' ' O ' ' A' ' 164' ' ' GLY . 78.3 m-20 -81.98 -0.03 42.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.135 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.7 t -77.98 -57.82 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.614 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 46.8 m-85 -48.79 -43.54 38.16 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.686 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.763 ' O ' HG22 ' A' ' 173' ' ' ILE . 62.6 t0 -67.12 -49.48 64.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.205 0.526 . . . . 0.0 109.913 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.541 ' OE1' ' NZ ' ' A' ' 153' ' ' LYS . 87.5 tt0 -59.06 -25.54 63.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.785 ' HB2' HD22 ' A' ' 53' ' ' LEU . . . -55.02 -32.2 61.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.314 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 170' ' ' ASP . 3.6 tt -59.13 -30.08 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.7 tp -57.42 -38.54 74.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.1 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.528 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -71.8 -15.79 62.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 1' ' ' MET . . . -63.59 -32.28 73.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 110.562 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.02 -34.04 71.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.456 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.483 ' OE2' ' OD2' ' A' ' 76' ' ' ASP . 96.9 mt-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 99.99 110.561 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.469 ' HG2' HD12 ' A' ' 177' ' ' LEU . 59.6 mtm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' THR . 92.6 mt-30 -124.38 174.69 7.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.53 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.46 ' H ' HG23 ' A' ' 3' ' ' THR . 0.6 OUTLIER -38.48 133.56 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.16 -179.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.663 HD11 ' OD2' ' A' ' 76' ' ' ASP . 4.5 tp -131.06 152.21 37.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.336 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.507 ' HA ' ' H ' ' A' ' 54' ' ' GLY . 25.2 mttm -109.26 161.26 15.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.198 0.523 . . . . 0.0 111.504 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -122.85 144.96 48.86 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.457 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.5 145.28 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG23 ' NZ ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -68.0 128.12 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.05 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.524 HG11 HD13 ' A' ' 101' ' ' ILE . 44.8 t -141.77 128.45 19.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.788 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.53 -174.96 38.13 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.884 -1.151 . . . . 0.0 112.106 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.467 ' N ' HG22 ' A' ' 93' ' ' VAL . 60.5 t0 -90.96 124.24 35.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.973 0.416 . . . . 0.0 110.755 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -47.39 101.82 0.04 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 150.16 30.67 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.707 0.299 . . . . 0.0 110.871 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 82' ' ' PHE . 29.2 m -127.47 132.84 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.024 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.53 97.75 2.27 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.555 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' NZ ' HG23 ' A' ' 8' ' ' VAL . 23.4 mttm -83.0 -2.51 55.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.674 0.273 . . . . 0.0 110.964 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.2 m -65.93 -57.78 7.07 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.742 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.439 ' O ' HG22 ' A' ' 21' ' ' ILE . 92.3 m -68.73 -25.95 65.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.489 0.661 . . . . 0.0 110.14 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.668 HD12 ' SG ' ' A' ' 157' ' ' CYS . 7.4 tp -50.94 -56.15 13.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.641 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.539 HD13 HD22 ' A' ' 55' ' ' LEU . 55.2 mt -71.19 -35.09 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.83 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 18' ' ' CYS . 2.0 tt -47.7 -11.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.268 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.572 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -55.75 -76.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.318 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.572 ' N ' ' OG ' ' A' ' 22' ' ' SER . 49.7 t80 -56.59 -39.21 73.15 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.916 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -66.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 73.6 p -111.72 -23.57 10.55 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 25' ' ' THR . 31.6 t30 83.35 95.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.909 0.385 . . . . 0.0 110.658 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 26' ' ' ASN . 11.2 pttm 33.32 73.26 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.279 0.561 . . . . 0.0 111.574 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.26 79.45 70.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.414 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.89 146.69 77.82 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.912 2.408 . . . . 0.0 112.742 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -128.33 143.18 50.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.139 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.86 -36.61 72.58 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.734 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 33' ' ' VAL . 77.4 t80 -124.82 138.23 54.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.597 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.408 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 9.6 t -73.0 123.32 89.46 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.519 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.39 158.12 36.81 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.227 1.951 . . . . 0.0 112.057 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -76.97 157.03 31.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.437 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.38 156.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.83 156.83 29.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.186 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -73.94 88.57 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 110.357 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -144.77 108.73 4.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.673 ' CB ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -101.2 -24.71 14.21 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.27 95.53 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.352 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.654 HG21 HD11 ' A' ' 55' ' ' LEU . 55.4 t -134.81 137.59 50.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.232 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 43' ' ' THR . 6.8 t -120.41 133.98 55.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.726 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.428 HG21 ' CZ ' ' A' ' 23' ' ' TYR . 8.8 p -141.31 141.8 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.408 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.9 mtm -110.5 118.84 37.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.435 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.0 mt -129.14 119.57 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.554 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.94 25.85 73.22 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.22 48.54 14.6 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -131.87 105.27 14.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.59 100.09 1.2 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.132 1.888 . . . . 0.0 112.479 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.854 ' CD1' HD11 ' A' ' 173' ' ' ILE . 33.5 p90 -142.08 165.58 27.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.317 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.29 127.49 35.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.067 0.461 . . . . 0.0 111.812 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.678 HD13 ' HB1' ' A' ' 172' ' ' ALA . 62.8 tp -107.36 138.08 44.22 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.842 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -81.6 147.6 26.9 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.673 ' H ' ' CB ' ' A' ' 40' ' ' TYR . 48.3 mt -99.51 98.52 9.41 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.243 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 57' ' ' ASP . 7.9 p90 -55.54 -27.36 48.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.51 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 58' ' ' THR . 63.6 t0 -17.09 139.88 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.947 0.779 . . . . 0.0 112.578 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.54 ' CB ' ' O ' ' A' ' 57' ' ' ASP . 1.1 m 155.33 149.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.304 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.12 151.96 20.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.543 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.55 -174.06 38.19 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 62' ' ' GLU . 34.6 tt0 69.46 -132.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 77.2 tt0 36.47 51.36 0.86 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 38.8 t0 100.95 93.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.723 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -58.19 -33.93 69.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.877 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.36 145.34 55.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.637 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -118.71 153.53 34.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.8 tp -94.91 136.62 35.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.846 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.07 83.31 19.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.222 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.36 148.37 19.53 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.786 2.324 . . . . 0.0 112.549 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.37 -31.54 70.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.611 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.7 p -61.53 165.41 4.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -51.16 159.63 1.02 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.614 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.41 152.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.847 2.364 . . . . 0.0 112.181 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.503 ' O ' ' O ' ' A' ' 75' ' ' THR . 97.4 mt-30 -73.74 142.79 46.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.031 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 74' ' ' GLN . 59.8 p 44.43 -178.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.208 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.663 ' OD2' HD11 ' A' ' 4' ' ' ILE . 92.9 m-20 -123.3 -26.96 4.19 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.636 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.521 HG21 ' HB1' ' A' ' 175' ' ' ALA . 6.6 t -118.34 110.67 31.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.941 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -76.13 132.19 39.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.088 0.471 . . . . 0.0 111.52 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.488 ' CD2' ' CE1' ' A' ' 56' ' ' PHE . 4.1 mp -109.1 99.64 8.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.699 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 17.4 t -65.38 134.74 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.734 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.453 ' HB2' ' HZ3' ' A' ' 16' ' ' LYS . 19.0 t -123.85 130.32 52.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.427 . . . . 0.0 111.093 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.546 ' HA ' HG11 ' A' ' 14' ' ' VAL . 39.0 p90 -167.87 129.17 1.44 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.347 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.509 ' HA ' ' H ' ' A' ' 115' ' ' THR . 90.1 p -56.69 134.24 54.58 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.652 HG21 ' CB ' ' A' ' 156' ' ' GLU . 6.3 t -90.38 8.2 3.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.446 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.662 HG21 ' HG2' ' A' ' 120' ' ' ARG . 11.0 p -114.26 20.39 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.943 0.402 . . . . 0.0 110.163 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 t -139.61 137.7 19.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.196 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.494 ' O ' ' CD1' ' A' ' 90' ' ' PHE . 61.0 Cg_endo -73.76 -27.04 12.94 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.197 1.932 . . . . 0.0 113.224 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.2 p -81.6 -29.38 33.32 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -62.25 -37.42 85.36 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.612 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.528 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 2.0 p90 -91.25 -36.95 13.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.884 0.373 . . . . 0.0 111.328 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 85.6 tt0 -56.56 -38.43 71.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.182 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 96' ' ' LYS . 47.5 m-20 -90.0 -47.39 7.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.211 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 11' ' ' ASP . 42.9 t -57.31 -56.09 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.448 ' NZ ' HD13 ' A' ' 112' ' ' LEU . 35.0 mttm -71.32 -11.44 60.91 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -125.73 -65.78 0.98 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 92' ' ' ASN . 81.1 mttt -61.17 -33.31 73.22 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.412 ' CZ2' ' HA ' ' A' ' 11' ' ' ASP . 48.5 m95 -83.2 -31.47 27.06 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.777 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.2 t -40.77 -54.28 5.36 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.977 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 33.1 Cg_endo -66.11 -32.03 44.24 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.667 1.578 . . . . 0.0 111.51 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -61.62 -38.52 87.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.524 HD13 HG11 ' A' ' 9' ' ' VAL . 27.0 pt -94.42 -30.7 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.515 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' CYS . 55.4 m -60.28 -41.08 92.57 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.928 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -60.62 -39.13 87.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.556 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -57.26 -44.03 83.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.014 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -150.53 159.93 33.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 110.876 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.48 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 9.6 Cg_endo -55.32 155.86 18.89 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.877 2.385 . . . . 0.0 111.851 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -62.93 130.05 43.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.317 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.99 158.83 54.95 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.502 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.47 143.91 10.92 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.166 1.911 . . . . 0.0 112.064 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 151' ' ' ALA . 21.2 p90 -147.62 156.83 43.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.691 -0.804 . . . . 0.0 112.103 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 129.61 48.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.421 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.575 HD12 ' CD2' ' A' ' 154' ' ' TYR . 85.8 mt -84.26 132.12 34.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.498 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.615 HG11 HD21 ' A' ' 19' ' ' LEU . 44.3 t -144.69 151.47 15.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.048 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.502 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -145.36 176.21 24.5 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.625 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.509 ' H ' ' HA ' ' A' ' 83' ' ' SER . 9.2 p -121.66 179.13 4.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.572 ' N ' ' CB ' ' A' ' 158' ' ' SER . 98.7 mm-40 36.44 37.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.845 HG23 ' H ' ' A' ' 119' ' ' LEU . 5.8 tt 29.42 -150.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.435 0 O-C-N 123.071 0.232 . . . . 0.0 110.512 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.764 ' N ' HG23 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -108.76 11.09 26.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.845 ' H ' HG23 ' A' ' 117' ' ' ILE . 5.7 mp -139.22 12.19 2.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.981 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.662 ' HG2' HG21 ' A' ' 85' ' ' VAL . 25.4 ptt180 28.65 65.22 0.11 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.204 0.315 . . . . 0.0 110.18 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.55 ' O ' ' HB2' ' A' ' 122' ' ' ASP . 13.8 m-20 149.51 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.762 0.664 . . . . 0.0 111.111 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 121' ' ' ASP . 0.1 OUTLIER 94.37 -67.24 0.0 OUTLIER Pre-proline 0 C--O 1.222 -0.393 0 O-C-N 125.589 1.805 . . . . 0.0 109.706 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.497 ' CD ' ' O ' ' A' ' 121' ' ' ASP . 31.7 Cg_exo -57.48 -28.41 80.56 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 CA-C-N 121.32 1.507 . . . . 0.0 110.47 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.556 ' OG ' ' N ' ' A' ' 125' ' ' THR . 36.0 p -78.82 -67.69 0.72 Allowed 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.912 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.556 ' N ' ' OG ' ' A' ' 124' ' ' SER . 32.5 p -50.3 -11.57 0.07 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.651 0.739 . . . . 0.0 109.353 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.543 ' N ' ' C ' ' A' ' 124' ' ' SER . 13.5 mt -86.76 -70.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.294 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.473 ' N ' HG22 ' A' ' 126' ' ' ILE . 86.8 mt-10 -76.9 -41.01 45.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.052 0.453 . . . . 0.0 111.107 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' SER . 21.8 tttp -64.95 -15.83 62.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.834 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 29.8 tp -155.15 -82.41 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.327 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 125' ' ' THR . . . 168.91 -102.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.579 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.1 pttp 174.03 2.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.368 0.418 . . . . 0.0 111.967 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -80.13 -39.13 30.08 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.936 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -70.35 -44.19 68.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.679 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.473 ' O ' ' C ' ' A' ' 135' ' ' LYS . 99.6 mm-40 -55.94 -37.95 69.65 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.201 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER 32.99 87.95 0.1 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.74 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.4 139.98 28.06 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.363 2.042 . . . . 0.0 111.908 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.656 ' O ' HG23 ' A' ' 137' ' ' ILE . 15.3 tt -98.83 38.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.897 0.38 . . . . 0.0 110.596 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.698 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -119.6 -41.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.698 ' CD ' ' H ' ' A' ' 138' ' ' THR . 73.2 Cg_exo -47.97 -64.04 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.215 1.944 . . . . 0.0 113.262 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -105.9 -44.69 4.55 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.519 HG21 ' CG1' ' A' ' 137' ' ' ILE . 44.5 m -51.85 -43.3 63.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.762 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.77 -28.01 33.48 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.912 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.25 -44.13 95.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.03 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -63.86 -41.61 97.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.37 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 87.2 mt -61.31 -31.44 71.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.268 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.31 -40.49 70.78 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.46 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -56.48 -37.06 69.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.405 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.74 -25.35 10.87 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.3 mt -134.73 -115.12 0.2 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.844 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 151' ' ' ALA . 37.9 pttt 178.42 75.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.46 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.641 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . . . -56.04 -145.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.975 0.417 . . . . 0.0 111.843 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 110' ' ' PHE . 75.1 t -136.69 -56.03 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.978 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 24.6 tttt -125.46 -167.68 1.72 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.793 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.575 ' CD2' HD12 ' A' ' 112' ' ' LEU . 51.0 m-85 -156.67 96.71 1.66 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.32 139.52 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 122.148 0.975 . . . . 0.0 111.515 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.727 ' O ' ' OG1' ' A' ' 161' ' ' THR . 10.4 pt-20 -122.36 98.0 5.72 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.539 -1.664 . . . . 0.0 106.613 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.668 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -123.94 145.75 48.94 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 123.18 1.467 . . . . 0.0 113.112 -175.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.572 ' CB ' ' N ' ' A' ' 116' ' ' GLN . 10.0 t -173.22 93.89 0.1 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 112.013 -2.358 . . . . 0.0 107.831 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 50.21 38.74 18.08 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.332 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.742 ' O ' ' N ' ' A' ' 162' ' ' GLN . 22.1 tp -165.09 -82.17 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.031 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.727 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.8 OUTLIER -52.37 55.54 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.742 ' N ' ' O ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -80.42 15.8 1.52 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.545 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.605 ' H ' ' C ' ' A' ' 161' ' ' THR . 99.5 mttt -84.65 -3.44 58.51 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 113.751 -1.568 . . . . 0.0 108.426 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.45 -72.62 0.1 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -40.61 -16.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.366 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' A' ' 164' ' ' GLY . 81.2 tttt -84.57 -49.53 8.5 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 164' ' ' GLY . 81.3 m-20 -78.16 4.5 12.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.371 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.29 -58.73 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.2 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.477 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 94.4 m-85 -44.41 -44.7 8.57 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.521 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -69.38 -44.41 71.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.398 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.99 -25.17 68.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.15 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.678 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -56.46 -35.58 68.07 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.854 HD11 ' CD1' ' A' ' 51' ' ' TYR . 91.6 mt -55.19 -43.09 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 174' ' ' LEU . 8.0 mp -70.28 -36.18 74.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.002 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -63.63 -32.97 74.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.393 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.59 72.76 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 1' ' ' MET . 21.2 tp -59.32 -35.25 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.684 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 99.99 110.53 179.912 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -82.61 -48.09 11.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.288 0.566 . . . . 0.0 110.062 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.436 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.6 OUTLIER -107.83 150.27 27.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.6 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.693 HD11 ' OD2' ' A' ' 76' ' ' ASP . 11.0 tp -127.36 147.25 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.526 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -86.0 135.38 33.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.872 0.368 . . . . 0.0 110.539 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -135.94 130.9 34.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.283 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.423 HG23 ' HB ' ' A' ' 75' ' ' THR . 59.2 t -103.9 134.75 44.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.765 HG11 ' OD1' ' A' ' 57' ' ' ASP . 75.1 t -114.09 125.83 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.302 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.467 HG21 ' CZ3' ' A' ' 97' ' ' TRP . 13.3 p -136.94 146.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.486 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . -117.66 -157.44 10.68 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' HA ' ' HE1' ' A' ' 97' ' ' TRP . 51.3 p30 -74.09 24.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.067 0.46 . . . . 0.0 110.029 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 125.34 -77.32 0.38 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.86 94.9 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 110.472 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.406 HG11 ' H ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -120.04 169.56 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.389 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -69.05 56.46 0.57 Allowed Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -81.03 0.81 34.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.883 0.373 . . . . 0.0 110.255 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.8 p -69.16 -38.83 78.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.469 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.862 ' SG ' HG23 ' A' ' 33' ' ' VAL . 98.3 m -90.85 -14.54 31.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.136 0.494 . . . . 0.0 110.603 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.896 HD12 ' SG ' ' A' ' 157' ' ' CYS . 22.1 tp -59.8 -45.36 92.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.375 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD23 ' OD2' ' A' ' 57' ' ' ASP . 1.4 pp -74.07 -33.77 63.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 111.333 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 18' ' ' CYS . 52.6 mt -61.75 -5.72 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.346 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.492 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 43.7 t -44.82 -80.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.315 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -55.78 -38.33 69.77 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.535 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.592 ' O ' ' CB ' ' A' ' 25' ' ' THR . 3.7 m -44.54 -34.12 2.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.208 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' THR . 13.3 m 107.78 92.14 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.32 1.012 . . . . 0.0 109.839 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.634 ' ND2' ' HB2' ' A' ' 159' ' ' ALA . 27.8 t30 -110.22 -75.93 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.308 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt 57.95 43.42 21.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.246 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp 41.33 68.8 2.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.873 0.368 . . . . 0.0 110.248 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.48 157.15 22.11 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 123.014 2.476 . . . . 0.0 112.596 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 32' ' ' TYR . 20.2 m -56.91 -27.95 61.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.315 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -57.82 -2.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.265 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.539 ' H ' ' C ' ' A' ' 30' ' ' SER . 41.4 m-85 70.43 -116.01 0.1 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.145 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.862 HG23 ' SG ' ' A' ' 18' ' ' CYS . 7.1 p -125.28 79.45 66.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.482 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.53 154.08 44.41 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.663 2.242 . . . . 0.0 111.323 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -130.01 147.35 51.75 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.6 t -131.01 140.18 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.948 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -95.62 134.87 38.02 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.798 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 59.32 45.21 14.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.213 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LEU . 51.6 t-20 -97.79 124.03 41.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.346 . . . . 0.0 110.532 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.631 ' CG ' ' N ' ' A' ' 41' ' ' ALA . 17.4 p90 -165.28 -48.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.488 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.631 ' N ' ' CG ' ' A' ' 40' ' ' TYR . . . -77.99 104.36 8.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.635 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.75 126.2 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.324 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 43' ' ' THR . 12.6 t -82.6 127.38 33.3 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.259 0.552 . . . . 0.0 111.583 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.05 142.42 35.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.553 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.5 ptp -143.71 140.59 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.049 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.611 ' O ' ' N ' ' A' ' 48' ' ' GLY . 42.7 mm -119.81 102.85 13.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.238 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 20.98 43.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.719 0 O-C-N 123.784 0.678 . . . . 0.0 111.844 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -151.12 -76.64 0.02 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' OE1' ' OH ' ' A' ' 51' ' ' TYR . 6.5 mt-10 -153.8 161.83 28.23 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.367 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -84.45 139.26 7.84 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 C-N-CA 122.806 2.337 . . . . 0.0 113.197 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.561 ' HB2' HG21 ' A' ' 173' ' ' ILE . 42.4 m-85 -152.36 159.85 43.38 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.436 ' H ' ' HB ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -135.45 140.39 44.83 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.746 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.649 HD21 ' CD2' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -109.86 139.18 45.22 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.557 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -92.75 120.13 6.07 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.937 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.529 ' H ' ' CA ' ' A' ' 40' ' ' TYR . 57.9 mt -114.87 124.92 52.95 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 57' ' ' ASP . 25.3 t80 -115.48 34.44 4.91 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.765 ' OD1' HG11 ' A' ' 8' ' ' VAL . 72.2 m-20 -45.75 -177.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.147 0.499 . . . . 0.0 111.496 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.677 HG23 ' C ' ' A' ' 57' ' ' ASP . 1.7 p 76.59 147.98 0.1 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.936 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 64' ' ' TYR . . . 58.05 -173.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.118 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 148.36 -3.35 0.75 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.475 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 47.8 tt0 -179.33 76.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.581 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 149.93 -121.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.487 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 52.6 p30 -70.18 57.51 0.16 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 88.2 m-85 -35.98 -45.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.283 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 67' ' ' LEU . 52.9 p30 -171.22 166.8 7.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.507 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -58.7 -31.91 68.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.807 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.508 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 69.9 mt -79.43 148.08 32.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.628 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 157.07 82.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.667 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.18 -11.74 20.23 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.85 2.366 . . . . 0.0 112.115 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 41.6 tp -53.47 -35.91 61.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.939 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.6 p -62.11 155.69 23.56 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.181 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -131.97 78.07 70.41 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.037 0.446 . . . . 0.0 111.021 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.31 142.64 78.81 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.561 2.174 . . . . 0.0 111.471 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -108.72 133.93 52.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.747 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.423 ' HB ' HG23 ' A' ' 7' ' ' VAL . 6.2 t -135.98 153.42 51.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.977 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.693 ' OD2' HD11 ' A' ' 4' ' ' ILE . 85.5 m-20 -117.72 -19.28 9.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.47 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.437 HG12 HD13 ' A' ' 111' ' ' LEU . 23.0 t -127.2 114.56 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.556 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.15 126.0 34.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.293 0.568 . . . . 0.0 112.182 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 80' ' ' VAL . 6.8 tt -124.59 126.41 45.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.799 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.655 ' N ' HD23 ' A' ' 79' ' ' LEU . 22.7 t -117.67 136.45 54.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.863 ' SG ' HD22 ' A' ' 19' ' ' LEU . 17.7 t -130.62 129.64 42.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.364 0.602 . . . . 0.0 111.906 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.906 ' CD1' HG11 ' A' ' 93' ' ' VAL . 42.3 p90 -139.15 154.14 48.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.028 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.406 ' H ' HG11 ' A' ' 14' ' ' VAL . 32.0 t -67.98 134.0 49.99 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.204 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.792 ' O ' HG12 ' A' ' 84' ' ' VAL . 48.5 t -96.26 26.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.991 -0.683 . . . . 0.0 111.719 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.704 ' O ' HG12 ' A' ' 85' ' ' VAL . 62.9 t -122.58 12.87 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 0.0 110.953 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.2 m -137.34 145.32 49.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.009 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.436 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 60.4 Cg_endo -73.75 -20.79 19.64 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.26 1.973 . . . . 0.0 112.76 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.8 m -91.52 -25.22 19.36 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.916 -0.313 . . . . 0.0 111.771 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.3 m -64.03 -40.97 97.52 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.712 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 87' ' ' PRO . 2.7 p90 -85.13 -29.36 24.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.097 0.475 . . . . 0.0 110.808 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.94 -28.14 64.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.587 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 93' ' ' VAL . 11.0 m120 -87.53 -70.17 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.906 HG11 ' CD1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -31.95 -64.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.351 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.688 ' H ' HG13 ' A' ' 93' ' ' VAL . 16.0 mttp -64.49 -33.27 75.5 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -177.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 88.7 mt-10 -107.73 -63.59 1.29 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -62.02 -38.93 90.53 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.573 ' CZ2' ' O ' ' A' ' 10' ' ' GLY . 74.1 m95 -77.0 -30.58 55.98 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.376 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.469 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.4 t -45.72 -55.33 12.82 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 19.4 Cg_endo -60.03 -36.94 87.82 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.733 1.622 . . . . 0.0 111.717 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.486 ' OE1' ' CE3' ' A' ' 97' ' ' TRP . 85.2 tt0 -59.59 -44.29 93.41 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.724 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.4 mt -76.38 -31.37 20.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.204 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 105' ' ' CYS . 37.1 m -52.85 -37.63 60.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.999 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -49.58 -40.07 37.29 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.21 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.533 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 80.5 m80 -78.6 -20.54 50.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.052 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 6.8 p 39.13 58.6 6.01 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.791 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.79 133.36 12.6 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.794 2.329 . . . . 0.0 112.145 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -89.5 -1.13 57.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.957 0.408 . . . . 0.0 110.167 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.82 155.79 84.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.744 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.96 150.04 58.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.761 2.307 . . . . 0.0 111.98 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.729 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -129.65 131.15 46.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.688 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.3 mp -93.96 130.54 40.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.117 0.484 . . . . 0.0 111.877 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.464 HD13 ' CD2' ' A' ' 149' ' ' LEU . 50.4 tp -102.11 130.4 48.7 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.46 179.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.529 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.586 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -149.04 178.9 26.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 13.0 t -128.27 163.74 24.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.811 0.339 . . . . 0.0 110.298 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.602 ' N ' ' OG ' ' A' ' 158' ' ' SER . 96.9 mt-30 56.49 18.19 3.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.272 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.744 HG13 ' H ' ' A' ' 119' ' ' LEU . 15.7 pt 33.94 -150.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.363 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.452 ' OD1' ' C ' ' A' ' 118' ' ' ASP . 50.9 p30 -118.32 17.28 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.403 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.744 ' H ' HG13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -144.72 -36.14 0.32 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.245 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.737 ' H ' ' CG1' ' A' ' 117' ' ' ILE . 65.3 ttp85 -56.19 -48.96 75.34 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.812 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.596 ' HB2' HG21 ' A' ' 85' ' ' VAL . 10.9 t0 -43.64 -17.77 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 120' ' ' ARG . 5.3 m-20 13.38 -76.82 0.0 OUTLIER Pre-proline 0 C--O 1.222 -0.345 0 O-C-N 124.257 0.973 . . . . 0.0 112.395 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.573 ' N ' ' O ' ' A' ' 121' ' ' ASP . 78.4 Cg_exo -33.83 -30.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 CA-C-N 120.224 1.116 . . . . 0.0 111.589 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 122' ' ' ASP . 14.7 m -100.5 -33.38 10.36 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.8 t -100.58 -23.3 14.71 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.218 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 6.4 tt -82.49 -36.8 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.856 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -76.26 -35.85 58.75 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 120.727 0.299 . . . . 0.0 111.09 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.02 -65.79 0.94 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.406 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.412 ' CD2' ' OE1' ' A' ' 134' ' ' GLN . 39.4 mt -78.0 46.03 0.56 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.886 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -82.37 51.46 1.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.994 0.426 . . . . 0.0 110.066 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.6 mttp 63.87 72.39 0.47 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.389 0.614 . . . . 0.0 110.004 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -118.38 46.06 1.89 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.961 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 77.7 mttt 63.44 37.26 10.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.0 -178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.412 ' OE1' ' CD2' ' A' ' 129' ' ' LEU . 10.0 pt20 -158.82 162.78 37.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.232 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.71 155.35 80.51 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.002 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -49.91 173.88 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.426 2.084 . . . . 0.0 112.084 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.478 ' O ' HG13 ' A' ' 84' ' ' VAL . 82.6 mt -91.43 78.4 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.852 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -129.98 -48.19 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.646 ' CD ' ' H ' ' A' ' 138' ' ' THR . 59.7 Cg_endo -87.66 -67.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.416 2.078 . . . . 0.0 114.598 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 139' ' ' PRO . 77.7 mm-40 -31.55 -72.88 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.2 p -116.79 4.38 12.99 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.852 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -94.2 -65.2 1.0 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.512 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' THR . 84.2 tt0 -69.79 -41.49 75.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.219 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -66.68 -38.16 86.23 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.832 0.349 . . . . 0.0 111.462 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 145' ' ' LEU . 23.3 tp -74.73 -19.97 60.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.582 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.14 -36.71 77.74 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.178 0.513 . . . . 0.0 110.833 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -58.83 -41.16 86.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.236 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -89.96 -27.06 20.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.663 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 54.3 tp -44.52 -25.98 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.113 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.604 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 55.5 mttp 91.54 -0.93 0.17 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.898 0.479 . . . . 0.0 110.407 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -59.04 -136.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.327 0.584 . . . . 0.0 111.789 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -159.92 -36.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.278 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -110.31 -179.07 3.67 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.623 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 34.7 p90 -169.82 97.43 0.3 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.798 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.467 ' O ' ' CD ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -161.15 171.94 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.98 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.733 ' O ' ' OG1' ' A' ' 161' ' ' THR . 20.1 mm-40 -138.81 96.51 3.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.896 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -107.02 147.75 29.55 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 123.17 1.462 . . . . 0.0 112.51 -177.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.602 ' OG ' ' N ' ' A' ' 116' ' ' GLN . 0.3 OUTLIER -169.85 91.72 0.21 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 111.555 -2.566 . . . . 0.0 106.236 177.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.634 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . . . 43.35 21.59 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.221 -1.809 . . . . 0.0 109.503 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.78 ' O ' ' N ' ' A' ' 162' ' ' GLN . 0.5 OUTLIER -133.73 -84.05 0.45 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.585 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.733 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 1.2 m -53.66 46.86 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.725 0.641 . . . . 0.0 111.814 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.78 ' N ' ' O ' ' A' ' 160' ' ' LEU . 7.2 tt0 -80.44 9.39 5.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.594 ' H ' ' C ' ' A' ' 161' ' ' THR . 16.1 tttp -84.6 -5.41 59.3 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 112.781 -2.009 . . . . 0.0 108.435 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.671 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -129.9 -72.0 0.12 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 107.811 -2.115 . . . . 0.0 107.811 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.417 ' N ' HD22 ' A' ' 165' ' ' LEU . 4.3 mm? -38.75 -15.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.245 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.9 tttt -84.14 -47.68 10.63 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 164' ' ' GLY . 18.6 p-10 -79.41 4.99 13.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.028 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 171' ' ' GLU . 24.4 t -84.1 -52.65 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.892 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.649 ' CD2' HD21 ' A' ' 53' ' ' LEU . 4.4 m-85 -37.65 -48.17 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.501 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.418 ' O ' ' CG1' ' A' ' 173' ' ' ILE . 53.3 t0 -62.84 -37.52 87.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 168' ' ' VAL . 77.5 mm-40 -77.3 -30.07 54.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.196 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.42 -40.01 89.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.955 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.561 HG21 ' HB2' ' A' ' 51' ' ' TYR . 21.1 pt -67.41 -29.73 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.67 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.69 -36.73 77.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.04 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.96 -21.28 66.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -65.01 -32.54 74.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.609 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 41.8 tp -56.97 -36.05 69.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.405 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 99.99 110.559 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.584 ' O ' ' HB2' ' A' ' 176' ' ' ALA . 94.6 mt-30 42.28 -119.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.669 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -41.2 115.66 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.233 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 176' ' ' ALA . 18.3 tt -122.97 146.46 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.957 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 30.6 mttm -104.47 163.29 12.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.853 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.4 136.98 26.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.518 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.531 HG23 ' HB ' ' A' ' 75' ' ' THR . 57.4 t -77.48 131.22 35.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 79' ' ' LEU . 57.3 t -117.8 125.88 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.793 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 101' ' ' ILE . 21.9 m -135.64 159.77 39.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.797 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.69 -177.09 36.24 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.273 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB2' HG23 ' A' ' 93' ' ' VAL . 25.2 t70 -81.05 124.94 29.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.684 0.278 . . . . 0.0 110.463 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 36.03 39.56 0.31 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 55.2 124.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.629 HG23 ' SG ' ' A' ' 81' ' ' CYS . 1.4 m -120.91 -168.33 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.889 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.58 49.64 0.01 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 121.428 -0.415 . . . . 0.0 112.408 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.617 ' N ' ' O ' ' A' ' 14' ' ' VAL . 23.2 pttt -57.4 -39.69 76.67 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.455 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 54.1 p -65.49 -43.87 88.85 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.1 m -53.9 -24.63 16.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.1 0.476 . . . . 0.0 111.026 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.57 -39.04 70.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.222 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 42' ' ' VAL . 36.6 tp -63.29 -38.74 92.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.046 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.3 pt -87.5 5.23 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.788 ' CB ' HD13 ' A' ' 165' ' ' LEU . 38.7 t -59.06 -75.5 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.695 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -67.18 -39.52 86.41 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.957 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -49.27 -45.7 45.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.992 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 t 179.42 75.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.624 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 26' ' ' ASN . 6.8 p-10 -60.15 113.52 2.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.224 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 28' ' ' LEU . 85.5 mttt -150.86 50.03 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.295 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.632 HD12 HD21 ' A' ' 160' ' ' LEU . 3.9 mp 57.68 129.36 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.658 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 159' ' ' ALA . 73.6 Cg_endo -76.42 156.94 36.92 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.15 1.9 . . . . 0.0 111.905 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.9 m -117.07 146.96 42.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.328 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -56.51 -34.94 67.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.165 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -64.66 -33.51 76.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.544 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.7 t 48.18 69.54 2.63 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.431 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.494 ' O ' ' O ' ' A' ' 35' ' ' THR . 51.3 Cg_exo -50.56 -14.69 1.23 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.927 2.418 . . . . 0.0 112.16 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 50.03 171.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.702 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 38' ' ' ASP . 22.5 t -121.0 142.43 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.29 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -49.07 -30.11 5.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 109.802 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.548 ' H ' HG12 ' A' ' 36' ' ' VAL . 90.0 m-20 -58.73 160.11 6.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.438 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.594 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 81.6 m-20 -133.21 -8.06 2.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.954 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER 163.85 28.45 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.929 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.77 108.06 5.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 20' ' ' LEU . 22.8 t -130.0 130.18 66.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.793 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.31 106.22 14.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.958 0.409 . . . . 0.0 111.425 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.46 154.81 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.074 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.22 133.93 55.37 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.478 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.543 HG21 ' HB2' ' A' ' 170' ' ' ASP . 13.5 tt -129.65 126.89 63.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.523 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.18 25.93 60.66 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.32 50.05 7.79 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -130.43 79.03 73.17 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.741 0.305 . . . . 0.0 110.361 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.58 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 26.9 Cg_exo -58.77 108.87 0.44 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.883 2.389 . . . . 0.0 112.437 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 50' ' ' PRO . 64.3 m-85 -160.33 174.53 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.27 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 p -133.55 142.01 47.98 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.676 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.665 HD13 ' CB ' ' A' ' 172' ' ' ALA . 66.5 tp -116.22 126.73 54.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.717 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.09 134.43 11.68 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.277 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.532 ' HG ' ' H ' ' A' ' 57' ' ' ASP . 11.6 tp -113.79 119.89 38.9 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.708 ' O ' ' O ' ' A' ' 57' ' ' ASP . 63.2 t80 -91.26 8.83 33.97 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.708 ' O ' ' O ' ' A' ' 56' ' ' PHE . 36.2 p30 30.47 177.26 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.468 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 82.4 p -88.57 156.61 18.97 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.612 -0.68 . . . . 0.0 110.77 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.459 ' C ' ' H ' ' A' ' 61' ' ' GLN . . . -132.61 20.12 4.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.33 -1.67 2.49 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 59' ' ' ALA . 95.6 mt-30 -141.72 -172.18 3.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.442 . . . . 0.0 111.103 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 77.2 mm-40 43.5 55.16 5.03 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 18.9 t0 84.84 103.09 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -177.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -56.5 164.05 1.55 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.303 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -82.25 115.78 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.893 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -108.29 -1.68 19.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.586 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.404 ' C ' ' CG ' ' A' ' 68' ' ' ARG . 51.9 mt -103.25 137.43 41.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.638 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.756 ' H ' ' CD ' ' A' ' 69' ' ' PRO . 3.2 mtt180 -152.61 -43.2 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.737 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.756 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 17.0 Cg_exo -65.2 -19.86 62.66 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.37 2.047 . . . . 0.0 112.517 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 71' ' ' SER . 0.3 OUTLIER -95.18 120.3 35.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.843 0.354 . . . . 0.0 110.256 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.67 ' N ' HD13 ' A' ' 70' ' ' LEU . 79.5 p -150.86 163.58 38.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.525 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -127.53 159.78 63.99 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.269 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' O ' ' CG ' ' A' ' 76' ' ' ASP . 11.6 Cg_endo -57.69 -26.57 73.56 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.766 2.311 . . . . 0.0 112.088 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 5' ' ' LYS . 96.8 mt-30 -61.42 -29.18 69.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.475 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.531 ' HB ' HG23 ' A' ' 7' ' ' VAL . 48.2 p -98.12 66.93 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.461 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 73' ' ' PRO . 88.8 m-20 -101.97 0.87 35.94 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.519 ' CG1' HD13 ' A' ' 111' ' ' LEU . 45.5 t -125.28 110.66 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.408 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -70.81 134.81 47.67 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.228 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.596 ' HB3' HG22 ' A' ' 8' ' ' VAL . 8.3 tt -119.0 126.96 52.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.699 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 112' ' ' LEU . 24.7 t -97.01 132.77 40.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.086 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.629 ' SG ' HG23 ' A' ' 14' ' ' VAL . 42.5 t -128.59 118.82 23.63 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.323 0.583 . . . . 0.0 111.675 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 115' ' ' THR . 28.3 p90 -149.43 157.53 43.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.181 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.0 t -70.72 132.32 45.19 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.294 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 84' ' ' VAL . 50.4 t -56.17 -9.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.306 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.773 HG21 ' OG1' ' A' ' 125' ' ' THR . 27.1 m -127.18 169.47 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.508 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.646 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.5 OUTLIER -25.38 -68.16 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.826 -178.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.563 ' O ' ' CB ' ' A' ' 88' ' ' SER . 99.1 Cg_exo -28.09 74.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.841 3.027 . . . . 0.0 114.465 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 86' ' ' SER . 2.9 t 146.26 -11.46 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.624 0.577 . . . . 0.0 109.983 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 91' ' ' GLU . 0.7 OUTLIER 40.24 89.54 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' SER . 43.7 p90 -36.01 -26.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.824 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 89' ' ' SER . 97.2 mt-10 -62.05 -23.81 66.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.664 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.559 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 83.1 m-20 -80.23 -48.45 13.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.564 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 11' ' ' ASP . 56.0 t -77.63 -68.68 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.58 ' HE2' HD11 ' A' ' 112' ' ' LEU . 87.9 mttt -61.56 -15.1 35.61 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 78.1 mm-40 -129.06 -48.37 1.22 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -77.78 -35.69 51.31 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 69.1 m95 -99.13 -21.04 16.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.339 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -59.84 -41.79 87.45 Favored Pre-proline 0 C--N 1.333 -0.135 0 C-N-CA 120.119 -0.633 . . . . 0.0 109.955 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 4.1 Cg_exo -70.62 -38.42 5.93 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.703 2.269 . . . . 0.0 111.15 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.579 ' OE2' ' NH1' ' A' ' 68' ' ' ARG . 48.1 tp10 -59.08 -39.03 80.87 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.63 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 9' ' ' VAL . 34.3 pt -85.01 -34.12 8.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' CYS . 76.2 m -60.22 -36.83 78.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.019 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.588 ' ND1' ' O ' ' A' ' 99' ' ' PRO . 37.7 m80 -50.5 -32.69 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.222 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -55.7 -45.57 77.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.411 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -143.55 160.7 50.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 110.984 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.479 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 8.0 Cg_endo -52.79 163.57 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.938 2.425 . . . . 0.0 111.935 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -64.86 131.47 46.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.861 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.85 161.21 33.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.158 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -46.38 146.15 5.22 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.261 1.974 . . . . 0.0 111.844 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.546 ' O ' ' N ' ' A' ' 152' ' ' VAL . 19.1 p90 -147.26 156.89 43.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.744 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.519 HD13 ' CG1' ' A' ' 77' ' ' VAL . 8.0 mp -97.32 125.67 42.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.665 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.58 HD11 ' HE2' ' A' ' 94' ' ' LYS . 16.1 tp -96.21 122.61 39.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.469 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.3 t -130.24 150.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.053 0.454 . . . . 0.0 111.747 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.5 156.87 17.11 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -119.22 167.58 11.71 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.563 0.697 . . . . 0.0 111.978 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.603 ' O ' ' O ' ' A' ' 117' ' ' ILE . 97.0 mm-40 50.75 24.45 1.73 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.777 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.838 HG23 ' H ' ' A' ' 119' ' ' LEU . 4.8 tt 30.62 -156.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.79 ' N ' HG23 ' A' ' 117' ' ' ILE . 53.0 p30 -120.81 29.27 7.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.838 ' H ' HG23 ' A' ' 117' ' ' ILE . 34.9 tp -137.31 -38.65 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.069 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.559 ' H ' HG22 ' A' ' 117' ' ' ILE . 6.9 tpm_? -59.29 -63.56 1.26 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 123' ' ' PRO . 72.3 m-20 -48.34 -32.69 7.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.343 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.53 ' C ' ' O ' ' A' ' 121' ' ' ASP . 2.0 t0 7.08 -72.26 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 123.807 0.692 . . . . 0.0 112.675 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 121' ' ' ASP . 52.2 Cg_exo -35.04 -39.43 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.069 1.18 . . . . 0.0 111.484 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.2 p -115.88 -0.12 12.94 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.565 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.773 ' OG1' HG21 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -107.83 -29.6 8.98 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.101 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.16 -18.74 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.07 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -107.98 -32.69 7.46 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.752 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 129' ' ' LEU . 82.1 tttt -66.63 -42.61 86.5 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.954 0.797 . . . . 0.0 111.094 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.683 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 10.8 mp -41.24 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.719 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . 94.7 12.58 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' A' ' 134' ' ' GLN . 76.2 mttt -141.52 81.22 1.76 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.352 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -46.54 -29.79 1.95 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.414 ' N ' ' C ' ' A' ' 131' ' ' LYS . 57.5 tttp -58.42 -36.45 73.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.666 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 131' ' ' LYS . 85.6 mm-40 -63.18 153.19 35.23 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.066 0.46 . . . . 0.0 111.294 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.652 ' CD ' ' H ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -126.37 162.06 48.66 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.117 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.65 157.16 12.93 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.725 2.284 . . . . 0.0 112.326 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 137' ' ' ILE . 1.3 tt -104.92 46.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.209 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.593 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -131.15 -65.66 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.593 ' HD2' ' H ' ' A' ' 138' ' ' THR . 84.3 Cg_exo -23.92 -69.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.758 2.972 . . . . 0.0 114.489 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -113.37 -37.8 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.6 m -52.57 -40.22 62.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.732 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.423 ' CB ' ' HZ3' ' A' ' 94' ' ' LYS . . . -72.75 -28.87 62.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.672 0.272 . . . . 0.0 111.506 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.24 -38.24 88.47 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -63.35 -46.19 87.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 110.897 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 65.3 mt -54.29 -33.47 58.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.051 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.77 81.73 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.064 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -60.42 -41.58 94.26 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.667 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -51.65 -31.98 27.69 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.4 mt -131.23 -115.58 0.23 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.459 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.701 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 63.5 mttm -134.96 -142.03 0.18 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.219 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 150.88 177.98 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.386 0.429 . . . . 0.0 111.059 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 110' ' ' PHE . 94.0 t -145.66 -59.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.567 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 154' ' ' TYR . 16.4 mmtt -100.81 170.56 8.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.505 ' CG ' ' C ' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -173.2 97.36 0.12 Allowed 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.321 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.899 HG22 ' H ' ' A' ' 156' ' ' GLU . 2.7 p -170.42 -167.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.165 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.899 ' H ' HG22 ' A' ' 155' ' ' VAL . 96.1 mt-10 -106.88 166.56 10.5 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.578 ' HB2' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -178.29 119.91 0.09 Allowed 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 178.061 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 160' ' ' LEU . 16.4 t -156.77 94.77 1.48 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.508 -1.678 . . . . 0.0 107.022 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.566 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . 35.12 28.57 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.565 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.768 ' O ' ' N ' ' A' ' 162' ' ' GLN . 41.9 mt -142.8 -78.89 0.23 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.238 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.705 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.6 m -44.09 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.768 ' N ' ' O ' ' A' ' 160' ' ' LEU . 11.8 pt20 -72.07 10.25 0.78 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.705 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.1 tttm -62.14 -27.03 68.65 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.062 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.679 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -125.12 -63.62 0.18 Allowed Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.788 HD13 ' CB ' ' A' ' 22' ' ' SER . 4.1 mt -39.19 -13.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.416 -0.513 . . . . 0.0 112.181 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 164' ' ' GLY . 43.4 tttm -81.29 -46.55 14.59 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' GLY . 32.6 m-20 -83.33 6.56 19.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.102 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 165' ' ' LEU . 54.8 t -86.41 -57.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.376 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.659 ' HA ' HD22 ' A' ' 53' ' ' LEU . 27.2 m-85 -45.84 -45.78 15.18 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.247 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.543 ' HB2' HG21 ' A' ' 46' ' ' ILE . 55.8 t0 -69.69 -45.16 68.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.481 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.0 -25.41 64.5 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.665 ' CB ' HD13 ' A' ' 53' ' ' LEU . . . -61.97 -36.11 80.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.348 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 8.5 mm -60.75 -37.03 75.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 36.9 tp -58.46 -35.87 72.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.879 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.475 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -63.88 -24.25 67.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.073 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -61.04 -36.25 79.08 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.695 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.3 mt -59.42 -32.98 70.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.411 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 99.99 110.641 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttm . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.452 ' O ' ' CB ' ' A' ' 176' ' ' ALA . 8.3 tp-100 -56.23 -38.82 71.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.055 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.7 OUTLIER -49.76 132.41 22.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.105 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.677 HD11 ' OD2' ' A' ' 76' ' ' ASP . 3.9 tp -126.13 145.91 32.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.937 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -91.28 142.18 27.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.732 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -138.61 130.69 28.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.621 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG13 ' CB ' ' A' ' 56' ' ' PHE . 44.0 t -98.24 135.28 33.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.754 HG22 ' HB3' ' A' ' 79' ' ' LEU . 62.6 t -99.03 131.53 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.979 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.0 136.23 59.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.063 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' CA ' HG23 ' A' ' 58' ' ' THR . . . -148.94 -173.72 19.9 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 13' ' ' ALA . 54.6 t0 -80.3 118.3 21.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 29.87 -87.68 0.01 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -133.12 150.0 52.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.914 HG23 ' H ' ' A' ' 15' ' ' GLY . 8.5 m -153.7 -96.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.914 ' H ' HG23 ' A' ' 14' ' ' VAL . . . -137.76 19.52 3.32 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.037 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -39.13 -36.31 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.187 0.494 . . . . 0.0 111.832 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.0 p -65.31 -46.87 78.63 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.808 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -79.45 -35.87 39.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.453 . . . . 0.0 110.797 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.725 HD12 ' SG ' ' A' ' 157' ' ' CYS . 12.7 tp -58.32 -40.35 81.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.496 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.17 -37.81 78.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.368 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 21' ' ' ILE . 93.8 mt -70.19 -1.73 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.726 ' CB ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -29.36 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.634 -178.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.539 ' CE2' HG11 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -98.27 -12.33 21.69 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.546 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -48.61 -49.2 37.99 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.28 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.496 ' OG1' HD12 ' A' ' 28' ' ' LEU . 73.2 p -133.9 -16.01 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.532 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.585 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER 70.86 111.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 57.09 136.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.658 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.685 HD23 ' HD2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER 177.56 113.21 0.15 Allowed Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.245 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.685 ' HD2' HD23 ' A' ' 28' ' ' LEU . 66.6 Cg_exo -46.51 149.18 2.96 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.981 1.787 . . . . 0.0 112.316 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.8 t -58.27 -18.55 27.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.65 -34.13 57.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.859 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -119.69 126.8 51.98 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.845 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.84 157.38 38.16 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.53 66.07 3.74 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.673 2.249 . . . . 0.0 111.915 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.3 p -76.47 -15.95 59.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.229 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.0 -44.62 95.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.837 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -175.26 124.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 0.0 110.685 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -73.66 144.33 45.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.755 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -111.46 168.63 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.004 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.598 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 26.3 p90 -155.85 35.43 0.35 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.27 97.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.285 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.521 ' O ' ' OG1' ' A' ' 52' ' ' THR . 21.8 t -129.92 132.83 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.36 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 t -103.0 133.78 47.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.12 0.486 . . . . 0.0 111.219 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.539 HG11 ' CE2' ' A' ' 23' ' ' TYR . 19.1 m -132.44 156.48 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.951 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -113.37 123.93 51.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.985 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' GLY . 9.2 tp -134.6 137.63 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.103 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 34.09 28.29 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 82.53 47.03 6.16 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -128.22 83.6 65.64 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.166 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 59.2 Cg_endo -78.84 99.88 1.31 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.45 2.1 . . . . 0.0 112.674 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' A' ' 50' ' ' PRO . 62.4 m-85 -156.36 177.85 10.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.491 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.521 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 9.2 t -139.96 150.04 44.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.901 HD22 ' CB ' ' A' ' 172' ' ' ALA . 19.9 tp -118.11 128.39 54.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.86 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -86.31 138.02 15.52 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.813 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' A' ' 40' ' ' TYR . 81.2 mt -124.38 126.7 46.4 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.626 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.613 ' O ' ' O ' ' A' ' 57' ' ' ASP . 45.4 t80 -108.5 35.4 3.2 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.961 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 56' ' ' PHE . 90.6 m-20 36.79 178.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.566 HG23 ' CA ' ' A' ' 10' ' ' GLY . 98.4 m -64.77 132.08 48.59 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.606 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.84 149.04 33.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.643 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.84 157.69 7.28 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 43.28 -120.37 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.716 0.293 . . . . 0.0 110.433 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 64' ' ' TYR . 78.4 mm-40 45.69 85.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' OD2' ' OD2' ' A' ' 65' ' ' ASP . 36.6 t0 63.69 -4.5 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.958 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.584 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 65.3 t80 52.72 14.97 0.47 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.561 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.497 ' OD2' ' OD2' ' A' ' 63' ' ' ASP . 86.0 m-20 -65.16 155.12 35.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.533 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.437 HH21 ' H ' ' A' ' 70' ' ' LEU . 73.5 mtp180 53.75 96.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.0 tp -59.25 -37.57 77.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.332 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 -139.9 155.94 70.83 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.566 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.92 152.1 83.46 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.734 2.289 . . . . 0.0 112.28 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.437 ' H ' HH21 ' A' ' 66' ' ' ARG . 90.6 mt -58.3 -32.66 68.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.576 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 73.65 -8.4 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.676 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.602 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -58.46 -41.92 91.8 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.673 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 24.5 Cg_exo -60.42 147.87 92.57 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.452 2.101 . . . . 0.0 111.868 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -94.34 121.49 35.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.5 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 5.8 t -141.72 155.98 45.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.459 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.677 ' OD2' HD11 ' A' ' 4' ' ' ILE . 91.2 m-20 -122.76 -33.07 3.44 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.09 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.91 152.56 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.417 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 75' ' ' THR . 21.0 m-85 -120.83 160.53 23.22 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.754 ' HB3' HG22 ' A' ' 8' ' ' VAL . 7.9 tt -119.15 123.25 43.93 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.246 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.9 m -102.27 133.49 45.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.607 ' SG ' ' CG1' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -134.07 134.82 42.78 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 111.516 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 115' ' ' THR . 39.3 p90 -142.83 153.84 43.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.873 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.1 p -95.63 134.74 38.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.928 HG13 ' H ' ' A' ' 85' ' ' VAL . 5.4 p -49.23 -68.23 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.416 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.928 ' H ' HG13 ' A' ' 84' ' ' VAL . 7.6 p -56.17 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.533 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.0 OUTLIER 157.84 80.76 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.472 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -56.39 -36.13 96.94 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.506 2.137 . . . . 0.0 112.061 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 m -57.65 -38.02 74.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.192 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.3 p -71.21 -34.26 70.67 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.509 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.545 ' C ' ' CD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -70.48 -43.79 69.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 0.0 111.41 -179.315 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 96.8 mt-10 -61.48 -34.09 74.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.595 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 96' ' ' LYS . 28.0 m120 -89.75 -63.33 1.3 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.983 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.2 t -36.04 -62.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.255 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -70.44 -19.47 62.97 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.542 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 82.6 tt0 -124.87 -55.7 1.59 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 92' ' ' ASN . 19.3 tttt -74.99 -16.3 60.63 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -96.31 -50.32 4.83 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.123 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.47 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -43.04 -46.69 13.84 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.251 -178.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.542 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 15.7 Cg_exo -65.69 -39.55 20.39 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.049 1.833 . . . . 0.0 112.338 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.56 -36.26 83.2 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.404 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.631 HG13 HG23 ' A' ' 102' ' ' THR . 20.4 pt -89.83 -32.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.266 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.631 HG23 HG13 ' A' ' 101' ' ' ILE . 81.9 p -99.5 17.65 19.83 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.098 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -54.31 -46.45 72.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.494 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.66 -42.12 98.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.479 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.7 t -127.33 87.39 56.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.42 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.02 -27.98 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.312 2.008 . . . . 0.0 112.116 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -103.5 117.87 35.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.238 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 108' ' ' THR . 3.2 m -170.88 101.77 0.41 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.857 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.41 148.17 11.3 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.028 1.819 . . . . 0.0 112.008 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 151' ' ' ALA . 21.0 p90 -148.31 162.93 38.53 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.618 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.694 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.3 mp -91.14 129.58 37.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.806 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.4 tp -95.08 121.83 37.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.661 HG11 HD11 ' A' ' 19' ' ' LEU . 40.1 t -135.8 168.51 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.91 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.631 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -155.16 97.86 0.17 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.261 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 82' ' ' PHE . 2.6 p -51.47 177.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.92 0.39 . . . . 0.0 110.4 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.507 ' O ' ' C ' ' A' ' 117' ' ' ILE . 43.7 tp60 47.37 29.96 1.43 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.007 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.774 ' CD1' HD23 ' A' ' 160' ' ' LEU . 13.0 tt 27.43 -142.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 122.404 0.282 . . . . 0.0 110.367 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.744 ' N ' HG23 ' A' ' 117' ' ' ILE . 86.3 m-20 -88.24 3.32 49.91 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.882 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.617 ' H ' HG23 ' A' ' 117' ' ' ILE . 16.8 tp 137.34 90.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 124.572 1.17 . . . . 0.0 109.515 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.533 ' C ' ' O ' ' A' ' 119' ' ' LEU . 27.8 ttm180 15.44 58.88 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.986 0.804 . . . . 0.0 111.161 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER 165.12 -91.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.713 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 11.8 t0 105.68 -45.31 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 O-C-N 124.124 0.89 . . . . 0.0 111.219 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 71.3 Cg_endo -90.78 -34.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 121.227 1.284 . . . . 0.0 110.432 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 46.6 p -98.35 1.47 47.03 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.051 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.578 ' OG1' HD23 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -102.06 -27.02 13.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.094 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 62.3 mt -71.77 -42.47 70.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.697 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -75.84 -32.61 59.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.529 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -74.36 -42.5 59.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.011 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 131' ' ' LYS . 13.3 mt -50.32 -53.55 27.91 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.479 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 43.24 13.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mmtt -56.87 -72.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 45.0 t30 94.48 -39.33 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.574 ' O ' ' O ' ' A' ' 134' ' ' GLN . 28.1 mttt -99.51 -15.23 18.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.427 176.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.574 ' O ' ' O ' ' A' ' 133' ' ' LYS . 98.3 mt-30 34.32 -170.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.8 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.789 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 0.3 OUTLIER -145.05 -44.19 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.635 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.789 ' CD ' ' H ' ' A' ' 135' ' ' LYS . 1.8 Cg_endo -80.81 -157.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.108 2.539 . . . . 0.0 111.998 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.533 HG21 ' HB2' ' A' ' 90' ' ' PHE . 4.9 tt -114.14 112.78 41.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.249 0.547 . . . . 0.0 111.044 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.628 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -135.37 -66.06 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.256 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 141' ' ' THR . 48.7 Cg_exo -19.42 151.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 124.1 3.2 . . . . 0.0 114.329 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -48.05 -2.76 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.508 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.654 ' H ' ' C ' ' A' ' 139' ' ' PRO . 58.6 p -82.14 -8.37 59.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.92 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.63 -48.56 59.52 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.161 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.76 -31.11 72.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.691 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -57.71 -41.53 81.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.106 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.0 mt -49.07 -35.15 15.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.944 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.13 -37.87 69.35 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -63.81 -38.2 90.2 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.753 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -49.25 -35.27 17.2 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.38 -113.35 0.31 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.003 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.583 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 43.1 tttp -132.4 -117.46 0.21 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.913 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.587 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . . . 109.47 -162.96 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.133 0.895 . . . . 0.0 109.24 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 110' ' ' PHE . 50.7 t -149.26 -63.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.462 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.42 ' HZ2' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -86.89 -173.93 4.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.261 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.61 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 31.0 p90 -170.8 95.94 0.21 Allowed 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.743 HG13 ' N ' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -172.63 -169.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.167 -178.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.743 ' N ' HG13 ' A' ' 155' ' ' VAL . 77.1 mt-10 -153.14 114.81 4.26 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.309 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.725 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -121.29 138.11 54.39 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 122.474 1.13 . . . . 0.0 112.595 -177.346 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.473 ' C ' ' N ' ' A' ' 160' ' ' LEU . 37.7 t -145.57 93.96 2.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.005 -1.907 . . . . 0.0 106.659 176.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 39.61 30.54 0.06 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.986 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.867 ' O ' ' N ' ' A' ' 162' ' ' GLN . 58.2 tp -145.52 -86.61 0.11 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.281 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.563 ' C ' ' H ' ' A' ' 163' ' ' LYS . 1.5 m -44.7 41.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -176.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.867 ' N ' ' O ' ' A' ' 160' ' ' LEU . 13.1 pt20 -69.4 -0.79 6.92 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 161' ' ' THR . 63.9 mttp -56.84 -28.64 61.9 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 113.815 -1.539 . . . . 0.0 107.663 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.627 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -114.84 -65.21 0.41 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.726 HD12 ' CB ' ' A' ' 22' ' ' SER . 0.5 OUTLIER -42.52 -6.92 0.01 OUTLIER 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' A' ' 164' ' ' GLY . 38.2 tttt -92.85 -44.47 8.46 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 164' ' ' GLY . 33.3 m120 -81.73 -1.72 48.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.013 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.427 HG21 HD22 ' A' ' 165' ' ' LEU . 22.0 t -71.95 -52.28 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.449 ' CZ ' HD11 ' A' ' 55' ' ' LEU . 38.9 m-85 -55.79 -40.73 73.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.335 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.469 ' OD1' HG21 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -69.01 -47.8 64.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.497 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.56 -25.98 59.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.942 0.401 . . . . 0.0 111.215 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.901 ' CB ' HD22 ' A' ' 53' ' ' LEU . . . -52.03 -46.43 65.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.0 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.434 HG21 ' HB2' ' A' ' 51' ' ' TYR . 10.9 pt -66.2 -36.47 77.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.4 tp -61.37 -35.27 77.0 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.51 68.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.176 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -58.79 -30.68 67.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.871 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 31.0 tp -53.32 -37.51 62.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.483 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 99.99 110.665 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' HB1' ' A' ' 176' ' ' ALA . 86.3 mtp . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -85.71 -75.28 0.38 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.532 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.451 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.5 OUTLIER -73.4 134.81 44.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.971 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.433 ' HA ' HD12 ' A' ' 4' ' ' ILE . 10.5 tp -126.45 152.22 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.609 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 75' ' ' THR . 25.0 mttm -104.15 149.02 25.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.201 0.524 . . . . 0.0 111.342 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 128.09 46.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.835 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.72 HG23 HG21 ' A' ' 75' ' ' THR . 84.9 t -98.92 139.45 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.456 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.48 HG21 ' CA ' ' A' ' 57' ' ' ASP . 86.8 t -95.66 136.59 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.031 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.571 HG11 ' CG1' ' A' ' 101' ' ' ILE . 22.8 t -119.79 137.58 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 12' ' ' GLY . . . 81.85 -81.33 1.68 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 52.9 t0 63.8 -52.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.705 0.288 . . . . 0.0 110.614 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.694 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 93.19 -9.42 74.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 90.88 -4.54 0.26 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.766 0.317 . . . . 0.0 110.698 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.4 146.04 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.813 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 17' ' ' THR . . . 122.04 -53.56 0.72 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.436 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HD3' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -41.87 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.615 ' N ' ' O ' ' A' ' 15' ' ' GLY . 58.3 p -61.99 -43.65 98.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.412 ' HB3' ' H ' ' A' ' 159' ' ' ALA . 20.8 m -127.11 0.53 6.49 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.382 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.011 HD13 ' SG ' ' A' ' 157' ' ' CYS . 0.3 OUTLIER -93.43 -52.11 4.66 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.138 178.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 20' ' ' LEU . 47.2 tp -52.08 -37.33 53.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.046 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.9 tt -92.03 3.91 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.94 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.6 p -38.61 -80.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -72.14 -29.25 63.86 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 119.603 1.092 . . . . 0.0 111.215 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.7 m -41.96 -47.38 4.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.924 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.551 HG21 HD13 ' A' ' 28' ' ' LEU . 85.9 m -119.58 -8.91 9.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.881 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.554 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 40.9 t-20 55.68 94.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.303 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 59.84 86.71 0.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.375 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.551 HD13 HG21 ' A' ' 25' ' ' THR . 30.8 tp -127.94 68.86 76.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.996 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.38 128.94 16.14 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.287 1.992 . . . . 0.0 111.935 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -149.93 144.8 26.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.711 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.13 -34.07 76.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.464 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.49 140.41 49.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.391 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG11 ' HB ' ' A' ' 17' ' ' THR . 48.3 t -124.69 79.51 62.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.1 141.99 67.43 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.601 2.201 . . . . 0.0 111.674 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 36' ' ' VAL . 69.6 p -69.3 -23.92 63.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.295 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 37' ' ' PHE . 9.7 t 37.69 -124.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.413 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.563 ' N ' HG12 ' A' ' 36' ' ' VAL . 95.7 m-85 -113.61 147.42 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.341 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -68.36 135.65 52.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.398 . . . . 0.0 110.4 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -105.58 138.35 41.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.972 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.583 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 13.0 p90 -175.51 4.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.095 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.38 99.63 2.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.609 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.89 138.11 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.631 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t -100.37 115.17 29.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.414 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -136.47 145.05 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.008 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 72.2 mtm -102.3 128.18 48.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.778 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 170' ' ' ASP . 12.8 tt -124.18 125.53 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.469 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.14 24.71 44.82 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.9 56.55 5.3 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -141.76 91.29 8.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 30.5 Cg_exo -58.63 103.59 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.57 2.18 . . . . 0.0 112.683 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' CD2' HD13 ' A' ' 173' ' ' ILE . 89.2 m-85 -159.86 161.19 34.39 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.451 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.7 p -132.31 143.67 50.04 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.885 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.8 HD13 ' HB1' ' A' ' 172' ' ' ALA . 59.2 tp -120.55 139.12 53.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -110.65 123.61 6.67 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.629 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.583 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 62.0 mt -109.36 131.58 54.93 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.626 0.25 . . . . 0.0 110.478 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.602 ' O ' ' CD2' ' A' ' 56' ' ' PHE . 41.2 t80 -113.67 31.11 6.73 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.556 ' CG ' ' H ' ' A' ' 58' ' ' THR . 33.0 t0 -54.06 -154.5 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.183 0.447 . . . . 0.0 110.937 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.556 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 11.3 m 65.56 -70.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.653 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . -67.45 146.57 53.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.523 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . 151.18 38.55 0.03 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.396 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -116.46 -178.68 3.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 83.9 tt0 -110.42 128.29 55.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 21.2 t0 92.61 -4.85 0.16 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.455 ' C ' ' O ' ' A' ' 63' ' ' ASP . 51.3 m-85 30.95 96.47 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.136 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.8 -35.38 74.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.952 0.406 . . . . 0.0 110.327 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 37.3 mtm105 -56.63 147.05 23.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.707 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.3 mt -89.79 139.16 30.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.297 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 4.6 mmm180 51.66 65.53 6.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.274 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 35.3 Cg_exo -55.43 143.05 79.04 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.835 2.357 . . . . 0.0 112.638 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.1 mt -101.52 139.77 36.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.962 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.3 p -121.11 150.45 41.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 110.795 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -131.97 68.76 80.63 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.772 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.38 -19.84 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.94 1.76 . . . . 0.0 112.257 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.94 71.93 6.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 110.207 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 5' ' ' LYS . 26.2 m -146.65 131.68 18.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.118 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.8 ' OD1' HG23 ' A' ' 77' ' ' VAL . 46.4 p30 -115.07 6.56 15.22 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.506 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.8 HG23 ' OD1' ' A' ' 76' ' ' ASP . 40.6 t -121.47 110.5 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.964 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -87.26 120.42 28.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 110.468 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tt -119.39 127.55 53.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.315 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.86 128.44 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.474 ' SG ' ' CG2' ' A' ' 115' ' ' THR . 0.0 OUTLIER -134.34 147.72 50.61 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.356 -179.296 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.49 ' CG ' HG21 ' A' ' 93' ' ' VAL . 24.9 p90 -170.63 146.55 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.672 ' OG ' HG12 ' A' ' 85' ' ' VAL . 30.4 t -62.86 127.25 30.36 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.618 HG21 ' CD ' ' A' ' 156' ' ' GLU . 3.9 t -76.31 30.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.672 HG12 ' OG ' ' A' ' 83' ' ' SER . 14.9 p -130.04 141.62 45.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.974 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER 83.99 142.16 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.492 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.08 -3.3 13.4 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.529 2.152 . . . . 0.0 112.563 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.9 m -91.64 -38.61 12.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.7 p -60.91 -34.04 74.07 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -82.78 -41.84 18.65 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.998 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 83.8 tt0 -60.26 -30.32 69.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.623 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 86.7 m-20 -66.24 -43.36 86.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -92.24 -70.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -177.786 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.708 ' O ' HD21 ' A' ' 149' ' ' LEU . 24.7 mttt -52.78 -16.19 0.93 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 95.6 mt-10 -130.31 -52.88 1.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -73.63 -47.43 40.15 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.623 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 63.9 m95 -81.74 -30.19 32.57 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.134 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 93' ' ' VAL . 2.5 t -44.78 -56.48 8.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.835 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.52 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 12.0 Cg_endo -57.39 -37.21 98.21 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.428 1.419 . . . . 0.0 110.915 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.44 -40.92 98.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.78 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.571 ' CG1' HG11 ' A' ' 9' ' ' VAL . 86.8 mt -68.21 -39.7 81.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 105' ' ' CYS . 47.8 m -54.81 -44.36 73.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.561 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -66.2 -41.11 90.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.973 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -58.03 -46.45 85.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.547 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -141.79 162.77 44.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 111.072 -179.471 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.457 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 59.1 Cg_endo -73.61 -155.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.997 2.464 . . . . 0.0 111.783 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -81.36 120.95 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.827 0.346 . . . . 0.0 110.451 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.606 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -153.45 156.81 32.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.065 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.73 132.0 44.23 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.151 1.9 . . . . 0.0 111.483 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.747 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -133.55 132.11 40.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.9 mp -86.34 128.49 34.94 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.935 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.885 HD22 ' HB2' ' A' ' 146' ' ' ALA . 34.9 tp -92.7 130.66 38.25 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.59 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 21.8 t -142.26 160.06 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.911 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.532 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -136.09 165.66 24.85 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.474 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 1.0 OUTLIER -129.9 172.46 11.66 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.44 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.725 ' O ' ' N ' ' A' ' 118' ' ' ASP . 67.6 mt-30 50.15 24.2 1.37 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.472 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.594 ' O ' ' CB ' ' A' ' 118' ' ' ASP . 0.4 OUTLIER 21.36 32.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 116' ' ' GLN . 15.7 t0 93.95 48.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.673 -0.642 . . . . 0.0 110.143 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 121' ' ' ASP . 0.5 OUTLIER 77.43 87.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.942 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' A' ' 119' ' ' LEU . 43.4 ptt85 7.72 56.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 O-C-N 124.321 1.013 . . . . 0.0 112.272 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' A' ' 119' ' ' LEU . 0.5 OUTLIER 173.97 -91.53 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.834 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 8.7 t0 104.22 -46.41 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 123.999 0.812 . . . . 0.0 110.876 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 52.5 Cg_endo -92.32 -41.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 121.727 1.618 . . . . 0.0 109.955 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.448 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 75.8 m -89.78 -1.0 57.89 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.5 ' HB ' ' H ' ' A' ' 122' ' ' ASP . 1.1 m -85.32 -35.23 21.57 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.29 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 mm -67.04 -42.12 88.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.473 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -72.49 -33.0 66.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.856 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -72.0 -45.41 61.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.867 0.365 . . . . 0.0 111.04 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 129' ' ' LEU . 81.1 mt -60.45 -40.15 90.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.68 24.33 8.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.885 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.42 ' C ' ' N ' ' A' ' 133' ' ' LYS . 33.6 mttm -127.44 77.22 1.73 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.015 0.436 . . . . 0.0 110.906 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -49.66 -28.08 5.47 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.42 ' N ' ' C ' ' A' ' 131' ' ' LYS . 22.1 mttt -61.45 -17.99 56.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.203 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -60.76 157.18 15.39 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.033 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -120.49 75.42 25.11 Favored Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.139 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.87 156.34 39.13 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.665 2.243 . . . . 0.0 111.873 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.546 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 3.2 tt -125.12 92.84 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.973 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.524 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -133.38 -69.23 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 1.5 Cg_endo -38.61 -84.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 123.413 2.742 . . . . 0.0 113.939 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 144' ' ' LYS . 96.9 mt-10 -110.55 -36.12 5.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.387 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.435 ' O ' HD13 ' A' ' 145' ' ' LEU . 8.4 p -44.87 -43.14 8.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.522 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.5 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -70.78 -58.18 3.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.57 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.6 -35.53 73.04 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 140' ' ' GLU . 19.4 tttm -58.24 -43.91 88.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 7.5 mp -66.85 -29.3 69.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.368 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.885 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -70.89 -30.94 67.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.707 0.289 . . . . 0.0 111.488 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.438 HH21 ' HG3' ' A' ' 144' ' ' LYS . 60.1 mtm180 -59.62 -36.55 76.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -119.56 -34.88 3.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.708 HD21 ' O ' ' A' ' 94' ' ' LYS . 13.1 tp -67.02 -3.27 6.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.575 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.729 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 67.4 mttm 98.95 150.2 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.495 0.718 . . . . 0.0 109.685 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 157.08 -172.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.755 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.686 HG23 ' H ' ' A' ' 110' ' ' PHE . 28.7 t -144.68 -53.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.605 ' NZ ' ' OE1' ' A' ' 171' ' ' GLU . 15.6 mmtt -95.53 -177.21 4.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.131 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.608 ' CD1' ' N ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -168.12 93.82 0.37 Allowed 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.704 HG22 ' H ' ' A' ' 156' ' ' GLU . 0.8 OUTLIER -172.6 -167.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.383 -178.24 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.704 ' H ' HG22 ' A' ' 155' ' ' VAL . 41.9 mt-10 -139.34 -165.43 1.86 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.158 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 1.011 ' SG ' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -174.95 120.0 0.2 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.139 0.971 . . . . 0.0 111.717 178.723 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 160' ' ' LEU . 42.6 t -165.99 91.08 0.46 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 33.67 30.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.092 -1.867 . . . . 0.0 109.085 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.614 ' C ' ' H ' ' A' ' 162' ' ' GLN . 16.0 tp -157.65 -74.73 0.09 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.48 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.721 ' C ' ' H ' ' A' ' 163' ' ' LYS . 7.4 m -64.54 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.126 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.614 ' H ' ' C ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -80.3 23.28 0.49 Allowed 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 175.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.721 ' H ' ' C ' ' A' ' 161' ' ' THR . 16.2 tttp -74.6 -4.38 36.8 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 112.665 -2.061 . . . . 0.0 108.297 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.715 ' O ' ' N ' ' A' ' 167' ' ' ASN . . . -120.71 -54.77 0.24 Allowed Glycine 0 C--O 1.221 -0.661 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.565 ' H ' ' CD2' ' A' ' 165' ' ' LEU . 4.0 mm? -34.16 -23.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.654 0.264 . . . . 0.0 110.845 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.67 ' N ' ' O ' ' A' ' 164' ' ' GLY . 28.2 tttp -77.95 -46.99 19.62 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.715 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.8 m120 -79.65 10.68 3.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.051 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 171' ' ' GLU . 53.2 t -96.44 -63.25 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.048 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 168' ' ' VAL . 13.1 m-85 -38.9 -43.1 0.92 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.784 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 54.1 p-10 -68.88 -38.08 79.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.547 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.63 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 34.8 tt0 -68.67 -24.85 64.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.028 0.442 . . . . 0.0 110.144 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.8 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -61.83 -32.38 72.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.26 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.491 HD13 ' CD2' ' A' ' 51' ' ' TYR . 61.9 mt -59.98 -39.17 79.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.651 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.9 -36.11 83.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.668 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.36 77.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.621 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 1' ' ' MET . . . -59.82 -28.19 67.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.252 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.92 -35.88 71.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 99.99 110.503 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -85.82 -63.52 1.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.436 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.509 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -79.79 138.62 37.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.119 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.759 ' O ' HD12 ' A' ' 53' ' ' LEU . 11.2 tp -129.35 141.5 46.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.388 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -91.77 144.52 25.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.845 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 t -124.22 135.45 53.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.439 ' HB ' HG21 ' A' ' 75' ' ' THR . 6.2 p -110.51 154.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 111.898 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 81' ' ' CYS . 7.2 p -96.77 132.63 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.084 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.678 HG11 HD13 ' A' ' 101' ' ' ILE . 43.1 t -133.94 130.55 55.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.04 -163.89 37.58 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.778 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.7 t0 -87.42 117.84 26.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 111.263 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 32.11 33.67 0.01 OUTLIER Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.149 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.541 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 17.05 108.28 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 16' ' ' LYS . 1.4 t -75.36 -138.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.74 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.414 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -59.09 57.73 0.01 OUTLIER Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.476 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.763 ' NZ ' ' H ' ' A' ' 59' ' ' ALA . 1.1 pttt -64.66 -25.44 67.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.604 0.24 . . . . 0.0 111.372 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.658 HG21 ' CG1' ' A' ' 33' ' ' VAL . 38.0 m -66.38 -67.55 0.44 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.352 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' ILE . 92.3 m -55.6 -28.78 57.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.544 0.688 . . . . 0.0 109.837 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 165' ' ' LEU . 24.1 tp -60.71 -39.08 87.24 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.294 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -78.13 -30.36 49.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.101 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 18' ' ' CYS . 1.6 tt -58.49 -9.21 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.876 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -48.24 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.81 -178.441 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -57.05 -38.27 72.99 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.675 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.75 -65.0 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.873 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.6 p -122.08 -18.98 6.75 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.399 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 22' ' ' SER . 69.2 m-80 60.94 42.99 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.819 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 179.0 152.27 0.35 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.629 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -40.45 148.48 0.35 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.139 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.15 144.86 99.24 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.41 2.074 . . . . 0.0 111.96 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 32' ' ' TYR . 48.2 t -69.4 67.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.412 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 62.02 -17.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.523 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.609 ' H ' ' C ' ' A' ' 30' ' ' SER . 86.6 m-85 -120.97 145.8 47.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.658 ' CG1' HG21 ' A' ' 17' ' ' THR . 22.1 t -123.31 66.35 32.96 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.047 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.77 156.62 65.25 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.621 2.214 . . . . 0.0 112.667 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.1 p -116.74 170.37 8.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.378 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.89 157.86 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.891 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -58.05 -37.0 73.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.056 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -72.09 123.57 23.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.877 0.37 . . . . 0.0 110.835 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -59.88 -36.96 78.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.738 ' CB ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -158.08 -22.32 0.08 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.544 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.63 98.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.177 0.513 . . . . 0.0 111.13 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.563 HG21 HD11 ' A' ' 55' ' ' LEU . 64.5 t -131.14 132.33 63.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.035 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 43' ' ' THR . 12.9 t -112.62 123.6 50.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.105 0.479 . . . . 0.0 111.107 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.9 m -134.32 154.72 38.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.953 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.585 ' SD ' ' N ' ' A' ' 45' ' ' MET . 1.3 pmm? -126.52 125.93 42.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.228 0.537 . . . . 0.0 110.491 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.3 mt -126.42 112.2 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 4.48 85.87 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.93 5.49 59.7 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -83.06 115.07 56.95 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.93 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.29 109.26 2.09 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.127 1.885 . . . . 0.0 112.682 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -151.77 171.13 18.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.509 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.1 p -143.67 126.74 16.45 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.945 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.759 HD12 ' O ' ' A' ' 4' ' ' ILE . 48.3 tp -109.98 130.34 55.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.169 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.62 147.13 41.49 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.738 ' H ' ' CB ' ' A' ' 40' ' ' TYR . 49.2 mt -83.08 98.83 9.51 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.161 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.518 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 11.0 p90 -57.04 -40.94 77.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.593 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -43.02 165.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.187 -179.407 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.584 ' H ' ' CG ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 77.19 95.98 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.868 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.763 ' H ' ' NZ ' ' A' ' 16' ' ' LYS . . . -176.83 -124.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.338 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.11 37.72 24.33 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 64' ' ' TYR . 94.9 mt-30 -136.75 98.92 3.9 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.048 0.452 . . . . 0.0 110.115 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 61' ' ' GLN . 97.8 mt-10 -40.96 -35.68 0.56 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -98.28 50.97 1.01 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.151 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 61' ' ' GLN . 61.6 m-85 -43.58 -43.73 5.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.873 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 65' ' ' ASP . 51.4 p30 -159.09 -176.16 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.568 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -120.37 150.35 40.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.573 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.5 mt 56.28 78.67 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.859 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -88.41 153.06 50.63 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.242 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.9 123.02 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.324 2.016 . . . . 0.0 112.13 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.19 -36.71 83.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.554 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -125.43 151.61 45.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 58.26 70.47 1.23 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.827 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -51.11 152.48 10.61 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.905 2.404 . . . . 0.0 112.06 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -53.49 -38.37 63.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.817 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.439 HG21 ' HB ' ' A' ' 7' ' ' VAL . 40.8 p -123.42 154.28 39.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.71 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -115.93 0.08 12.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.534 ' CG1' HD13 ' A' ' 111' ' ' LEU . 21.8 t -115.42 101.52 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CZ ' ' SG ' ' A' ' 105' ' ' CYS . 87.9 m-85 -73.84 118.96 17.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.185 0.517 . . . . 0.0 111.13 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.518 HD11 HG21 ' A' ' 113' ' ' VAL . 8.0 tt -116.68 128.19 55.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.766 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.579 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 40.6 t -94.03 130.95 42.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.952 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.566 ' HB2' HG23 ' A' ' 8' ' ' VAL . 42.8 t -123.61 127.42 48.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.023 0.44 . . . . 0.0 111.152 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.737 ' HB3' HG21 ' A' ' 93' ' ' VAL . 33.9 p90 -171.23 139.24 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.091 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -62.37 132.69 53.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 156' ' ' GLU . 2.9 t -74.53 15.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.612 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.712 HG11 ' HE ' ' A' ' 120' ' ' ARG . 19.4 t -138.86 26.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.272 0.558 . . . . 0.0 109.894 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.424 ' C ' HD11 ' A' ' 137' ' ' ILE . 8.0 t -121.31 86.82 43.95 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.06 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.56 -29.3 18.58 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.403 2.068 . . . . 0.0 112.352 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.1 m -70.45 -41.46 72.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.989 0.424 . . . . 0.0 110.484 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.869 ' O ' HG23 ' A' ' 93' ' ' VAL . 49.5 m -73.97 -53.45 10.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.765 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.493 ' CB ' HD13 ' A' ' 137' ' ' ILE . 87.2 t80 -54.38 -46.2 72.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.449 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -66.19 -28.15 68.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.531 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.582 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 24.2 m120 -102.64 -3.4 26.69 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.126 -0.629 . . . . 0.0 111.076 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 89' ' ' SER . 38.5 t -89.53 -71.6 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.831 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HZ1' ' N ' ' A' ' 146' ' ' ALA . 46.9 mtpt -70.69 -20.21 62.7 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -112.64 -10.59 13.64 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -129.61 -29.04 2.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.452 -0.899 . . . . 0.0 113.03 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.582 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 53.8 m95 -98.26 -31.38 12.09 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.827 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.552 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -67.85 -44.27 40.74 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.751 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 17.0 Cg_exo -63.51 -36.67 52.85 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.315 2.01 . . . . 0.0 111.757 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.31 -41.41 96.95 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.962 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.678 HD13 HG11 ' A' ' 9' ' ' VAL . 39.1 pt -83.19 -34.28 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.04 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.8 m -61.25 -40.7 95.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.486 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -58.67 -43.86 90.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.435 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -82.3 -15.02 54.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.101 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.612 ' SG ' ' CZ ' ' A' ' 78' ' ' PHE . 1.7 t -114.66 108.77 48.74 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.316 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.01 163.1 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.947 1.764 . . . . 0.0 111.337 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -48.34 118.28 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.75 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.617 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -151.84 156.74 34.44 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.027 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.18 132.41 47.86 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.259 1.973 . . . . 0.0 112.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.745 ' H ' HG23 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -130.9 130.35 43.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.154 0.502 . . . . 0.0 110.504 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 111' ' ' LEU . 7.4 mp -92.73 131.58 37.68 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.914 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.679 HD22 ' HB2' ' A' ' 146' ' ' ALA . 36.0 tp -93.35 123.53 36.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.622 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.518 HG21 HD11 ' A' ' 79' ' ' LEU . 42.1 t -143.3 152.17 16.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.299 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.499 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -141.15 -179.06 18.08 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 p -124.74 174.23 8.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.23 0.538 . . . . 0.0 110.848 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 117' ' ' ILE . 52.4 mt-30 48.5 28.97 1.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.904 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.955 HG23 ' H ' ' A' ' 119' ' ' LEU . 3.8 tt 31.23 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.78 ' N ' HG23 ' A' ' 117' ' ' ILE . 27.4 p-10 -109.66 9.07 25.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.312 0.577 . . . . 0.0 110.254 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.955 ' H ' HG23 ' A' ' 117' ' ' ILE . 77.1 mt -123.15 4.32 9.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.78 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.712 ' HE ' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER 30.99 66.48 0.14 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.336 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 120' ' ' ARG . 89.7 m-20 31.09 45.96 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.388 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.799 ' CG ' HD13 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -31.73 -62.56 0.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.957 -179.13 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.489 ' C ' ' O ' ' A' ' 122' ' ' ASP . 82.6 Cg_exo -31.57 -34.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.113 1.875 . . . . 0.0 111.1 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 122' ' ' ASP . 2.5 p -107.91 -53.24 2.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.11 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 129' ' ' LEU . 12.0 m -59.58 -45.91 90.5 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.996 -0.681 . . . . 0.0 109.665 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.799 HD13 ' CG ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -63.72 -48.67 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.679 179.094 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' N ' HG22 ' A' ' 126' ' ' ILE . 85.4 tt0 -44.42 -40.53 5.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.58 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -110.52 -49.2 3.07 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 18.3 tp -55.5 -45.2 77.07 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -176.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . 97.66 125.57 0.01 OUTLIER 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -52.78 -44.38 66.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.393 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -62.27 -27.66 69.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.725 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -88.2 -3.29 58.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.621 ' NE2' HD11 ' A' ' 126' ' ' ILE . 42.3 mt-30 -65.82 -41.48 91.8 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.52 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt 59.19 61.23 4.58 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.499 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.697 ' HA ' HG13 ' A' ' 85' ' ' VAL . 11.9 Cg_endo -59.81 146.19 96.28 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.75 2.3 . . . . 0.0 112.315 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.872 HG22 ' N ' ' A' ' 138' ' ' THR . 94.6 mt -88.99 -119.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.216 0.531 . . . . 0.0 110.93 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.872 ' N ' HG22 ' A' ' 137' ' ' ILE . 49.8 p -133.33 37.75 0.39 Allowed Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.612 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 138' ' ' THR . 87.8 Cg_exo -23.63 -39.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.384 2.723 . . . . 0.0 112.663 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 138' ' ' THR . 97.3 mt-10 -66.02 -47.68 73.64 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.138 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 143' ' ' GLU . 84.4 m -54.37 -71.56 0.08 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.601 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 141' ' ' THR . . . -28.06 -31.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 141' ' ' THR . 78.6 mm-40 -60.62 -39.91 89.94 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.834 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 141' ' ' THR . 20.8 tttt -98.04 -19.3 18.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.786 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -64.12 -32.35 73.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.099 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.716 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -80.24 -39.83 28.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.922 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.04 -36.73 77.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.476 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 148' ' ' ASP . 59.3 t0 -98.36 -16.44 19.31 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 3.8 tp -117.46 34.4 5.15 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.051 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 23.2 mttm 80.85 149.41 0.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.282 0.563 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.716 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . 156.34 -177.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.762 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.745 HG23 ' H ' ' A' ' 110' ' ' PHE . 24.4 t -141.63 -52.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.846 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.475 ' HZ1' ' CG ' ' A' ' 167' ' ' ASN . 5.6 tttm -119.77 -172.54 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.553 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.616 ' CG ' ' O ' ' A' ' 154' ' ' TYR . 29.9 p90 -154.28 96.77 1.96 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 165' ' ' LEU . 7.8 p -140.81 138.48 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 122.118 0.961 . . . . 0.0 111.848 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.744 ' O ' ' OG1' ' A' ' 161' ' ' THR . 88.7 mt-10 -123.62 98.33 5.78 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.518 ' SG ' HD22 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -114.62 146.11 41.21 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 123.188 1.471 . . . . 0.0 113.167 -176.176 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.514 ' N ' ' SG ' ' A' ' 157' ' ' CYS . 15.2 t -169.9 93.23 0.24 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 111.629 -2.532 . . . . 0.0 107.201 176.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 42.92 28.09 0.12 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.976 -1.466 . . . . 0.0 110.215 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 162' ' ' GLN . 21.4 mt -145.65 -81.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.488 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.744 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -57.39 52.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.164 0.507 . . . . 0.0 111.481 -178.234 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.706 ' N ' ' O ' ' A' ' 160' ' ' LEU . 5.4 pp0? -82.62 15.52 2.55 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 176.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.585 ' H ' ' C ' ' A' ' 161' ' ' THR . 25.5 mttt -89.47 0.63 56.74 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.752 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.622 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.04 -72.76 0.11 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 177.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 19' ' ' LEU . 11.1 mp -40.22 -19.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.686 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.622 ' N ' ' O ' ' A' ' 164' ' ' GLY . 28.4 tttt -80.06 -49.78 11.29 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 164' ' ' GLY . 17.6 p-10 -77.9 4.53 11.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.791 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 171' ' ' GLU . 17.6 t -81.25 -58.11 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.243 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 40.0 m-85 -39.31 -39.88 0.7 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.705 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.685 ' O ' HG22 ' A' ' 173' ' ' ILE . 58.2 t0 -65.89 -47.66 74.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.057 0.456 . . . . 0.0 110.022 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 168' ' ' VAL . 77.1 mm-40 -67.76 -18.92 65.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.153 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.643 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -63.35 -38.62 91.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.821 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 170' ' ' ASP . 15.0 tt -62.11 -31.79 52.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.1 tp -63.36 -38.1 89.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.464 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.69 -22.92 66.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.19 68.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.427 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 38.9 tp -56.61 -36.77 69.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.57 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 99.99 110.583 -179.763 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.557 ' O ' ' HB1' ' A' ' 176' ' ' ALA . 90.5 mt-30 . . . . . 0 N--CA 1.458 -0.058 0 CA-C-O 120.894 0.378 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 2' ' ' GLN . 1.8 t -39.93 142.19 0.37 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.876 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.91 HD11 ' OD2' ' A' ' 76' ' ' ASP . 8.3 tp -128.57 149.68 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.953 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -95.93 141.09 29.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.795 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -134.76 147.49 50.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.825 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.476 ' HA ' ' H ' ' A' ' 56' ' ' PHE . 28.4 m -131.9 147.28 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.14 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.417 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 55.3 t -109.0 124.45 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.158 0.504 . . . . 0.0 110.942 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -127.25 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.849 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.528 ' HA3' HG21 ' A' ' 14' ' ' VAL . . . -148.71 -164.36 11.44 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.611 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.7 t0 -78.62 126.53 30.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 110.833 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.14 -88.62 0.01 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -136.6 127.7 27.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.78 0.324 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.528 HG21 ' HA3' ' A' ' 10' ' ' GLY . 8.6 m -140.64 150.8 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.305 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.596 ' CA ' ' OG1' ' A' ' 115' ' ' THR . . . 23.76 54.24 0.04 OUTLIER Glycine 0 N--CA 1.471 1.015 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.888 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.5 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 85.1 mttt -35.12 -58.85 0.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 20' ' ' LEU . 4.0 m -130.37 -55.94 1.09 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 17' ' ' THR . 87.7 m -34.84 -28.58 0.01 OUTLIER 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.045 0.45 . . . . 0.0 111.049 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 17' ' ' THR . 4.2 tt -76.3 -43.39 41.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.432 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.791 HD21 ' O ' ' A' ' 56' ' ' PHE . 96.0 mt -59.33 -35.96 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.089 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.016 HD12 HD22 ' A' ' 26' ' ' ASN . 12.8 pt -90.14 8.19 3.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.766 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -39.85 -77.83 0.02 OUTLIER 'General case' 0 C--O 1.241 0.611 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.504 -179.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.585 ' C ' ' N ' ' A' ' 25' ' ' THR . 14.9 p90 -39.93 -34.72 0.3 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 118.226 0.466 . . . . 0.0 111.499 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.508 ' CB ' ' O ' ' A' ' 21' ' ' ILE . 1.1 m -45.95 -14.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.648 ' O ' HG22 ' A' ' 25' ' ' THR . 55.7 m 50.53 37.31 15.68 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.705 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 1.016 HD22 HD12 ' A' ' 21' ' ' ILE . 91.7 m-20 -63.12 -40.37 97.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.757 ' H ' HE22 ' A' ' 162' ' ' GLN . 36.8 mttt 57.84 131.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.886 0.374 . . . . 0.0 110.457 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.606 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.8 mt -39.6 -55.84 3.24 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.984 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 28' ' ' LEU . 85.0 Cg_exo -38.64 -15.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.65 2.233 . . . . 0.0 113.048 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 28' ' ' LEU . 23.0 t -104.32 131.29 51.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.573 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 33' ' ' VAL . 96.9 mt-10 -67.54 -29.36 68.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.104 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -53.91 122.04 9.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.75 0.31 . . . . 0.0 110.806 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 33' ' ' VAL . 14.8 p -178.18 50.73 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.543 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 14.7 Cg_endo -59.68 131.42 40.0 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.626 2.217 . . . . 0.0 112.002 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 p -119.55 5.39 11.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.672 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.1 t -62.11 -40.59 88.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -109.79 132.94 53.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.204 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -84.67 124.02 31.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.796 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -99.37 144.99 27.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.046 0.45 . . . . 0.0 111.205 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.606 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 20.4 p90 -167.13 19.6 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.45 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.62 100.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.58 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 t -137.38 134.03 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.977 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 43' ' ' THR . 8.9 t -103.62 108.21 19.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.603 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -135.17 144.2 34.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.219 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.5 ptp -111.46 146.03 37.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.545 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 47' ' ' GLY . 39.1 mm -118.73 125.7 74.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.127 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 32.12 45.51 0.19 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.51 47.76 5.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.742 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 2.8 mt-10 -133.46 77.48 65.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.359 . . . . 0.0 110.108 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.29 106.85 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.965 2.443 . . . . 0.0 112.959 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.552 ' CE1' ' O ' ' A' ' 169' ' ' PHE . 30.7 p90 -155.84 166.27 34.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.3 127.18 37.19 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.955 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.914 HD22 ' HB2' ' A' ' 172' ' ' ALA . 41.5 tp -119.35 127.79 53.49 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.019 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -93.1 144.17 16.9 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.671 HD23 ' SG ' ' A' ' 6' ' ' CYS . 64.9 mt -137.29 129.74 29.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.201 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.791 ' O ' HD21 ' A' ' 20' ' ' LEU . 1.9 t80 -97.3 -164.27 1.13 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 58' ' ' THR . 49.1 p30 -162.33 -162.38 0.82 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.401 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.796 HG23 ' H ' ' A' ' 59' ' ' ALA . 4.4 t -8.25 -112.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.039 0.837 . . . . 0.0 112.803 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.796 ' H ' HG23 ' A' ' 58' ' ' THR . . . 39.81 83.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.42 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.77 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 121.017 0.437 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -136.65 151.15 48.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.538 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.91 ' OD2' HD11 ' A' ' 4' ' ' ILE . 84.1 m-20 -112.1 -19.61 12.23 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.924 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.487 ' CG1' HD13 ' A' ' 111' ' ' LEU . 19.7 t -122.24 120.43 61.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.144 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.587 ' C ' HD12 ' A' ' 79' ' ' LEU . 98.3 m-85 -87.53 122.18 30.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.128 0.489 . . . . 0.0 111.548 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.795 HD22 ' SG ' ' A' ' 6' ' ' CYS . 10.6 mp -111.73 114.2 27.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.002 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.4 m -98.59 129.23 49.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 114' ' ' GLY . 6.8 t -129.86 135.86 48.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.499 0.666 . . . . 0.0 112.042 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.453 ' H ' ' HA2' ' A' ' 114' ' ' GLY . 49.9 p90 -142.24 144.92 33.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.372 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.6 t -66.55 130.69 44.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 84' ' ' VAL . 10.7 t -63.64 4.24 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' SER . 14.7 p -129.99 144.1 39.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 118.557 0.617 . . . . 0.0 109.556 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.7 OUTLIER 83.65 92.16 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -48.11 -0.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.648 2.232 . . . . 0.0 113.113 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 86' ' ' SER . 19.9 m -66.19 -61.52 1.98 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.888 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.8 p -64.94 -35.02 79.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.525 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.771 ' CZ ' HD22 ' A' ' 145' ' ' LEU . 78.5 t80 -69.01 -50.52 48.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -64.12 -24.16 67.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.851 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 96' ' ' LYS . 14.0 m120 -86.99 -64.09 1.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.858 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 30.1 t -41.07 -61.92 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 142' ' ' ALA . 43.5 mtpt -67.96 -21.26 65.1 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 68.3 tt0 -106.11 -63.24 1.28 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 92' ' ' ASN . 17.4 mttp -67.19 -35.95 80.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.46 ' CD1' ' HA ' ' A' ' 93' ' ' VAL . 29.7 m95 -84.82 -33.93 22.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.899 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.948 ' O ' HG23 ' A' ' 102' ' ' THR . 2.3 t -44.69 -54.34 13.01 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.267 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 16.6 Cg_endo -60.46 -36.49 86.28 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.568 1.512 . . . . 0.0 111.61 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.84 -40.51 97.66 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.096 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 83.7 mt -73.8 -38.52 50.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.948 HG23 ' O ' ' A' ' 98' ' ' VAL . 49.8 p -61.42 -37.42 83.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.562 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -56.69 -36.99 70.25 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.22 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -55.19 -44.74 75.57 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.268 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.5 153.8 29.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.735 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -43.34 -76.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.293 1.995 . . . . 0.0 112.141 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -140.47 142.85 35.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.587 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -152.79 156.57 33.09 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.09 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.29 128.73 31.23 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.209 1.94 . . . . 0.0 110.91 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.727 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -124.0 123.5 40.51 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.72 -178.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.8 mp -97.68 129.86 44.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.44 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -96.76 129.32 44.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.561 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.673 HG12 ' N ' ' A' ' 114' ' ' GLY . 51.5 t -147.38 168.12 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.347 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.673 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -135.51 166.63 24.46 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.596 ' OG1' ' CA ' ' A' ' 15' ' ' GLY . 11.2 t -123.56 174.58 7.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.109 0.48 . . . . 0.0 112.017 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.56 ' O ' ' C ' ' A' ' 117' ' ' ILE . 33.1 mt-30 34.16 31.04 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.232 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.883 HG23 ' N ' ' A' ' 118' ' ' ASP . 7.7 tt 24.84 -138.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 O-C-N 123.944 0.777 . . . . 0.0 109.452 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.883 ' N ' HG23 ' A' ' 117' ' ' ILE . 61.8 m-20 -84.87 71.93 10.83 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.573 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.599 ' C ' HD23 ' A' ' 119' ' ' LEU . 5.9 tt 66.1 91.42 0.08 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.631 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 119' ' ' LEU . 56.9 ttp180 . . . . . 0 N--CA 1.469 0.479 0 O-C-N 124.259 0.974 . . . . 0.0 111.181 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 137' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.149 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.584 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -133.23 -65.29 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.6 Cg_exo -20.54 -73.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 124.001 3.134 . . . . 0.0 113.983 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -114.82 -31.05 6.25 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.496 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.472 HG21 ' CD1' ' A' ' 137' ' ' ILE . 40.2 m -55.78 -42.61 75.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.305 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.513 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -69.55 -38.22 77.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.526 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.59 -35.27 79.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.316 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.97 -50.41 72.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.319 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.771 HD22 ' CZ ' ' A' ' 90' ' ' PHE . 11.0 mp -64.05 -33.04 74.85 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.684 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.78 -41.4 75.18 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 -62.43 -35.11 78.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.468 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -47.39 -30.83 3.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.1 mt -123.48 -117.67 0.29 Allowed 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 151' ' ' ALA . 76.9 tttt -177.46 69.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.219 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -53.13 -121.94 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.666 0.746 . . . . 0.0 111.093 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.469 HG23 ' H ' ' A' ' 110' ' ' PHE . 71.6 t -155.02 -61.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.213 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.527 ' C ' ' CG ' ' A' ' 154' ' ' TYR . 18.5 mttp -101.76 -173.65 2.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.815 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -170.03 95.5 0.26 Allowed 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.926 HG22 ' H ' ' A' ' 156' ' ' GLU . 3.6 p -171.92 -167.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.399 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.926 ' H ' HG22 ' A' ' 155' ' ' VAL . 27.9 mp0 -130.66 -170.62 2.38 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.313 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.808 ' SG ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -171.76 121.13 0.48 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.878 0.847 . . . . 0.0 109.508 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.665 ' HB3' ' H ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -173.88 92.74 0.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.097 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 31.34 31.25 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.578 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.705 HD23 ' CD1' ' A' ' 117' ' ' ILE . 21.7 tp -164.76 -77.45 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.805 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.834 ' C ' ' H ' ' A' ' 163' ' ' LYS . 2.8 m -58.98 3.45 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.132 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.757 HE22 ' H ' ' A' ' 27' ' ' LYS . 13.9 pt20 -64.8 30.38 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.834 ' H ' ' C ' ' A' ' 161' ' ' THR . 94.2 mttt -90.89 3.95 53.17 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -118.2 -70.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.808 HD12 ' SG ' ' A' ' 157' ' ' CYS . 7.3 mt -41.03 -14.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.899 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 164' ' ' GLY . 60.0 tttp -82.93 -50.58 8.43 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 164' ' ' GLY . 29.9 m120 -77.61 3.73 13.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.487 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 171' ' ' GLU . 33.2 t -84.04 -51.76 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.759 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.552 ' O ' ' CE1' ' A' ' 51' ' ' TYR . 6.7 m-85 -37.69 -42.36 0.56 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.808 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 173' ' ' ILE . 61.5 t0 -67.52 -40.64 85.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.35 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 168' ' ' VAL . 76.7 mm-40 -67.03 -23.31 65.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.05 0.453 . . . . 0.0 109.951 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.914 ' HB2' HD22 ' A' ' 53' ' ' LEU . . . -59.78 -39.5 85.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.903 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 170' ' ' ASP . 14.0 tt -60.58 -31.69 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.625 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.1 tp -65.7 -38.56 89.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.139 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.47 -33.8 76.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 2' ' ' GLN . . . -59.14 -32.5 69.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.64 -36.01 69.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.386 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 99.989999999999995 110.641 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 3' ' ' THR . 91.6 mt-30 . . . . . 0 C--O 1.231 0.09 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.486 ' CB ' ' HG1' ' A' ' 52' ' ' THR . 2.0 t -36.83 135.07 0.46 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.241 0.543 . . . . 0.0 110.737 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 tp -127.27 150.76 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.282 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -114.05 157.91 21.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.214 0.53 . . . . 0.0 111.623 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.23 153.35 47.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.388 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 9' ' ' VAL . 45.8 t -122.48 133.09 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.539 -0.465 . . . . 0.0 112.027 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.668 HG11 ' O ' ' A' ' 58' ' ' THR . 10.5 p -50.02 120.86 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.166 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 7' ' ' VAL . 47.9 t -127.63 131.49 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.19 -169.91 37.56 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.314 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 92' ' ' ASN . 58.5 t0 -123.29 139.63 53.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.923 0.392 . . . . 0.0 110.677 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 63.42 -117.19 10.5 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.95 128.83 10.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 110.421 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.51 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 24.2 m -136.53 164.33 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.552 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -74.65 80.76 0.89 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.118 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.634 ' H ' ' CD ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -81.46 -1.16 44.83 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.469 -0.43 . . . . 0.0 110.914 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.3 p -68.42 -53.32 24.47 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.107 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.586 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 93.2 m -69.25 -22.42 63.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.69 0.757 . . . . 0.0 109.811 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.47 -56.06 16.67 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.626 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.11 -34.09 74.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.027 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 18' ' ' CYS . 1.7 tp -55.17 -10.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.818 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 97.3 p -42.21 -80.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.076 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.539 ' N ' ' OG ' ' A' ' 22' ' ' SER . 79.7 t80 -62.08 -33.37 74.3 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.482 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.7 m -47.86 -45.14 29.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.819 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -151.9 -12.53 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.804 -179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 25' ' ' THR . 47.9 t30 53.98 119.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.73 0.3 . . . . 0.0 111.18 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 mttm 61.08 62.87 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.567 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -116.19 89.66 26.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.05 158.91 1.15 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.375 2.05 . . . . 0.0 111.691 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.2 m -55.13 141.89 33.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.99 0.424 . . . . 0.0 110.931 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 33' ' ' VAL . 84.0 tt0 -178.56 88.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.633 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' O ' ' C ' ' A' ' 33' ' ' VAL . 56.6 t80 64.77 -13.2 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.17 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.615 ' H ' ' C ' ' A' ' 31' ' ' GLU . 39.0 t 36.17 61.83 2.94 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.426 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.58 133.52 32.36 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.362 2.041 . . . . 0.0 111.562 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 p -128.63 163.11 25.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 111.029 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 38' ' ' ASP . 41.0 t -118.98 132.36 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.953 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.97 -3.3 24.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.124 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.491 ' H ' HG12 ' A' ' 36' ' ' VAL . 91.7 m-20 -60.82 -48.5 81.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.575 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -176.8 172.87 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.417 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 55' ' ' LEU . 82.8 m-85 -125.66 15.94 8.13 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.86 98.02 5.46 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.602 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.22 135.8 52.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.628 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 51' ' ' TYR . 2.1 t -107.83 138.87 43.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.173 0.511 . . . . 0.0 111.71 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.2 144.62 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.861 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.1 mtm -112.11 136.46 51.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.713 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.617 HG21 ' CG ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER -150.88 99.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.553 178.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.02 56.76 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.47 41.69 24.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.02 76.87 75.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 110.68 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.433 ' C ' ' CD2' ' A' ' 51' ' ' TYR . 82.1 Cg_endo -86.0 117.68 1.65 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.113 2.542 . . . . 0.0 112.563 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' A' ' 50' ' ' PRO . 97.8 m-85 -154.49 174.04 15.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.777 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.532 ' C ' HD22 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -121.75 126.97 50.11 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.499 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.908 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -109.9 123.41 49.55 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.264 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.724 ' C ' HD12 ' A' ' 55' ' ' LEU . . . -93.76 135.51 12.6 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.724 HD12 ' C ' ' A' ' 54' ' ' GLY . 5.8 mp -142.58 108.89 5.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.091 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.454 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 75.3 m-85 -80.26 168.99 18.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 58' ' ' THR . 51.9 p30 -138.11 -179.4 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 13.4 m 48.62 174.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.857 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 58' ' ' THR . . . 87.06 124.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.704 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.759 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.578 -179.98 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.553 0.216 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 t -133.99 157.36 46.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.693 0.282 . . . . 0.0 110.348 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.487 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 59.9 t0 -150.17 -10.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.396 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.67 ' CG1' HD13 ' A' ' 111' ' ' LEU . 22.8 t -119.03 106.22 19.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.285 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -81.16 129.96 34.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.013 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.565 HD11 HG21 ' A' ' 113' ' ' VAL . 30.4 tp -114.21 113.09 24.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.6 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.73 132.56 33.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' VAL . 49.4 t -132.81 116.71 16.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.094 0.473 . . . . 0.0 111.287 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.432 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 39.6 p90 -153.53 155.72 36.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.792 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' A' ' 86' ' ' SER . 30.1 t -71.85 128.85 37.07 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.479 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.749 HG11 ' OE2' ' A' ' 156' ' ' GLU . 2.1 t -59.77 -2.17 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.825 ' O ' HG22 ' A' ' 85' ' ' VAL . 7.2 p -127.75 30.98 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.461 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 83' ' ' SER . 5.2 p -122.51 82.94 47.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.472 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -51.44 -30.29 34.29 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.667 2.245 . . . . 0.0 112.286 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.477 ' O ' ' OD1' ' A' ' 92' ' ' ASN . 22.5 m -67.72 -47.65 68.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.444 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.955 ' O ' HG22 ' A' ' 93' ' ' VAL . 97.0 p -67.87 -35.22 78.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.46 -47.51 85.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.802 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -71.49 -18.52 62.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.609 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 88' ' ' SER . 11.3 m120 -93.17 -67.08 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.955 HG22 ' O ' ' A' ' 89' ' ' SER . 31.0 m -45.23 -50.1 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.495 ' N ' HG23 ' A' ' 93' ' ' VAL . 59.5 mttm -70.71 -32.27 69.42 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 83.5 tt0 -107.6 -60.92 1.64 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 92' ' ' ASN . 75.4 mttt -63.44 -34.92 78.81 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.419 ' CE3' ' OE1' ' A' ' 100' ' ' GLU . 49.8 m95 -86.26 -29.4 23.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.523 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -44.77 -53.98 14.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.853 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 29.1 Cg_endo -65.14 -33.13 51.04 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.615 1.543 . . . . 0.0 111.474 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.419 ' OE1' ' CE3' ' A' ' 97' ' ' TRP . 84.6 tt0 -59.76 -37.73 79.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.8 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.1 pt -94.91 -29.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.329 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 105' ' ' CYS . 55.1 m -52.33 -40.72 62.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.62 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -53.78 -33.33 55.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -54.55 -43.56 72.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.119 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -152.3 152.88 30.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.769 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.69 -42.87 2.17 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.664 2.243 . . . . 0.0 112.651 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 13.3 tttm -138.34 130.19 28.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 t -165.66 147.45 6.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.262 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.39 135.57 58.43 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.187 1.925 . . . . 0.0 111.427 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.695 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -116.52 119.28 35.1 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.005 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.67 HD13 ' CG1' ' A' ' 77' ' ' VAL . 10.0 mp -94.64 119.37 33.18 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.445 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 113' ' ' VAL . 46.0 mt -90.94 130.19 36.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.592 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 114' ' ' GLY . 52.0 t -153.22 162.49 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.368 0.604 . . . . 0.0 112.122 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.569 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -137.08 170.37 23.55 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 9.8 t -136.06 167.03 22.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.343 0.572 . . . . 0.0 111.776 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.534 ' O ' ' O ' ' A' ' 117' ' ' ILE . 40.7 mt-30 55.6 25.76 8.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.881 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.833 HG23 ' N ' ' A' ' 118' ' ' ASP . 6.3 tt 30.28 -151.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.304 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.833 ' N ' HG23 ' A' ' 117' ' ' ILE . 52.9 p30 -122.86 29.76 6.69 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.831 ' H ' HG23 ' A' ' 117' ' ' ILE . 7.7 tt -139.78 -43.02 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.242 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.593 ' H ' HG22 ' A' ' 117' ' ' ILE . 25.7 mmt180 . . . . . 0 CA--C 1.516 -0.348 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 137' ' ' ILE . 7.7 tt . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.696 0.284 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.604 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.99 -65.77 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.604 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.2 Cg_exo -24.27 -68.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 123.7 2.933 . . . . 0.0 114.38 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -109.12 -35.13 6.39 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.653 -0.419 . . . . 0.0 112.102 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.447 ' OG1' ' C ' ' A' ' 137' ' ' ILE . 61.0 p -56.42 -38.2 71.24 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.344 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.3 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.745 0.307 . . . . 0.0 111.18 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.48 -37.52 81.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.007 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -59.88 -50.4 73.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 80.4 mt -58.87 -28.91 66.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.795 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.48 -38.74 87.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.058 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -58.47 -40.39 82.59 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.296 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -53.88 -29.59 42.3 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 146' ' ' ALA . 81.8 mt -137.76 -112.02 0.17 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.045 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.73 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 59.9 mttm -143.78 -136.87 0.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.094 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 153.89 -160.85 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 O-C-N 123.319 0.387 . . . . 0.0 110.229 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 110' ' ' PHE . 88.2 t -155.88 -68.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.613 ' CE ' HD23 ' A' ' 111' ' ' LEU . 3.9 mtmp? -101.94 177.97 4.75 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.603 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 27.3 p90 -169.11 94.11 0.3 Allowed 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.601 HG22 ' C ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -170.72 -167.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.409 -177.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.749 ' OE2' HG11 ' A' ' 84' ' ' VAL . 57.8 mt-10 -126.37 -172.3 2.59 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.33 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.533 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 1.2 p -171.71 117.2 0.4 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.692 ' OG ' ' N ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -173.14 93.75 0.11 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.974 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.696 ' H ' ' NE2' ' A' ' 162' ' ' GLN . . . 31.51 32.69 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.722 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.605 ' N ' ' O ' ' A' ' 158' ' ' SER . 5.6 tt -165.98 -77.5 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.995 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.813 ' C ' ' H ' ' A' ' 163' ' ' LYS . 2.4 m -59.3 5.6 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.18 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.696 ' NE2' ' H ' ' A' ' 159' ' ' ALA . 87.4 mt-30 -65.77 30.96 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.813 ' H ' ' C ' ' A' ' 161' ' ' THR . 99.5 mttt -90.57 5.43 47.89 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -128.41 -71.4 0.15 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 164' ' ' GLY . 3.9 mm? -37.45 -21.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.052 0.453 . . . . 0.0 110.341 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.634 ' N ' ' O ' ' A' ' 164' ' ' GLY . 16.7 tttm -78.98 -52.56 8.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 164' ' ' GLY . 14.7 t-20 -78.98 4.06 15.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.907 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 171' ' ' GLU . 2.9 t -76.57 -58.2 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.468 ' C ' ' O ' ' A' ' 168' ' ' VAL . 71.6 m-85 -35.48 -37.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.73 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.617 ' CG ' HG21 ' A' ' 46' ' ' ILE . 76.4 m-20 -71.28 -45.16 63.79 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.622 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 168' ' ' VAL . 97.1 mt-10 -69.37 -27.47 65.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.988 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.609 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . . . -63.3 -30.79 71.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.56 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 176' ' ' ALA . 1.2 pp -66.08 -27.1 39.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.73 -37.38 78.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.526 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.01 -19.54 64.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.462 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -59.85 -35.76 75.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.27 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 62.0 mt -59.44 -33.47 71.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.19 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 99.989999999999995 110.426 -179.845 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 3' ' ' THR . 91.0 mt-30 . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.827 0.346 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -40.5 114.93 0.5 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.388 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.899 HD11 ' OD2' ' A' ' 76' ' ' ASP . 9.7 tp -117.59 144.38 25.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.207 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -91.99 140.1 29.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 110.612 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.87 ' SG ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -141.01 151.26 43.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.711 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.462 HG22 ' OG1' ' A' ' 75' ' ' THR . 29.3 m -127.2 142.86 42.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.585 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.491 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 43.3 t -111.19 124.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.199 0.523 . . . . 0.0 110.895 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.529 ' C ' ' HZ3' ' A' ' 16' ' ' LYS . 19.6 m -133.42 161.51 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.938 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.759 ' N ' ' HZ3' ' A' ' 16' ' ' LYS . . . -172.75 -168.76 34.5 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.584 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.596 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 42.9 t0 -80.35 121.86 26.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 110.817 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.688 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -45.72 98.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 151.34 20.58 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.663 0.273 . . . . 0.0 111.522 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.63 135.97 58.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.037 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.71 88.76 0.74 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HZ3' ' N ' ' A' ' 10' ' ' GLY . 84.7 mttt -81.65 -0.21 41.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.664 0.269 . . . . 0.0 110.79 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.81 HG21 ' O ' ' A' ' 34' ' ' PRO . 21.4 m -80.49 -70.29 0.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.163 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.652 ' HA ' HD12 ' A' ' 21' ' ' ILE . 18.0 m -50.91 -25.25 4.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.62 0.724 . . . . 0.0 109.345 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.61 ' CD2' ' SG ' ' A' ' 81' ' ' CYS . 62.4 tp -55.05 -55.0 35.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.375 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' SER . 82.1 mt -69.96 -32.66 71.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 18' ' ' CYS . 93.2 mt -62.06 -1.8 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.966 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.5 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -56.35 -75.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.059 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.689 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -62.5 -28.64 69.98 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.165 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.651 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 2.6 m -54.46 -48.5 71.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.8 p -131.52 -21.84 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.474 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 22' ' ' SER . 83.0 m-20 61.43 114.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.131 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.679 ' N ' HE22 ' A' ' 162' ' ' GLN . 75.0 mttt 61.92 59.21 1.76 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.093 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 tp -125.34 66.85 54.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.026 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.51 145.06 37.08 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.595 2.197 . . . . 0.0 111.877 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 89.1 p -138.2 153.34 49.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.868 0.366 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.48 -32.62 74.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -115.37 156.44 25.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.927 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 t -118.56 83.83 22.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.825 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.81 ' O ' HG21 ' A' ' 17' ' ' THR . 13.1 Cg_exo -63.89 144.41 88.18 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.666 2.244 . . . . 0.0 111.508 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.0 p -123.97 156.9 35.57 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.946 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 38' ' ' ASP . 40.2 t -123.16 131.34 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 78.1 t80 -97.42 -9.28 27.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.886 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' H ' HG12 ' A' ' 36' ' ' VAL . 96.0 m-20 -69.41 -70.96 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.111 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 40' ' ' TYR . 40.3 t-20 -173.8 174.06 3.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.669 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.455 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -139.0 23.83 2.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.51 98.62 10.22 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.446 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.486 ' O ' ' OG1' ' A' ' 52' ' ' THR . 15.6 m -115.55 158.16 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.219 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.6 t -123.22 140.92 52.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.015 0.436 . . . . 0.0 111.225 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 45' ' ' MET . 13.2 p -149.04 152.49 12.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.968 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.403 ' N ' HG22 ' A' ' 44' ' ' VAL . 70.7 mtm -101.3 123.35 45.26 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.674 HD13 ' HB2' ' A' ' 170' ' ' ASP . 9.1 tt -134.17 136.79 52.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.217 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.19 28.06 4.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.5 49.04 16.05 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -131.45 78.13 72.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.753 0.311 . . . . 0.0 110.329 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.598 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 20.6 Cg_exo -61.62 99.37 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.736 2.291 . . . . 0.0 112.143 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 83.5 m-85 -161.12 -179.38 7.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.508 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.549 ' C ' HD22 ' A' ' 53' ' ' LEU . 4.8 t -144.43 144.15 31.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.37 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.908 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.1 mm? -111.64 127.32 55.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.526 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -83.1 122.67 5.83 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.591 HD23 ' SG ' ' A' ' 6' ' ' CYS . 86.5 mt -127.55 145.6 50.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.297 0.57 . . . . 0.0 112.254 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.491 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 39.7 t80 -119.55 -168.39 1.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 59' ' ' ALA . 52.0 p30 -174.11 -162.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.574 0.624 . . . . 0.0 110.327 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 60' ' ' GLY . 81.7 p 43.23 -93.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.7 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 43.6 17.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.717 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 58' ' ' THR . . . . . . . . 0 CA--C 1.528 0.87 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.506 ' O ' ' C ' ' A' ' 75' ' ' THR . 95.7 mt-30 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.349 0.118 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.506 ' C ' ' O ' ' A' ' 74' ' ' GLN . 2.1 t 23.19 61.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.603 0.564 . . . . 0.0 111.439 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.899 ' OD2' HD11 ' A' ' 4' ' ' ILE . 90.1 m-20 -65.01 -39.22 93.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 ' HB1' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -105.88 104.11 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.54 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.621 ' C ' HD12 ' A' ' 79' ' ' LEU . 96.8 m-85 -78.92 125.15 28.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.162 0.506 . . . . 0.0 111.87 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.87 HD13 ' SG ' ' A' ' 6' ' ' CYS . 10.5 mp -112.59 128.43 56.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.974 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.0 m -109.88 136.84 44.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.675 ' O ' HG21 ' A' ' 93' ' ' VAL . 1.3 m -112.36 127.23 55.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.075 0.464 . . . . 0.0 111.43 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 113' ' ' VAL . 48.7 p90 -149.73 115.75 5.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.419 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.664 ' OG ' HG12 ' A' ' 85' ' ' VAL . 35.5 t -58.59 139.78 55.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.774 ' O ' HG22 ' A' ' 84' ' ' VAL . 11.1 p -101.01 38.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.544 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.664 HG12 ' OG ' ' A' ' 83' ' ' SER . 1.9 p -129.3 -7.38 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.832 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.1 154.71 55.92 Favored Pre-proline 0 C--N 1.331 -0.218 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.733 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.594 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 57.8 Cg_endo -73.04 -40.79 1.58 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.667 2.245 . . . . 0.0 112.758 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.4 p -82.86 -7.94 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.31 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 83' ' ' SER . 84.2 p -60.63 -41.1 94.2 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.177 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.594 ' CE1' ' O ' ' A' ' 87' ' ' PRO . 22.6 p90 -89.35 -41.25 12.24 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.181 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.2 tt0 -57.7 -32.81 67.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.116 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 90.5 m-20 -77.34 -39.38 47.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.326 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.675 HG21 ' O ' ' A' ' 81' ' ' CYS . 9.6 t -84.8 -66.87 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 93' ' ' VAL . 92.9 mttt -61.43 -17.67 55.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.528 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 95.3 mt-10 -125.72 -48.44 1.65 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -78.53 -41.01 33.39 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.606 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 57.6 m95 -92.61 -25.53 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.381 -0.928 . . . . 0.0 112.29 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.539 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -56.34 -45.37 99.93 Favored Pre-proline 0 CA--C 1.527 0.092 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.118 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 25.7 Cg_exo -57.46 -43.92 47.03 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.119 1.88 . . . . 0.0 110.76 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -57.4 -42.52 82.4 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.555 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.7 mt -69.79 -36.34 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.908 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 105' ' ' CYS . 49.8 m -57.11 -31.68 65.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.178 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -46.85 -45.54 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.063 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -59.9 -33.47 71.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 109.953 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' THR . 5.1 t 70.79 58.9 0.46 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.49 120.44 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.731 2.287 . . . . 0.0 112.057 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.7 0.29 57.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.391 . . . . 0.0 110.437 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.3 157.4 80.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.419 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -50.08 144.61 21.79 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.606 2.204 . . . . 0.0 111.662 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.734 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -118.8 119.18 33.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.193 0.521 . . . . 0.0 110.577 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.5 mp -97.63 130.89 44.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.38 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.421 HD12 ' CD1' ' A' ' 154' ' ' TYR . 92.3 mt -94.58 129.04 41.56 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.603 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 30.5 t -136.33 153.64 31.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.584 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -134.96 168.28 23.73 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.472 ' H ' ' HA ' ' A' ' 83' ' ' SER . 3.4 p -124.81 177.44 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.167 0.508 . . . . 0.0 110.794 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.55 ' O ' ' C ' ' A' ' 117' ' ' ILE . 16.4 tt0 36.55 30.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.158 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.875 HG23 ' N ' ' A' ' 118' ' ' ASP . 6.0 tt 19.94 -138.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 O-C-N 123.602 0.564 . . . . 0.0 110.012 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.875 ' N ' HG23 ' A' ' 117' ' ' ILE . 1.0 OUTLIER -93.27 55.5 2.3 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.626 -0.829 . . . . 0.0 109.846 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.54 ' O ' ' C ' ' A' ' 120' ' ' ARG . 2.3 tt 85.93 77.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.824 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.54 ' C ' ' O ' ' A' ' 119' ' ' LEU . 45.2 mtm180 . . . . . 0 N--CA 1.47 0.551 0 O-C-N 123.944 0.778 . . . . 0.0 110.817 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.68 ' O ' HG23 ' A' ' 84' ' ' VAL . 73.3 mt . . . . . 0 C--O 1.231 0.107 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.754 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -131.38 -39.66 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.754 ' CD ' ' H ' ' A' ' 138' ' ' THR . 69.4 Cg_endo -88.93 -48.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.126 1.884 . . . . 0.0 114.591 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.67 -52.74 41.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.617 ' OG1' HG22 ' A' ' 137' ' ' ILE . 30.9 p -83.32 -10.74 58.31 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -83.93 -63.07 1.41 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.365 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.15 -39.1 93.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.97 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -66.34 -57.07 8.26 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.361 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.38 -33.8 71.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.322 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.53 -38.67 87.66 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -61.4 -40.58 94.89 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.065 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -51.95 -32.42 33.2 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 146' ' ' ALA . 75.6 mt -130.59 -116.61 0.23 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.178 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.701 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 53.2 mmtt -133.32 -145.32 0.24 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.041 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 151.41 -166.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.894 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 151' ' ' ALA . 41.2 t -159.16 -66.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.68 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 2.5 tttm -105.58 -176.83 3.19 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.079 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 153' ' ' LYS . 13.8 m-85 -161.13 95.95 1.07 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' A' ' 165' ' ' LEU . 9.6 p -143.82 144.46 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-O 121.925 0.869 . . . . 0.0 111.956 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.658 ' O ' ' OG1' ' A' ' 161' ' ' THR . 8.3 mm-40 -126.75 98.57 5.42 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.441 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.95 144.21 43.45 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 123.127 1.441 . . . . 0.0 113.609 -175.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 160' ' ' LEU . 38.2 t -158.38 93.6 1.22 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 111.793 -2.458 . . . . 0.0 106.621 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 37.23 29.71 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.587 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.773 ' O ' ' N ' ' A' ' 162' ' ' GLN . 77.2 mt -145.32 -82.05 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.425 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.673 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -53.6 44.25 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.504 0.502 . . . . 0.0 112.341 -177.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.773 ' N ' ' O ' ' A' ' 160' ' ' LEU . 2.2 pt20 -75.72 14.72 0.6 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.673 ' H ' ' C ' ' A' ' 161' ' ' THR . 89.8 mttt -78.33 -4.91 50.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.822 -1.536 . . . . 0.0 107.434 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.7 -70.99 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 107.754 -2.139 . . . . 0.0 107.754 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.43 ' CD2' HG11 ' A' ' 155' ' ' VAL . 2.2 mm? -38.25 -19.1 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.447 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 164' ' ' GLY . 60.2 tttm -84.12 -48.33 9.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 164' ' ' GLY . 77.8 m-20 -78.53 6.53 8.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.029 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 169' ' ' PHE . 5.7 t -83.26 -60.09 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.196 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.689 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 57.8 m-85 -40.34 -47.8 2.58 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.355 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.674 ' HB2' HD13 ' A' ' 46' ' ' ILE . 64.6 t0 -67.13 -43.17 83.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.845 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.56 -27.04 66.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.325 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.521 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . . . -63.68 -33.25 75.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.096 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.76 -37.81 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.578 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.633 ' N ' HD22 ' A' ' 174' ' ' LEU . 3.5 mm? -64.27 -31.92 73.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.049 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.448 ' HB1' HG13 ' A' ' 77' ' ' VAL . . . -62.2 -27.4 68.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.807 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.498 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . . . -63.79 -32.6 74.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 110.206 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.81 -35.76 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.618 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.369 -0.378 . . . . 99.989999999999995 110.683 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 3' ' ' THR . 25.3 mt-30 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.861 0.363 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -37.76 128.34 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.055 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 176' ' ' ALA . 19.7 tt -122.2 135.73 61.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.425 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -77.15 145.93 37.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.049 0.452 . . . . 0.0 111.517 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -139.65 136.73 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.033 179.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 56' ' ' PHE . 25.9 m -130.48 148.15 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.364 . . . . 0.0 111.485 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.574 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 47.1 t -115.95 120.78 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 111.078 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.95 158.27 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.095 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.49 -174.65 34.49 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.64 ' H ' ' CG2' ' A' ' 93' ' ' VAL . 23.5 t70 -81.2 121.94 26.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.019 0.438 . . . . 0.0 110.588 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . 43.75 64.6 1.83 Allowed Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.534 ' HB2' ' HZ2' ' A' ' 16' ' ' LYS . . . -16.98 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.854 0.359 . . . . 0.0 111.948 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.597 HG12 ' OE1' ' A' ' 116' ' ' GLN . 99.5 t -66.32 -55.78 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.94 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.76 59.63 0.31 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.716 -0.755 . . . . 0.0 111.902 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.534 ' HZ2' ' HB2' ' A' ' 13' ' ' ALA . 17.8 mttt -77.25 -7.2 55.54 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.659 -0.318 . . . . 0.0 110.838 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.7 p -63.17 -44.69 94.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.582 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.5 m -84.64 -14.04 49.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.59 0.71 . . . . 0.0 110.167 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.594 HD22 ' SG ' ' A' ' 81' ' ' CYS . 14.0 tp -73.58 -42.99 60.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.847 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.796 ' CD1' HD12 ' A' ' 55' ' ' LEU . 26.7 tp -65.45 -39.14 91.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.429 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.468 ' O ' ' OG1' ' A' ' 24' ' ' THR . 10.5 pt -76.38 -3.51 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 21' ' ' ILE . 2.0 m -42.14 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.768 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.569 ' C ' ' H ' ' A' ' 25' ' ' THR . 40.0 t80 -54.31 -39.94 67.46 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.029 0.377 . . . . 0.0 111.96 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 21' ' ' ILE . 23.0 p -49.57 -9.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.013 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.569 ' H ' ' C ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER 76.5 95.52 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.749 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.513 ' HB3' HE22 ' A' ' 162' ' ' GLN . 25.9 t30 -141.11 -69.56 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.4 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.773 ' H ' HE22 ' A' ' 162' ' ' GLN . 30.9 tttt 48.22 53.09 12.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mt -147.0 87.24 6.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.42 134.08 55.89 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.056 1.838 . . . . 0.0 111.378 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -125.02 145.08 50.07 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.872 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.37 -31.65 72.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.519 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -123.03 146.25 47.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.037 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 33' ' ' VAL . 15.9 m -119.79 88.13 39.2 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.31 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -53.77 148.06 38.38 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.639 2.226 . . . . 0.0 112.316 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.6 m -76.68 142.92 40.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.45 163.29 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.68 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -115.97 156.96 25.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.522 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 0.8 OUTLIER 51.73 -146.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.993 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 15.6 t-20 81.66 64.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 110.56 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.608 ' CD2' ' O ' ' A' ' 40' ' ' TYR . 26.6 p90 -157.0 38.53 0.31 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.14 98.35 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.612 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.507 ' O ' ' OG1' ' A' ' 52' ' ' THR . 18.5 t -135.66 130.45 49.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.318 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 t -94.54 133.94 37.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.685 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -135.25 142.86 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.3 mtm -113.15 130.27 56.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.298 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 48' ' ' GLY . 7.7 tp -131.96 136.2 57.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.636 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 31.14 35.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.889 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 79.63 65.37 1.78 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.572 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -151.26 88.09 4.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.59 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 42.7 Cg_endo -76.04 112.55 3.52 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.09 1.86 . . . . 0.0 112.575 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 95.9 m-85 -162.59 166.95 24.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 6.8 t -138.04 148.4 45.05 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.217 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -122.74 133.3 54.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.748 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -73.0 148.15 40.8 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.796 HD12 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -132.52 119.11 20.11 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.33 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.574 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 17.2 t80 -107.9 -176.34 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.79 ' OD2' HD22 ' A' ' 20' ' ' LEU . 52.7 p30 -176.86 -165.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.065 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.508 ' H ' ' HB2' ' A' ' 16' ' ' LYS . 31.5 p 36.59 -148.86 0.01 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.073 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 54.75 172.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.322 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.724 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.466 0.174 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.448 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 10.3 t -41.18 135.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 110.685 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -91.95 -24.37 19.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.725 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.411 HG12 HD13 ' A' ' 111' ' ' LEU . 4.2 t -119.14 110.02 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.216 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.547 ' C ' HD12 ' A' ' 79' ' ' LEU . 96.8 m-85 -86.33 126.65 34.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.165 0.507 . . . . 0.0 112.006 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.3 mp -106.38 110.01 22.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.367 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 113' ' ' VAL . 39.0 t -74.53 129.0 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.739 ' O ' HG21 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -122.27 129.89 52.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.113 0.482 . . . . 0.0 112.003 -179.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 82' ' ' PHE . 4.0 p90 -166.42 125.75 1.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.36 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.546 ' HB3' HG11 ' A' ' 14' ' ' VAL . 84.2 p -52.89 146.36 10.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.319 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.58 4.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.493 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 119' ' ' LEU . 80.3 t -127.79 148.86 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.25 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.9 t 93.24 96.24 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.244 0 O-C-N 123.643 0.589 . . . . 0.0 110.328 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.446 ' O ' ' CE2' ' A' ' 90' ' ' PHE . 61.9 Cg_exo -48.97 -2.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.67 2.247 . . . . 0.0 112.72 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 86' ' ' SER . 2.2 t -97.48 -34.73 10.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -57.01 -40.74 77.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.702 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.461 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 2.4 p90 -82.29 -32.8 29.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.319 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.1 tt0 -54.3 -28.67 43.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.925 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' LYS . 72.1 m-20 -90.51 -64.79 1.08 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.578 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.739 HG21 ' O ' ' A' ' 81' ' ' CYS . 54.7 t -50.12 -60.59 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.35 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.733 ' HZ3' HD11 ' A' ' 112' ' ' LEU . 26.6 mttt -71.57 -9.83 58.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -126.32 -62.02 1.18 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 92' ' ' ASN . 20.0 tptm -64.77 -34.6 78.73 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.4 ' O ' ' C ' ' A' ' 98' ' ' VAL . 51.1 m95 -81.94 -34.95 29.57 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.924 ' O ' HG23 ' A' ' 102' ' ' THR . 2.3 t -39.21 -55.21 3.16 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.184 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 17.2 Cg_endo -60.0 -37.19 86.58 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 121.553 1.502 . . . . 0.0 111.175 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -61.75 -42.68 99.28 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.162 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.92 -39.68 67.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.793 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 98' ' ' VAL . 44.1 p -62.71 -12.71 25.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.05 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -54.18 -41.59 68.73 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -87.85 -15.41 36.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.482 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.2 m 55.35 58.59 10.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.916 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -78.17 124.09 6.45 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.644 2.229 . . . . 0.0 112.01 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -92.27 2.97 56.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.729 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.35 155.18 91.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.88 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.33 149.11 57.58 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.96 2.44 . . . . 0.0 112.115 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.737 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -130.72 139.14 50.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.272 0.558 . . . . 0.0 110.521 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.653 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.0 mp -104.76 136.16 44.78 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.558 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.733 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 18.3 tp -88.11 128.43 35.43 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 155' ' ' VAL . 1.9 t -142.29 151.89 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.682 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.534 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -134.46 171.54 22.22 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.475 ' H ' ' HA ' ' A' ' 83' ' ' SER . 1.5 p -119.82 173.73 6.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.97 0.414 . . . . 0.0 110.461 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.604 ' O ' ' O ' ' A' ' 117' ' ' ILE . 33.8 mt-30 37.8 34.0 0.05 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.24 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.888 HG23 ' N ' ' A' ' 118' ' ' ASP . 2.5 tt 19.96 -143.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 123.595 0.559 . . . . 0.0 110.485 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.888 ' N ' HG23 ' A' ' 117' ' ' ILE . 59.5 t0 -59.98 -2.92 0.47 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.726 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.682 ' HB2' HG21 ' A' ' 85' ' ' VAL . 59.2 tp 132.52 92.01 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.182 0.926 . . . . 0.0 110.105 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.522 ' C ' ' O ' ' A' ' 119' ' ' LEU . 41.7 ptt85 . . . . . 0 N--CA 1.471 0.604 0 O-C-N 124.201 0.938 . . . . 0.0 111.625 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.1 mm . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.913 0.387 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.954 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.0 OUTLIER -130.91 -53.89 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.57 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 138' ' ' THR . 66.1 Cg_endo -92.87 -36.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.559 2.173 . . . . 0.0 113.294 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.53 -70.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.47 ' O ' HD13 ' A' ' 145' ' ' LEU . 43.3 p -123.11 4.42 9.27 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.954 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -79.84 -71.08 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.829 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.41 ' OE1' ' CD1' ' A' ' 154' ' ' TYR . 77.7 mm-40 -73.24 -31.46 64.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -56.97 -38.26 72.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.69 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 145' ' ' LEU . 9.9 mp -86.06 -6.91 58.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -91.17 -61.56 1.63 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.129 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -61.07 -37.8 83.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.192 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.67 -12.61 23.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 0.6 OUTLIER -124.71 29.4 6.24 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.485 -178.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 49.0 mttp 95.01 143.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.375 0.67 . . . . 0.0 111.454 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 152.88 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.104 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 151' ' ' ALA . 89.1 t -159.32 -59.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.232 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 12.3 mmtm -104.69 -170.94 1.83 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.605 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 153' ' ' LYS . 18.5 m-85 -153.67 96.4 2.0 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.707 ' O ' HG13 ' A' ' 113' ' ' VAL . 13.2 m -134.79 98.49 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-O 121.36 0.6 . . . . 0.0 110.559 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.561 ' O ' ' OG1' ' A' ' 161' ' ' THR . 91.1 mt-10 -103.16 99.06 8.9 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.534 ' SG ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -119.0 155.68 30.96 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 123.306 1.527 . . . . 0.0 114.362 -175.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' LEU . 47.0 t -164.07 94.73 0.75 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 111.341 -2.663 . . . . 0.0 106.858 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 39.54 26.58 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.647 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.737 ' O ' ' N ' ' A' ' 162' ' ' GLN . 76.0 mt -142.05 -81.17 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.169 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.561 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -57.19 45.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 O-C-N 123.36 0.412 . . . . 0.0 110.778 -178.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.773 HE22 ' H ' ' A' ' 27' ' ' LYS . 77.2 mt-30 -85.73 14.67 5.53 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.8 mttt -88.95 1.75 54.96 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 112.613 -2.085 . . . . 0.0 107.115 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.61 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -129.74 -73.6 0.14 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.534 HD12 ' SG ' ' A' ' 157' ' ' CYS . 12.4 mt -41.72 -17.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.017 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.61 ' N ' ' O ' ' A' ' 164' ' ' GLY . 22.3 tttp -83.06 -48.47 10.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' GLY . 21.2 m120 -75.1 2.38 10.85 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.225 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 169' ' ' PHE . 24.7 t -84.1 -53.72 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.628 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 168' ' ' VAL . 6.0 m-85 -37.31 -52.78 1.1 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.207 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 53.1 p-10 -65.8 -39.23 90.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.199 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.615 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 99.2 mt-10 -70.67 -22.05 62.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.767 0.318 . . . . 0.0 110.7 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.581 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -63.41 -34.21 77.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.49 -37.45 70.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.333 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.6 tp -57.25 -34.51 68.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.541 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 172' ' ' ALA . . . -63.51 -23.69 67.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.152 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 4' ' ' ILE . . . -63.95 -30.96 72.0 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.328 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.39 -35.54 70.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.607 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 99.989999999999995 110.679 -179.816 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 3' ' ' THR . 89.7 mt-30 . . . . . 0 C--O 1.227 -0.107 0 CA-C-O 120.684 0.278 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.463 ' H ' HG22 ' A' ' 3' ' ' THR . 0.5 OUTLIER -39.39 140.77 0.42 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 11.0 tp -130.35 152.43 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.955 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.463 ' CB ' HG22 ' A' ' 75' ' ' THR . 55.7 mttp -102.5 162.79 12.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.293 0.568 . . . . 0.0 111.567 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.53 157.2 46.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.329 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.75 ' O ' HG23 ' A' ' 9' ' ' VAL . 61.5 t -122.16 134.81 64.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.54 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.3 p -50.05 125.73 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.223 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 7' ' ' VAL . 21.4 t -127.04 133.44 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.424 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.581 ' HA3' HG13 ' A' ' 93' ' ' VAL . . . 106.06 -67.99 0.24 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 60' ' ' GLY . 81.7 m-20 58.53 -82.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.581 0.229 . . . . 0.0 111.377 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 40.57 33.75 0.62 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 47.88 101.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.789 0.328 . . . . 0.0 110.564 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.79 HG23 ' H ' ' A' ' 15' ' ' GLY . 26.4 m -135.5 -111.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.057 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.79 ' H ' HG23 ' A' ' 14' ' ' VAL . . . -169.12 63.64 0.18 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' HD2' ' H ' ' A' ' 58' ' ' THR . 16.2 mttp -73.11 -2.9 23.28 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.215 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.8 p -61.43 -41.33 97.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.295 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' ILE . 99.2 m -95.81 -7.57 36.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.054 0.454 . . . . 0.0 111.013 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.905 HD11 HG12 ' A' ' 113' ' ' VAL . 24.9 tp -66.7 -68.25 0.39 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.109 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.461 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 67.4 mt -65.66 -26.48 67.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.615 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 18' ' ' CYS . 3.6 tt -58.86 -18.93 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.697 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -66.53 -75.95 0.09 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.397 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.735 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.9 p90 -41.24 -31.8 0.24 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.659 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.466 ' N ' ' CG ' ' A' ' 23' ' ' TYR . 2.5 m -57.12 -46.68 82.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.272 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.445 ' OG1' ' C ' ' A' ' 24' ' ' THR . 0.0 OUTLIER 175.99 -6.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.524 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 59.1 t-20 57.3 87.13 0.07 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.756 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -89.93 8.18 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.414 ' N ' ' HB1' ' A' ' 159' ' ' ALA . 0.8 OUTLIER 62.79 148.93 0.1 OUTLIER Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.288 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -42.04 143.18 1.32 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.247 1.965 . . . . 0.0 112.413 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.1 p -130.9 154.89 47.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.305 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' OE2' ' CE2' ' A' ' 32' ' ' TYR . 22.1 pt-20 -71.28 -15.65 62.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.854 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.422 ' CE2' ' OE2' ' A' ' 31' ' ' GLU . 69.3 m-85 -112.51 138.35 49.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.647 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.7 77.67 69.58 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.063 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.22 140.01 34.41 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.715 2.277 . . . . 0.0 112.334 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.7 p -116.6 25.68 10.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.271 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 m -124.05 160.49 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.628 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.449 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 80.9 t80 59.78 72.04 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.522 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -65.01 147.71 52.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.348 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.509 ' O ' ' O ' ' A' ' 55' ' ' LEU . 10.3 m120 -89.49 144.96 25.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.383 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.1 p90 -175.57 -4.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.556 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.98 99.8 3.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG21 ' OH ' ' A' ' 23' ' ' TYR . 21.8 t -140.78 133.45 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.17 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.9 111.92 24.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.419 . . . . 0.0 110.825 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.419 HG23 HG12 ' A' ' 42' ' ' VAL . 58.7 t -137.43 145.83 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.154 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.657 ' N ' ' SD ' ' A' ' 45' ' ' MET . 2.3 mmt -97.08 132.93 42.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 170' ' ' ASP . 4.8 mt -120.66 127.0 75.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.141 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.73 31.12 5.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.05 52.13 6.48 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -138.75 79.07 29.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 36.1 Cg_exo -52.82 103.96 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.941 2.427 . . . . 0.0 112.965 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 76.6 m-85 -159.99 169.66 22.97 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.589 ' C ' HD22 ' A' ' 53' ' ' LEU . 10.1 t -140.32 135.91 32.68 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.61 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.861 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -115.39 132.86 56.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.122 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 40' ' ' TYR . . . -107.77 126.41 8.31 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 55' ' ' LEU . 4.0 mp -136.3 125.97 25.46 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.845 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.468 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 69.7 m-85 -77.39 160.69 28.57 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.611 ' C ' HG22 ' A' ' 58' ' ' THR . 55.9 p30 -166.26 174.73 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.643 ' OG1' ' N ' ' A' ' 59' ' ' ALA . 1.7 t 147.63 -140.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.826 0.704 . . . . 0.0 109.568 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.643 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -140.37 135.55 32.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.132 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' ' OD2' ' A' ' 11' ' ' ASP . . . . . . . . 0 CA--C 1.524 0.655 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.518 0.199 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.675 ' OG1' HG23 ' A' ' 7' ' ' VAL . 5.5 p -85.05 159.9 20.11 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.469 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 75' ' ' THR . 97.0 m-20 -139.96 3.2 2.0 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.83 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.451 HG12 HD13 ' A' ' 111' ' ' LEU . 2.4 t -109.26 109.71 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.615 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -78.44 122.5 25.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.399 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.651 HD23 ' C ' ' A' ' 79' ' ' LEU . 7.4 tt -121.52 116.73 25.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.379 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.472 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 41.4 t -90.37 130.19 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.268 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 118.84 26.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.72 ' HA ' HG11 ' A' ' 14' ' ' VAL . 36.8 p90 -144.69 163.91 32.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.74 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 85' ' ' VAL . 35.6 t -85.83 134.22 33.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.621 HG13 ' CG2' ' A' ' 138' ' ' THR . 71.0 t -41.81 -17.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.103 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.594 ' HB ' HD21 ' A' ' 119' ' ' LEU . 38.9 t -135.22 131.81 52.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.731 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 2.9 m 151.94 81.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.19 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -52.75 -29.61 42.97 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.385 2.056 . . . . 0.0 111.855 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.0 m -71.08 -49.98 38.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 109.796 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 93' ' ' VAL . 59.6 p -62.02 -30.91 71.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.467 ' CG ' HD11 ' A' ' 137' ' ' ILE . 91.0 t80 -57.8 -50.71 72.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.498 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -79.09 -18.79 52.72 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.164 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 25.4 m120 -93.78 -10.42 34.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.344 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.581 HG13 ' HA3' ' A' ' 10' ' ' GLY . 52.3 t -104.4 -71.25 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.392 0.615 . . . . 0.0 112.241 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.675 ' HE2' HD11 ' A' ' 112' ' ' LEU . 78.8 mttt -69.67 -21.3 63.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.272 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.544 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 97.4 mt-10 -106.07 -38.4 6.31 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -76.21 -30.66 58.06 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.881 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 23.3 m95 -89.57 -42.61 11.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.299 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 2.2 t -40.22 -54.38 4.67 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.249 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.544 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 27.9 Cg_endo -64.2 -37.84 39.07 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.649 1.566 . . . . 0.0 112.162 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.57 -37.94 89.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.257 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 101' ' ' ILE . 22.8 pt -86.29 -28.22 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.127 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 105' ' ' CYS . 86.3 m -59.99 -36.47 77.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.922 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -56.18 -37.69 69.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.88 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -55.99 -46.32 78.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.935 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 102' ' ' THR . 1.3 m -146.83 155.39 48.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.693 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.76 -60.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.482 2.122 . . . . 0.0 111.872 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -125.31 128.47 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.529 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.596 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -157.42 152.39 21.31 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.079 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -56.73 126.01 20.89 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.028 1.819 . . . . 0.0 111.39 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.691 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -116.58 111.29 19.68 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.453 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.687 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.7 mp -86.54 123.14 31.42 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.053 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.675 HD11 ' HE2' ' A' ' 94' ' ' LYS . 23.7 tp -100.94 123.58 45.34 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.905 HG12 HD11 ' A' ' 19' ' ' LEU . 4.7 t -136.18 147.47 28.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.47 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.495 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -121.14 153.01 16.69 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 p -114.3 172.49 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.168 0.509 . . . . 0.0 110.804 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.578 ' O ' ' O ' ' A' ' 117' ' ' ILE . 31.5 mt-30 48.73 21.29 0.41 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.164 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.793 HG23 ' N ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER 36.32 -160.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.401 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.793 ' N ' HG23 ' A' ' 117' ' ' ILE . 19.1 m-20 -69.07 75.42 0.33 Allowed 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.463 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 85' ' ' VAL . 98.0 mt 64.86 85.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.832 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 119' ' ' LEU . 57.1 ttm-85 . . . . . 0 N--CA 1.472 0.646 0 O-C-N 124.108 0.88 . . . . 0.0 111.132 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 137' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.548 0.213 . . . . 0.0 111.153 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.621 ' CG2' HG13 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -118.69 -50.28 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 138' ' ' THR . 72.9 Cg_endo -81.87 -83.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.127 1.885 . . . . 0.0 114.464 -176.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.51 -43.8 98.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.701 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 137' ' ' ILE . 81.9 p -60.56 -40.96 93.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -77.31 -36.46 54.02 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.601 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.66 -42.33 96.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.755 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -66.4 -46.57 76.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.804 0.335 . . . . 0.0 110.986 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.4 tt -53.72 -35.16 60.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.06 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.03 -38.38 88.27 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.39 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -62.91 -39.78 95.6 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.789 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -52.31 -32.56 38.34 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 146' ' ' ALA . 62.6 mt -133.29 -113.41 0.22 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.479 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.718 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 51.3 mttp -143.83 -132.94 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.464 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 156.09 -165.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.866 0.365 . . . . 0.0 110.448 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.615 HG23 ' H ' ' A' ' 110' ' ' PHE . 19.8 t -143.83 -51.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 3.5 tttm -143.62 -169.92 3.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.847 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -166.18 96.02 0.59 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 114' ' ' GLY . 16.5 m -136.14 153.61 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.474 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.594 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -133.11 94.0 3.27 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.562 ' SG ' HD22 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -110.87 148.1 33.14 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 123.155 1.455 . . . . 0.0 113.504 -176.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.47 ' C ' ' N ' ' A' ' 160' ' ' LEU . 8.8 t -155.3 91.29 1.32 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 111.576 -2.556 . . . . 0.0 105.224 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.484 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . 42.03 28.16 0.09 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.739 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.702 ' O ' ' N ' ' A' ' 162' ' ' GLN . 47.0 mt -139.52 -74.02 0.37 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.841 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.71 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.1 m -57.82 44.12 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 120.918 0.39 . . . . 0.0 112.05 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.702 ' N ' ' O ' ' A' ' 160' ' ' LEU . 38.4 tt0 -74.83 19.32 0.14 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.71 ' H ' ' C ' ' A' ' 161' ' ' THR . 56.8 mttp -108.14 -1.49 20.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.779 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 168' ' ' VAL . . . -133.17 -38.07 0.23 Allowed Glycine 0 C--O 1.225 -0.46 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.735 HD23 ' H ' ' A' ' 23' ' ' TYR . 9.9 tp -73.62 -22.99 59.84 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.034 0.445 . . . . 0.0 110.53 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -61.86 -34.15 75.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.597 ' O ' ' N ' ' A' ' 170' ' ' ASP . 7.9 m120 -72.29 -59.07 2.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 165' ' ' LEU . 59.0 t -29.25 -55.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.446 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.688 ' CZ ' ' CZ ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -56.9 -48.76 77.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.316 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.609 ' HB2' HG21 ' A' ' 46' ' ' ILE . 56.0 t0 -67.63 -47.44 69.6 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 111.477 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.51 -29.05 70.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.324 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.61 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . . . -57.43 -32.49 66.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.32 -37.09 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.741 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.8 -37.73 77.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.426 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.54 -28.05 69.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.589 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.461 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . . . -57.26 -37.1 71.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.979 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 177' ' ' LEU . 8.0 mp -60.04 -32.18 70.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.669 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.381 -0.372 . . . . 99.989999999999995 110.504 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.458 -0.049 0 CA-C-O 121.029 0.442 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 3' ' ' THR . 3.5 t -40.37 125.59 2.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.392 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.49 149.93 22.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.894 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -105.08 147.3 28.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.223 0.535 . . . . 0.0 112.002 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.592 ' SG ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -132.61 145.23 50.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.393 179.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.407 HG13 ' CD1' ' A' ' 56' ' ' PHE . 16.6 t -127.4 135.9 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.548 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 56' ' ' PHE . 5.2 t -74.81 120.81 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.443 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.648 HG11 HD13 ' A' ' 101' ' ' ILE . 38.9 t -120.5 130.66 74.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.875 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.51 -162.01 29.67 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' ALA . 44.7 t0 -148.85 -117.09 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.992 0.425 . . . . 0.0 111.084 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.571 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -29.83 -29.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.657 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -38.18 136.65 0.61 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.421 0.611 . . . . 0.0 110.046 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 12' ' ' GLY . 31.5 m -125.88 27.48 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.77 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.53 ' CA ' HE21 ' A' ' 116' ' ' GLN . . . -143.22 36.87 1.54 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.053 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.704 ' NZ ' ' HB3' ' A' ' 59' ' ' ALA . 26.8 mttt -74.59 -7.58 53.61 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.043 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 19' ' ' LEU . 85.7 m -78.38 -69.63 0.54 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.897 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.694 ' HA ' HD12 ' A' ' 21' ' ' ILE . 32.4 m -61.75 0.16 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.357 0.598 . . . . 0.0 109.913 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.756 ' O ' HD13 ' A' ' 165' ' ' LEU . 7.8 tt -69.72 -52.29 26.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.989 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.63 -32.45 64.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.144 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 18' ' ' CYS . 77.4 mt -55.03 -20.26 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.929 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.489 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 5.2 m -50.62 -74.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.457 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.707 ' CZ ' ' CZ ' ' A' ' 169' ' ' PHE . 23.9 p90 -63.03 -28.08 69.85 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.141 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.4 m -51.17 -46.03 61.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.562 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.9 m -157.44 -19.46 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 110.41 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 22' ' ' SER . 1.4 m-80 64.16 133.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.904 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.739 ' NZ ' HE22 ' A' ' 162' ' ' GLN . 40.6 mttp 66.71 59.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.734 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 21' ' ' ILE . 1.3 tp -128.87 67.28 77.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.4 0.619 . . . . 0.0 110.295 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -79.55 6.52 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.147 2.564 . . . . 0.0 112.533 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.6 m -49.18 137.21 14.03 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.384 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.26 -34.81 78.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.799 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -59.03 -40.85 86.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.527 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 33' ' ' VAL . 70.8 t 52.39 77.84 0.43 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.573 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.07 141.73 36.88 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.603 2.202 . . . . 0.0 112.038 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.5 m -126.26 149.61 48.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.15 157.63 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.396 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -57.25 -41.03 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.52 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.35 130.15 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.978 0.418 . . . . 0.0 111.042 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LEU . 87.4 m-20 -123.9 14.95 9.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.516 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.547 ' CB ' ' CE1' ' A' ' 56' ' ' PHE . 22.3 p90 -175.73 12.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.9 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.22 99.9 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.844 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.6 t -144.68 140.57 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.889 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 43' ' ' THR . 7.6 t -124.51 132.01 53.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.343 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.8 t -133.69 138.9 49.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.762 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.9 mtm -113.49 120.92 42.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.153 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.8 pp -128.15 154.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.936 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.491 ' O ' ' OE1' ' A' ' 49' ' ' GLU . . . 32.81 27.95 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 74.19 50.22 10.83 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.491 ' OE1' ' O ' ' A' ' 47' ' ' GLY . 4.1 mp0 -130.4 96.53 24.16 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.44 ' C ' ' CD1' ' A' ' 51' ' ' TYR . 57.7 Cg_endo -76.8 108.65 2.69 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.05 1.833 . . . . 0.0 113.033 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.583 ' CE1' HG23 ' A' ' 173' ' ' ILE . 93.7 m-85 -150.55 165.44 33.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.957 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.21 125.78 30.14 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.709 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.562 HD13 ' HB1' ' A' ' 172' ' ' ALA . 51.8 tp -113.1 125.4 54.33 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.813 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -89.43 136.42 13.54 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.544 HD12 ' SG ' ' A' ' 6' ' ' CYS . 29.2 tp -137.11 125.69 23.7 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.85 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CE1' ' CB ' ' A' ' 40' ' ' TYR . 26.3 m-85 -97.93 -177.93 3.92 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 177.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.495 ' O ' ' OG1' ' A' ' 58' ' ' THR . 50.8 p30 -171.49 -174.89 1.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.629 ' H ' ' CB ' ' A' ' 16' ' ' LYS . 29.3 p 56.89 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.087 0.47 . . . . 0.0 111.664 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.704 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . . . -177.77 149.35 0.59 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.075 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.662 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.744 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.56 0.219 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.4 p 48.66 46.48 21.3 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.96 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -62.03 -37.81 86.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.381 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.532 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -119.34 99.79 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.345 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.579 ' C ' HD12 ' A' ' 79' ' ' LEU . 98.2 m-85 -71.14 127.76 33.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.958 -177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.592 HD13 ' SG ' ' A' ' 6' ' ' CYS . 9.1 mp -114.69 137.13 52.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.766 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 113' ' ' VAL . 62.3 t -104.75 132.4 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.578 ' SG ' HD13 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -114.38 123.81 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 111.54 -179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.464 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 44.1 p90 -150.78 128.53 11.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.047 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -62.64 126.32 26.92 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 156' ' ' GLU . 21.5 t -66.69 -20.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.675 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 85' ' ' VAL . 7.7 p -105.79 11.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.183 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.14 84.42 45.79 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 0.0 110.416 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -52.84 -27.38 34.48 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.457 2.104 . . . . 0.0 112.491 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.8 m -64.91 -44.84 88.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.199 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.691 ' O ' HG23 ' A' ' 93' ' ' VAL . 83.8 p -70.71 -24.91 62.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 0.0 110.995 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.482 ' CG ' HG21 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -73.4 -40.45 64.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.44 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.09 -37.33 84.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.148 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -93.01 -39.82 10.89 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.071 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 89' ' ' SER . 37.4 t -51.68 -64.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.41 . . . . 0.0 111.573 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -72.61 -8.58 55.98 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.031 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.545 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 81.0 tt0 -103.77 -71.99 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -88.07 -9.13 54.29 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.41 ' CE2' ' HB2' ' A' ' 11' ' ' ASP . 93.0 m95 -97.4 -41.24 8.32 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.135 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.479 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -53.1 -54.64 42.15 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.545 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 17.9 Cg_endo -60.47 -34.05 93.34 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.674 1.583 . . . . 0.0 112.283 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -57.96 -37.56 74.4 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.954 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.648 HD13 HG11 ' A' ' 9' ' ' VAL . 44.1 pt -95.37 -31.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.495 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.487 HG22 ' HG3' ' A' ' 106' ' ' PRO . 28.7 m -51.08 -37.86 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.316 . . . . 0.0 110.948 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -50.63 -31.84 17.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.994 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.632 ' ND1' ' SG ' ' A' ' 105' ' ' CYS . 50.4 t-80 -57.33 -45.58 84.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.346 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.632 ' SG ' ' ND1' ' A' ' 104' ' ' HIS . 0.8 OUTLIER -174.59 82.74 0.34 Allowed Pre-proline 0 C--O 1.233 0.188 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.962 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.487 ' HG3' HG22 ' A' ' 102' ' ' THR . 18.0 Cg_exo -63.13 -16.78 56.64 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.921 2.414 . . . . 0.0 112.808 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -77.64 -3.19 39.67 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.633 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 105' ' ' CYS . 13.9 p -94.8 150.31 37.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.826 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.95 142.69 93.82 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.437 2.091 . . . . 0.0 111.274 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.705 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -119.98 125.83 49.34 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.548 0.69 . . . . 0.0 111.404 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -99.92 133.69 43.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.777 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.8 mt -99.99 124.86 45.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.444 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 80' ' ' VAL . 41.5 t -128.05 129.44 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.302 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -106.47 142.54 15.65 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.431 HG21 ' HB1' ' A' ' 13' ' ' ALA . 0.6 OUTLIER -102.32 169.1 8.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.339 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.915 ' O ' ' N ' ' A' ' 118' ' ' ASP . 56.8 mm-40 52.1 23.52 2.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.918 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.921 HG23 ' H ' ' A' ' 119' ' ' LEU . 15.8 tt 27.66 -46.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.915 ' N ' ' O ' ' A' ' 116' ' ' GLN . 47.0 t0 120.69 6.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.401 1.081 . . . . 0.0 108.505 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.921 ' H ' HG23 ' A' ' 117' ' ' ILE . 8.9 tp -133.13 -24.74 1.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.8 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.768 HH21 ' NE2' ' A' ' 116' ' ' GLN . 65.5 ttp85 . . . . . 0 CA--C 1.516 -0.345 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.482 HG21 ' CG ' ' A' ' 90' ' ' PHE . 4.8 mp . . . . . 0 C--O 1.232 0.133 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.805 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -132.31 -52.48 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.19 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.1 Cg_endo -83.87 -93.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.975 1.783 . . . . 0.0 114.585 -175.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.0 -38.83 76.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.554 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.2 p -69.59 -34.55 74.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.602 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -91.96 -42.3 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.361 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 139' ' ' PRO . 84.2 tt0 -60.98 -39.67 90.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.001 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -63.53 -43.92 95.73 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.171 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.621 HD22 ' N ' ' A' ' 145' ' ' LEU . 3.1 mm? -79.23 -7.16 58.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.913 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.03 -66.43 0.9 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.581 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -59.77 -37.56 79.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.491 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -93.66 -13.82 27.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.8 tp -134.75 51.09 2.13 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.249 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.702 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 67.7 mttm 65.11 158.7 0.1 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.205 0.526 . . . . 0.0 111.311 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 158.06 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.444 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.648 HG12 ' HG3' ' A' ' 153' ' ' LYS . 72.6 t -142.5 -66.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.379 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.648 ' HG3' HG12 ' A' ' 152' ' ' VAL . 25.0 mttm -136.42 -167.75 2.12 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.411 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -150.27 97.15 2.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 155' ' ' VAL . 21.1 m -116.2 97.96 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.147 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.647 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -95.33 98.75 10.81 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.683 ' HB2' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -125.61 149.31 48.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 123.007 1.384 . . . . 0.0 113.098 -176.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.607 ' OG ' ' NE ' ' A' ' 120' ' ' ARG . 22.3 t -157.03 92.76 1.29 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 111.906 -2.406 . . . . 0.0 106.289 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 42.27 27.42 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.242 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.676 ' O ' ' N ' ' A' ' 162' ' ' GLN . 19.8 mt -144.57 -73.37 0.26 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.125 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.647 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 2.2 m -57.06 65.31 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.315 0.578 . . . . 0.0 111.8 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.739 HE22 ' NZ ' ' A' ' 27' ' ' LYS . 7.9 pt20 -82.68 15.07 2.77 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.592 ' H ' ' C ' ' A' ' 161' ' ' THR . 24.9 tttt -86.44 -6.53 58.89 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 113.421 -1.718 . . . . 0.0 108.486 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 167' ' ' ASN . . . -131.4 -74.73 0.12 Allowed Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.756 HD13 ' O ' ' A' ' 19' ' ' LEU . 14.8 mt -41.49 -22.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.746 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.6 tttt -77.85 -46.59 21.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 164' ' ' GLY . 32.4 m120 -76.03 -0.45 21.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.784 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 171' ' ' GLU . 46.7 t -83.91 -60.14 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.762 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.707 ' CZ ' ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -43.05 -45.64 5.32 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.018 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.653 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 32.6 p30 -70.03 -30.56 67.88 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.779 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.653 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 85.5 tt0 -64.72 -31.38 72.58 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.133 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.562 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -60.12 -29.43 68.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.583 HG23 ' CE1' ' A' ' 51' ' ' TYR . 77.3 mt -52.41 -39.75 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.14 -37.79 88.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.589 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -76.78 -13.03 60.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.708 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -66.14 -29.21 69.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.916 0.388 . . . . 0.0 110.15 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.65 -35.27 70.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.431 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 99.989999999999995 110.575 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.754 HG22 HG22 ' A' ' 52' ' ' THR . 40.9 p -42.73 113.68 0.5 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.384 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 176' ' ' ALA . 17.8 tt -117.28 138.97 46.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.133 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -96.47 150.85 20.15 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.136 0.493 . . . . 0.0 111.106 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.886 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -143.1 137.03 28.87 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.013 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 p -106.61 139.66 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.692 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 79' ' ' LEU . 57.6 t -115.63 131.35 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.592 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 t -128.58 138.69 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.839 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 60' ' ' GLY . . . -135.4 -177.33 14.89 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.497 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 53.8 p30 -72.25 -123.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.345 . . . . 0.0 111.221 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.711 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -151.21 72.51 0.28 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 152.23 27.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.58 0.224 . . . . 0.0 111.398 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.57 HG11 ' H ' ' A' ' 83' ' ' SER . 16.8 m -125.28 133.85 68.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.412 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.3 93.59 1.86 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.429 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -73.27 -8.53 56.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.013 0.435 . . . . 0.0 110.102 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -59.27 -55.12 38.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.029 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HA ' HD12 ' A' ' 21' ' ' ILE . 82.6 m -58.91 -36.19 74.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.701 . . . . 0.0 109.317 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.659 ' O ' HD23 ' A' ' 165' ' ' LEU . 4.0 tt -65.71 -54.09 32.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.699 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.803 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -59.78 -32.53 70.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.063 0.459 . . . . 0.0 110.207 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 21' ' ' ILE . 33.7 mt -62.36 -9.6 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.378 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.462 ' CB ' HD23 ' A' ' 165' ' ' LEU . 23.3 t -53.43 -82.16 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.936 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -52.62 -31.61 37.45 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.851 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.3 m -47.18 -39.63 14.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -140.98 -87.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.985 178.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.559 ' N ' ' OG1' ' A' ' 25' ' ' THR . 2.1 t-20 156.58 83.94 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.798 ' H ' HE21 ' A' ' 162' ' ' GLN . 24.7 tttt 65.53 91.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.646 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 tp -125.14 85.64 57.84 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.45 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.61 47.18 2.25 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.85 2.367 . . . . 0.0 112.692 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.9 m -64.13 152.67 39.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.349 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -59.41 -39.57 83.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.555 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.6 ' CE2' ' O ' ' A' ' 33' ' ' VAL . 81.7 t80 -137.38 136.27 37.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.416 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 17.1 m -78.03 148.78 75.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.387 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.97 -162.4 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.386 2.057 . . . . 0.0 112.059 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.3 p -76.11 164.88 25.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -126.56 158.0 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.407 . . . . 0.0 110.805 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -117.93 161.04 20.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.363 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 51.5 p30 -77.92 4.29 12.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.974 0.416 . . . . 0.0 110.454 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -127.28 132.17 50.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.14 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -125.7 15.71 8.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.0 97.69 10.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.225 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.7 t -111.91 143.36 21.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 43' ' ' THR . 14.2 t -118.84 121.49 40.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.756 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 169' ' ' PHE . 33.1 m -136.11 166.41 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.59 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.2 mtm -111.82 128.51 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.028 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 46' ' ' ILE . 10.9 tt -130.63 123.57 55.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.442 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.26 28.55 54.89 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.87 51.34 7.91 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -130.52 89.54 43.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.597 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 41.9 Cg_endo -74.72 103.9 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.135 1.89 . . . . 0.0 112.707 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 53.2 m-85 -162.01 174.81 12.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.564 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.754 HG22 HG22 ' A' ' 3' ' ' THR . 4.2 t -145.94 141.67 27.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.908 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.98 HD13 ' HB1' ' A' ' 172' ' ' ALA . 59.2 tp -107.84 129.24 55.09 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.607 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -96.48 119.58 6.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.596 HD23 ' SG ' ' A' ' 6' ' ' CYS . 71.7 mt -115.99 153.31 31.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.644 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 56' ' ' PHE . 46.2 t80 -135.52 32.66 3.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.446 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' O ' ' OG1' ' A' ' 58' ' ' THR . 49.5 p30 -80.44 -173.59 4.16 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.638 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 1.2 m 168.74 -58.06 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.371 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . 164.02 139.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.204 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 10' ' ' GLY . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 . . . . . 0 CA--C 1.523 -0.06 0 CA-C-O 120.783 0.325 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.0 p -129.82 158.43 39.48 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.564 ' HB2' HD11 ' A' ' 4' ' ' ILE . 93.3 m-20 -121.84 -23.79 5.4 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.221 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.548 HG21 ' HB1' ' A' ' 175' ' ' ALA . 21.3 t -131.16 124.27 55.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.526 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.498 ' C ' HD12 ' A' ' 79' ' ' LEU . 97.5 m-85 -89.8 127.38 35.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.886 HD22 ' SG ' ' A' ' 6' ' ' CYS . 10.6 mp -104.64 135.58 45.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.814 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.554 HG11 HG23 ' A' ' 98' ' ' VAL . 41.3 t -117.83 131.94 69.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.794 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.64 135.82 53.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.306 0.574 . . . . 0.0 111.315 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.989 ' CG ' HG11 ' A' ' 93' ' ' VAL . 41.2 p90 -160.41 132.29 6.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.758 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.57 ' H ' HG11 ' A' ' 14' ' ' VAL . 75.7 p -59.0 135.98 57.8 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.447 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.594 ' O ' HG22 ' A' ' 84' ' ' VAL . 9.0 p -114.76 23.64 5.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.197 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.678 HG23 HD12 ' A' ' 119' ' ' LEU . 8.7 p -63.6 -38.06 81.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.273 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -133.77 155.78 80.05 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.562 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -59.79 -13.59 23.02 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.897 2.398 . . . . 0.0 112.684 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 m -66.16 -67.06 0.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.004 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.542 ' O ' HG12 ' A' ' 93' ' ' VAL . 59.3 m -60.61 -38.16 83.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.693 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' CZ ' ' OG1' ' A' ' 141' ' ' THR . 0.3 OUTLIER -60.03 -36.27 76.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.121 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.476 ' OE2' ' OE1' ' A' ' 95' ' ' GLU . 45.0 tp10 -81.91 -23.42 36.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.848 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.62 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 80.3 m-20 -85.84 5.46 32.6 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.989 HG11 ' CG ' ' A' ' 82' ' ' PHE . 1.5 p -119.07 -65.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.689 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.726 ' H ' HG13 ' A' ' 93' ' ' VAL . 74.0 mttt -54.8 -19.69 6.97 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.467 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.476 ' OE1' ' OE2' ' A' ' 91' ' ' GLU . 85.2 tt0 -113.89 -27.63 7.68 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -113.01 -40.31 3.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.62 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 47.4 m95 -90.63 -51.1 5.56 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.484 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.554 HG23 HG11 ' A' ' 80' ' ' VAL . 3.0 t -50.28 -58.9 8.27 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.4 Cg_endo -51.84 -39.13 68.61 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.652 1.568 . . . . 0.0 112.013 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.99 -43.79 98.32 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.015 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.2 mt -70.28 -36.56 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.494 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 105' ' ' CYS . 56.8 m -53.19 -43.33 67.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.852 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -63.39 -42.98 98.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.841 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.07 -42.39 98.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.63 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -103.97 161.57 22.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 0.0 111.204 -179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.469 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 41.5 Cg_endo -70.23 -157.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.856 2.371 . . . . 0.0 112.381 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -86.18 9.07 18.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.88 156.07 0.76 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.464 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.51 143.71 54.57 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.683 2.255 . . . . 0.0 111.821 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.752 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -129.72 114.84 16.48 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.852 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.95 122.72 27.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.424 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.603 HD13 ' CD2' ' A' ' 149' ' ' LEU . 27.5 tp -85.53 133.05 34.09 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.015 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.491 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -142.47 163.73 17.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.418 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.541 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -146.4 176.59 25.24 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 116' ' ' GLN . 9.2 p -127.94 179.93 5.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 117.191 0.496 . . . . 0.0 109.87 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.551 HE21 ' HB2' ' A' ' 120' ' ' ARG . 9.5 mt-30 37.36 33.64 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.687 HD12 ' H ' ' A' ' 118' ' ' ASP . 1.0 OUTLIER 23.82 -141.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.236 0 O-C-N 123.506 0.503 . . . . 0.0 111.149 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.687 ' H ' HD12 ' A' ' 117' ' ' ILE . 86.7 m-20 -86.65 -2.48 58.55 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.568 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.678 HD12 HG23 ' A' ' 85' ' ' VAL . 6.0 tp 178.11 45.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.677 0.275 . . . . 0.0 111.18 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.551 ' HB2' HE21 ' A' ' 116' ' ' GLN . 57.7 ttp180 . . . . . 0 C--N 1.326 -0.414 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 137' ' ' ILE . 10.1 tt . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.874 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.2 OUTLIER -131.12 -45.74 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.684 ' CD ' ' H ' ' A' ' 138' ' ' THR . 56.9 Cg_endo -88.2 -62.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.585 2.19 . . . . 0.0 114.389 -177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 139' ' ' PRO . 95.9 mt-10 -29.76 -72.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.422 ' OG1' ' CZ ' ' A' ' 90' ' ' PHE . 23.1 p -127.8 7.92 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.874 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -83.5 -70.64 0.55 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.754 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -74.1 -40.58 62.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.632 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -62.13 -36.48 81.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.38 . . . . 0.0 111.445 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 145' ' ' LEU . 35.6 tp -72.26 -22.47 61.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.232 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.65 -33.26 75.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.089 0.471 . . . . 0.0 110.81 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -59.89 -45.93 90.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.336 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -84.94 -29.53 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.736 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.603 ' CD2' HD13 ' A' ' 112' ' ' LEU . 55.5 tp -43.21 -28.46 0.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.268 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.527 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 63.0 mttm 88.17 -0.13 0.42 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.647 0.379 . . . . 0.0 110.009 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.46 -132.49 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.194 0.521 . . . . 0.0 111.518 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 110' ' ' PHE . 3.7 t -151.84 -54.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.336 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -107.25 -167.76 1.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.348 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.616 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 34.2 p90 -161.95 97.13 1.03 Allowed 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.61 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.957 0.884 . . . . 0.0 111.613 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.562 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -153.39 96.93 2.09 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.572 ' HA ' HG22 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -112.83 145.49 40.56 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 123.274 1.511 . . . . 0.0 113.157 -176.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.673 ' HB3' HG23 ' A' ' 117' ' ' ILE . 13.6 t -173.35 90.19 0.08 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 111.707 -2.497 . . . . 0.0 107.168 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 57.07 29.38 16.41 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.619 ' C ' ' H ' ' A' ' 162' ' ' GLN . 21.2 tp -156.18 -85.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.693 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.9 OUTLIER -46.41 -9.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.798 HE21 ' H ' ' A' ' 27' ' ' LYS . 19.4 mt-30 -51.35 -1.58 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.693 ' H ' ' C ' ' A' ' 161' ' ' THR . 43.0 mttm -82.01 -2.69 52.47 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -116.45 -70.13 0.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 19' ' ' LEU . 43.1 tp -39.81 -16.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.826 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 164' ' ' GLY . 79.3 tttt -80.99 -53.51 6.37 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 164' ' ' GLY . 40.1 t-20 -71.15 -2.51 16.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.667 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 171' ' ' GLU . 29.6 t -78.3 -47.45 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.016 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 168' ' ' VAL . 63.0 t80 -39.12 -43.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.533 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.7 -37.82 88.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.36 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 168' ' ' VAL . 96.8 mt-10 -72.71 -20.82 61.15 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.049 0.452 . . . . 0.0 110.132 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.98 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -64.66 -36.73 85.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.742 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.425 ' CG1' ' N ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -62.04 -36.45 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.425 ' N ' ' CG1' ' A' ' 173' ' ' ILE . 45.3 tp -61.39 -35.01 76.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.016 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.548 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -60.55 -29.66 69.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.852 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.753 ' HA ' HD12 ' A' ' 4' ' ' ILE . . . -65.98 -31.62 72.63 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.943 0.401 . . . . 0.0 110.285 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 32.8 tp -57.17 -35.86 70.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.671 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.41 ' OE2' ' OD2' ' A' ' 76' ' ' ASP . 97.0 mt-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 99.989999999999995 110.44 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 176' ' ' ALA . 91.2 mt-30 . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 121.17 0.509 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.668 HG22 ' HA ' ' A' ' 51' ' ' TYR . 11.4 p -84.01 157.22 21.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.117 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 76' ' ' ASP . 20.1 tt -134.12 152.9 34.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.821 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -103.04 146.79 27.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.036 0.445 . . . . 0.0 111.186 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -139.51 158.35 44.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.018 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.808 HG12 HG21 ' A' ' 75' ' ' THR . 12.2 p -127.6 134.4 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.771 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.665 HG11 HD21 ' A' ' 19' ' ' LEU . 13.6 t -110.98 133.81 55.31 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.812 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.3 t -114.62 132.47 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.225 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.37 123.34 7.76 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.538 ' OD1' ' NE1' ' A' ' 97' ' ' TRP . 25.5 t70 -82.76 121.48 26.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.602 0.239 . . . . 0.0 110.397 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.706 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 56.75 -0.82 0.14 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 82.12 125.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.745 HG23 ' H ' ' A' ' 15' ' ' GLY . 1.8 m -142.27 -88.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.816 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.745 ' H ' HG23 ' A' ' 14' ' ' VAL . . . -159.59 55.51 0.34 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.997 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.715 ' H ' ' CD ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.71 -34.64 78.31 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.673 -0.31 . . . . 0.0 111.339 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.1 m -52.18 -43.84 64.36 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.901 ' SG ' HD23 ' A' ' 28' ' ' LEU . 74.2 m -61.14 -26.97 68.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.168 0.509 . . . . 0.0 110.667 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.812 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -78.96 -35.91 42.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.173 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.64 HD11 ' HB3' ' A' ' 57' ' ' ASP . 81.4 mt -63.82 -36.09 82.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.487 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 28' ' ' LEU . 17.9 pt -98.78 12.85 5.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.616 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.579 ' CB ' HD13 ' A' ' 165' ' ' LEU . 13.1 p -48.36 -77.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.893 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.405 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 80.1 t80 -62.77 -38.06 89.11 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.582 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.424 ' C ' HG22 ' A' ' 25' ' ' THR . 0.6 OUTLIER -48.68 -44.69 38.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.265 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER 171.2 77.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.796 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.659 HD22 ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -58.05 83.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 25' ' ' THR . 24.1 mttm -148.17 60.26 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.901 HD23 ' SG ' ' A' ' 18' ' ' CYS . 11.0 tp -123.34 68.56 39.06 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.78 -14.0 26.89 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.561 2.174 . . . . 0.0 112.246 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.9 p -67.78 120.8 14.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.945 0.403 . . . . 0.0 110.628 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -67.8 -32.67 73.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.145 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -56.66 -41.47 77.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.03 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 33' ' ' VAL . 65.1 t 54.06 70.38 1.75 Allowed Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.432 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -53.93 137.45 68.65 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.817 2.345 . . . . 0.0 112.61 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.0 m -128.45 140.36 51.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.6 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.66 HG13 ' N ' ' A' ' 37' ' ' PHE . 9.1 p -159.75 -52.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.789 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.66 ' N ' HG13 ' A' ' 36' ' ' VAL . 66.9 t80 -100.07 130.79 46.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.845 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 89.9 m-20 -75.83 136.9 40.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.495 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -111.48 148.27 33.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.784 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.421 ' H ' ' H ' ' A' ' 41' ' ' ALA . 26.8 p90 -176.14 -7.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.98 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.421 ' H ' ' H ' ' A' ' 40' ' ' TYR . . . -138.79 103.25 4.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.393 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.6 131.82 62.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.641 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 43' ' ' THR . 15.3 t -105.64 123.03 47.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.744 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.78 157.3 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.473 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 66.1 mtm -129.97 132.0 46.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.338 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.446 HG21 ' HB2' ' A' ' 170' ' ' ASP . 17.6 tt -135.17 131.77 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.97 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.37 26.57 51.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.55 58.43 3.86 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -136.23 101.36 10.21 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.43 103.19 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 122.266 1.977 . . . . 0.0 113.004 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.668 ' HA ' HG22 ' A' ' 3' ' ' THR . 52.6 p90 -154.12 169.7 22.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.832 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.495 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.0 OUTLIER -136.11 125.47 24.89 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.093 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.84 HD13 ' HB1' ' A' ' 172' ' ' ALA . 43.5 tp -107.86 121.16 44.18 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.221 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -94.42 134.41 12.01 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.956 ' H ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -140.95 117.96 11.18 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.493 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.542 ' HB2' HG23 ' A' ' 7' ' ' VAL . 10.9 t80 -65.97 -158.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.64 ' HB3' HD11 ' A' ' 20' ' ' LEU . 50.2 p30 -166.88 172.76 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.652 0.263 . . . . 0.0 110.63 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.702 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 0.3 OUTLIER 35.31 -157.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 110.836 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . 158.23 -50.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.271 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.655 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.729 0.299 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.808 HG21 HG12 ' A' ' 7' ' ' VAL . 54.1 m -126.65 127.51 45.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.529 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.512 ' CB ' HD11 ' A' ' 4' ' ' ILE . 85.4 m-20 -83.63 -36.22 24.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.68 122.86 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.291 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -84.97 123.3 30.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.365 0.602 . . . . 0.0 111.377 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.553 HD22 HG22 ' A' ' 8' ' ' VAL . 7.4 tt -115.39 130.76 56.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.754 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -118.4 135.53 58.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.152 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.741 ' SG ' HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -130.79 132.07 45.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 110.893 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.795 ' CD1' HG21 ' A' ' 93' ' ' VAL . 44.5 p90 -152.84 143.89 23.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.173 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.631 ' H ' HG11 ' A' ' 14' ' ' VAL . 14.0 t -53.12 132.22 37.91 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 138' ' ' THR . 0.0 OUTLIER -99.51 24.18 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.755 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -113.8 7.82 7.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.659 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.43 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -124.29 150.01 62.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.124 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.93 -38.31 3.02 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.43 2.087 . . . . 0.0 113.345 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.1 p -85.67 -18.62 32.67 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.43 ' OG ' ' OG ' ' A' ' 86' ' ' SER . 50.6 m -59.09 -35.2 72.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.746 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 90' ' ' PHE . 2.1 p90 -89.77 -29.25 18.81 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.381 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 90' ' ' PHE . 98.7 mt-10 -63.73 -31.93 73.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.714 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -80.56 -38.09 30.21 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.939 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.795 HG21 ' CD1' ' A' ' 82' ' ' PHE . 76.5 t -68.39 -62.78 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.554 ' HE2' HD21 ' A' ' 112' ' ' LEU . 19.7 mttt -70.69 -7.12 42.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 76.7 tt0 -131.37 -52.97 1.02 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -74.34 -42.54 59.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.538 ' NE1' ' OD1' ' A' ' 11' ' ' ASP . 96.5 m95 -88.58 -32.77 17.96 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.518 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -53.22 -45.03 98.54 Favored Pre-proline 0 N--CA 1.466 0.364 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.526 -178.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 12.8 Cg_exo -64.0 -45.12 10.97 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.259 1.973 . . . . 0.0 111.515 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.64 -40.78 80.05 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.793 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.22 -35.38 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.418 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.2 m -52.75 -39.46 62.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.162 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.22 -46.43 79.5 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.625 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -61.14 -44.95 96.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.908 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.9 87.57 48.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.531 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -51.59 -34.84 54.35 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.312 2.008 . . . . 0.0 112.212 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -143.55 112.31 6.54 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.602 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.606 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -171.08 151.81 3.3 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.292 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.62 142.49 98.01 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.308 2.005 . . . . 0.0 111.257 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.725 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -135.92 137.4 41.32 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.39 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 111' ' ' LEU . 6.6 mp -95.46 130.27 42.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.74 HD22 ' HB2' ' A' ' 146' ' ' ALA . 34.2 tp -97.05 127.45 43.03 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.7 t -146.29 167.46 7.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.655 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -142.59 170.92 24.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.499 ' O ' HG22 ' A' ' 84' ' ' VAL . 3.1 p -122.9 177.6 5.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.182 0.515 . . . . 0.0 110.115 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.701 ' O ' ' N ' ' A' ' 118' ' ' ASP . 83.2 mt-30 57.78 11.28 1.3 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.402 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.742 ' CG2' ' H ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 35.57 19.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.342 0 CA-C-O 120.979 0.419 . . . . 0.0 111.178 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 116' ' ' GLN . 2.4 p30 50.48 13.82 0.14 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.692 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.9 tp -144.12 -36.1 0.35 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 119.804 -0.758 . . . . 0.0 112.816 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.742 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 8.0 tpm_? . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 137' ' ' ILE . 15.5 tt . . . . . 0 N--CA 1.465 0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.811 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 6.8 m -128.56 -30.5 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.811 ' CD ' ' H ' ' A' ' 138' ' ' THR . 79.7 Cg_exo -44.41 -59.7 1.03 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.691 1.594 . . . . 0.0 112.754 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -122.07 -35.14 3.21 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.73 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.7 m -53.98 -40.42 66.87 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.061 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.549 ' HB1' ' NZ ' ' A' ' 94' ' ' LYS . . . -80.18 -37.37 33.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.665 0.269 . . . . 0.0 111.265 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.2 -41.44 83.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.409 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.14 -42.42 99.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 110.513 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 89.3 mt -64.23 -34.12 77.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.326 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.74 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -73.73 -30.59 62.92 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.472 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -54.43 -38.26 66.07 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 149' ' ' LEU . 55.0 p30 -123.27 -26.56 4.27 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.59 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 5.9 tp -74.94 2.35 10.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.315 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.703 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 47.7 mttt 100.44 147.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.624 0.77 . . . . 0.0 110.384 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 155.25 -173.27 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.08 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 110' ' ' PHE . 46.3 t -150.35 -57.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.281 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -98.76 -176.36 3.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.656 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.619 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 31.6 p90 -170.62 97.13 0.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.958 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.461 HG22 ' C ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -161.3 -176.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.186 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.746 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.4 OUTLIER -148.18 96.08 2.57 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.838 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.721 ' SG ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -108.64 147.26 32.13 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 123.129 1.443 . . . . 0.0 113.058 -178.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.534 ' HB2' ' N ' ' A' ' 116' ' ' GLN . 5.3 t -165.94 90.98 0.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 111.64 -2.527 . . . . 0.0 106.102 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.813 ' HB1' ' H ' ' A' ' 28' ' ' LEU . . . 48.5 31.6 2.94 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.962 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.816 ' O ' ' N ' ' A' ' 162' ' ' GLN . 1.9 mt -153.46 -76.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.886 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.746 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 3.1 m -51.78 44.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.816 ' N ' ' O ' ' A' ' 160' ' ' LEU . 36.2 tt0 -72.7 8.47 1.46 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.707 ' H ' ' C ' ' A' ' 161' ' ' THR . 26.4 mttt -81.24 -6.31 58.73 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.16 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -126.89 -67.84 0.16 Allowed Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 106.648 -2.581 . . . . 0.0 106.648 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.721 HD12 ' SG ' ' A' ' 157' ' ' CYS . 4.7 mt -41.68 -7.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.652 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 164' ' ' GLY . 48.7 tttt -83.51 -45.49 13.53 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 164' ' ' GLY . 24.4 m120 -81.22 4.75 19.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.29 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 165' ' ' LEU . 58.2 t -86.8 -62.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.765 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 23' ' ' TYR . 78.4 m-85 -45.19 -40.44 7.21 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.217 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 46' ' ' ILE . 59.5 t0 -68.04 -42.96 79.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.203 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.99 -27.85 69.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.973 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.84 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -62.76 -32.29 73.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.92 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.513 HG22 ' CG ' ' A' ' 51' ' ' TYR . 1.1 pp -64.61 -27.21 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.338 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.84 -35.02 79.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.569 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.46 -28.93 62.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.839 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -59.46 -42.18 91.41 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.85 -25.93 66.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.411 . . . . 0.0 110.483 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 99.989999999999995 110.52 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' THR . 90.4 mt-30 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.871 0.367 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -40.52 134.96 1.65 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.739 HD11 ' OD2' ' A' ' 76' ' ' ASP . 5.2 tp -123.79 144.6 32.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.727 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HA ' ' H ' ' A' ' 54' ' ' GLY . 91.2 mttt -100.88 153.83 19.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.272 0.558 . . . . 0.0 111.365 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -135.65 160.38 38.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.892 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.537 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 33.1 m -125.4 157.47 34.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.458 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.477 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 21.6 t -108.76 126.65 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.294 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.9 t -133.66 129.26 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.651 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.602 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . -164.59 -143.09 3.6 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.444 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.5 t0 -83.42 111.63 19.2 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 28.2 -90.3 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -131.23 126.8 36.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.071 0.462 . . . . 0.0 111.56 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -136.52 -174.4 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.303 178.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.471 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -65.08 42.24 0.11 Allowed Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 59' ' ' ALA . 37.1 mttt -62.05 -36.4 81.5 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.7 m -66.04 -48.85 69.71 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -62.37 -29.92 70.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.152 0.501 . . . . 0.0 110.727 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.597 HD21 HG11 ' A' ' 113' ' ' VAL . 57.7 tp -57.29 -41.36 79.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.858 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tt -66.99 -37.93 85.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 0.0 110.672 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 21' ' ' ILE . 93.4 mt -70.31 3.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.195 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.483 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 10.5 t -62.38 -74.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.864 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.614 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 0.7 OUTLIER -59.93 -31.06 69.49 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.234 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 6.7 m -52.04 -43.36 63.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.489 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -163.14 -38.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.377 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 22' ' ' SER . 2.6 p-10 43.55 95.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -152.92 13.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.4 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.691 HD11 ' HG3' ' A' ' 120' ' ' ARG . 5.1 tp 61.24 60.64 3.07 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.213 0.53 . . . . 0.0 110.519 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.35 -168.43 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.862 2.375 . . . . 0.0 112.003 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 m -56.71 151.04 14.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.455 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.76 -34.74 74.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -115.54 132.21 56.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.737 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.05 70.64 82.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.394 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.07 9.53 3.02 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.994 2.463 . . . . 0.0 112.678 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.1 m -51.5 -38.92 56.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.65 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.7 p -130.09 141.8 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.252 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -58.2 -49.5 76.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.279 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 51.3 p30 -176.14 157.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.544 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' LEU . 38.0 t-20 -124.45 169.27 12.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.55 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.492 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -178.36 11.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.172 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.24 100.31 3.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.857 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.413 HG11 ' OH ' ' A' ' 23' ' ' TYR . 42.2 t -134.87 134.17 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.217 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 43' ' ' THR . 14.8 t -119.44 126.64 51.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.422 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.76 144.88 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.676 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 73.8 mtm -105.76 123.53 48.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.14 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.4 mt -132.72 117.11 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.804 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.35 70.96 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.07 43.9 15.46 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.494 ' OE1' ' OD1' ' A' ' 170' ' ' ASP . 64.8 mt-10 -123.2 86.01 51.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.467 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 50.2 Cg_endo -76.9 102.02 1.57 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.211 1.941 . . . . 0.0 112.423 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 88.9 m-85 -155.46 170.39 22.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.965 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.492 ' H ' ' HB ' ' A' ' 3' ' ' THR . 3.4 p -134.8 142.83 46.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.159 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.785 HD22 ' HB2' ' A' ' 172' ' ' ALA . 46.0 tp -122.36 126.85 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.954 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -98.07 130.72 10.33 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.695 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.492 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 66.6 mt -116.76 123.41 47.09 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.532 ' O ' ' O ' ' A' ' 57' ' ' ASP . 34.9 t80 -91.15 32.13 1.05 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.961 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 56' ' ' PHE . 50.5 p30 -36.24 168.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.062 0.458 . . . . 0.0 112.059 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 58' ' ' THR . 46.4 m 59.8 53.67 4.72 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.174 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.595 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . . . -141.36 157.34 45.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.429 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.738 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.898 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 . . . . . 0 CA--C 1.527 0.063 0 CA-C-O 120.537 0.208 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.7 t -131.09 150.63 52.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.739 ' OD2' HD11 ' A' ' 4' ' ' ILE . 88.1 m-20 -127.37 -15.69 5.08 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.639 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.12 107.56 13.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.941 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -74.04 135.29 43.06 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.721 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.468 HD11 HG21 ' A' ' 113' ' ' VAL . 7.9 tt -117.47 125.26 50.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.621 HG21 HD12 ' A' ' 112' ' ' LEU . 10.7 m -100.66 132.27 46.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.949 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.7 t -125.91 128.46 47.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.398 0.618 . . . . 0.0 111.675 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' HB3' HG21 ' A' ' 93' ' ' VAL . 12.8 p90 -153.44 157.63 40.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.511 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.52 ' OG ' ' CB ' ' A' ' 89' ' ' SER . 16.3 p -66.42 132.33 48.06 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -78.71 32.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.934 -177.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' A' ' 119' ' ' LEU . 32.6 m -121.62 160.78 22.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.075 0.464 . . . . 0.0 110.347 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -42.22 -58.61 3.34 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 89' ' ' SER . 20.0 Cg_exo -22.69 65.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 124.634 3.556 . . . . 0.0 115.984 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 86' ' ' SER . 50.5 m 34.02 10.76 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 87' ' ' PRO . 88.5 p -69.46 -33.67 73.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.388 0.54 . . . . 0.0 110.806 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.6 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 5.8 p90 -89.12 -41.38 12.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.202 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.6 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.7 tt0 -55.98 -34.17 65.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.267 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 96' ' ' LYS . 73.4 m-20 -85.75 -64.4 1.16 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.123 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 82' ' ' PHE . 52.7 t -49.67 -52.97 11.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.707 ' NZ ' HD21 ' A' ' 112' ' ' LEU . 23.3 mttm -67.37 -20.08 65.51 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 84.4 tt0 -126.61 -58.54 1.32 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 92' ' ' ASN . 14.7 tptp -60.49 -35.2 75.36 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 10' ' ' GLY . 42.2 m95 -84.16 -35.0 23.9 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.006 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -37.45 -54.53 2.1 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 20.0 Cg_endo -63.64 -36.5 52.4 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 121.271 1.314 . . . . 0.0 110.979 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 97' ' ' TRP . 48.2 tp10 -61.45 -43.91 98.04 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.042 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.9 mt -74.74 -35.3 36.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.812 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.7 m -50.49 -41.7 53.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.023 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -57.7 -39.9 78.24 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.363 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -58.37 -44.9 89.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.483 ' O ' ' OG1' ' A' ' 108' ' ' THR . 8.6 t -167.48 108.61 0.61 Allowed Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.49 150.56 22.09 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.199 1.933 . . . . 0.0 112.419 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 60.41 49.37 6.91 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.972 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -121.42 108.81 35.34 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.814 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -47.82 148.29 6.39 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.993 1.796 . . . . 0.0 111.441 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 152' ' ' VAL . 20.3 p90 -151.02 161.63 42.37 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.824 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.3 mp -96.6 127.51 42.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.347 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.707 HD21 ' NZ ' ' A' ' 94' ' ' LYS . 16.9 tp -88.77 119.86 29.64 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.643 HG12 ' N ' ' A' ' 114' ' ' GLY . 40.0 t -136.3 165.3 29.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 0.0 111.815 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.643 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -142.15 174.36 23.29 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 12.5 t -137.79 161.14 37.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.949 0.404 . . . . 0.0 110.451 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.697 HE22 ' CZ ' ' A' ' 120' ' ' ARG . 2.8 mm100 54.55 33.19 18.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.773 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.889 HG23 ' N ' ' A' ' 118' ' ' ASP . 7.2 tt 21.84 -138.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.424 0 O-C-N 123.544 0.527 . . . . 0.0 110.812 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.889 ' N ' HG23 ' A' ' 117' ' ' ILE . 23.7 p30 -87.07 83.49 7.46 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.277 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.589 ' N ' ' CG1' ' A' ' 85' ' ' VAL . 16.6 tp 56.75 42.5 26.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.023 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.697 ' CZ ' HE22 ' A' ' 116' ' ' GLN . 50.6 ttm-85 . . . . . 0 CA--C 1.519 -0.238 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.152 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 84' ' ' VAL . 6.1 tt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.849 0.356 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.609 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.49 -64.34 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.802 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 138' ' ' THR . 72.1 Cg_exo -22.52 -72.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 123.495 2.797 . . . . 0.0 113.485 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -102.45 -44.28 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.047 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.567 HG21 HG13 ' A' ' 137' ' ' ILE . 41.9 m -51.39 -46.26 62.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.518 ' HB1' ' NZ ' ' A' ' 94' ' ' LYS . . . -76.73 -38.57 54.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.825 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.444 ' CD ' ' O ' ' A' ' 139' ' ' PRO . 97.7 mt-10 -60.21 -39.47 86.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.255 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.96 -49.62 75.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 109.96 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 91.1 mt -57.56 -31.93 66.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.475 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.69 75.73 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.942 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -59.75 -35.38 74.47 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.611 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -49.56 -31.17 9.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.6 mt -126.68 -114.64 0.28 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.633 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -175.9 71.85 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.87 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . . . -61.01 -138.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.841 0.353 . . . . 0.0 110.628 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 110' ' ' PHE . 54.9 t -154.16 -50.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.829 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.541 ' NZ ' ' OE1' ' A' ' 171' ' ' GLU . 1.1 mmtm -114.41 -175.62 2.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.651 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.653 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -170.7 96.21 0.22 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.497 HG11 ' CD2' ' A' ' 165' ' ' LEU . 9.4 p -143.51 142.95 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.515 0.674 . . . . 0.0 111.245 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.736 ' O ' ' OG1' ' A' ' 161' ' ' THR . 3.6 pt-20 -119.92 96.19 5.07 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -120.25 131.11 54.8 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -176.165 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 160' ' ' LEU . 77.1 p -119.83 87.94 2.84 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 173.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 37.02 26.93 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.865 ' O ' ' N ' ' A' ' 162' ' ' GLN . 34.9 tp -133.64 -79.25 0.47 Allowed 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.467 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 4.6 m -45.59 49.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.865 ' N ' ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -71.49 0.81 7.52 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 175.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.6 ' H ' ' C ' ' A' ' 161' ' ' THR . 8.7 mtmp? -58.86 -23.54 60.99 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 113.546 -1.661 . . . . 0.0 106.849 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -119.28 -65.99 0.29 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.497 ' CD2' HG11 ' A' ' 155' ' ' VAL . 0.5 OUTLIER -40.67 -10.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.647 ' N ' ' O ' ' A' ' 164' ' ' GLY . 41.8 tttp -91.52 -42.05 10.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.584 ' N ' ' O ' ' A' ' 164' ' ' GLY . 78.3 m-20 -81.98 -0.03 42.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.135 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.7 t -77.98 -57.82 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.614 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 46.8 m-85 -48.79 -43.54 38.16 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.686 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.763 ' O ' HG22 ' A' ' 173' ' ' ILE . 62.6 t0 -67.12 -49.48 64.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.205 0.526 . . . . 0.0 109.913 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.541 ' OE1' ' NZ ' ' A' ' 153' ' ' LYS . 87.5 tt0 -59.06 -25.54 63.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.785 ' HB2' HD22 ' A' ' 53' ' ' LEU . . . -55.02 -32.2 61.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.314 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 170' ' ' ASP . 3.6 tt -59.13 -30.08 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.7 tp -57.42 -38.54 74.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.1 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.528 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -71.8 -15.79 62.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -63.59 -32.28 73.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 110.562 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.02 -34.04 71.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.456 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.483 ' OE2' ' OD2' ' A' ' 76' ' ' ASP . 96.9 mt-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 99.989999999999995 110.561 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' THR . 92.6 mt-30 . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.827 0.346 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 3' ' ' THR . 0.6 OUTLIER -38.48 133.56 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.16 -179.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.663 HD11 ' OD2' ' A' ' 76' ' ' ASP . 4.5 tp -131.06 152.21 37.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.336 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.507 ' HA ' ' H ' ' A' ' 54' ' ' GLY . 25.2 mttm -109.26 161.26 15.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.198 0.523 . . . . 0.0 111.504 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -122.85 144.96 48.86 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.457 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.5 145.28 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG23 ' NZ ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -68.0 128.12 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.05 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.524 HG11 HD13 ' A' ' 101' ' ' ILE . 44.8 t -141.77 128.45 19.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.788 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.53 -174.96 38.13 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.884 -1.151 . . . . 0.0 112.106 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.467 ' N ' HG22 ' A' ' 93' ' ' VAL . 60.5 t0 -90.96 124.24 35.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.973 0.416 . . . . 0.0 110.755 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -47.39 101.82 0.04 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 150.16 30.67 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.707 0.299 . . . . 0.0 110.871 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 82' ' ' PHE . 29.2 m -127.47 132.84 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.024 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.53 97.75 2.27 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.555 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.497 ' NZ ' HG23 ' A' ' 8' ' ' VAL . 23.4 mttm -83.0 -2.51 55.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.674 0.273 . . . . 0.0 110.964 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.2 m -65.93 -57.78 7.07 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.742 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.439 ' O ' HG22 ' A' ' 21' ' ' ILE . 92.3 m -68.73 -25.95 65.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.489 0.661 . . . . 0.0 110.14 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.668 HD12 ' SG ' ' A' ' 157' ' ' CYS . 7.4 tp -50.94 -56.15 13.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.641 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.539 HD13 HD22 ' A' ' 55' ' ' LEU . 55.2 mt -71.19 -35.09 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.83 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 18' ' ' CYS . 2.0 tt -47.7 -11.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.268 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.572 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -55.75 -76.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.318 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.572 ' N ' ' OG ' ' A' ' 22' ' ' SER . 49.7 t80 -56.59 -39.21 73.15 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.916 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -66.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 73.6 p -111.72 -23.57 10.55 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 25' ' ' THR . 31.6 t30 83.35 95.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.909 0.385 . . . . 0.0 110.658 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 26' ' ' ASN . 11.2 pttm 33.32 73.26 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.279 0.561 . . . . 0.0 111.574 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.26 79.45 70.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.414 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.89 146.69 77.82 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.912 2.408 . . . . 0.0 112.742 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -128.33 143.18 50.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.139 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.86 -36.61 72.58 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.734 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 33' ' ' VAL . 77.4 t80 -124.82 138.23 54.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.597 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.408 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 9.6 t -73.0 123.32 89.46 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.519 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.39 158.12 36.81 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.227 1.951 . . . . 0.0 112.057 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -76.97 157.03 31.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.437 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.38 156.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.83 156.83 29.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.186 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -73.94 88.57 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 110.357 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -144.77 108.73 4.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.673 ' CB ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -101.2 -24.71 14.21 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.27 95.53 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.352 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.654 HG21 HD11 ' A' ' 55' ' ' LEU . 55.4 t -134.81 137.59 50.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.232 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 43' ' ' THR . 6.8 t -120.41 133.98 55.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.726 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.428 HG21 ' CZ ' ' A' ' 23' ' ' TYR . 8.8 p -141.31 141.8 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.408 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.9 mtm -110.5 118.84 37.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.435 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.0 mt -129.14 119.57 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.554 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.94 25.85 73.22 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.22 48.54 14.6 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -131.87 105.27 14.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.59 100.09 1.2 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.132 1.888 . . . . 0.0 112.479 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.854 ' CD1' HD11 ' A' ' 173' ' ' ILE . 33.5 p90 -142.08 165.58 27.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.317 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.29 127.49 35.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.067 0.461 . . . . 0.0 111.812 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.678 HD13 ' HB1' ' A' ' 172' ' ' ALA . 62.8 tp -107.36 138.08 44.22 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.842 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -81.6 147.6 26.9 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.673 ' H ' ' CB ' ' A' ' 40' ' ' TYR . 48.3 mt -99.51 98.52 9.41 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.243 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 57' ' ' ASP . 7.9 p90 -55.54 -27.36 48.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.51 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 58' ' ' THR . 63.6 t0 -17.09 139.88 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.947 0.779 . . . . 0.0 112.578 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.54 ' CB ' ' O ' ' A' ' 57' ' ' ASP . 1.1 m 155.33 149.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.304 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.12 151.96 20.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.543 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.654 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.503 ' O ' ' O ' ' A' ' 75' ' ' THR . 97.4 mt-30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.866 0.365 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 74' ' ' GLN . 59.8 p 44.43 -178.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.208 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.663 ' OD2' HD11 ' A' ' 4' ' ' ILE . 92.9 m-20 -123.3 -26.96 4.19 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.636 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.521 HG21 ' HB1' ' A' ' 175' ' ' ALA . 6.6 t -118.34 110.67 31.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.941 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -76.13 132.19 39.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.088 0.471 . . . . 0.0 111.52 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.488 ' CD2' ' CE1' ' A' ' 56' ' ' PHE . 4.1 mp -109.1 99.64 8.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.699 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 17.4 t -65.38 134.74 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.734 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.453 ' HB2' ' HZ3' ' A' ' 16' ' ' LYS . 19.0 t -123.85 130.32 52.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.427 . . . . 0.0 111.093 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.546 ' HA ' HG11 ' A' ' 14' ' ' VAL . 39.0 p90 -167.87 129.17 1.44 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.347 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.509 ' HA ' ' H ' ' A' ' 115' ' ' THR . 90.1 p -56.69 134.24 54.58 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.652 HG21 ' CB ' ' A' ' 156' ' ' GLU . 6.3 t -90.38 8.2 3.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.446 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.662 HG21 ' HG2' ' A' ' 120' ' ' ARG . 11.0 p -114.26 20.39 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.943 0.402 . . . . 0.0 110.163 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 t -139.61 137.7 19.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.196 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.494 ' O ' ' CD1' ' A' ' 90' ' ' PHE . 61.0 Cg_endo -73.76 -27.04 12.94 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.197 1.932 . . . . 0.0 113.224 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.2 p -81.6 -29.38 33.32 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -62.25 -37.42 85.36 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.612 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.528 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 2.0 p90 -91.25 -36.95 13.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.884 0.373 . . . . 0.0 111.328 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 85.6 tt0 -56.56 -38.43 71.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.182 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 96' ' ' LYS . 9.6 m120 -90.0 -47.39 7.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.211 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 11' ' ' ASP . 42.9 t -57.31 -56.09 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.448 ' NZ ' HD13 ' A' ' 112' ' ' LEU . 35.0 mttm -71.32 -11.44 60.91 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -125.73 -65.78 0.98 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 92' ' ' ASN . 81.1 mttt -61.17 -33.31 73.22 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.412 ' CZ2' ' HA ' ' A' ' 11' ' ' ASP . 48.5 m95 -83.2 -31.47 27.06 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.777 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.2 t -40.77 -54.28 5.36 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.977 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 33.1 Cg_endo -66.11 -32.03 44.24 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.667 1.578 . . . . 0.0 111.51 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -61.62 -38.52 87.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.524 HD13 HG11 ' A' ' 9' ' ' VAL . 27.0 pt -94.42 -30.7 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.515 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' CYS . 55.4 m -60.28 -41.08 92.57 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.928 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -60.62 -39.13 87.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.556 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -57.26 -44.03 83.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.014 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -150.53 159.93 33.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 110.876 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.48 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 9.6 Cg_endo -55.32 155.86 18.89 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.877 2.385 . . . . 0.0 111.851 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -62.93 130.05 43.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.317 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.99 158.83 54.95 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.502 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.47 143.91 10.92 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.166 1.911 . . . . 0.0 112.064 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 151' ' ' ALA . 21.2 p90 -147.62 156.83 43.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.691 -0.804 . . . . 0.0 112.103 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 129.61 48.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.421 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.575 HD12 ' CD2' ' A' ' 154' ' ' TYR . 85.8 mt -84.26 132.12 34.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.498 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.615 HG11 HD21 ' A' ' 19' ' ' LEU . 44.3 t -144.69 151.47 15.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.048 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.502 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -145.36 176.21 24.5 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.625 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.509 ' H ' ' HA ' ' A' ' 83' ' ' SER . 9.2 p -121.66 179.13 4.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.572 ' N ' ' CB ' ' A' ' 158' ' ' SER . 98.7 mm-40 36.44 37.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.845 HG23 ' H ' ' A' ' 119' ' ' LEU . 5.8 tt 29.42 -150.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.435 0 O-C-N 123.071 0.232 . . . . 0.0 110.512 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.764 ' N ' HG23 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -108.76 11.09 26.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.845 ' H ' HG23 ' A' ' 117' ' ' ILE . 5.7 mp -139.22 12.19 2.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.981 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.662 ' HG2' HG21 ' A' ' 85' ' ' VAL . 25.4 ptt180 . . . . . 0 N--CA 1.467 0.392 0 O-C-N 123.204 0.315 . . . . 0.0 110.18 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.656 HG23 ' O ' ' A' ' 137' ' ' ILE . 15.3 tt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.897 0.38 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.698 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -119.6 -41.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.698 ' CD ' ' H ' ' A' ' 138' ' ' THR . 73.2 Cg_exo -47.97 -64.04 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.215 1.944 . . . . 0.0 113.262 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -105.9 -44.69 4.55 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.519 HG21 ' CG1' ' A' ' 137' ' ' ILE . 44.5 m -51.85 -43.3 63.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.762 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.77 -28.01 33.48 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.912 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.25 -44.13 95.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.03 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -63.86 -41.61 97.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.37 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 87.2 mt -61.31 -31.44 71.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.268 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.31 -40.49 70.78 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.46 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -56.48 -37.06 69.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.405 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.74 -25.35 10.87 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.3 mt -134.73 -115.12 0.2 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.844 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 151' ' ' ALA . 37.9 pttt 178.42 75.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.46 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.641 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . . . -56.04 -145.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.975 0.417 . . . . 0.0 111.843 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 110' ' ' PHE . 75.1 t -136.69 -56.03 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.978 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.455 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 24.6 tttt -125.46 -167.68 1.72 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.793 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.575 ' CD2' HD12 ' A' ' 112' ' ' LEU . 51.0 m-85 -156.67 96.71 1.66 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.32 139.52 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 122.148 0.975 . . . . 0.0 111.515 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.727 ' O ' ' OG1' ' A' ' 161' ' ' THR . 10.4 pt-20 -122.36 98.0 5.72 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.539 -1.664 . . . . 0.0 106.613 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.668 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -123.94 145.75 48.94 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 123.18 1.467 . . . . 0.0 113.112 -175.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.572 ' CB ' ' N ' ' A' ' 116' ' ' GLN . 10.0 t -173.22 93.89 0.1 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 112.013 -2.358 . . . . 0.0 107.831 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 50.21 38.74 18.08 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.332 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.742 ' O ' ' N ' ' A' ' 162' ' ' GLN . 22.1 tp -165.09 -82.17 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.031 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.727 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.8 OUTLIER -52.37 55.54 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.742 ' N ' ' O ' ' A' ' 160' ' ' LEU . 2.3 pp0? -80.42 15.8 1.52 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.605 ' H ' ' C ' ' A' ' 161' ' ' THR . 99.5 mttt -84.65 -3.44 58.51 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 113.751 -1.568 . . . . 0.0 108.426 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.45 -72.62 0.1 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -40.61 -16.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.366 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' A' ' 164' ' ' GLY . 81.2 tttt -84.57 -49.53 8.5 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 164' ' ' GLY . 81.3 m-20 -78.16 4.5 12.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.371 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.29 -58.73 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.2 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.477 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 94.4 m-85 -44.41 -44.7 8.57 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.521 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -69.38 -44.41 71.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.398 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.99 -25.17 68.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.15 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.678 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -56.46 -35.58 68.07 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.854 HD11 ' CD1' ' A' ' 51' ' ' TYR . 91.6 mt -55.19 -43.09 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 174' ' ' LEU . 8.0 mp -70.28 -36.18 74.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.002 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -63.63 -32.97 74.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.393 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.59 72.76 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 21.2 tp -59.32 -35.25 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.684 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 99.989999999999995 110.53 179.912 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 121.288 0.566 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.436 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.6 OUTLIER -107.83 150.27 27.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.6 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.693 HD11 ' OD2' ' A' ' 76' ' ' ASP . 11.0 tp -127.36 147.25 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.526 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -86.0 135.38 33.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.872 0.368 . . . . 0.0 110.539 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -135.94 130.9 34.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.283 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.423 HG23 ' HB ' ' A' ' 75' ' ' THR . 59.2 t -103.9 134.75 44.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.765 HG11 ' OD1' ' A' ' 57' ' ' ASP . 75.1 t -114.09 125.83 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.302 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.467 HG21 ' CZ3' ' A' ' 97' ' ' TRP . 13.3 p -136.94 146.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.486 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . -117.66 -157.44 10.68 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.464 ' HA ' ' HE1' ' A' ' 97' ' ' TRP . 51.3 p30 -74.09 24.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.067 0.46 . . . . 0.0 110.029 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 125.34 -77.32 0.38 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.86 94.9 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 110.472 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.406 HG11 ' H ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -120.04 169.56 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.389 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -69.05 56.46 0.57 Allowed Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -81.03 0.81 34.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.883 0.373 . . . . 0.0 110.255 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.8 p -69.16 -38.83 78.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.469 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.862 ' SG ' HG23 ' A' ' 33' ' ' VAL . 98.3 m -90.85 -14.54 31.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.136 0.494 . . . . 0.0 110.603 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.896 HD12 ' SG ' ' A' ' 157' ' ' CYS . 22.1 tp -59.8 -45.36 92.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.375 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD23 ' OD2' ' A' ' 57' ' ' ASP . 1.4 pp -74.07 -33.77 63.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 111.333 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 18' ' ' CYS . 52.6 mt -61.75 -5.72 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.346 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.492 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 43.7 t -44.82 -80.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.315 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -55.78 -38.33 69.77 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.535 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.592 ' O ' ' CB ' ' A' ' 25' ' ' THR . 3.7 m -44.54 -34.12 2.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.208 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' THR . 13.3 m 107.78 92.14 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.32 1.012 . . . . 0.0 109.839 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.634 ' ND2' ' HB2' ' A' ' 159' ' ' ALA . 27.8 t30 -110.22 -75.93 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.308 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt 57.95 43.42 21.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.246 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp 41.33 68.8 2.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.873 0.368 . . . . 0.0 110.248 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.48 157.15 22.11 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 123.014 2.476 . . . . 0.0 112.596 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 32' ' ' TYR . 20.2 m -56.91 -27.95 61.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.315 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -57.82 -2.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.265 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.539 ' H ' ' C ' ' A' ' 30' ' ' SER . 41.4 m-85 70.43 -116.01 0.1 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.145 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.862 HG23 ' SG ' ' A' ' 18' ' ' CYS . 7.1 p -125.28 79.45 66.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.482 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.53 154.08 44.41 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.663 2.242 . . . . 0.0 111.323 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -130.01 147.35 51.75 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.6 t -131.01 140.18 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.948 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -95.62 134.87 38.02 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.798 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 59.32 45.21 14.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.213 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LEU . 51.6 t-20 -97.79 124.03 41.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.346 . . . . 0.0 110.532 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.631 ' CG ' ' N ' ' A' ' 41' ' ' ALA . 17.4 p90 -165.28 -48.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.488 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.631 ' N ' ' CG ' ' A' ' 40' ' ' TYR . . . -77.99 104.36 8.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.635 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.75 126.2 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.324 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 43' ' ' THR . 12.6 t -82.6 127.38 33.3 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.259 0.552 . . . . 0.0 111.583 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.05 142.42 35.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.553 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.5 ptp -143.71 140.59 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.049 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.611 ' O ' ' N ' ' A' ' 48' ' ' GLY . 42.7 mm -119.81 102.85 13.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.238 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 20.98 43.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.719 0 O-C-N 123.784 0.678 . . . . 0.0 111.844 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -151.12 -76.64 0.02 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' OE1' ' OH ' ' A' ' 51' ' ' TYR . 6.5 mt-10 -153.8 161.83 28.23 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.367 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -84.45 139.26 7.84 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 C-N-CA 122.806 2.337 . . . . 0.0 113.197 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.561 ' HB2' HG21 ' A' ' 173' ' ' ILE . 42.4 m-85 -152.36 159.85 43.38 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.436 ' H ' ' HB ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -135.45 140.39 44.83 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.746 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.649 HD21 ' CD2' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -109.86 139.18 45.22 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.557 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -92.75 120.13 6.07 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.937 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.529 ' H ' ' CA ' ' A' ' 40' ' ' TYR . 57.9 mt -114.87 124.92 52.95 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 57' ' ' ASP . 25.3 t80 -115.48 34.44 4.91 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.765 ' OD1' HG11 ' A' ' 8' ' ' VAL . 72.2 m-20 -45.75 -177.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.147 0.499 . . . . 0.0 111.496 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.677 HG23 ' C ' ' A' ' 57' ' ' ASP . 1.7 p 76.59 147.98 0.1 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.936 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 58.05 -173.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.118 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.739 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.83 0.348 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.423 ' HB ' HG23 ' A' ' 7' ' ' VAL . 6.2 t -135.98 153.42 51.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.977 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.693 ' OD2' HD11 ' A' ' 4' ' ' ILE . 85.5 m-20 -117.72 -19.28 9.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.47 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.437 HG12 HD13 ' A' ' 111' ' ' LEU . 23.0 t -127.2 114.56 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.556 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.15 126.0 34.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.293 0.568 . . . . 0.0 112.182 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 80' ' ' VAL . 6.8 tt -124.59 126.41 45.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.799 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.655 ' N ' HD23 ' A' ' 79' ' ' LEU . 22.7 t -117.67 136.45 54.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.863 ' SG ' HD22 ' A' ' 19' ' ' LEU . 17.7 t -130.62 129.64 42.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.364 0.602 . . . . 0.0 111.906 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.906 ' CD1' HG11 ' A' ' 93' ' ' VAL . 42.3 p90 -139.15 154.14 48.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.028 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.406 ' H ' HG11 ' A' ' 14' ' ' VAL . 32.0 t -67.98 134.0 49.99 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.204 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.792 ' O ' HG12 ' A' ' 84' ' ' VAL . 48.5 t -96.26 26.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.991 -0.683 . . . . 0.0 111.719 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 85' ' ' VAL . 62.9 t -122.58 12.87 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 0.0 110.953 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.2 m -137.34 145.32 49.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.009 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.436 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 60.4 Cg_endo -73.75 -20.79 19.64 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.26 1.973 . . . . 0.0 112.76 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.8 m -91.52 -25.22 19.36 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.916 -0.313 . . . . 0.0 111.771 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.3 m -64.03 -40.97 97.52 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.712 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 87' ' ' PRO . 2.7 p90 -85.13 -29.36 24.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.097 0.475 . . . . 0.0 110.808 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.94 -28.14 64.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.587 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 93' ' ' VAL . 11.0 m120 -87.53 -70.17 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.906 HG11 ' CD1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -31.95 -64.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.688 ' H ' HG13 ' A' ' 93' ' ' VAL . 16.0 mttp -64.49 -33.27 75.5 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -177.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 88.7 mt-10 -107.73 -63.59 1.29 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -62.02 -38.93 90.53 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.573 ' CZ2' ' O ' ' A' ' 10' ' ' GLY . 74.1 m95 -77.0 -30.58 55.98 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.376 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.469 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.4 t -45.72 -55.33 12.82 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 19.4 Cg_endo -60.03 -36.94 87.82 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.733 1.622 . . . . 0.0 111.717 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.486 ' OE1' ' CE3' ' A' ' 97' ' ' TRP . 85.2 tt0 -59.59 -44.29 93.41 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.724 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.4 mt -76.38 -31.37 20.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.204 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 105' ' ' CYS . 37.1 m -52.85 -37.63 60.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.999 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -49.58 -40.07 37.29 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.21 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.533 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 80.5 m80 -78.6 -20.54 50.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.052 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 6.8 p 39.13 58.6 6.01 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.791 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.79 133.36 12.6 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.794 2.329 . . . . 0.0 112.145 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -89.5 -1.13 57.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.957 0.408 . . . . 0.0 110.167 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.82 155.79 84.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.744 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.96 150.04 58.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.761 2.307 . . . . 0.0 111.98 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.729 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -129.65 131.15 46.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.688 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.3 mp -93.96 130.54 40.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.117 0.484 . . . . 0.0 111.877 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.464 HD13 ' CD2' ' A' ' 149' ' ' LEU . 50.4 tp -102.11 130.4 48.7 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.46 179.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.529 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.586 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -149.04 178.9 26.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 13.0 t -128.27 163.74 24.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.811 0.339 . . . . 0.0 110.298 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.602 ' N ' ' OG ' ' A' ' 158' ' ' SER . 96.9 mt-30 56.49 18.19 3.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.272 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.744 HG13 ' H ' ' A' ' 119' ' ' LEU . 15.7 pt 33.94 -150.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.363 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 118' ' ' ASP . 50.9 p30 -118.32 17.28 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.403 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.744 ' H ' HG13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -144.72 -36.14 0.32 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.245 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.737 ' H ' ' CG1' ' A' ' 117' ' ' ILE . 65.3 ttp85 . . . . . 0 CA--C 1.515 -0.368 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.812 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.478 ' O ' HG13 ' A' ' 84' ' ' VAL . 82.6 mt . . . . . 0 N--CA 1.461 0.084 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.852 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -129.98 -48.19 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.646 ' CD ' ' H ' ' A' ' 138' ' ' THR . 59.7 Cg_endo -87.66 -67.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.416 2.078 . . . . 0.0 114.598 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 139' ' ' PRO . 77.7 mm-40 -31.55 -72.88 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.2 p -116.79 4.38 12.99 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.852 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -94.2 -65.2 1.0 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.512 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' THR . 84.2 tt0 -69.79 -41.49 75.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.219 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -66.68 -38.16 86.23 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.832 0.349 . . . . 0.0 111.462 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 145' ' ' LEU . 23.3 tp -74.73 -19.97 60.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.582 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.14 -36.71 77.74 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.178 0.513 . . . . 0.0 110.833 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -58.83 -41.16 86.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.236 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -89.96 -27.06 20.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.663 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 54.3 tp -44.52 -25.98 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.113 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.604 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 55.5 mttp 91.54 -0.93 0.17 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.898 0.479 . . . . 0.0 110.407 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -59.04 -136.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.327 0.584 . . . . 0.0 111.789 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -159.92 -36.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.278 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -110.31 -179.07 3.67 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.623 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 34.7 p90 -169.82 97.43 0.3 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.798 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.467 ' O ' ' CD ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -161.15 171.94 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.98 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.733 ' O ' ' OG1' ' A' ' 161' ' ' THR . 20.1 mm-40 -138.81 96.51 3.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.896 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -107.02 147.75 29.55 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 123.17 1.462 . . . . 0.0 112.51 -177.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.602 ' OG ' ' N ' ' A' ' 116' ' ' GLN . 0.3 OUTLIER -169.85 91.72 0.21 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 111.555 -2.566 . . . . 0.0 106.236 177.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.634 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . . . 43.35 21.59 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.221 -1.809 . . . . 0.0 109.503 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.78 ' O ' ' N ' ' A' ' 162' ' ' GLN . 0.5 OUTLIER -133.73 -84.05 0.45 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.585 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.733 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 1.2 m -53.66 46.86 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.725 0.641 . . . . 0.0 111.814 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.78 ' N ' ' O ' ' A' ' 160' ' ' LEU . 7.2 tt0 -80.44 9.39 5.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.594 ' H ' ' C ' ' A' ' 161' ' ' THR . 16.1 tttp -84.6 -5.41 59.3 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 112.781 -2.009 . . . . 0.0 108.435 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.671 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -129.9 -72.0 0.12 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 107.811 -2.115 . . . . 0.0 107.811 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 165' ' ' LEU . 4.3 mm? -38.75 -15.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.245 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.9 tttt -84.14 -47.68 10.63 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 164' ' ' GLY . 18.6 p-10 -79.41 4.99 13.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.028 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 171' ' ' GLU . 24.4 t -84.1 -52.65 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.892 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.649 ' CD2' HD21 ' A' ' 53' ' ' LEU . 4.4 m-85 -37.65 -48.17 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.501 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.418 ' O ' ' CG1' ' A' ' 173' ' ' ILE . 53.3 t0 -62.84 -37.52 87.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 168' ' ' VAL . 77.5 mm-40 -77.3 -30.07 54.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.196 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.42 -40.01 89.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.955 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.561 HG21 ' HB2' ' A' ' 51' ' ' TYR . 21.1 pt -67.41 -29.73 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.67 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.69 -36.73 77.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.04 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.96 -21.28 66.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -65.01 -32.54 74.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.609 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 41.8 tp -56.97 -36.05 69.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.405 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 99.989999999999995 110.559 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.584 ' O ' ' HB2' ' A' ' 176' ' ' ALA . 94.6 mt-30 . . . . . 0 C--O 1.228 -0.027 0 CA-C-O 121.03 0.443 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -41.2 115.66 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.233 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 176' ' ' ALA . 18.3 tt -122.97 146.46 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.957 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 30.6 mttm -104.47 163.29 12.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.853 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.4 136.98 26.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.518 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.531 HG23 ' HB ' ' A' ' 75' ' ' THR . 57.4 t -77.48 131.22 35.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 79' ' ' LEU . 57.3 t -117.8 125.88 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.793 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 101' ' ' ILE . 21.9 m -135.64 159.77 39.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.797 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.69 -177.09 36.24 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.273 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB2' HG23 ' A' ' 93' ' ' VAL . 25.2 t70 -81.05 124.94 29.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.684 0.278 . . . . 0.0 110.463 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 36.03 39.56 0.31 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 55.2 124.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.629 HG23 ' SG ' ' A' ' 81' ' ' CYS . 1.4 m -120.91 -168.33 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.889 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.58 49.64 0.01 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 121.428 -0.415 . . . . 0.0 112.408 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.617 ' N ' ' O ' ' A' ' 14' ' ' VAL . 23.2 pttt -57.4 -39.69 76.67 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.455 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 54.1 p -65.49 -43.87 88.85 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.1 m -53.9 -24.63 16.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.1 0.476 . . . . 0.0 111.026 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.57 -39.04 70.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.222 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 42' ' ' VAL . 36.6 tp -63.29 -38.74 92.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.046 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.3 pt -87.5 5.23 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.788 ' CB ' HD13 ' A' ' 165' ' ' LEU . 38.7 t -59.06 -75.5 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.695 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -67.18 -39.52 86.41 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.957 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -49.27 -45.7 45.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.992 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 t 179.42 75.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.624 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.591 ' ND2' ' OE1' ' A' ' 162' ' ' GLN . 2.3 p30 -60.15 113.52 2.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.224 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 28' ' ' LEU . 85.5 mttt -150.86 50.03 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.295 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.632 HD12 HD21 ' A' ' 160' ' ' LEU . 3.9 mp 57.68 129.36 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.658 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 159' ' ' ALA . 73.6 Cg_endo -76.42 156.94 36.92 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.15 1.9 . . . . 0.0 111.905 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.9 m -117.07 146.96 42.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.328 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -56.51 -34.94 67.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.165 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -64.66 -33.51 76.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.544 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.7 t 48.18 69.54 2.63 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.431 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.494 ' O ' ' O ' ' A' ' 35' ' ' THR . 51.3 Cg_exo -50.56 -14.69 1.23 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.927 2.418 . . . . 0.0 112.16 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 50.03 171.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.702 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 38' ' ' ASP . 22.5 t -121.0 142.43 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.29 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -49.07 -30.11 5.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 109.802 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.548 ' H ' HG12 ' A' ' 36' ' ' VAL . 90.0 m-20 -58.73 160.11 6.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.438 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.594 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 81.6 m-20 -133.21 -8.06 2.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.954 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER 163.85 28.45 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.929 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.77 108.06 5.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 20' ' ' LEU . 22.8 t -130.0 130.18 66.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.793 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.31 106.22 14.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.958 0.409 . . . . 0.0 111.425 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.46 154.81 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.074 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.22 133.93 55.37 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.478 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.543 HG21 ' HB2' ' A' ' 170' ' ' ASP . 13.5 tt -129.65 126.89 63.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.523 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.18 25.93 60.66 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.32 50.05 7.79 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -130.43 79.03 73.17 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.741 0.305 . . . . 0.0 110.361 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.58 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 26.9 Cg_exo -58.77 108.87 0.44 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.883 2.389 . . . . 0.0 112.437 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 50' ' ' PRO . 64.3 m-85 -160.33 174.53 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.27 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 p -133.55 142.01 47.98 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.676 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.665 HD13 ' CB ' ' A' ' 172' ' ' ALA . 66.5 tp -116.22 126.73 54.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.717 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.09 134.43 11.68 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.277 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.532 ' HG ' ' H ' ' A' ' 57' ' ' ASP . 11.6 tp -113.79 119.89 38.9 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.708 ' O ' ' O ' ' A' ' 57' ' ' ASP . 63.2 t80 -91.26 8.83 33.97 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.708 ' O ' ' O ' ' A' ' 56' ' ' PHE . 36.2 p30 30.47 177.26 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.468 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 82.4 p -88.57 156.61 18.97 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.612 -0.68 . . . . 0.0 110.77 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.61 20.12 4.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.548 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.837 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 5' ' ' LYS . 96.8 mt-30 . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.914 0.388 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.531 ' HB ' HG23 ' A' ' 7' ' ' VAL . 48.2 p -98.12 66.93 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.461 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -101.97 0.87 35.94 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.519 ' CG1' HD13 ' A' ' 111' ' ' LEU . 45.5 t -125.28 110.66 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.408 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -70.81 134.81 47.67 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.228 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.596 ' HB3' HG22 ' A' ' 8' ' ' VAL . 8.3 tt -119.0 126.96 52.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.699 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 112' ' ' LEU . 24.7 t -97.01 132.77 40.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.086 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.629 ' SG ' HG23 ' A' ' 14' ' ' VAL . 42.5 t -128.59 118.82 23.63 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.323 0.583 . . . . 0.0 111.675 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 115' ' ' THR . 28.3 p90 -149.43 157.53 43.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.181 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.0 t -70.72 132.32 45.19 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.294 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 84' ' ' VAL . 50.4 t -56.17 -9.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.306 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 86' ' ' SER . 27.1 m -127.18 169.47 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.508 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.646 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.5 OUTLIER -25.38 -68.16 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.826 -178.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.563 ' O ' ' CB ' ' A' ' 88' ' ' SER . 99.1 Cg_exo -28.09 74.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.841 3.027 . . . . 0.0 114.465 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 86' ' ' SER . 2.9 t 146.26 -11.46 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.624 0.577 . . . . 0.0 109.983 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 91' ' ' GLU . 0.7 OUTLIER 40.24 89.54 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' SER . 43.7 p90 -36.01 -26.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.824 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 89' ' ' SER . 97.2 mt-10 -62.05 -23.81 66.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.664 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.559 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 83.1 m-20 -80.23 -48.45 13.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.564 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 11' ' ' ASP . 56.0 t -77.63 -68.68 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.58 ' HE2' HD11 ' A' ' 112' ' ' LEU . 87.9 mttt -61.56 -15.1 35.61 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 78.1 mm-40 -129.06 -48.37 1.22 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -77.78 -35.69 51.31 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 69.1 m95 -99.13 -21.04 16.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.339 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -59.84 -41.79 87.45 Favored Pre-proline 0 C--N 1.333 -0.135 0 C-N-CA 120.119 -0.633 . . . . 0.0 109.955 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 4.1 Cg_exo -70.62 -38.42 5.93 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.703 2.269 . . . . 0.0 111.15 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -59.08 -39.03 80.87 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.63 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 9' ' ' VAL . 34.3 pt -85.01 -34.12 8.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' CYS . 76.2 m -60.22 -36.83 78.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.019 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.588 ' ND1' ' O ' ' A' ' 99' ' ' PRO . 37.7 m80 -50.5 -32.69 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.222 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -55.7 -45.57 77.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.411 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -143.55 160.7 50.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 110.984 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.479 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 8.0 Cg_endo -52.79 163.57 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.938 2.425 . . . . 0.0 111.935 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -64.86 131.47 46.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.861 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.85 161.21 33.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.158 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -46.38 146.15 5.22 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.261 1.974 . . . . 0.0 111.844 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.546 ' O ' ' N ' ' A' ' 152' ' ' VAL . 19.1 p90 -147.26 156.89 43.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.744 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.519 HD13 ' CG1' ' A' ' 77' ' ' VAL . 8.0 mp -97.32 125.67 42.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.665 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.58 HD11 ' HE2' ' A' ' 94' ' ' LYS . 16.1 tp -96.21 122.61 39.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.469 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.3 t -130.24 150.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.053 0.454 . . . . 0.0 111.747 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.5 156.87 17.11 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -119.22 167.58 11.71 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.563 0.697 . . . . 0.0 111.978 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.603 ' O ' ' O ' ' A' ' 117' ' ' ILE . 97.0 mm-40 50.75 24.45 1.73 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.777 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.838 HG23 ' H ' ' A' ' 119' ' ' LEU . 4.8 tt 30.62 -156.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.79 ' N ' HG23 ' A' ' 117' ' ' ILE . 53.0 p30 -120.81 29.27 7.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.838 ' H ' HG23 ' A' ' 117' ' ' ILE . 34.9 tp -137.31 -38.65 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.069 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.559 ' H ' HG22 ' A' ' 117' ' ' ILE . 6.9 tpm_? . . . . . 0 CA--C 1.518 -0.274 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.533 ' O ' ' CG1' ' A' ' 137' ' ' ILE . 1.3 tt . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 120.763 0.316 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.593 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -131.15 -65.66 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.593 ' HD2' ' H ' ' A' ' 138' ' ' THR . 84.3 Cg_exo -23.92 -69.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.758 2.972 . . . . 0.0 114.489 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -113.37 -37.8 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.6 m -52.57 -40.22 62.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.732 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.423 ' CB ' ' HZ3' ' A' ' 94' ' ' LYS . . . -72.75 -28.87 62.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.672 0.272 . . . . 0.0 111.506 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.24 -38.24 88.47 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -63.35 -46.19 87.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 110.897 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 65.3 mt -54.29 -33.47 58.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.051 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.77 81.73 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.064 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -60.42 -41.58 94.26 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.667 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -51.65 -31.98 27.69 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.4 mt -131.23 -115.58 0.23 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.459 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.701 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 63.5 mttm -134.96 -142.03 0.18 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.219 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 150.88 177.98 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.386 0.429 . . . . 0.0 111.059 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 110' ' ' PHE . 94.0 t -145.66 -59.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.567 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 154' ' ' TYR . 16.4 mmtt -100.81 170.56 8.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.505 ' CG ' ' C ' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -173.2 97.36 0.12 Allowed 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.321 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.899 HG22 ' H ' ' A' ' 156' ' ' GLU . 2.7 p -170.42 -167.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.165 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.899 ' H ' HG22 ' A' ' 155' ' ' VAL . 96.1 mt-10 -106.88 166.56 10.5 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.578 ' HB2' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -178.29 119.91 0.09 Allowed 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 178.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 160' ' ' LEU . 16.4 t -156.77 94.77 1.48 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.508 -1.678 . . . . 0.0 107.022 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.566 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . 35.12 28.57 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.565 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.768 ' O ' ' N ' ' A' ' 162' ' ' GLN . 41.9 mt -142.8 -78.89 0.23 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.238 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.705 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.6 m -44.09 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.768 ' N ' ' O ' ' A' ' 160' ' ' LEU . 11.8 pt20 -72.07 10.25 0.78 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.705 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.1 tttm -62.14 -27.03 68.65 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.062 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.679 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -125.12 -63.62 0.18 Allowed Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.788 HD13 ' CB ' ' A' ' 22' ' ' SER . 4.1 mt -39.19 -13.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.416 -0.513 . . . . 0.0 112.181 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 164' ' ' GLY . 43.4 tttm -81.29 -46.55 14.59 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' GLY . 2.7 m120 -83.33 6.56 19.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.102 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 165' ' ' LEU . 54.8 t -86.41 -57.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.376 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.659 ' HA ' HD22 ' A' ' 53' ' ' LEU . 27.2 m-85 -45.84 -45.78 15.18 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.247 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.543 ' HB2' HG21 ' A' ' 46' ' ' ILE . 55.8 t0 -69.69 -45.16 68.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.481 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.0 -25.41 64.5 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.665 ' CB ' HD13 ' A' ' 53' ' ' LEU . . . -61.97 -36.11 80.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.348 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 8.5 mm -60.75 -37.03 75.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 36.9 tp -58.46 -35.87 72.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.879 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.475 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -63.88 -24.25 67.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.073 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -61.04 -36.25 79.08 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.695 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.3 mt -59.42 -32.98 70.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.411 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 99.989999999999995 110.641 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.452 ' O ' ' CB ' ' A' ' 176' ' ' ALA . 58.8 tp60 . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.875 0.369 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.7 OUTLIER -49.76 132.41 22.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.105 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.677 HD11 ' OD2' ' A' ' 76' ' ' ASP . 3.9 tp -126.13 145.91 32.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.937 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -91.28 142.18 27.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.732 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -138.61 130.69 28.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.621 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.422 HG13 ' CB ' ' A' ' 56' ' ' PHE . 44.0 t -98.24 135.28 33.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.754 HG22 ' HB3' ' A' ' 79' ' ' LEU . 62.6 t -99.03 131.53 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.979 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.0 136.23 59.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.063 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.566 ' CA ' HG23 ' A' ' 58' ' ' THR . . . -148.94 -173.72 19.9 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 13' ' ' ALA . 54.6 t0 -80.3 118.3 21.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 29.87 -87.68 0.01 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -133.12 150.0 52.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.914 HG23 ' H ' ' A' ' 15' ' ' GLY . 8.5 m -153.7 -96.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.914 ' H ' HG23 ' A' ' 14' ' ' VAL . . . -137.76 19.52 3.32 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.037 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -39.13 -36.31 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.187 0.494 . . . . 0.0 111.832 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.0 p -65.31 -46.87 78.63 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.808 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -79.45 -35.87 39.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.453 . . . . 0.0 110.797 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.725 HD12 ' SG ' ' A' ' 157' ' ' CYS . 12.7 tp -58.32 -40.35 81.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.496 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.17 -37.81 78.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.368 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 21' ' ' ILE . 93.8 mt -70.19 -1.73 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.726 ' CB ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -29.36 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.634 -178.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.539 ' CE2' HG11 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -98.27 -12.33 21.69 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.546 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -48.61 -49.2 37.99 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.28 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.496 ' OG1' HD12 ' A' ' 28' ' ' LEU . 73.2 p -133.9 -16.01 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.532 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.585 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER 70.86 111.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 57.09 136.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.658 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.685 HD23 ' HD2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER 177.56 113.21 0.15 Allowed Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.245 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.685 ' HD2' HD23 ' A' ' 28' ' ' LEU . 66.6 Cg_exo -46.51 149.18 2.96 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.981 1.787 . . . . 0.0 112.316 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.8 t -58.27 -18.55 27.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.65 -34.13 57.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.859 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -119.69 126.8 51.98 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.845 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.84 157.38 38.16 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.53 66.07 3.74 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.673 2.249 . . . . 0.0 111.915 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.3 p -76.47 -15.95 59.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.229 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.0 -44.62 95.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.837 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -175.26 124.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 0.0 110.685 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -73.66 144.33 45.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.755 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -111.46 168.63 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.004 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 40' ' ' TYR . 26.3 p90 -155.85 35.43 0.35 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.27 97.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.285 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.521 ' O ' ' OG1' ' A' ' 52' ' ' THR . 21.8 t -129.92 132.83 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.36 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 t -103.0 133.78 47.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.12 0.486 . . . . 0.0 111.219 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.539 HG11 ' CE2' ' A' ' 23' ' ' TYR . 19.1 m -132.44 156.48 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.951 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -113.37 123.93 51.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.985 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' GLY . 9.2 tp -134.6 137.63 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.103 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 34.09 28.29 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 82.53 47.03 6.16 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -128.22 83.6 65.64 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.166 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 59.2 Cg_endo -78.84 99.88 1.31 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.45 2.1 . . . . 0.0 112.674 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' A' ' 50' ' ' PRO . 62.4 m-85 -156.36 177.85 10.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.491 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.521 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 9.2 t -139.96 150.04 44.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.901 HD22 ' CB ' ' A' ' 172' ' ' ALA . 19.9 tp -118.11 128.39 54.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.86 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -86.31 138.02 15.52 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.813 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' A' ' 40' ' ' TYR . 81.2 mt -124.38 126.7 46.4 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.626 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.613 ' O ' ' O ' ' A' ' 57' ' ' ASP . 45.4 t80 -108.5 35.4 3.2 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.961 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 56' ' ' PHE . 90.6 m-20 36.79 178.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.566 HG23 ' CA ' ' A' ' 10' ' ' GLY . 98.4 m -64.77 132.08 48.59 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.606 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.84 149.04 33.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.643 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.682 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.815 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.841 0.353 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.5 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 5.8 t -141.72 155.98 45.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.459 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.677 ' OD2' HD11 ' A' ' 4' ' ' ILE . 91.2 m-20 -122.76 -33.07 3.44 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.09 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.91 152.56 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.417 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 75' ' ' THR . 21.0 m-85 -120.83 160.53 23.22 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.754 ' HB3' HG22 ' A' ' 8' ' ' VAL . 7.9 tt -119.15 123.25 43.93 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.246 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.9 m -102.27 133.49 45.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.607 ' SG ' ' CG1' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -134.07 134.82 42.78 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 111.516 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 115' ' ' THR . 39.3 p90 -142.83 153.84 43.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.873 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.1 p -95.63 134.74 38.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.928 HG13 ' H ' ' A' ' 85' ' ' VAL . 5.4 p -49.23 -68.23 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.416 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.928 ' H ' HG13 ' A' ' 84' ' ' VAL . 7.6 p -56.17 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.533 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.0 OUTLIER 157.84 80.76 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.472 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -56.39 -36.13 96.94 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.506 2.137 . . . . 0.0 112.061 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 m -57.65 -38.02 74.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.192 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.3 p -71.21 -34.26 70.67 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.509 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -70.48 -43.79 69.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 0.0 111.41 -179.315 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 96.8 mt-10 -61.48 -34.09 74.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.595 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 96' ' ' LYS . 28.0 m120 -89.75 -63.33 1.3 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.983 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.2 t -36.04 -62.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.255 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -70.44 -19.47 62.97 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.542 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 82.6 tt0 -124.87 -55.7 1.59 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 92' ' ' ASN . 19.3 tttt -74.99 -16.3 60.63 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -96.31 -50.32 4.83 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.123 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.47 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -43.04 -46.69 13.84 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.251 -178.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.542 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 15.7 Cg_exo -65.69 -39.55 20.39 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.049 1.833 . . . . 0.0 112.338 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.56 -36.26 83.2 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.404 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.631 HG13 HG23 ' A' ' 102' ' ' THR . 20.4 pt -89.83 -32.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.266 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.631 HG23 HG13 ' A' ' 101' ' ' ILE . 81.9 p -99.5 17.65 19.83 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.098 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -54.31 -46.45 72.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.494 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.66 -42.12 98.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.479 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.7 t -127.33 87.39 56.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.42 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.02 -27.98 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.312 2.008 . . . . 0.0 112.116 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -103.5 117.87 35.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.238 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 108' ' ' THR . 3.2 m -170.88 101.77 0.41 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.857 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.41 148.17 11.3 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.028 1.819 . . . . 0.0 112.008 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 151' ' ' ALA . 21.0 p90 -148.31 162.93 38.53 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.618 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.3 mp -91.14 129.58 37.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.806 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.4 tp -95.08 121.83 37.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.661 HG11 HD11 ' A' ' 19' ' ' LEU . 40.1 t -135.8 168.51 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.91 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.631 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -155.16 97.86 0.17 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.261 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 82' ' ' PHE . 2.6 p -51.47 177.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.92 0.39 . . . . 0.0 110.4 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.507 ' O ' ' C ' ' A' ' 117' ' ' ILE . 43.7 tp60 47.37 29.96 1.43 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.007 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.774 ' CD1' HD23 ' A' ' 160' ' ' LEU . 13.0 tt 27.43 -142.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 122.404 0.282 . . . . 0.0 110.367 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.744 ' N ' HG23 ' A' ' 117' ' ' ILE . 86.3 m-20 -88.24 3.32 49.91 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.882 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.617 ' H ' HG23 ' A' ' 117' ' ' ILE . 16.8 tp 137.34 90.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 124.572 1.17 . . . . 0.0 109.515 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.533 ' C ' ' O ' ' A' ' 119' ' ' LEU . 27.8 ttm180 . . . . . 0 N--CA 1.469 0.487 0 O-C-N 123.986 0.804 . . . . 0.0 111.161 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.533 HG21 ' HB2' ' A' ' 90' ' ' PHE . 4.9 tt . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 121.249 0.547 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.628 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -135.37 -66.06 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.256 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 141' ' ' THR . 48.7 Cg_exo -19.42 151.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 124.1 3.2 . . . . 0.0 114.329 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -48.05 -2.76 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.508 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.654 ' H ' ' C ' ' A' ' 139' ' ' PRO . 58.6 p -82.14 -8.37 59.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.92 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.63 -48.56 59.52 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.161 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.76 -31.11 72.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.691 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -57.71 -41.53 81.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.106 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.0 mt -49.07 -35.15 15.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.944 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.13 -37.87 69.35 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -63.81 -38.2 90.2 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.753 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -49.25 -35.27 17.2 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.38 -113.35 0.31 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.003 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.583 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 43.1 tttp -132.4 -117.46 0.21 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.913 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.587 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . . . 109.47 -162.96 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.133 0.895 . . . . 0.0 109.24 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 110' ' ' PHE . 50.7 t -149.26 -63.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.462 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.42 ' HZ2' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -86.89 -173.93 4.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.61 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 31.0 p90 -170.8 95.94 0.21 Allowed 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.743 HG13 ' N ' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -172.63 -169.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.167 -178.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.743 ' N ' HG13 ' A' ' 155' ' ' VAL . 77.1 mt-10 -153.14 114.81 4.26 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.309 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.725 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -121.29 138.11 54.39 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 122.474 1.13 . . . . 0.0 112.595 -177.346 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.473 ' C ' ' N ' ' A' ' 160' ' ' LEU . 37.7 t -145.57 93.96 2.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.005 -1.907 . . . . 0.0 106.659 176.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.456 ' HB1' ' H ' ' A' ' 28' ' ' LEU . . . 39.61 30.54 0.06 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.986 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.867 ' O ' ' N ' ' A' ' 162' ' ' GLN . 58.2 tp -145.52 -86.61 0.11 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.281 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.563 ' C ' ' H ' ' A' ' 163' ' ' LYS . 1.5 m -44.7 41.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -176.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.867 ' N ' ' O ' ' A' ' 160' ' ' LEU . 13.1 pt20 -69.4 -0.79 6.92 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 161' ' ' THR . 63.9 mttp -56.84 -28.64 61.9 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 113.815 -1.539 . . . . 0.0 107.663 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.627 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -114.84 -65.21 0.41 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.726 HD12 ' CB ' ' A' ' 22' ' ' SER . 0.5 OUTLIER -42.52 -6.92 0.01 OUTLIER 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' A' ' 164' ' ' GLY . 38.2 tttt -92.85 -44.47 8.46 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 164' ' ' GLY . 33.3 m120 -81.73 -1.72 48.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.013 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.427 HG21 HD22 ' A' ' 165' ' ' LEU . 22.0 t -71.95 -52.28 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.449 ' CZ ' HD11 ' A' ' 55' ' ' LEU . 38.9 m-85 -55.79 -40.73 73.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.335 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.469 ' OD1' HG21 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -69.01 -47.8 64.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.497 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.56 -25.98 59.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.942 0.401 . . . . 0.0 111.215 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.901 ' CB ' HD22 ' A' ' 53' ' ' LEU . . . -52.03 -46.43 65.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.0 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.434 HG21 ' HB2' ' A' ' 51' ' ' TYR . 10.9 pt -66.2 -36.47 77.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.4 tp -61.37 -35.27 77.0 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.51 68.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.176 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -58.79 -30.68 67.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.871 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.438 ' HA ' HE22 ' A' ' 2' ' ' GLN . 31.0 tp -53.32 -37.51 62.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.483 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 99.989999999999995 110.665 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 121.015 0.436 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.451 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.5 OUTLIER -73.4 134.81 44.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.971 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 4' ' ' ILE . 10.5 tp -126.45 152.22 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.609 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 75' ' ' THR . 25.0 mttm -104.15 149.02 25.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.201 0.524 . . . . 0.0 111.342 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 128.09 46.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.835 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.72 HG23 HG21 ' A' ' 75' ' ' THR . 84.9 t -98.92 139.45 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.456 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.48 HG21 ' CA ' ' A' ' 57' ' ' ASP . 86.8 t -95.66 136.59 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.031 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.571 HG11 ' CG1' ' A' ' 101' ' ' ILE . 22.8 t -119.79 137.58 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 12' ' ' GLY . . . 81.85 -81.33 1.68 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 52.9 t0 63.8 -52.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.705 0.288 . . . . 0.0 110.614 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.694 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 93.19 -9.42 74.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 90.88 -4.54 0.26 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.766 0.317 . . . . 0.0 110.698 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.4 146.04 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.813 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 17' ' ' THR . . . 122.04 -53.56 0.72 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.436 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HD3' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -41.87 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.615 ' N ' ' O ' ' A' ' 15' ' ' GLY . 58.3 p -61.99 -43.65 98.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.412 ' HB3' ' H ' ' A' ' 159' ' ' ALA . 20.8 m -127.11 0.53 6.49 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.382 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.011 HD13 ' SG ' ' A' ' 157' ' ' CYS . 0.3 OUTLIER -93.43 -52.11 4.66 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.138 178.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 20' ' ' LEU . 47.2 tp -52.08 -37.33 53.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.046 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.9 tt -92.03 3.91 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.94 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.6 p -38.61 -80.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -72.14 -29.25 63.86 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 119.603 1.092 . . . . 0.0 111.215 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.7 m -41.96 -47.38 4.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.924 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.551 HG21 HD13 ' A' ' 28' ' ' LEU . 85.9 m -119.58 -8.91 9.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.881 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.554 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 40.9 t-20 55.68 94.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.303 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 59.84 86.71 0.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.375 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.551 HD13 HG21 ' A' ' 25' ' ' THR . 30.8 tp -127.94 68.86 76.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.996 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.38 128.94 16.14 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.287 1.992 . . . . 0.0 111.935 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -149.93 144.8 26.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.711 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.13 -34.07 76.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.464 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.49 140.41 49.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.391 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG11 ' HB ' ' A' ' 17' ' ' THR . 48.3 t -124.69 79.51 62.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.1 141.99 67.43 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.601 2.201 . . . . 0.0 111.674 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 36' ' ' VAL . 69.6 p -69.3 -23.92 63.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.295 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 37' ' ' PHE . 9.7 t 37.69 -124.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.413 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.563 ' N ' HG12 ' A' ' 36' ' ' VAL . 95.7 m-85 -113.61 147.42 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.341 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.438 ' C ' HD22 ' A' ' 39' ' ' ASN . 90.5 m-20 -68.36 135.65 52.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.398 . . . . 0.0 110.4 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.438 HD22 ' C ' ' A' ' 38' ' ' ASP . 2.9 m120 -105.58 138.35 41.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.972 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.583 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 13.0 p90 -175.51 4.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.095 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.38 99.63 2.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.609 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.89 138.11 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.631 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t -100.37 115.17 29.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.414 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -136.47 145.05 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.008 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 72.2 mtm -102.3 128.18 48.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.778 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 170' ' ' ASP . 12.8 tt -124.18 125.53 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.469 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.14 24.71 44.82 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.9 56.55 5.3 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -141.76 91.29 8.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.479 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 30.5 Cg_exo -58.63 103.59 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.57 2.18 . . . . 0.0 112.683 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' CD2' HD13 ' A' ' 173' ' ' ILE . 89.2 m-85 -159.86 161.19 34.39 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.451 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.7 p -132.31 143.67 50.04 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.885 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.8 HD13 ' HB1' ' A' ' 172' ' ' ALA . 59.2 tp -120.55 139.12 53.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -110.65 123.61 6.67 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.629 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.583 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 62.0 mt -109.36 131.58 54.93 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.626 0.25 . . . . 0.0 110.478 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.602 ' CD2' ' O ' ' A' ' 56' ' ' PHE . 41.2 t80 -113.67 31.11 6.73 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.556 ' CG ' ' H ' ' A' ' 58' ' ' THR . 33.0 t0 -54.06 -154.5 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.183 0.447 . . . . 0.0 110.937 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.556 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 11.3 m 65.56 -70.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.653 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . -67.45 146.57 53.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.523 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . . . . . . 0 CA--C 1.525 0.679 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.396 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.899 0.38 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 5' ' ' LYS . 26.2 m -146.65 131.68 18.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.118 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.8 ' OD1' HG23 ' A' ' 77' ' ' VAL . 46.4 p30 -115.07 6.56 15.22 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.506 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.8 HG23 ' OD1' ' A' ' 76' ' ' ASP . 40.6 t -121.47 110.5 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.964 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -87.26 120.42 28.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 110.468 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tt -119.39 127.55 53.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.315 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.86 128.44 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.474 ' SG ' ' CG2' ' A' ' 115' ' ' THR . 0.0 OUTLIER -134.34 147.72 50.61 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.356 -179.296 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.49 ' CG ' HG21 ' A' ' 93' ' ' VAL . 24.9 p90 -170.63 146.55 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.672 ' OG ' HG12 ' A' ' 85' ' ' VAL . 30.4 t -62.86 127.25 30.36 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.618 HG21 ' CD ' ' A' ' 156' ' ' GLU . 3.9 t -76.31 30.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.672 HG12 ' OG ' ' A' ' 83' ' ' SER . 14.9 p -130.04 141.62 45.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.974 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER 83.99 142.16 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.492 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.08 -3.3 13.4 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.529 2.152 . . . . 0.0 112.563 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.9 m -91.64 -38.61 12.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.7 p -60.91 -34.04 74.07 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -82.78 -41.84 18.65 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.998 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 83.8 tt0 -60.26 -30.32 69.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.623 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 86.7 m-20 -66.24 -43.36 86.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -92.24 -70.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -177.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.708 ' O ' HD21 ' A' ' 149' ' ' LEU . 24.7 mttt -52.78 -16.19 0.93 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 95.6 mt-10 -130.31 -52.88 1.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -73.63 -47.43 40.15 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.623 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 63.9 m95 -81.74 -30.19 32.57 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.134 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 93' ' ' VAL . 2.5 t -44.78 -56.48 8.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.835 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.52 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 12.0 Cg_endo -57.39 -37.21 98.21 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.428 1.419 . . . . 0.0 110.915 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.44 -40.92 98.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.78 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.571 ' CG1' HG11 ' A' ' 9' ' ' VAL . 86.8 mt -68.21 -39.7 81.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 105' ' ' CYS . 47.8 m -54.81 -44.36 73.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.561 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -66.2 -41.11 90.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.973 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -58.03 -46.45 85.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.547 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -141.79 162.77 44.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 111.072 -179.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.457 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 59.1 Cg_endo -73.61 -155.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.997 2.464 . . . . 0.0 111.783 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -81.36 120.95 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.827 0.346 . . . . 0.0 110.451 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.606 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -153.45 156.81 32.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.065 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.73 132.0 44.23 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.151 1.9 . . . . 0.0 111.483 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.747 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -133.55 132.11 40.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.9 mp -86.34 128.49 34.94 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.935 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.885 HD22 ' HB2' ' A' ' 146' ' ' ALA . 34.9 tp -92.7 130.66 38.25 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.59 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 21.8 t -142.26 160.06 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.911 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.532 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -136.09 165.66 24.85 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.474 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 1.0 OUTLIER -129.9 172.46 11.66 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.44 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.725 ' O ' ' N ' ' A' ' 118' ' ' ASP . 20.0 mt-30 50.15 24.2 1.37 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.472 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.594 ' O ' ' CB ' ' A' ' 118' ' ' ASP . 0.4 OUTLIER 21.36 32.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 116' ' ' GLN . 15.7 t0 93.95 48.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.673 -0.642 . . . . 0.0 110.143 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 116' ' ' GLN . 0.5 OUTLIER 77.43 87.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.942 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' A' ' 119' ' ' LEU . 43.4 ptt85 . . . . . 0 N--CA 1.469 0.475 0 O-C-N 124.321 1.013 . . . . 0.0 112.272 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.546 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 3.2 tt . . . . . 0 N--CA 1.464 0.25 0 CA-C-O 120.384 0.135 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.524 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -133.38 -69.23 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 1.5 Cg_endo -38.61 -84.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 123.413 2.742 . . . . 0.0 113.939 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 144' ' ' LYS . 96.9 mt-10 -110.55 -36.12 5.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.387 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.435 ' O ' HD13 ' A' ' 145' ' ' LEU . 8.4 p -44.87 -43.14 8.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.522 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.5 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -70.78 -58.18 3.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.57 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.6 -35.53 73.04 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 140' ' ' GLU . 19.4 tttm -58.24 -43.91 88.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 7.5 mp -66.85 -29.3 69.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.368 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.885 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -70.89 -30.94 67.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.707 0.289 . . . . 0.0 111.488 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.438 HH21 ' HG3' ' A' ' 144' ' ' LYS . 60.1 mtm180 -59.62 -36.55 76.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -119.56 -34.88 3.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.708 HD21 ' O ' ' A' ' 94' ' ' LYS . 13.1 tp -67.02 -3.27 6.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.575 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.729 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 67.4 mttm 98.95 150.2 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.495 0.718 . . . . 0.0 109.685 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 157.08 -172.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.755 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.686 HG23 ' H ' ' A' ' 110' ' ' PHE . 28.7 t -144.68 -53.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.605 ' NZ ' ' OE1' ' A' ' 171' ' ' GLU . 15.6 mmtt -95.53 -177.21 4.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.131 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -168.12 93.82 0.37 Allowed 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.704 HG22 ' H ' ' A' ' 156' ' ' GLU . 0.8 OUTLIER -172.6 -167.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.383 -178.24 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.704 ' H ' HG22 ' A' ' 155' ' ' VAL . 41.9 mt-10 -139.34 -165.43 1.86 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.158 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 1.011 ' SG ' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -174.95 120.0 0.2 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.139 0.971 . . . . 0.0 111.717 178.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 160' ' ' LEU . 42.6 t -165.99 91.08 0.46 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 33.67 30.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.092 -1.867 . . . . 0.0 109.085 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.614 ' C ' ' H ' ' A' ' 162' ' ' GLN . 16.0 tp -157.65 -74.73 0.09 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.48 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.721 ' C ' ' H ' ' A' ' 163' ' ' LYS . 7.4 m -64.54 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.126 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.614 ' H ' ' C ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -80.3 23.28 0.49 Allowed 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 175.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.721 ' H ' ' C ' ' A' ' 161' ' ' THR . 16.2 tttp -74.6 -4.38 36.8 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 112.665 -2.061 . . . . 0.0 108.297 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.715 ' O ' ' N ' ' A' ' 167' ' ' ASN . . . -120.71 -54.77 0.24 Allowed Glycine 0 C--O 1.221 -0.661 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.565 ' CD2' ' H ' ' A' ' 165' ' ' LEU . 4.0 mm? -34.16 -23.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.654 0.264 . . . . 0.0 110.845 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.67 ' N ' ' O ' ' A' ' 164' ' ' GLY . 28.2 tttp -77.95 -46.99 19.62 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.715 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.8 m120 -79.65 10.68 3.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.051 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 171' ' ' GLU . 53.2 t -96.44 -63.25 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.048 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 168' ' ' VAL . 13.1 m-85 -38.9 -43.1 0.92 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.784 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 54.1 p-10 -68.88 -38.08 79.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.547 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.63 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 34.8 tt0 -68.67 -24.85 64.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.028 0.442 . . . . 0.0 110.144 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.8 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -61.83 -32.38 72.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.26 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.491 HD13 ' CD2' ' A' ' 51' ' ' TYR . 61.9 mt -59.98 -39.17 79.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.651 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.9 -36.11 83.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.668 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.36 77.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.621 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.82 -28.19 67.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.252 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.92 -35.88 71.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 99.989999999999995 110.503 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.347 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.509 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -79.79 138.62 37.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.119 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.759 ' O ' HD12 ' A' ' 53' ' ' LEU . 11.2 tp -129.35 141.5 46.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.388 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -91.77 144.52 25.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.845 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 t -124.22 135.45 53.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.439 ' HB ' HG21 ' A' ' 75' ' ' THR . 6.2 p -110.51 154.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 111.898 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 81' ' ' CYS . 7.2 p -96.77 132.63 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.084 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.678 HG11 HD13 ' A' ' 101' ' ' ILE . 43.1 t -133.94 130.55 55.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.04 -163.89 37.58 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.778 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.7 t0 -87.42 117.84 26.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 111.263 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 32.11 33.67 0.01 OUTLIER Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.149 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.541 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 17.05 108.28 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 16' ' ' LYS . 1.4 t -75.36 -138.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.74 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.414 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -59.09 57.73 0.01 OUTLIER Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.476 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.763 ' NZ ' ' H ' ' A' ' 59' ' ' ALA . 1.1 pttt -64.66 -25.44 67.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.604 0.24 . . . . 0.0 111.372 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.658 HG21 ' CG1' ' A' ' 33' ' ' VAL . 38.0 m -66.38 -67.55 0.44 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.352 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' ILE . 92.3 m -55.6 -28.78 57.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.544 0.688 . . . . 0.0 109.837 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 165' ' ' LEU . 24.1 tp -60.71 -39.08 87.24 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.294 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -78.13 -30.36 49.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.101 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 18' ' ' CYS . 1.6 tt -58.49 -9.21 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.876 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -48.24 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.81 -178.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -57.05 -38.27 72.99 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.675 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.75 -65.0 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.873 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.6 p -122.08 -18.98 6.75 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.399 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 22' ' ' SER . 69.2 m-80 60.94 42.99 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.819 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 179.0 152.27 0.35 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.629 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -40.45 148.48 0.35 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.139 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.15 144.86 99.24 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.41 2.074 . . . . 0.0 111.96 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 32' ' ' TYR . 48.2 t -69.4 67.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.412 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 62.02 -17.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.523 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.609 ' H ' ' C ' ' A' ' 30' ' ' SER . 86.6 m-85 -120.97 145.8 47.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.658 ' CG1' HG21 ' A' ' 17' ' ' THR . 22.1 t -123.31 66.35 32.96 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.047 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.77 156.62 65.25 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.621 2.214 . . . . 0.0 112.667 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.1 p -116.74 170.37 8.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.378 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.89 157.86 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.891 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -58.05 -37.0 73.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.056 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -72.09 123.57 23.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.877 0.37 . . . . 0.0 110.835 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -59.88 -36.96 78.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.738 ' CB ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -158.08 -22.32 0.08 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.544 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.63 98.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.177 0.513 . . . . 0.0 111.13 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.563 HG21 HD11 ' A' ' 55' ' ' LEU . 64.5 t -131.14 132.33 63.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.035 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 43' ' ' THR . 12.9 t -112.62 123.6 50.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.105 0.479 . . . . 0.0 111.107 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.9 m -134.32 154.72 38.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.953 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.3 pmm? -126.52 125.93 42.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.228 0.537 . . . . 0.0 110.491 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.3 mt -126.42 112.2 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 4.48 85.87 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.93 5.49 59.7 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -83.06 115.07 56.95 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.93 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.29 109.26 2.09 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.127 1.885 . . . . 0.0 112.682 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -151.77 171.13 18.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.509 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.1 p -143.67 126.74 16.45 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.945 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.759 HD12 ' O ' ' A' ' 4' ' ' ILE . 48.3 tp -109.98 130.34 55.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.169 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.62 147.13 41.49 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.738 ' H ' ' CB ' ' A' ' 40' ' ' TYR . 49.2 mt -83.08 98.83 9.51 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.161 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.518 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 11.0 p90 -57.04 -40.94 77.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.593 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -43.02 165.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.187 -179.407 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.584 ' H ' ' CG ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 77.19 95.98 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.868 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.763 ' H ' ' NZ ' ' A' ' 16' ' ' LYS . . . -176.83 -124.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.338 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.682 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.747 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.707 0.289 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.439 HG21 ' HB ' ' A' ' 7' ' ' VAL . 40.8 p -123.42 154.28 39.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.71 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -115.93 0.08 12.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.534 ' CG1' HD13 ' A' ' 111' ' ' LEU . 21.8 t -115.42 101.52 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CZ ' ' SG ' ' A' ' 105' ' ' CYS . 87.9 m-85 -73.84 118.96 17.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.185 0.517 . . . . 0.0 111.13 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.518 HD11 HG21 ' A' ' 113' ' ' VAL . 8.0 tt -116.68 128.19 55.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.766 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.579 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 40.6 t -94.03 130.95 42.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.952 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.566 ' HB2' HG23 ' A' ' 8' ' ' VAL . 42.8 t -123.61 127.42 48.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.023 0.44 . . . . 0.0 111.152 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.737 ' HB3' HG21 ' A' ' 93' ' ' VAL . 33.9 p90 -171.23 139.24 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.091 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -62.37 132.69 53.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 156' ' ' GLU . 2.9 t -74.53 15.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.612 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.712 HG11 ' HE ' ' A' ' 120' ' ' ARG . 19.4 t -138.86 26.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.272 0.558 . . . . 0.0 109.894 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.424 ' C ' HD11 ' A' ' 137' ' ' ILE . 8.0 t -121.31 86.82 43.95 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.06 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.56 -29.3 18.58 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.403 2.068 . . . . 0.0 112.352 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.1 m -70.45 -41.46 72.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.989 0.424 . . . . 0.0 110.484 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.869 ' O ' HG23 ' A' ' 93' ' ' VAL . 49.5 m -73.97 -53.45 10.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.765 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.493 ' CB ' HD13 ' A' ' 137' ' ' ILE . 87.2 t80 -54.38 -46.2 72.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.449 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -66.19 -28.15 68.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.531 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.582 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 24.2 m120 -102.64 -3.4 26.69 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.126 -0.629 . . . . 0.0 111.076 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 89' ' ' SER . 38.5 t -89.53 -71.6 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.831 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HZ1' ' N ' ' A' ' 146' ' ' ALA . 46.9 mtpt -70.69 -20.21 62.7 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -112.64 -10.59 13.64 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -129.61 -29.04 2.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.452 -0.899 . . . . 0.0 113.03 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.582 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 53.8 m95 -98.26 -31.38 12.09 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.827 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.552 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -67.85 -44.27 40.74 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.751 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 17.0 Cg_exo -63.51 -36.67 52.85 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.315 2.01 . . . . 0.0 111.757 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.31 -41.41 96.95 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.962 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.678 HD13 HG11 ' A' ' 9' ' ' VAL . 39.1 pt -83.19 -34.28 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.04 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.8 m -61.25 -40.7 95.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.486 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -58.67 -43.86 90.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.435 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -82.3 -15.02 54.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.101 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.612 ' SG ' ' CZ ' ' A' ' 78' ' ' PHE . 1.7 t -114.66 108.77 48.74 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.316 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.01 163.1 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.947 1.764 . . . . 0.0 111.337 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -48.34 118.28 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.75 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.617 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -151.84 156.74 34.44 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.027 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.18 132.41 47.86 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.259 1.973 . . . . 0.0 112.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.745 ' H ' HG23 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -130.9 130.35 43.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.154 0.502 . . . . 0.0 110.504 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.4 mp -92.73 131.58 37.68 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.914 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.679 HD22 ' HB2' ' A' ' 146' ' ' ALA . 36.0 tp -93.35 123.53 36.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.622 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.518 HG21 HD11 ' A' ' 79' ' ' LEU . 42.1 t -143.3 152.17 16.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.299 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.499 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -141.15 -179.06 18.08 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 p -124.74 174.23 8.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.23 0.538 . . . . 0.0 110.848 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 117' ' ' ILE . 52.4 mt-30 48.5 28.97 1.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.904 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.955 HG23 ' H ' ' A' ' 119' ' ' LEU . 3.8 tt 31.23 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.78 ' N ' HG23 ' A' ' 117' ' ' ILE . 27.4 p-10 -109.66 9.07 25.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.312 0.577 . . . . 0.0 110.254 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.955 ' H ' HG23 ' A' ' 117' ' ' ILE . 77.1 mt -123.15 4.32 9.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.78 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.712 ' HE ' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.553 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.336 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.872 HG22 ' N ' ' A' ' 138' ' ' THR . 94.6 mt . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 121.216 0.531 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.872 ' N ' HG22 ' A' ' 137' ' ' ILE . 49.8 p -133.33 37.75 0.39 Allowed Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.612 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 138' ' ' THR . 87.8 Cg_exo -23.63 -39.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.384 2.723 . . . . 0.0 112.663 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 138' ' ' THR . 97.3 mt-10 -66.02 -47.68 73.64 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.138 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 143' ' ' GLU . 84.4 m -54.37 -71.56 0.08 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.601 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 141' ' ' THR . . . -28.06 -31.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 141' ' ' THR . 78.6 mm-40 -60.62 -39.91 89.94 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.834 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 141' ' ' THR . 20.8 tttt -98.04 -19.3 18.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.786 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.64 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -64.12 -32.35 73.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.099 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.716 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -80.24 -39.83 28.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.922 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.04 -36.73 77.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.476 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 59.3 t0 -98.36 -16.44 19.31 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 3.8 tp -117.46 34.4 5.15 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.051 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 23.2 mttm 80.85 149.41 0.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.282 0.563 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.716 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . 156.34 -177.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.762 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.745 HG23 ' H ' ' A' ' 110' ' ' PHE . 24.4 t -141.63 -52.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.846 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.475 ' HZ1' ' CG ' ' A' ' 167' ' ' ASN . 5.6 tttm -119.77 -172.54 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.553 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.616 ' CG ' ' O ' ' A' ' 154' ' ' TYR . 29.9 p90 -154.28 96.77 1.96 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 165' ' ' LEU . 7.8 p -140.81 138.48 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 122.118 0.961 . . . . 0.0 111.848 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.744 ' O ' ' OG1' ' A' ' 161' ' ' THR . 88.7 mt-10 -123.62 98.33 5.78 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.518 ' SG ' HD22 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -114.62 146.11 41.21 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 123.188 1.471 . . . . 0.0 113.167 -176.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.514 ' N ' ' SG ' ' A' ' 157' ' ' CYS . 15.2 t -169.9 93.23 0.24 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 111.629 -2.532 . . . . 0.0 107.201 176.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 42.92 28.09 0.12 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.976 -1.466 . . . . 0.0 110.215 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 162' ' ' GLN . 21.4 mt -145.65 -81.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.488 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.744 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -57.39 52.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.164 0.507 . . . . 0.0 111.481 -178.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.706 ' N ' ' O ' ' A' ' 160' ' ' LEU . 5.4 pp0? -82.62 15.52 2.55 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 176.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.585 ' H ' ' C ' ' A' ' 161' ' ' THR . 25.5 mttt -89.47 0.63 56.74 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.752 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.622 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.04 -72.76 0.11 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 177.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 19' ' ' LEU . 11.1 mp -40.22 -19.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.686 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.622 ' N ' ' O ' ' A' ' 164' ' ' GLY . 28.4 tttt -80.06 -49.78 11.29 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 164' ' ' GLY . 17.6 p-10 -77.9 4.53 11.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.791 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 171' ' ' GLU . 17.6 t -81.25 -58.11 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.243 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 40.0 m-85 -39.31 -39.88 0.7 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.705 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.685 ' O ' HG22 ' A' ' 173' ' ' ILE . 58.2 t0 -65.89 -47.66 74.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.057 0.456 . . . . 0.0 110.022 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 168' ' ' VAL . 77.1 mm-40 -67.76 -18.92 65.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.153 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.643 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -63.35 -38.62 91.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.821 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 170' ' ' ASP . 15.0 tt -62.11 -31.79 52.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.1 tp -63.36 -38.1 89.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.464 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.69 -22.92 66.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.19 68.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.427 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 38.9 tp -56.61 -36.77 69.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.57 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 99.989999999999995 110.583 -179.763 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.538 ' N ' ' C ' ' A' ' 176' ' ' ALA . 65.0 mtt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.557 ' O ' ' HB1' ' A' ' 176' ' ' ALA . 90.5 mt-30 -115.68 164.64 14.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.819 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 2' ' ' GLN . 1.8 t -39.93 142.19 0.37 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.876 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.91 HD11 ' OD2' ' A' ' 76' ' ' ASP . 8.3 tp -128.57 149.68 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.953 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -95.93 141.09 29.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.795 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -134.76 147.49 50.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.825 179.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.476 ' HA ' ' H ' ' A' ' 56' ' ' PHE . 28.4 m -131.9 147.28 32.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.14 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.417 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 55.3 t -109.0 124.45 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-O 121.158 0.504 . . . . 0.0 110.942 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -127.25 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.849 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.528 ' HA3' HG21 ' A' ' 14' ' ' VAL . . . -148.71 -164.36 11.44 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.611 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.7 t0 -78.62 126.53 30.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 110.833 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.14 -88.62 0.01 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -136.6 127.7 27.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.78 0.324 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.528 HG21 ' HA3' ' A' ' 10' ' ' GLY . 8.6 m -140.64 150.8 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.305 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.596 ' CA ' ' OG1' ' A' ' 115' ' ' THR . . . 23.76 54.24 0.04 OUTLIER Glycine 0 N--CA 1.471 1.015 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.888 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.5 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 85.1 mttt -35.12 -58.85 0.53 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.576 ' O ' ' N ' ' A' ' 20' ' ' LEU . 4.0 m -130.37 -55.94 1.09 Allowed 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' C ' ' O ' ' A' ' 17' ' ' THR . 87.7 m -34.84 -28.58 0.01 OUTLIER 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.045 0.45 . . . . 0.0 111.049 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' O ' ' A' ' 17' ' ' THR . 4.2 tt -76.3 -43.39 41.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.432 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.791 HD21 ' O ' ' A' ' 56' ' ' PHE . 96.0 mt -59.33 -35.96 74.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.089 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.016 HD12 HD22 ' A' ' 26' ' ' ASN . 12.8 pt -90.14 8.19 3.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.766 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.458 ' C ' ' O ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -39.85 -77.83 0.02 OUTLIER 'General case' 0 C--O 1.241 0.611 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.504 -179.177 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.585 ' C ' ' N ' ' A' ' 25' ' ' THR . 14.9 p90 -39.93 -34.72 0.3 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 118.226 0.466 . . . . 0.0 111.499 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.508 ' CB ' ' O ' ' A' ' 21' ' ' ILE . 1.1 m -45.95 -14.29 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.648 ' O ' HG22 ' A' ' 25' ' ' THR . 55.7 m 50.53 37.31 15.68 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.705 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 1.016 HD22 HD12 ' A' ' 21' ' ' ILE . 91.7 m-20 -63.12 -40.37 97.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.168 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.757 ' H ' HE22 ' A' ' 162' ' ' GLN . 36.8 mttt 57.84 131.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.886 0.374 . . . . 0.0 110.457 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.606 ' O ' ' N ' ' A' ' 30' ' ' SER . 1.8 mt -39.6 -55.84 3.24 Favored Pre-proline 0 N--CA 1.465 0.278 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.984 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 28' ' ' LEU . 85.0 Cg_exo -38.64 -15.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.65 2.233 . . . . 0.0 113.048 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 28' ' ' LEU . 23.0 t -104.32 131.29 51.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.573 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' HG12 ' A' ' 33' ' ' VAL . 96.9 mt-10 -67.54 -29.36 68.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.104 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -53.91 122.04 9.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.75 0.31 . . . . 0.0 110.806 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 33' ' ' VAL . 14.8 p -178.18 50.73 0.05 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.543 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 33' ' ' VAL . 14.7 Cg_endo -59.68 131.42 40.0 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.626 2.217 . . . . 0.0 112.002 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 p -119.55 5.39 11.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.672 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.1 t -62.11 -40.59 88.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -109.79 132.94 53.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.204 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -84.67 124.02 31.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.796 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -99.37 144.99 27.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.046 0.45 . . . . 0.0 111.205 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.606 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 20.4 p90 -167.13 19.6 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.45 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.62 100.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.58 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 25.4 t -137.38 134.03 46.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.977 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 43' ' ' THR . 8.9 t -103.62 108.21 19.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.603 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -135.17 144.2 34.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.219 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.5 ptp -111.46 146.03 37.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.545 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.465 ' O ' ' C ' ' A' ' 47' ' ' GLY . 39.1 mm -118.73 125.7 74.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.127 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 32.12 45.51 0.19 Allowed Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.51 47.76 5.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.742 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 2.8 mt-10 -133.46 77.48 65.22 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.855 0.359 . . . . 0.0 110.108 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.29 106.85 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.965 2.443 . . . . 0.0 112.959 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.552 ' CE1' ' O ' ' A' ' 169' ' ' PHE . 30.7 p90 -155.84 166.27 34.0 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.3 127.18 37.19 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.955 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.914 HD22 ' HB2' ' A' ' 172' ' ' ALA . 41.5 tp -119.35 127.79 53.49 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.019 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.524 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -93.1 144.17 16.9 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.671 HD23 ' SG ' ' A' ' 6' ' ' CYS . 64.9 mt -137.29 129.74 29.79 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.471 -0.491 . . . . 0.0 112.201 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.791 ' O ' HD21 ' A' ' 20' ' ' LEU . 1.9 t80 -97.3 -164.27 1.13 Allowed 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.516 ' O ' ' C ' ' A' ' 58' ' ' THR . 49.1 p30 -162.33 -162.38 0.82 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.401 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.796 HG23 ' H ' ' A' ' 59' ' ' ALA . 4.4 t -8.25 -112.43 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.039 0.837 . . . . 0.0 112.803 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.796 ' H ' HG23 ' A' ' 58' ' ' THR . . . 39.81 83.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.42 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -40.84 -89.4 0.01 OUTLIER Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.479 ' OE1' ' O ' ' A' ' 63' ' ' ASP . 46.6 tt0 -59.75 -15.37 19.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.679 0.276 . . . . 0.0 110.757 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 65.2 tt0 58.79 21.07 8.56 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 60.5 t0 176.58 45.48 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.498 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.439 ' C ' ' O ' ' A' ' 63' ' ' ASP . 98.9 m-85 -33.25 -40.75 0.07 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.133 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' A' ' 63' ' ' ASP . 88.1 m-20 -83.8 116.99 22.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 111.089 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -65.54 -28.37 69.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.886 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.623 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -46.73 -38.41 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.49 -179.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -63.04 152.64 83.43 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.407 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.93 136.59 62.3 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.648 2.232 . . . . 0.0 112.526 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.55 1.33 53.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.621 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.565 ' O ' ' CB ' ' A' ' 72' ' ' TYR . 49.3 m -121.26 157.69 29.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.122 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.565 ' CB ' ' O ' ' A' ' 71' ' ' SER . 6.6 t80 91.39 71.17 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.922 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.52 133.6 59.03 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.704 2.269 . . . . 0.0 111.765 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -104.18 14.12 31.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 0.0 110.124 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -136.65 151.15 48.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.538 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.91 ' OD2' HD11 ' A' ' 4' ' ' ILE . 84.1 m-20 -112.1 -19.61 12.23 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.924 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.487 ' CG1' HD13 ' A' ' 111' ' ' LEU . 19.7 t -122.24 120.43 61.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.144 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.587 ' C ' HD12 ' A' ' 79' ' ' LEU . 98.3 m-85 -87.53 122.18 30.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.128 0.489 . . . . 0.0 111.548 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.795 HD22 ' SG ' ' A' ' 6' ' ' CYS . 10.6 mp -111.73 114.2 27.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.002 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.4 m -98.59 129.23 49.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 114' ' ' GLY . 6.8 t -129.86 135.86 48.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.499 0.666 . . . . 0.0 112.042 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.453 ' H ' ' HA2' ' A' ' 114' ' ' GLY . 49.9 p90 -142.24 144.92 33.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.372 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.6 t -66.55 130.69 44.03 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 84' ' ' VAL . 10.7 t -63.64 4.24 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' SER . 14.7 p -129.99 144.1 39.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 118.557 0.617 . . . . 0.0 109.556 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.7 OUTLIER 83.65 92.16 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -48.11 -0.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.648 2.232 . . . . 0.0 113.113 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 86' ' ' SER . 19.9 m -66.19 -61.52 1.98 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.888 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.8 p -64.94 -35.02 79.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.525 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.771 ' CZ ' HD22 ' A' ' 145' ' ' LEU . 78.5 t80 -69.01 -50.52 48.06 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -64.12 -24.16 67.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.851 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 96' ' ' LYS . 14.0 m120 -86.99 -64.09 1.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.858 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 97' ' ' TRP . 30.1 t -41.07 -61.92 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 142' ' ' ALA . 43.5 mtpt -67.96 -21.26 65.1 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 68.3 tt0 -106.11 -63.24 1.28 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 92' ' ' ASN . 17.4 mttp -67.19 -35.95 80.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -177.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.46 ' CD1' ' HA ' ' A' ' 93' ' ' VAL . 29.7 m95 -84.82 -33.93 22.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.899 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.948 ' O ' HG23 ' A' ' 102' ' ' THR . 2.3 t -44.69 -54.34 13.01 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.267 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 16.6 Cg_endo -60.46 -36.49 86.28 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.568 1.512 . . . . 0.0 111.61 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.84 -40.51 97.66 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.357 -0.537 . . . . 0.0 110.096 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 83.7 mt -73.8 -38.52 50.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.948 HG23 ' O ' ' A' ' 98' ' ' VAL . 49.8 p -61.42 -37.42 83.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.562 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -56.69 -36.99 70.25 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.22 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -55.19 -44.74 75.57 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.268 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.5 153.8 29.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.735 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -43.34 -76.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.293 1.995 . . . . 0.0 112.141 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.0 mtpt -140.47 142.85 35.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.877 0.37 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.587 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -152.79 156.57 33.09 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.09 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.29 128.73 31.23 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.209 1.94 . . . . 0.0 110.91 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.727 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -124.0 123.5 40.51 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.72 -178.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.618 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.8 mp -97.68 129.86 44.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.44 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.6 tp -96.76 129.32 44.2 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.561 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.673 HG12 ' N ' ' A' ' 114' ' ' GLY . 51.5 t -147.38 168.12 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.347 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.673 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -135.51 166.63 24.46 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.596 ' OG1' ' CA ' ' A' ' 15' ' ' GLY . 11.2 t -123.56 174.58 7.33 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.109 0.48 . . . . 0.0 112.017 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.56 ' O ' ' C ' ' A' ' 117' ' ' ILE . 33.1 mt-30 34.16 31.04 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.232 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.883 HG23 ' N ' ' A' ' 118' ' ' ASP . 7.7 tt 24.84 -138.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 O-C-N 123.944 0.777 . . . . 0.0 109.452 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.883 ' N ' HG23 ' A' ' 117' ' ' ILE . 61.8 m-20 -84.87 71.93 10.83 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.573 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.646 HD13 ' OG1' ' A' ' 125' ' ' THR . 5.9 tt 66.1 91.42 0.08 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.631 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 119' ' ' LEU . 56.9 ttp180 5.72 62.39 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 O-C-N 124.259 0.974 . . . . 0.0 111.181 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.602 ' N ' ' O ' ' A' ' 119' ' ' LEU . 0.6 OUTLIER 168.54 -96.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.606 -179.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.913 ' H ' HG22 ' A' ' 125' ' ' THR . 39.7 t0 108.08 -43.5 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.398 0 C-N-CA 123.487 0.715 . . . . 0.0 111.116 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.432 ' CD ' ' C ' ' A' ' 121' ' ' ASP . 56.3 Cg_endo -91.75 -37.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 121.501 1.467 . . . . 0.0 112.179 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.7 p -99.04 -0.86 41.06 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.93 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.936 ' O ' HD13 ' A' ' 129' ' ' LEU . 13.2 t -111.71 -13.72 13.7 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.778 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.494 HG23 ' N ' ' A' ' 127' ' ' GLU . 16.3 tt -86.19 -42.78 16.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.494 ' N ' HG23 ' A' ' 126' ' ' ILE . 96.5 mt-10 -73.81 -34.48 64.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.041 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.3 tttt -74.12 -32.28 63.13 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.48 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 125' ' ' THR . 4.6 mp -66.97 -33.11 74.87 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.596 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . 109.08 130.6 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.3 mttp -48.54 -37.74 18.57 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.732 -178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -82.84 -3.09 56.36 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.322 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.5 tttm -110.3 -9.15 14.66 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.165 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' A' ' 135' ' ' LYS . 91.1 mt-30 -52.37 -40.91 62.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.81 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 134' ' ' GLN . 41.0 mttp 26.71 59.94 0.53 Allowed Pre-proline 0 N--CA 1.464 0.27 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.141 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.86 143.04 78.4 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.441 2.094 . . . . 0.0 111.363 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 137' ' ' ILE . 0.6 OUTLIER -133.02 47.41 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 120.161 -0.616 . . . . 0.0 111.814 -179.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.584 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -133.23 -65.29 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.584 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.6 Cg_exo -20.54 -73.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 124.001 3.134 . . . . 0.0 113.983 -178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -114.82 -31.05 6.25 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.496 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.472 HG21 ' CD1' ' A' ' 137' ' ' ILE . 40.2 m -55.78 -42.61 75.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.305 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.513 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -69.55 -38.22 77.37 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.526 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.59 -35.27 79.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.316 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.97 -50.41 72.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.319 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.771 HD22 ' CZ ' ' A' ' 90' ' ' PHE . 11.0 mp -64.05 -33.04 74.85 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.684 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.78 -41.4 75.18 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.8 mmm-85 -62.43 -35.11 78.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.468 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -47.39 -30.83 3.54 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.1 mt -123.48 -117.67 0.29 Allowed 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 151' ' ' ALA . 76.9 tttt -177.46 69.99 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.219 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.525 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -53.13 -121.94 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.666 0.746 . . . . 0.0 111.093 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.469 HG23 ' H ' ' A' ' 110' ' ' PHE . 71.6 t -155.02 -61.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.213 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.527 ' C ' ' CG ' ' A' ' 154' ' ' TYR . 18.5 mttp -101.76 -173.65 2.4 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.815 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -170.03 95.5 0.26 Allowed 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.926 HG22 ' H ' ' A' ' 156' ' ' GLU . 3.6 p -171.92 -167.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.399 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.926 ' H ' HG22 ' A' ' 155' ' ' VAL . 27.9 mp0 -130.66 -170.62 2.38 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.313 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.808 ' SG ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -171.76 121.13 0.48 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.878 0.847 . . . . 0.0 109.508 178.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.665 ' HB3' ' H ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -173.88 92.74 0.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.097 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.489 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 31.34 31.25 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.774 -1.557 . . . . 0.0 109.578 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.705 HD23 ' CD1' ' A' ' 117' ' ' ILE . 21.7 tp -164.76 -77.45 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.805 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.834 ' C ' ' H ' ' A' ' 163' ' ' LYS . 2.8 m -58.98 3.45 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.132 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.757 HE22 ' H ' ' A' ' 27' ' ' LYS . 13.9 pt20 -64.8 30.38 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.834 ' H ' ' C ' ' A' ' 161' ' ' THR . 94.2 mttt -90.89 3.95 53.17 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -118.2 -70.83 0.38 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.808 HD12 ' SG ' ' A' ' 157' ' ' CYS . 7.3 mt -41.03 -14.09 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.899 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 164' ' ' GLY . 60.0 tttp -82.93 -50.58 8.43 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.593 ' N ' ' O ' ' A' ' 164' ' ' GLY . 29.9 m120 -77.61 3.73 13.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.487 179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 171' ' ' GLU . 33.2 t -84.04 -51.76 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.759 178.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.552 ' O ' ' CE1' ' A' ' 51' ' ' TYR . 6.7 m-85 -37.69 -42.36 0.56 Allowed 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.808 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 173' ' ' ILE . 61.5 t0 -67.52 -40.64 85.08 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.35 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.575 ' N ' ' O ' ' A' ' 168' ' ' VAL . 76.7 mm-40 -67.03 -23.31 65.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.05 0.453 . . . . 0.0 109.951 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.914 ' HB2' HD22 ' A' ' 53' ' ' LEU . . . -59.78 -39.5 85.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.903 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 170' ' ' ASP . 14.0 tt -60.58 -31.69 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.625 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 28.1 tp -65.7 -38.56 89.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.139 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.47 -33.8 76.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 2' ' ' GLN . . . -59.14 -32.5 69.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.501 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.64 -36.01 69.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.386 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 99.989999999999995 110.641 -179.973 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.1 mtp . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 3' ' ' THR . 91.6 mt-30 49.68 -148.65 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.135 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.486 ' CB ' ' HG1' ' A' ' 52' ' ' THR . 2.0 t -36.83 135.07 0.46 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.241 0.543 . . . . 0.0 110.737 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 tp -127.27 150.76 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.282 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -114.05 157.91 21.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.214 0.53 . . . . 0.0 111.623 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.23 153.35 47.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.388 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 9' ' ' VAL . 45.8 t -122.48 133.09 69.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 120.539 -0.465 . . . . 0.0 112.027 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.668 HG11 ' O ' ' A' ' 58' ' ' THR . 10.5 p -50.02 120.86 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.166 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 7' ' ' VAL . 47.9 t -127.63 131.49 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.19 -169.91 37.56 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.314 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.469 ' OD2' ' OD1' ' A' ' 92' ' ' ASN . 58.5 t0 -123.29 139.63 53.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.923 0.392 . . . . 0.0 110.677 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 11' ' ' ASP . . . 63.42 -117.19 10.5 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.95 128.83 10.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.822 0.344 . . . . 0.0 110.421 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.51 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . 24.2 m -136.53 164.33 31.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.552 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -74.65 80.76 0.89 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.118 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.634 ' H ' ' CD ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -81.46 -1.16 44.83 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.469 -0.43 . . . . 0.0 110.914 179.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.3 p -68.42 -53.32 24.47 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.562 -0.455 . . . . 0.0 111.107 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.586 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 93.2 m -69.25 -22.42 63.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.69 0.757 . . . . 0.0 109.811 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.47 -56.06 16.67 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.626 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.3 tp -69.11 -34.09 74.52 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.027 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 18' ' ' CYS . 1.7 tp -55.17 -10.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.818 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 97.3 p -42.21 -80.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.076 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.539 ' N ' ' OG ' ' A' ' 22' ' ' SER . 79.7 t80 -62.08 -33.37 74.3 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.482 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.7 m -47.86 -45.14 29.95 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.819 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.502 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -151.9 -12.53 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.804 -179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 25' ' ' THR . 47.9 t30 53.98 119.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.73 0.3 . . . . 0.0 111.18 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 mttm 61.08 62.87 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.567 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 tt -116.19 89.66 26.45 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.05 158.91 1.15 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.375 2.05 . . . . 0.0 111.691 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.2 m -55.13 141.89 33.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.99 0.424 . . . . 0.0 110.931 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.615 ' C ' ' H ' ' A' ' 33' ' ' VAL . 84.0 tt0 -178.56 88.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.633 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' O ' ' C ' ' A' ' 33' ' ' VAL . 56.6 t80 64.77 -13.2 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.17 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.615 ' H ' ' C ' ' A' ' 31' ' ' GLU . 39.0 t 36.17 61.83 2.94 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.426 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -66.58 133.52 32.36 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.362 2.041 . . . . 0.0 111.562 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 p -128.63 163.11 25.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 111.029 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 38' ' ' ASP . 41.0 t -118.98 132.36 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.953 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.97 -3.3 24.86 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.124 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.491 ' H ' HG12 ' A' ' 36' ' ' VAL . 91.7 m-20 -60.82 -48.5 81.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.575 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 -176.8 172.87 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.417 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CG ' ' O ' ' A' ' 55' ' ' LEU . 82.8 m-85 -125.66 15.94 8.13 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.86 98.02 5.46 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.602 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.22 135.8 52.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.628 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 51' ' ' TYR . 2.1 t -107.83 138.87 43.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.173 0.511 . . . . 0.0 111.71 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.2 144.62 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.861 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.1 mtm -112.11 136.46 51.47 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.713 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.617 HG21 ' CG ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER -150.88 99.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.553 178.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.41 35.02 56.76 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.47 41.69 24.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.02 76.87 75.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 120.91 0.386 . . . . 0.0 110.68 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.433 ' C ' ' CD2' ' A' ' 51' ' ' TYR . 82.1 Cg_endo -86.0 117.68 1.65 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.113 2.542 . . . . 0.0 112.563 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' A' ' 50' ' ' PRO . 97.8 m-85 -154.49 174.04 15.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.777 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.532 ' C ' HD22 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -121.75 126.97 50.11 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.499 179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.908 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -109.9 123.41 49.55 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.264 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.724 ' C ' HD12 ' A' ' 55' ' ' LEU . . . -93.76 135.51 12.6 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.724 HD12 ' C ' ' A' ' 54' ' ' GLY . 5.8 mp -142.58 108.89 5.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.013 -0.675 . . . . 0.0 112.091 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.454 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 75.3 m-85 -80.26 168.99 18.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 58' ' ' THR . 51.9 p30 -138.11 -179.4 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.715 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 13.4 m 48.62 174.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 0.0 110.857 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 58' ' ' THR . . . 87.06 124.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.704 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -176.97 6.52 0.03 OUTLIER Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.578 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -96.18 159.33 15.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.256 0.551 . . . . 0.0 110.01 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.98 -42.72 99.92 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.743 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -108.93 32.41 4.93 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.89 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.447 ' CE2' ' HB2' ' A' ' 59' ' ' ALA . 87.3 t80 -50.87 -44.42 59.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.16 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 66' ' ' ARG . 42.3 t0 -167.02 168.41 13.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 111.022 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.516 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 83.5 mtm180 -59.19 146.39 39.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.659 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.598 ' N ' HD22 ' A' ' 67' ' ' LEU . 3.4 mm? -63.22 -38.28 90.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.007 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 40.61 70.64 1.47 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.842 0.353 . . . . 0.0 110.373 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -51.53 138.39 48.29 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 122.821 2.348 . . . . 0.0 112.369 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 48.3 mt -106.63 140.32 39.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.49 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.3 t -59.36 -36.56 75.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -148.18 103.62 3.56 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.556 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -47.99 132.5 22.5 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.056 1.837 . . . . 0.0 112.111 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -100.8 26.31 7.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.027 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.3 t -133.99 157.36 46.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.693 0.282 . . . . 0.0 110.348 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.487 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 59.9 t0 -150.17 -10.94 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.396 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.67 ' CG1' HD13 ' A' ' 111' ' ' LEU . 22.8 t -119.03 106.22 19.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.285 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -81.16 129.96 34.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.013 -178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.565 HD11 HG21 ' A' ' 113' ' ' VAL . 30.4 tp -114.21 113.09 24.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.6 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.73 132.56 33.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' VAL . 49.4 t -132.81 116.71 16.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.094 0.473 . . . . 0.0 111.287 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.432 ' CE1' ' O ' ' A' ' 113' ' ' VAL . 39.6 p90 -153.53 155.72 36.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.792 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.458 ' OG ' ' OD2' ' A' ' 121' ' ' ASP . 30.1 t -71.85 128.85 37.07 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.479 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.749 HG11 ' OE2' ' A' ' 156' ' ' GLU . 2.1 t -59.77 -2.17 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.825 ' O ' HG22 ' A' ' 85' ' ' VAL . 7.2 p -127.75 30.98 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.461 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 83' ' ' SER . 5.2 p -122.51 82.94 47.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.472 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -51.44 -30.29 34.29 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.667 2.245 . . . . 0.0 112.286 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.477 ' O ' ' OD1' ' A' ' 92' ' ' ASN . 22.5 m -67.72 -47.65 68.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.942 0.401 . . . . 0.0 110.444 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.955 ' O ' HG22 ' A' ' 93' ' ' VAL . 97.0 p -67.87 -35.22 78.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.46 -47.51 85.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.802 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -71.49 -18.52 62.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.609 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 88' ' ' SER . 11.3 m120 -93.17 -67.08 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.955 HG22 ' O ' ' A' ' 89' ' ' SER . 31.0 m -45.23 -50.1 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -177.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.495 ' N ' HG23 ' A' ' 93' ' ' VAL . 59.5 mttm -70.71 -32.27 69.42 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.444 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 83.5 tt0 -107.6 -60.92 1.64 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 92' ' ' ASN . 75.4 mttt -63.44 -34.92 78.81 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.419 ' CE3' ' OE1' ' A' ' 100' ' ' GLU . 49.8 m95 -86.26 -29.4 23.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.523 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -44.77 -53.98 14.12 Favored Pre-proline 0 C--N 1.328 -0.331 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.853 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 29.1 Cg_endo -65.14 -33.13 51.04 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 121.615 1.543 . . . . 0.0 111.474 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.419 ' OE1' ' CE3' ' A' ' 97' ' ' TRP . 84.6 tt0 -59.76 -37.73 79.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.8 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.1 pt -94.91 -29.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.329 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 105' ' ' CYS . 55.1 m -52.33 -40.72 62.26 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.62 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -53.78 -33.33 55.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -54.55 -43.56 72.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.119 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -152.3 152.88 30.12 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.769 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.69 -42.87 2.17 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.664 2.243 . . . . 0.0 112.651 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 13.3 tttm -138.34 130.19 28.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 111.084 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.1 t -165.66 147.45 6.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.262 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.39 135.57 58.43 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.187 1.925 . . . . 0.0 111.427 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.695 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -116.52 119.28 35.1 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.005 -179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.67 HD13 ' CG1' ' A' ' 77' ' ' VAL . 10.0 mp -94.64 119.37 33.18 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.445 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 113' ' ' VAL . 46.0 mt -90.94 130.19 36.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.592 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.569 HG12 ' N ' ' A' ' 114' ' ' GLY . 52.0 t -153.22 162.49 2.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.368 0.604 . . . . 0.0 112.122 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.569 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -137.08 170.37 23.55 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 9.8 t -136.06 167.03 22.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 117.343 0.572 . . . . 0.0 111.776 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.534 ' O ' ' O ' ' A' ' 117' ' ' ILE . 40.7 mt-30 55.6 25.76 8.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.881 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.833 HG23 ' N ' ' A' ' 118' ' ' ASP . 6.3 tt 30.28 -151.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.304 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.833 ' N ' HG23 ' A' ' 117' ' ' ILE . 52.9 p30 -122.86 29.76 6.69 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.831 ' H ' HG23 ' A' ' 117' ' ' ILE . 7.7 tt -139.78 -43.02 0.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.242 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.593 ' H ' HG22 ' A' ' 117' ' ' ILE . 25.7 mmt180 -52.86 -58.72 5.99 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.559 ' O ' ' C ' ' A' ' 122' ' ' ASP . 93.4 m-20 -44.28 -14.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.962 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -0.56 -68.44 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 O-C-N 124.036 0.835 . . . . 0.0 112.054 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.551 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 53.1 Cg_exo -32.71 -33.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.947 0 C-N-CA 121.291 1.327 . . . . 0.0 111.727 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 122' ' ' ASP . 1.9 m -111.49 -39.44 4.65 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.901 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.674 ' OG1' HG11 ' A' ' 85' ' ' VAL . 75.2 m -73.66 -36.26 65.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.276 0.56 . . . . 0.0 110.578 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.02 -47.65 16.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.982 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.21 -36.0 74.61 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.51 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -97.08 -68.14 0.81 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.324 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 130' ' ' ALA . 42.9 mt -85.17 45.51 1.18 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.153 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 129' ' ' LEU . . . -46.53 -99.11 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -150.22 92.64 1.9 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.457 0.646 . . . . 0.0 109.751 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -155.04 60.25 0.65 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.21 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 49.0 mttp 62.6 42.82 8.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.988 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.468 ' OE1' HD23 ' A' ' 129' ' ' LEU . 42.3 mt-30 -121.03 136.99 54.86 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.357 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.55 161.63 55.74 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.96 0.41 . . . . 0.0 111.377 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -67.17 161.96 40.54 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 123.205 2.604 . . . . 0.0 112.556 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 137' ' ' ILE . 7.7 tt -101.93 51.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.019 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.604 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.99 -65.77 0.02 OUTLIER Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.604 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.2 Cg_exo -24.27 -68.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 123.7 2.933 . . . . 0.0 114.38 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -109.12 -35.13 6.39 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.653 -0.419 . . . . 0.0 112.102 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.447 ' OG1' ' C ' ' A' ' 137' ' ' ILE . 61.0 p -56.42 -38.2 71.24 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.344 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.4 -38.3 77.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.745 0.307 . . . . 0.0 111.18 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -60.48 -37.52 81.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.007 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -59.88 -50.4 73.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 0.0 110.879 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 80.4 mt -58.87 -28.91 66.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.795 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.48 -38.74 87.95 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.058 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -58.47 -40.39 82.59 Favored 'General case' 0 CA--C 1.523 -0.081 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.296 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -53.88 -29.59 42.3 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 146' ' ' ALA . 81.8 mt -137.76 -112.02 0.17 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.045 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.73 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 59.9 mttm -143.78 -136.87 0.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.094 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 153.89 -160.85 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 O-C-N 123.319 0.387 . . . . 0.0 110.229 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 110' ' ' PHE . 88.2 t -155.88 -68.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.613 ' CE ' HD23 ' A' ' 111' ' ' LEU . 3.9 mtmp? -101.94 177.97 4.75 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.603 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 27.3 p90 -169.11 94.11 0.3 Allowed 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.601 HG22 ' C ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -170.72 -167.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.409 -177.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.749 ' OE2' HG11 ' A' ' 84' ' ' VAL . 57.8 mt-10 -126.37 -172.3 2.59 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.33 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.533 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 1.2 p -171.71 117.2 0.4 Allowed 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.692 ' OG ' ' N ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -173.14 93.75 0.11 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.974 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.696 ' H ' ' NE2' ' A' ' 162' ' ' GLN . . . 31.51 32.69 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.722 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.605 ' N ' ' O ' ' A' ' 158' ' ' SER . 5.6 tt -165.98 -77.5 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.995 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.813 ' C ' ' H ' ' A' ' 163' ' ' LYS . 2.4 m -59.3 5.6 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.18 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.696 ' NE2' ' H ' ' A' ' 159' ' ' ALA . 87.4 mt-30 -65.77 30.96 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.813 ' H ' ' C ' ' A' ' 161' ' ' THR . 99.5 mttt -90.57 5.43 47.89 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.634 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -128.41 -71.4 0.15 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 164' ' ' GLY . 3.9 mm? -37.45 -21.79 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.052 0.453 . . . . 0.0 110.341 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.634 ' N ' ' O ' ' A' ' 164' ' ' GLY . 16.7 tttm -78.98 -52.56 8.07 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 164' ' ' GLY . 14.7 t-20 -78.98 4.06 15.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.907 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 171' ' ' GLU . 2.9 t -76.57 -58.2 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.9 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.468 ' C ' ' O ' ' A' ' 168' ' ' VAL . 71.6 m-85 -35.48 -37.49 0.09 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.482 -0.487 . . . . 0.0 109.73 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.617 ' CG ' HG21 ' A' ' 46' ' ' ILE . 76.4 m-20 -71.28 -45.16 63.79 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.622 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.585 ' N ' ' O ' ' A' ' 168' ' ' VAL . 97.1 mt-10 -69.37 -27.47 65.35 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.988 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.609 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . . . -63.3 -30.79 71.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.56 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.461 ' O ' ' HB3' ' A' ' 176' ' ' ALA . 1.2 pp -66.08 -27.1 39.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.73 -37.38 78.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.526 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.01 -19.54 64.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.462 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -59.85 -35.76 75.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.27 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 62.0 mt -59.44 -33.47 71.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.19 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 99.989999999999995 110.426 -179.845 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 3' ' ' THR . 91.0 mt-30 -111.67 -138.75 0.38 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.574 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -40.5 114.93 0.5 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.388 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.899 HD11 ' OD2' ' A' ' 76' ' ' ASP . 9.7 tp -117.59 144.38 25.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.207 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -91.99 140.1 29.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.928 0.394 . . . . 0.0 110.612 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.87 ' SG ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -141.01 151.26 43.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.711 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.462 HG22 ' OG1' ' A' ' 75' ' ' THR . 29.3 m -127.2 142.86 42.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.585 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.491 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 43.3 t -111.19 124.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.199 0.523 . . . . 0.0 110.895 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.529 ' C ' ' HZ3' ' A' ' 16' ' ' LYS . 19.6 m -133.42 161.51 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.938 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.759 ' N ' ' HZ3' ' A' ' 16' ' ' LYS . . . -172.75 -168.76 34.5 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.584 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.596 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 42.9 t0 -80.35 121.86 26.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.894 0.378 . . . . 0.0 110.817 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.688 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -45.72 98.58 0.01 OUTLIER Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 151.34 20.58 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.663 0.273 . . . . 0.0 111.522 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.2 m -131.63 135.97 58.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.037 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.71 88.76 0.74 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.759 ' HZ3' ' N ' ' A' ' 10' ' ' GLY . 84.7 mttt -81.65 -0.21 41.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.664 0.269 . . . . 0.0 110.79 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.81 HG21 ' O ' ' A' ' 34' ' ' PRO . 21.4 m -80.49 -70.29 0.53 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.163 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.652 ' HA ' HD12 ' A' ' 21' ' ' ILE . 18.0 m -50.91 -25.25 4.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.62 0.724 . . . . 0.0 109.345 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.61 ' CD2' ' SG ' ' A' ' 81' ' ' CYS . 62.4 tp -55.05 -55.0 35.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.375 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 22' ' ' SER . 82.1 mt -69.96 -32.66 71.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.652 HD12 ' HA ' ' A' ' 18' ' ' CYS . 93.2 mt -62.06 -1.8 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.966 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.5 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -56.35 -75.47 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.059 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.689 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 0.1 OUTLIER -62.5 -28.64 69.98 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.165 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.651 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 2.6 m -54.46 -48.5 71.69 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.8 p -131.52 -21.84 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.474 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.463 ' N ' ' O ' ' A' ' 22' ' ' SER . 83.0 m-20 61.43 114.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.131 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.679 ' N ' HE22 ' A' ' 162' ' ' GLN . 75.0 mttt 61.92 59.21 1.76 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.093 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 tp -125.34 66.85 54.71 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.026 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.51 145.06 37.08 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.595 2.197 . . . . 0.0 111.877 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 89.1 p -138.2 153.34 49.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.868 0.366 . . . . 0.0 110.759 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -65.48 -32.62 74.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.474 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -115.37 156.44 25.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.927 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.5 t -118.56 83.83 22.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.825 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.81 ' O ' HG21 ' A' ' 17' ' ' THR . 13.1 Cg_exo -63.89 144.41 88.18 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.666 2.244 . . . . 0.0 111.508 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.0 p -123.97 156.9 35.57 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.946 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 38' ' ' ASP . 40.2 t -123.16 131.34 73.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.461 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 78.1 t80 -97.42 -9.28 27.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.886 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' H ' HG12 ' A' ' 36' ' ' VAL . 96.0 m-20 -69.41 -70.96 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.889 -0.325 . . . . 0.0 111.111 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 40' ' ' TYR . 40.3 t-20 -173.8 174.06 3.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.669 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.455 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -139.0 23.83 2.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.51 98.62 10.22 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.446 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.486 ' O ' ' OG1' ' A' ' 52' ' ' THR . 15.6 m -115.55 158.16 16.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.219 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.6 t -123.22 140.92 52.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.015 0.436 . . . . 0.0 111.225 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 45' ' ' MET . 13.2 p -149.04 152.49 12.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.968 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.403 ' N ' HG22 ' A' ' 44' ' ' VAL . 70.7 mtm -101.3 123.35 45.26 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.674 HD13 ' HB2' ' A' ' 170' ' ' ASP . 9.1 tt -134.17 136.79 52.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.217 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 47.19 28.06 4.11 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.374 -0.69 . . . . 0.0 111.374 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.5 49.04 16.05 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -131.45 78.13 72.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.753 0.311 . . . . 0.0 110.329 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.598 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 20.6 Cg_exo -61.62 99.37 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.736 2.291 . . . . 0.0 112.143 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 83.5 m-85 -161.12 -179.38 7.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.508 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.549 ' C ' HD22 ' A' ' 53' ' ' LEU . 4.8 t -144.43 144.15 31.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.37 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.908 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.1 mm? -111.64 127.32 55.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.526 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -83.1 122.67 5.83 Favored Glycine 0 CA--C 1.52 0.387 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.591 HD23 ' SG ' ' A' ' 6' ' ' CYS . 86.5 mt -127.55 145.6 50.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.297 0.57 . . . . 0.0 112.254 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.491 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 39.7 t80 -119.55 -168.39 1.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 59' ' ' ALA . 52.0 p30 -174.11 -162.76 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.574 0.624 . . . . 0.0 110.327 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 60' ' ' GLY . 81.7 p 43.23 -93.31 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.7 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . 43.6 17.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.717 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 58' ' ' THR . . . -56.94 -29.64 59.28 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 94.2 mt-30 -79.77 99.86 7.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.145 0.498 . . . . 0.0 110.453 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.0 -35.51 64.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.934 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 64' ' ' TYR . 60.7 t0 -91.81 11.53 24.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.436 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.691 ' CD2' ' NH2' ' A' ' 68' ' ' ARG . 40.7 m-85 23.97 -120.19 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.327 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -139.42 141.17 37.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.24 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 62.3 mtt85 -58.09 147.29 30.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.563 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.7 tp 49.7 79.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.383 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.691 ' NH2' ' CD2' ' A' ' 64' ' ' TYR . 16.4 mtt180 -65.91 143.64 98.55 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.323 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -68.75 -30.82 26.8 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.285 1.99 . . . . 0.0 112.402 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.9 mt -100.46 140.79 34.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 72' ' ' TYR . 51.7 p -77.09 162.42 27.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.473 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.471 ' C ' ' O ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -30.59 93.88 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.026 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 75' ' ' THR . 27.8 Cg_exo -58.53 142.95 98.55 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.38 2.053 . . . . 0.0 112.297 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.506 ' O ' ' C ' ' A' ' 75' ' ' THR . 95.7 mt-30 -62.41 -33.66 75.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.506 ' C ' ' O ' ' A' ' 74' ' ' GLN . 2.1 t 23.19 61.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.603 0.564 . . . . 0.0 111.439 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.899 ' OD2' HD11 ' A' ' 4' ' ' ILE . 90.1 m-20 -65.01 -39.22 93.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.448 HG13 ' HB1' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -105.88 104.11 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.54 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.621 ' C ' HD12 ' A' ' 79' ' ' LEU . 96.8 m-85 -78.92 125.15 28.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.162 0.506 . . . . 0.0 111.87 -177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.87 HD13 ' SG ' ' A' ' 6' ' ' CYS . 10.5 mp -112.59 128.43 56.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.974 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.0 m -109.88 136.84 44.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.675 ' O ' HG21 ' A' ' 93' ' ' VAL . 1.3 m -112.36 127.23 55.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.075 0.464 . . . . 0.0 111.43 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 113' ' ' VAL . 48.7 p90 -149.73 115.75 5.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.419 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.664 ' OG ' HG12 ' A' ' 85' ' ' VAL . 35.5 t -58.59 139.78 55.33 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.774 ' O ' HG22 ' A' ' 84' ' ' VAL . 11.1 p -101.01 38.81 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.544 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.664 HG12 ' OG ' ' A' ' 83' ' ' SER . 1.9 p -129.3 -7.38 3.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.832 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.1 154.71 55.92 Favored Pre-proline 0 C--N 1.331 -0.218 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.733 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.594 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 57.8 Cg_endo -73.04 -40.79 1.58 Allowed 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.667 2.245 . . . . 0.0 112.758 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.4 p -82.86 -7.94 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.31 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 83' ' ' SER . 84.2 p -60.63 -41.1 94.2 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.177 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.594 ' CE1' ' O ' ' A' ' 87' ' ' PRO . 22.6 p90 -89.35 -41.25 12.24 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.181 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.2 tt0 -57.7 -32.81 67.73 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.116 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 90.5 m-20 -77.34 -39.38 47.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.326 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.675 HG21 ' O ' ' A' ' 81' ' ' CYS . 9.6 t -84.8 -66.87 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 93' ' ' VAL . 92.9 mttt -61.43 -17.67 55.37 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.528 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 95.3 mt-10 -125.72 -48.44 1.65 Allowed 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -78.53 -41.01 33.39 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.606 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 57.6 m95 -92.61 -25.53 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 119.381 -0.928 . . . . 0.0 112.29 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.539 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -56.34 -45.37 99.93 Favored Pre-proline 0 CA--C 1.527 0.092 0 C-N-CA 119.951 -0.699 . . . . 0.0 110.118 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 25.7 Cg_exo -57.46 -43.92 47.03 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.119 1.88 . . . . 0.0 110.76 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -57.4 -42.52 82.4 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.555 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.7 mt -69.79 -36.34 69.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.908 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 105' ' ' CYS . 49.8 m -57.11 -31.68 65.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.178 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -46.85 -45.54 20.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.063 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -59.9 -33.47 71.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 109.953 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' THR . 5.1 t 70.79 58.9 0.46 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.847 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -78.49 120.44 4.83 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.731 2.287 . . . . 0.0 112.057 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -91.7 0.29 57.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.92 0.391 . . . . 0.0 110.437 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.3 157.4 80.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.419 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -50.08 144.61 21.79 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.606 2.204 . . . . 0.0 111.662 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.734 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -118.8 119.18 33.63 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.193 0.521 . . . . 0.0 110.577 -179.287 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.621 ' N ' HD12 ' A' ' 111' ' ' LEU . 8.5 mp -97.63 130.89 44.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.38 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.421 HD12 ' CD1' ' A' ' 154' ' ' TYR . 92.3 mt -94.58 129.04 41.56 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.603 ' O ' ' CD1' ' A' ' 82' ' ' PHE . 30.5 t -136.33 153.64 31.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.584 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -134.96 168.28 23.73 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.472 ' H ' ' HA ' ' A' ' 83' ' ' SER . 3.4 p -124.81 177.44 6.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.167 0.508 . . . . 0.0 110.794 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.55 ' O ' ' C ' ' A' ' 117' ' ' ILE . 16.4 tt0 36.55 30.65 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.158 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.875 HG23 ' N ' ' A' ' 118' ' ' ASP . 6.0 tt 19.94 -138.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.64 0 O-C-N 123.602 0.564 . . . . 0.0 110.012 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.875 ' N ' HG23 ' A' ' 117' ' ' ILE . 1.0 OUTLIER -93.27 55.5 2.3 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.626 -0.829 . . . . 0.0 109.846 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.857 HD13 ' OG1' ' A' ' 125' ' ' THR . 2.3 tt 85.93 77.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.824 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.54 ' C ' ' O ' ' A' ' 119' ' ' LEU . 45.2 mtm180 17.63 57.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.944 0.778 . . . . 0.0 110.817 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.569 ' O ' ' CB ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER 164.21 -91.63 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.989 -179.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 40.5 t0 107.68 -46.23 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 124.021 0.826 . . . . 0.0 110.671 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' CD ' ' C ' ' A' ' 121' ' ' ASP . 49.3 Cg_endo -92.93 -33.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.324 -0.746 0 C-N-CA 121.416 1.411 . . . . 0.0 111.868 178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.9 m -98.75 2.22 46.78 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 120.189 -0.605 . . . . 0.0 111.038 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.857 ' OG1' HD13 ' A' ' 119' ' ' LEU . 8.8 t -105.74 -19.0 13.89 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 122' ' ' ASP . 73.4 mt -80.67 -50.3 17.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.87 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -74.66 -39.97 61.73 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -79.0 -37.66 38.66 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.712 HD22 ' CD1' ' A' ' 119' ' ' LEU . 15.9 tp -73.15 -39.65 65.51 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.635 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.591 ' CB ' ' O ' ' A' ' 129' ' ' LEU . . . 136.69 115.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.06 -37.58 77.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.936 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -81.69 3.91 23.78 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.15 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -108.49 -34.62 6.7 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.99 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.481 ' NE2' HD12 ' A' ' 119' ' ' LEU . 79.8 mm-40 -89.86 120.62 31.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.135 0.493 . . . . 0.0 111.169 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.78 78.3 75.2 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.619 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.66 134.84 41.11 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.609 2.206 . . . . 0.0 112.213 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.68 ' O ' HG23 ' A' ' 84' ' ' VAL . 73.3 mt -116.07 89.9 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.037 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.754 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -131.38 -39.66 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -178.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.754 ' CD ' ' H ' ' A' ' 138' ' ' THR . 69.4 Cg_endo -88.93 -48.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.126 1.884 . . . . 0.0 114.591 -177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.67 -52.74 41.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.617 ' OG1' HG22 ' A' ' 137' ' ' ILE . 30.9 p -83.32 -10.74 58.31 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -83.93 -63.07 1.41 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.365 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.15 -39.1 93.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.97 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -66.34 -57.07 8.26 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.361 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 67.9 mt -59.38 -33.8 71.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.322 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.53 -38.67 87.66 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -61.4 -40.58 94.89 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.065 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -51.95 -32.42 33.2 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.454 ' C ' ' O ' ' A' ' 146' ' ' ALA . 75.6 mt -130.59 -116.61 0.23 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.178 177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.701 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 53.2 mmtt -133.32 -145.32 0.24 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.041 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 151.41 -166.3 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.894 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 151' ' ' ALA . 41.2 t -159.16 -66.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.68 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.552 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 2.5 tttm -105.58 -176.83 3.19 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.079 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 153' ' ' LYS . 13.8 m-85 -161.13 95.95 1.07 Allowed 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' A' ' 165' ' ' LEU . 9.6 p -143.82 144.46 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-O 121.925 0.869 . . . . 0.0 111.956 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.658 ' O ' ' OG1' ' A' ' 161' ' ' THR . 8.3 mm-40 -126.75 98.57 5.42 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.441 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -113.95 144.21 43.45 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 123.127 1.441 . . . . 0.0 113.609 -175.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 160' ' ' LEU . 38.2 t -158.38 93.6 1.22 Allowed 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 111.793 -2.458 . . . . 0.0 106.621 176.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 37.23 29.71 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.587 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.773 ' O ' ' N ' ' A' ' 162' ' ' GLN . 77.2 mt -145.32 -82.05 0.15 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.425 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.673 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -53.6 44.25 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 O-C-N 123.504 0.502 . . . . 0.0 112.341 -177.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.773 ' N ' ' O ' ' A' ' 160' ' ' LEU . 2.2 pt20 -75.72 14.72 0.6 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 176.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.673 ' H ' ' C ' ' A' ' 161' ' ' THR . 89.8 mttt -78.33 -4.91 50.45 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.822 -1.536 . . . . 0.0 107.434 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.7 -70.99 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 107.754 -2.139 . . . . 0.0 107.754 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.43 ' CD2' HG11 ' A' ' 155' ' ' VAL . 2.2 mm? -38.25 -19.1 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.447 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.625 ' N ' ' O ' ' A' ' 164' ' ' GLY . 60.2 tttm -84.12 -48.33 9.96 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 164' ' ' GLY . 77.8 m-20 -78.53 6.53 8.43 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.029 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 169' ' ' PHE . 5.7 t -83.26 -60.09 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.196 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.689 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 57.8 m-85 -40.34 -47.8 2.58 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.355 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.674 ' HB2' HD13 ' A' ' 46' ' ' ILE . 64.6 t0 -67.13 -43.17 83.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.87 0.367 . . . . 0.0 110.845 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.56 -27.04 66.62 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.325 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.521 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . . . -63.68 -33.25 75.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.096 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.76 -37.81 73.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.578 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.633 ' N ' HD22 ' A' ' 174' ' ' LEU . 3.5 mm? -64.27 -31.92 73.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.049 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.448 ' HB1' HG13 ' A' ' 77' ' ' VAL . . . -62.2 -27.4 68.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.807 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.498 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . . . -63.79 -32.6 74.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.966 0.412 . . . . 0.0 110.206 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.81 -35.76 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.618 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.369 -0.378 . . . . 99.989999999999995 110.683 179.968 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' A' ' 3' ' ' THR . 25.3 mt-30 -123.62 174.94 7.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.543 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -37.76 128.34 1.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.055 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 176' ' ' ALA . 19.7 tt -122.2 135.73 61.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.425 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 35.2 mttp -77.15 145.93 37.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.049 0.452 . . . . 0.0 111.517 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -139.65 136.73 34.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.033 179.585 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 56' ' ' PHE . 25.9 m -130.48 148.15 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.364 . . . . 0.0 111.485 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.574 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 47.1 t -115.95 120.78 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.263 0.554 . . . . 0.0 111.078 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.0 m -140.95 158.27 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.095 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.49 -174.65 34.49 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.64 ' H ' ' CG2' ' A' ' 93' ' ' VAL . 23.5 t70 -81.2 121.94 26.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.019 0.438 . . . . 0.0 110.588 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . 43.75 64.6 1.83 Allowed Glycine 0 CA--C 1.528 0.894 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.534 ' HB2' ' HZ2' ' A' ' 16' ' ' LYS . . . -16.98 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.854 0.359 . . . . 0.0 111.948 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.597 HG12 ' OE1' ' A' ' 116' ' ' GLN . 99.5 t -66.32 -55.78 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.94 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -159.76 59.63 0.31 Allowed Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.716 -0.755 . . . . 0.0 111.902 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.534 ' HZ2' ' HB2' ' A' ' 13' ' ' ALA . 17.8 mttt -77.25 -7.2 55.54 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.659 -0.318 . . . . 0.0 110.838 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.7 p -63.17 -44.69 94.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.582 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.5 m -84.64 -14.04 49.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.59 0.71 . . . . 0.0 110.167 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.594 HD22 ' SG ' ' A' ' 81' ' ' CYS . 14.0 tp -73.58 -42.99 60.87 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.847 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.796 ' CD1' HD12 ' A' ' 55' ' ' LEU . 26.7 tp -65.45 -39.14 91.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.429 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.468 ' O ' ' OG1' ' A' ' 24' ' ' THR . 10.5 pt -76.38 -3.51 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 21' ' ' ILE . 2.0 m -42.14 -77.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.768 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.569 ' C ' ' H ' ' A' ' 25' ' ' THR . 40.0 t80 -54.31 -39.94 67.46 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.029 0.377 . . . . 0.0 111.96 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 21' ' ' ILE . 23.0 p -49.57 -9.14 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.013 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.569 ' H ' ' C ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER 76.5 95.52 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.749 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.513 ' HB3' HE22 ' A' ' 162' ' ' GLN . 25.9 t30 -141.11 -69.56 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.4 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.773 ' H ' HE22 ' A' ' 162' ' ' GLN . 30.9 tttt 48.22 53.09 12.32 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mt -147.0 87.24 6.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -53.42 134.08 55.89 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.056 1.838 . . . . 0.0 111.378 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -125.02 145.08 50.07 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.872 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.37 -31.65 72.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.519 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -123.03 146.25 47.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.037 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 33' ' ' VAL . 15.9 m -119.79 88.13 39.2 Favored Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.31 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -53.77 148.06 38.38 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.639 2.226 . . . . 0.0 112.316 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.6 m -76.68 142.92 40.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.762 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.45 163.29 31.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.68 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -115.97 156.96 25.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.522 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 0.8 OUTLIER 51.73 -146.04 0.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.993 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 15.6 t-20 81.66 64.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 110.56 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.608 ' CD2' ' O ' ' A' ' 40' ' ' TYR . 26.6 p90 -157.0 38.53 0.31 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -165.14 98.35 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.612 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.507 ' O ' ' OG1' ' A' ' 52' ' ' THR . 18.5 t -135.66 130.45 49.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.318 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.6 t -94.54 133.94 37.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.685 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -135.25 142.86 38.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.608 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.3 mtm -113.15 130.27 56.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.298 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 48' ' ' GLY . 7.7 tp -131.96 136.2 57.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.636 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 31.14 35.21 0.01 OUTLIER Glycine 0 CA--C 1.528 0.853 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.889 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 79.63 65.37 1.78 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.572 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -151.26 88.09 4.46 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.59 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 42.7 Cg_endo -76.04 112.55 3.52 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 122.09 1.86 . . . . 0.0 112.575 -179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 95.9 m-85 -162.59 166.95 24.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 6.8 t -138.04 148.4 45.05 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.217 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -122.74 133.3 54.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.748 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -73.0 148.15 40.8 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.796 HD12 ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -132.52 119.11 20.11 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.33 -179.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.574 ' HB3' ' H ' ' A' ' 8' ' ' VAL . 17.2 t80 -107.9 -176.34 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.79 ' OD2' HD22 ' A' ' 20' ' ' LEU . 52.7 p30 -176.86 -165.81 0.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.065 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.508 ' H ' ' HB2' ' A' ' 16' ' ' LYS . 31.5 p 36.59 -148.86 0.01 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.073 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 54.75 172.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.322 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 154.31 8.42 0.08 OUTLIER Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -73.74 116.57 14.5 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.361 0.6 . . . . 0.0 110.042 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -57.83 -32.64 67.8 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.461 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.507 ' O ' ' O ' ' A' ' 64' ' ' TYR . 88.3 m-20 -93.7 7.5 44.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.991 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.507 ' O ' ' O ' ' A' ' 63' ' ' ASP . 66.0 m-85 34.26 -158.46 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.881 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.88 130.41 35.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.308 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.3 mtt85 -59.48 -36.72 76.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.941 0.4 . . . . 0.0 110.397 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.9 mt -64.3 -36.6 84.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.099 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 34.6 ttm-85 -130.65 76.29 77.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.237 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -74.05 -10.71 23.02 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.353 2.035 . . . . 0.0 111.545 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 36.8 tp -58.12 -35.72 71.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t 64.53 -176.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.101 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -127.1 71.73 76.1 Favored Pre-proline 0 C--N 1.33 -0.256 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.232 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.77 0.02 10.3 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.912 2.408 . . . . 0.0 111.465 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.61 -29.64 64.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.219 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.448 ' CG2' ' CE1' ' A' ' 78' ' ' PHE . 10.3 t -41.18 135.19 1.93 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 110.685 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -91.95 -24.37 19.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.725 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.411 HG12 HD13 ' A' ' 111' ' ' LEU . 4.2 t -119.14 110.02 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.216 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.547 ' C ' HD12 ' A' ' 79' ' ' LEU . 96.8 m-85 -86.33 126.65 34.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.165 0.507 . . . . 0.0 112.006 -177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 79' ' ' LEU . 7.3 mp -106.38 110.01 22.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.367 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 113' ' ' VAL . 39.0 t -74.53 129.0 36.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.739 ' O ' HG21 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -122.27 129.89 52.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.113 0.482 . . . . 0.0 112.003 -179.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.613 ' CG ' ' O ' ' A' ' 82' ' ' PHE . 4.0 p90 -166.42 125.75 1.55 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.36 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.546 ' HB3' HG11 ' A' ' 14' ' ' VAL . 84.2 p -52.89 146.36 10.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.319 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 t -77.58 4.57 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.194 -0.602 . . . . 0.0 112.493 -178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 119' ' ' LEU . 80.3 t -127.79 148.86 32.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.25 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.576 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.9 t 93.24 96.24 0.02 OUTLIER Pre-proline 0 N--CA 1.464 0.244 0 O-C-N 123.643 0.589 . . . . 0.0 110.328 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.446 ' O ' ' CE2' ' A' ' 90' ' ' PHE . 61.9 Cg_exo -48.97 -2.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.67 2.247 . . . . 0.0 112.72 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.539 ' H ' ' C ' ' A' ' 86' ' ' SER . 2.2 t -97.48 -34.73 10.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.998 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -57.01 -40.74 77.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.702 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.461 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 2.4 p90 -82.29 -32.8 29.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.063 0.459 . . . . 0.0 110.319 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.1 tt0 -54.3 -28.67 43.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.925 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 96' ' ' LYS . 72.1 m-20 -90.51 -64.79 1.08 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 120.299 -0.56 . . . . 0.0 110.578 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.739 HG21 ' O ' ' A' ' 81' ' ' CYS . 54.7 t -50.12 -60.59 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.35 -178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.733 ' HZ3' HD11 ' A' ' 112' ' ' LEU . 26.6 mttt -71.57 -9.83 58.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -126.32 -62.02 1.18 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 92' ' ' ASN . 20.0 tptm -64.77 -34.6 78.73 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.4 ' O ' ' C ' ' A' ' 98' ' ' VAL . 51.1 m95 -81.94 -34.95 29.57 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.681 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.924 ' O ' HG23 ' A' ' 102' ' ' THR . 2.3 t -39.21 -55.21 3.16 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.184 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 17.2 Cg_endo -60.0 -37.19 86.58 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 121.553 1.502 . . . . 0.0 111.175 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -61.75 -42.68 99.28 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.162 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 72.7 mt -71.92 -39.68 67.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.793 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.924 HG23 ' O ' ' A' ' 98' ' ' VAL . 44.1 p -62.71 -12.71 25.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.05 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -54.18 -41.59 68.73 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.173 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -87.85 -15.41 36.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.482 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 22.2 m 55.35 58.59 10.49 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.916 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -78.17 124.09 6.45 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.644 2.229 . . . . 0.0 112.01 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -92.27 2.97 56.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.729 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.35 155.18 91.63 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.88 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.33 149.11 57.58 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.96 2.44 . . . . 0.0 112.115 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.737 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -130.72 139.14 50.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.272 0.558 . . . . 0.0 110.521 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.653 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.0 mp -104.76 136.16 44.78 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.558 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.733 HD11 ' HZ3' ' A' ' 94' ' ' LYS . 18.3 tp -88.11 128.43 35.43 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 155' ' ' VAL . 1.9 t -142.29 151.89 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.682 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.534 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -134.46 171.54 22.22 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.475 ' H ' ' HA ' ' A' ' 83' ' ' SER . 1.5 p -119.82 173.73 6.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.97 0.414 . . . . 0.0 110.461 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.604 ' O ' ' O ' ' A' ' 117' ' ' ILE . 33.8 mt-30 37.8 34.0 0.05 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.24 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.888 HG23 ' N ' ' A' ' 118' ' ' ASP . 2.5 tt 19.96 -143.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 123.595 0.559 . . . . 0.0 110.485 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.888 ' N ' HG23 ' A' ' 117' ' ' ILE . 59.5 t0 -59.98 -2.92 0.47 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.726 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.861 HD23 ' OG1' ' A' ' 125' ' ' THR . 59.2 tp 132.52 92.01 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 O-C-N 124.182 0.926 . . . . 0.0 110.105 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' C ' ' O ' ' A' ' 119' ' ' LEU . 41.7 ptt85 15.01 50.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.201 0.938 . . . . 0.0 111.625 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 119' ' ' LEU . 0.8 OUTLIER 169.65 -95.94 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.1 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 10.9 t0 109.08 -44.9 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.31 0 O-C-N 123.876 0.735 . . . . 0.0 110.483 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.423 ' CD ' ' C ' ' A' ' 121' ' ' ASP . 83.6 Cg_endo -88.91 -36.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.786 0 C-N-CA 121.481 1.454 . . . . 0.0 110.524 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 52.5 p -98.38 -6.97 29.6 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.793 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.861 ' OG1' HD23 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -85.66 -23.19 27.56 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.704 ' CG1' HE22 ' A' ' 134' ' ' GLN . 10.4 tt -80.08 -43.35 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.792 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.515 ' N ' ' CG2' ' A' ' 126' ' ' ILE . 98.3 mt-10 -61.91 -33.59 74.52 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.084 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -58.68 -35.96 73.43 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.682 ' O ' ' N ' ' A' ' 131' ' ' LYS . 26.6 mt -90.18 22.52 3.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.544 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.502 ' C ' ' O ' ' A' ' 129' ' ' LEU . . . -4.82 63.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 O-C-N 125.072 1.483 . . . . 0.0 111.977 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.682 ' N ' ' O ' ' A' ' 129' ' ' LEU . 80.3 mttt 47.3 75.97 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.767 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -126.82 57.13 1.46 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 65.1 tttt 67.07 43.18 2.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.556 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.704 HE22 ' CG1' ' A' ' 126' ' ' ILE . 26.2 mt-30 -58.07 137.68 56.69 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.532 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.96 66.88 9.84 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.178 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -58.03 152.53 50.88 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.665 2.243 . . . . 0.0 111.497 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 31.1 mm -107.19 101.15 12.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.84 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.954 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.0 OUTLIER -130.91 -53.89 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.57 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 138' ' ' THR . 66.1 Cg_endo -92.87 -36.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.559 2.173 . . . . 0.0 113.294 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.53 -70.75 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.47 ' O ' HD13 ' A' ' 145' ' ' LEU . 43.3 p -123.11 4.42 9.27 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.954 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -79.84 -71.08 0.47 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.829 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.41 ' OE1' ' CD1' ' A' ' 154' ' ' TYR . 77.7 mm-40 -73.24 -31.46 64.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.191 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -56.97 -38.26 72.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.69 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 145' ' ' LEU . 9.9 mp -86.06 -6.91 58.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.852 0.358 . . . . 0.0 110.99 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -91.17 -61.56 1.63 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.129 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -61.07 -37.8 83.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.971 -0.558 . . . . 0.0 112.192 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -96.67 -12.61 23.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 0.6 OUTLIER -124.71 29.4 6.24 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.485 -178.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.674 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 49.0 mttp 95.01 143.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.375 0.67 . . . . 0.0 111.454 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 152.88 -172.56 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.104 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 151' ' ' ALA . 89.1 t -159.32 -59.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.232 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 12.3 mmtm -104.69 -170.94 1.83 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.605 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 153' ' ' LYS . 18.5 m-85 -153.67 96.4 2.0 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.707 ' O ' HG13 ' A' ' 113' ' ' VAL . 13.2 m -134.79 98.49 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 CA-C-O 121.36 0.6 . . . . 0.0 110.559 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.561 ' O ' ' OG1' ' A' ' 161' ' ' THR . 91.1 mt-10 -103.16 99.06 8.9 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.534 ' SG ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -119.0 155.68 30.96 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 123.306 1.527 . . . . 0.0 114.362 -175.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' LEU . 47.0 t -164.07 94.73 0.75 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 111.341 -2.663 . . . . 0.0 106.858 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 39.54 26.58 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.647 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.737 ' O ' ' N ' ' A' ' 162' ' ' GLN . 76.0 mt -142.05 -81.17 0.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.169 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.561 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -57.19 45.95 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 O-C-N 123.36 0.412 . . . . 0.0 110.778 -178.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.773 HE22 ' H ' ' A' ' 27' ' ' LYS . 77.2 mt-30 -85.73 14.67 5.53 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.8 mttt -88.95 1.75 54.96 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 112.613 -2.085 . . . . 0.0 107.115 178.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.61 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -129.74 -73.6 0.14 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 108.739 -1.744 . . . . 0.0 108.739 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.534 HD12 ' SG ' ' A' ' 157' ' ' CYS . 12.4 mt -41.72 -17.47 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.017 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.61 ' N ' ' O ' ' A' ' 164' ' ' GLY . 22.3 tttp -83.06 -48.47 10.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' GLY . 21.2 m120 -75.1 2.38 10.85 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.541 -1.209 . . . . 0.0 109.225 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 169' ' ' PHE . 24.7 t -84.1 -53.72 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.628 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 168' ' ' VAL . 6.0 m-85 -37.31 -52.78 1.1 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.207 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 53.1 p-10 -65.8 -39.23 90.73 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.199 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.615 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 99.2 mt-10 -70.67 -22.05 62.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.767 0.318 . . . . 0.0 110.7 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.581 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -63.41 -34.21 77.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.49 -37.45 70.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.333 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.6 tp -57.25 -34.51 68.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.541 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 172' ' ' ALA . . . -63.51 -23.69 67.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.152 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 4' ' ' ILE . . . -63.95 -30.96 72.0 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.328 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.39 -35.54 70.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.607 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 99.989999999999995 110.679 -179.816 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.446 ' O ' ' C ' ' A' ' 3' ' ' THR . 89.7 mt-30 -116.03 167.21 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.264 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.463 ' H ' HG22 ' A' ' 3' ' ' THR . 0.5 OUTLIER -39.39 140.77 0.42 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 176' ' ' ALA . 11.0 tp -130.35 152.43 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.955 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' CB ' HG22 ' A' ' 75' ' ' THR . 55.7 mttp -102.5 162.79 12.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.293 0.568 . . . . 0.0 111.567 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.53 157.2 46.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.329 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.75 ' O ' HG23 ' A' ' 9' ' ' VAL . 61.5 t -122.16 134.81 64.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.54 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.3 p -50.05 125.73 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.223 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 7' ' ' VAL . 21.4 t -127.04 133.44 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.424 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.581 ' HA3' HG13 ' A' ' 93' ' ' VAL . . . 106.06 -67.99 0.24 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 60' ' ' GLY . 81.7 m-20 58.53 -82.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.581 0.229 . . . . 0.0 111.377 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 40.57 33.75 0.62 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.453 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 47.88 101.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.789 0.328 . . . . 0.0 110.564 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.79 HG23 ' H ' ' A' ' 15' ' ' GLY . 26.4 m -135.5 -111.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.057 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.79 ' H ' HG23 ' A' ' 14' ' ' VAL . . . -169.12 63.64 0.18 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' HD2' ' H ' ' A' ' 58' ' ' THR . 16.2 mttp -73.11 -2.9 23.28 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.215 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.8 p -61.43 -41.33 97.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.295 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' ILE . 99.2 m -95.81 -7.57 36.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.054 0.454 . . . . 0.0 111.013 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.905 HD11 HG12 ' A' ' 113' ' ' VAL . 24.9 tp -66.7 -68.25 0.39 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.109 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.461 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 67.4 mt -65.66 -26.48 67.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.615 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 18' ' ' CYS . 3.6 tt -58.86 -18.93 14.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.697 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -66.53 -75.95 0.09 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 119.384 -0.927 . . . . 0.0 111.397 -178.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.735 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.9 p90 -41.24 -31.8 0.24 Allowed 'General case' 0 C--N 1.342 0.257 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.659 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.466 ' N ' ' CG ' ' A' ' 23' ' ' TYR . 2.5 m -57.12 -46.68 82.45 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.272 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.445 ' OG1' ' C ' ' A' ' 24' ' ' THR . 0.0 OUTLIER 175.99 -6.24 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.524 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 159' ' ' ALA . 59.1 t-20 57.3 87.13 0.07 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.756 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -89.93 8.18 33.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.414 ' N ' ' HB1' ' A' ' 159' ' ' ALA . 0.8 OUTLIER 62.79 148.93 0.1 OUTLIER Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.288 -179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -42.04 143.18 1.32 Allowed 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.247 1.965 . . . . 0.0 112.413 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.1 p -130.9 154.89 47.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.305 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' OE2' ' CE2' ' A' ' 32' ' ' TYR . 22.1 pt-20 -71.28 -15.65 62.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.854 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' CE2' ' OE2' ' A' ' 31' ' ' GLU . 69.3 m-85 -112.51 138.35 49.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.647 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.0 t -125.7 77.67 69.58 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.063 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.22 140.01 34.41 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.715 2.277 . . . . 0.0 112.334 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.7 p -116.6 25.68 10.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.271 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 m -124.05 160.49 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.628 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.449 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 80.9 t80 59.78 72.04 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.522 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -65.01 147.71 52.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.348 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.509 ' O ' ' O ' ' A' ' 55' ' ' LEU . 10.3 m120 -89.49 144.96 25.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.383 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 25.1 p90 -175.57 -4.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.556 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.98 99.8 3.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.889 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG21 ' OH ' ' A' ' 23' ' ' TYR . 21.8 t -140.78 133.45 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.17 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.9 111.92 24.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.979 0.419 . . . . 0.0 110.825 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.419 HG23 HG12 ' A' ' 42' ' ' VAL . 58.7 t -137.43 145.83 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.154 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.657 ' N ' ' SD ' ' A' ' 45' ' ' MET . 2.3 mmt -97.08 132.93 42.38 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.609 HG21 ' HB2' ' A' ' 170' ' ' ASP . 4.8 mt -120.66 127.0 75.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.141 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.73 31.12 5.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.05 52.13 6.48 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -138.75 79.07 29.35 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.498 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 36.1 Cg_exo -52.82 103.96 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.941 2.427 . . . . 0.0 112.965 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.498 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 76.6 m-85 -159.99 169.66 22.97 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.589 ' C ' HD22 ' A' ' 53' ' ' LEU . 10.1 t -140.32 135.91 32.68 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.851 -0.74 . . . . 0.0 111.61 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.861 HD22 ' N ' ' A' ' 53' ' ' LEU . 1.4 mm? -115.39 132.86 56.49 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.122 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 40' ' ' TYR . . . -107.77 126.41 8.31 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 55' ' ' LEU . 4.0 mp -136.3 125.97 25.46 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.845 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.468 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 69.7 m-85 -77.39 160.69 28.57 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.611 ' C ' HG22 ' A' ' 58' ' ' THR . 55.9 p30 -166.26 174.73 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.643 ' OG1' ' N ' ' A' ' 59' ' ' ALA . 1.7 t 147.63 -140.99 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.826 0.704 . . . . 0.0 109.568 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.643 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -140.37 135.55 32.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.132 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.487 ' O ' ' OD2' ' A' ' 11' ' ' ASP . . . 76.52 -163.65 52.91 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.491 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 65.9 tp60 -63.81 -26.83 68.8 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.785 -0.244 . . . . 0.0 110.678 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 61' ' ' GLN . 37.5 mt-10 139.74 -105.5 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.707 1.254 . . . . 0.0 108.693 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 65' ' ' ASP . 93.0 m-20 -78.94 -3.88 47.04 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 53.2 t80 66.18 -10.67 0.24 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.516 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.552 ' H ' ' C ' ' A' ' 63' ' ' ASP . 83.4 m-20 -73.82 140.77 46.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.164 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.0 mtm180 -95.09 4.27 53.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.733 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 mt -60.38 -33.57 72.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.485 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -123.56 77.42 55.24 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.616 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -77.53 -8.32 17.11 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.631 2.221 . . . . 0.0 112.261 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 74.5 mt -88.17 143.14 27.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.65 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.1 t -113.55 142.37 46.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.265 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -60.97 116.94 21.1 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.342 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.29 6.7 4.54 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.245 1.963 . . . . 0.0 112.409 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -55.91 -37.18 68.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.114 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.675 ' OG1' HG23 ' A' ' 7' ' ' VAL . 5.5 p -85.05 159.9 20.11 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.469 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 75' ' ' THR . 97.0 m-20 -139.96 3.2 2.0 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.83 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.451 HG12 HD13 ' A' ' 111' ' ' LEU . 2.4 t -109.26 109.71 29.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.615 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -78.44 122.5 25.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.399 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.651 HD23 ' C ' ' A' ' 79' ' ' LEU . 7.4 tt -121.52 116.73 25.21 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.379 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.472 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 41.4 t -90.37 130.19 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.268 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.38 118.84 26.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.72 ' HA ' HG11 ' A' ' 14' ' ' VAL . 36.8 p90 -144.69 163.91 32.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.74 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 85' ' ' VAL . 35.6 t -85.83 134.22 33.93 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.621 HG13 ' CG2' ' A' ' 138' ' ' THR . 71.0 t -41.81 -17.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.103 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.594 ' HB ' HD21 ' A' ' 119' ' ' LEU . 38.9 t -135.22 131.81 52.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.731 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 2.9 m 151.94 81.26 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.19 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -52.75 -29.61 42.97 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.385 2.056 . . . . 0.0 111.855 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.0 m -71.08 -49.98 38.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 109.796 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 93' ' ' VAL . 59.6 p -62.02 -30.91 71.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.318 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.467 ' CG ' HD11 ' A' ' 137' ' ' ILE . 91.0 t80 -57.8 -50.71 72.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.498 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -79.09 -18.79 52.72 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.708 -0.397 . . . . 0.0 111.164 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.588 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 25.4 m120 -93.78 -10.42 34.23 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.344 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.581 HG13 ' HA3' ' A' ' 10' ' ' GLY . 52.3 t -104.4 -71.25 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.392 0.615 . . . . 0.0 112.241 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.675 ' HE2' HD11 ' A' ' 112' ' ' LEU . 78.8 mttt -69.67 -21.3 63.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.272 -177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.544 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 97.4 mt-10 -106.07 -38.4 6.31 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -76.21 -30.66 58.06 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.881 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 23.3 m95 -89.57 -42.61 11.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.299 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 2.2 t -40.22 -54.38 4.67 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.249 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.544 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 27.9 Cg_endo -64.2 -37.84 39.07 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.649 1.566 . . . . 0.0 112.162 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.57 -37.94 89.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.257 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 101' ' ' ILE . 22.8 pt -86.29 -28.22 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.127 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 105' ' ' CYS . 86.3 m -59.99 -36.47 77.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.922 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -56.18 -37.69 69.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.88 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -55.99 -46.32 78.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.935 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.492 ' O ' ' O ' ' A' ' 102' ' ' THR . 1.3 m -146.83 155.39 48.09 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.693 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.76 -60.59 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.482 2.122 . . . . 0.0 111.872 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -125.31 128.47 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.529 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.596 ' O ' ' CZ ' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -157.42 152.39 21.31 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.079 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -56.73 126.01 20.89 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.028 1.819 . . . . 0.0 111.39 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.691 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -116.58 111.29 19.68 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.453 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.687 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.7 mp -86.54 123.14 31.42 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.053 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.675 HD11 ' HE2' ' A' ' 94' ' ' LYS . 23.7 tp -100.94 123.58 45.34 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.905 HG12 HD11 ' A' ' 19' ' ' LEU . 4.7 t -136.18 147.47 28.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.47 -178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.495 ' O ' HD13 ' A' ' 19' ' ' LEU . . . -121.14 153.01 16.69 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.3 p -114.3 172.49 6.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.168 0.509 . . . . 0.0 110.804 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.578 ' O ' ' O ' ' A' ' 117' ' ' ILE . 31.5 mt-30 48.73 21.29 0.41 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.164 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.793 HG23 ' N ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER 36.32 -160.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.401 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.793 ' N ' HG23 ' A' ' 117' ' ' ILE . 19.1 m-20 -69.07 75.42 0.33 Allowed 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.463 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 85' ' ' VAL . 98.0 mt 64.86 85.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.832 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.559 ' C ' ' O ' ' A' ' 119' ' ' LEU . 57.1 ttm-85 8.8 59.75 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.108 0.88 . . . . 0.0 111.132 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.584 ' N ' ' O ' ' A' ' 119' ' ' LEU . 0.5 OUTLIER 167.12 -90.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.249 -179.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.714 ' O ' HD12 ' A' ' 126' ' ' ILE . 11.4 t0 109.93 -46.45 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 O-C-N 123.99 0.806 . . . . 0.0 110.339 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -92.78 -37.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.321 -0.888 0 C-N-CA 121.447 1.431 . . . . 0.0 111.794 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.2 m -98.38 -1.99 40.28 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.307 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -110.47 -12.09 14.42 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.958 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.714 HD12 ' O ' ' A' ' 122' ' ' ASP . 67.7 mt -85.78 -46.84 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.31 -32.1 69.72 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.273 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.1 tttp -61.98 -29.22 70.1 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.125 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.663 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 44.0 mt -54.58 -38.57 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.007 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . 78.23 9.52 2.14 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.191 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.492 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 51.9 mttp 56.9 83.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.068 0.461 . . . . 0.0 110.248 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.492 ' OD1' ' O ' ' A' ' 131' ' ' LYS . 87.8 m-20 -141.02 -25.91 0.73 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.094 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -178.75 45.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.22 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.483 ' HG2' HD13 ' A' ' 129' ' ' LEU . 93.2 mt-30 -50.75 -38.31 47.0 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.905 0.383 . . . . 0.0 110.129 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.45 ' C ' ' O ' ' A' ' 134' ' ' GLN . 11.9 mmtm 31.75 61.05 1.25 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.751 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -60.23 144.16 99.5 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.203 1.935 . . . . 0.0 111.185 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 137' ' ' ILE . 0.5 OUTLIER -144.81 45.93 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.153 -179.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.621 ' CG2' HG13 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -118.69 -50.28 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.553 ' HD2' ' H ' ' A' ' 138' ' ' THR . 72.9 Cg_endo -81.87 -83.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.127 1.885 . . . . 0.0 114.464 -176.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.51 -43.8 98.21 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.701 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 137' ' ' ILE . 81.9 p -60.56 -40.96 93.56 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -77.31 -36.46 54.02 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.601 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.66 -42.33 96.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.755 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -66.4 -46.57 76.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.804 0.335 . . . . 0.0 110.986 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.4 tt -53.72 -35.16 60.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.06 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 149' ' ' LEU . . . -66.03 -38.38 88.27 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.39 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -62.91 -39.78 95.6 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.789 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -52.31 -32.56 38.34 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 146' ' ' ALA . 62.6 mt -133.29 -113.41 0.22 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.479 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.718 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 51.3 mttp -143.83 -132.94 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.464 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.718 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 156.09 -165.9 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.866 0.365 . . . . 0.0 110.448 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.615 HG23 ' H ' ' A' ' 110' ' ' PHE . 19.8 t -143.83 -51.31 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.572 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 3.5 tttm -143.62 -169.92 3.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.847 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CD2' ' O ' ' A' ' 153' ' ' LYS . 0.0 OUTLIER -166.18 96.02 0.59 Allowed 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 114' ' ' GLY . 16.5 m -136.14 153.61 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.474 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.594 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -133.11 94.0 3.27 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.562 ' SG ' HD22 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -110.87 148.1 33.14 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 123.155 1.455 . . . . 0.0 113.504 -176.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.47 ' C ' ' N ' ' A' ' 160' ' ' LEU . 8.8 t -155.3 91.29 1.32 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 111.576 -2.556 . . . . 0.0 105.224 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.484 ' O ' ' OD1' ' A' ' 26' ' ' ASN . . . 42.03 28.16 0.09 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.739 -177.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.702 ' O ' ' N ' ' A' ' 162' ' ' GLN . 47.0 mt -139.52 -74.02 0.37 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.841 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.71 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.1 m -57.82 44.12 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 120.918 0.39 . . . . 0.0 112.05 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.702 ' N ' ' O ' ' A' ' 160' ' ' LEU . 38.4 tt0 -74.83 19.32 0.14 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.71 ' H ' ' C ' ' A' ' 161' ' ' THR . 56.8 mttp -108.14 -1.49 20.3 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.583 -1.644 . . . . 0.0 107.779 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 168' ' ' VAL . . . -133.17 -38.07 0.23 Allowed Glycine 0 C--O 1.225 -0.46 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.735 HD23 ' H ' ' A' ' 23' ' ' TYR . 9.9 tp -73.62 -22.99 59.84 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.034 0.445 . . . . 0.0 110.53 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -61.86 -34.15 75.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.597 ' O ' ' N ' ' A' ' 170' ' ' ASP . 7.9 m120 -72.29 -59.07 2.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.556 HG21 HD12 ' A' ' 165' ' ' LEU . 59.0 t -29.25 -55.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.446 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.688 ' CZ ' ' CZ ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -56.9 -48.76 77.44 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.316 179.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.609 ' HB2' HG21 ' A' ' 46' ' ' ILE . 56.0 t0 -67.63 -47.44 69.6 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.783 0.325 . . . . 0.0 111.477 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.51 -29.05 70.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.324 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.61 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . . . -57.43 -32.49 66.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.32 -37.09 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.741 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 38.1 tp -58.8 -37.73 77.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.426 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.54 -28.05 69.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.589 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.461 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . . . -57.26 -37.1 71.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.979 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.66 HD12 ' N ' ' A' ' 177' ' ' LEU . 8.0 mp -60.04 -32.18 70.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.669 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.381 -0.372 . . . . 99.989999999999995 110.504 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -90.98 -69.52 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.305 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 3' ' ' THR . 3.5 t -40.37 125.59 2.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.392 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tp -119.49 149.93 22.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.894 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -105.08 147.3 28.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.223 0.535 . . . . 0.0 112.002 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.592 ' SG ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -132.61 145.23 50.93 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.393 179.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.407 HG13 ' CD1' ' A' ' 56' ' ' PHE . 16.6 t -127.4 135.9 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.548 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 56' ' ' PHE . 5.2 t -74.81 120.81 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.443 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.648 HG11 HD13 ' A' ' 101' ' ' ILE . 38.9 t -120.5 130.66 74.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.875 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.51 -162.01 29.67 Favored Glycine 0 CA--C 1.52 0.369 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' ALA . 44.7 t0 -148.85 -117.09 0.06 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.992 0.425 . . . . 0.0 111.084 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.571 ' O ' HG13 ' A' ' 14' ' ' VAL . . . -29.83 -29.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.657 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -38.18 136.65 0.61 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.421 0.611 . . . . 0.0 110.046 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 12' ' ' GLY . 31.5 m -125.88 27.48 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.77 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.53 ' CA ' HE21 ' A' ' 116' ' ' GLN . . . -143.22 36.87 1.54 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.053 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.704 ' NZ ' ' HB3' ' A' ' 59' ' ' ALA . 26.8 mttt -74.59 -7.58 53.61 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.043 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 19' ' ' LEU . 85.7 m -78.38 -69.63 0.54 Allowed 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.897 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.694 ' HA ' HD12 ' A' ' 21' ' ' ILE . 32.4 m -61.75 0.16 0.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.357 0.598 . . . . 0.0 109.913 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.756 ' O ' HD13 ' A' ' 165' ' ' LEU . 7.8 tt -69.72 -52.29 26.78 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.989 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.63 -32.45 64.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.144 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 18' ' ' CYS . 77.4 mt -55.03 -20.26 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.929 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.489 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 5.2 m -50.62 -74.86 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.457 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.707 ' CZ ' ' CZ ' ' A' ' 169' ' ' PHE . 23.9 p90 -63.03 -28.08 69.85 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.141 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.4 m -51.17 -46.03 61.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.562 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.9 m -157.44 -19.46 0.09 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.967 0.413 . . . . 0.0 110.41 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 22' ' ' SER . 1.4 m-80 64.16 133.52 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.904 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.739 ' NZ ' HE22 ' A' ' 162' ' ' GLN . 40.6 mttp 66.71 59.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.734 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 21' ' ' ILE . 1.3 tp -128.87 67.28 77.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.4 0.619 . . . . 0.0 110.295 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -79.55 6.52 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 123.147 2.564 . . . . 0.0 112.533 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.6 m -49.18 137.21 14.03 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.384 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.26 -34.81 78.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.799 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -59.03 -40.85 86.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.527 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 33' ' ' VAL . 70.8 t 52.39 77.84 0.43 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.573 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.07 141.73 36.88 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.603 2.202 . . . . 0.0 112.038 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.5 m -126.26 149.61 48.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.674 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -124.15 157.63 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.396 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -57.25 -41.03 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.52 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.35 130.15 41.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.978 0.418 . . . . 0.0 111.042 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LEU . 87.4 m-20 -123.9 14.95 9.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.516 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.547 ' CB ' ' CE1' ' A' ' 56' ' ' PHE . 22.3 p90 -175.73 12.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.9 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.22 99.9 6.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.844 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.6 t -144.68 140.57 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.889 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 43' ' ' THR . 7.6 t -124.51 132.01 53.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.343 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.8 t -133.69 138.9 49.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.762 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.9 mtm -113.49 120.92 42.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.153 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 48' ' ' GLY . 1.8 pp -128.15 154.32 38.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.936 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.491 ' O ' ' OE1' ' A' ' 49' ' ' GLU . . . 32.81 27.95 0.01 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 74.19 50.22 10.83 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.491 ' OE1' ' O ' ' A' ' 47' ' ' GLY . 4.1 mp0 -130.4 96.53 24.16 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' C ' ' CD1' ' A' ' 51' ' ' TYR . 57.7 Cg_endo -76.8 108.65 2.69 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 122.05 1.833 . . . . 0.0 113.033 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.583 ' CE1' HG23 ' A' ' 173' ' ' ILE . 93.7 m-85 -150.55 165.44 33.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.957 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.21 125.78 30.14 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.709 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.562 HD13 ' HB1' ' A' ' 172' ' ' ALA . 51.8 tp -113.1 125.4 54.33 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.813 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -89.43 136.42 13.54 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.544 HD12 ' SG ' ' A' ' 6' ' ' CYS . 29.2 tp -137.11 125.69 23.7 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.85 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.547 ' CE1' ' CB ' ' A' ' 40' ' ' TYR . 26.3 m-85 -97.93 -177.93 3.92 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 177.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.495 ' O ' ' OG1' ' A' ' 58' ' ' THR . 50.8 p30 -171.49 -174.89 1.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.629 ' H ' ' CB ' ' A' ' 16' ' ' LYS . 29.3 p 56.89 119.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.087 0.47 . . . . 0.0 111.664 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.704 ' HB3' ' NZ ' ' A' ' 16' ' ' LYS . . . -177.77 149.35 0.59 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.075 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 55.0 60.72 8.3 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -106.5 -47.47 3.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.913 0.387 . . . . 0.0 111.064 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.608 ' O ' ' N ' ' A' ' 64' ' ' TYR . 84.7 tt0 -140.44 133.82 29.88 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.608 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.556 ' C ' ' O ' ' A' ' 62' ' ' GLU . 51.2 p30 8.94 57.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.259 0.975 . . . . 0.0 111.731 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER 9.68 100.9 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.979 0.799 . . . . 0.0 112.188 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 30.5 p30 -78.9 86.78 4.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.054 0.454 . . . . 0.0 110.835 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -61.41 -32.71 72.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.269 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 43.5 tp -52.19 -37.5 54.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.333 -178.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -54.25 151.62 13.0 Favored Pre-proline 0 C--N 1.33 -0.265 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.365 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.71 138.28 78.64 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.744 2.296 . . . . 0.0 112.483 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 63.2 mt -111.72 142.3 44.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.503 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 96.9 p -128.56 158.09 39.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.687 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -129.62 76.45 78.53 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -61.3 179.11 0.47 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.941 2.428 . . . . 0.0 111.812 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -56.36 -41.65 76.52 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.714 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.4 p 48.66 46.48 21.3 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.96 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -62.03 -37.81 86.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.381 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.532 ' O ' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -119.34 99.79 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.345 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.579 ' C ' HD12 ' A' ' 79' ' ' LEU . 98.2 m-85 -71.14 127.76 33.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.958 -177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.592 HD13 ' SG ' ' A' ' 6' ' ' CYS . 9.1 mp -114.69 137.13 52.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.766 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 113' ' ' VAL . 62.3 t -104.75 132.4 51.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.578 ' SG ' HD13 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -114.38 123.81 50.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 111.54 -179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.464 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 44.1 p90 -150.78 128.53 11.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.047 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 t -62.64 126.32 26.92 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 156' ' ' GLU . 21.5 t -66.69 -20.17 26.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.675 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.769 ' O ' HG22 ' A' ' 85' ' ' VAL . 7.7 p -105.79 11.36 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.183 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.14 84.42 45.79 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.007 0.432 . . . . 0.0 110.416 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -52.84 -27.38 34.48 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.457 2.104 . . . . 0.0 112.491 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.8 m -64.91 -44.84 88.24 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.199 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.691 ' O ' HG23 ' A' ' 93' ' ' VAL . 83.8 p -70.71 -24.91 62.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.927 0.394 . . . . 0.0 110.995 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.482 ' CG ' HG21 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -73.4 -40.45 64.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.44 -179.626 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.09 -37.33 84.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.148 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -93.01 -39.82 10.89 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.071 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 89' ' ' SER . 37.4 t -51.68 -64.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.96 0.41 . . . . 0.0 111.573 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -72.61 -8.58 55.98 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.651 -0.42 . . . . 0.0 112.031 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.545 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 81.0 tt0 -103.77 -71.99 0.71 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -88.07 -9.13 54.29 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.41 ' CE2' ' HB2' ' A' ' 11' ' ' ASP . 93.0 m95 -97.4 -41.24 8.32 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.135 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.479 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -53.1 -54.64 42.15 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.545 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 17.9 Cg_endo -60.47 -34.05 93.34 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.674 1.583 . . . . 0.0 112.283 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -57.96 -37.56 74.4 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.954 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.648 HD13 HG11 ' A' ' 9' ' ' VAL . 44.1 pt -95.37 -31.9 4.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.495 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.487 HG22 ' HG3' ' A' ' 106' ' ' PRO . 28.7 m -51.08 -37.86 48.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.316 . . . . 0.0 110.948 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -50.63 -31.84 17.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.994 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.632 ' ND1' ' SG ' ' A' ' 105' ' ' CYS . 50.4 t-80 -57.33 -45.58 84.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.346 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.632 ' SG ' ' ND1' ' A' ' 104' ' ' HIS . 0.8 OUTLIER -174.59 82.74 0.34 Allowed Pre-proline 0 C--O 1.233 0.188 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.962 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.487 ' HG3' HG22 ' A' ' 102' ' ' THR . 18.0 Cg_exo -63.13 -16.78 56.64 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.921 2.414 . . . . 0.0 112.808 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -77.64 -3.19 39.67 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.633 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 105' ' ' CYS . 13.9 p -94.8 150.31 37.69 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.826 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.95 142.69 93.82 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 122.437 2.091 . . . . 0.0 111.274 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.705 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -119.98 125.83 49.34 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.548 0.69 . . . . 0.0 111.404 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mt -99.92 133.69 43.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.777 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.8 mt -99.99 124.86 45.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.444 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.495 ' O ' ' O ' ' A' ' 80' ' ' VAL . 41.5 t -128.05 129.44 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.302 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -106.47 142.54 15.65 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.431 HG21 ' HB1' ' A' ' 13' ' ' ALA . 0.6 OUTLIER -102.32 169.1 8.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.12 0.486 . . . . 0.0 110.339 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.915 ' O ' ' N ' ' A' ' 118' ' ' ASP . 56.8 mm-40 52.1 23.52 2.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.918 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.921 HG23 ' H ' ' A' ' 119' ' ' LEU . 15.8 tt 27.66 -46.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.915 ' N ' ' O ' ' A' ' 116' ' ' GLN . 47.0 t0 120.69 6.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.401 1.081 . . . . 0.0 108.505 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.921 ' H ' HG23 ' A' ' 117' ' ' ILE . 8.9 tp -133.13 -24.74 1.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.8 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.768 HH21 ' NE2' ' A' ' 116' ' ' GLN . 65.5 ttp85 -71.33 -60.99 1.93 Allowed 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 123' ' ' PRO . 38.0 m-20 -43.93 -29.16 0.53 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.629 ' O ' ' N ' ' A' ' 124' ' ' SER . 5.2 m-20 10.11 -73.9 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.781 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' A' ' 121' ' ' ASP . 57.3 Cg_exo -34.83 -26.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 120.928 1.085 . . . . 0.0 111.415 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.629 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.5 OUTLIER -107.74 -34.1 7.07 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.657 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.502 HG22 HG21 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -87.97 -33.99 18.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.125 0.488 . . . . 0.0 110.848 -179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.44 ' N ' ' O ' ' A' ' 122' ' ' ASP . 0.7 OUTLIER -79.8 -46.2 22.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.941 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.403 ' CD ' ' O ' ' A' ' 123' ' ' PRO . 96.8 mt-10 -65.7 -34.47 78.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.597 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -95.86 -69.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.584 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' ALA . 61.9 mt -85.7 40.26 0.84 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.415 -178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.542 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -38.57 -91.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -148.16 91.37 1.91 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.387 0.613 . . . . 0.0 109.626 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 30.8 p-10 -145.61 36.26 1.07 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.318 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 27.0 ttmt 87.34 55.28 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.095 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.542 ' NE2' ' O ' ' A' ' 130' ' ' ALA . 50.8 mt-30 -59.22 149.35 28.7 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.365 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.3 tptt -132.54 70.08 79.6 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-O 121.006 0.431 . . . . 0.0 110.92 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.8 145.55 97.12 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.644 2.229 . . . . 0.0 111.962 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.56 ' H ' HD12 ' A' ' 137' ' ' ILE . 4.8 mp -86.31 78.14 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.805 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -132.31 -52.48 0.03 OUTLIER Pre-proline 0 CA--C 1.53 0.19 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' A' ' 138' ' ' THR . 86.1 Cg_endo -83.87 -93.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.975 1.783 . . . . 0.0 114.585 -175.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.0 -38.83 76.86 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.554 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.2 p -69.59 -34.55 74.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.602 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -91.96 -42.3 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.361 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 139' ' ' PRO . 84.2 tt0 -60.98 -39.67 90.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.001 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -63.53 -43.92 95.73 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.171 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.621 HD22 ' N ' ' A' ' 145' ' ' LEU . 3.1 mm? -79.23 -7.16 58.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.913 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.03 -66.43 0.9 Allowed 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.581 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -59.77 -37.56 79.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.491 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -93.66 -13.82 27.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.8 tp -134.75 51.09 2.13 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.249 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.702 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 67.7 mttm 65.11 158.7 0.1 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.205 0.526 . . . . 0.0 111.311 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 158.06 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.444 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.648 HG12 ' HG3' ' A' ' 153' ' ' LYS . 72.6 t -142.5 -66.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.379 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.648 ' HG3' HG12 ' A' ' 152' ' ' VAL . 25.0 mttm -136.42 -167.75 2.12 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.411 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.594 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -150.27 97.15 2.51 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.737 HG23 ' O ' ' A' ' 155' ' ' VAL . 21.1 m -116.2 97.96 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.147 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.647 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.1 OUTLIER -95.33 98.75 10.81 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.683 ' HB2' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -125.61 149.31 48.51 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 123.007 1.384 . . . . 0.0 113.098 -176.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.607 ' OG ' ' NE ' ' A' ' 120' ' ' ARG . 22.3 t -157.03 92.76 1.29 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 111.906 -2.406 . . . . 0.0 106.289 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 42.27 27.42 0.08 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.242 -178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.676 ' O ' ' N ' ' A' ' 162' ' ' GLN . 19.8 mt -144.57 -73.37 0.26 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.125 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.647 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 2.2 m -57.06 65.31 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.315 0.578 . . . . 0.0 111.8 -177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.739 HE22 ' NZ ' ' A' ' 27' ' ' LYS . 7.9 pt20 -82.68 15.07 2.77 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 175.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.592 ' H ' ' C ' ' A' ' 161' ' ' THR . 24.9 tttt -86.44 -6.53 58.89 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 113.421 -1.718 . . . . 0.0 108.486 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 167' ' ' ASN . . . -131.4 -74.73 0.12 Allowed Glycine 0 N--CA 1.444 -0.816 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 177.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.756 HD13 ' O ' ' A' ' 19' ' ' LEU . 14.8 mt -41.49 -22.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.746 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.6 tttt -77.85 -46.59 21.02 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 164' ' ' GLY . 32.4 m120 -76.03 -0.45 21.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.784 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 171' ' ' GLU . 46.7 t -83.91 -60.14 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.762 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.707 ' CZ ' ' CZ ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -43.05 -45.64 5.32 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.018 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.653 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 32.6 p30 -70.03 -30.56 67.88 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.779 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.653 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 85.5 tt0 -64.72 -31.38 72.58 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.133 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.562 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -60.12 -29.43 68.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.583 HG23 ' CE1' ' A' ' 51' ' ' TYR . 77.3 mt -52.41 -39.75 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.1 tp -63.14 -37.79 88.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.589 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -76.78 -13.03 60.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.708 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -66.14 -29.21 69.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.916 0.388 . . . . 0.0 110.15 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.65 -35.27 70.31 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.431 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 99.989999999999995 110.575 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.565 ' N ' ' O ' ' A' ' 176' ' ' ALA . 64.1 mtt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -110.31 -113.83 0.31 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.459 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.754 HG22 HG22 ' A' ' 52' ' ' THR . 40.9 p -42.73 113.68 0.5 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.384 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 176' ' ' ALA . 17.8 tt -117.28 138.97 46.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.133 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -96.47 150.85 20.15 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.136 0.493 . . . . 0.0 111.106 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.886 ' SG ' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -143.1 137.03 28.87 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.013 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.0 p -106.61 139.66 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.692 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 79' ' ' LEU . 57.6 t -115.63 131.35 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.592 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 t -128.58 138.69 53.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.839 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 60' ' ' GLY . . . -135.4 -177.33 14.89 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.497 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.582 ' OD1' ' N ' ' A' ' 12' ' ' GLY . 53.8 p30 -72.25 -123.17 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.826 0.345 . . . . 0.0 111.221 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.711 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -151.21 72.51 0.28 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 152.23 27.7 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.58 0.224 . . . . 0.0 111.398 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.57 HG11 ' H ' ' A' ' 83' ' ' SER . 16.8 m -125.28 133.85 68.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.412 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.3 93.59 1.86 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.429 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.71 ' CE ' HE21 ' A' ' 61' ' ' GLN . 44.2 mttp -73.27 -8.53 56.22 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.013 0.435 . . . . 0.0 110.102 179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -59.27 -55.12 38.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.029 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HA ' HD12 ' A' ' 21' ' ' ILE . 82.6 m -58.91 -36.19 74.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.701 . . . . 0.0 109.317 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.659 ' O ' HD23 ' A' ' 165' ' ' LEU . 4.0 tt -65.71 -54.09 32.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.699 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.803 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -59.78 -32.53 70.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.063 0.459 . . . . 0.0 110.207 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 21' ' ' ILE . 33.7 mt -62.36 -9.6 4.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.378 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.462 ' CB ' HD23 ' A' ' 165' ' ' LEU . 23.3 t -53.43 -82.16 0.01 OUTLIER 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.936 -178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -52.62 -31.61 37.45 Favored 'General case' 0 C--N 1.344 0.35 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.851 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.3 m -47.18 -39.63 14.26 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -140.98 -87.97 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.985 178.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.559 ' N ' ' OG1' ' A' ' 25' ' ' THR . 2.1 t-20 156.58 83.94 0.0 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.798 ' H ' HE21 ' A' ' 162' ' ' GLN . 24.7 tttt 65.53 91.82 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.646 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 tp -125.14 85.64 57.84 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.45 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.61 47.18 2.25 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.85 2.367 . . . . 0.0 112.692 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.9 m -64.13 152.67 39.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.349 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -59.41 -39.57 83.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.555 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.6 ' CE2' ' O ' ' A' ' 33' ' ' VAL . 81.7 t80 -137.38 136.27 37.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.416 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.6 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 17.1 m -78.03 148.78 75.73 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.387 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.97 -162.4 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.386 2.057 . . . . 0.0 112.059 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.3 p -76.11 164.88 25.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.166 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -126.56 158.0 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.954 0.407 . . . . 0.0 110.805 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -117.93 161.04 20.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.363 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 51.5 p30 -77.92 4.29 12.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.974 0.416 . . . . 0.0 110.454 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -127.28 132.17 50.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.14 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -125.7 15.71 8.11 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -86.0 97.69 10.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.225 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.7 t -111.91 143.36 21.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 43' ' ' THR . 14.2 t -118.84 121.49 40.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.007 0.432 . . . . 0.0 110.756 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 169' ' ' PHE . 33.1 m -136.11 166.41 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.59 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.2 mtm -111.82 128.51 56.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.028 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 46' ' ' ILE . 10.9 tt -130.63 123.57 55.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.442 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.26 28.55 54.89 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.87 51.34 7.91 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -130.52 89.54 43.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.597 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 41.9 Cg_endo -74.72 103.9 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.135 1.89 . . . . 0.0 112.707 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 53.2 m-85 -162.01 174.81 12.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.564 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.754 HG22 HG22 ' A' ' 3' ' ' THR . 4.2 t -145.94 141.67 27.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.908 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.98 HD13 ' HB1' ' A' ' 172' ' ' ALA . 59.2 tp -107.84 129.24 55.09 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.607 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.443 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -96.48 119.58 6.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.596 HD23 ' SG ' ' A' ' 6' ' ' CYS . 71.7 mt -115.99 153.31 31.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.644 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.585 ' CD2' ' O ' ' A' ' 56' ' ' PHE . 46.2 t80 -135.52 32.66 3.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.446 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' O ' ' OG1' ' A' ' 58' ' ' THR . 49.5 p30 -80.44 -173.59 4.16 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.742 0.306 . . . . 0.0 111.247 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.638 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 1.2 m 168.74 -58.06 0.01 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.371 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . 164.02 139.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.204 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 10' ' ' GLY . . . 53.47 -82.03 0.01 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.71 HE21 ' CE ' ' A' ' 16' ' ' LYS . 47.4 mt-30 67.43 17.92 10.1 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.19 -72.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 65' ' ' ASP . 48.3 p30 -93.72 4.87 53.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.732 178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.507 ' C ' ' O ' ' A' ' 63' ' ' ASP . 66.1 t80 18.54 -80.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.797 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 63' ' ' ASP . 21.3 t70 -141.63 151.33 42.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.538 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -56.75 -34.57 67.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.572 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.3 mt -91.23 136.73 32.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.232 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -128.54 69.5 79.23 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.737 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.13 146.99 25.92 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.769 2.312 . . . . 0.0 112.273 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.3 mt -60.63 -33.13 72.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.446 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.3 t 36.44 37.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.388 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 54.43 85.64 0.18 Allowed Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.802 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.81 -63.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.557 2.171 . . . . 0.0 112.214 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 41.25 82.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.448 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.0 p -129.82 158.43 39.48 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.564 ' HB2' HD11 ' A' ' 4' ' ' ILE . 93.3 m-20 -121.84 -23.79 5.4 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.221 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.548 HG21 ' HB1' ' A' ' 175' ' ' ALA . 21.3 t -131.16 124.27 55.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.526 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.498 ' C ' HD12 ' A' ' 79' ' ' LEU . 97.5 m-85 -89.8 127.38 35.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.886 HD22 ' SG ' ' A' ' 6' ' ' CYS . 10.6 mp -104.64 135.58 45.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.814 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.554 HG11 HG23 ' A' ' 98' ' ' VAL . 41.3 t -117.83 131.94 69.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.794 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.64 135.82 53.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.306 0.574 . . . . 0.0 111.315 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.989 ' CG ' HG11 ' A' ' 93' ' ' VAL . 41.2 p90 -160.41 132.29 6.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.758 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.57 ' H ' HG11 ' A' ' 14' ' ' VAL . 75.7 p -59.0 135.98 57.8 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.447 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.594 ' O ' HG22 ' A' ' 84' ' ' VAL . 9.0 p -114.76 23.64 5.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.197 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.678 HG23 HD12 ' A' ' 119' ' ' LEU . 8.7 p -63.6 -38.06 81.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.273 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 85' ' ' VAL . 0.4 OUTLIER -133.77 155.78 80.05 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.562 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -59.79 -13.59 23.02 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.897 2.398 . . . . 0.0 112.684 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 m -66.16 -67.06 0.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.004 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.542 ' O ' HG12 ' A' ' 93' ' ' VAL . 59.3 m -60.61 -38.16 83.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.693 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' CZ ' ' OG1' ' A' ' 141' ' ' THR . 0.3 OUTLIER -60.03 -36.27 76.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.121 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' OE2' ' OE1' ' A' ' 95' ' ' GLU . 45.0 tp10 -81.91 -23.42 36.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.848 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.62 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 80.3 m-20 -85.84 5.46 32.6 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.989 HG11 ' CG ' ' A' ' 82' ' ' PHE . 1.5 p -119.07 -65.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.689 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.726 ' H ' HG13 ' A' ' 93' ' ' VAL . 74.0 mttt -54.8 -19.69 6.97 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.467 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' OE1' ' OE2' ' A' ' 91' ' ' GLU . 85.2 tt0 -113.89 -27.63 7.68 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -113.01 -40.31 3.99 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.62 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 47.4 m95 -90.63 -51.1 5.56 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.484 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.554 HG23 HG11 ' A' ' 80' ' ' VAL . 3.0 t -50.28 -58.9 8.27 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.414 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 6.4 Cg_endo -51.84 -39.13 68.61 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.652 1.568 . . . . 0.0 112.013 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -60.99 -43.79 98.32 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.015 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.2 mt -70.28 -36.56 67.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.494 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 105' ' ' CYS . 56.8 m -53.19 -43.33 67.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.852 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -63.39 -42.98 98.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.825 0.345 . . . . 0.0 110.841 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -61.07 -42.39 98.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.63 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -103.97 161.57 22.54 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 0.0 111.204 -179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.469 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 41.5 Cg_endo -70.23 -157.76 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.856 2.371 . . . . 0.0 112.381 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -86.18 9.07 18.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.88 156.07 0.76 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.464 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.51 143.71 54.57 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.683 2.255 . . . . 0.0 111.821 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.752 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -129.72 114.84 16.48 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.852 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 tp -79.95 122.72 27.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.424 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.603 HD13 ' CD2' ' A' ' 149' ' ' LEU . 27.5 tp -85.53 133.05 34.09 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.015 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.491 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 0.2 OUTLIER -142.47 163.73 17.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.418 -179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.541 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -146.4 176.59 25.24 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 116' ' ' GLN . 9.2 p -127.94 179.93 5.3 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 117.191 0.496 . . . . 0.0 109.87 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.551 HE21 ' HB2' ' A' ' 120' ' ' ARG . 9.5 mt-30 37.36 33.64 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.487 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.687 HD12 ' H ' ' A' ' 118' ' ' ASP . 1.0 OUTLIER 23.82 -141.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.236 0 O-C-N 123.506 0.503 . . . . 0.0 111.149 -179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.687 ' H ' HD12 ' A' ' 117' ' ' ILE . 86.7 m-20 -86.65 -2.48 58.55 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.568 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.678 HD12 HG23 ' A' ' 85' ' ' VAL . 6.0 tp 178.11 45.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.677 0.275 . . . . 0.0 111.18 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.558 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 57.7 ttp180 26.34 69.53 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.6 ' O ' ' C ' ' A' ' 122' ' ' ASP . 18.0 t0 94.25 15.01 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.731 ' OD1' HD12 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -4.11 -64.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.45 0 O-C-N 123.456 0.472 . . . . 0.0 111.284 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.598 ' N ' ' O ' ' A' ' 121' ' ' ASP . 14.7 Cg_exo -30.76 -61.83 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.282 1.988 . . . . 0.0 112.6 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.4 p -108.36 -3.02 18.67 Favored 'General case' 0 C--N 1.337 0.055 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.869 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.572 HG21 ' O ' ' A' ' 119' ' ' LEU . 1.1 m -96.29 -24.96 15.96 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.731 HD12 ' OD1' ' A' ' 122' ' ' ASP . 11.6 tt -73.25 -47.02 48.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.903 177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.548 ' N ' ' CG2' ' A' ' 126' ' ' ILE . 97.8 mt-10 -66.59 -37.83 85.72 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.483 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -70.68 -38.83 73.78 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.701 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 17.4 mt -52.26 -56.0 17.6 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.775 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 129' ' ' LEU . . . 149.62 1.43 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.292 0.37 . . . . 0.0 110.743 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 134' ' ' GLN . 51.3 mttp 71.7 -63.87 0.41 Allowed 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 122.895 0.478 . . . . 0.0 110.294 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -59.38 -25.17 64.04 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.731 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -89.33 1.25 56.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.468 ' OE1' HD11 ' A' ' 126' ' ' ILE . 1.3 pp0? -82.72 127.99 33.94 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.392 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.69 68.99 59.63 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.516 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -81.26 139.35 11.64 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 C-N-CA 123.091 2.527 . . . . 0.0 113.042 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 137' ' ' ILE . 10.1 tt -127.96 112.67 28.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.161 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.874 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.2 OUTLIER -131.12 -45.74 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.684 ' CD ' ' H ' ' A' ' 138' ' ' THR . 56.9 Cg_endo -88.2 -62.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.585 2.19 . . . . 0.0 114.389 -177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 139' ' ' PRO . 95.9 mt-10 -29.76 -72.61 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.422 ' OG1' ' CZ ' ' A' ' 90' ' ' PHE . 23.1 p -127.8 7.92 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.874 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -83.5 -70.64 0.55 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.754 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -74.1 -40.58 62.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.632 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -62.13 -36.48 81.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.897 0.38 . . . . 0.0 111.445 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 145' ' ' LEU . 35.6 tp -72.26 -22.47 61.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.232 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.65 -33.26 75.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.089 0.471 . . . . 0.0 110.81 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -59.89 -45.93 90.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.336 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -84.94 -29.53 25.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.736 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.603 ' CD2' HD13 ' A' ' 112' ' ' LEU . 55.5 tp -43.21 -28.46 0.31 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.268 -178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.527 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 63.0 mttm 88.17 -0.13 0.42 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.647 0.379 . . . . 0.0 110.009 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.46 -132.49 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.194 0.521 . . . . 0.0 111.518 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 110' ' ' PHE . 3.7 t -151.84 -54.66 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.336 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 154' ' ' TYR . 0.4 OUTLIER -107.25 -167.76 1.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.348 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.616 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 34.2 p90 -161.95 97.13 1.03 Allowed 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.61 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.957 0.884 . . . . 0.0 111.613 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.562 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.0 OUTLIER -153.39 96.93 2.09 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 178.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.572 ' HA ' HG22 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -112.83 145.49 40.56 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 123.274 1.511 . . . . 0.0 113.157 -176.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.673 ' HB3' HG23 ' A' ' 117' ' ' ILE . 13.6 t -173.35 90.19 0.08 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 111.707 -2.497 . . . . 0.0 107.168 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 57.07 29.38 16.41 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.695 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.619 ' C ' ' H ' ' A' ' 162' ' ' GLN . 21.2 tp -156.18 -85.23 0.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.693 ' C ' ' H ' ' A' ' 163' ' ' LYS . 0.9 OUTLIER -46.41 -9.55 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.798 HE21 ' H ' ' A' ' 27' ' ' LYS . 19.4 mt-30 -51.35 -1.58 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.693 ' H ' ' C ' ' A' ' 161' ' ' THR . 43.0 mttm -82.01 -2.69 52.47 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.648 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -116.45 -70.13 0.44 Allowed Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 19' ' ' LEU . 43.1 tp -39.81 -16.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.826 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.648 ' N ' ' O ' ' A' ' 164' ' ' GLY . 79.3 tttt -80.99 -53.51 6.37 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 164' ' ' GLY . 40.1 t-20 -71.15 -2.51 16.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.667 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 171' ' ' GLU . 29.6 t -78.3 -47.45 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.016 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.442 ' C ' ' O ' ' A' ' 168' ' ' VAL . 63.0 t80 -39.12 -43.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.533 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.7 -37.82 88.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.36 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 168' ' ' VAL . 96.8 mt-10 -72.71 -20.82 61.15 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.049 0.452 . . . . 0.0 110.132 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.98 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -64.66 -36.73 85.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.742 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.425 ' CG1' ' N ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -62.04 -36.45 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.425 ' N ' ' CG1' ' A' ' 173' ' ' ILE . 45.3 tp -61.39 -35.01 76.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.016 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.548 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -60.55 -29.66 69.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.852 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.753 ' HA ' HD12 ' A' ' 4' ' ' ILE . . . -65.98 -31.62 72.63 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.943 0.401 . . . . 0.0 110.285 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 32.8 tp -57.17 -35.86 70.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.671 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.41 ' OE2' ' OD2' ' A' ' 76' ' ' ASP . 97.0 mt-10 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 99.989999999999995 110.44 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 176' ' ' ALA . 91.2 mt-30 73.23 45.39 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.667 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.668 HG22 ' HA ' ' A' ' 51' ' ' TYR . 11.4 p -84.01 157.22 21.91 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.117 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.512 HD11 ' CB ' ' A' ' 76' ' ' ASP . 20.1 tt -134.12 152.9 34.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.821 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -103.04 146.79 27.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.036 0.445 . . . . 0.0 111.186 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.494 ' N ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -139.51 158.35 44.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.018 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.808 HG12 HG21 ' A' ' 75' ' ' THR . 12.2 p -127.6 134.4 65.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.771 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.665 HG11 HD21 ' A' ' 19' ' ' LEU . 13.6 t -110.98 133.81 55.31 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.812 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.3 t -114.62 132.47 63.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.225 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.37 123.34 7.76 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.538 ' OD1' ' NE1' ' A' ' 97' ' ' TRP . 25.5 t70 -82.76 121.48 26.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.602 0.239 . . . . 0.0 110.397 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.706 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 56.75 -0.82 0.14 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 82.12 125.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.745 HG23 ' H ' ' A' ' 15' ' ' GLY . 1.8 m -142.27 -88.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.816 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.745 ' H ' HG23 ' A' ' 14' ' ' VAL . . . -159.59 55.51 0.34 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.997 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.715 ' H ' ' CD ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.71 -34.64 78.31 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 122.673 -0.31 . . . . 0.0 111.339 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.1 m -52.18 -43.84 64.36 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.901 ' SG ' HD23 ' A' ' 28' ' ' LEU . 74.2 m -61.14 -26.97 68.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.168 0.509 . . . . 0.0 110.667 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.812 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -78.96 -35.91 42.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.173 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.64 HD11 ' HB3' ' A' ' 57' ' ' ASP . 81.4 mt -63.82 -36.09 82.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.487 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.5 HD11 ' HB2' ' A' ' 28' ' ' LEU . 17.9 pt -98.78 12.85 5.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.616 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.579 ' CB ' HD13 ' A' ' 165' ' ' LEU . 13.1 p -48.36 -77.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.893 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.405 ' HB3' ' CE2' ' A' ' 169' ' ' PHE . 80.1 t80 -62.77 -38.06 89.11 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.582 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.424 ' C ' HG22 ' A' ' 25' ' ' THR . 0.6 OUTLIER -48.68 -44.69 38.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.265 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER 171.2 77.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.796 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.659 HD22 ' N ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -58.05 83.21 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.521 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 25' ' ' THR . 24.1 mttm -148.17 60.26 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.901 HD23 ' SG ' ' A' ' 18' ' ' CYS . 11.0 tp -123.34 68.56 39.06 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.78 -14.0 26.89 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.561 2.174 . . . . 0.0 112.246 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.9 p -67.78 120.8 14.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.945 0.403 . . . . 0.0 110.628 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -67.8 -32.67 73.39 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.145 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -56.66 -41.47 77.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.03 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 33' ' ' VAL . 65.1 t 54.06 70.38 1.75 Allowed Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.432 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -53.93 137.45 68.65 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.817 2.345 . . . . 0.0 112.61 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.0 m -128.45 140.36 51.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.6 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.66 HG13 ' N ' ' A' ' 37' ' ' PHE . 9.1 p -159.75 -52.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.789 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.66 ' N ' HG13 ' A' ' 36' ' ' VAL . 66.9 t80 -100.07 130.79 46.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.845 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 89.9 m-20 -75.83 136.9 40.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.495 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -111.48 148.27 33.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.784 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.421 ' H ' ' H ' ' A' ' 41' ' ' ALA . 26.8 p90 -176.14 -7.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.98 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' H ' ' H ' ' A' ' 40' ' ' TYR . . . -138.79 103.25 4.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.393 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.6 131.82 62.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.641 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 43' ' ' THR . 15.3 t -105.64 123.03 47.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.744 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.3 m -133.78 157.3 42.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.473 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 66.1 mtm -129.97 132.0 46.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.338 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.446 HG21 ' HB2' ' A' ' 170' ' ' ASP . 17.6 tt -135.17 131.77 52.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.97 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.37 26.57 51.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.55 58.43 3.86 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -136.23 101.36 10.21 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -79.43 103.19 1.58 Allowed 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 122.266 1.977 . . . . 0.0 113.004 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.668 ' HA ' HG22 ' A' ' 3' ' ' THR . 52.6 p90 -154.12 169.7 22.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.832 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.495 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.0 OUTLIER -136.11 125.47 24.89 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.093 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.84 HD13 ' HB1' ' A' ' 172' ' ' ALA . 43.5 tp -107.86 121.16 44.18 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.221 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 6' ' ' CYS . . . -94.42 134.41 12.01 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.956 ' H ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -140.95 117.96 11.18 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.493 -179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.542 ' HB2' HG23 ' A' ' 7' ' ' VAL . 10.9 t80 -65.97 -158.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.64 ' HB3' HD11 ' A' ' 20' ' ' LEU . 50.2 p30 -166.88 172.76 10.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.652 0.263 . . . . 0.0 110.63 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.702 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 0.3 OUTLIER 35.31 -157.79 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.918 0.389 . . . . 0.0 110.836 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . 158.23 -50.0 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.271 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 61' ' ' GLN . . . -85.11 -175.78 50.63 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 60' ' ' GLY . 92.9 mt-30 35.31 -158.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.743 0.306 . . . . 0.0 110.542 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.57 ' C ' ' H ' ' A' ' 64' ' ' TYR . 85.3 tt0 54.68 81.63 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.346 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 57.1 t0 55.11 -1.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.129 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.57 ' H ' ' C ' ' A' ' 62' ' ' GLU . 58.0 t80 61.05 111.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.857 0.36 . . . . 0.0 110.133 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -82.53 123.27 29.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.184 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -67.35 153.1 44.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.318 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 mt -73.23 147.78 44.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.541 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -122.93 80.75 50.25 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.617 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -52.33 -11.65 1.22 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.777 2.318 . . . . 0.0 112.205 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.2 146.33 39.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.667 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 72' ' ' TYR . 40.1 p -85.23 6.46 25.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.039 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.45 ' C ' ' O ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -34.39 -59.16 0.59 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.983 -179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 72' ' ' TYR . 37.0 Cg_endo -68.09 135.86 36.01 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.154 1.903 . . . . 0.0 111.885 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -121.6 122.01 38.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.797 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.808 HG21 HG12 ' A' ' 7' ' ' VAL . 54.1 m -126.65 127.51 45.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.529 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.512 ' CB ' HD11 ' A' ' 4' ' ' ILE . 85.4 m-20 -83.63 -36.22 24.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.546 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 m -132.68 122.86 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.291 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -84.97 123.3 30.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.365 0.602 . . . . 0.0 111.377 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.553 HD22 HG22 ' A' ' 8' ' ' VAL . 7.4 tt -115.39 130.76 56.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.754 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -118.4 135.53 58.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.152 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.741 ' SG ' HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -130.79 132.07 45.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.141 0.496 . . . . 0.0 110.893 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.795 ' CD1' HG21 ' A' ' 93' ' ' VAL . 44.5 p90 -152.84 143.89 23.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.173 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.631 ' H ' HG11 ' A' ' 14' ' ' VAL . 14.0 t -53.12 132.22 37.91 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 138' ' ' THR . 0.0 OUTLIER -99.51 24.18 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.755 -178.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -113.8 7.82 7.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.659 179.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.43 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -124.29 150.01 62.67 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.124 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.93 -38.31 3.02 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.43 2.087 . . . . 0.0 113.345 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 60.1 p -85.67 -18.62 32.67 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.43 ' OG ' ' OG ' ' A' ' 86' ' ' SER . 50.6 m -59.09 -35.2 72.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.746 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 90' ' ' PHE . 2.1 p90 -89.77 -29.25 18.81 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.381 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 90' ' ' PHE . 98.7 mt-10 -63.73 -31.93 73.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.714 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -80.56 -38.09 30.21 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.939 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.795 HG21 ' CD1' ' A' ' 82' ' ' PHE . 76.5 t -68.39 -62.78 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.554 ' HE2' HD21 ' A' ' 112' ' ' LEU . 19.7 mttt -70.69 -7.12 42.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.535 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 76.7 tt0 -131.37 -52.97 1.02 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -74.34 -42.54 59.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.538 ' NE1' ' OD1' ' A' ' 11' ' ' ASP . 96.5 m95 -88.58 -32.77 17.96 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.518 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -53.22 -45.03 98.54 Favored Pre-proline 0 N--CA 1.466 0.364 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.526 -178.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.535 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 12.8 Cg_exo -64.0 -45.12 10.97 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.259 1.973 . . . . 0.0 111.515 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.64 -40.78 80.05 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.793 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 80.0 mt -73.22 -35.38 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.418 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.2 m -52.75 -39.46 62.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.162 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -56.22 -46.43 79.5 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.625 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -61.14 -44.95 96.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.908 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.9 87.57 48.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.531 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -51.59 -34.84 54.35 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.312 2.008 . . . . 0.0 112.212 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -143.55 112.31 6.54 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.602 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.606 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -171.08 151.81 3.3 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.292 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.62 142.49 98.01 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.308 2.005 . . . . 0.0 111.257 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.725 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -135.92 137.4 41.32 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.39 -179.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 111' ' ' LEU . 6.6 mp -95.46 130.27 42.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.74 HD22 ' HB2' ' A' ' 146' ' ' ALA . 34.2 tp -97.05 127.45 43.03 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.7 t -146.29 167.46 7.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.655 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -142.59 170.92 24.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.499 ' O ' HG22 ' A' ' 84' ' ' VAL . 3.1 p -122.9 177.6 5.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.182 0.515 . . . . 0.0 110.115 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.701 ' O ' ' N ' ' A' ' 118' ' ' ASP . 83.2 mt-30 57.78 11.28 1.3 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.402 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.742 ' CG2' ' H ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER 35.57 19.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.342 0 CA-C-O 120.979 0.419 . . . . 0.0 111.178 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.701 ' N ' ' O ' ' A' ' 116' ' ' GLN . 2.4 p30 50.48 13.82 0.14 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.692 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.9 tp -144.12 -36.1 0.35 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 119.804 -0.758 . . . . 0.0 112.816 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.742 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 8.0 tpm_? -63.25 -53.75 48.07 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 125' ' ' THR . 81.2 m-20 -88.05 -11.28 47.64 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.167 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.813 ' OD2' HD12 ' A' ' 126' ' ' ILE . 0.9 OUTLIER -43.82 -61.76 1.8 Allowed Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.903 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 122' ' ' ASP . 1.6 Cg_endo -46.32 -20.12 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.159 1.24 . . . . 0.0 109.846 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.467 ' N ' ' C ' ' A' ' 122' ' ' ASP . 0.4 OUTLIER -103.93 -64.2 1.12 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.478 179.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 121' ' ' ASP . 41.3 m -62.04 -41.4 98.08 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.694 -178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.813 HD12 ' OD2' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -76.44 -46.16 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.453 ' N ' HG22 ' A' ' 126' ' ' ILE . 84.8 tt0 -55.2 -38.32 68.23 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.699 -0.4 . . . . 0.0 112.015 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -63.29 -38.16 90.07 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.212 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.72 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 50.2 mt -47.73 -48.52 29.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.557 -178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . 86.67 22.68 0.06 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -133.97 77.48 1.71 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.712 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -51.98 -28.14 15.81 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -55.59 -34.41 64.81 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.348 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -54.71 144.32 22.49 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.344 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -143.81 158.79 55.62 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 120.936 0.398 . . . . 0.0 111.187 -179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -62.88 150.38 88.55 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.967 2.445 . . . . 0.0 111.983 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 137' ' ' ILE . 15.5 tt -136.15 48.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.072 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.811 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 6.8 m -128.56 -30.5 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.811 ' CD ' ' H ' ' A' ' 138' ' ' THR . 79.7 Cg_exo -44.41 -59.7 1.03 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.691 1.594 . . . . 0.0 112.754 -177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -122.07 -35.14 3.21 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.73 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.7 m -53.98 -40.42 66.87 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.061 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.549 ' HB1' ' NZ ' ' A' ' 94' ' ' LYS . . . -80.18 -37.37 33.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.665 0.269 . . . . 0.0 111.265 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -58.2 -41.44 83.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.409 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -63.14 -42.42 99.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.051 0.453 . . . . 0.0 110.513 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 89.3 mt -64.23 -34.12 77.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.326 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.74 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -73.73 -30.59 62.92 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.472 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.8 ttt85 -54.43 -38.26 66.07 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.59 ' OD1' ' N ' ' A' ' 149' ' ' LEU . 55.0 p30 -123.27 -26.56 4.27 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.59 ' N ' ' OD1' ' A' ' 148' ' ' ASP . 5.9 tp -74.94 2.35 10.61 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.315 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.703 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 47.7 mttt 100.44 147.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.624 0.77 . . . . 0.0 110.384 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 155.25 -173.27 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.08 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 110' ' ' PHE . 46.3 t -150.35 -57.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.281 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 4.2 mmtm -98.76 -176.36 3.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.656 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.619 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 31.6 p90 -170.62 97.13 0.24 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.958 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.461 HG22 ' C ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -161.3 -176.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.186 -179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.746 ' O ' ' OG1' ' A' ' 161' ' ' THR . 0.4 OUTLIER -148.18 96.08 2.57 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.838 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.721 ' SG ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -108.64 147.26 32.13 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 123.129 1.443 . . . . 0.0 113.058 -178.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.534 ' HB2' ' N ' ' A' ' 116' ' ' GLN . 5.3 t -165.94 90.98 0.46 Allowed 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 111.64 -2.527 . . . . 0.0 106.102 176.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.813 ' HB1' ' H ' ' A' ' 28' ' ' LEU . . . 48.5 31.6 2.94 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.261 -1.791 . . . . 0.0 109.962 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.816 ' O ' ' N ' ' A' ' 162' ' ' GLN . 1.9 mt -153.46 -76.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.886 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.746 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 3.1 m -51.78 44.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.816 ' N ' ' O ' ' A' ' 160' ' ' LEU . 36.2 tt0 -72.7 8.47 1.46 Allowed 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.707 ' H ' ' C ' ' A' ' 161' ' ' THR . 26.4 mttt -81.24 -6.31 58.73 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 113.196 -1.82 . . . . 0.0 108.16 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -126.89 -67.84 0.16 Allowed Glycine 0 CA--C 1.502 -0.778 0 N-CA-C 106.648 -2.581 . . . . 0.0 106.648 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.721 HD12 ' SG ' ' A' ' 157' ' ' CYS . 4.7 mt -41.68 -7.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.652 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 164' ' ' GLY . 48.7 tttt -83.51 -45.49 13.53 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 176.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 164' ' ' GLY . 24.4 m120 -81.22 4.75 19.24 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.29 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 165' ' ' LEU . 58.2 t -86.8 -62.09 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.765 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 23' ' ' TYR . 78.4 m-85 -45.19 -40.44 7.21 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.217 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 46' ' ' ILE . 59.5 t0 -68.04 -42.96 79.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.203 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.99 -27.85 69.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.973 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.84 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -62.76 -32.29 73.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.92 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.513 HG22 ' CG ' ' A' ' 51' ' ' TYR . 1.1 pp -64.61 -27.21 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.338 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.84 -35.02 79.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.569 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.46 -28.93 62.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.839 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -59.46 -42.18 91.41 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.85 -25.93 66.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.964 0.411 . . . . 0.0 110.483 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 99.989999999999995 110.52 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' N ' ' O ' ' A' ' 176' ' ' ALA . 63.7 mtt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' THR . 90.4 mt-30 -122.63 167.17 13.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.581 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.492 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -40.52 134.96 1.65 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.739 HD11 ' OD2' ' A' ' 76' ' ' ASP . 5.2 tp -123.79 144.6 32.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.727 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' HA ' ' H ' ' A' ' 54' ' ' GLY . 91.2 mttt -100.88 153.83 19.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.272 0.558 . . . . 0.0 111.365 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -135.65 160.38 38.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.892 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.537 ' N ' ' SG ' ' A' ' 6' ' ' CYS . 33.1 m -125.4 157.47 34.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.458 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.477 ' H ' ' HB3' ' A' ' 56' ' ' PHE . 21.6 t -108.76 126.65 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.294 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.9 t -133.66 129.26 55.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.651 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.602 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . -164.59 -143.09 3.6 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.226 -0.988 . . . . 0.0 111.444 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.556 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.5 t0 -83.42 111.63 19.2 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 28.2 -90.3 0.01 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -131.23 126.8 36.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.071 0.462 . . . . 0.0 111.56 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -136.52 -174.4 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.303 178.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.471 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -65.08 42.24 0.11 Allowed Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 59' ' ' ALA . 37.1 mttt -62.05 -36.4 81.5 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.7 m -66.04 -48.85 69.71 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -62.37 -29.92 70.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.152 0.501 . . . . 0.0 110.727 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.597 HD21 HG11 ' A' ' 113' ' ' VAL . 57.7 tp -57.29 -41.36 79.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.858 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 tt -66.99 -37.93 85.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.106 0.479 . . . . 0.0 110.672 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 21' ' ' ILE . 93.4 mt -70.31 3.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.195 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.483 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 10.5 t -62.38 -74.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.864 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.614 ' CD1' ' CE1' ' A' ' 169' ' ' PHE . 0.7 OUTLIER -59.93 -31.06 69.49 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.234 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 6.7 m -52.04 -43.36 63.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.489 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -163.14 -38.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.377 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.483 ' OD1' ' O ' ' A' ' 22' ' ' SER . 2.6 p-10 43.55 95.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -152.92 13.09 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.4 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.691 HD11 ' HG3' ' A' ' 120' ' ' ARG . 5.1 tp 61.24 60.64 3.07 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.213 0.53 . . . . 0.0 110.519 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.35 -168.43 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.862 2.375 . . . . 0.0 112.003 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 m -56.71 151.04 14.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.455 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.76 -34.74 74.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.069 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -115.54 132.21 56.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.737 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.05 70.64 82.55 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.394 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.07 9.53 3.02 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.994 2.463 . . . . 0.0 112.678 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.1 m -51.5 -38.92 56.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.781 0.324 . . . . 0.0 110.65 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.7 p -130.09 141.8 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.252 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -58.2 -49.5 76.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.279 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 38' ' ' ASP . 51.3 p30 -176.14 157.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.544 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 55' ' ' LEU . 38.0 t-20 -124.45 169.27 12.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.55 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.492 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -178.36 11.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.172 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.24 100.31 3.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.857 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.413 HG11 ' OH ' ' A' ' 23' ' ' TYR . 42.2 t -134.87 134.17 53.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.217 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 43' ' ' THR . 14.8 t -119.44 126.64 51.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.422 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.3 p -140.76 144.88 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.676 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 73.8 mtm -105.76 123.53 48.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.14 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 81.4 mt -132.72 117.11 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.804 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.2 29.35 70.96 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.116 -0.793 . . . . 0.0 111.116 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.07 43.9 15.46 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' OE1' ' OD1' ' A' ' 170' ' ' ASP . 64.8 mt-10 -123.2 86.01 51.5 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 110.509 -0.182 . . . . 0.0 110.509 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.467 ' O ' ' CG ' ' A' ' 51' ' ' TYR . 50.2 Cg_endo -76.9 102.02 1.57 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.211 1.941 . . . . 0.0 112.423 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 50' ' ' PRO . 88.9 m-85 -155.46 170.39 22.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.965 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.492 ' H ' ' HB ' ' A' ' 3' ' ' THR . 3.4 p -134.8 142.83 46.78 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.159 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.785 HD22 ' HB2' ' A' ' 172' ' ' ALA . 46.0 tp -122.36 126.85 48.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.954 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -98.07 130.72 10.33 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.695 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.492 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 66.6 mt -116.76 123.41 47.09 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.532 ' O ' ' O ' ' A' ' 57' ' ' ASP . 34.9 t80 -91.15 32.13 1.05 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.961 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 56' ' ' PHE . 50.5 p30 -36.24 168.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.062 0.458 . . . . 0.0 112.059 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 58' ' ' THR . 46.4 m 59.8 53.67 4.72 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.174 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.595 ' O ' ' NZ ' ' A' ' 16' ' ' LYS . . . -141.36 157.34 45.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.429 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' A' ' 64' ' ' TYR . . . 167.54 -42.73 0.24 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -139.41 -87.37 0.22 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.967 0.413 . . . . 0.0 111.204 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -64.0 -46.97 82.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.906 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -87.7 5.54 39.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.328 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.411 ' HA ' ' H ' ' A' ' 60' ' ' GLY . 76.2 t80 -45.8 -43.79 13.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.133 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 52.6 p30 -175.93 154.45 1.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.375 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.552 ' C ' HD22 ' A' ' 67' ' ' LEU . 93.7 mtt180 -107.35 -73.4 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.071 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.7 ' N ' HD22 ' A' ' 67' ' ' LEU . 2.9 mm? -99.38 134.86 41.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.164 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -110.22 131.74 21.85 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.271 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.63 135.95 27.19 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.022 1.815 . . . . 0.0 112.128 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.8 -37.87 86.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.125 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.4 p -155.15 163.28 40.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.523 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 54.59 79.18 0.35 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.752 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.22 148.74 17.8 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.749 2.299 . . . . 0.0 111.945 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -83.55 8.61 13.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.978 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.7 t -131.09 150.63 52.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.739 ' OD2' HD11 ' A' ' 4' ' ' ILE . 88.1 m-20 -127.37 -15.69 5.08 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.639 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.12 107.56 13.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.941 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -74.04 135.29 43.06 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.721 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.468 HD11 HG21 ' A' ' 113' ' ' VAL . 7.9 tt -117.47 125.26 50.61 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.966 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.621 HG21 HD12 ' A' ' 112' ' ' LEU . 10.7 m -100.66 132.27 46.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.949 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 41.7 t -125.91 128.46 47.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.398 0.618 . . . . 0.0 111.675 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.549 ' HB3' HG21 ' A' ' 93' ' ' VAL . 12.8 p90 -153.44 157.63 40.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.511 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.52 ' OG ' ' CB ' ' A' ' 89' ' ' SER . 16.3 p -66.42 132.33 48.06 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -78.71 32.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.934 -177.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.589 ' CG1' ' N ' ' A' ' 119' ' ' LEU . 32.6 m -121.62 160.78 22.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.075 0.464 . . . . 0.0 110.347 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.686 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -42.22 -58.61 3.34 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.199 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 89' ' ' SER . 20.0 Cg_exo -22.69 65.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 124.634 3.556 . . . . 0.0 115.984 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 86' ' ' SER . 50.5 m 34.02 10.76 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.689 ' N ' ' O ' ' A' ' 87' ' ' PRO . 88.5 p -69.46 -33.67 73.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 118.388 0.54 . . . . 0.0 110.806 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.6 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 5.8 p90 -89.12 -41.38 12.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.202 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.6 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 84.7 tt0 -55.98 -34.17 65.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.267 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.566 ' O ' ' N ' ' A' ' 96' ' ' LYS . 73.4 m-20 -85.75 -64.4 1.16 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.123 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 82' ' ' PHE . 52.7 t -49.67 -52.97 11.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.707 ' NZ ' HD21 ' A' ' 112' ' ' LEU . 23.3 mttm -67.37 -20.08 65.51 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 84.4 tt0 -126.61 -58.54 1.32 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 92' ' ' ASN . 14.7 tptp -60.49 -35.2 75.36 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.937 0.718 . . . . 0.0 112.937 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.602 ' CZ2' ' O ' ' A' ' 10' ' ' GLY . 42.2 m95 -84.16 -35.0 23.9 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.006 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.3 t -37.45 -54.53 2.1 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 20.0 Cg_endo -63.64 -36.5 52.4 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 121.271 1.314 . . . . 0.0 110.979 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 97' ' ' TRP . 48.2 tp10 -61.45 -43.91 98.04 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.042 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.9 mt -74.74 -35.3 36.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.812 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.7 m -50.49 -41.7 53.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.023 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -57.7 -39.9 78.24 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.363 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -58.37 -44.9 89.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.003 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.483 ' O ' ' OG1' ' A' ' 108' ' ' THR . 8.6 t -167.48 108.61 0.61 Allowed Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.925 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.49 150.56 22.09 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.199 1.933 . . . . 0.0 112.419 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 80.3 mttt 60.41 49.37 6.91 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.972 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -121.42 108.81 35.34 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.814 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -47.82 148.29 6.39 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.993 1.796 . . . . 0.0 111.441 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 152' ' ' VAL . 20.3 p90 -151.02 161.63 42.37 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.453 -0.899 . . . . 0.0 112.824 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.3 mp -96.6 127.51 42.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.347 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.707 HD21 ' NZ ' ' A' ' 94' ' ' LYS . 16.9 tp -88.77 119.86 29.64 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.643 HG12 ' N ' ' A' ' 114' ' ' GLY . 40.0 t -136.3 165.3 29.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 0.0 111.815 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.643 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -142.15 174.36 23.29 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 12.5 t -137.79 161.14 37.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.949 0.404 . . . . 0.0 110.451 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.697 HE22 ' CZ ' ' A' ' 120' ' ' ARG . 2.8 mm100 54.55 33.19 18.48 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.773 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.889 HG23 ' N ' ' A' ' 118' ' ' ASP . 7.2 tt 21.84 -138.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.424 0 O-C-N 123.544 0.527 . . . . 0.0 110.812 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.929 ' OD2' HG21 ' A' ' 125' ' ' THR . 23.7 p30 -87.07 83.49 7.46 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.277 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.667 HD23 ' CB ' ' A' ' 124' ' ' SER . 16.6 tp 56.75 42.5 26.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.023 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.697 ' CZ ' HE22 ' A' ' 116' ' ' GLN . 50.6 ttm-85 51.03 65.79 1.37 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.152 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.642 ' H ' ' CG2' ' A' ' 117' ' ' ILE . 59.3 t0 5.82 66.67 0.0 OUTLIER 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.328 1.061 . . . . 0.0 109.979 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.654 ' O ' ' N ' ' A' ' 124' ' ' SER . 0.4 OUTLIER -107.15 -179.39 0.7 Allowed Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 113.097 -1.865 . . . . 0.0 107.861 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 127' ' ' GLU . 30.3 Cg_exo -59.62 35.26 0.05 OUTLIER 'Trans proline' 0 C--N 1.299 -2.05 0 C-N-CA 121.257 1.304 . . . . 0.0 111.114 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.667 ' CB ' HD23 ' A' ' 119' ' ' LEU . 0.5 OUTLIER -115.53 -57.54 2.23 Favored 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.484 179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.929 HG21 ' OD2' ' A' ' 118' ' ' ASP . 17.4 m -66.73 -33.63 76.06 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 177.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 127' ' ' GLU . 52.7 mt -88.95 -70.65 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 113.613 -1.63 . . . . 0.0 114.363 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 126' ' ' ILE . 76.9 tt0 -65.73 -32.16 73.55 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -91.9 -68.96 0.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.769 -0.772 . . . . 0.0 111.158 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.647 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 4.1 mm? -58.13 -33.17 68.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.433 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . 99.09 122.64 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -50.1 -35.83 27.13 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.749 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -86.86 5.55 36.26 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.905 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 134' ' ' GLN . 35.0 tttp -134.34 -6.6 2.6 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.959 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.571 ' HG2' HG22 ' A' ' 125' ' ' THR . 92.1 mt-30 -14.4 -71.21 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.533 0.521 . . . . 0.0 111.862 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.7 tptt 54.41 60.7 10.36 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.825 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -53.64 154.42 16.1 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.374 2.049 . . . . 0.0 111.41 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 84' ' ' VAL . 6.1 tt -76.77 43.12 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.226 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.609 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.49 -64.34 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.802 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.609 ' HD2' ' H ' ' A' ' 138' ' ' THR . 72.1 Cg_exo -22.52 -72.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 123.495 2.797 . . . . 0.0 113.485 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -102.45 -44.28 5.41 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.047 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.567 HG21 HG13 ' A' ' 137' ' ' ILE . 41.9 m -51.39 -46.26 62.78 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.518 ' HB1' ' NZ ' ' A' ' 94' ' ' LYS . . . -76.73 -38.57 54.04 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.825 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.444 ' CD ' ' O ' ' A' ' 139' ' ' PRO . 97.7 mt-10 -60.21 -39.47 86.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.255 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.96 -49.62 75.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.205 0.526 . . . . 0.0 109.96 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 91.1 mt -57.56 -31.93 66.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.475 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.69 75.73 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.503 -0.479 . . . . 0.0 109.942 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -59.75 -35.38 74.47 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.611 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -49.56 -31.17 9.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.6 mt -126.68 -114.64 0.28 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.816 -1.084 . . . . 0.0 108.633 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.0 tttp -175.9 71.85 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.87 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.508 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . . . -61.01 -138.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.841 0.353 . . . . 0.0 110.628 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 110' ' ' PHE . 54.9 t -154.16 -50.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.829 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.541 ' NZ ' ' OE1' ' A' ' 171' ' ' GLU . 1.1 mmtm -114.41 -175.62 2.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 121.093 -0.243 . . . . 0.0 110.651 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.653 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -170.7 96.21 0.22 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.497 HG11 ' CD2' ' A' ' 165' ' ' LEU . 9.4 p -143.51 142.95 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-O 121.515 0.674 . . . . 0.0 111.245 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.736 ' O ' ' OG1' ' A' ' 161' ' ' THR . 3.6 pt-20 -119.92 96.19 5.07 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.584 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 0.1 OUTLIER -120.25 131.11 54.8 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -176.165 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 160' ' ' LEU . 77.1 p -119.83 87.94 2.84 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 103.929 -2.619 . . . . 0.0 103.929 173.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 37.02 26.93 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.865 ' O ' ' N ' ' A' ' 162' ' ' GLN . 34.9 tp -133.64 -79.25 0.47 Allowed 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.467 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.736 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 4.6 m -45.59 49.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.865 ' N ' ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -71.49 0.81 7.52 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 175.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.6 ' H ' ' C ' ' A' ' 161' ' ' THR . 8.7 mtmp? -58.86 -23.54 60.99 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 113.546 -1.661 . . . . 0.0 106.849 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -119.28 -65.99 0.29 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 107.387 -2.285 . . . . 0.0 107.387 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.497 ' CD2' HG11 ' A' ' 155' ' ' VAL . 0.5 OUTLIER -40.67 -10.41 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.647 ' N ' ' O ' ' A' ' 164' ' ' GLY . 41.8 tttp -91.52 -42.05 10.47 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.584 ' N ' ' O ' ' A' ' 164' ' ' GLY . 78.3 m-20 -81.98 -0.03 42.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.651 -1.159 . . . . 0.0 109.135 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.7 t -77.98 -57.82 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.614 ' CE1' ' CD1' ' A' ' 23' ' ' TYR . 46.8 m-85 -48.79 -43.54 38.16 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.686 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.763 ' O ' HG22 ' A' ' 173' ' ' ILE . 62.6 t0 -67.12 -49.48 64.76 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.205 0.526 . . . . 0.0 109.913 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.541 ' OE1' ' NZ ' ' A' ' 153' ' ' LYS . 87.5 tt0 -59.06 -25.54 63.83 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.785 ' HB2' HD22 ' A' ' 53' ' ' LEU . . . -55.02 -32.2 61.64 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.314 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 170' ' ' ASP . 3.6 tt -59.13 -30.08 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 25.7 tp -57.42 -38.54 74.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.1 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.528 ' HB3' HG21 ' A' ' 4' ' ' ILE . . . -71.8 -15.79 62.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 1' ' ' MET . . . -63.59 -32.28 73.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.828 0.346 . . . . 0.0 110.562 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.02 -34.04 71.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.456 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.483 ' OE2' ' OD2' ' A' ' 76' ' ' ASP . 96.9 mt-10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 99.989999999999995 110.561 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.469 ' HG2' HD12 ' A' ' 177' ' ' LEU . 59.6 mtm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' THR . 92.6 mt-30 -124.38 174.69 7.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.53 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.46 HG23 ' H ' ' A' ' 3' ' ' THR . 0.6 OUTLIER -38.48 133.56 1.0 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.16 -179.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.663 HD11 ' OD2' ' A' ' 76' ' ' ASP . 4.5 tp -131.06 152.21 37.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.336 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.507 ' HA ' ' H ' ' A' ' 54' ' ' GLY . 25.2 mttm -109.26 161.26 15.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.198 0.523 . . . . 0.0 111.504 -179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.556 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -122.85 144.96 48.86 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.457 179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.5 145.28 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG23 ' NZ ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -68.0 128.12 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.05 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.524 HG11 HD13 ' A' ' 101' ' ' ILE . 44.8 t -141.77 128.45 19.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.788 178.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.53 -174.96 38.13 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.884 -1.151 . . . . 0.0 112.106 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.467 ' N ' HG22 ' A' ' 93' ' ' VAL . 60.5 t0 -90.96 124.24 35.07 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.973 0.416 . . . . 0.0 110.755 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.701 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -47.39 101.82 0.04 OUTLIER Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 150.16 30.67 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.707 0.299 . . . . 0.0 110.871 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 82' ' ' PHE . 29.2 m -127.47 132.84 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.024 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.53 97.75 2.27 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.555 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' NZ ' HG23 ' A' ' 8' ' ' VAL . 23.4 mttm -83.0 -2.51 55.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.674 0.273 . . . . 0.0 110.964 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.2 m -65.93 -57.78 7.07 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.742 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.439 ' O ' HG22 ' A' ' 21' ' ' ILE . 92.3 m -68.73 -25.95 65.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.489 0.661 . . . . 0.0 110.14 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.668 HD12 ' SG ' ' A' ' 157' ' ' CYS . 7.4 tp -50.94 -56.15 13.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.641 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.539 HD13 HD22 ' A' ' 55' ' ' LEU . 55.2 mt -71.19 -35.09 71.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.83 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 18' ' ' CYS . 2.0 tt -47.7 -11.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.268 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.572 ' OG ' ' N ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -55.75 -76.74 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.318 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.572 ' N ' ' OG ' ' A' ' 22' ' ' SER . 49.7 t80 -56.59 -39.21 73.15 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.916 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -66.77 0.34 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 73.6 p -111.72 -23.57 10.55 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 25' ' ' THR . 31.6 t30 83.35 95.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.909 0.385 . . . . 0.0 110.658 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 26' ' ' ASN . 11.2 pttm 33.32 73.26 0.07 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.279 0.561 . . . . 0.0 111.574 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.26 79.45 70.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.414 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -56.89 146.69 77.82 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.912 2.408 . . . . 0.0 112.742 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.6 t -128.33 143.18 50.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.139 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.86 -36.61 72.58 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.734 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CE2' ' O ' ' A' ' 33' ' ' VAL . 77.4 t80 -124.82 138.23 54.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.597 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.408 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 9.6 t -73.0 123.32 89.46 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.519 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.39 158.12 36.81 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.227 1.951 . . . . 0.0 112.057 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.4 p -76.97 157.03 31.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.437 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 m -131.38 156.53 42.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.83 156.83 29.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.186 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -73.94 88.57 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.947 0.403 . . . . 0.0 110.357 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -144.77 108.73 4.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.347 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.673 ' CB ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -101.2 -24.71 14.21 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.27 95.53 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.352 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.654 HG21 HD11 ' A' ' 55' ' ' LEU . 55.4 t -134.81 137.59 50.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.232 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 43' ' ' THR . 6.8 t -120.41 133.98 55.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.726 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.428 HG21 ' CZ ' ' A' ' 23' ' ' TYR . 8.8 p -141.31 141.8 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.408 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.9 mtm -110.5 118.84 37.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.435 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 75.0 mt -129.14 119.57 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.554 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.94 25.85 73.22 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.22 48.54 14.6 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -131.87 105.27 14.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.59 100.09 1.2 Allowed 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.132 1.888 . . . . 0.0 112.479 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.854 ' CD1' HD11 ' A' ' 173' ' ' ILE . 33.5 p90 -142.08 165.58 27.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.317 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.29 127.49 35.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.067 0.461 . . . . 0.0 111.812 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.678 HD13 ' HB1' ' A' ' 172' ' ' ALA . 62.8 tp -107.36 138.08 44.22 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.842 178.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -81.6 147.6 26.9 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.673 ' H ' ' CB ' ' A' ' 40' ' ' TYR . 48.3 mt -99.51 98.52 9.41 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.243 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.53 ' O ' ' O ' ' A' ' 57' ' ' ASP . 7.9 p90 -55.54 -27.36 48.49 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.51 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' O ' ' CB ' ' A' ' 58' ' ' THR . 63.6 t0 -17.09 139.88 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.947 0.779 . . . . 0.0 112.578 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.54 ' CB ' ' O ' ' A' ' 57' ' ' ASP . 1.1 m 155.33 149.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.304 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.12 151.96 20.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.543 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.55 -174.06 38.19 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.469 ' O ' ' C ' ' A' ' 62' ' ' GLU . 34.6 tt0 69.46 -132.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.571 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 77.2 tt0 36.47 51.36 0.86 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.571 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 38.8 t0 100.95 93.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.723 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -58.19 -33.93 69.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.877 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -66.36 145.34 55.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.637 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -118.71 153.53 34.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.537 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.8 tp -94.91 136.62 35.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.846 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.07 83.31 19.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.222 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.36 148.37 19.53 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.786 2.324 . . . . 0.0 112.549 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.37 -31.54 70.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.611 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.7 p -61.53 165.41 4.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.884 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -51.16 159.63 1.02 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.614 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.41 152.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.847 2.364 . . . . 0.0 112.181 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.503 ' O ' ' O ' ' A' ' 75' ' ' THR . 97.4 mt-30 -73.74 142.79 46.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.031 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 74' ' ' GLN . 59.8 p 44.43 -178.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.208 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.663 ' OD2' HD11 ' A' ' 4' ' ' ILE . 92.9 m-20 -123.3 -26.96 4.19 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.636 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.521 HG21 ' HB1' ' A' ' 175' ' ' ALA . 6.6 t -118.34 110.67 31.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.941 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -76.13 132.19 39.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.088 0.471 . . . . 0.0 111.52 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.488 ' CD2' ' CE1' ' A' ' 56' ' ' PHE . 4.1 mp -109.1 99.64 8.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.699 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.458 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 17.4 t -65.38 134.74 29.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.734 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.453 ' HB2' ' HZ3' ' A' ' 16' ' ' LYS . 19.0 t -123.85 130.32 52.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.998 0.427 . . . . 0.0 111.093 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.546 ' HA ' HG11 ' A' ' 14' ' ' VAL . 39.0 p90 -167.87 129.17 1.44 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.347 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.509 ' HA ' ' H ' ' A' ' 115' ' ' THR . 90.1 p -56.69 134.24 54.58 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.652 HG21 ' CB ' ' A' ' 156' ' ' GLU . 6.3 t -90.38 8.2 3.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.446 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.662 HG21 ' HG2' ' A' ' 120' ' ' ARG . 11.0 p -114.26 20.39 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.943 0.402 . . . . 0.0 110.163 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 t -139.61 137.7 19.09 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.196 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.494 ' O ' ' CD1' ' A' ' 90' ' ' PHE . 61.0 Cg_endo -73.76 -27.04 12.94 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.197 1.932 . . . . 0.0 113.224 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 84.2 p -81.6 -29.38 33.32 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -62.25 -37.42 85.36 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.612 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.528 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 2.0 p90 -91.25 -36.95 13.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.884 0.373 . . . . 0.0 111.328 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.528 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 85.6 tt0 -56.56 -38.43 71.92 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.182 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.486 ' O ' ' N ' ' A' ' 96' ' ' LYS . 9.6 m120 -90.0 -47.39 7.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.211 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 11' ' ' ASP . 42.9 t -57.31 -56.09 17.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.448 ' NZ ' HD13 ' A' ' 112' ' ' LEU . 35.0 mttm -71.32 -11.44 60.91 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -125.73 -65.78 0.98 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 92' ' ' ASN . 81.1 mttt -61.17 -33.31 73.22 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.412 ' CZ2' ' HA ' ' A' ' 11' ' ' ASP . 48.5 m95 -83.2 -31.47 27.06 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.777 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.2 t -40.77 -54.28 5.36 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.977 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 33.1 Cg_endo -66.11 -32.03 44.24 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 121.667 1.578 . . . . 0.0 111.51 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -61.62 -38.52 87.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.984 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.524 HD13 HG11 ' A' ' 9' ' ' VAL . 27.0 pt -94.42 -30.7 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.515 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' CYS . 55.4 m -60.28 -41.08 92.57 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.928 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -60.62 -39.13 87.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.556 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -57.26 -44.03 83.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.014 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -150.53 159.93 33.71 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 110.876 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.48 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 9.6 Cg_endo -55.32 155.86 18.89 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.877 2.385 . . . . 0.0 111.851 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -62.93 130.05 43.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.317 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.99 158.83 54.95 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.502 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -47.47 143.91 10.92 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.166 1.911 . . . . 0.0 112.064 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.641 ' CE1' ' HB2' ' A' ' 151' ' ' ALA . 21.2 p90 -147.62 156.83 43.19 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.691 -0.804 . . . . 0.0 112.103 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.97 129.61 48.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.421 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.575 HD12 ' CD2' ' A' ' 154' ' ' TYR . 85.8 mt -84.26 132.12 34.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 120.285 -0.566 . . . . 0.0 109.498 179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.615 HG11 HD21 ' A' ' 19' ' ' LEU . 44.3 t -144.69 151.47 15.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.048 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.502 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -145.36 176.21 24.5 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.625 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.509 ' H ' ' HA ' ' A' ' 83' ' ' SER . 9.2 p -121.66 179.13 4.57 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.572 ' N ' ' CB ' ' A' ' 158' ' ' SER . 98.7 mm-40 36.44 37.36 0.06 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.049 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.845 HG23 ' H ' ' A' ' 119' ' ' LEU . 5.8 tt 29.42 -150.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.435 0 O-C-N 123.071 0.232 . . . . 0.0 110.512 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.764 ' N ' HG23 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -108.76 11.09 26.54 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.991 -179.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.845 ' H ' HG23 ' A' ' 117' ' ' ILE . 5.7 mp -139.22 12.19 2.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.981 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.662 ' HG2' HG21 ' A' ' 85' ' ' VAL . 25.4 ptt180 28.65 65.22 0.11 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.204 0.315 . . . . 0.0 110.18 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.55 ' O ' ' HB2' ' A' ' 122' ' ' ASP . 13.8 m-20 149.51 -79.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 123.762 0.664 . . . . 0.0 111.111 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 121' ' ' ASP . 0.1 OUTLIER 94.37 -67.24 0.0 OUTLIER Pre-proline 0 C--O 1.222 -0.393 0 O-C-N 125.589 1.805 . . . . 0.0 109.706 -178.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.497 ' CD ' ' O ' ' A' ' 121' ' ' ASP . 31.7 Cg_exo -57.48 -28.41 80.56 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 CA-C-N 121.32 1.507 . . . . 0.0 110.47 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.556 ' OG ' ' N ' ' A' ' 125' ' ' THR . 36.0 p -78.82 -67.69 0.72 Allowed 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.912 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.556 ' N ' ' OG ' ' A' ' 124' ' ' SER . 32.5 p -50.3 -11.57 0.07 Allowed 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.651 0.739 . . . . 0.0 109.353 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.543 ' N ' ' C ' ' A' ' 124' ' ' SER . 13.5 mt -86.76 -70.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.294 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.473 ' N ' HG22 ' A' ' 126' ' ' ILE . 86.8 mt-10 -76.9 -41.01 45.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.052 0.453 . . . . 0.0 111.107 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' SER . 21.8 tttp -64.95 -15.83 62.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.834 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.548 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 29.8 tp -155.15 -82.41 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.327 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 125' ' ' THR . . . 168.91 -102.26 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.579 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.1 pttp 174.03 2.13 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.368 0.418 . . . . 0.0 111.967 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -80.13 -39.13 30.08 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.936 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -70.35 -44.19 68.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.679 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.473 ' O ' ' C ' ' A' ' 135' ' ' LYS . 99.6 mm-40 -55.94 -37.95 69.65 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.201 -179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 134' ' ' GLN . 0.8 OUTLIER 32.99 87.95 0.1 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.74 179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.4 139.98 28.06 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.363 2.042 . . . . 0.0 111.908 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.656 HG23 ' O ' ' A' ' 137' ' ' ILE . 15.3 tt -98.83 38.4 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.897 0.38 . . . . 0.0 110.596 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.698 ' H ' ' CD ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -119.6 -41.13 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.698 ' CD ' ' H ' ' A' ' 138' ' ' THR . 73.2 Cg_exo -47.97 -64.04 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.215 1.944 . . . . 0.0 113.262 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -105.9 -44.69 4.55 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.519 HG21 ' CG1' ' A' ' 137' ' ' ILE . 44.5 m -51.85 -43.3 63.15 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.762 -178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.77 -28.01 33.48 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.912 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.25 -44.13 95.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.03 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -63.86 -41.61 97.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.37 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 87.2 mt -61.31 -31.44 71.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.268 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.31 -40.49 70.78 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.46 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -56.48 -37.06 69.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.405 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -52.74 -25.35 10.87 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.3 mt -134.73 -115.12 0.2 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.456 -1.247 . . . . 0.0 107.844 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 151' ' ' ALA . 37.9 pttt 178.42 75.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.46 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.641 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . . . -56.04 -145.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.975 0.417 . . . . 0.0 111.843 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 110' ' ' PHE . 75.1 t -136.69 -56.03 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.978 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' C ' ' CD1' ' A' ' 154' ' ' TYR . 24.6 tttt -125.46 -167.68 1.72 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.793 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.575 ' CD2' HD12 ' A' ' 112' ' ' LEU . 51.0 m-85 -156.67 96.71 1.66 Allowed 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.32 139.52 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 122.148 0.975 . . . . 0.0 111.515 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.727 ' O ' ' OG1' ' A' ' 161' ' ' THR . 10.4 pt-20 -122.36 98.0 5.72 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 113.539 -1.664 . . . . 0.0 106.613 178.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.668 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -123.94 145.75 48.94 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 123.18 1.467 . . . . 0.0 113.112 -175.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.572 ' CB ' ' N ' ' A' ' 116' ' ' GLN . 10.0 t -173.22 93.89 0.1 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 112.013 -2.358 . . . . 0.0 107.831 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 50.21 38.74 18.08 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.332 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.742 ' O ' ' N ' ' A' ' 162' ' ' GLN . 22.1 tp -165.09 -82.17 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.031 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.727 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.8 OUTLIER -52.37 55.54 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.742 ' N ' ' O ' ' A' ' 160' ' ' LEU . 2.3 pp0? -80.42 15.8 1.52 Allowed 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.605 ' H ' ' C ' ' A' ' 161' ' ' THR . 99.5 mttt -84.65 -3.44 58.51 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 113.751 -1.568 . . . . 0.0 108.426 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.616 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.45 -72.62 0.1 Allowed Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -40.61 -16.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.366 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.616 ' N ' ' O ' ' A' ' 164' ' ' GLY . 81.2 tttt -84.57 -49.53 8.5 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 164' ' ' GLY . 81.3 m-20 -78.16 4.5 12.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.371 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.29 -58.73 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.2 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.477 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 94.4 m-85 -44.41 -44.7 8.57 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.521 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -69.38 -44.41 71.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.398 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -62.99 -25.17 68.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.15 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.678 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -56.46 -35.58 68.07 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.854 HD11 ' CD1' ' A' ' 51' ' ' TYR . 91.6 mt -55.19 -43.09 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 174' ' ' LEU . 8.0 mp -70.28 -36.18 74.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.002 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -63.63 -32.97 74.6 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.393 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.59 72.76 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 1' ' ' MET . 21.2 tp -59.32 -35.25 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.684 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.687 -0.688 . . . . 99.989999999999995 110.53 179.912 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -82.61 -48.09 11.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.288 0.566 . . . . 0.0 110.062 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.436 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.6 OUTLIER -107.83 150.27 27.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.6 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.693 HD11 ' OD2' ' A' ' 76' ' ' ASP . 11.0 tp -127.36 147.25 32.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.526 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.1 mttt -86.0 135.38 33.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.872 0.368 . . . . 0.0 110.539 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.557 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -135.94 130.9 34.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.283 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.423 HG23 ' HB ' ' A' ' 75' ' ' THR . 59.2 t -103.9 134.75 44.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.765 HG11 ' OD1' ' A' ' 57' ' ' ASP . 75.1 t -114.09 125.83 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.302 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.467 HG21 ' CZ3' ' A' ' 97' ' ' TRP . 13.3 p -136.94 146.33 28.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.486 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' CZ2' ' A' ' 97' ' ' TRP . . . -117.66 -157.44 10.68 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.558 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.464 ' HA ' ' HE1' ' A' ' 97' ' ' TRP . 51.3 p30 -74.09 24.37 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.067 0.46 . . . . 0.0 110.029 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 10' ' ' GLY . . . 125.34 -77.32 0.38 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.86 94.9 2.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 110.472 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.406 HG11 ' H ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -120.04 169.56 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.389 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' OG1' ' A' ' 115' ' ' THR . . . -69.05 56.46 0.57 Allowed Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 mtmm -81.03 0.81 34.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.883 0.373 . . . . 0.0 110.255 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 42.8 p -69.16 -38.83 78.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.469 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.862 ' SG ' HG23 ' A' ' 33' ' ' VAL . 98.3 m -90.85 -14.54 31.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.136 0.494 . . . . 0.0 110.603 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.896 HD12 ' SG ' ' A' ' 157' ' ' CYS . 22.1 tp -59.8 -45.36 92.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.375 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD23 ' OD2' ' A' ' 57' ' ' ASP . 1.4 pp -74.07 -33.77 63.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 111.333 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 18' ' ' CYS . 52.6 mt -61.75 -5.72 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.346 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.492 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 43.7 t -44.82 -80.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.315 -178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -55.78 -38.33 69.77 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.535 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.592 ' O ' ' CB ' ' A' ' 25' ' ' THR . 3.7 m -44.54 -34.12 2.0 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.208 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' THR . 13.3 m 107.78 92.14 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.32 1.012 . . . . 0.0 109.839 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.634 ' ND2' ' HB2' ' A' ' 159' ' ' ALA . 27.8 t30 -110.22 -75.93 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.308 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt 57.95 43.42 21.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.246 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp 41.33 68.8 2.31 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.873 0.368 . . . . 0.0 110.248 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -80.48 157.15 22.11 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 123.014 2.476 . . . . 0.0 112.596 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 32' ' ' TYR . 20.2 m -56.91 -27.95 61.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.315 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -57.82 -2.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.265 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.539 ' H ' ' C ' ' A' ' 30' ' ' SER . 41.4 m-85 70.43 -116.01 0.1 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.145 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.862 HG23 ' SG ' ' A' ' 18' ' ' CYS . 7.1 p -125.28 79.45 66.32 Favored Pre-proline 0 C--N 1.33 -0.282 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.482 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -58.53 154.08 44.41 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.663 2.242 . . . . 0.0 111.323 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 t -130.01 147.35 51.75 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.6 t -131.01 140.18 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.948 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -95.62 134.87 38.02 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.798 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 59.32 45.21 14.29 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.213 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 55' ' ' LEU . 51.6 t-20 -97.79 124.03 41.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.346 . . . . 0.0 110.532 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.631 ' CG ' ' N ' ' A' ' 41' ' ' ALA . 17.4 p90 -165.28 -48.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.488 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.631 ' N ' ' CG ' ' A' ' 40' ' ' TYR . . . -77.99 104.36 8.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.635 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.75 126.2 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.324 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 43' ' ' THR . 12.6 t -82.6 127.38 33.3 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.259 0.552 . . . . 0.0 111.583 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -138.05 142.42 35.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.553 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.5 ptp -143.71 140.59 30.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.049 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.611 ' O ' ' N ' ' A' ' 48' ' ' GLY . 42.7 mm -119.81 102.85 13.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.238 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.517 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 20.98 43.57 0.01 OUTLIER Glycine 0 CA--C 1.525 0.719 0 O-C-N 123.784 0.678 . . . . 0.0 111.844 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -151.12 -76.64 0.02 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' OE1' ' OH ' ' A' ' 51' ' ' TYR . 6.5 mt-10 -153.8 161.83 28.23 Favored Pre-proline 0 C--O 1.235 0.292 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.367 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -84.45 139.26 7.84 Favored 'Trans proline' 0 C--N 1.313 -1.289 0 C-N-CA 122.806 2.337 . . . . 0.0 113.197 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.561 ' HB2' HG21 ' A' ' 173' ' ' ILE . 42.4 m-85 -152.36 159.85 43.38 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.436 ' H ' ' HB ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -135.45 140.39 44.83 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.746 -179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.649 HD21 ' CD2' ' A' ' 169' ' ' PHE . 0.4 OUTLIER -109.86 139.18 45.22 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.557 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -92.75 120.13 6.07 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.937 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.529 ' H ' ' CA ' ' A' ' 40' ' ' TYR . 57.9 mt -114.87 124.92 52.95 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 57' ' ' ASP . 25.3 t80 -115.48 34.44 4.91 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.765 ' OD1' HG11 ' A' ' 8' ' ' VAL . 72.2 m-20 -45.75 -177.09 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.147 0.499 . . . . 0.0 111.496 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.677 HG23 ' C ' ' A' ' 57' ' ' ASP . 1.7 p 76.59 147.98 0.1 Allowed 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.936 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 64' ' ' TYR . . . 58.05 -173.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.118 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 148.36 -3.35 0.75 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.475 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 47.8 tt0 -179.33 76.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.581 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 149.93 -121.3 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 63' ' ' ASP . 52.6 p30 -70.18 57.51 0.16 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 62' ' ' GLU . 88.2 m-85 -35.98 -45.64 0.43 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.283 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.508 ' OD1' ' O ' ' A' ' 67' ' ' LEU . 52.9 p30 -171.22 166.8 7.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.507 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -58.7 -31.91 68.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.807 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.508 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 69.9 mt -79.43 148.08 32.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.628 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 157.07 82.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.667 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.18 -11.74 20.23 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.85 2.366 . . . . 0.0 112.115 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 41.6 tp -53.47 -35.91 61.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.939 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.6 p -62.11 155.69 23.56 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.181 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -131.97 78.07 70.41 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.037 0.446 . . . . 0.0 111.021 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -55.31 142.64 78.81 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 122.561 2.174 . . . . 0.0 111.471 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -108.72 133.93 52.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.747 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.423 ' HB ' HG23 ' A' ' 7' ' ' VAL . 6.2 t -135.98 153.42 51.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.977 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.693 ' OD2' HD11 ' A' ' 4' ' ' ILE . 85.5 m-20 -117.72 -19.28 9.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.47 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.437 HG12 HD13 ' A' ' 111' ' ' LEU . 23.0 t -127.2 114.56 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.556 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.15 126.0 34.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.293 0.568 . . . . 0.0 112.182 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 80' ' ' VAL . 6.8 tt -124.59 126.41 45.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.799 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.655 ' N ' HD23 ' A' ' 79' ' ' LEU . 22.7 t -117.67 136.45 54.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.863 ' SG ' HD22 ' A' ' 19' ' ' LEU . 17.7 t -130.62 129.64 42.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.364 0.602 . . . . 0.0 111.906 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.906 ' CD1' HG11 ' A' ' 93' ' ' VAL . 42.3 p90 -139.15 154.14 48.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.028 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.406 ' H ' HG11 ' A' ' 14' ' ' VAL . 32.0 t -67.98 134.0 49.99 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.204 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.792 ' O ' HG12 ' A' ' 84' ' ' VAL . 48.5 t -96.26 26.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 119.991 -0.683 . . . . 0.0 111.719 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 85' ' ' VAL . 62.9 t -122.58 12.87 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 0.0 110.953 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.2 m -137.34 145.32 49.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.009 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.436 ' O ' ' CE1' ' A' ' 90' ' ' PHE . 60.4 Cg_endo -73.75 -20.79 19.64 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.26 1.973 . . . . 0.0 112.76 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.8 m -91.52 -25.22 19.36 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.916 -0.313 . . . . 0.0 111.771 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.3 m -64.03 -40.97 97.52 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.876 -0.329 . . . . 0.0 111.712 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.436 ' CE1' ' O ' ' A' ' 87' ' ' PRO . 2.7 p90 -85.13 -29.36 24.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.097 0.475 . . . . 0.0 110.808 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -57.94 -28.14 64.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.587 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.435 ' O ' ' C ' ' A' ' 93' ' ' VAL . 11.0 m120 -87.53 -70.17 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.906 HG11 ' CD1' ' A' ' 82' ' ' PHE . 0.5 OUTLIER -31.95 -64.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.351 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.688 ' H ' HG13 ' A' ' 93' ' ' VAL . 16.0 mttp -64.49 -33.27 75.5 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -177.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 88.7 mt-10 -107.73 -63.59 1.29 Allowed 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp -62.02 -38.93 90.53 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.573 ' CZ2' ' O ' ' A' ' 10' ' ' GLY . 74.1 m95 -77.0 -30.58 55.98 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.376 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.469 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.4 t -45.72 -55.33 12.82 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 19.4 Cg_endo -60.03 -36.94 87.82 Favored 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 121.733 1.622 . . . . 0.0 111.717 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.486 ' OE1' ' CE3' ' A' ' 97' ' ' TRP . 85.2 tt0 -59.59 -44.29 93.41 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.724 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 84.4 mt -76.38 -31.37 20.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.204 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 105' ' ' CYS . 37.1 m -52.85 -37.63 60.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.999 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -49.58 -40.07 37.29 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.21 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.533 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 80.5 m80 -78.6 -20.54 50.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.052 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.533 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 6.8 p 39.13 58.6 6.01 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.791 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.79 133.36 12.6 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.794 2.329 . . . . 0.0 112.145 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -89.5 -1.13 57.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.957 0.408 . . . . 0.0 110.167 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.82 155.79 84.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.744 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.96 150.04 58.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.761 2.307 . . . . 0.0 111.98 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.729 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -129.65 131.15 46.33 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.688 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.3 mp -93.96 130.54 40.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.117 0.484 . . . . 0.0 111.877 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.464 HD13 ' CD2' ' A' ' 149' ' ' LEU . 50.4 tp -102.11 130.4 48.7 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.46 179.32 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.073 -0.651 . . . . 0.0 111.529 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.586 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -149.04 178.9 26.28 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 15' ' ' GLY . 13.0 t -128.27 163.74 24.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.811 0.339 . . . . 0.0 110.298 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.602 ' N ' ' OG ' ' A' ' 158' ' ' SER . 96.9 mt-30 56.49 18.19 3.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.272 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.744 HG13 ' H ' ' A' ' 119' ' ' LEU . 15.7 pt 33.94 -150.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.363 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 118' ' ' ASP . 50.9 p30 -118.32 17.28 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.403 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.744 ' H ' HG13 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -144.72 -36.14 0.32 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.245 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.737 ' H ' ' CG1' ' A' ' 117' ' ' ILE . 65.3 ttp85 -56.19 -48.96 75.34 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.812 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.596 ' HB2' HG21 ' A' ' 85' ' ' VAL . 10.9 t0 -43.64 -17.77 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.595 ' N ' ' O ' ' A' ' 120' ' ' ARG . 5.3 m-20 13.38 -76.82 0.0 OUTLIER Pre-proline 0 C--O 1.222 -0.345 0 O-C-N 124.257 0.973 . . . . 0.0 112.395 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.573 ' N ' ' O ' ' A' ' 121' ' ' ASP . 78.4 Cg_exo -33.83 -30.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.219 0 CA-C-N 120.224 1.116 . . . . 0.0 111.589 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 122' ' ' ASP . 14.7 m -100.5 -33.38 10.36 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.8 t -100.58 -23.3 14.71 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.218 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.776 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 6.4 tt -82.49 -36.8 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.572 -0.451 . . . . 0.0 109.856 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -76.26 -35.85 58.75 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-O 120.727 0.299 . . . . 0.0 111.09 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.02 -65.79 0.94 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.406 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.562 ' CD2' ' NE2' ' A' ' 134' ' ' GLN . 39.4 mt -78.0 46.03 0.56 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.886 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -82.37 51.46 1.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.994 0.426 . . . . 0.0 110.066 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.6 mttp 63.87 72.39 0.47 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.389 0.614 . . . . 0.0 110.004 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -118.38 46.06 1.89 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.999 -1.001 . . . . 0.0 108.961 179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 77.7 mttt 63.44 37.26 10.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.0 -178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.562 ' NE2' ' CD2' ' A' ' 129' ' ' LEU . 21.3 pt20 -158.82 162.78 37.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.232 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.71 155.35 80.51 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.002 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -49.91 173.88 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.426 2.084 . . . . 0.0 112.084 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.478 ' O ' HG13 ' A' ' 84' ' ' VAL . 82.6 mt -91.43 78.4 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.852 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 0.1 OUTLIER -129.98 -48.19 0.03 OUTLIER Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.646 ' CD ' ' H ' ' A' ' 138' ' ' THR . 59.7 Cg_endo -87.66 -67.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.416 2.078 . . . . 0.0 114.598 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 139' ' ' PRO . 77.7 mm-40 -31.55 -72.88 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 44.2 p -116.79 4.38 12.99 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.852 ' HB3' ' O ' ' A' ' 138' ' ' THR . . . -94.2 -65.2 1.0 Allowed 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.512 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' THR . 84.2 tt0 -69.79 -41.49 75.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.219 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -66.68 -38.16 86.23 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.832 0.349 . . . . 0.0 111.462 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 145' ' ' LEU . 23.3 tp -74.73 -19.97 60.02 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.582 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -69.14 -36.71 77.74 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.178 0.513 . . . . 0.0 110.833 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -58.83 -41.16 86.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.236 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -89.96 -27.06 20.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.663 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 54.3 tp -44.52 -25.98 0.31 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 119.143 -0.456 . . . . 0.0 112.113 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.604 ' O ' ' CE1' ' A' ' 110' ' ' PHE . 55.5 mttp 91.54 -0.93 0.17 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.898 0.479 . . . . 0.0 110.407 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -59.04 -136.28 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.327 0.584 . . . . 0.0 111.789 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 110' ' ' PHE . 0.4 OUTLIER -159.92 -36.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.278 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -110.31 -179.07 3.67 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.623 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 34.7 p90 -169.82 97.43 0.3 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.798 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.467 ' O ' ' CD ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -161.15 171.94 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.98 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.733 ' O ' ' OG1' ' A' ' 161' ' ' THR . 20.1 mm-40 -138.81 96.51 3.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.896 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -107.02 147.75 29.55 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 123.17 1.462 . . . . 0.0 112.51 -177.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.602 ' OG ' ' N ' ' A' ' 116' ' ' GLN . 0.3 OUTLIER -169.85 91.72 0.21 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 111.555 -2.566 . . . . 0.0 106.236 177.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.634 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . . . 43.35 21.59 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.221 -1.809 . . . . 0.0 109.503 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.78 ' O ' ' N ' ' A' ' 162' ' ' GLN . 0.5 OUTLIER -133.73 -84.05 0.45 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.585 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.733 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 1.2 m -53.66 46.86 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.725 0.641 . . . . 0.0 111.814 -177.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.78 ' N ' ' O ' ' A' ' 160' ' ' LEU . 7.2 tt0 -80.44 9.39 5.98 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 175.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.594 ' H ' ' C ' ' A' ' 161' ' ' THR . 16.1 tttp -84.6 -5.41 59.3 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 112.781 -2.009 . . . . 0.0 108.435 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.671 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -129.9 -72.0 0.12 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 107.811 -2.115 . . . . 0.0 107.811 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 165' ' ' LEU . 4.3 mm? -38.75 -15.99 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.245 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.671 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.9 tttt -84.14 -47.68 10.63 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 164' ' ' GLY . 18.6 p-10 -79.41 4.99 13.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.028 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 171' ' ' GLU . 24.4 t -84.1 -52.65 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.892 178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.649 ' CD2' HD21 ' A' ' 53' ' ' LEU . 4.4 m-85 -37.65 -48.17 1.02 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.501 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.418 ' O ' ' CG1' ' A' ' 173' ' ' ILE . 53.3 t0 -62.84 -37.52 87.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.85 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 168' ' ' VAL . 77.5 mm-40 -77.3 -30.07 54.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.196 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.42 -40.01 89.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.955 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.561 HG21 ' HB2' ' A' ' 51' ' ' TYR . 21.1 pt -67.41 -29.73 46.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.67 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.69 -36.73 77.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.04 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.96 -21.28 66.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 173' ' ' ILE . . . -65.01 -32.54 74.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.609 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 41.8 tp -56.97 -36.05 69.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.405 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 99.989999999999995 110.559 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.584 ' O ' ' HB2' ' A' ' 176' ' ' ALA . 94.6 mt-30 42.28 -119.79 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.669 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -41.2 115.66 0.64 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.233 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 176' ' ' ALA . 18.3 tt -122.97 146.46 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.957 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 74' ' ' GLN . 30.6 mttm -104.47 163.29 12.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.853 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.4 136.98 26.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.518 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.531 HG23 ' HB ' ' A' ' 75' ' ' THR . 57.4 t -77.48 131.22 35.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 79' ' ' LEU . 57.3 t -117.8 125.88 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.793 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 101' ' ' ILE . 21.9 m -135.64 159.77 39.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.797 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.69 -177.09 36.24 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.273 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB2' HG23 ' A' ' 93' ' ' VAL . 25.2 t70 -81.05 124.94 29.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.684 0.278 . . . . 0.0 110.463 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 36.03 39.56 0.31 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 55.2 124.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 110.88 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.629 HG23 ' SG ' ' A' ' 81' ' ' CYS . 1.4 m -120.91 -168.33 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.889 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.58 49.64 0.01 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 121.428 -0.415 . . . . 0.0 112.408 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.617 ' N ' ' O ' ' A' ' 14' ' ' VAL . 23.2 pttt -57.4 -39.69 76.67 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.455 ' N ' ' CG ' ' A' ' 16' ' ' LYS . 54.1 p -65.49 -43.87 88.85 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.1 m -53.9 -24.63 16.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.1 0.476 . . . . 0.0 111.026 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.57 -39.04 70.87 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.222 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 42' ' ' VAL . 36.6 tp -63.29 -38.74 92.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.046 -178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 28.3 pt -87.5 5.23 3.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.788 ' CB ' HD13 ' A' ' 165' ' ' LEU . 38.7 t -59.06 -75.5 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.695 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -67.18 -39.52 86.41 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.957 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -49.27 -45.7 45.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.992 -179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.2 t 179.42 75.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.624 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.591 ' ND2' ' OE1' ' A' ' 162' ' ' GLN . 2.3 p30 -60.15 113.52 2.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.224 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 28' ' ' LEU . 85.5 mttt -150.86 50.03 0.86 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.295 -179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.632 HD12 HD21 ' A' ' 160' ' ' LEU . 3.9 mp 57.68 129.36 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.658 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 159' ' ' ALA . 73.6 Cg_endo -76.42 156.94 36.92 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.15 1.9 . . . . 0.0 111.905 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.9 m -117.07 146.96 42.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.328 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -56.51 -34.94 67.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.165 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -64.66 -33.51 76.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.544 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.7 t 48.18 69.54 2.63 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.431 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.494 ' O ' ' O ' ' A' ' 35' ' ' THR . 51.3 Cg_exo -50.56 -14.69 1.23 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.927 2.418 . . . . 0.0 112.16 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 50.03 171.94 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.702 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 38' ' ' ASP . 22.5 t -121.0 142.43 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.29 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -49.07 -30.11 5.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.093 0.473 . . . . 0.0 109.802 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.548 ' H ' HG12 ' A' ' 36' ' ' VAL . 90.0 m-20 -58.73 160.11 6.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.438 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.594 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 81.6 m-20 -133.21 -8.06 2.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.954 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER 163.85 28.45 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.929 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.77 108.06 5.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.935 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.615 HG21 HD11 ' A' ' 20' ' ' LEU . 22.8 t -130.0 130.18 66.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.793 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -114.31 106.22 14.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.958 0.409 . . . . 0.0 111.425 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.46 154.81 37.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.074 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.22 133.93 55.37 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.478 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.543 HG21 ' HB2' ' A' ' 170' ' ' ASP . 13.5 tt -129.65 126.89 63.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.523 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 59.18 25.93 60.66 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.32 50.05 7.79 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -130.43 79.03 73.17 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.741 0.305 . . . . 0.0 110.361 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.58 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 26.9 Cg_exo -58.77 108.87 0.44 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.883 2.389 . . . . 0.0 112.437 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 50' ' ' PRO . 64.3 m-85 -160.33 174.53 14.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.27 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 p -133.55 142.01 47.98 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.676 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.665 HD13 ' CB ' ' A' ' 172' ' ' ALA . 66.5 tp -116.22 126.73 54.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.717 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.09 134.43 11.68 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.277 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.532 ' HG ' ' H ' ' A' ' 57' ' ' ASP . 11.6 tp -113.79 119.89 38.9 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.708 ' O ' ' O ' ' A' ' 57' ' ' ASP . 63.2 t80 -91.26 8.83 33.97 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.708 ' O ' ' O ' ' A' ' 56' ' ' PHE . 36.2 p30 30.47 177.26 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.468 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 82.4 p -88.57 156.61 18.97 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 121.612 -0.68 . . . . 0.0 110.77 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.459 ' C ' ' H ' ' A' ' 61' ' ' GLN . . . -132.61 20.12 4.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.33 -1.67 2.49 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 59' ' ' ALA . 95.6 mt-30 -141.72 -172.18 3.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.027 0.442 . . . . 0.0 111.103 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 77.2 mm-40 43.5 55.16 5.03 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 18.9 t0 84.84 103.09 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -177.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -56.5 164.05 1.55 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.354 -0.538 . . . . 0.0 110.303 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -82.25 115.78 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.893 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.3 mtt85 -108.29 -1.68 19.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.586 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.404 ' C ' ' CG ' ' A' ' 68' ' ' ARG . 51.9 mt -103.25 137.43 41.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.638 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.756 ' H ' ' CD ' ' A' ' 69' ' ' PRO . 3.2 mtt180 -152.61 -43.2 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.737 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.756 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 17.0 Cg_exo -65.2 -19.86 62.66 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.37 2.047 . . . . 0.0 112.517 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 71' ' ' SER . 0.3 OUTLIER -95.18 120.3 35.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.843 0.354 . . . . 0.0 110.256 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.67 ' N ' HD13 ' A' ' 70' ' ' LEU . 79.5 p -150.86 163.58 38.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.525 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -127.53 159.78 63.99 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.269 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' O ' ' CG ' ' A' ' 76' ' ' ASP . 11.6 Cg_endo -57.69 -26.57 73.56 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.766 2.311 . . . . 0.0 112.088 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.403 ' O ' ' N ' ' A' ' 5' ' ' LYS . 96.8 mt-30 -61.42 -29.18 69.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.475 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.531 ' HB ' HG23 ' A' ' 7' ' ' VAL . 48.2 p -98.12 66.93 1.86 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.461 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.439 ' CG ' ' O ' ' A' ' 73' ' ' PRO . 88.8 m-20 -101.97 0.87 35.94 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.519 ' CG1' HD13 ' A' ' 111' ' ' LEU . 45.5 t -125.28 110.66 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.274 -0.571 . . . . 0.0 111.408 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -70.81 134.81 47.67 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.228 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.596 ' HB3' HG22 ' A' ' 8' ' ' VAL . 8.3 tt -119.0 126.96 52.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.699 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 112' ' ' LEU . 24.7 t -97.01 132.77 40.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.086 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.629 ' SG ' HG23 ' A' ' 14' ' ' VAL . 42.5 t -128.59 118.82 23.63 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.323 0.583 . . . . 0.0 111.675 -179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 115' ' ' THR . 28.3 p90 -149.43 157.53 43.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.181 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.0 t -70.72 132.32 45.19 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.294 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.506 ' O ' HG12 ' A' ' 84' ' ' VAL . 50.4 t -56.17 -9.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.306 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.773 HG21 ' OG1' ' A' ' 125' ' ' THR . 27.1 m -127.18 169.47 18.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.873 0.368 . . . . 0.0 110.508 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.646 ' O ' ' N ' ' A' ' 88' ' ' SER . 0.5 OUTLIER -25.38 -68.16 0.07 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.826 -178.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.563 ' O ' ' CB ' ' A' ' 88' ' ' SER . 99.1 Cg_exo -28.09 74.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 123.841 3.027 . . . . 0.0 114.465 -178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 86' ' ' SER . 2.9 t 146.26 -11.46 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 O-C-N 123.624 0.577 . . . . 0.0 109.983 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 91' ' ' GLU . 0.7 OUTLIER 40.24 89.54 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 89' ' ' SER . 43.7 p90 -36.01 -26.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.824 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.595 ' N ' ' O ' ' A' ' 89' ' ' SER . 97.2 mt-10 -62.05 -23.81 66.7 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.664 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.559 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 83.1 m-20 -80.23 -48.45 13.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.564 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.494 HG23 ' HB2' ' A' ' 11' ' ' ASP . 56.0 t -77.63 -68.68 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.58 ' HE2' HD11 ' A' ' 112' ' ' LEU . 87.9 mttt -61.56 -15.1 35.61 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -177.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 78.1 mm-40 -129.06 -48.37 1.22 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -77.78 -35.69 51.31 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 69.1 m95 -99.13 -21.04 16.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.854 -0.738 . . . . 0.0 112.339 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -59.84 -41.79 87.45 Favored Pre-proline 0 C--N 1.333 -0.135 0 C-N-CA 120.119 -0.633 . . . . 0.0 109.955 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 4.1 Cg_exo -70.62 -38.42 5.93 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.703 2.269 . . . . 0.0 111.15 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.579 ' OE2' ' NH1' ' A' ' 68' ' ' ARG . 48.1 tp10 -59.08 -39.03 80.87 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.63 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.499 HG21 HG21 ' A' ' 9' ' ' VAL . 34.3 pt -85.01 -34.12 8.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.876 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 105' ' ' CYS . 76.2 m -60.22 -36.83 78.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.019 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.588 ' ND1' ' O ' ' A' ' 99' ' ' PRO . 37.7 m80 -50.5 -32.69 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.222 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 68' ' ' ARG . 55.8 t-80 -55.7 -45.57 77.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.411 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -143.55 160.7 50.12 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 110.984 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.479 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 8.0 Cg_endo -52.79 163.57 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.938 2.425 . . . . 0.0 111.935 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -64.86 131.47 46.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.861 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.85 161.21 33.51 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.158 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -46.38 146.15 5.22 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.261 1.974 . . . . 0.0 111.844 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.546 ' O ' ' N ' ' A' ' 152' ' ' VAL . 19.1 p90 -147.26 156.89 43.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.744 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.519 HD13 ' CG1' ' A' ' 77' ' ' VAL . 8.0 mp -97.32 125.67 42.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.665 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.58 HD11 ' HE2' ' A' ' 94' ' ' LYS . 16.1 tp -96.21 122.61 39.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.469 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.3 t -130.24 150.57 34.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.053 0.454 . . . . 0.0 111.747 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.5 156.87 17.11 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 82' ' ' PHE . 0.9 OUTLIER -119.22 167.58 11.71 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.563 0.697 . . . . 0.0 111.978 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.603 ' O ' ' O ' ' A' ' 117' ' ' ILE . 97.0 mm-40 50.75 24.45 1.73 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.777 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.838 HG23 ' H ' ' A' ' 119' ' ' LEU . 4.8 tt 30.62 -156.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.79 ' N ' HG23 ' A' ' 117' ' ' ILE . 53.0 p30 -120.81 29.27 7.48 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.838 ' H ' HG23 ' A' ' 117' ' ' ILE . 34.9 tp -137.31 -38.65 0.61 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.069 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.559 ' H ' HG22 ' A' ' 117' ' ' ILE . 6.9 tpm_? -59.29 -63.56 1.26 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.574 ' O ' ' N ' ' A' ' 123' ' ' PRO . 72.3 m-20 -48.34 -32.69 7.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.343 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.53 ' C ' ' O ' ' A' ' 121' ' ' ASP . 2.0 t0 7.08 -72.26 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 123.807 0.692 . . . . 0.0 112.675 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.574 ' N ' ' O ' ' A' ' 121' ' ' ASP . 52.2 Cg_exo -35.04 -39.43 0.2 Allowed 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.069 1.18 . . . . 0.0 111.484 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.2 p -115.88 -0.12 12.94 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.565 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.773 ' OG1' HG21 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -107.83 -29.6 8.98 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.101 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -108.16 -18.74 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.07 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -107.98 -32.69 7.46 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.752 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 129' ' ' LEU . 82.1 tttt -66.63 -42.61 86.5 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 118.954 0.797 . . . . 0.0 111.094 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.683 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 10.8 mp -41.24 -74.33 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.719 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.683 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . 94.7 12.58 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.576 ' O ' ' N ' ' A' ' 134' ' ' GLN . 76.2 mttt -141.52 81.22 1.76 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.107 -0.952 . . . . 0.0 110.352 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -46.54 -29.79 1.95 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.414 ' N ' ' C ' ' A' ' 131' ' ' LYS . 57.5 tttp -58.42 -36.45 73.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.666 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 131' ' ' LYS . 85.6 mm-40 -63.18 153.19 35.23 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.066 0.46 . . . . 0.0 111.294 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.652 ' H ' ' CD ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -126.37 162.06 48.66 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.117 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.65 157.16 12.93 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.725 2.284 . . . . 0.0 112.326 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.533 ' O ' ' CG1' ' A' ' 137' ' ' ILE . 1.3 tt -104.92 46.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.209 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.593 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -131.15 -65.66 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.593 ' HD2' ' H ' ' A' ' 138' ' ' THR . 84.3 Cg_exo -23.92 -69.59 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.758 2.972 . . . . 0.0 114.489 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -113.37 -37.8 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 62.6 m -52.57 -40.22 62.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.732 -178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.423 ' CB ' ' HZ3' ' A' ' 94' ' ' LYS . . . -72.75 -28.87 62.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.672 0.272 . . . . 0.0 111.506 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.24 -38.24 88.47 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -63.35 -46.19 87.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.909 0.385 . . . . 0.0 110.897 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 65.3 mt -54.29 -33.47 58.78 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.051 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.84 -35.77 81.73 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.064 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -60.42 -41.58 94.26 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.667 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -51.65 -31.98 27.69 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.4 mt -131.23 -115.58 0.23 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.459 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.701 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 63.5 mttm -134.96 -142.03 0.18 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.219 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 150.88 177.98 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.386 0.429 . . . . 0.0 111.059 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 110' ' ' PHE . 94.0 t -145.66 -59.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.567 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 154' ' ' TYR . 16.4 mmtt -100.81 170.56 8.24 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.505 ' CG ' ' C ' ' A' ' 153' ' ' LYS . 0.1 OUTLIER -173.2 97.36 0.12 Allowed 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.321 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.899 HG22 ' H ' ' A' ' 156' ' ' GLU . 2.7 p -170.42 -167.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.165 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.899 ' H ' HG22 ' A' ' 155' ' ' VAL . 96.1 mt-10 -106.88 166.56 10.5 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.578 ' HB2' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -178.29 119.91 0.09 Allowed 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 178.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.602 ' O ' ' N ' ' A' ' 160' ' ' LEU . 16.4 t -156.77 94.77 1.48 Allowed 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.508 -1.678 . . . . 0.0 107.022 176.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.566 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . 35.12 28.57 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.565 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.768 ' O ' ' N ' ' A' ' 162' ' ' GLN . 41.9 mt -142.8 -78.89 0.23 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.238 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.705 ' C ' ' H ' ' A' ' 163' ' ' LYS . 3.6 m -44.09 59.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.768 ' N ' ' O ' ' A' ' 160' ' ' LEU . 11.8 pt20 -72.07 10.25 0.78 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.705 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.1 tttm -62.14 -27.03 68.65 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.062 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.679 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -125.12 -63.62 0.18 Allowed Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.788 HD13 ' CB ' ' A' ' 22' ' ' SER . 4.1 mt -39.19 -13.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.416 -0.513 . . . . 0.0 112.181 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.679 ' N ' ' O ' ' A' ' 164' ' ' GLY . 43.4 tttm -81.29 -46.55 14.59 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 176.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.594 ' N ' ' O ' ' A' ' 164' ' ' GLY . 2.7 m120 -83.33 6.56 19.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.102 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 165' ' ' LEU . 54.8 t -86.41 -57.9 3.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.376 178.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.659 ' HA ' HD22 ' A' ' 53' ' ' LEU . 27.2 m-85 -45.84 -45.78 15.18 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.247 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.543 ' HB2' HG21 ' A' ' 46' ' ' ILE . 55.8 t0 -69.69 -45.16 68.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.481 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.0 -25.41 64.5 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.665 ' CB ' HD13 ' A' ' 53' ' ' LEU . . . -61.97 -36.11 80.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.348 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 8.5 mm -60.75 -37.03 75.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 36.9 tp -58.46 -35.87 72.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.879 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.475 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -63.88 -24.25 67.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.073 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -61.04 -36.25 79.08 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.695 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.3 mt -59.42 -32.98 70.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.411 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 99.989999999999995 110.641 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttm . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.452 ' O ' ' CB ' ' A' ' 176' ' ' ALA . 58.8 tp60 -56.23 -38.82 71.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.055 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.426 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.7 OUTLIER -49.76 132.41 22.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.105 179.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.677 HD11 ' OD2' ' A' ' 76' ' ' ASP . 3.9 tp -126.13 145.91 32.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.937 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -91.28 142.18 27.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.732 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -138.61 130.69 28.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.621 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.422 HG13 ' CB ' ' A' ' 56' ' ' PHE . 44.0 t -98.24 135.28 33.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.754 HG22 ' HB3' ' A' ' 79' ' ' LEU . 62.6 t -99.03 131.53 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.979 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -130.0 136.23 59.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.063 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.566 ' CA ' HG23 ' A' ' 58' ' ' THR . . . -148.94 -173.72 19.9 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 13' ' ' ALA . 54.6 t0 -80.3 118.3 21.83 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 29.87 -87.68 0.01 OUTLIER Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.591 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . -133.12 150.0 52.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 0.0 110.522 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.914 HG23 ' H ' ' A' ' 15' ' ' GLY . 8.5 m -153.7 -96.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.835 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.914 ' H ' HG23 ' A' ' 14' ' ' VAL . . . -137.76 19.52 3.32 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.037 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -39.13 -36.31 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.187 0.494 . . . . 0.0 111.832 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.0 p -65.31 -46.87 78.63 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.808 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.0 m -79.45 -35.87 39.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.05 0.453 . . . . 0.0 110.797 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.725 HD12 ' SG ' ' A' ' 157' ' ' CYS . 12.7 tp -58.32 -40.35 81.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.496 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.17 -37.81 78.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 0.0 110.368 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 21' ' ' ILE . 93.8 mt -70.19 -1.73 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.726 ' CB ' HD12 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -29.36 -77.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.634 -178.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.539 ' CE2' HG11 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -98.27 -12.33 21.69 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.546 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 m -48.61 -49.2 37.99 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.28 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.496 ' OG1' HD12 ' A' ' 28' ' ' LEU . 73.2 p -133.9 -16.01 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.532 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.585 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER 70.86 111.51 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.564 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 57.09 136.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.658 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.685 HD23 ' HD2' ' A' ' 29' ' ' PRO . 0.6 OUTLIER 177.56 113.21 0.15 Allowed Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.245 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.685 ' HD2' HD23 ' A' ' 28' ' ' LEU . 66.6 Cg_exo -46.51 149.18 2.96 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.981 1.787 . . . . 0.0 112.316 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.8 t -58.27 -18.55 27.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.952 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.65 -34.13 57.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.859 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -119.69 126.8 51.98 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.845 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.84 157.38 38.16 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.367 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.53 66.07 3.74 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.673 2.249 . . . . 0.0 111.915 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 44.3 p -76.47 -15.95 59.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.229 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.0 -44.62 95.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.837 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -175.26 124.8 0.24 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 0.0 110.685 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -73.66 144.33 45.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.755 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -111.46 168.63 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.004 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 40' ' ' TYR . 26.3 p90 -155.85 35.43 0.35 Allowed 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -171.27 97.32 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.285 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.521 ' O ' ' OG1' ' A' ' 52' ' ' THR . 21.8 t -129.92 132.83 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.36 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 t -103.0 133.78 47.54 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.12 0.486 . . . . 0.0 111.219 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.539 HG11 ' CE2' ' A' ' 23' ' ' TYR . 19.1 m -132.44 156.48 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.951 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -113.37 123.93 51.27 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.985 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 48' ' ' GLY . 9.2 tp -134.6 137.63 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.103 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 34.09 28.29 0.01 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 82.53 47.03 6.16 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -128.22 83.6 65.64 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-O 120.872 0.368 . . . . 0.0 110.166 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' CD1' ' A' ' 51' ' ' TYR . 59.2 Cg_endo -78.84 99.88 1.31 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.45 2.1 . . . . 0.0 112.674 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' A' ' 50' ' ' PRO . 62.4 m-85 -156.36 177.85 10.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.491 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.521 ' OG1' ' O ' ' A' ' 42' ' ' VAL . 9.2 t -139.96 150.04 44.02 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.901 HD22 ' CB ' ' A' ' 172' ' ' ALA . 19.9 tp -118.11 128.39 54.69 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.327 -0.851 . . . . 0.0 108.86 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -86.31 138.02 15.52 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.813 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.547 ' O ' ' CB ' ' A' ' 40' ' ' TYR . 81.2 mt -124.38 126.7 46.4 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.626 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.613 ' O ' ' O ' ' A' ' 57' ' ' ASP . 45.4 t80 -108.5 35.4 3.2 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.961 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.613 ' O ' ' O ' ' A' ' 56' ' ' PHE . 90.6 m-20 36.79 178.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 178.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.566 HG23 ' CA ' ' A' ' 10' ' ' GLY . 98.4 m -64.77 132.08 48.59 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.606 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.84 149.04 33.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.643 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.84 157.69 7.28 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 43.28 -120.37 0.63 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.716 0.293 . . . . 0.0 110.433 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' C ' ' H ' ' A' ' 64' ' ' TYR . 78.4 mm-40 45.69 85.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' OD2' ' OD2' ' A' ' 65' ' ' ASP . 36.6 t0 63.69 -4.5 0.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.958 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.584 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 65.3 t80 52.72 14.97 0.47 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.561 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.497 ' OD2' ' OD2' ' A' ' 63' ' ' ASP . 86.0 m-20 -65.16 155.12 35.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.533 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.437 HH21 ' H ' ' A' ' 70' ' ' LEU . 73.5 mtp180 53.75 96.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.0 tp -59.25 -37.57 77.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.332 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.5 mtm-85 -139.9 155.94 70.83 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.566 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.92 152.1 83.46 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.734 2.289 . . . . 0.0 112.28 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.437 ' H ' HH21 ' A' ' 66' ' ' ARG . 90.6 mt -58.3 -32.66 68.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.576 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 73.65 -8.4 1.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.676 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.602 ' N ' ' CD ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -58.46 -41.92 91.8 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.673 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 72' ' ' TYR . 24.5 Cg_exo -60.42 147.87 92.57 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.452 2.101 . . . . 0.0 111.868 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -94.34 121.49 35.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.5 HG21 ' CZ ' ' A' ' 78' ' ' PHE . 5.8 t -141.72 155.98 45.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.459 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.677 ' OD2' HD11 ' A' ' 4' ' ' ILE . 91.2 m-20 -122.76 -33.07 3.44 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.09 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.91 152.56 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.417 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.5 ' CZ ' HG21 ' A' ' 75' ' ' THR . 21.0 m-85 -120.83 160.53 23.22 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.754 ' HB3' HG22 ' A' ' 8' ' ' VAL . 7.9 tt -119.15 123.25 43.93 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.731 -0.387 . . . . 0.0 110.246 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.9 m -102.27 133.49 45.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.607 ' SG ' ' CG1' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -134.07 134.82 42.78 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.261 0.553 . . . . 0.0 111.516 -179.376 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 115' ' ' THR . 39.3 p90 -142.83 153.84 43.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.873 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.1 p -95.63 134.74 38.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.928 HG13 ' H ' ' A' ' 85' ' ' VAL . 5.4 p -49.23 -68.23 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.416 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.928 ' H ' HG13 ' A' ' 84' ' ' VAL . 7.6 p -56.17 83.99 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.533 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.0 OUTLIER 157.84 80.76 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.472 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -56.39 -36.13 96.94 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.506 2.137 . . . . 0.0 112.061 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.2 m -57.65 -38.02 74.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.192 -179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.3 p -71.21 -34.26 70.67 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.509 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -70.48 -43.79 69.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.817 0.341 . . . . 0.0 111.41 -179.315 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 96.8 mt-10 -61.48 -34.09 74.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.595 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 96' ' ' LYS . 28.0 m120 -89.75 -63.33 1.3 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.983 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.2 t -36.04 -62.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.255 -177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -70.44 -19.47 62.97 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.542 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 82.6 tt0 -124.87 -55.7 1.59 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 92' ' ' ASN . 19.3 tttt -74.99 -16.3 60.63 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -96.31 -50.32 4.83 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.551 -0.86 . . . . 0.0 112.123 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.47 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -43.04 -46.69 13.84 Favored Pre-proline 0 C--N 1.332 -0.194 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.251 -178.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.542 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 15.7 Cg_exo -65.69 -39.55 20.39 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.049 1.833 . . . . 0.0 112.338 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.56 -36.26 83.2 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.404 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.631 HG13 HG23 ' A' ' 102' ' ' THR . 20.4 pt -89.83 -32.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.266 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.631 HG23 HG13 ' A' ' 101' ' ' ILE . 81.9 p -99.5 17.65 19.83 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.098 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -54.31 -46.45 72.81 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.494 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.66 -42.12 98.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.479 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.7 t -127.33 87.39 56.44 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.42 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -49.02 -27.98 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.312 2.008 . . . . 0.0 112.116 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -103.5 117.87 35.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.238 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 108' ' ' THR . 3.2 m -170.88 101.77 0.41 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.857 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -49.41 148.17 11.3 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.028 1.819 . . . . 0.0 112.008 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 151' ' ' ALA . 21.0 p90 -148.31 162.93 38.53 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.618 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.3 mp -91.14 129.58 37.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.806 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 33.4 tp -95.08 121.83 37.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.304 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.661 HG11 HD11 ' A' ' 19' ' ' LEU . 40.1 t -135.8 168.51 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.91 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.631 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -155.16 97.86 0.17 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.307 -0.949 . . . . 0.0 111.261 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 82' ' ' PHE . 2.6 p -51.47 177.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.92 0.39 . . . . 0.0 110.4 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.507 ' O ' ' C ' ' A' ' 117' ' ' ILE . 43.7 tp60 47.37 29.96 1.43 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.007 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.774 ' CD1' HD23 ' A' ' 160' ' ' LEU . 13.0 tt 27.43 -142.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.179 0 C-N-CA 122.404 0.282 . . . . 0.0 110.367 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.744 ' N ' HG23 ' A' ' 117' ' ' ILE . 86.3 m-20 -88.24 3.32 49.91 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.882 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.617 ' H ' HG23 ' A' ' 117' ' ' ILE . 16.8 tp 137.34 90.94 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.344 0 O-C-N 124.572 1.17 . . . . 0.0 109.515 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.533 ' C ' ' O ' ' A' ' 119' ' ' LEU . 27.8 ttm180 15.44 58.88 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.986 0.804 . . . . 0.0 111.161 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.575 ' O ' ' CB ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER 165.12 -91.58 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.713 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.575 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 11.8 t0 105.68 -45.31 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.435 0 O-C-N 124.124 0.89 . . . . 0.0 111.219 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 71.3 Cg_endo -90.78 -34.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.792 0 C-N-CA 121.227 1.284 . . . . 0.0 110.432 178.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 46.6 p -98.35 1.47 47.03 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.051 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.578 ' OG1' HD23 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -102.06 -27.02 13.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.094 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 62.3 mt -71.77 -42.47 70.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.697 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -75.84 -32.61 59.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.529 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -74.36 -42.5 59.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.011 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.598 ' O ' ' N ' ' A' ' 131' ' ' LYS . 13.3 mt -50.32 -53.55 27.91 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.479 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 43.24 13.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.665 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 129' ' ' LEU . 68.5 mmtt -56.87 -72.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.494 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 131' ' ' LYS . 45.0 t30 94.48 -39.33 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -177.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.574 ' O ' ' O ' ' A' ' 134' ' ' GLN . 28.1 mttt -99.51 -15.23 18.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.427 176.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.574 ' O ' ' O ' ' A' ' 133' ' ' LYS . 98.3 mt-30 34.32 -170.42 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.8 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.789 ' H ' ' CD ' ' A' ' 136' ' ' PRO . 0.3 OUTLIER -145.05 -44.19 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.635 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.789 ' CD ' ' H ' ' A' ' 135' ' ' LYS . 1.8 Cg_endo -80.81 -157.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.108 2.539 . . . . 0.0 111.998 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.533 HG21 ' HB2' ' A' ' 90' ' ' PHE . 4.9 tt -114.14 112.78 41.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.249 0.547 . . . . 0.0 111.044 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.628 ' H ' ' HD2' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -135.37 -66.06 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.256 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.654 ' C ' ' H ' ' A' ' 141' ' ' THR . 48.7 Cg_exo -19.42 151.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 124.1 3.2 . . . . 0.0 114.329 -178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -48.05 -2.76 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.508 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.654 ' H ' ' C ' ' A' ' 139' ' ' PRO . 58.6 p -82.14 -8.37 59.65 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.92 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.63 -48.56 59.52 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 120.134 -0.626 . . . . 0.0 110.161 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.76 -31.11 72.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.691 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -57.71 -41.53 81.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.106 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 81.0 mt -49.07 -35.15 15.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.944 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.13 -37.87 69.35 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -63.81 -38.2 90.2 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.753 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -49.25 -35.27 17.2 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.0 mt -122.38 -113.35 0.31 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.003 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.583 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 43.1 tttp -132.4 -117.46 0.21 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.913 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.587 ' HB2' ' CE1' ' A' ' 110' ' ' PHE . . . 109.47 -162.96 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.133 0.895 . . . . 0.0 109.24 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 110' ' ' PHE . 50.7 t -149.26 -63.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.462 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.42 ' HZ2' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -86.89 -173.93 4.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.61 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 31.0 p90 -170.8 95.94 0.21 Allowed 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.743 HG13 ' N ' ' A' ' 156' ' ' GLU . 0.4 OUTLIER -172.63 -169.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.167 -178.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.743 ' N ' HG13 ' A' ' 155' ' ' VAL . 77.1 mt-10 -153.14 114.81 4.26 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.755 -1.111 . . . . 0.0 108.309 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.725 ' SG ' HD12 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -121.29 138.11 54.39 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-O 122.474 1.13 . . . . 0.0 112.595 -177.346 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.473 ' C ' ' N ' ' A' ' 160' ' ' LEU . 37.7 t -145.57 93.96 2.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.005 -1.907 . . . . 0.0 106.659 176.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.456 ' HB1' ' H ' ' A' ' 28' ' ' LEU . . . 39.61 30.54 0.06 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.986 -178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.867 ' O ' ' N ' ' A' ' 162' ' ' GLN . 58.2 tp -145.52 -86.61 0.11 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.281 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.563 ' C ' ' H ' ' A' ' 163' ' ' LYS . 1.5 m -44.7 41.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -176.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.867 ' N ' ' O ' ' A' ' 160' ' ' LEU . 13.1 pt20 -69.4 -0.79 6.92 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 161' ' ' THR . 63.9 mttp -56.84 -28.64 61.9 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 113.815 -1.539 . . . . 0.0 107.663 178.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.627 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -114.84 -65.21 0.41 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.726 HD12 ' CB ' ' A' ' 22' ' ' SER . 0.5 OUTLIER -42.52 -6.92 0.01 OUTLIER 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.627 ' N ' ' O ' ' A' ' 164' ' ' GLY . 38.2 tttt -92.85 -44.47 8.46 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 164' ' ' GLY . 33.3 m120 -81.73 -1.72 48.06 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.013 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.427 HG21 HD22 ' A' ' 165' ' ' LEU . 22.0 t -71.95 -52.28 25.97 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.449 ' CZ ' HD11 ' A' ' 55' ' ' LEU . 38.9 m-85 -55.79 -40.73 73.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.335 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.469 ' OD1' HG21 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -69.01 -47.8 64.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.497 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -74.56 -25.98 59.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.942 0.401 . . . . 0.0 111.215 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.901 ' CB ' HD22 ' A' ' 53' ' ' LEU . . . -52.03 -46.43 65.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.0 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.434 HG21 ' HB2' ' A' ' 51' ' ' TYR . 10.9 pt -66.2 -36.47 77.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.4 tp -61.37 -35.27 77.0 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.67 -26.51 68.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.176 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -58.79 -30.68 67.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.871 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.438 ' HA ' HE22 ' A' ' 2' ' ' GLN . 31.0 tp -53.32 -37.51 62.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.483 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 99.989999999999995 110.665 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.481 ' O ' ' HB1' ' A' ' 176' ' ' ALA . 86.3 mtp . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -85.71 -75.28 0.38 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.532 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.451 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.5 OUTLIER -73.4 134.81 44.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.971 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 4' ' ' ILE . 10.5 tp -126.45 152.22 33.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.609 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 75' ' ' THR . 25.0 mttm -104.15 149.02 25.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.201 0.524 . . . . 0.0 111.342 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 128.09 46.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.835 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.72 HG23 HG21 ' A' ' 75' ' ' THR . 84.9 t -98.92 139.45 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.456 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.48 HG21 ' CA ' ' A' ' 57' ' ' ASP . 86.8 t -95.66 136.59 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.031 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.571 HG11 ' CG1' ' A' ' 101' ' ' ILE . 22.8 t -119.79 137.58 53.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.766 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.573 ' O ' ' N ' ' A' ' 12' ' ' GLY . . . 81.85 -81.33 1.68 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 52.9 t0 63.8 -52.62 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.705 0.288 . . . . 0.0 110.614 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.694 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 93.19 -9.42 74.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.694 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 90.88 -4.54 0.26 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.766 0.317 . . . . 0.0 110.698 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.5 m -129.4 146.04 34.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.813 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.615 ' O ' ' N ' ' A' ' 17' ' ' THR . . . 122.04 -53.56 0.72 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.436 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HD3' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -41.87 -10.46 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.615 ' N ' ' O ' ' A' ' 15' ' ' GLY . 58.3 p -61.99 -43.65 98.39 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.412 ' HB3' ' H ' ' A' ' 159' ' ' ALA . 20.8 m -127.11 0.53 6.49 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.382 -178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.011 HD13 ' SG ' ' A' ' 157' ' ' CYS . 0.3 OUTLIER -93.43 -52.11 4.66 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.472 -0.491 . . . . 0.0 110.138 178.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 20' ' ' LEU . 47.2 tp -52.08 -37.33 53.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.046 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 21' ' ' ILE . 6.9 tt -92.03 3.91 7.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.94 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.6 p -38.61 -80.82 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -72.14 -29.25 63.86 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-N 119.603 1.092 . . . . 0.0 111.215 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.7 m -41.96 -47.38 4.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.924 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.551 HG21 HD13 ' A' ' 28' ' ' LEU . 85.9 m -119.58 -8.91 9.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.881 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.554 ' OD1' ' NE2' ' A' ' 162' ' ' GLN . 40.9 t-20 55.68 94.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.303 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.6 mttt 59.84 86.71 0.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.375 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.551 HD13 HG21 ' A' ' 25' ' ' THR . 30.8 tp -127.94 68.86 76.27 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.996 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -70.38 128.94 16.14 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.287 1.992 . . . . 0.0 111.935 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -149.93 144.8 26.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.711 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.13 -34.07 76.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.464 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -117.49 140.41 49.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.391 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG11 ' HB ' ' A' ' 17' ' ' THR . 48.3 t -124.69 79.51 62.94 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.918 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -54.1 141.99 67.43 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.601 2.201 . . . . 0.0 111.674 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 36' ' ' VAL . 69.6 p -69.3 -23.92 63.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.295 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 37' ' ' PHE . 9.7 t 37.69 -124.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 0.0 110.413 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.563 ' N ' HG12 ' A' ' 36' ' ' VAL . 95.7 m-85 -113.61 147.42 38.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.341 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.438 ' C ' HD22 ' A' ' 39' ' ' ASN . 90.5 m-20 -68.36 135.65 52.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.935 0.398 . . . . 0.0 110.4 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.438 HD22 ' C ' ' A' ' 38' ' ' ASP . 2.9 m120 -105.58 138.35 41.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.972 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.583 ' HA ' ' H ' ' A' ' 55' ' ' LEU . 13.0 p90 -175.51 4.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.095 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.38 99.63 2.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.609 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.4 p -145.89 138.11 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.631 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.8 t -100.37 115.17 29.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.414 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -136.47 145.05 31.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.008 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 72.2 mtm -102.3 128.18 48.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.778 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 170' ' ' ASP . 12.8 tt -124.18 125.53 70.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.469 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 56.14 24.71 44.82 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.9 56.55 5.3 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -141.76 91.29 8.32 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.479 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 30.5 Cg_exo -58.63 103.59 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.57 2.18 . . . . 0.0 112.683 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' CD2' HD13 ' A' ' 173' ' ' ILE . 89.2 m-85 -159.86 161.19 34.39 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.451 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.7 p -132.31 143.67 50.04 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.885 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.8 HD13 ' HB1' ' A' ' 172' ' ' ALA . 59.2 tp -120.55 139.12 53.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -110.65 123.61 6.67 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.629 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.583 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 62.0 mt -109.36 131.58 54.93 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.626 0.25 . . . . 0.0 110.478 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.602 ' CD2' ' O ' ' A' ' 56' ' ' PHE . 41.2 t80 -113.67 31.11 6.73 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.556 ' CG ' ' H ' ' A' ' 58' ' ' THR . 33.0 t0 -54.06 -154.5 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.183 0.447 . . . . 0.0 110.937 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.556 ' H ' ' CG ' ' A' ' 57' ' ' ASP . 11.3 m 65.56 -70.53 0.09 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.653 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' ASP . . . -67.45 146.57 53.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.523 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . 151.18 38.55 0.03 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.396 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -116.46 -178.68 3.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 63' ' ' ASP . 83.9 tt0 -110.42 128.29 55.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 21.2 t0 92.61 -4.85 0.16 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.455 ' C ' ' O ' ' A' ' 63' ' ' ASP . 51.3 m-85 30.95 96.47 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.136 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.8 -35.38 74.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.952 0.406 . . . . 0.0 110.327 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 37.3 mtm105 -56.63 147.05 23.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.707 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.3 mt -89.79 139.16 30.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.297 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 69' ' ' PRO . 4.6 mmm180 51.66 65.53 6.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.274 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 35.3 Cg_exo -55.43 143.05 79.04 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.835 2.357 . . . . 0.0 112.638 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.1 mt -101.52 139.77 36.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.962 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 94.3 p -121.11 150.45 41.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 110.795 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -131.97 68.76 80.63 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.772 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -56.38 -19.84 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.94 1.76 . . . . 0.0 112.257 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -79.94 71.93 6.66 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.899 0.38 . . . . 0.0 110.207 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 5' ' ' LYS . 26.2 m -146.65 131.68 18.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.118 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.8 ' OD1' HG23 ' A' ' 77' ' ' VAL . 46.4 p30 -115.07 6.56 15.22 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.506 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.8 HG23 ' OD1' ' A' ' 76' ' ' ASP . 40.6 t -121.47 110.5 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.964 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -87.26 120.42 28.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.02 0.438 . . . . 0.0 110.468 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tt -119.39 127.55 53.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.315 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.7 t -107.86 128.44 63.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.474 ' SG ' ' CG2' ' A' ' 115' ' ' THR . 0.0 OUTLIER -134.34 147.72 50.61 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.356 -179.296 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.49 ' CG ' HG21 ' A' ' 93' ' ' VAL . 24.9 p90 -170.63 146.55 2.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.205 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.672 ' OG ' HG12 ' A' ' 85' ' ' VAL . 30.4 t -62.86 127.25 30.36 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.618 HG21 ' CD ' ' A' ' 156' ' ' GLU . 3.9 t -76.31 30.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.672 HG12 ' OG ' ' A' ' 83' ' ' SER . 14.9 p -130.04 141.62 45.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.697 -0.401 . . . . 0.0 109.974 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 0.7 OUTLIER 83.99 142.16 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.492 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.08 -3.3 13.4 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.529 2.152 . . . . 0.0 112.563 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.9 m -91.64 -38.61 12.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.7 p -60.91 -34.04 74.07 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.58 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -82.78 -41.84 18.65 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.998 -179.578 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 83.8 tt0 -60.26 -30.32 69.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.623 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 86.7 m-20 -66.24 -43.36 86.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -92.24 -70.5 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 -177.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.708 ' O ' HD21 ' A' ' 149' ' ' LEU . 24.7 mttt -52.78 -16.19 0.93 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' CD ' ' A' ' 99' ' ' PRO . 95.6 mt-10 -130.31 -52.88 1.1 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -73.63 -47.43 40.15 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.623 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 63.9 m95 -81.74 -30.19 32.57 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.134 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 93' ' ' VAL . 2.5 t -44.78 -56.48 8.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.835 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.52 ' CD ' ' O ' ' A' ' 95' ' ' GLU . 12.0 Cg_endo -57.39 -37.21 98.21 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.428 1.419 . . . . 0.0 110.915 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.44 -40.92 98.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.78 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.571 ' CG1' HG11 ' A' ' 9' ' ' VAL . 86.8 mt -68.21 -39.7 81.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.306 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 105' ' ' CYS . 47.8 m -54.81 -44.36 73.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.561 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -66.2 -41.11 90.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.973 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -58.03 -46.45 85.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.547 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.457 ' SG ' ' N ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -141.79 162.77 44.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 111.072 -179.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.457 ' N ' ' SG ' ' A' ' 105' ' ' CYS . 59.1 Cg_endo -73.61 -155.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.997 2.464 . . . . 0.0 111.783 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.0 mttm -81.36 120.95 25.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.827 0.346 . . . . 0.0 110.451 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.606 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -153.45 156.81 32.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.065 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.73 132.0 44.23 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.151 1.9 . . . . 0.0 111.483 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.747 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -133.55 132.11 40.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 -179.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.636 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.9 mp -86.34 128.49 34.94 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.935 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.885 HD22 ' HB2' ' A' ' 146' ' ' ALA . 34.9 tp -92.7 130.66 38.25 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.59 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 21.8 t -142.26 160.06 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.911 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.532 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -136.09 165.66 24.85 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.474 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 1.0 OUTLIER -129.9 172.46 11.66 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.44 179.073 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.725 ' O ' ' N ' ' A' ' 118' ' ' ASP . 20.0 mt-30 50.15 24.2 1.37 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.472 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.594 ' O ' ' CB ' ' A' ' 118' ' ' ASP . 0.4 OUTLIER 21.36 32.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.725 ' N ' ' O ' ' A' ' 116' ' ' GLN . 15.7 t0 93.95 48.51 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.673 -0.642 . . . . 0.0 110.143 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.611 ' O ' ' N ' ' A' ' 121' ' ' ASP . 0.5 OUTLIER 77.43 87.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.942 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' A' ' 119' ' ' LEU . 43.4 ptt85 7.72 56.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 O-C-N 124.321 1.013 . . . . 0.0 112.272 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' A' ' 119' ' ' LEU . 0.5 OUTLIER 173.97 -91.53 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.834 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 121' ' ' ASP . 8.7 t0 104.22 -46.41 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 123.999 0.812 . . . . 0.0 110.876 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 52.5 Cg_endo -92.32 -41.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 121.727 1.618 . . . . 0.0 109.955 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.448 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 75.8 m -89.78 -1.0 57.89 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.5 ' HB ' ' H ' ' A' ' 122' ' ' ASP . 1.1 m -85.32 -35.23 21.57 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.29 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 mm -67.04 -42.12 88.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.473 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -72.49 -33.0 66.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.856 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -72.0 -45.41 61.04 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.867 0.365 . . . . 0.0 111.04 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 129' ' ' LEU . 81.1 mt -60.45 -40.15 90.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.881 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.68 24.33 8.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.885 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.42 ' C ' ' N ' ' A' ' 133' ' ' LYS . 33.6 mttm -127.44 77.22 1.73 Allowed 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.015 0.436 . . . . 0.0 110.906 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -49.66 -28.08 5.47 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.42 ' N ' ' C ' ' A' ' 131' ' ' LYS . 22.1 mttt -61.45 -17.99 56.91 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.203 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.8 mm-40 -60.76 157.18 15.39 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.033 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -120.49 75.42 25.11 Favored Pre-proline 0 C--N 1.33 -0.244 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.139 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.87 156.34 39.13 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.665 2.243 . . . . 0.0 111.873 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.546 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 3.2 tt -125.12 92.84 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.973 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.524 ' CB ' ' CD ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -133.38 -69.23 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 138' ' ' THR . 1.5 Cg_endo -38.61 -84.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 123.413 2.742 . . . . 0.0 113.939 -176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 144' ' ' LYS . 96.9 mt-10 -110.55 -36.12 5.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.387 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.435 ' O ' HD13 ' A' ' 145' ' ' LEU . 8.4 p -44.87 -43.14 8.6 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.522 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.5 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . . . -70.78 -58.18 3.89 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.57 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.6 -35.53 73.04 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 140' ' ' GLU . 19.4 tttm -58.24 -43.91 88.0 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 149' ' ' LEU . 7.5 mp -66.85 -29.3 69.18 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.368 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.885 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -70.89 -30.94 67.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.707 0.289 . . . . 0.0 111.488 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.438 HH21 ' HG3' ' A' ' 144' ' ' LYS . 60.1 mtm180 -59.62 -36.55 76.55 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -119.56 -34.88 3.68 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.708 HD21 ' O ' ' A' ' 94' ' ' LYS . 13.1 tp -67.02 -3.27 6.79 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.575 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.729 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 67.4 mttm 98.95 150.2 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.495 0.718 . . . . 0.0 109.685 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.729 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 157.08 -172.22 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.755 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.686 HG23 ' H ' ' A' ' 110' ' ' PHE . 28.7 t -144.68 -53.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.605 ' NZ ' ' OE1' ' A' ' 171' ' ' GLU . 15.6 mmtt -95.53 -177.21 4.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.131 178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -168.12 93.82 0.37 Allowed 'General case' 0 CA--C 1.503 -0.856 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 178.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.704 HG22 ' H ' ' A' ' 156' ' ' GLU . 0.8 OUTLIER -172.6 -167.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.383 -178.24 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.704 ' H ' HG22 ' A' ' 155' ' ' VAL . 41.9 mt-10 -139.34 -165.43 1.86 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.158 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 1.011 ' SG ' HD13 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -174.95 120.0 0.2 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.139 0.971 . . . . 0.0 111.717 178.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.612 ' O ' ' N ' ' A' ' 160' ' ' LEU . 42.6 t -165.99 91.08 0.46 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 177.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 158' ' ' SER . . . 33.67 30.1 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.092 -1.867 . . . . 0.0 109.085 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.614 ' C ' ' H ' ' A' ' 162' ' ' GLN . 16.0 tp -157.65 -74.73 0.09 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.48 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.721 ' C ' ' H ' ' A' ' 163' ' ' LYS . 7.4 m -64.54 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.126 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.614 ' H ' ' C ' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -80.3 23.28 0.49 Allowed 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 175.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.721 ' H ' ' C ' ' A' ' 161' ' ' THR . 16.2 tttp -74.6 -4.38 36.8 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 112.665 -2.061 . . . . 0.0 108.297 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.715 ' O ' ' N ' ' A' ' 167' ' ' ASN . . . -120.71 -54.77 0.24 Allowed Glycine 0 C--O 1.221 -0.661 0 N-CA-C 107.643 -2.183 . . . . 0.0 107.643 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.565 ' CD2' ' H ' ' A' ' 165' ' ' LEU . 4.0 mm? -34.16 -23.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.654 0.264 . . . . 0.0 110.845 -179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.67 ' N ' ' O ' ' A' ' 164' ' ' GLY . 28.2 tttp -77.95 -46.99 19.62 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.715 ' N ' ' O ' ' A' ' 164' ' ' GLY . 30.8 m120 -79.65 10.68 3.74 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.051 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 171' ' ' GLU . 53.2 t -96.44 -63.25 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.048 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 168' ' ' VAL . 13.1 m-85 -38.9 -43.1 0.92 Allowed 'General case' 0 C--N 1.34 0.188 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.784 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 171' ' ' GLU . 54.1 p-10 -68.88 -38.08 79.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.547 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.63 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 34.8 tt0 -68.67 -24.85 64.56 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.028 0.442 . . . . 0.0 110.144 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.8 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -61.83 -32.38 72.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.26 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.491 HD13 ' CD2' ' A' ' 51' ' ' TYR . 61.9 mt -59.98 -39.17 79.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.651 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.9 -36.11 83.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.668 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.01 -34.36 77.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.621 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 1' ' ' MET . . . -59.82 -28.19 67.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.252 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.92 -35.88 71.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 99.989999999999995 110.503 179.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -85.82 -63.52 1.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.436 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.509 ' HB ' ' H ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -79.79 138.62 37.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.119 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.759 ' O ' HD12 ' A' ' 53' ' ' LEU . 11.2 tp -129.35 141.5 46.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.388 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -91.77 144.52 25.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.845 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.9 t -124.22 135.45 53.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.439 ' HB ' HG21 ' A' ' 75' ' ' THR . 6.2 p -110.51 154.02 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.97 0.414 . . . . 0.0 111.898 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.566 HG23 ' HB2' ' A' ' 81' ' ' CYS . 7.2 p -96.77 132.63 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.084 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.678 HG11 HD13 ' A' ' 101' ' ' ILE . 43.1 t -133.94 130.55 55.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.04 -163.89 37.58 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.778 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 13' ' ' ALA . 60.7 t0 -87.42 117.84 26.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.057 0.456 . . . . 0.0 111.263 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 32.11 33.67 0.01 OUTLIER Glycine 0 CA--C 1.532 1.124 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.149 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.541 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . 17.05 108.28 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.558 ' O ' ' N ' ' A' ' 16' ' ' LYS . 1.4 t -75.36 -138.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.74 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.414 ' H ' HG12 ' A' ' 14' ' ' VAL . . . -59.09 57.73 0.01 OUTLIER Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.476 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.763 ' NZ ' ' H ' ' A' ' 59' ' ' ALA . 1.1 pttt -64.66 -25.44 67.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 120.604 0.24 . . . . 0.0 111.372 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.658 HG21 ' CG1' ' A' ' 33' ' ' VAL . 38.0 m -66.38 -67.55 0.44 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.352 -178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' ILE . 92.3 m -55.6 -28.78 57.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.544 0.688 . . . . 0.0 109.837 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 165' ' ' LEU . 24.1 tp -60.71 -39.08 87.24 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.294 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.742 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -78.13 -30.36 49.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.101 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 18' ' ' CYS . 1.6 tt -58.49 -9.21 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.876 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.55 ' O ' ' N ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -48.24 -78.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.81 -178.441 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -57.05 -38.27 72.99 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.675 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.75 -65.0 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.873 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.6 p -122.08 -18.98 6.75 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.399 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 22' ' ' SER . 69.2 m-80 60.94 42.99 12.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.819 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 179.0 152.27 0.35 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.629 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -40.45 148.48 0.35 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.139 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.15 144.86 99.24 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.41 2.074 . . . . 0.0 111.96 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 32' ' ' TYR . 48.2 t -69.4 67.18 0.2 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.412 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 62.02 -17.09 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.523 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.609 ' H ' ' C ' ' A' ' 30' ' ' SER . 86.6 m-85 -120.97 145.8 47.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.925 0.393 . . . . 0.0 110.848 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.658 ' CG1' HG21 ' A' ' 17' ' ' THR . 22.1 t -123.31 66.35 32.96 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.047 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.77 156.62 65.25 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.621 2.214 . . . . 0.0 112.667 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 35.1 p -116.74 170.37 8.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.378 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.89 157.86 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.891 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -58.05 -37.0 73.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.056 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -72.09 123.57 23.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.877 0.37 . . . . 0.0 110.835 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 31.6 m120 -59.88 -36.96 78.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.738 ' CB ' ' H ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -158.08 -22.32 0.08 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.544 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -52.63 98.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.177 0.513 . . . . 0.0 111.13 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.563 HG21 HD11 ' A' ' 55' ' ' LEU . 64.5 t -131.14 132.33 63.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.035 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 43' ' ' THR . 12.9 t -112.62 123.6 50.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.105 0.479 . . . . 0.0 111.107 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.9 m -134.32 154.72 38.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.953 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.585 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.3 pmm? -126.52 125.93 42.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.228 0.537 . . . . 0.0 110.491 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.3 mt -126.42 112.2 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 4.48 85.87 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.93 5.49 59.7 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -83.06 115.07 56.95 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.93 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -81.29 109.26 2.09 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.127 1.885 . . . . 0.0 112.682 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -151.77 171.13 18.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.509 ' H ' ' HB ' ' A' ' 3' ' ' THR . 1.1 p -143.67 126.74 16.45 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.945 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.759 HD12 ' O ' ' A' ' 4' ' ' ILE . 48.3 tp -109.98 130.34 55.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.169 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.62 147.13 41.49 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.738 ' H ' ' CB ' ' A' ' 40' ' ' TYR . 49.2 mt -83.08 98.83 9.51 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.161 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.518 ' O ' ' CG1' ' A' ' 8' ' ' VAL . 11.0 p90 -57.04 -40.94 77.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.593 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.454 ' O ' ' CB ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -43.02 165.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.187 -179.407 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.584 ' H ' ' CG ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 77.19 95.98 0.06 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.868 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.763 ' H ' ' NZ ' ' A' ' 16' ' ' LYS . . . -176.83 -124.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.338 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.11 37.72 24.33 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 64' ' ' TYR . 94.9 mt-30 -136.75 98.92 3.9 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 121.048 0.452 . . . . 0.0 110.115 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 61' ' ' GLN . 97.8 mt-10 -40.96 -35.68 0.56 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -98.28 50.97 1.01 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.151 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.588 ' N ' ' O ' ' A' ' 61' ' ' GLN . 61.6 m-85 -43.58 -43.73 5.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.873 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 65' ' ' ASP . 51.4 p30 -159.09 -176.16 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.568 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -120.37 150.35 40.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.573 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.5 mt 56.28 78.67 0.2 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.859 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -88.41 153.06 50.63 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.242 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -64.9 123.02 11.02 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.324 2.016 . . . . 0.0 112.13 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.19 -36.71 83.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.554 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -125.43 151.61 45.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 58.26 70.47 1.23 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.827 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -51.11 152.48 10.61 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.905 2.404 . . . . 0.0 112.06 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -53.49 -38.37 63.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.817 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.439 HG21 ' HB ' ' A' ' 7' ' ' VAL . 40.8 p -123.42 154.28 39.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.71 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -115.93 0.08 12.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.078 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.534 ' CG1' HD13 ' A' ' 111' ' ' LEU . 21.8 t -115.42 101.52 12.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.612 ' CZ ' ' SG ' ' A' ' 105' ' ' CYS . 87.9 m-85 -73.84 118.96 17.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.185 0.517 . . . . 0.0 111.13 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.518 HD11 HG21 ' A' ' 113' ' ' VAL . 8.0 tt -116.68 128.19 55.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.766 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.579 ' CG1' ' CG1' ' A' ' 93' ' ' VAL . 40.6 t -94.03 130.95 42.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.952 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.566 ' HB2' HG23 ' A' ' 8' ' ' VAL . 42.8 t -123.61 127.42 48.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.023 0.44 . . . . 0.0 111.152 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.737 ' HB3' HG21 ' A' ' 93' ' ' VAL . 33.9 p90 -171.23 139.24 1.32 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.091 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 33.4 t -62.37 132.69 53.44 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 156' ' ' GLU . 2.9 t -74.53 15.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.612 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.712 HG11 ' HE ' ' A' ' 120' ' ' ARG . 19.4 t -138.86 26.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.272 0.558 . . . . 0.0 109.894 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.424 ' C ' HD11 ' A' ' 137' ' ' ILE . 8.0 t -121.31 86.82 43.95 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.06 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -49.56 -29.3 18.58 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.403 2.068 . . . . 0.0 112.352 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.1 m -70.45 -41.46 72.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.989 0.424 . . . . 0.0 110.484 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.869 ' O ' HG23 ' A' ' 93' ' ' VAL . 49.5 m -73.97 -53.45 10.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.765 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.493 ' CB ' HD13 ' A' ' 137' ' ' ILE . 87.2 t80 -54.38 -46.2 72.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.449 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -66.19 -28.15 68.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.531 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.582 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 24.2 m120 -102.64 -3.4 26.69 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.126 -0.629 . . . . 0.0 111.076 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 89' ' ' SER . 38.5 t -89.53 -71.6 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.831 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' HZ1' ' N ' ' A' ' 146' ' ' ALA . 46.9 mtpt -70.69 -20.21 62.7 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -112.64 -10.59 13.64 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -129.61 -29.04 2.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.452 -0.899 . . . . 0.0 113.03 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.582 ' CD1' ' O ' ' A' ' 92' ' ' ASN . 53.8 m95 -98.26 -31.38 12.09 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.827 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.552 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -67.85 -44.27 40.74 Favored Pre-proline 0 CA--C 1.53 0.188 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.751 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 17.0 Cg_exo -63.51 -36.67 52.85 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.315 2.01 . . . . 0.0 111.757 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.31 -41.41 96.95 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.962 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.678 HD13 HG11 ' A' ' 9' ' ' VAL . 39.1 pt -83.19 -34.28 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.04 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.8 m -61.25 -40.7 95.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.486 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -58.67 -43.86 90.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.435 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -82.3 -15.02 54.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.101 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.612 ' SG ' ' CZ ' ' A' ' 78' ' ' PHE . 1.7 t -114.66 108.77 48.74 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.859 -0.337 . . . . 0.0 111.316 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -49.01 163.1 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.947 1.764 . . . . 0.0 111.337 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -48.34 118.28 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.0 0.429 . . . . 0.0 110.75 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.617 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -151.84 156.74 34.44 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.027 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.18 132.41 47.86 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.259 1.973 . . . . 0.0 112.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.745 ' H ' HG23 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -130.9 130.35 43.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.154 0.502 . . . . 0.0 110.504 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 111' ' ' LEU . 7.4 mp -92.73 131.58 37.68 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.914 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.679 HD22 ' HB2' ' A' ' 146' ' ' ALA . 36.0 tp -93.35 123.53 36.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.622 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.518 HG21 HD11 ' A' ' 79' ' ' LEU . 42.1 t -143.3 152.17 16.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.299 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.499 ' HA2' ' H ' ' A' ' 82' ' ' PHE . . . -141.15 -179.06 18.08 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 p -124.74 174.23 8.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.23 0.538 . . . . 0.0 110.848 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 117' ' ' ILE . 52.4 mt-30 48.5 28.97 1.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.904 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.955 HG23 ' H ' ' A' ' 119' ' ' LEU . 3.8 tt 31.23 -154.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.78 ' N ' HG23 ' A' ' 117' ' ' ILE . 27.4 p-10 -109.66 9.07 25.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.312 0.577 . . . . 0.0 110.254 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.955 ' H ' HG23 ' A' ' 117' ' ' ILE . 77.1 mt -123.15 4.32 9.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.78 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.712 ' HE ' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER 30.99 66.48 0.14 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.336 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.523 ' C ' ' O ' ' A' ' 120' ' ' ARG . 89.7 m-20 31.09 45.96 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.388 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.799 ' CG ' HD13 ' A' ' 126' ' ' ILE . 0.6 OUTLIER -31.73 -62.56 0.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.957 -179.13 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.489 ' C ' ' O ' ' A' ' 122' ' ' ASP . 82.6 Cg_exo -31.57 -34.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.113 1.875 . . . . 0.0 111.1 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 122' ' ' ASP . 2.5 p -107.91 -53.24 2.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.11 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.606 ' O ' ' N ' ' A' ' 129' ' ' LEU . 12.0 m -59.58 -45.91 90.5 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.996 -0.681 . . . . 0.0 109.665 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.799 HD13 ' CG ' ' A' ' 122' ' ' ASP . 1.0 OUTLIER -63.72 -48.67 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.679 179.094 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' N ' HG22 ' A' ' 126' ' ' ILE . 85.4 tt0 -44.42 -40.53 5.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 120.334 -0.547 . . . . 0.0 110.58 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -110.52 -49.2 3.07 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.665 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 18.3 tp -55.5 -45.2 77.07 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -176.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 129' ' ' LEU . . . 97.66 125.57 0.01 OUTLIER 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -52.78 -44.38 66.5 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.393 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -62.27 -27.66 69.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.725 -178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.1 mttt -88.2 -3.29 58.89 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.621 ' NE2' HD11 ' A' ' 126' ' ' ILE . 42.3 mt-30 -65.82 -41.48 91.8 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.52 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt 59.19 61.23 4.58 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.499 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.697 ' HA ' HG13 ' A' ' 85' ' ' VAL . 11.9 Cg_endo -59.81 146.19 96.28 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.75 2.3 . . . . 0.0 112.315 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.872 HG22 ' N ' ' A' ' 138' ' ' THR . 94.6 mt -88.99 -119.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.216 0.531 . . . . 0.0 110.93 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.872 ' N ' HG22 ' A' ' 137' ' ' ILE . 49.8 p -133.33 37.75 0.39 Allowed Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.612 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 138' ' ' THR . 87.8 Cg_exo -23.63 -39.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.384 2.723 . . . . 0.0 112.663 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 138' ' ' THR . 97.3 mt-10 -66.02 -47.68 73.64 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.138 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.639 ' O ' ' N ' ' A' ' 143' ' ' GLU . 84.4 m -54.37 -71.56 0.08 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.601 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 141' ' ' THR . . . -28.06 -31.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 141' ' ' THR . 78.6 mm-40 -60.62 -39.91 89.94 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.834 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 141' ' ' THR . 20.8 tttt -98.04 -19.3 18.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.786 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.64 ' O ' HD13 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -64.12 -32.35 73.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.099 179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.716 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -80.24 -39.83 28.23 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.922 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.04 -36.73 77.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.476 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 59.3 t0 -98.36 -16.44 19.31 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 3.8 tp -117.46 34.4 5.15 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.292 -0.563 . . . . 0.0 112.051 -179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.694 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 23.2 mttm 80.85 149.41 0.09 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.282 0.563 . . . . 0.0 110.895 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.716 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . 156.34 -177.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.762 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.745 HG23 ' H ' ' A' ' 110' ' ' PHE . 24.4 t -141.63 -52.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.846 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.475 ' HZ1' ' CG ' ' A' ' 167' ' ' ASN . 5.6 tttm -119.77 -172.54 2.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.553 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.616 ' CG ' ' O ' ' A' ' 154' ' ' TYR . 29.9 p90 -154.28 96.77 1.96 Allowed 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 165' ' ' LEU . 7.8 p -140.81 138.48 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-O 122.118 0.961 . . . . 0.0 111.848 -178.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.744 ' O ' ' OG1' ' A' ' 161' ' ' THR . 88.7 mt-10 -123.62 98.33 5.78 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.518 ' SG ' HD22 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -114.62 146.11 41.21 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-O 123.188 1.471 . . . . 0.0 113.167 -176.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.514 ' N ' ' SG ' ' A' ' 157' ' ' CYS . 15.2 t -169.9 93.23 0.24 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 111.629 -2.532 . . . . 0.0 107.201 176.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 42.92 28.09 0.12 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.976 -1.466 . . . . 0.0 110.215 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 162' ' ' GLN . 21.4 mt -145.65 -81.57 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.488 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.744 ' OG1' ' O ' ' A' ' 156' ' ' GLU . 0.2 OUTLIER -57.39 52.63 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.164 0.507 . . . . 0.0 111.481 -178.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.706 ' N ' ' O ' ' A' ' 160' ' ' LEU . 5.4 pp0? -82.62 15.52 2.55 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 176.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.585 ' H ' ' C ' ' A' ' 161' ' ' THR . 25.5 mttt -89.47 0.63 56.74 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.752 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.622 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -131.04 -72.76 0.11 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 177.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 19' ' ' LEU . 11.1 mp -40.22 -19.73 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.686 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.622 ' N ' ' O ' ' A' ' 164' ' ' GLY . 28.4 tttt -80.06 -49.78 11.29 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 164' ' ' GLY . 17.6 p-10 -77.9 4.53 11.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.791 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 171' ' ' GLU . 17.6 t -81.25 -58.11 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.243 178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 172' ' ' ALA . 40.0 m-85 -39.31 -39.88 0.7 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.705 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.685 ' O ' HG22 ' A' ' 173' ' ' ILE . 58.2 t0 -65.89 -47.66 74.08 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.057 0.456 . . . . 0.0 110.022 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 168' ' ' VAL . 77.1 mm-40 -67.76 -18.92 65.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.153 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.643 ' HB1' HD13 ' A' ' 53' ' ' LEU . . . -63.35 -38.62 91.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.821 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 170' ' ' ASP . 15.0 tt -62.11 -31.79 52.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.1 tp -63.36 -38.1 89.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.464 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.69 -22.92 66.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.867 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.19 68.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.427 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 38.9 tp -56.61 -36.77 69.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.57 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.318 -0.401 . . . . 99.989999999999995 110.583 -179.763 . . . . . . . . 0 0 . 1 stop_ save_